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The present PhD thesis describes the synthesis and characterization of novel planar-chiral
1,2-P ,O-ferrocenes and their application in the Pd-catalyzed Suzuki-Miyaura reaction. It was
especially focused on the development of a new synthetic pathway to this type of substitution
pattern by applying the anionic phospho-Fries rearrangement in ferrocene chemistry.
Starting from hydroxy ferrocene, a high diversity of Fc–O–P-type (Fc = (η5-C5H5)(η5-C5H4))
compounds were synthesized, whereby the electronic properties of the phosphorus fragments
were varied. The anionic phospho-Fries rearrangement successfully occurred subsequent to
an ortho-lithiation with a non-nucleophilic base giving the 1,2-P ,O-ferrocenes in up to quan-
titative yields. The usage of chiral pool-based alcohols for the synthesis of chiral ferro-
cenyl phosphates allowed a diastereoselective proceeding, giving single isomers in up to 95%
de. Temperature-dependent investigations of mixed ferrocenyl-, phenyl- and N -heterocyclic-
phosphates revealed a limitation of ferrocenyl-based rearrangements per reaction step, con-
trary to phenyls.
1,2-P ,O-ferrocenyl phosphonates could successfully be converted into phosphines by applying
Stelzer P ,C cross-coupling reactions on ferrocenes for the first time. Their usage as ligands
for C,C cross-coupling reactions was confirmed by the synthesis of sterically hindered biaryls
in high yields at 70℃ with a low catalyst loading of 1mol-% Pd.
Functionalization of the 1,2-P ,O-structural motif could be achieved by applying nucleophilic
aromatic substitution reactions (SNAr) as an alternative pathway for the synthesis of fer-
rocenyl aryl ethers. Subsequent to a Fries rearrangement sterically-demanding 1,3-di-ortho-
substituted aryloxy ferrocenes could be obtained. Multi SNAr reactions of hydroxyferrocenes
at polyfluorinated arenes gave up to penta-ferrocenyl-functionalized aryl ethers, whose elec-
trochemical properties were investigated.
The reaction of CH2-enlarged ferrocenylmethanols gave α-ferrocenylcarbenium ions instead of
phosphates, while treating them with chlorophosphates. Enantiopure 2-P(S)Ph2-substituted
derivatives of these ions underwent a subsequent intermolecular “S2−“ migration, resulting
in thioethers, for example (Sp,Sp)-(2-(P(S)Ph2)FcCH2)2S, in a unique mechanism. Instead,
the presence of electronrich arenes gave electrophilic aromatic substituted benzenes bearing
chiral ferrocenylmethyl backbones. These type of ligands gave biaryls with up to 26% ee.
Keywords: Ferrocene, Planar Chirality, Fries Rearrangement, Suzuki-Miyaura Reaction,
Chiral Pool, Phosphate, Phosphonate, Phosphine, Biaryl Coupling, Electro-
chemistry, Single-Crystal X-Ray Diffraction Analysis, Ether Formation
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1 Introduction
The declared purpose of becoming a greenhouse gas neutral nation until 2050 by the German
government requires a reduction of green house gas emission by 80 to 95% with respect to
1990. [1] This means one ton of CO2-equivalents per person in 2050. One decisive factor there-
fore, is the reduction of fossil energy sources like crude oil, coal and natural gas. Chemical
processes, which use these carbon sources as starting materials for bulk and fine chemicals,
need to increase the efficiency for their synthetic procedures. Thus, reaction steps and times,
required energy and by-products have to be reduced, while increasing the yield of the desired
products. Catalytic reactions, and especially C,C coupling reactions, turned out to play a
key-role within this optimization process. Nowadays, already 80% of all chemical products
required at lease one catalytic transformation, generating a turnover of 3 trillion US-Dollar. [2]
Thus, catalysis plays an important role within each persons life for example by using fuels or
by consuming fruits and vegetables, which were grown by using agrochemicals. Furthermore,
drugs (e.g. Ibuprofen as an analgesic), perfumes and flavors are prominent examples for
everyday products derived by catalytic processes. [3]
In general, catalysts or catalytic systems are compounds or systems that increase the speed
of a reaction by lowering the activation barrier for the desired product. Thus, less energy
is required, since the temperature for the reaction can commonly be reduced. They are not
degenerated and can be applied for several runs, enabling the synthesis of huge amounts of
the product, while using low quantities of catalyst. A skillful design of the catalytic systems
also enhances the formation of single products by avoiding the formation of by-products.
Catalysis is part of the “green-chemistry“ approach, due to their waste preventing, atom-
economic and energy efficient proceeding and by reducing protection group strategies to a
minimum.
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O
O N
O
O
∗
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(R)-Thalidomid
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(S)-Thalidomid
teratogen
H HO
OH
NH2
(S)-Valin
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O
HO
NH2
(R)-Valin
bitter
mirror plane
σ
mirror plane
σ
Figure 1.1 (R)-/(S)-Valine (left) with their natural taste and both enantiomers of Thalido-
mide (right) with their physiological effect.
Catalysis also plays an important role for the synthesis of pharmaceuticals and natural prod-
ucts. [4] They are moreover discovered by isolating them from plants or bacteria as stereo-
chemically pure substances. In combination with biological processes in humans, which are
based on chiral genetic material and enzymes, enantiomers can cause different effects for each
isomer. For example, the olfactory perception of the two isomers of carvon differs between
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mint (the (S)-isomer) and caraway (the (R)-isomer). The (–)-isomer of menthol has a three
times more intense smell than the (+)-derivative. [5] The amino acid valine differs in its taste
between sweet for the essential proteinogenic L-form, and bitter in case of the D-from (Fig-
ure 1.1). An unpleasant and sustainable defining example was the usage of Contergan® since
1957. Initially invented as a sedative, it readily showed up to act against morning nausea.
Unfortunately, the usage by pregnant women resulted in disabled children, due to the terato-
genic properties of the (S)-isomer of Thalidomid (Figure 1.1). Further investigations revealed
that this incident would not have been obviated by treatment with the enantiopure (R)-drug,
since both isomers racemize in the blood plasme within minutes. [6] Nevertheless, aggravated
standards, regarding pharmacological and toxicological activity, were established in the USA
and the EU in 1992. Since then, both enantiomers have to be examined separately in clinical
tests. This resulted in an increase of enantiopure drugs. A further advantage of avoiding
the inactive isomer is the lowering of the costs. In 2004, more than 50% of the 10 most-sold
drugs were sold enantiopure. [7]
The production of enantiopure products requires a more efficient synthetic procedure. The
resolution of racemic mixtures might be sufficient for lab scale applications or for their clinical
investigations, whereas in industrial processes a huge amount of waste would be generated.
As a key-step, asymmetric homogeneous catalysis plays the most important role, since only
low amounts of chiral substances are required. The initial chiral information is easily avail-
able from chiral pool based substances. They can be isolated stereopure and are commercially
available. The improvements within the field of catalytic C,C cross-coupling catalysis enables
the formation of complex molecules by using low amounts of a metal source, which lowers the
price. Nevertheless, most of the catalysts are optimized for single processes or substrates and
still degrade too fast. As a goal, the German society of catalysis announced a program for
robust, predictable and efficient catalytic systems and their complete mechanistic compre-
hension. [7] A key-role is the design and development of stable, well-defined ligands, whereas
the costs and effort for their synthesis must not be neglected.
The task of this PhD thesis is the synthesis of planar-chiral 1,2-P ,O-functionalized ferrocenes
by anionic phospho-Fries rearrangements. This reaction has not yet been described for
organometallic systems and thus, requires basic investigation regarding reaction conditions
and substrate scope. The suitability of the respective 1,2-P ,O-phosphines in for catalytic
transformations shall be investigated for the (atropselective) synthesis of hindered biaryls by
Suzuki-Miyaura C,C cross-coupling reactions.
Hereinafter, the principles of C,C coupling reactions are explained, whereas the synthesis of
biaryls is paramount. The special features of ferrocenes as a three-dimensional backbone are
discussed regarding reactivity and chirality. The synthesis of planar-chiral derivatives and
especially the 1,2-P ,O-substitution pattern will be focused, whereby chiral pool substances
shall be used for establishing the planar-chirality. For a better comprehension of the anionic
Fries rearrangement, its mechanism will be explained and successful proceedings shall be
examined for estimating the structure and electronic properties of suitable organometallic
starting materials.
4
2 State of Knowledge
2.1 Transition Metal Catalyzed C,C Cross-Coupling
Reactions
The field of transition metal catalyzed C,C cross-coupling reactions has been discovered in
the 1970s as a labor curiosity. Within the recent decades they have become an indispens-
able component in chemistry. They also evolved from the laboratory to the industrial scale
synthesis of, e.g., agro-, pharmaceutical- and fine chemicals. [8] Thus, their discoverers Akira
Suzuki, Ei-ichi Negishi and Richard F. Heck were awarded with the Nobel Prize in 2010
“for palladium-catalyzed cross couplings in organic synthesis“, which underscores the high
importance of this type of reaction. [9,10]
Cross-coupling reactions are characterized by the formation of a covalent bond between
two different reactions partners (Figure 2.1). One of them is an organic electrophilic aryl,
alkyl, and vinyl (pseudo-)halide R–X. As the nucleophilic coupling partner, metal- or
non-metal-functionalized alkyl, allyl, aryl, alkenyl, and alkinyl compounds R'–M are used.
Both are reacted in the presence of catalytic amounts of a transition metal complex, whereas
Pd is most commonly used. [11] The generated organo-palladium compounds are comparably
stable towards oxygen and moisture, and tolerate a wide range of functional groups, [11]
which makes them suitable for the synthesis of natural products and therein reduces the
required protective groups. [4] The systems are robust and can easily be scaled up, making
them attractive for industrial applications. [8]
X
R1
R1 R1
R1
R1
R2 R2
R2 R2
NR22
R1
PR22
R1
R2
M
R2
M
R2 Cu R2
M = SnR3: Stille
M = SiR3: Hiyama
M = B(OR)2: Suzuki-Miyaura
Negishi: M = ZnX
Kumada: M = MgX
Murahashi: M = Li
/ Pd
SonogashiraHeck
C,C Cross-Coupling
C,E Cross-Coupling
HPR22
Stelzer
HNR22
Buchwald-
Hartwig
Figure 2.1 Selected Pd-catalyzed C,C [12] and C,E [13–15] (E = N, P) cross-coupling reactions
starting from aryl halides.
R, R1, R2 = H or a singly bounded organic fragment; X = halogen or suitable leaving group.
The most important C,C cross-coupling reactions are the Kumada, Murahashi, Sonogashira,
Negishi, Suzuki-Miyaura, Stille and Hiyama ractions (Figure 2.1). [11] The Heck reaction also
gives C,C coupled products, whereby the mechanism differs. Thus, the C–C bond is formed
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prior to the reductive elimination in an olefin-insertion step. Besides the C,C also C,N and
C,P cross-coupling reactions have to be mentioned as important transition metal catalyzed
reactions (Figure 2.1). [13–15]
2.2 Suzuki-Miyaura Reaction
As the most convenient C,C cross-coupling reaction, the Suzuki-Miyaura reaction has to be
attributed. It has first been described in 1979 by N. Miyaura, K. Yamada and A. Suzuki [16]
and uses, for example, aryl, alkyl and alkinyl boron compounds as the nucleophilic reaction
partner. As electrophiles, allyl, benzyl, alkyl and aryl halides are most commonly used. The
most important substrate combination is the synthesis of biaryls. Especially the synthesis
of natural products, which can be used as active substances in drugs, is of high importance
(Figure 2.2). [11,17–20]
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Figure 2.2 Natural products bearing biaryl axes (light grey bonds). [11,17–20]
The fungicide Boscalid (K-1) is produced in a more than 1000 tons per year by the BASF
AG. [11,18] Knipholone (K-2) was successfully tested as an anti-malaria and anti-cancer
drug. [19] Vancomycin (K-3) is used as a 3rd line glycopeptide antibioticum against multi
resistend bacteria, [20] and Michellamine B (K-4) has been found to efficiently treat HIV
(Figure 2.2). [17,21]
The variety of structural motifs and functional groups, which are tolerated in Suzuki-Miyaura
reactions, is exemplarily shown by the synthesis of LosartanK-8 (Figure 2.3) [22] The coupling
exclusively occurs at the bromine substituent of K-5, whereas the more strongly bonded
chlorine atom is not attacked. Subsequent removal of the trityl protective group from K-
7 gives Losartan (K-8) in high yield. [23] Losartan was initially developed by DuPont® in
1986 and is sold since 1995 as the first AT1-antagonist by a joint venture of DuPont® and
Merck under the name Cozaar® for the treatment of high blood pressure and diabetes. [24]
The synthetic strategy evolved, whereas a biaryl coupling has always been a decisive step. [23]
The separate synthesis of the two different building blocks K-5 and K-6 and their final
combination simplifies the overall effort, which is impressively demonstrated by this example.
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Figure 2.3 C,C Cross-coupling step within the synthesis of the drug Losartan K-8 for low-
ering the blood pressure. [22]
The most important organo-boron compounds for Suzuki-Miyaura couplings are boronic acids
(Figures 2.1 and 2.3). Their ester or amide derivatives can also be applied and are accessible
from the boronic acids. [25] The boron functionality can, for example, be introduced by a hy-
droboration reaction of terminal alkynes with boranes (Figure 2.4). [26] C,C Cross-coupling or
C–H activation reactions of arenes with dialkyl boronates become increasingly popular. [11,27]
However, the most important strategy is the conversion of lithio- [28] or magnesio-arenes, [29]
in a transmetalation type process. This can most easily be achieved by a lithium-halogene
exchange of aryl halides with an organolithium reagent and reaction with BX3 (X = halo-
genes) as the electrophile. Subsequent acid-catalyzed hydrolysis gives the respective boronic
acids. [28]
M B(OR')2
B(OR')2
RR
H BX2
R, R' = H, or carbon bonded groupX = Br, OR' or a carbon bonded group
Hydroboration Transmetalation Cross-Coupling Reactions
M = Li, MgX
Y B(OR')2
(R'O)2B B(OR')2
[Pd] (Y = Br)
[Ir]   (Y = H)B(OR)3
Figure 2.4 Synthetic methodologies for the synthesis of boronic acids and esters. [11,26–29]
The advantage of the Suzuki-Miyaura reaction compared to the other types of C,C cross-
couplings (Figure 2.1) is the stability of the nucleophilic organo-boron reagents towards air
and moisture, their thermal stability and low toxicity. Thus, they are commercially available
and can easily be stored. Besides the C,C coupled product, borates are formed as the only
by-product, which can easily be separated by an aqueous work-up procedure. However, the
usage of stoichiometric amounts of a base is required for the activation of the boronic acid,
due to their low nucleophilicity. [30,31]
2.2.1 Catalytic Cycle
The catalytic cycle of the Suzuki-Miyaura reaction starts with the oxidative addition of the
organic electrophile R–X at a Pd(0) species, followed by the transmetalation of the boronic
acid or a boronate. Finally, the reductive elimination releases the C,C -coupled product
R–R' and regenerates the Pd(0) species as the active catalyst (Figure 2.5). [11] Cis-/trans-
isomerizations have been omitted for clarity.
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[Pd]
[Pd][Pd]
+0
+II +II
Oxidative
Addition
Reductive
Elimination
Transmetalation
R XR R'
R
X
R
R'
(HO)3B R'B(OH)3
X
(HO)2B R'
base,
H2O
Figure 2.5 Catalytic cycle of the Suzuki-Miyaura reaction. [11]
The catalytically active 12 or 14VE Pd(0) species is generated in situ from a Pd-precatalyst
(Figure 2.6). [11] In case of the 18VE Pd(0) complex Pd(PPh3)4 the phosphino ligands dis-
sociate step-wisely. This equilibrium is influenced by the concentration of the phosphino
ligands, whereby an excess decreases the catalytic activity. Another common Pd(0) source is
the 16VE Pd(0) complex Pd2(dba)3 (dba = dibenzylideneacetone). The dissociation of the
weakly-bonded η2-bonded alkenes proceeds irreversibly, which requires the addition of further
donor molecules. Thus, Pd2(dba)3 is predominantly used if the stabilizing properties of new
ligands within catalytic reactions shall be investigated, since no competing equilibrium with
the starting ligands occurs.
If Pd(II) complexes, for example Pd(OAc)2 or PdCl2(PPh3)2, are used as precatalysts, a
they initially have to be reduced. If phosphines are present, the inter- or intramolecular
attack of nucleophiles, such as OAc– or OH– , results in the formation of phosphine oxides as
the driving force (Figure 2.6). [32] Thus, higher amounts of the potential ligands are required,
since their consumption has to be considered. Furthermore, in a transmetalation-type process
the boronic acid ArB(OH)2 can replace anionic-bonded groups. A subsequent reductive
elimination releases a homo-coupled product and the active catalyst. [11,33]
Starting from Pd(0)
Pd(PPh3)4
− 2 PPh3
18 VE
+0
Pd(PPh3)2
14 VE
+0
Starting from Pd(+II)
Pd(OAc)2 (n+1) PPh3H2O
18 VE
+II
Pd(PPh3)n + P(O)Ph3 + 2 AcOH
12+2n VE
+0
Pd(PPh3)2Cl2 ArB(OH)2, OH
−
16 VE
+II
Pd(PPh3)2
14 VE
+0
Pd(PPh3)2Ar2 − Ar−Ar
16 VE
+II
n = 2−4
Reductive
Elimination
Pd2(dba)3 4 L
− dba
16 VE
+0
2 PdL2
14 VE
+0
Transmetalation
Figure 2.6 Generation of the catalytically active 14VE Pd(0) species.
L = two-electron donor; dba = dibenzylideneacetone; PPh3 is representative for any suitable
phosphine.
Besides phosphines also N-heterocyclic carbenes (= NHC’s) are widely used in catalysis as
strong ligands (Figure 2.9). [34]
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Oxidative Addition
The most important step of the catalytic cycle for all cross-coupling reactions is the oxidative
addition of the arylhalide to a coordinative and electronically unsaturated Pd(0) complex. In
organometallic chemistry four pathways are known, which include a synchron/consecutive,
a SN2, an ionic, and a radical mechanism. [11,33] Within the oxidative addition the number
of valence electrons, ligands, and the oxidation state are increased by 2 for mononuclear
complexes. [11,33]
X + PdL2 X
Pd
L
L
X
Pd
L
L
Pd
L
L
X
cis-ProductTransition State
Adduct
Formation
Figure 2.7 Synchron/consecutive oxidative oxidation mechanism. [11,33]
X = halogenes, OTf; L = singly-binding two-electron donor.
The underlying mechanism within a reaction depends on the polarity of the C–X bond, the
type and electronic properties of X (X = halogene, OTf) and on the chemical environment of
the Pd atom. [35] For Suzuki-Miyaura reactions, moreover a synchron/consecutive mechanism
is considered (Figure 2.7). Results from DFT calculations reveal, that the SN2 pathway is
only passed for a few particular substrates. [35,36] The synchron pathway is induced by an
adduct formation of the 12/14VE Pd(0) species with the aromatic pi-system and the C–X
bond. [37] The donation of electron density from the Pd atom into the LUMO of the C–X
bond weakens, and finally breaks the bond. This includes a three-membered transition state,
giving a cis-Pd(II) complex (Figure 2.7). It also explains, why the rate of the oxidative
addition strongly depends on the C–X bond strength is facilitated from Cl<Br<I. For X =
Cl, the oxidative addition is the rate determing step, whereas for X = Br and I the activation
barrier can be exceeded by the transmetalation process. [11]
The cis-complexes readily isomerize into their respective trans-derivatives as shown by Casado
und Espinet. [38] They investigated the oxidative addition of a fluorinated iodo-arene with
Pd(PPh3)4.
FCl
F
Cl F
I
FCl
F
Cl F
Pd
PPh3
I
PPh3
FCl
F
Cl F
Pd
PPh3
PPh3
I
Pd(PPh3)4
19F NMR: −90.6 ppm (dd)
4JP,F = 12.0, 6.0 Hz
31P NMR: 29.6, 16.7 ppm
19F NMR: −92.5 ppm (t)
4JP,F = 7.2 Hz
31P NMR: 22.6 ppm
Oxidative Addition Isomerization
Figure 2.8 Investigation of the oxidative addition and isomerization of a fluorinated aryl
iodide at Pd(PPh3)4. [38]
The progress of the reaction was monitored by 19F and 31P NMR spectroscopy (Figure 2.8).
They showed that the cis-Pd(II) complex was exclusively formed at 25℃ after one hour in
THF. Slow isomerization takes place at 60℃, and after 5 h a 1:2 mixture of the cis-/trans-
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complexes was detected. The reversed trans-cis-isomerization did not occur, ascribing the
trans-complex to be thermodynamically stable. The initial formation of the cis-derivative is
thus only compatible with the synchron mechanism.
As mentioned before, organic bromides, iodides and triflates were the preferred substrates for
Suzuki-Miyaura reactions until the end of the 1990s. They could be converted within a few
hours, whereas the respective chloroarenes turned out to be unreactive. However, the usage of
chloro-substituted educts was highly requested, since a huge substrate scope is commercially
available, and for lower prices, as compared to the higher bromo and iodo derivatives.
Nolan
1999
P
Fu
1998
PCy2
MeO OMe
N N N N
Herrmann
2002
P(tBu)2
 
Buchwald
1999, 2005
PCy2
O
O
Bei, Guram
1999
Hartwig
2002
P
2
Beller
2000, 2004
N P
Fe
P(tBu)2
2
PCy2
SO3Na
Plenio
2008
NaO3S
Figure 2.9 Common literature reported compounds that enable an efficient conversion of
chloroarenes within Suzuki-Miyaura reactions. [39–47]
The first ligand system for a successful coupling of chloroarenes was published in 1998 by
the group of Fu [39] and has rapidly been extended by Buchwald, [40,41] Bei and Guram, [42]
and Nolan [43] in the same year. A few years later the groups of Beller, [44] Herrmann, [45]
Hartwig [46] and Plenio [47] also contributed within this field (Figure 2.9). They are all char-
acterized by an increased steric demand and σ-donor strength. [48] A special feature for
Buchwalds biaryls is a stabilization of the catalytically active Pd species by the aromatic
pi-system. [41] Nowadays, even deactivated chloroarenes can be coupled at 25℃ with a low
catalyst loading of 0.01mol %.
PdL2
−L PdL
12 VE
more active
R−X Pd
L
X
R
+L
Pd
L
X
R L
Pd
L
X
R
2
14 VE
Figure 2.10 Oxidative addition of R–X to a 12VE mono-phosphino Pd complex.
X = halogene; L = two-electron donor; R = singly-binding organic substituent.
The sterically demanding phosphines force the formation of a 12VE mono-phosphino-Pd(0)
complex (Figure 2.10). The equilibrium is shifted from the PdL2 to the PdL species, while
reducing the ligand concentration. [49] This allowed the isolation of a T -shaped complex,
formed within the oxidative addition. [50] Besides the steric demand of the phosphine ligands,
also non-classical C–H hydrogen bridge-bonds stabilize this unsaturated complexes, which has
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been proven not only by singly-crystal X-ray diffraction analysis. [50] The presence of PdL as
the catalytically more active species is further supported by an optimized Pd/L ratio of 1:1.5
for L = P(tBu)3. [39] In similarity, a Pd(dba)2/L mixture with L = P(1-Adamantyl)(tBu)2
reacts faster in an oxidative addition reaction than the prepared PdL2 complex. [50] The
lower activation barrier for the oxidative addition of PdL compared to PdL2 was proven
by calculations. [33] The interaction of hetero-atoms and aromatic pi-systems with the active
catalyst further stabilize these systems. [48]
As shown in Figure 2.8 the oxidative addition process is followed by a cis-trans-isomerization,
if non-chelating ligands, such as PPh3, are used. This can proceed via three different mech-
anisms (Figure 2.11).
Pd
L
X
R L Pd
R
X
L L
Pd
L
X
R Pd
R
X
LPd
L
X
R
Pd
L
X
R Ldissociative−L
PdL
X S
LR
pseudorotation
PdR
X S
LL+S
ass
ocia
tive
square-planar/tetrahedral
Isomerization
−S
+L
Figure 2.11 Possible reaction pathways for the cis-/trans-isomerization of
PdL2(R)(X). [33,38,51]
X = halogene; L = two-electron donor; R = singly-binding organic substituent; S = solvent
or L.
During the associative pathway a further donor molecule, which can be an additional ligand,
halide or solvent molecule, binds to the Pd(II) complex, resulting in an 18VE trigonal pyra-
midal coordination. Within this molecular geometry, the axial and equatorial positions can
isomerize for example by a pseudorotation process, giving the trans-complex after release of
a ligand. Within the dissociative pathway, the ligand is initially released, giving a T -shaped
trigonal complex. After a Y -shaped transition state, the trans-addition of the ligand gives the
isomerized complex. The third path proceeds without changing the coordination number by a
tetrahedral transition. However, quantum chemical calculations revealed that the activation
barrier for the square-planar/tetrahedral reordering is too high. [33,51] Kinetic investigations
supported the proceeding by an associative or dissociative mechanism. [38]
Transmetalation
Within the transmetalation process, the second organic group is transferred from the organo-
boron compound to the Pd(II) complex. The designation of this step is similar in all men-
tioned Pd-catalyzed C,C cross-coupling reactions (Figure 2.1) but misleading in case of the
Suzuki-Miyaura reaction, since boron is not classified as a classic metal. Thus, the term
metathesis might also be used. As mentioned before, this requires stoichiometric amounts
of base. As shown for the synthesis of Losartan (Figure 2.3) moreover inorganic bases, e.g.
carbonates or phosphates, are added. Solely quaternary borates, such as sodium tetraphenyl
borate [52] (A, Figure 2.4), and boronates [53] (B, Figure 2.4) can be converted without the
11
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need for additional amounts of a base. However, it could also be shown that hydroxy palla-
date complexes rapidly undergo a transmetalation reaction with boronic acids in the absence
of an additional base (C, Figure 2.4). [54] This leads to the question if the transmetalation
proceeds via an hydroxy palladate (Path A, Figure 2.13) or an boronate mechanism (Path
B, Figure 2.13).
I
Br R
up to 90 %
R
(HO)3B
Na
PdCl2(dppf),
toluene, reflux
NaBPh4
PdCl2 1 mol-%,
DMF/H2O (2:1)
77 %
O2NO2N
PhB(OH)2
Pd(PPh3)4
no reaction
Pd
Ph
Ph3P PPh3
I
Pd
Ph
Ph3P
HO
CsOH
2
ArB(OH)2, PPh3
25 °C, < 2 min Ar Ph
81 %
Pd(PPh3)4+
A
B
C
+
Figure 2.12 Transmetalation in the Suzuki-Miyaura reaction without additional amounts
of base. [52–54]
Kinetic investigations in which the rate constants of both paths could be determined, revealed
that the hydroxy palladate pathway is approximately 104-times faster than the boronate
one. [55] It should be noted that the kinetic properties were determined for reactions of aryl
boronic acids/esters with aryl halides (X = Cl, Br, I) in aqueous DMF, acetone or THF with
PPh3 or PCy3 as ligands in the presence of carbonate bases. While changing the reaction
conditions, the rate constants and the preference of the hydroxy palladate pathway may also
no longer be relevant. [55] Nevertheless, the hydroxy palladate and the boronate pathway led
to the formation of a zwitterionic species, which passes a 4-membered transition state and
released the transmetalated complex. The B(OH)3 species is complexed by the halide. The
transmetalation can also occur from the respective cis-configured complex, which has been
omitted for clarity in Figure 2.13. A cis-trans-isomerization during this step does not occur,
due to the concerted mechanism.
Pd
L
L
R X
Pd
L
L
R O
H
[R'B(OH)3]−
OH−
R'B(OH)2
OH−   X− Pd
L
L
R R'Pd
L
L
R O
H
B(OH)2
R'
+
−
Pd
L
L
R B(OH)2
R'
O
H
Path A: k = 1.6 . 10−2 M−1s−1
Path B: k = 1.1 . 10−6 M−1s−1
X = halogene; L = two-electron donor; 
R, R' = singly-binding organic substituent
Figure 2.13 The two reaction pathways for the transmetalation process in the Suzuki-
Miyaura reaction. [55]
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Reductive Elimination
The catalytic cycle of the Suzuki-Miyaura reaction (Figure 2.5) is finalized by the reductive
elimination process. Therein, the C–C bond formation takes place and the catalytically ac-
tive Pd(0)-species is regenerated. The reductive elimation proceeds reversed compared to
the oxidative addition process. This requires a cis-configured complex to reach the three-
membered transision state (Figure 2.7). In case of a diaryl-Pd(II)-species this can readily
occur without the dissociation of a ligand. [30] Based on quantum chemical calculations, the
isomerization requires an activation barrier of only 25–50 kJ/mol [33] In contrast to the oxida-
tive addition, where associative and dissociative pathways can be passed (Figure 2.11), the
reductive elimination exclusively proceeds dissociatively. [51]
The reaction rate of the reductive elimination depends on the chemical environment of the
Pd(II)-species. Electron-poor and sterically demanding ligands (L) accelerate the process.
In case of the reactive ligands R and R', electron-rich derivatives are easier reductively elim-
inated, due to a weaker Pd–C bond. [56] Kinetic investigations of the reductive elimination of
Pd(II) complexes could not be performed, since they are too instable and readily eliminate
the product. Thus, the respective Pt complexes PtL2(C6H4R)(C6H4R') were examined. As
expected, the reductive elimination of the electron-rich R, R' = NMe2 derivatives proceeds
faster than for the CF3 complexes. Notably, an electronically inverse ligand system with R
= NMe2 and R' = CF3 further accelerates the reaction. [56]
2.2.2 Synthesis of Sterically Hindered Biaryls
Within their first results in 1981, Suzuki and Miyaura investigated the reaction of 2-
bromotoluene and 2-bromomesitylene with phenylboronic acid (Figure 2.14). [57] They ob-
served that the yield of the mono-ortho-substituted biaryl exceeded those for the di-
substituted derivative, even at higher temperatures and longer reaction times. The synthesis
of tri-functionalized biaryls can be achieved, if stronger bases, for example Ba(OH)2, K3PO4,
and Cs2CO3, are used. [58]
Pd(PPh3)4 3 mol-%, 
Na2CO3
R
Br (HO)2B
R
R
R
H
Me
T
80 °C
110 °C
t
6 h
17 h
Yield
94 %
80 %
+
Pd(PPh3)4 2 mol-%, 
Ba(OH)2, DME/H2O,
80 °C, 13-20 hO
I (HO)2B
O
+ 80 %
R
Pd2(dba)3 4 mol-%, 
L, K3PO4, 110 °C
Br (HO)2B+ 91 %, L =
PCy2
Figure 2.14 Synthesis of mono-, [57] di-, [57] tri- [58] and tetra-ortho-substituted biaryls. [59]
The most challenging task is the synthesis of tetra-ortho-substituted biaryls, whereby the sim-
ple change of the reaction conditions is not sufficient. The steric demand of the aryl halide and
13
CHAPTER 2. STATE OF KNOWLEDGE
the boronic acid complicates the oxidative addition and the transmetalation process. In sim-
ilarity to the conversion of chloro- compared to bromo- or iodo-arenes, sterically demanding
and electronically modified ligands are required (Figures 2.9 and 2.14). [59] As a prerequi-
site for a succesful coupling of tetra-ortho-substituted biaryls within Suzuki-Miyaura C,C
cross-coupling reactions stericically demanding phosphines (Hoshi and Hagiwara, [60] Hor, [61]
Ackermann, [62] Tang, [63] Kwong, [64] and Qiu [65]) N-heterocyclic carbenes (Dorta, [66] Tu, [67]
Glorius, [68] Schmidt, [69] Willans, [70] Nolan [71]) or amides (Jin [72]) are required as complex
ligands for palladium (Figure 2.15).
Nolan
 2014
MeO OMe
N N
MeO OMe
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2015
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O
O
PPh2
NMe2
Qiu
2016
Dorta
 2011
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Cyoct
Cyoct
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iPr
iPr
iPr
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N N
Cl
Figure 2.15 Prominent compounds applied in the synthesis of tetra-ortho-substituted
biaryls. [60–72]
Besides the shown examples for the synthesis of tetra-ortho biaryls, the number of com-
pounds that facilitate the synthesis of tri-substituted derivatives is also rising. Therefore,
also phosphines are predominantly applied. [73–75]
Fe O(o-tol)2P
Fe
O
Br
Me
(HO)2B
Me
i)
100 °C
40 %
rac
50 °C
94 %
P(2-fur)2
Me
Me
+
Figure 2.16 Comparison of the 1,1'- and a 1,2-P ,O-substitution pattern within the synthesis
of tri-ortho-substituted biaryls. [74]
Reaction conditions: i) aryl halide (1.0mmol), boronic acid (1.5mmol), K3PO4 (3.0mmol),
toluene (2mL), Pd2(dba)3 (0.05mol-%), phosphine (0.2mol-%), 24 h.
Of high interest, within the field of tri-ortho-substituted biaryls, is the increase of the catalytic
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activity by lowering the temperature and catalyst concentration. [76] The estimation of the
activity is very complex and depends, inter alia, on the substitution pattern as shown for a
1,1'- and 1,2-substituted system (Figure 2.16). [74] Both molecules allow for a lowering of the
Pd-concentration to 0.1mol-%, whereas the spatial proximity of both donor atoms further
stabilizes the catalytically active Pd species and gives the biaryl in higher yield at even lower
temperatures.
2.2.3 Atropselective Biaryl Couplings
The rising number of ortho-substituents was not only necessary for a better classification of
the increasing number of catalytically more active ligands, and for a better understanding
of the mechanism of the coupling reaction. The steric demand of the ortho-substituents also
affects the rotation of both phenyls around the biaryl C–C bond.
NO2
HO2C NO2
HO2C
NO2
HO2C
HO2C
NO2
Sa/P Ra/M
NO2
CO2R
I Cu-powder
Ullmann
coupling
fractional
crystallization
with Brucine
Brucine
N
O
H
H
OH
O
O
N
Figure 2.17 Separation of both isomers of 6,6'-dinitrobiphenyl-2,2'-dicarboxylic acid by
racemic resolution with Brucine, as a first example of atropisomerism. [77]
The phenomena of a hindered rotation around the biaryl axis has first been observed
by Christie and Kenner in 1922, who separated both isomers of 6,6'-dinitrobiphenyl-2,2'-
dicarboxylic acid by racemic resolution with Brucine (2,3-dimethoxystrychnine) (Figure
2.17). [77] Both isomers solely differed by their optical activity, and thus Christie and Kenner
postulated a new type of axial chirality, which is based on a steric hinderance of the rotation
around the biaryl axis. In 1933, this type of chirality was described as atropisomerism by
Kuhn, [78] who also received a Nobel Prize in 1938 “for his work on carotenoids and vita-
mins“. [79] Atropisomers can be recognized as physically separable, if the half life time (t1/2)
of the racemization exceed 1000 s (16.7min) at a given temperature. [80] The half life times
(t1/2) were determined by a time-dependent measurement of the loss of optical activity, which
were found to be first order. [81]
Thus, a long half life time is required while working with stereopure biaryls. The stability to-
wards racemization is improved, if the number and the steric demand of the ortho-substituents
is increased. While di-substituted K-9 racemizes within one hour below 50℃, [82] tri- (K-10
and K-11) and tetra-substituted derivatives (K-12) achieve half life times of minimum 3,
and up to >200 h at >120℃. [81–83] In Addition the steric demand and size of the backbone
affects t1/2, although it does not contribute to the properties of the ortho-groups. However,
the lower flexibility of the biaryls enhances t1/2 from 3h (K-10) to 12 h (K-11c) for equally
substituted ortho-positions. Increasing the size of the ortho-bonded group from, for example,
OMe (K-11a) to Me (K-11f), or from CHO (K-11a) to CH2OH (K-11b), also stabilizes
the biaryl towards racemization, illustrated by the enhanced activation barrier (∆G) (Figure
15
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2.18). [84] Stirring of K-9 and K-12 in different solvents revealed a strong dependency on the
polarity. Increasing the polarity shortens t1/2 from 69 to 15min for K-9 and from 4.5 h to
60min for K-12.
However, if the ortho-substituents are connected to each other and involve the biaryl axis
in a cyclic structure, a flattening of both aryls can occur, which reduces the activation bar-
rier. Thus, tetra-ortho-substituted biaryls lactams equilibrate at ambient temperature within
seconds. [80] While working with hydroxy-functionalized biaryls, for example BINOL (K-12),
the usage of even weakly acidic media (1.2M HCl in dioxane/water) can result in the proto-
nation of one of the aromatic ring systems. The connection of the biaryl axis to the formed
sp3-carbon allows for a rapid rotation and racemizes K-12 within 24 h at 100℃. [82]
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Figure 2.18 Racemization times of di-, tri-, and tetra-ortho-substituted biaryls. [81–83]
Besides a racemic resolution, stereoselective couplings and desymmetrization reactions be-
came a focus of attention. [85] Especially atrop-diastereo- and enantioselective Suzuki-Miyaura
C,C couplings are discussed herein, whereas numerous couplings with other transition metals
are known. [80] The post-functionalization of racemic biaryls has been reviewed recently. [80]
Atrop-Diastereoselective Couplings
A diastereoselective proceeding can be achieved by using aryl halides bearing a stereogenic
center in close proximity to the position where the coupling occurs. [85]
The group of Buchwald showed that ortho-donors take part within the catalytic cycle by
coordinating to the Pd species (Figure 2.19). [40,86] Using (R)-K-13 revealed the formation
of an oxo-palladacycle K-14. The configuration of biaryl (R,P )-K-15, which is established
within the transmetalation process, depends on the configuration of the methyl group and its
steric interaction with the MOM-group (= methoxymethyl) and the ligandK-16. [40,85,86] Re-
placing the MOM by the steric more demanding TES (= triethylsilyl) group further increases
the de. [85]
The approach of ortho-directing donors has been extended, whereby non-acidic instead of
hydroxy-groups were chosen. A well understood example is the coupling of the β-methoxy
sulfoxide (R,RS)-K-17 with 2-methoxynaphthylboronic acid, giving the biaryl (R,RS)-K-
18 in >98% de and 99% yield (Figure 2.20) [87] The presence of the two stereo centers is
decisive for the complete control of the configuration. Thus, removal of the S-stereogenic
center by converting it into a sulfon gives biaryl (R)-K-19 with only 70% de. Even more
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Figure 2.19 Diastereoselective Suzuki-Miyaura reaction via an oxa-palladacycle. [40,85,86]
Reaction conditions: i) Pd(OAc)2 (5mol-%), L (10mol-%), dioxane/water (9:1), Ba(OH)2,
100℃; ii) NaH, BnBr, THF, 25℃, 4 h. MOM = methoxymethyl; pin = pinacol, Bn = benzyl.
important is the relative configuration of both stereocenters towards each other. Inverting
the configuration of the methoxy group also inverts the configuration of the biaryl axis in
biaryl (S,RS)-K-20, whereas the de drops to 10% (Figure 2.20). [87]
Pd(OAc)2 10 mol-%
dppf 15 mol-%, CsF
dioxane, reflux, 1 h
I OMe
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Figure 2.20 Influence of the number and relative configuration of stereocenters on a di-
astereoselective Suzuki-Miyaura reaction. [87]
These results were used for the synthesis of a axial chiral thioether (M)-K-24. When sulfoxid
(RS)-K-21 was coupled with the N -functionalized boronic ester K-22 biaryl (RS ,M)-K-23
could be obtained with 90% de (Figure 2.21). [88] Subsequent removal of the boc group and
reduction of the sulfoxide gave (M)-K-24.
S
I O
MeO
(RS)-K-21
BocHN
B Pd(OAc)2, SPhos
Cs2CO3
dioxane/H2O
(RS,M)-K-23
86 %, 90 % de
OO S
O
MeO
BocHN
SMeO
H2N
(M)-K-24K-22
+
72 %
Figure 2.21 Diastereoselective Suzuki-Miyaura reaction with a chiral sulfoxide. [88]
SPhos = 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl; boc = tert-butyloxycarbonyl.
That also donor atoms, which are not in spatial proximity to the reaction center, influence
the diastereoselective proceeding, could be shown be the coupling of boronic ester K-25
with aryl halides K-26a,b (Figure 2.22). Using the innocent TIPS (= triisopropylsilyl)
group a de of only 11% could be detected in the product K-27a. [89] Increasing the donor
abilities by replacing the TIPS by a phosphinyl-bearing group (K-26b) enhances the de to
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>98% in K-27b, due to a coordination of the phosphorus to palladium during the catalytic
cycle. [21,40,86,90]
BO O
N
OBn OMe
OTIPS
I
MeO
OMe
Ts
OR
OBn OMe
OTIPS
NH
MeO
OMe
OR
P
K-25
K-26a
K-26b
PdCl2(dppf) 
20 mol-%, K3PO4,
BHT, DMF, 117 °C
K-27a, 81 %; de = 11 %a)
K-27b, 81 %, de > 98 %
a: R = TIPS
b: R =
O
Ph2P
Figure 2.22 Diastereoselective Suzuki-Miyaura reaction with intramolecular stereoinduction
by a phosphine. [21,40,86,89,90]
a) Pd(PPh3)4, 96℃; TIPS = triisopropylsilyl, BHT = 2,6-di-tert-butyl-4-methylphenol.
Another approach, besides the usage of chiral donor groups, was introduced by Uemura et
al. by complexing the aryl halide with a tricarbonylchromium fragment (Figure 2.23). [91]
This approach combines several advantages. The organometallic group reduces the electron
density and accelerates the oxidative addition of the aryl halide and hence, smoother reaction
conditions can be applied. The planar benzene core is converted into an three-dimensional
backbone, bearing a steric demanding group at one site, which allows for the introduction of
planar chirality. The Cr(CO)3 fragment is sensitive towards oxidation and can thus easily be
removed.
Br
(OC)3Cr
CHO
OMe
CHO
OMe
Me
OMe
Me
AcO
syn-K-29a (M)-K-30
(OC)3Cr
OHC
OMe
anti-K-29b
Me
OMe
Me
(P)-K-30
AcO
MeOH, 75 °C
30  min, 82 %
xylene, 140 °C
2 h, 80 %
kinetic product
46 %
46 %
(OC)3Cr
(Sp)-K-28
thermodynamic
product
i) xylene 140 °C
98 %
Figure 2.23 Planar-chiral tricarbonylchromium complexes within diastereoselective Suzuki-
Miyaura reactions. [91]
Reaction conditions: i) 2-tolylboronic acid, Pd(PPh3)4, Na2CO3.
Reacting planar-chiral K-28 with o-tolylboronic acid gave biaryl K-29 within <2h (Figure
2.23). The relative configuration depended on the reaction temperature and gave the kinetic
product syn-K29a at 75℃. Changing the steric demands by interchanging the CHO with
the Me substituent inverts the relative configuration. [4] The thermodynamic product anti-
K29b, where steric interactions by the methyl group and the Cr(CO)3 fragment are avoided,
can either be achieved by performing the reaction, or stirring of syn-K29a at 140℃ in
xylene. Post-functionalization and removal of the protective Cr(CO)3 fragment gave each
biaryl (M )/(P)K-30 enantiomerically pure and they could be used as key intermediates for
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the synthesis of (–)-Steganone. [91,92]
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Cr(CO)3
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iPrO Cr(CO)3
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OH iPrO
iPrO Cr(CO)3
OH
OMeOBn
HO
OH
OMeOBn
NH
Korupensamine AK-32, 63 %
de = 96 %
K-33, 88 %
i,ii) iii)
K-31
16-steps
Figure 2.24 Diastereoselective Suzuki-Miyaura reaction with a Cr(CO)3-functionalized aryl
halide. [92]
Reaction conditions: i) BuLi, Et2O, –78℃, C2Br2F4, TiCl4, 64% based onK-31; ii) NaBH4,
MeOH/CH2Cl2 (2:1), 0℃, 99%; iii) Pd(PPh3)4 5mol-%, 1M aq. Na2CO3/MeOH (1:10),
75℃, 30min, the B(OH)2 derivat of the naphthyl fragment was used as the boronic acid
The introduction of planar chirality at the tricarbonylchromium complex was achieved by
diastereoselective ortho-lithiation with a chiral ortho-directing acetal (Figure 2.24). [92] Sub-
sequent bromination gave K-32 diastereomerically pure. Applying K-32 in Suzuki-Miyaura
reactions at low temperatures (75℃) gave the kinetically favored syn-complex K-33, similar
to the reaction shown in Figure 2.23. Enantiomerically pure K-33 was a key-intermediate for
the synthesis of Korupensamine A, which was obtained as the desired (P)-derivative by post-
functionalization and removal of the Cr(CO)3 fragment without changing the configuration
of the biaryl axis (Figure 2.24). [92]
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Figure 2.25 Suzuki-Miyaura reaction as a part of the total synthesis of Vancomycin. [93]
BINAP = 2,2'-bis(diphenylphosphino)-1,1'-binaphthalene
The presence of chiral backbones bearing donor atoms does not inevitably result in a high
diastereoselectivity as shown for the synthesis of the glycopeptide Vancomycin. [93] When
the chiral aryl halide K-34 was reacted with K-35 and PPh3 as a non-chiral ligand within
a Suzuki-Miyaura reaction, the biaryl K-36 was obtained as a racemic mixture of both
atropisomers (Figure 2.25). [93] However, both isomers were separated from each other by
column chromatography and were enantiomerically pure. Applying the chiral (P)- and (M )-
isomers of BINAP as ligands for the Suzuki-Miyaura coupling, instead of PPh3, gave only
one diastereomer in a high isomeric purity of > 90% de). [93]. However, the interaction of the
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BINAP ligand and the chiral backbone of K-34 gave each isomer with only 40% yield. The
usage of BINAP for an atropselective proceeding ascribes this as an atrop-enantioselective
reactions, since the chiral information of the chiral backbone in K-34 is negligible.
Atrop-Enantioselective Couplings
In 2000 the first examples of atrop-enantioselective Suzuki-Miyaura reactions, that require
the chiral information in only catalytic amounts, were published by Cammidge and Buch-
wald. [94,95] They performed the reaction of 2-tolylboronic acid with phosphonate K-37 in the
presence of the chiral biaryl-based phosphine (P )-K-40 and obtained the coupling product
K-38 with 87% and high yield (98%) (Figure 2.26). It is remarkable that solely 0.24–6mol-%
of the ligand (P )-K-40 and 0.2–3mol-% of the palladium source were used. Replacing of all
methyl by ethyl groups in the substrates further increased the ee to 92%. The phosphonate
moiety inn K-38 could easily be converted to phosphine K-39, giving a catalytic access to
enantiomerically pure phosphines, which can be used as ligands in catalysis. [95]
Br
P(OMe)2
B(OH)2
Me
Pd2(dba)3, (P)-L
K3PO4, toluene
60-80 °C
P(OMe)2
O
OMe
K-38
98 %, 87 % ee
PPh2
Me
K-39, 77 %
NMe2
PCy2
(P)-L = (P)-K-40
K-37
Figure 2.26 Enantioselective Suzuki-Miyaura reaction with subsequent conversion into an
axial-chiral phosphine. [95]
Other stereopure molecules, which have been tested in different stereoselective reactions,
were applied for the atrop-enantioselective synthesis of biaryls with high ee as shown by the
groups of Lassaletta, [96] Uozumi, [97] Lin, [98] Qiu, [99,100] Iwasawa, [101] Tang, [102] Zhang [103]
and Kündig [104] (Figure 2.27).
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Figure 2.27 Selected compounds for atrop-enantioselective Suzuki-Miyaura reac-
tions. [96–104]
Nevertheless, the synthesis of sterically hindered, tri- and tetra-ortho-substituted biaryls in
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high yields is still a challenging task. They can either be obtained with low catalyst and ligand
loadings within a few hours as low enantioenriched mixtures, or by enantioselective couplings
that require high catalyst and ligand loadings, which can take severeal days. This discrepancy
is illustrated in Figure 2.28, showing the synthesis of 2,2'-dimethyl-1,1'-binaphthyl by either
a diastereopure (Sp)-1,2-ferrocene derived from Ugi’s amine, [105] or by a sterically demanding
1,1'-ferrocenylimine. [61] The 1,1'-imino ferrocene is known to be an effective ligand for the
synthesis of tetra-ortho-substituted biaryls (Figure 2.15) and gives the product with a low
catalyst loading within 24 h in 98% yield. In contrast, the planar-chiral derivative, which is
required for an atrop-enantioselective proceeding, requires a 5-times higher Pd and 15-times
higher phosphine loading and 72 h reaction time for at least 85% ee.
Up to date only two systems showed an effective chirality transfer from the ligand to the sub-
strate at low catalyst loadings, which were reported by the group of Dorta [106] and Tang [102]
(Figure 2.27), clarifying the huge demand of research within this field.
Br (HO)2B
FePh2P Fe
(tBu)2P
N
NMe2
Pd
L
t
yield
5 mol-%
20 mol-%
72 h
85 %
(ee 85 %)
1 mol-%
1.2 mol-%
24 h
98 %
CsF, THF
Pd2(dba)3
L, 65 °C
Figure 2.28 Comparison between 1,2- and 1,1'-substituted ferrocenes for atrop-
enantioselective Suzuki-Miyaura reactions. [61,105]
Besides this example, further planar-chiral compounds have successfully been applied in
atrop-enantioselective Suzuki-Miyaura couplings, for example, the phosphines from Jo-
hannsen [107] and Yiao [108], the N-heterocyclic carbene from Labande [109], and Duninas
[2.2]paracyclophane [110] (Figure 2.29). Recently, our research group [75] and Manoury [111]
contributed with ferrocenes bearing hemilabile ortho-vinyl- or oxygen-donors.
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2013
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Johannsen
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Figure 2.29 Planar-chiral compounds, which have been investigated for atrop-
enantioselective Suzuki-Miyaura reactions. [75,107–111]
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2.3 Planar-Chiral Ferrocenes
Ferrocene (bis(η5-cyclopentadienyl)iron)) is probably the most prominent three-dimensionally
expanded molecule for establishing planar chirality. Its first synthesis has been reported
independently by Kealy & Pauson [112] and Miller et al. [113] and has been described as a σ-
complex. R. B. Woodward proposed the name ferrocene based on the combination of ferrum
and benzene. [114] The correction of the structure and verification of its three-dimensional
nature was reported by E. O. Fischer in 1952 [115], who received a Nobel Prize for this work
in 1973. [79]
Fe YX Fe XY
mirror plane
σ
Fe
X Y
Fe
Y X
Top view
Frontal view
Priority
Fe > X > Y
Sp Rp
33
2 11 2
SR
Figure 2.30 Configuration of the planar-chiral ferrocenes, determined by Cahn, Ingold and
Prelog [116] (top) and Schlögl [117] (bottom).
The chemical properties have rapidly been investigated and showed a similar behavior to ben-
zene, whereas the partial negatively charged cyclopentadienyl rings accelerate electrophilic
aromatic substitution reactions by 3·106. [118] In contrast, the ferrocenyl backbone can be de-
composed by strong oxidants, for example bromine and hydrogen peroxide, which complicates
the synthesis of, e.g., nitroferrocene. [118]
Planar-chirality at ferrocenes occurs if two different substituents are attached in 1,2- or 1,3-
position at one cyclopentadienyl ring, which therefore acts as the chirality element (Figure
2.30). The stereodescriptor can be defined by the method of Cahn, Ingold and Prelog, where
the configuration of the carbon-atom, bearing the substituent with the highest priority, is
determined. [116] In this case, the iron atom is assigned with the lowest priority. Another,
more common method has been introduced by Schlögl, using the top view of towards the
respective plane in a Newman projection. [117] The priorities of each group (Fe, X and Y)
are assigned according to Cahn, Ingold and Prelog. Their clockwise arrangement gives a Rp
configuration, and a descending order counterclockwise the Sp isomer. If X and Y posses a
lower priority than Fe, both methods give opposed stereodescriptors.
2.3.1 Racemic Functionalization
A 1,2-functionalization can be achieved by lithiation of ferrocenes bearing ortho-directing
groups and subsequent reaction with the desired electrophile. These ortho-directing sub-
stituents should contain donor atoms to stabilize the lithium ion, otherwise 1,3- and 1,1'-
functionalizations occure as found for alkyl groups. [119] Due to the oxophilic properties of the
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lithium ion oxygen-donors, as found in THP-ether [120] K-41 (= tetrahydropyranyl), alco-
hols [121,122] of type K-42, acetals [123] (K-43), carboxylic acids [124] and amides [125] (K-44),
sulfonic acids [126] (K-45), and phosphine oxides [127] (K-46) were investigated, but also the
usage of N -donors [128,129] (K-47) is common (Figure 2.31). The application of ortho-directing
groups in ortho-directed metalations has been reviewed recently. [130]
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Figure 2.31 Mono-substituted ferrocenes applied in ortho-directed metalations. [120–129].
2.3.2 Racemic Resolution
The separation of both isomers of the formed 1,2-substituted ferrocenes can be achieved by
kinetic or classic resolution, such as fractional crystallization or column chromatography. An
example for a classic racemic resolution is the separation of 2-haloferrocenes K-48, which
were obtained as a racemic mixture by ortho-lithiation of K-47 and subsequent reaction with
iodine (Figure 2.32). [129]
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N
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Figure 2.32 Resolution of 2-N,N -dimethylaminomethyl-1-iodoferrocene with ephedrine. [129]
Quarternization with MeI and subsequent nucleophilic substitution with the chiral auxiliary
(1R,2S)-ephedrine gave both diastereomers of K-49 in a 1:1 mixture that were separated
by column chromatography. Nucleophilic substitution reaction of the methiodide of K-49
with dimethylamine gave the (Rp)- and (Sp)-isomer of K-48 enantiomerically pure (Figure
2.32). [129] After the separation, ephedrine is obtained as its N -methylated derivative and
cannot be reused, which is the main disadvantage of this approach.
A similar method is illustrated by the ortho-functionalization of ferrocenecarboxylic acid
K-44a with ClPPh2, giving K-50 as a racemic mixture. Racemic resolution of the acid
was achieved by reaction with the diacetonide of d-glucose and column chromatographic
separation of both diastereomers (Figure 2.33). [124] Hydrolysis under basic conditions gave
(Sp)-K-50 and (Rp)-K-50 isomerically pure, as well as the chiral auxiliary.
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(Sp)-K-50, 29 %
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(Rp)-K-50, 37 %
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Figure 2.33 Resolution of 2-(diphenylphosphino)ferrocenecarboxylic acid by ester formation
with the diacetonide of d-glucose. [124]
Reaction conditions: i) 1st DCC, DMAP, G*; 2nd KOtBu, H2O. DCC = N,N '-dicyclohexyl-
carbodiimide; DMAP = 4-dimethylaminopyridine.
In recent years, kinetic resolutions of ferrocenyl derivatives have also been investigated.
Compared to classic racemic resolutions, the chiral information is solely required in cat-
alytic amounts. The first example has been reported by Thomson in 1959, who converted
a cyclohaxenone-annelated ferrocene with (–)-menthhydrazid into the respective hydrazone.
Kinetic resolution gave the (Rp)-isomer of the cyclohexanone. [131]
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Figure 2.34 Kinetic resolution of a 1,2-diallylferrocene by ring-closing metathesis. [132]
A few years later, Ogasawara et al. applied a ring-closing metathesis reaction for the res-
olution of the 1,2-diallyl ferrocene rac-K-51. [132] Only 5mol% of the chiral biaryl-based
molybdenum carbene complex (R)-K-52 were required as a catalyst, giving the cyclized
product (Rp)-K-53 and the remaining starting material (Sp)-K-51 within 24 h at ambient
temperature virtually isomerically pure (Figure 2.34). [132]
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Figure 2.35 Desymmetrization of a homodisubstituted ferrocenyl acetate by amminoly-
sis. [133]
Disadvantageous within all racemic resolution reactions is maximum yield of 50%, which
can be achieved for the desired isomer. In contrast, desymmetrization reactions are not
limited to one isomer as demonstrated for the 1,2-homodisubstituted ferrocene (R,R)-K-
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54 (Figure 2.35). [133] Ammonolysis in aqueous ammonia removes the exo-positioned acetate
group, whereby the formed positive charge is stabilized by an interaction with the iron atom.
Subsequent nucleophilic addition of NH3 gave (R,R,Sp)-K-56 in 89% yield. The choice about
which of the two acetates is in exo-position depends on the orientation of the steric demanding
phenyl groups that have to be positioned away from each other. The intermediate amine
(R,R,Sp)-K-55 rapidly reacts with the present acetate anions, which could be prevented
shortening of the reaction time.
2.3.3 Enantioselective Functionalization
A more efficient pathway for the synthesis of isomerically pure planar chiral ferrocenes is the
stereoselective introduction of substituents, instead of a racemic formation with subsequent
resolution. The first attempts were reported in 1969, where isopropylferrocene was lithiated
with a BuLi/(–)-Sparteine mixture (Figure 2.36). Subsequent reaction with ClSiMe3 gave a
1,3,1'-substituted ferrocene with 3% ee. [134]
This method was improved 1996 by the group of Snieckus, who used K-44b as a more
ortho-directing substrate, giving the huge variety of 1,2-substituted products (K-57) in 81–
98% ee (Figure 2.36). [135] Further improvement of the reaction by reducing the loading of
(–)-Sparteine to 0.4 equiv was recently reported. [136]
(−)-Sparteine
N
NH
H
N NFe Fe
EBuLi, (−)-Sparteine, Et2O
−78 °C, E +
K-57, 45−96 %
81−99 % ee
K-44b
N(iPr)2
O
N(iPr)2
O
E = Me, Ph2C(OH), I,
TMS, PhS, PhSe, Ph2P, B(OH)2
Figure 2.36 Enantioselective ortho-lithiation of a ferrocenecarboxamide with (–)-
Sparteine. [135]
In the same year of Snieckus’ approach by using (–)-Sparteine, Uemura introduced (R,R)-
tetramethyl-1,2-diaminocyclohexane as a suitable additive for the successful enantioselective
synthesis of 1,2-disubstituted planar-chiral ferrocenes (Figure 2.37) [137] Starting from the
dimethylaminomethylferrocene K-47 ortho-directed lithiation and subsequent reaction with
DMF gave formylferrocene (Rp)-K-58 in 80% ee. The amount of the chiral additive could
be reduced to only 0.2 equiv, by changing the base from BuLi to iPrLi, which enhanced the
stereoselectivity of the ortho-lithiation to 98%. [138]
A different approach was reported by Simpkins, who used lithium bis((R)-1-
phenylethyl)amide (Simpkins base) as a chiral base instead of BuLi. [139] Lithiation of phos-
phine oxide K-46a with Simpkins base gave the ortho-substituted ferrocene K-59 with 54%
ee in high yield (Figure 2.37). It should be noted that the usage of simpkins base for other
substrates gave rather racemic mixtures. [139]
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Figure 2.37 Enantioselective ortho-lithiation with (R,R)-N,N,N ',N '-tetramethylcyclo-
hexane-1,2-diamine [137] and Simpkins-base. [139]
2.3.4 Diastereoselective Functionalization
The diastereoselective functionalization is also based on ortho-directed lithiations and is the
predominantly used approach for the synthesis of stereopure planar-chiral ferrocenes. A
successful diastereoselective ortho-lithiation can be achieved, if the source of the chiral infor-
mation is in close proximity to the ferrocenyl backbone. [130] The first example has already
been reported in 1969 by using the (S)-methylpiperidine in K-60 as the ortho-directing group
(Figure 2.38). The ferrocenecarboxylic acid K-61 was obtained by addition of dry ice to the
lithiated species. Removal of the chiral piperidine group was achieved by quaternization
of the nitrogen atom with methyl iodide and subsequent reduction, whereby the obtained
ferrocene (Rp)-K-62 exclusively shows planar-chirality. [130]
Fe
N BuLi, CO2
24 %, 98 % de
Fe CO2H
N
(Rp)-K-61
1. MeI
2. Na(Hg), H2O
3. CH2N2
Fe CO2Me
(Rp)-K-62K-60
Figure 2.38 Diastereoselective ortho-lithiation of (S)-1-ferrocenylmethyl-2-methyl-
piperidine. [130]
Ugis doubts concerning the optical purity of the products prompted him to report an improved
protocol by replacing the piperidylmethyl group in K-60. He introduced N,N -dimethyl-1-
ferrocenylethylamine (K-63), whereby both isomers are accessible by resolution with tartaric
acid. Amine K-63 served as a starting point for a huge variety of related compounds and
was since then known as Ugi’s amine. It can readily be deprotonated with BuLi, whereby a
steric repulsion of the methyl group and the ferrocenyl backbone result in excellent selectivi-
ties (Figure 2.39). [140] Treatment with an electrophile gave (R,Sp)-K-64 in 92% de, whereby
the minor isomer can easily be removed by column chromatography or crystallization. The
dimethylamino group can be replaced by huge variety of nucleophiles (Figure 2.39) by quater-
nization with methyl iodide and removal of NMe3. The formed carbenium ion is stabilized by
an interaction with the iron atom, which required exo-elimination of NMe3 and exo-addition
of the nucleophiles, respectively. Thus, the substitution proceeds under retention of the con-
figuration, whereby the methyl group has to be directed away from the phosphine to avoid
steric interactions (Figure 2.39). [130]
Diastereoselective ortho-directed lithiations have emerged as a straightforward approach for
the synthesis of stereopure planar-chiral ferrocenes. Recently, many groups joined this field
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Figure 2.39 Diastereoselective ortho-lithiation of Ugi’s amine and subsequent functionaliza-
tion of the chiral auxiliary. [140]
of ferrocene chemistry and established a huge variety of different ortho-directing groups. [130]
As shown in Figure 2.39 they can easily be functionalized, or were introduced as protecting
groups and can thus be cleaved by standard reaction protocols. Figure 2.40 gives an overview
of chiral ortho-directing functionalities and highlights the hydrogen atom, which is removed
within the lithiation process. Furthermore, reagents for the functionalization or cleavage of
the chiral auxiliary are given. [130]
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Figure 2.40 Chiral ferrocenes applied in diastereoselective ortho-lithiations and functional-
ization of the chiral auxiliary I. [140–145]
Replacing the methyl group in Ugi’s amine by a phenyl group (K-65a) does not influence the
configuration within the lithiation process. However, the introduction of an ortho-bromine in
K-65b gives, upon treatment with tBuLi, a double-lithiated species. The interaction of both
organolithium fragments superseded the ortho-directing propterties of the NMe2 substituent,
which therefore acted as the steric interacting group. [141] The phenyl substituent in K-66
is crucial for a diastereoselective proceeding, [142,146] in contrast to K-63 and K-65a where
both groups gave products in high de. As shown in Figure 2.39, α-substituents can easily be
removed by a cationic activation and subsequent reaction with an nucleophile. [130] Formyl-
ferrocene [147] is a key compound for the introduction of several different functionalities. An
excellent combination of protecting and ortho-directing group is their conversion to chiral
acetals (K-67) [143] and aminals (K-68). [144] The formyl group can smoothly be released un-
der acidic conditions. Also non-carbon-based chiral ortho-directing groups were successfully
applied, for example the highly versatile sulfoxideK-69. [145], which can easily be obtained by
reaction of a commercially available menthyl-sulfinate with lithioferrocene. Ortho-lithiations
proceed diastereomerically pure, ascribed to the donor-abilities of the oxide oxygen. The
sulfoxide functionality can be removed by treatment with tBuLi or PhLi and the remaining
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planar-chiral lithioferrocene is available for a subsequent reaction with an electrophile (Figure
2.40). [130]
The number of reaction steps for the synthesis of stereopure planar-chiral ferrocenes can
be reduced, if the ortho-directing group is generated in situ, as shown for hemiaminal an-
ions. They can be obtained by the reaction of 1,1'-diformylferrocene and a pyrrolidine amide
K-70. The combination of the sterically demanding chiral backbone and the strong oxy-
gen donor gave dilithiated ferrocenes. Addition of electrophiles and simple aqueous work-up
result in tetra-substituted diformylferrocenes within one reaction step (Figure 2.41). [148] Car-
bonyl compounds can also be converted into chiral oxazolines (K-71), by reacting carboxylic
acids, acid chlorides or nitriles with aminoethanols. The steric repulsion occurs between the
substituent R and the organolithium derivative, which is coordinated by the nitrogen atom
and thus, positioned above the ferrocenyl plane. [130,149] Hydrazones (K-72), which were de-
rived from ketones and chiral hydrazines, can stabilize the lithium ion by nitrogen and oxy-
gen donors. Their cleavage requires oxidants, such as O3, TiCl3, or VCl2. [150] Axial-chiral
binaphthyl backbones in combination with a nitrogen donor also acted as stereoselective or-
tho-directing backbones (K-73), enabeling diastereopure lithiations at ambient temperature.
The removal of the biaryl backbone is similar to Ugi’s amine. [151]
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Figure 2.41 Chiral ferrocenes applied in diastereoselective ortho-lithiations and functional-
ization of the chiral auxiliary II. [148–151]
With respect to C,C cross-coupling reactions, in which phosphines are required as ligands,
phosphorus-based ortho-directing groups are of special interest. Suitable P -chiral ferrocenes
are based on phosphine oxides (K-74), [152] ephedrine-based phosphonates (K-75) [153] and
BH3-adducts of phosphoramidates (K-76) [154] (Figure 2.42). After their successful stereopure
ortho-functionalization they can be converted into phosphines. [130]
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Figure 2.42 P-Chiral ferrocenes applied in diastereoselective ortho-lithiations. [152–154]
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2.4 P,O-Substituted Ferrocenes
The ortho-functionalization of ferrocenes is based on carbon-, sulfur- and phosphorus-bonded
ortho-directing groups. As electrophiles, silanes, phosphines and a huge variety of carbon-
based electrophiles have been applied in the recent years. However, the usage of oxygen-based
ortho-directing groups and electrophiles has not been mentioned within Section 2.3, although
oxygen atoms have been shown to be very effective donor atoms for the stabilization of ortho-
lithium atoms. The lack of oxygen electrophiles limits its application in this field of chemistry.
Thus, the number of P ,O-substituted ferrocenes as suitable ligands in catalytic reactions has
sparsely been investigated. For the synthesis of 1,2-X,O-substituted ferrocenes (X = C,
S, P, ...) two pathways can be applied, whereby one starts with an oxygen-functionalized
ferrocene and one requires an oxygen-based electrophile. The key-step in both procedures is
the formation of a direct ferrocenyl C–O bond.
2.4.1 Oxygen-Electrophiles
Up to date, two possibilities for the introduction of oxygen-bonded groups are known. A
standard procedure has been reported in 1959 by Nesmeyanov by applying copper-mediated
Ullmann-type couplings on iodoferrocene, giving ferrocenyl acetate in the presence of acetic
acid as an air and moisture stable compound (Figure 2.43). [147] In similarity, ferrocenylboronic
acid can be reacted with Cu(OAc)2. [155] Both reactions were also applied on the respective
1,1'-homodisubstituted ferrocenes. [147,155] Ferrocenylacetate can be hydrolyzed to ferrocenol
in deoxygenated ethanolic KOH-solutions. Hydroxyferrocene can be seen as the organometal-
lic analogue of phenol. Ferrocenol is rapidly oxidized to a cyclopentadienone complex and
decomposes within hours under atmospheric conditions in solution, and is thus generated in
situ from ferrocenyl acetate. However, it can easily be handled in the absence of oxygen and
was applied in Williamson ether syntheses, whereas sterically non-demanding substrates are
preferably converted (Figure 2.43). [156] However, sterically demanding, secondary substrates
could successfully be reacted by reacting the respective alcoholate in Ullmann-type couplings
with iodoferrocene, in similarity to the synthesis of ferrocenyl acetate.
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AcOH, Cu2O
CH3CN
reflux, 3 h
Fe O
O
Fe OH
Fe O
R
Ullmann
NaOR, CuI
2,2'-bipyridine
R = Yield
Ullmann    Williamson
cyclohexyl (b)
isopropyl (c)
n-butyl (d)
82 %            0 %
Williamson
DMF, 100 °C, 18 h
R−X, X = Cl or OSO2Me
45 %            3 %
10 %          32 %
24 %          50 %
K-77a−d
(a)
OH−, EtOH
hydrolysis
Figure 2.43 Synthesis of oxygen-functionalized ferrocenes by Ullmann-type couplings or
Williamson ether synthesis. [147,156]
The yields of ferrocenyl ethers K-77a–d for both pathways show opposite trends. The
high yields for sterically demanding substrates within Ullmann couplings are due to an
increased nucleophilicity of secondary alcohols. Substituted phenols, which are not avail-
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able for Williamson reactions, were also applied in Ullman-type couplings, whereas electron-
withdrawing groups proved to be disadvantegous. [157]
A rare example of an oxygen electrophile is bis(trimethylsilyl)peroxide. It can be reacted
with lithio- or 1,1'-dilithioferrocene giving the trimethylsilyl ethers in 82 and 51% yield,
respectively (Figure 2.44). [158] The hydroxy functionality can easily be released from the
silylethers under basic conditions or with a fluoride source. [159] The synthesis of ferrocenol
by hydrolysis of ferrocenyl acetate is very common and almost exclusively used, whereas the
peroxide approach is hardly applied. This is moreover due to the handling of the peroxide,
which has to be stored at <0℃ and rapidly decomposes in the presence of traces of transition
metals. [160] Further applications of (Me3SiO)2 can be found besides ferrocene chemistry, by
converting phosphine sulfides and selenides into oxides [161] and also induces Baeyer-Villiger
oxidations. [162] Nevertheless, the successful formation of a Fc–O bond is remarkable, since the
usage of peroxides usually oxidizes the ferrocenyl backbone, which my result in decomposition.
Fe Li
O O SiMe3
Me3Si
−78 °C, Et 2O
Fe O
K-78, 82 %
SiMe3
Fe Li
O O SiMe3
Me3Si
−78 °C, Et 2O
Fe O
K-79, 51 %
SiMe3
Li O SiMe3
Figure 2.44 Oxygen functionalization of ferrocenes with bis(trimethylsilyl)peroxide. [158,159]
The introduction of hydroxy functionalities in ortho-position to a given substituent is even
more challenging. In case of the peroxide approach, solely the chiral ortho-directing ox-
azoline derivative K-71 was applied, besides its racemic derivative (Figure 2.45). [163] The
1,2-disubstituted stereopure hydroxyferrocene (S,Sp)-K-82 was obtained in an average over-
all yield of 43%, due the formation of the silylated side product K-80.
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Figure 2.45 Diastereoselective oxygen functionalization of ferrocene with bis(trimethyl-
silyl)peroxide. [163]
In contrast, the Ullmann-type coupling is more common for the ortho-hydroxylation of fer-
rocenes, since the required iodo-substituent can easily be introduced by several methods,
including diastereoselective ortho-directing groups, as shown in Figures 2.40 and 2.41. How-
ever, the formation of the Fc–O bond by the Ullmann-type coupling is the key-step within
this procedures, and its low tolerance towards ortho-substituents mainly restricted a broad
application. Thus, since its development in 1959, [155] the adoption to substrates bearing or-
tho-directing groups occurred first in 2008 by the group of Erker. [164] They used non-chiral
(K-43, Figure 2.31) and C -chiral acetals (K-67, Figure 2.40) for the introduction of iodo sub-
stituents and could successfully convert them into the respective acetates K-84 in excellent
yield (Figure 2.46). Prior to the acid-catalyzed removal of the chiral auxiliary they replaced
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the acyl- by a sterically demanding silyl-substituent, which is stable under basic conditions
but readily releases the hydroxy group by addition of [Bu4N]F. It could recently be shown
that the coupling reaction tolerates acidic NH-functionalities and can also be applied on
different carboxylic acids than acetic acid (Figure 2.43). [165] Directly nitrogen-functionalized
ferrocenes also allowed the conversion of their ortho-iodo derivatives into acetates with up
to 78% yield for an NMe2 group, whereas a pyrrolidine substituent decreased the yield to
33%. [166]
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(b) R = NHBoc, X = O;   54 %
Figure 2.46 Stereoselective introduction of different carboxylic acids at ortho-substituted
ferrocenes by Ullmann-type couplings. [164,165]
Reaction conditions: i) Cu2O, MeCN, carboxylic acid, 3 h, reflux; ii) NaOMe, DMF,
tBuPh2SiCl; iii) p-TsOH, H2O/CH2Cl2.
Remarkable results were reported by the group of Butenschön, who lithiated methoxyfer-
roceneK-88 in ortho-position (K-89) and subsequently converted it to the first 1,2-dioxygen-
functionalized ferrocene K-90 (Figure 2.47). [167] They also used 1,2-diiodoferrocene K-91,
which allowed for two Ullmann-couplings and successfully gave 1,2-diacetylatedK-92 in 88%.
FeO Fe IO
rac-K-89, 64 %
Fe OO
rac-K-90, 89 %
O
Fe II Fe OO
K-92, 88 %
OO
i) ii)
K-88
ii)
K-91
Figure 2.47 Acetylation of 1-iodo-2-methoxy and 1,2-diiodoferrocene by Ullamnn-type cou-
plings. [167]
Reaction conditions: i) BuLi, KOtBu, THF, –78℃, I2; ii) HOAc, Cu2O, MeCN, 3 h, reflux.
The functionalization of ferrocenes with oxygen-based substituents in the presence of
ortho-directing groups is still a challenging task. The remarkable results by using
bis(trimethylsilyl)peroxide and applying Ullmann couplings may not distract that besides
the shown examples no further research has been published.
2.4.2 Introduction of Phosphorus by Oxygen-Based ortho-Directing
Groups
Phosphorus-based reagents are widely used as electrophiles for the reaction with lithiated
species. Thus, a promising strategy for the synthesis of P ,O-substituted ferrocenes is the
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reaction of ortho-lithiated oxygen-functionalized ferrocenes. Extensive research was published
by Schaarschmidt as a member of the research group of Lang within a recent PhD thesis. [76]
As shown in Section 2.4.1, aromatic and aliphatic ferrocenylether are easily accessible. [156,157]
The ortho-directing properties of ferrocenyl ether K-93 were investigated by treatment with
BuLi in different amounts and subsequent reaction with ClPPh2 (Figure 2.48). [73] Applying
a K-93/BuLi ratio of 1:1 gave K-94 as the main product besides K-95–97. Changing to 1:2
gave K-95 instead. Compounds K-96 and K-97 could not be separated from each other.
The multiple lithiations that occur already at low BuLi ratios ascribing the ether functionality
to be a rather weak ortho-directing group.
Fe OPh2P
Ar
Fe O
tBu
Fe OPh2P
Ar
Fe OPh2P
tBu
Fe OPh2P
tBu
Ar
Ph2P Ph2P
i)
rac-K-94, 64 %K-93
PPh2
rac-K-95, 67 %a)
PPh2
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Figure 2.48 Lithiation behavior of ferrocenylether K-93 and subsequent reaction with
ClPPh2. [73]
Reaction conditions: i) 1st BuLi (1 equiv), TMEDA, hexane, 25℃, 12 h; 2nd –78℃, ClPPh2,
1 h; a) 2 equiv of BuLi.
Switching from the phenyl (ClPPh2) to the cyclohexyl chlorophosphine ClPCy2, as a stronger
σ-donor, gave mixtures of single- and multi-substituted products, which could not be sepa-
rated from each other. [73] This problem was circumvented by reacting the mixture of lithio-
ferrocenes, derived from K-93, with ClSn(Bu)3. Compound K-98 could be separated by
column chromatography and successfully be converted to phosphine K-99 (Figure 2.49). [73]
Nevertheless, the huge amount of side products in the first reaction step gave K-99 in a poor
overall yield of 21%.
Fe O(Bu)3SnFe O
tBu
Fe OCy2P
1st  BuLi, 25 °C,
      hexane, 12 h
2nd ClSn(Bu)3, 
      THF, −78 °C, 1 h
rac-K-98, 23 %
tBu tBu
rac-K-99, 91 %
1st  BuLi, THF,
      −78 °C, 1 h
2nd ClP(Cy)2,
      −78 °C, 1 h
K-93
Figure 2.49 Synthesis of a 1,2-P ,O-substituted ferrocene by a two-step process by using
ClSn(Bu)3. [73]
The diastereoselective lithiation was investigated by using the menthyl-functionalized ferro-
cenylether K-77a (Figure 2.50). A diastereomeric ratio (dr) of 1.6:1 for the 1,2-P ,O product
revealed a weak influence of the chiral menthyl group towards the lithiation process. Never-
theless, the absence of TMEDA clarified the weak ortho-stabilization of lithiated species by
ether functionalities and resulted in the formation of a dimeric structure, which explains the
the exclusive formation of the 1,1'-derivative (Figure 2.50). [76]
The competition between a lithiation in 2- and 1'-position was avoided by a double lithia-
tion in the presence of TMEDA or (–)-Sparteine (Figure 2.51). While increasing the steric
demand gradually within the series menthyl<borneyl<fenchyl enhances the de accordingly
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Figure 2.50 1,2- and 1,1'-Functionalization of ferrocenylmenthylether by a dimeric lithiated
species. [73]
by 20<70<80%. [76] The replacement of TMEDA (65% de) by the chiral amine (80% de)
resulted in a positive interaction of both chiral groups for the fenchyl (K-77e) and the bor-
neyl ether K-77f, contrary to the menthyl derivative K-77a where a decrease from 26% to
20% de was observed. [76] The effective chirality transfer in case of the borneyl and fenchyl
substituents is due to the steric demand and bicyclic backbone and the presence of three
methyl groups in close proximity to the oxygen donor atom. [168]
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Figure 2.51 Diastereoselective 2,1'-dilithiation of fenchylferrocenylether K-77e. [76]
Reaction conditions: i) BuLi, (–)-Sparteine or TMEDA, hexane, 25℃, 12 h; ii) ClPPh2,
–78℃ to 25℃, 12 h.
1,1'-Dilithiated ferrocenes can be converted into [1]ferrocenophanes, which allowed for more
diverse substitution pattern. Addition of Cl2PPh to the dilithiated species of borneyl ether
K-77f gave [1]phosphaferrocenophaneK-101 (Figure 2.52). [76] The strained ring was opened
by subsequent addition of PhLi, whereas the Li ion was positioned in 2-position, due to the
stabilization by the oxygen atom.
The diastereomeric excess of the ortho-lithiation is not influenced by the ferrocenophane
formation and remains at 70%.
The regioselectivity for the position of the phosphorus substituents can be inverted by us-
ing [1]sila- instead of [1]phosphaferrocenophanes. They are also derived from 1,1'-dilithiated
ferrocenes, e.g. derived from K-77e, by reation with Cl2SiMe2. The treatment of [1]silafer-
rocenophane K-104 with organolithium compounds exclusively ring-opened with the lithium
ion positioned ortho towards the ether functionality. Thus, the subsequent addition of the
phosphorus electrophile moreover gave the respective 1,2-P ,O ferrocene (Sp)-K-105 as a
single isomer after crystallization (Figure 2.53). However, the overall process is rather inef-
fective and gave the products in less than 7% yield, due to a polymerization of the strained
[1]silaferrocene K-104. The silyl-substituent acts as an “place holder“ for H+ or further elec-
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Figure 2.52 Synthesis and ring opening of [1]phosphaferrocenophane K-101. [76]
Reaction conditions: i) BuLi, (–)-Sparteine (2 equiv), hexane, 25℃, 12 h; ii) Cl2PPh, –78℃
to 25℃, 12 h. The overall yield of K-103a,b is 36%. (Rp)-K103a is formed as the main
diastereomer.
trophiles. Nevertheless, it does neither positively, nor negatively influence the performance
of the respective ligand within C,C cross-coupling reactions. [76]
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Fe OR FeLi
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OR FeMe2Si
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PhMe2Si
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Figure 2.53 Synthesis and ring opening of [1]silaferrocenophane K-104 to 1,2-P ,O-
substituted ferrocenes. [76]
Reaction conditions: i) BuLi, (–)-Sparteine (2 equiv), hexane, 25℃, 12 h; ii) Cl2SiMe2, –78℃
to 25℃, 12 h.
Although 1,2-P ,O-substituted ferrocenes could be obtained in the past, a high-yielding regio-
and stereoselective synthetic strategy is still pending.
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2.5 Fries Rearrangements
The Fries rearrangement is a 1,3-O→C migration at aromatic compounds named after Karl
Fries, who published his first examples in 1908. [169] He reacted phenolic esters in the presence
of a Lewis acid to acyl phenoles (Figure 2.54). The reaction is induced by the coordination
of the Lewis acid to either the ketone or the phenolic oxygen, or in acidic media, [170] respec-
tively. The activated ester splits off an acylium carbocation, which undergoes an electrophilic
aromatic substitution reaction (SEAr) with the aromatic backbone. Based on the electron
density in ortho- and para-position the acyl group can be substitutet in 2- (1,3-O→C) and
4-position (1,5-O→C), respectively. Besides this cationic version, Fries rearrangements can
proceed via radical/photo-induced mechanisms, [171] first reported 1960 by Anderson and
Reese, [172] and anionic pathways. Photo-induction results in a homolytic O–C bond cleav-
age of the ester-functionality. The formed acyl radical recombines in 2-/4-position with the
aromatic backbone, similar to the cationic proceeding (Figure 2.54).
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Figure 2.54 Cationic and radicalic Fries rearrangements. [169,171,172]
2.5.1 Anionic Fries Rearrangements at Non-Organometallics
The anionic Fries rearrangement is induced by an ortho-lithiation and subsequent intramolec-
ular 1,3-O→C migration (Figure 2.55), which combines several advantages compared to
cationic and radicalic proceedings.
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Figure 2.55 Different types of anionic Fries rearrangements depending on the rearranging
group. [169,173–176]
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As shown in the previous Sections, ortho-lithiations can be performed at low or ambient
temperatures, whereas the activation with Lewis acids requires harsh reaction conditions,
and photo-excitation affects the whole molecule. Furthermore, the regioselective lithiation
exclusively results in the formation of 1,2-substituted products, since the migrating group
rearranges by an intramolecular mechanism and is not released during the process.
Besides the initially reported carbo-Fries rearrangements, [169,172,177] also heteroatom-based
versions with X = Si (sila-), [173] S (thia-) [174,175] and P (phospho-) [176] were explored, whereas
the names are derived from the binding atom of the migrating groups (Figure 2.55). It should
be noted that anionic carbo-Fries rearrangements of N,N -dialkyl carbamates have also been
described as Snieckus rearrangements, [178,179] although Snieckus himself described this type
of reaction as anionic ortho-Fries. [180]
N
S
O O
CH3Li
fast
CH3Li
slow
N
S
O O
N
S
O OLi Li
Li
N
S
H
O OH
89 %
N
S
O O
no
rearrangement
Figure 2.56 Double lithiation within thia-Fries rearrangements at phenylsulfonamides. [181]
It should be noted that recently 1,3-N→C migrations where described as Fries rearrange-
ments, [171] which consequently needs to consider S→C versions within this topic. Electron-
withdrawing substituents at the migrating groups accelerate the lithiation, and facilitate the
rearrangement by ensuring a nucleophilic addition at the bonded atom. For S-based rear-
rangements sulfones are applied, which also stabilize hydroxy functionalities in the formed
product towards tautomerization by forming intramolecular hydrogen bridge bonds. [175] It
could also be shown that, although bearing the less acidic hydrogens, rearrangements exclu-
sively occurred in the ortho-position of the N -based aromatic (Figure 2.56). [181] This has to
be considered by choosing the appropriate amount of base and the addition of electrophiles.
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Figure 2.57 Anionic phospho-Fries rearrangements at phenyl phosphates and natural prod-
ucts. [176,182]
The first phospho-version of the Fries rearrangement has been accidantely been discovered
by Melvin in 1981. [182] He converted substituted phenols with diethyl phosphate into the
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respective phosphoric esters. Treatment with LDA at –78℃ gave the 1,2-P ,O-substituted
ortho-hydroxy phosphonates (Figure 2.57). The reaction tolerates several substitution pat-
tern and can be adopted to natural products, where no loss of chiral information at the
backbone is observed within the products. Rearrangements at chiral BINOL backbones also
proceed under maintenance of the axial-chiral information. [183] The progress of the anionic
phospho-Fries rearrangement (apFr) was nicely reviewed by Taylor and Watson in 2004. [176]
Changing from monoaryl- to di- and triaryl phosphoric esters allows for two and three con-
secutive rearrangements within one reaction step at the same molecule, as shown for the
conversion of triphenyl phosphate into its phosphine oxide (Figure 2.58). [176] This behavior
is unique, compared to the carbo-, thia-, and sila-versions.
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Figure 2.58 Simultaneous double and triple anionic phospho-Fries rearrangements at diaryl
phosphonates and triaryl phosphates. [176,184–190]
Using phosphorus-chiral groups gave the rearrangement products with retention of configura-
tion at the phosphorus atom, which unambiguously confirms the intramolecular proceeding.
By applying the apFr to phosphorus-chiral groups it could unambiguously be proven that
the anionic version of the Fries rearrangement proceeds by an intramolecular mechanism and
does not release the migrating group (Figure 2.59). The reaction proceeded under retention
of configuration at the phosphorus atom, which suggests a 5-coordinated transition state
caused by a syn addition/elimination mechanism, which was proven by single crystal X-ray
diffraction analysis. [191,192]
P
N
N
Ph
O
O
F
Li
P
N
N
Ph
O
O
F
P
N
N
Ph
OO
F
syn-addition syn-elimination
Li
(S,RP) (S,SP)
Figure 2.59 Retention of configuration at P -chiral substituents within anionic phospho-Fries
rearrangements. [191,192]
The regioselectivity of Fries rearrangements at phenyl-based compounds is accompanied with
the selectivity of the lithiation process and thus, depends on the steric demand of ortho-
/meta-substituents, electronic effects or selective metalations induced by halogen-metal ex-
change. [176,184]
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2.5.2 Anionic Fries Rearrangements at Organometallics
Accidentally discovered in 1990, the sila-version was the first example of an anionic Fries
rearrangement that proceeded at organometallic compounds. [173] Attempts to introduce a
dimethylallyl group by lithiation of the tricarbonylchromium complex K-106 resulted in the
migration of the silyl protecting group, which gave K-108 instead (Figure 2.60). Tricar-
bonylchromium fragments act as electron-withdrawing groups and are usually introduced
to facilitate deprotonation reactions at low temperatures, which explains the low yield of
K-108.
Cr(CO)3
O O SiiPr3
rac-K-106
Cr(CO)3
O OR
rac-K107 (R = SiiPr3),          78 %
rac-K108 (R =                   ), 23 %
BuLi, THF, −78 °C
ClSiiPr3 or
SiiPr3
Br
Figure 2.60 Anionic sila-Fries rearrangement at tricarbonylchromium complex K-106. [173]
The group of Butenschön, who also explored the anionic thia-Fries rearrangement at Cr(CO)3
complexes, [193] showed that anionic Fries rearrangements also proceed at ferrocenyl-based tri-
flates (Figure 2.61). [167,194] Although deprotonation reactions at the electron-rich ferrocenyl
backbones are decelerated, and their C5-ring geometry enlarges the distance to the ortho-
substituents, the 1,2-S,O rearranged products K-111a–c were obtained in virtually quan-
titative yields. The usage of K-111c, where triflic anhydride was used as an electrophile,
allowed for a subsequent anionic Fries rearrangement to the 1,3-di-ortho-substituted ferrocene
K-112 (Figure 2.61). [194]
Fe OH (Tf)2O, CH2Cl2
pyridine, −78 °C
Fe OF3CO2S
K-110, 90 %
RLDA, THF
−78 °C, E +
rac-K-111a (R = Me), 82 %
rac-K-111b (R = Ac),  99 %
rac-K-111c (R = Tf),   99 %
Fe OF3CO2S
SO2CF3
Fe OSO2CF3
K-109
LDA, THF
−78 °C
Me2SO4 K-112, 75 %
Figure 2.61 Anionic thia-Fries rearrangements for the synthesis of ortho- and 1,3-di-ortho-
substituted ferrocenes. [194]
Consecutive rearrangements within one reaction step were observed, when 1,1'-functionalized
K-113 was applied (Figure 2.62). The rearrangement exclusively gave the meso-isomers,
which was explained by a step-wise proceeding and a stereoinduction after the first process
towards the hitherto non-rearranged cyclopentadienyl ring. [167]
The respective phospho-Fries version has, with exception of the results described herein, not
been reported for ferrocenyl-based compounds or further organometallics. However, examples
for non-classic 1,3-S→C migrations of phosphoryl fragments have been reported, which should
be considered due to their similar mechanism. Based on mercaptoferrocene K-113, which is
more stable towards oxidation than the respective hydroxy derivative, S-ferrocenyl phosphate
K-114 could be converted to the 1,2-S,P-ferrocenes K-115 (Figure 2.63). [195]
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Fe
K-113
OSO2CF3
2.2 equiv, LDA
THF, −78 °C, E +
Fe
meso-K-114 (R = H),   85 %
meso-K-115 (R = Ac), 91 %
OR
RO
SO2CF3
F3CO2S
OSO2CF3
Fe
rac-K-114
not formed
OH
F3CO2S
SO2CF3
HO
2.2 equiv, LDA
THF, −78 °C, H +
Figure 2.62 Anionic thia-Fries rearrangements at 1,1'-disubstituted ferrocenes for the syn-
thesis of 1,1',2,2'-S,O-derivatives. [194]
Investigations with P -chiral groups showed retention of the configuration at the phospho-
rus atom (Figure 2.59). Replacement of phenyl by ferrocenyl-based backbones allows for
diastereoselective rearrangements of the migrating groups. The chiral functionalization with
(R,R)-diaminocyclohexane in K-116 gave the 1,3-S→C-rearranged product K-117 as a sin-
gle diastereomer (Figure 2.64).
Fe SH NaH, THF
ClP(O)(OiPr)2
Fe S
P
O
O LDA, THF
−78 °C
Fe SP
R
O
O
2
rac-K-115a (R = H),    86 %
rac-K-115b (R = CH3), 58 %
K-113 K-114, 82 %
2
Figure 2.63 Anionic phospho-1,3-S→C rearrangements by starting from mercaptofer-
rocene. [195]
The successful investigations of anionic thia- and sila-Fries rearrangements and 1,3-S→C
migrations of phosphosphorus-based groups at a ferrocenyl backbone let to the conclusion
that the respective anionic phospho-Fries version may also be practicable and efficiently
yield the desired 1,2-P ,O-substituted ferrocenes. However, the lithiation and rearrangement
process is influenced by several parameters, which can cause side reactions.
FeS
P tBuLi, Et2O, reflux
CH3I
Fe PS
(R,R,Sp)-K-117, 55 %
de > 96 %
N
N
(R,R)-K-116
O
N
N
O
Figure 2.64 Diastereoselective anionic phospho-1,3-S→C rearrangement to 1,2-S,P -
substituted (R,R,Sp)-K-117. [195]
They are summarized in Figure 2.65 to illustrate the complexity of the system. The succesful
formation of an anionic phospho-Fries rearranged product E (Figure 2.65) requires a nega-
tive charge in ortho-position B, which is typically introduced by lithiation/deprotonation or
halogene-metal exchange from A. However, this process competes with a nucleophilic attack
at the phosphorus atom, resulting in a cleavage of the migration group (F). Thus, bases such
as non-nucleophilic, steric demanding amides are preferably applied. Furthermore, a strict
temperature regime has to be maintained. A successful Fries rearrangement also requires
an intramolecular addition at the binding atom. Otherwise, the ortho-lithiated species is
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protonated upon an aqueous work-up, indicating an unsuccessful lithiation. Addition of an
electrophile, e.g. Me2SO4 can verify a successful lithiation by giving the ortho-methylated
species C (Figure 2.65). [196]
Fe LiO
R2P
X
base
ortho-
lithiationPR2
X
base
+
phospho-Fries
rearrangement
E+ E+E+
F
C
D
nucleo-
philic
attack
A
B
ether cleavage
EG
Fe HO
R2P
X
FeO
FeO
E
Fe EO
R2P
X
Fe PR2O
X
Fe PR2O
X
E
Figure 2.65 Possible side reactions within anionic phospho-Fries rearrangements. [196]
2.5.3 Anionic Homo-Fries Rearrangements
Homo-Fries Rearrangements at Non-Organometallics
The homologation of the O→C migration from 1,3 to 1,4 O→C by insertion of a carbon
fragment is designated as an anionic homo-Fries rearrangement. This type of reaction is
sparsely investigated, but was an essential step for the synthesis of a cyclo-Mumbaistatin
derivative K-120 (Figure 2.66), which is used as a target for drugs against type-2 diabetes
mellitus and for brain tumor investigations. [197] The reaction is induced by an metal-halogen
exchange at K-118. After the 1,4-O→C migration of the ester functionality, the benzylic
alcoholate underwent a subsequent intramolecular cyclization, whereas a nucleophilic attack
at the established keto-carbonyl carbon atom occurred. The thus formed hemiacetal anion
consecutively trans-esterificates and forms the final spiroacetal K-120 in a diastereomeric
ratio (dr) of 13:1. Removal of protective groups gives the cyclo-Mumbaistatin derivative
rac-K-120.
OMe
CO2tBu
O O
I
OMOM
MeO
MeO
MeO
TIPSO
OMe
OMeO
MeO
MeO OMOM
LiO
O
OtBu
TIPSO
OMe
MeO OO
OMOM
HO2C
O
O
O
4
4
3
i) 1,4-O     C
anionic homo-Fries
rearrangement
ii)
K-118 K-119 rac-K-120, d.r. 13:1
cyclo-Mumbaistatin
Figure 2.66 Anionic homo-Fries rearrangement for the synthesis of cyclo-Mumbaistatin
K-120. [197]
Reaction conditions: i) iPrMgCl·LiCl, THF, –15℃ for 1.5 h, then 50℃, 2 h, 76%. ii) Jones
reagent (CrO3 ·H2SO4), 0℃, 30min, 59%.
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The 1,4-homo-Fries rearrangement occurs if other rearrangements are suppressed (Figure
2.67). [179] Lithiation of benzylcarbamate K-121a was attempted to occur in the benzylic
position, which was prevented by the electron-rich butyl group. Thus, lihtiation at the phenyl
ring occurred and gave K-122 after an anionic homo-Fries rearrangement. Replacement of
the butyl group by a hydrogen atom in K-121b allowed the lithiation in the benzylic position
to the 1,2-O→C rearranged product K-123.
R
O
O
O
R = Bu; sBuLi, 
THF, 2 h
1,4-O     C
homo-Fries
R = H; sBuLi, THF
TMEDA, 2 h
1,2-O     C
rearrangement
H
OH
O
O
O
NEt2
rac-K-121b (R = Bu)
rac-K-121a (R = H)
Bu
OH
O
O
rac-K-122, 91 %
O
NEt2
rac-K-123, 81 %
NEt2
O
Figure 2.67 Anionic homo-Fries rearrangement and 1,2-O→C migration. [179]
For ortho-cresyl derivatives K-124 an inverse proceeding of an anionic homo-phospho-Fries
rearrangement was observed, where the migration occurred from the aromatic to a benzylic
position in K-125 (Figure 2.68), contrary to Figures 2.66 and 2.67. [198] Lithiation exclusively
occurred in the benzylic position, probably due to a complexation of the lithiated species
by both phosphato-substituents. Lithiation at the phenyl core required a halogen-metal
exchanged of the brominated species K-124b, which induced the respective 1,3-migration
and gave K-126 quantitatively.
O OP PEtOEtO
OEt
OEt
S S
HO OH
S S
tBuLi, THF
−78 °C
PEtO
EtO P
OEt
OEt
HO OH
S
P
EtO
EtO P OEt
OEt
S
K-126, 97 %K-125, 29 % K-124a (R = H)
K-124b (R = Br)
R R
R = H R = Br
nBuLi, THF
−78 °C
1,4-O    C 1,3-O    C
Figure 2.68 Benzylic homo-phospho-Fries vs phenylic ortho-phospho-Fries rearrange-
ment. [198]
Homo-Fries Rearrangements at Organometallics
Anionic homo-Fries rearrangements at organometallics have solely been reported as sila-
versions. It should be kept in mind that in case of sila derivatives, the proceeding of
1,3-migrations at aromatics are classified as Fries rearrangements, whereas the respective
1,4-homo-Fries modifications could also be considered as retro-Brook rearrangements. [199,200]
Within the synthesis of the 1,3-disubstituted ferrocene K-127 the place holding bromine
atom in K-124 should be exchanged by a lithium atom (K-125; Figure 2.69). [201] Sub-
sequent 1,4-O→C anionic homo-sila-Fries rearrangement of the hydroxy protective group
occurred, resulting in the 1,2,3-trisubstituted K-126 prior to protonation. [201]
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K-124a (R = SiMe3)
K-124b (R = S-p-tol)
FeBr
R
O SitBuMe2 FeMe2
tBuSi
R
OH
K-126a (R = SiMe3),  85 %
K-126b (R = S-p-tol), 77 %
Fe
R
OH
K-127a, 0 %
K-127a, 0 %
H2OBuLi
K-125a (R = SiMe3)
K-125b (R = S-p-tol)
FeLi
R
O SitBuMe2
Figure 2.69 Anionic homo-sila-Fries rearrangement for the synthesis of 1,2,3-trisubstituted
K-126. [201]
The presence of two electronically different aromatics allows for miscellaneous 1,4-O→C mi-
grations. The regioselectivity towards the phenyl ring was ensured by a halogene-metal-
exchange at K-128 (Figure 2.70). [199] A lithium exchange between the phenyl and ferrocenyl
groups was not observed. Treatment of a non-brominated derivative of K-128 with BuLi,
moreover, resulted in the cleavage of the silyl group, whereas 9% of a product derived from
a lithiation at the ferrocenyl backbone could be isolated. Diastereoselective anionic homo-
sila-Fries rearrangement towards the ferrocenyl backbone could be achieved by replacing the
phenyl by a methyl group, giving K-131.
Fe
OSiMe3
Br
Fe
OH
SiMe3
BuLi, THF,
−78 °C
rac-K-128 rac-K-129, 79 %
BuLi, tBuOK
THF, −65 °C
(R)-K-130 (R,Rp)-K-131, 35 %
Fe Fe SiMe3
O HO
SiMe3
Figure 2.70 Regioselective anionic homo-sila-Fries rearrangement towards either phenyl or
ferrocenyl substituents. [199]
With regard to the synthesis of 1,2-P ,O-substituted ferrocenes, the anionic phospho-Fries
rearrangement might be the most suitable synthesis strategy, due to its regioselective, in-
tramolecular proceeding. The presence of the oxygen and phosphorus containing fragments
within the starting materials does not require for further electrophiles and should thus pre-
vent a 1'-functionalization, which is the main reason for the lack of knowledge within this
field of ferrocene chemistry.
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3.1 Anionic Phospho-Fries Rearrangements
As described in the previous chapter, the most frequent synthetic methodology relies on the
ortho-directed metalation of single-substituted ferrocenes followed by the addition of an elec-
trophile (Figure 3.1). [130] Just a few of these ortho-directing groups contain a heteroatom
directly bonded to ferrocene, thus limiting the diversity of accessible ferrocenes carrying two
heteroatoms in 1,2-positions. The synthesis of 1,2-P ,O-substituted ferrocenes can be realized
by ortho-directed metalation starting either from ferrocenyl ethers (Figure 3.1, path A) or
ferrocenyl phosphine oxides (path B). The first path suffers from the formation of several
byproducts due to di- and polymetalation of ferrocenyl aryl ethers, requiring an elaborate pu-
rification, [73,74] while for the respective alkyl derivatives lithiation occurs almost exclusively at
the heretofore unsubstituted cyclopentadienyl ring. [73,74,120,167] The small number of oxygen
electrophiles not affecting the ferrocene backbone or the questionable success of an Ullman-
type coupling limits the use of ferrocenyl phosphine oxides [127,202] as starting materials for this
approach, which has therefore not been realized yet. In contrast, intramolecular transforma-
tions, e.g. anionic hetero-Fries or Fries-like rearrangements, would allow the straightforward
synthesis of such metallocenes; however, the scope of this reaction has been scarcely explored,
as there are only three reports in ferrocene chemistry so far. [167,194,195] In principle, it should
be possible to access 1,2-P ,O-substituted ferrocenes exerting an apFr (Figure 3.1, path C),
circumventing difficulties in the synthesis of these molecules via the ortho-directed metalation
of ferrocenyl ethers.
Fe OR'R2P
recent work
AFe
OR'
Fe O
anionic phospho-
Fries rearrangement
(apFr)
C
P(X)R2
X = O, S, BH3
FeR2(O)P
B
Figure 3.1 Different pathways for the synthesis of 1,2-P ,O-substituted ferrocenes.
3.1.1 Suitable Starting Materials and Limitations
Oxygen-substituted ferrocenyl derivatives are most easily be obtained by reacting ferrocenol
(5) [147] with electrophiles. The organometallic analogue of phenol is obtained by a four-
step synthesis starting from ferrocene (1), which is converted to the stannyl-derivative 2 and
reacted with iodine giving 3 (Figure 3.2). [147] A Cu(I)-mediated coupling in the presence of
acetic acid results in the air and moisture stable acetate 4. Final alkaline hydrolysis gives
ferrocenol 5, which gets oxidized rapidly under atmospheric conditions. [147] Thus, it was
prepared under oxygen-free conditions and subsequently used for further reactions.
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Fe Fe Sn(Bu)3 Fe I
1 2 3 4 5
Fe O Fe OH
O
i) I2
ii)
Cu2O, AcOH
iii)
OH−
iv)
Figure 3.2 Synthesis of ferrocenol (5) starting from ferrocene.
Reaction conditions: i) tBuLi, 1 : 1 hexane/THF, 0℃, ClSn(Bu); ii) I2, CH2Cl2; iii) AcOH,
Cu2O, CH3CN, reflux, 3 h; iv) KOHaq, EtOH/H2O, reflux, 20min, HClaq.
The ferrocenolato P(III) and P(V) compounds 6–15 were synthesized starting from ferrocenol
(5) (Figure 3.3), which was reacted with the respective chlorophosphorus derivatives in the
presence of triethylamine or BuLi (Figure 3.3). The ferrocenolato P(III) compounds were
additionally either treated with BH3·THF (8, 12 and 15) or oxidized using H2O2 (9) or
elemental sulfur (7, 10 and 13), respectively. Except for the less electrophilic thio (7) and
nitrogen containing derivatives (12, 14 and 15), the products can typically be isolated in
good to excellent yields. For the synthesis of phosphoramidate 14 the usage of BuLi is
required for the deprotonation of 5, otherwise no conversion was observed.
5
PR2ClFe
OH Fe
6−15
PR2O
Fe
6, 90 %
P(OEt)2O Fe
7, 31 %
P(OEt)2O Fe
8, 76 %a)
P(OEt)2O
BH3
Fe
10, 95 %c)
PPh2OFe
9, 85 %b)
PPh2O
Fe
11, 62 %
P(OPh)2O Fe
12, 51 %a,d)
P(NEt2)2O
BH3
Fe
13, 85 %c,d)
P(NEt2)2O Fe
15, 34 %a,d)
PO N
2
Fe
14, 72 %d,e)
PO N
OH3B
NEt3,
CH2Cl2
O
O
O
O
S
S
S
E
E
Figure 3.3 Reaction of ferrocenol (5) with different phosphorus electrophiles to afford 6–15.
Reaction conditions: NEt3, CH2Cl2, ambient temperature. Yields are based on 5. a) BH3·THF
was added; b) H2O2 was added; c) S8 was added; d) THF was used as the solvent; e) BuLi was
used instead of NEt3.
When a solution of phosphate 6 in tetrahydrofuran was treated at temperatures below –40℃
for 4 h with 2 equiv of freshly prepared LDA (lithium diisopropylamide) with subsequent
addition of excess dimethyl sulfate, almost all starting material could be recovered, strongly
indicating that no ortho-directed lithiation took place. At –30℃, however, disubstituted
ferrocene 16 could be isolated in 94% yield as the only product (Figure 3.4).
The absences of phosphate 6 and an ortho-methylated ferrocene (C, Figure 2.65) indicate that
the rate of the apFr is sufficiently high under these conditions. [176,187,188,198,203,204] Replace-
ment of the P=O oxygen atom by a BH3 protecting group decreases the yield for ferrocene
18 to 37% (Figure 3.4). The recovery of only 31% of the starting material may be due to
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partial decomposition during the reaction. Thiophosphate 7 gives under these conditions
only recovered starting material. If the stronger base sBuLi is used at –30℃, however, thio-
phosphonate 17 can be isolated in 50% yield (Figure 3.4). Running this reaction at 0℃
decreases the yield to 11% (35% recovered starting material). Replacement of LDA by the
Simpkins base (+)-bis[(R)-1-phenylethyl]amine in the rearrangement of 6 resulted in a very
low enantioenrichment (<5% ee) of phosphonate 16, as evinced by chiral HPLC (Experimen-
tal Section). This is in accordance with other ortho-directed lithiations at ferrocene, where
a mere change of the base without further adoptions of the reaction conditions had only a
small effect. [194,205]
Fe
6 (E = O)
7 (E = S)
8 (E = BH3)
P(OEt)2O
E
base,
i)
H Fe
rac-16 (E = O),     94 % 
  rac-17 (E = S),     50 %a)
rac-18 (E = BH3), 37 %
O(EtO)2P
E
Figure 3.4 ApFr of phosphate 6, thiophosphate 7 and borane adduct 8.
Reaction conditions: LDA, THF, –30℃, 4 h, Me2SO4 or MeI; a) sBuLi was used instead of
LDA. Yields are based on 6–8.
Replacing the ethoxy (6) by phenoxy substituents in ferrocenyl phosphonate 11 opens two
different reaction pathways, as an apFr can take place at ferrocene and at the benzene rings
(Figure 3.5). When phosphate 11 was treated with LDA at –40℃, a double phospho-Fries
rearrangement was observed at the two benzene moieties, and phosphinate 19 could be iso-
lated in 8% yield. Although further products were formed, as evinced by 31P{1H} NMR
spectroscopy, no additional compound could be either isolated in pure form or identified.
Based on this results, further investigations were performed (Section 3.1.3). Likewise, phos-
phinate 9 gave a complex product mixture when similar reaction conditions were applied
(Figure 3.5), from which desired phosphine oxide 20 was isolated in 8% yield. However, for
this transformation partial nucleophilic attack of the base occurred at the phosphorus atoms,
which results in the formation of ferrocenyl methyl ether (22; 16%).
Fe
  9 (E = O, Ar = Ph)
10 (E = S, Ar = Ph)
11 (E = O, Ar = OPh)
PAr2O
E
H
Fe
rac-20 (E = O), 8 % 
rac-21 (E = S),
  
0 %
OP
E
Ar = OPh
apFr
i)
Fe
PO
O OH
2
19, 8 %
apFr
ii)
Ar = Ph
iii)
2
Fe O
S
PsBu
2
22, 86 % rac-23, 68 %
+
Figure 3.5 ApFr of phosphinates 9 and 10, and phosphate 11.
Reaction conditions: i) LDA, THF, –40℃, 4 h, MeI; ii) like i) at –30℃; iii) sBuLi, –30℃, 4 h,
MeI. Yields are based on 9–11.
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In the case of the corresponding thiophosphinate 10, LDA turned out to be a too weak base,
as the starting material could be recovered completely. The stronger base sBuLi exclusively
resulted in nucleophilic attack at the phosphorus atom, and hence only ferrocenyl methyl ether
(22) and sec-butyldiphenylphosphane sulfide (23) were formed (Figure 3.5). The identity
of15 and 23 has inter alia been proven by single-crystal X-ray diffraction analysis (Figure
3.17).
Fe
12 (E = BH3, R = NEt2)
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14 (E = O, R = PYI)
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            31 %c)
O
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rac-25 (E = S, R = NEt2),     85 %a)
rac-26 (E = O, R = PYI),      64 %b)
                                             48 %c)
Me
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+
Figure 3.6 Reaction of phosphoramidates 12–14 with sBuLi to afford ortho-methylated 24–
27.
Reaction conditions: a) THF, ≤ –10℃, 3.5 h; b) hexane, ambient temperature, 18 h; c) Et2O,
≤ –30℃, 4 h. Yields are based on 12–14.
Treatment of N -containing 12–15 with LDA and MeI did not result in the lithiation of these
species and hence > 80% of the starting material could be recovered. The high basicity of the
ferrocenyl backbone is caused by an increased electron density, due to the electron-donating
N -bonded substituents, as it could be confirmed by electrochemical investigations (Table 3.8).
Replacing LDA by the stronger base sBuLi allowed the synthesis of the ortho-methylated
derivatives 24–27 (starting from 12–14) (Figure 3.6).
CH3
1H NMR 31P{1H} NMR
–5.4 ppm 
24.0 ppm 
3.25 ppm 
1.36 ppm 
3JH,H = 7.1 Hz
4JH,P = 1.0 Hz
3JH,H = 7.1 Hz
1.11 ppm 
1.15 ppm 
3JH,H = 7.1 Hz
OCH3
CH2C5H5
C5H4 C5H4
C5H3 C5H3 C5H3
CH3 CH3C5H5
CH2
Figure 3.7 Comparison of selected parts of the 1H (left) and 31P{1H} NMR spectra (right)
of 6 (top) and its apFr product 16 (bottom).
Measurement conditions: 25℃, CDCl3 (6 and 31P{1H} NMR of 16) or C6D6 (1H NMR of
16).
Within these reactions, lithiation occurred in ortho-position, whereby the lithium ion is sta-
46
3.1. ANIONIC PHOSPHO-FRIES REARRANGEMENTS
bilized by the oxygen atom of the ferrocenyl entity. An involvement of the P→E moiety is
possible for E = O and S, however, in case of the borane adduct 25 (E = BH3) it failed.
Nevertheless, the ortho-methylated species 24–27 could not be separated from their starting
materials 12–15, due to their similar properties within the column chromatographic workup.
However, they could be identified by inter alia 1H and 13C1H NMR spectroscopy and are
highlighted in Figure 3.7 and 3.8.
CH2
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C5H5
C5H5
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C5H3, 
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OCH3
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CH3, 16.1 ppm
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CH3
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2JC,P = 5.6 Hz
16.66 ppm
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Figure 3.8 Comparison of selected parts of the 13C{1H} NMR spectra of 6 (top) and its
apFr product 16 (bottom).
Measurement conditions: 25℃, CDCl3 (6 and the left part of the 13C{1H} NMR of 16) or
C6D6 (right part of the 13C{1H} NMR of 16).
The lithiation behavior strongly depends on the solvent applied, as it could be shown for
pyrrolidine containing 14. Thus, running the reaction in hexane gave 26 in a mixture along
with 14 and 27 of ratio 1 : 0.24 :< 0.05, whereas in diethyl ether a ratio of 1 : 0.06 : 0.65
is characteristic, due to the increased reactivity of sBuLi. The methyl group should be
substituted in ortho-position to the oxygen atom (1,2-subsitution), due to a stabilization of
the lithium ion, as found for derivatives possessing a Fc–P bond. [206,207] To the best of our
knowledge, 1,3-disubstituted products can merely be obtained by multiple step lithiations
including reactions with electrophiles, [208] or were formed in a negligible yield compared to
the 1,2-main product. [209] Hence, a 1,3-substitution pattern is rather expected for electrophilic
aromatic substitution reactions and not for lithiation reactions as depicted in Figure 3.6. [210]
The distinction between apFr-derived, e.g. 16–18, and non-rearranged-methylated products
24–27 could be unambiguously proven using NMR spectroscopy. For apFr-derived products,
on the one hand, the resonance in the 31P1H NMR spectra are shifted downfield from –5.4
(6), 63.8 (7), and 128.2 ppm (8) to 36.4 (16), 89.6 (17), and 135.4 ppm (18), respectively.
Additionally, a singlet for the methoxy groups was observed at ∼ 3.5 ppm (16–18) in the
1H NMR spectra (Figure 3.7). Due to the established planar chirality at ferrocene the two
ethoxy moieties become diastereotopic, resulting in a doubling of all their resonances in 1H
and 13C1H NMR spectra, respectively (Figure 3.7).
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Figure 3.9 Comparison of selected parts of the 13C{1H} NMR spectra of 14 (bottom) and
its methylated derivatives 26 (middle) and 27 (top). Measurement conditions:
25℃, C6D6
The C–P ipso-carbon atom gives a doublet in the 13C1H NMR spectra at 59.2 ppm with
a large 1JC,P coupling constant of 213Hz (16), in agreement with the values for similar
compounds (Figure 3.8). [211] While the apFr occurred, a singlet for the methoxy groups
could be observed at ∼58 ppm and the attached ipso-carbon is shifted downfield from 118
(6) to 129 ppm (16). The presence of the phosphorus atom attache at the cyclopentadienyl
increased the JC,P couplings from 4–7 to 11–14Hz (Figure 3.8).
For methylated ferrocenes 24–27, where no apFr occurred, the methylation could be identified
besides the presence of starting material (18% of 12 for 24, 7% of 13 for 25, and 6% of 14
for 26 and 27, Figure 3.9). The methyl groups were observed at ∼2 ppm in the 1H and at
∼12 ppm in the 13C{1H} NMR spectra, which are characteristic, e.g., for methylferrocene. [212]
The CH3-bonded ipso-carbons of the cyclopentadienyls showed resonances between 74 and
75 ppm. For the 2,1'-functionalized ferrocene 27 the additional methyl group in 1'-position
was observed at 13.9 ppm. The respective ipso-carbon of the cyclopentadienyls occurred
at 85.0 ppm. The 11B NMR values for the borane adducts 12, 15 and 24 slightly differ
between the (NEt2)2-functionalized compounds 12 and 24 with –39.5 ppm and the cyclic 2-
aminoethanol containing species 15 (–42.6 ppm). The appropriate signals appear as doublets
with a 1JB,P coupling constant of ∼90Hz.
3.1.2 Chiral Pool derived Ferrocenyl Phosphates
The apFr of a non-chiral ferrocenyl phosphate (6) in the presence of a chiral base did not
result in an enantiomerically enriched rearrangement product (Section 3.1.1). [137,194,205,213]
Therefore, a diastereoselective procedure is needed, with the chiral information present in the
starting phosphates. The known procedures for the synthesis of (chiral) chlorophosphates are
based on the reaction of the respective alcohols in the presence of a base, such as triethylamine
or pyridine, and subsequent filtration and distillation of the product mixture. [214,215] Thus,
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P(OR)2O
O
28a−f 29a−f, > 95 % 30a, 70 %
30b, 91 %
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30d, 46 %
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(a)
R = Cy
(b) R =
(1R)-Mt
(c) R =
(1S)-Mt
(d) R =
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OR
Figure 3.10 Synthesis of chiral pool derived dialkylchlorophosphates 29a–f and their con-
version to ferrocenyl phosphates 30a–f.
Reaction conditions: i) Et2O, BuLi, POCl3 (0.5 equiv); ii) Et2O, 5, BuLi, –30℃, 29a–f.
Yields are based on 5.
the applied purification process results in a lower yield of the (di)chlorophosphates and high
amounts of ammonium salts.
Thus, the reported procedure were amended into a straightforward, high-yielding syn-
thetic protocol including lithiation of cyclohexyl (28a, Cy), (1R)-menthyl (28b, (1R)-Mt),
(1S)-menthyl (28c, (1S)-Mt), (1S)-borneyl (28d, Bo), (1R)-α-fenchyl (28e, Fn) and (1S)-
isopinocampheyl alcohols (28f, Ip) in diethyl ether as the solvent at 0℃ and subsequent
addition of POCl3 (Figure 3.10).
After removal of any lithium salt by simple filtration over Celite, the respective chlorophos-
phates 29a–f were obtained in quantitative yields without the need for further purification
(Experimental Section). Conversion of 29a–f to the ferrocenyl phosphates 30a–f was real-
ized by the deprotonation of ferrocenol (5) using BuLi and subsequent treatment 5-Li with
the chlorophosphates 29a–f (Figure 3.10). After the appropriate workup, ferrocenes 30a–f
could be isolated in good to excellent yields.
However, the apFr of 30a–f does not proceed under the reaction conditions which we have
reported recently for short-chain diethyl phosphate (Section 3.1.1). Low yields obtained in the
temperature range from –30 to 0℃ and the beginning of ether cleavage at higher temperatures
prompted us to use nonpolar instead of polar solvents. The required activity of the lithium
base can be enabled by addition of a diamine such as TMEDA (tetramethylethylenediamine)
or the chiral (–)-Sparteine (=(–)-Spart) (Table 3.1).
Using the optimized reaction conditions (hexane, diamine, base, ambient temperature, 18 h)
from Table 3.1, the desired rearrangement products could be obtained in good to quanti-
tative yields (Table 3.2). It should be noted that the sterically more demanding aliphatic
substituents, in comparison to ethyl groups, stabilize all phosphates as well as all further
products toward hydrolysis and, hence, these compounds can be handled in air and moisture
for several weeks without a notable rate of decomposition.
The kinetically controlled lithiation of ferrocenyl phosphates 30a–f resulted in a diastere-
omeric excess during the apFr that depends on the demand of the aliphatic substituents
(Table 3.1). Therefore, the fenchyl derivative 31e exhibits with 80% the highest de, due
to the three methyl groups located closer to the oxygen-bonded carbon in comparison with
the other chiral pool alcohols. The de of the rearrangement products 31a–f can easily be
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Table 3.1 Optimization of the reaction conditions for the apFr of chiral pool derived ferro-
cenyl phosphate 30b.
Fe O(RO)2P
31b
O
Fe
P(OR)2O
O
30b
1st) hexane, additive, 
       base, T, time
2nd) Me2SO4, 60 °C,
       1 h
Me-30b
Fe
P(OR)2O
O
R =
+
Entry Base equiv T Additive Solvent Yield /%a
/ ℃ (time / h) 30b 31b Me-30b
1 LDA 3 –20 – THF (4) 60 19 –
2 LDA 1.3 –5 – THF (4) 38 15 –
3 LDA 3 0 – THF (4) 50 – –
4 sBuLi 1 0 – Et2O (2) 7 – 22
5 LDAb 2 –10 – THF (3) 71 – 24
6 sBuLi 2 0 – Et2O (3) – 40 –
7 LDA 2 –78 to 25 TMEDA hexane (18) – 63 –
8 sBuLi 2 25 – TBMEc(4) 91 – –
9 LDA 2 25 TMEDA hexane (18) – 99d –
10 LiTMP 2 25 TMEDA hexane (18) – 99d –
a The yields were determined from 31P{1H} and 1H NMR spectra of the mixture.
b 2 M solution in Et2O.
c tert-butyl methyl ether.
d Isolated yields.
obtained by the integration of fitted signals in the 31P{1H} NMR spectra (Table 3.2) and is
further influenced by the required diamine and the base. Instead of LDA the use of the steri-
cally more demanding base LiTMP (=lithium tetramethyl piperidide) resulted in an increase
of the de for 31e from 0.72 (LDA) to 0.80 (LiTMP).
Fe
P(OEt)2O Fe
P(OEt)2O(EtO)2P
rac-32, 33 %6
O
i) ii) Fe
Me
O(EtO)2P
rac-33, 21 %
P(OEt)2O O O
O
Figure 3.11 Conversion of 6 to ortho-phosphonato ferrocenyl phosphate rac-32 and con-
secutive apFr.
Reaction conditions: i) LDA, THF, –20℃, 4 h, ClP(O)(OEt)2. Yield based on 6; ii) LDA,
THF, –30℃, 4 h, MeI. Yield based on rac-32.
Recrystallization of 31e further improved the de to 90%, which confirms the fenchyl sub-
stituent to be the most appropriate for establishing diastereomerically enriched products.
However, when the diamine from the achiral TMEDA is changed to the chiral (–)-Sparteine,
no further positive influence on the de of 31e was observed. Interestingly, when (–)-Sparteine
is used for the rearrangement of the (1R)- and (1S)-menthyl phosphates 30b,c, a double
stereo differentiation is not detectable, due to an enhanced de for both of the phosphonates
31b,c (Table 3.2). However, a mismatch situation occurred for 31d–f, in which (–)-Sparteine
is not beneficial for the stereoselectivity.
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Table 3.2 Optimization of the diastereoselective proceeding for the apFr of chiral pool de-
rived ferrocenyl phosphates 30a–f.
Fe O(RO)2P
31a−f
O
Fe
P(OR)2O
30a−f
1st) hexane, base
       amine, 18 h, 25 °C
2nd) Me2SO4, 60 °C, 1 h N
NH
H
(−)-Sparteine
O
Entry Educt R Base Amine Yielda deb
1 30a cyclohexyl (Cy) LDA TMEDA 70% –
2 30b (1R)-Mt
(b)
LDA TMEDA 99% 0.29
3 30b LDA (–)-Spart 99% 0.40
4 30b LiTMP (–)-Spart 99% 0.00
5 30c (1S)-Mt
(c)
LDA TMEDA 90% 0.24
6 30c LDA (–)-Spart 99% 0.38
7 30c LiTMP TMEDA 87% 0.37
8 30c LiTMP (–)-Spart 89% 0.00
9 30d
Bo (d)
LDA TMEDA 80% 0.38
10 30d LDA (–)-Spart 99% 0.32
11 30e
Fn (e)
LDA TMEDA 29% 0.72
12 30e LDA (–)-Spart 79% 0.58
13 30e LiTMP TMEDA 65% 0.80
14 30e 0.90c
15 30f
Ip (f)
LDA TMEDA 57% 0.40
16 30f LDA (–)-Spart 72% 0.30
17 30f LiTMP TMEDA 58% 0.27
18 30f LiTMP (–)-Spart 80% 0.13
a Yields refer to isolated compounds with respect to the starting ferrocenyl deriva-
tive.
b The values are based on the integrals of fitted signals of 31P{1H} NMR spectra.
c After single recrystallization.
After the apFr, the resulting hydroxy functionality is not limited to react with dimethyl
sulfate, which allows for two subsequent rearrangements. Subsequent addition of diethyl
chlorophosphate to the intermediate of the reaction of phosphate 6 with LDA gave ferrocene
32 (Figure 3.11). Both transformations proceeded as expected; no further ferrocene com-
pounds could be identified. The considerably lower yields in comparison to that for the
synthesis of 17 (Figure 3.4) are due to the lower stabilities of 32 and 33; partial decom-
position has been observed for both compounds even after purification. It is interesting to
note that the conversion of ferrocene 32 into bisphosphonate 33 clearly simplified the NMR
spectra, due to the higher symmetry of the latter compound.
In contrast to the simple OEt substituents, with the sterically more demanding alkyl groups
a limitation in reactivity might occur and, thus, chlorodiphenylphosphine for the synthesis of
34 and chlorophosphates 35a–c have been investigated, showing good (35a–c) to acceptable
(34) yields (Figure 3.12). A further enhancement of the de of the formed 1,2-P ,O ferrocene
was achieved by adding a chiral chlorophosphate, which was investigated during the reaction
of the fenchyl derivative 31e by adding the respective fenchyl chlorophosphate 29e (Figure
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30e (R = Fn)
Cy =
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rac-34, 44 %
Fe
(R'O)2P O P(OR)2
 rac-35a (R = R' = Cy),        81 %
        35b (R = Cy, R' = Fn), 84 %
          (de = 0.10)
(Rp)-35c (R = R' = Fn),        86 %
          (de = 0.95)
30a
i)
ii)
O O O O
S
Figure 3.12 Oxygen functionalization after the apFr of 30a,e.
Reaction conditions: i) LDA, hexane, TMEDA, ClPPh2, S8, 25℃, 18 h, 60℃, 1 h. Yield
based on 30a; ii) 30a: LDA, hexane, TMEDA, 29a for rac-35a and 29e for 35b, 25℃, 18 h,
60℃, 1 h; 30b: LiTMP, hexane, TMEDA, 29e, 25℃, 18 h, 60℃, 1 h. Yields are based on
30a or 30e.
3.12). The resulting 2-phosphato ferrocenyl phosphonate 35c could be obtained with a de
of 95%, due to a kinetically controlled phosphate formation. With the addition of Me2SO4,
10% of 31e could be isolated with a de of 68%. Reaction of nonchiral 30a with chiral
29e also resulted in the diastereomerically enriched phosphate 35b (10% de), revealing the
chirality of the chlorophosphates to be the main reason for the kinetic phosphate formation.
Single crystals of 31e and 35c exhibited the presence of the (Rp) diastereomer in both cases
(Figure 3.19), which therefore is assumed to be the mainly formed diastereomer during the
rearrangement.
 rac-35a (R = Cy)
(Rp)-35c (R = Fn)
Fe
(RO)2P O P(OR)2
36a (E = CH3, R = Cy), 41 %a)
36b (E = H, R = Fn),     99 %a)
                                      48 %b)
Fe
E
O P(OR)2
(Rp)-37, 0 %a)
             26 %b)
(de = 0.95)
FeO P(OFn)2
O
(RO)2P
P(OFn)2
i) Cy =
Fn =
+
OO O O
O
Figure 3.13 Consecutive apFr of ortho-phosphonato ferrocenyl phosphates rac-35a and
(Rp)-35c to bis-phosphonates 36a,b and the 1,1'-derivative (Rp)-37.
Reaction conditions: i) base, TMEDA, hexane, 18 h, 25℃, Me2SO4, 60℃, 1 h. Yields are
based on the ferrocenyl starting material; a) LDA as the base; b) LiTMP as the base.
Similar to the diethyl derivative 32 (Figure 3.11), the 2-phosphato phosphonates 35a,c can
undergo a further apFr (Figure 3.13). Using LDA as the base, bis(phosphonates) 36a,b
were formed in acceptable (36a) to quantitative (36b) yields. Interestingly, the OH func-
tionality in 36b cannot be converted into the respective methyl ether, even using an excess
of methyl sulfate at 60℃ giving a singlet for the OH functionality at 7.60 ppm in the 1H
NMR. Bis(phosphonato) hydroxyferrocene 36b is stable toward air and moisture and is most
probably stabilized by intramolecular hydrogen bridge bond formation to the phosphonato
oxygen atoms. [186,216] When the base is changed from LDA to LiTMP, the increased steric
demand significantly lowered the yield of 36b from 99 to 48%. Additionally, the formation
of 37 is observed with the phosphonato substituents located at the 1,1'-positions and the de
remaining at 95%, based on the de of the starting material 35c, which was also obtained in
11% (95% de) after the reaction. The lithiation exclusively occurred ortho to the phosphate
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and not to the phosphonate substituent, due to the absence of any ortho-methylated prod-
uct, which indicates a less attractive stabilization of the phosphonato in comparison to the
phosphato substituent.
OCH3
a
21.4 ppm 
b
23.8 ppm 
cbcb
2∙ca2∙aa bbbb
Figure 3.14 1H-31P–2D NMR spectra of 37 (CDCl3, 25℃).
The verification of the 1,1'-substitution pattern in the unexpectedly formed bis(phosphonate)
37 in comparison to bis(phosphonate) 36b (Figure 3.13) is indicated by the absence of the
C5H5 signal in the 1H and in the 13C{1H} NMR spectra and the appearance of the 31P{1H}
resonances as singlets at 21.3 and 23.8 ppm, in comparison with 36b, where doublets for
both signals (21.3 and 25.8 ppm; 3JP,P = 3.7Hz) are characteristic. Additional 2D 1H-31P/
experiments allowed the assignment of three (21.3 ppm) and four (23.8 ppm) 1H signals to
the respective phosphorus resonance (Figure 3.14).
Fe OH
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Figure 3.15 Synthesis and apFr of 1,1'-functionalized ferrocenyl phosphates 39a-c to phos-
phonates 40a-c and 41a-c.
Reaction conditions: i) 39a: hexane, BuLi, 29a, 12 h, 60℃, 4 h; 39b: THF, BuLi, 29e, 12 h,
80℃, 12 h; 39c: CH2Cl2, NEt3, ClP(O)(OEt)2, –20℃; ii) LDA (R = Cy), LiTMP (R =
Fn), TMEDA, hexane, 25℃, 18 h, Me2SO4, 50℃, 1 h; for 39c: LDA, THF, –30℃, Me2SO4.
Yields are based on the ferrocenyl starting material.
Using the 1,1'-ferrocenediol (38) allowed for the synthesis of bisphosphates 39a–c (Figure
3.15). The low yields of up to 60% for 39c are due to the rapid decomposition of Fc(OH)2.
However, the presence of the sterically more demanding (bi)cyclic alcohols increased the
stability of phosphates in 39a,b compared to the ethyl derivative 39c. However, the increased
steric demand required stirring in hexane (39a, 4 h, 60℃ bath temperature) or THF (39b,
12 h, 80℃ bath temperature) to complete the reaction of both hydroxyl moieties with the
chlorophosphates to 39a,b (Figure 3.15). The apFr of cyclohexyl-substituted 39a proceeded
to the expected doublerearranged product 41a as a mixture of both diastereomers with a de of
13%. Obviously, the lithiation of the C5H4 cycle is influenced by the configuration established
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at the first cyclopentadienyl ring. Using the reaction protocol for diastereomerically enriched
fenchyl derivatives (Figure 3.2), a slight increase of the de (84%) of 40b in comparison to
that for singly substituted 31e (80%) could be detected (Figure 3.15). Nevertheless, the
rearrangement product containing phosphonates at both cyclopentadienyls (41b) could not
be obtained for the fenchyl substituent during this reaction. This is attributed to the steric
demand of the chiral fenchyl substituents or an unfavorable stabilization of the lithiated
species, which prevents the rearrangement to 41b. When the reaction conditions for ethyl
phosphates (LDA, THF, –30℃) were applied for the rearrangement of 39c a complex mixture
of several phosphorus-containing molecules was obtained, from which no product could be
identified or isolated in pure form, due to their rapid decomposition.
FeO P
            Rp + Sp
44a (R = Cy),     57 %b)
44b (R = Mt),     74 %
44c (R = Bo),     49 %
44d (R = Fn),     91 %
44e (OR = NEt2), 0 %e)
PCl2RO
O
R OH i) ii) Fe O
O
28a
28b
28e
> 95 %
42a (R = Cy)
42b (R = Mt)
42d (R = Fn)
43a (R = Cy),       63 %
43b (R = Mt),       74 %
43c (R = Bo),       19 %a)
43d (R = Fn),       63 %
43e (OR = NEt2), 60 %d)
iii)
Cy = Mt = Fn =
FeO
P
OR
Bo =
O
OO Fc
R
FeO Fe OP
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O
R
+
  mixture of isomers
45a (R = Cy),     97 %c),*
45b (R = Mt),       0 %
45c (R = Bo),     37 %
45d (R = Fn),     37 %
45e (OR = NEt2), 0 %e)
iv)
 * rac : meso
  0.67 : 1
Figure 3.16 Synthesis and apFr of chiral pool diferrocenyl phosphates 43b-d.
Reaction conditions: i) Et2O, BuLi, > 3 equiv of POCl3, 25℃, 18 h; ii) Et2O, BuLi, 5,
42a,b,d, 25℃, 18 h. Yields are based on 5; iii) hexane, TMEDA, LDA (43a–c), LiTMP
(43d), 18 h, Me2SO4, 60℃, 1 h. Yields for 44a–d and 45a–care based on 43a–d; vi) hexane,
TMEDA, LDA, 18 h, Me2SO4, 60℃, 1 h. The yield is based on 44d; a) Obtained within the
synthesis of 30d; b) Using 2 equiv of LDA; c) Using > 8 equiv of LDA. d) The compound was
obtained by reacting 5, NEt2, ClP(NEt2)2 followed by the addition tBuOOH. Yield based on
5. e) Reaction of 43e with LDA and MeI in THF gave the starting material.
In addition to a single apFr at one aryl or ferrocenyl substituent, simultaneous rearrange-
ments are possible by replacing one alkyl by a ferrocenyl substituent. For ferrocenyls, the
simultaneous formation of two planar chiral ferrocene backbones should be possible. With
the chiral pool alcohols 28a,b,d,e as starting materials, the dichlorophosphates 42a,b,d
were synthesized in a more simple one-pot approach, in comparison to literature method-
ologies [214] (Figure 3.16), including deprotonation of the alcohols 28a,b,d,e and dropwise
addition of the formed alcoholates to an excess (> 3 equiv) of POCl3. After removal of
all volatiles dichlorophosphates 42a,b,d were obtained as pure colorless oils in quantitative
yields, avoiding the need for further purification. The alkyl diferrocenyl phosphates 43a–d
are accessible by reacting 42a–d with deprotonated FcOLi (5–Li) (Figure 3.16), whereas
borneyl derivative 43c was obtained as a side product during the synthesis of 30d. As de-
scribed in Section 3.1.1, the 31P{1H} NMR shift is a meaningful indication of a successful
conversion of chlorophosphates 29 and 42 (2 to 8 ppm) to mono-ferrocenyl phosphates 30
(–4 to –7 ppm) and diferrocenyl phosphates 43 (–9 to –11 ppm). Applying phosphates 43 in
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subsequent apFr primarily yielded the monorearranged phosphonates 44a–d, as mixtures of
the two possible isomers with regard to the planar chirality. For 44b–d four diastereomers
were formed, due to the asymmetrically substituted phosphorus atom, whereas 44a can be
obtained as a mixture of two diastereomers (45% de) (Table 3.3), which indicates that the
positions at the prochiral ferrocenes in the achiral phosphate are kinetically not equal. Thus,
a stereoselective apFr is possible without a further chiral input. The second rearrangement
to phosphinates 45a–d is only observed in low yields. Nevertheless, when the amount of
base (> 8 equiv) is increased for the nonchiral cyclohexyl-substituted 43a, a quantitative
conversion to the meso and the racemic isomers was achieved. After their separation, the
meso product is obtained as the main diastereomer (20% de). The distinction between the
racemic (Rp,Rp/Sp,Sp) and the meso (Rp,Sp,RP /Rp,Sp,SP ) is possible by comparing their
NMR spectra. The pseudochiral phosphorus atom in meso-45b caused two sets of signals
in the 1H and 13C{1H} NMR spectra, whereas for the racemic isomers one set of signals is
observed.
Table 3.3 Integral ratios for 44a–d and 45a–d.a
R Area ratio of 44b de Area ratio of 45b de
a Cyclohexyl 1 : 0.38 0.45 –c –c
0.98 : 1d,e 0d
b (1R)-Menthyl 0.41 : 0.29 : 1 : 0.19 – –f –
c Borneyl 1 : 0.07 : 0.90 : 0.07 – 1 : 1 0e
d Fenchyl 1 : 0.45 : 0.36 : 0.86g – 1 : 0.18 : 0.06 : 0.39 –
d Fenchyl 1 : 0.29 : 0.47 : 0.19h –
d Fenchyl 0.64 : 1 : 0.09 : 0.50i –
a The reaction conditions refer to those depicted in Figure 3.16.
b The ratio of the integrals of fitted 31P{1H} NMR spectra is reported from downfield (left)
to highfield (right). and 1H NMR spectra of the mixture.
c Racem compound.
d Meso compound.
e Areas of fitted 1H NMR spectra of the C5H5 signals were used.
f Not formed
g 2 Equiv of LiTMP were used as the base.
h 4 Equiv of LiTMP were used as the base.
i LDA was used as the base.
Attempts to obtain 45d by a similar approach failed, resulting in an almost quantitative
formation of 44d. However, lithiation of 44d resulted in the formation of the desired phos-
phinate 45d. With regard to the stereoselectivity of the rearrangement, the decreased number
of chiral substituents produced an unspecific mixture of isomers for 44b–d and 45b–d (Table
3.3). For 44d the influence of the amount of the base was examined (Table 3.3), showing
only a slight change in the integrals of the signals. However, when the base was changed
from LiTMP to LDA a significant change of the integral of each signal in the 31P{1H} NMR
was observed, but with none of the diastereomers formed primarily. Borneyl derivative 45c,
however, only resulted in the formation of two diastereomers instead of four, indicating a high
stereoselectivity for one rearrangement. The disfavored formation of phosphinates 45a–d as
well as the decreased diastereoselectivity can both be explained by the fact that apFr, in gen-
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eral, are favored for electron-poor compounds, [193,205] such as phosphates, which prevent the
nucleophilic attack at the phosphorus atom, due to the higher acidity of the ferrocenyl pro-
tons. The rearrangement products 44a–d are more electron rich in comparison to phosphates
43a–d, due to the ferrocenyl substituent. Furthermore, the lithium ion is well stabilized by
the hydroxy oxygen and the P=O moiety, [216] and a further lithiation is less desirable.
The distinction between phosphonates 44a–d (19 to 22 ppm) and phosphinates 45a–d (34
to 38 ppm) is also rather simple by comparing with the chemical shifts of phosphonates
31a–f and 36a–c (20 to 23 ppm for 31; 20 to 26 ppm for 36), due to the formation of up to
four diastereomers. The mentioned 1JC,P coupling constant of the ferrocenyl C–P bond in
Section 3.1.1, decreased from 217Hz for phosphonates to 160Hz for the more electron rich
phosphinates 45a–d.
Solid State Structures
The molecular structures of 15, 23, 30a,b,e, 31e, 35c, 43b,e, and 44a,c,d in the solid state
have been determined by single-crystal X-Ray diffraction analysis (Figures 3.17, 3.18, 3.19
and 3.20).
Figure 3.17 ORTEP (50% probability level) of the molecular structures of 15 (left), 23
(middle) and 43e (right) with the atom-numbering Scheme. All C-bonded
hydrogen atoms and a second molecule in the asymmetric units of 23 have
been omitted for clarity.
Selected bond lengths (Å): 15, P–BH3 = 1.881(5), P–N = 1.639(3); 23, P=S = 1.9592(13);
43e, P=O 1.463(2), P–N = 1.625(2).
Suitable crystals were obtained by different methods, e.g., crystallization from hexane so-
lutions at ambient temperature (Experimental Section). Non-chiral compounds crystallized
in the centrosymmetric triclinic (P 1¯, 23), monoclinic (P21/c, 30a and 43a; C2/c, 43e),
and orthorhombic (Pbca, 15) space groups, whereas the chiral substituents lead to the chi-
ral Sohncke space groups [217,218] P1 (30e), P212121 (30b, 31e), P21 (43b, 44c,d), and C2
(35c). Compounds 23, 30e, 35c, and 44c,d are present with two molecules in the asymmet-
ric unit, instead of one. Thus, the absolute configuration for 31e and 35c could be determined
as the Rp diastereomer (Figures 3.19), whereas for 44c,d a mixture of the Rp,SP and the
Sp,RP diastereomers emerges (Figure 3.20). The methyl and further O-bonded substituents
in the doubly substituted ferrocenes 31e, 35c, and 44a,c,d are consequently directed away
from the remaining free electron pairs in the vacant space between these two substituents.
Interestingly, in cyclohexyl phosphonate 44a an unfavorable axial conformation is observed,
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Figure 3.18 ORTEP (50% probability level) of the molecular structures of 30a (left), 30b
(middle) and 30e (right) with the atom-numbering Scheme. All hydrogen
atoms and a second molecule in the asymmetric unit of 30e have been omitted
for clarity.
Figure 3.19 ORTEP (50% probability level) of the molecular structures of (Rp)-31e (left),
(Rp)-35c (middle) and 43b (right) with the atom-numbering Scheme. All
hydrogen atoms and a second molecule in the asymmetric units of 35c and
43b have been omitted for clarity.
Figure 3.20 ORTEP (50% probability level) of the molecular structures of 44a (left),
44c (middle) and 44d (right) with the atom-numbering Scheme. All hydro-
gen atoms, a second molecule in the asymmetric units of 44c and 44d, two
molecules of diethyl ether for 44c have been omitted for clarity.
Intramolecular T -shaped pi interaction between the centroids (Ct) of the C5H3 and the C5H5:
a) Ct· · ·Ct, 4.5570(18)Å ; intersection, 72.6(3) °; b) Ct· · ·Ct, 4.556(3) and 4.572(3)Å ; inter-
section, 75.8(3) and 75.6(3) °; c) Ct· · ·Ct, 4.558(7) and 4.675(7)Å ; intersection, 75.8(7) and
72.9(7) °.
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in contrast to phosphate 30a, with the oxygen atom located in the equatorial position. In
compounds 44a,c,d strong intramolecular pi contacts are present between the unsubstituted
C5H5 and the top of the C5H3 rings (Figure 3.20).
3.1.3 Non-Chiral Multi-Aryl Phosphates
In addition to 11, the ferrocenyl phosphates 47–50 were synthesized by reacting lithiated
ferrocenol 5-Li with POCl3 or chlorophosphates Cl2P(O)(OR) (46b–46e) (Figure 3.21). The
usage of BuLi as the metalation reagent, instead of widely used nitrogen bases, increased the
yield, that is for 47 from 36 [219,220] to 92% and for 11 from 62 to 99% (Figures 3.3, 3.21,
Experimental Section).
Fe O
P R'
5
i)
(44a−f) R
47 (R = R' = OFc),
48 (R = OFc, R' = OPh),
11 (R = R' = OPh),
49 (R = OFc, R' = R1),
50 (R = OFc, R' = R2),
51 (R = OFc, R' = R3),
46a (POCl3)
46b (Cl2P(O)OPh)
46c (ClP(O)(OPh)2)
46d (Cl2P(O)R1)
46e (Cl2P(O)R2)
46f  (Cl2P(O)R3)
Fe OH
O
N
O
O
R1 =
R2 =
R3 =
O
92 %
63 %
99 %
25 %
65 %
60 %a)
Figure 3.21 Synthesis of ferrocenyl phosphates 47–51.
Reaction conditions: i) Et2O (11,47 and 48)/ THF (49–51), –30℃, BuLi, -70℃, 0.33 equiv
of 46a, 0.5 equiv of 46b, 46d-f or 1 equiv of 46c. Yields are based on 46 (46, 48, 50) or 5
(11, 49). a) Instead of 51, 47 was formed in 58%.
However, the reaction of 5-Li with the 3-hydroxypyridyl derivative 46f did not result in de-
sired phosphate 51, but rather gave 47 in 58 (in THF) or 25% yield (in Et2O) showing that
the solvent plays a crucial role within the appropriate reaction. Although a 2 : 1 ratio of 5:46f
was present, the 3-hydroxypyridyl substituent was replaced by a third nucleophilic substitu-
tion of 5-Li. The properties of R3 as the leaving group are due to the excellent stabilization
of a negative charge within the electron-poor heterocycle. The formation of a keto-amino
tautomeric structure, as possible for the 2- and 4-hydroxypyridine, is excluded, and thus, a
P–N formation is rather disfavored compared to a P–O bonding of the pyridine derivative.
Nevertheless, pyridyl triflates have been investigated for anionic 1,3-O→C migrations.
Fe O
P
47 52, 86 %
Fe O
meso-53, 86 %
de = 0.77
Fe O
P
3
54, 0 %
i) ii) FeO
P OFc
Fe O
P
3
FeO
2
O
O O O
Figure 3.22 Consecutive apFr of triferrocenyl phosphate 47 to phosphonate 52 and phos-
phinate 53.
Reaction conditions: i) LDA, THF, –30℃, 3 h, Me2SO4. Yield based on 47. ii) LDA, THF,
0℃, 3 h, Me2SO4. Yield based on 52.
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The electron-withdrawing character and their different chemical structure increase their sta-
bility toward the attack of a nucleophile. [175] Treatment of P(O)(OFc)3 (47) with LDA at
various temperatures (–70 to 25℃) resulted in the expected 1,3-O→C migration of the phos-
phorus fragment, which is initialized by an ortho-lithiation, producing 52 and 53 (Figure
3.22). After optimizing the reaction conditions for the apFr of 47 (Table 3.4), we obtained
the highest yield for 52 of 86% at a temperature of –30℃. Lower temperatures reduced
the conversion of 47. Above –30℃, partial decomposition takes place, lowering the yield.
Nevertheless, the double rearranged product 53 was not formed within this reaction step,
even using excess LDA (Table 3.22).
Table 3.4 Optimization of the reaction conditions for the apFr of triferrocenyl phosphate
(47).a
Entry Educt base Additiveb T /℃ Yield / %c
(6 equiv) (equiv) 47 52 53 54
1 47d LiTMP TMEDA 25 12 h 7 46
2 47d LDA TMEDA 25 12 h <1 7
3 47 LDA –70 2 h 17 74
4 47 LDA –30 3 h <1 86
5 47g LDA PhOLi (3) 0 4 h 59 16 (de 0.99)
6 47g LDA PhOLi (12) 0 4 h 44 46
7 52 LDAe –15 3 h 66 30
8 52 LDAe 0 4 h <5 86 (de 0.77)
9 53 LDAf 0 4 h
10 53 LDAf –10 3 h 86
11 53 LDAf 50 3 h
a Further reaction conditions are depicted in Figure 3.22.
b The equiv of the additive are equal to those of the base.
c The yields are based on the starting material.
d Hexane was used as the solvent.
e 4 Equivalents were used.
f 2 Equivalents were used.
g The reaction was started at –30℃ and warmed to 0℃ within 10min.
An apFr of 52 by treating it with LDA gave phosphinate 53 in 86% yield at 0℃. The in-
creased temperature, required for the lithiation reaction of 52, is due to the increased electron
density at the ferrocenyl backbone (vide infra). Phosphinate 53 was formed as a diastere-
omeric mixture of 0.89 : 0.11 (78% de), which was confirmed by 31P{1H} NMR spectroscopy.
Based on an X-ray measurement (Figure 3.29), where a similar ratio of two diastereomers
(0.9 : 0.1) was observed, the mainly formed diastereomer should be assigned as the meso-
enantiomers Rp,Sp,rP and Sp,Rp,sP . The rac-enantiomers Rp,Rp/Sp,Sp only cocrystallized
in a similar ratio, and are refined as a disorder. The meso-isomers should give two sets of
signals in the 1H and 13C{1H} NMR spectra; however, only one set was present. However, the
formation of phosphine oxide 54 was not observed because, by the reaction of 53 with LDA at
–10℃, the starting material could be recovered in 86% yield. In contrast, when the reaction
was run at 50℃ the educt 53 was not present and probably decomposed during the course
of the reaction or by a nucleophilic attack at the phosporus atom. The incomplete reaction
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of ferrocenyls toward apFr is contrary to triphenyl phosphate 55 giving phosphine oxide 56
within one reaction step (Table 3.5). [182,184–189] Until now, the apFr of phenyl derivatives
were warmed to 0℃ or even ambient temperature before being terminated them with HCl
or H2O. [176,182,190,221] Thus, the intermediately formed phosphonates (e.g., 56) and phosphi-
nates (e.g. 57) have not been isolated and reported yet. However, adding the scavenger,
while keeping the reaction temperature at –80℃, allowed the isolation of 56 (Table 3.5).
Increasing the temperature, at which the scavenger is added, consecutively shifts the product
ratio from 56 over 57 to 58 at 0℃. The identity of 56 was verified by using single-crystal
X-ray diffraction analysis (Figure 3.33). Initially, lithiation and subsequent rearrangement of
55 to form phosphonate 56 occurred at –70℃. Gradually, increasing the temperature exceeds
the activation energy for the lithiation of 56-Li, resulting in the formation of phosphinate
57 and finally phosphine oxide 58 (Table 3.5). Thus, the number of rearrangements solely
depends on the temperature required for the lithiation process, due to the absence of any
non-rearranged but ortho-methylated product, derived from 55. The amount of LDA used
for the synthesis of 58 was taken from reported procedures. [182,184–188,222]
Obviously, the phenylic hydroxyl groups in 56-Li and 57-Li2 do not prevent a further depro-
tonation by LDA. Contrary, starting at 47, the presence of already one ferrocenylic hydroxyl
group in 52-Li, inhibits a further lithiation to 53 with even a 6 fold excess of LDA (Table
3.4). To complex the lithium ions by phenyl- instead of ferrocenyl-based hydroxyls, 12 equiv
of PhOLi was added, which increased the yield of 53 from 0 to 46% and the de from 0.77 to
0.99.
Table 3.5 Temperature dependent apFr of triphenyl phosphate (55) to phosphonate (56),
phosphinate (57) and phosphine oxide (58).a
55
O
P
O
3
56
OH
P
O
57
OH
P
O
2
58
OH
P
O
3
+ +O
2
O
Entry T LDA Yield /%
/℃ / 6 equiv 56 57 58
1 –80 6 75 24
2 –75 12 70 29
3 –70 6 55 45
4 –70 2 78 21
5 0 12 9 90
a Reaction conditions: THF, LDA, 53, 2 h, H+/ H2O. Yields are based on 55.
However, treatment of 48 with 4 equiv of LDA at –75℃ (Table 3.6) produced only phos-
phonates 59 and 60 in minor yield. Increasing the reaction temperature to 0℃ resulted
in a complete conversion of 48 giving 61. Although excess dimethyl sulfate was present,
compounds 59 and 61 were obtained in form of 59a/61a (R = H) and as 59b/61b (R =
CH3). As observed for 47 (Figure 3.22), the ferrocenyls prevent the formation of any type of
phosphine oxides, within the apFr of 48 (Table 3.6). To examine the influence between one
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(48) and two phenyls (11) on the product mixture within an apFr, the treatment of ferrocenyl
diphenyl phosphate (11) has been reinvestigated (Figure 3.3). Replacing NEt3 by BuLi as
the base for the deprotonation of ferrocenol, increased the yield of 11 from 62 (Figure 3.3) to
99%. Unmethylated 63 could recently be obtained in a yield of 8% by running the reaction
at –40℃, due to an unsuccessful methylation by using iodomethane (Figure 3.3). Carrying
out the apFr below –75℃ reduces the amount of unreacted starting material from 80% for
48 to 25% for 11. The formation of phosphonate 62 and phosphinates 64 is observed. This
reveals a positive influence of the two phenyls toward the lithiation behavior compared to
48, where the formation of a phosphinate has not been observed. At –70℃ compound 11
was completely converted and the yields of 62 and 64 increased accordingly. Additionally,
the formation of phosphinate 63 is observed. Phosphine oxide 65 could be isolated at 0℃ in
a yield of 25%.
Table 3.6 Temperature dependent apFr of diferrocenylphenyl phosphate (48) to phospho-
nates 59a,b and 60, and phosphinates 61a,b.a
48 59a (R = H)
59b (R = CH3)
OR
Fe
P
O
FcO
61a (R = H)
61b (R = CH3)
60
OPh
Fe
P
O
FcO
Fe O
P
O
O
2
+ +Fe O
P
O
2
OR
O O
Entry T Time Yield /% (a/b)
/℃ / h 48 59 60 61
1 –75 2 80 10 (b) 9 (de 0.45)
2 –60 4 25 27 (a), 13 (b) 29 (de 0.27)∑ = 40
3 –35 3.5 25 (a), 10 (b) 20 (de 0.65) 19 (a), 9 (b)∑ = 35 ∑ = 28
4b 0 2 77 (a), 13 (b)∑ = 90
a Reaction conditions: THF, LDA (4 equiv), Me2SO4. Yields are based on 48.
b 7 Equiv of LDA were used.
In general, the rearrangement at the phenyl rings is favored compared to that at the ferro-
cenyls, as clarified by the higher yields of 59 and 62 at lower temperatures, when compared
to the rearrangement products 52, 60, and 62–65. However, the formation of 60 indicates a
low energy difference between lithiation at a phenyl and a ferrocenyl fragment. Furthermore,
the possibility of an ortho lithiation is higher at the ferrocenyls, due to the presence of 4-ortho
hydrogens in contrast to 2-ortho hydrogen atoms at the phenyl groups. As a consequence of
the different behavior of ferrocenyl (stepwise) and phenyl groups (temperature dependent),
phosphinates 61 was formed at 0℃ as the final rearranged product. In contrast, 11 gave
phosphine oxide 65 at 0℃ (Table 3.7), although an excess of LDA was used.
To prevent the decomposition of oxygen-sensitive hydroxy ferrocenes, [147,167,194,223] the lithi-
ation and rearrangement reactions were quenched by the addition of excess Me2SO4, result-
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Table 3.7 Temperature dependent apFr of ferrocenyldiphenyl phosphate (11) to phospho-
nate 62, phosphinates 63 and 64a,b, and phosphine oxides 65a,b.a
11
P(OPh)2
O
Fe O
62 63 (R = H, CH3)
OR
P
2
O
Fe O
P
OPhO
Fe O
HO
+ +
65a (R = H, H)
65b (R = H, CH3)
        de > 85 %
OR
P
O
2
OR
Fe
P
O
PhO
64a (R = H)
64b (R = CH3)
O O
Fe+
b)
Entry T Yield /% (a/b)
/℃ 11 62 63 64 65
1 –80 25 25 9 (a)
2 –70 58 4 4 (a), 11 (b)∑ = 15
3 0 11 20 (a), 18 (b) 18 (a), 7 (b)∑ = 38 ∑ = 25
a Reaction conditions: THF, LDA (8 equiv), 2 h, Me2SO4 (12 equiv).
Yields are based on 11.
b Addition of 12 equiv of Me2SO4.
ing in the methylation of all ferrocenyl-related hydroxy functionalities. However, the in situ
methylation of phenols is rather slow and moreover gave mixtures of the methylated and non-
methylated derivatives 59, 61 and 63–65 (Tables 3.6 and 3.7). For phosphine oxide 65, a
kinetic resolution was observed (Table 3.7). Most likely 65a initially was formed as a racemic
mixture (Rp/Sp enantiomers), due to the absence of external and internal chiral information.
For 65b (> 85% de) one set of signals was observed in the 31P{1H} NMR spectra, confirming
the diastereoselective proceeding. The 1H and 13C{1H} NMR spectra showed the formation
of small amounts of the respective diastereomer, which were used for calculation of the de
by using the integrals of the OCH3 (85% de) and the OH (87% de) resonances, confirming
the diastereoselective process. This lets to the conclusion that the 31P{1H} NMR resonances
of both diastereomers occurred isochron. The absolute configuration could be assigned to
Sp,SP /Rp,RP by single-crystal X-ray diffraction analysis (Figure 3.30). Compound 67 is the
first example of a solid-state structure of a 1-oxo-naphth-2-yl phosphinate. The differences
between ferrocenyls and phenyls toward apFr prompted us to extend the substrate scope to
condensed aromatics, which also allows us to investigate the regioselectivity of the 1,3-O→C
migrations. To reduce the number of possible rearrangement products, phosphates bearing
two ferrocenyls instead of one were applied. The apFr of 1-naphthyl derivative 49 resulted
in the formation of a 1,2-substitution pattern, both at the naphthyl and at the ferrocenyl
moieties, giving phosphonate 66 and phosphinate 67, respectively, as shown in Figure 3.23.
Phosphinate 67 was formed in a scalemic mixture (ratio of both diastereomers of 1 : 0.78), as
it was observed for 61 (Table 3.6). Similar to triferrocenyl- (47) and diferrocenyl phosphate
48, the lithiation of 49 required higher temperatures. Thus, 90% of the starting material 49
was recovered at –70℃.
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Figure 3.23 Temperature-dependent apFr of of diferrocenyl(1-naphthyl) phosphate 49 to
phosphonate 66 and phosphinate 67.
Reaction conditions: i) LDA (6 equiv), THF, 0℃, 2 h, Me2SO4 (8 equiv). Yields are based
on 49.
Replacement of the 1-naphthyl derivative 49 (Figure 3.23) with its 2-isomer 50 (Figure 3.24),
however, allowed the apFr at –80℃. Thus, phosphonate 68 reveals an increased reactivity
toward the lithiation process at the 2-position of the naphthyl moiety when compared with
that of the 1-substituted compound 49. Lithiation selectively occurred at more acidic 3-
position and not at the electronically richer 1-position, which is in accordance with similar
rearrangements of 2-naphthyl alkyl phosphonates and phosphates, where the 2,3-substitution
pattern was present in the predominantly formed products. [190,224] If the reaction temperature
is increased to 0℃, the 1,3-O→C migration occurred at both types of aromatics, resulting
in 69 with a 69a/69b ratio of 1 : 0.43 (Figure 3.24). Within this reaction, the phosphonate
68 could not be isolated.
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Fe O
69a (R = H)
69b (R = CH3)
Σ = 63 %a)
O RFcOP
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2
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Figure 3.24 Temperature-dependent apFr of of diferrocenyl(2-naphthyl) phosphate 50 to
phosphonate 68 and phosphinate 69.
Reaction conditions: i) LDA (6 equiv), THF, –80℃, 2 h, Me2SO4 (8 equiv). Yields are based
on 50; a) 0℃.
Phosphonate 70a [219,220] was obtained by the reaction of lithiated 1,1'-ferrocenediol
(Fc(OLi)2; 38-Li2) with POCl3 and subsequent addition of 5-Li (Figure 3.27). However,
70a was only produced in a yield of 20%, which is attributed to the reaction protocol ap-
plied (vide infra, Experimental Section). Phosphate (R)-70b, possessing a chiral (R)-BINOL
bridging backbone, was accessible by treatment of 5-Li with chlorophosphate (R)-46g (Fig-
ure 3.25). After appropriate workup, (R)-70b could be isolated in a yield of 49% (Figure
3.25). It was found that the addition of 2 equiv of POCl3 within the synthesis of (R)-46g did
not result in the formation of a bisphosphorylated BINOL. Treatment of phosphates 70a,b
with excess LDA (6 equiv) at –70℃ allowed apFr at the single substituted ferrocenyls. The
formation of compounds that were lithiated at the bridging backbones of 70a,b were not ob-
served, which is in accordance with the result obtained with the phenyl derivative of 70b. [203]
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The non-rotatable P=O bond prevents a stabilization of the negative charge in the 3-position
of the naphthyl ring. Therefore, an attack at the phosphorus atom is excluded. Phosphonate
71a (Figure 3.25) was isolated in virtually quantitative yield. The chiral information in the
backbone of 70b resulted in a diastereoselective lithiation, owing to a preferable rotation
of the P=O building block to one site of the ferrocenyl unit. After subsequent 1,3-O→C
migration, phosphonate 71b was isolated as the (R,Rp) diastereomer with a de of 91%, as
confirmed by single-crystal X-ray diffraction (Figure 3.32) in 57% yield. Within this reac-
tion, 38% of the starting material (R)-70b could be recovered. Increasing the temperature
to –20℃ for 2 h reduced the yield of (R,Rp)-71b to 37%, whereas the de remained at 89%.
Most likely, the high de of phosphonate 71b is due to the asymmetric BINOL group and an
efficient interaction with the ferrocenyl backbone. Thus, the P=O is directed to one site of
cyclopentadienyl where the lithiation occurred.
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1,1'-
Fc(OH)2
(38)
O
O
P
O
(R)-70a, 20 %
(R)-70b, 49 %
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O
P
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Fe Oii)
(R,Rp)-71a, 99 %
(R,Rp)-71b, 57 % 
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Figure 3.25 ApFr of phosphates 70a and (R)-BINOL-based (R)-70b.
Reaction conditions: i) 70a: 38, BuLi (2 equiv), POCl3, THF, 5-Li. Yield based on 38; 70b:
5, BuLi (1 equiv), Et2O, P(O)Cl((R)-BINOL). Yield based on 5. ii) LDA, THF, –10℃ (71a)
or –70℃ (71b), 2 h, Me2SO4 Yields are based on 70a/b.
To force metalation at the 1,3-dioxa[3]ferrocenophane backbone, phosphate (1R)-72 was syn-
thesized by reacting 38-Li2 with the chiral dichloro (1R)-α-fenchyl phosphate (46h), whereby
the aliphatic substituent does not undergo lithiation reactions (Figure 3.26). The fenchyl
methyl groups in the 1 and 3 positions of the bicycle enhance the stereoselectivity within
such types of reactions, when compared to other chiral pool alcohols (Section 3.1.2).
Within the synthesis of (1R)-72, the formation of a [3,3]ferrocenophane, containing two
phosphate bridged ferrocenyls, was not observed. Treatment of (1R)-72 with the sterically
demanding base LiTMP at –10℃ resulted only in the ortho-lithiation at both cyclopentadi-
enyls. Subsequent addition of Me2SO4 gave the 1,1'-double methylated phosphate 73 (Figure
3.26). This ansa compound was obtained as a mixture of three non-separable diastereomers
in a ratio of 1 : 0.25 : 0.3 (Experimental Section). Single-crystal X-ray diffraction analysis
allowed the determination of the absolute configuration of one diastereomer, which could be
assigned to (1R,Rp,Sp,sP ) containing a pseudochiral phosphorus atom (Figure 3.32). We
assume that the (1R,Rp,Sp,sP )-73 isomer is the main diastereomer formed within this reac-
tion. This can be explained by the steric hindrance of the two methyl groups at C3 at one
site of the ferrocenyl backbone (Figure 3.32). Furthermore, the P=O bond is fixed at one
site and favors a pseudo-meso lithiation. However, the absolute configuration of the other
two diastereomers could not be unequivocally determined. Most likely the pseudo-racemic
(Rp,Rp) and (Sp,Sp) isomers were formed since their ratio within the product mixture is
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similar (Experimental Section). Increasing the temperature within the reaction of (1R)-72
with LDA to ambient conditions did not change the dr of (1R)-73, whereby the amount
of the recovered starting material (1R)-72 increased from 0 to 6%. This can be explained
by the deprotonation and cleavage of tetrahydrofuran. [225] The addition of the methylation
reagent Me2SO4 also resulted in an activation of the P=O bond, which favors a nucleophilic
attack of water during the workup procedure and hence the cleavage of the ferrocenophane.
Methylation of the thus formed 1-hydroxy moiety gave (1R)-74 as a racemic mixture con-
cerning the configuration of the phosphorus atom. Additionally, 20% of 1,1'-Fc(OMe)2 was
isolated, indicating hydrolysis of the [3]ferrocenophane backbone of (1R)-72. The formation
of the ring-opened, double-methylated compound 74 has inter alia been verified by the 1H
NMR resonances of the methyl groups. The cyclopentadienyl attached fragment occurred as
a singlet at 3.37, whereas the P–O–CH3 fragment was observed as a doublet at 3.82 ppm with
a 3JH,P coupling constant of 8.4–11.3Hz.
38
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Figure 3.26 Synthesis and reaction behavior toward apFr of the chiral pool-based phosphate
(1R)-72.
Reaction conditions: i) BuLi, Cl2P(O)((1R)–α-Fn), Et2O. Yield based on 38. ii) LiTMP,
THF, –10℃, Me2SO4. Yield based on 72. a) Stirring for 18 h at ambient temperature:
besides 53% of 73, 20% of 1,1'-Fc(OMe)2 and 10% of 74 were formed based on 70. Rac-
refers to the configuration at the phosphorus atom.
The usage of ferrocene diol 38 could allow for the consecutive preparation of the super-
ferrocenophane 77 as depicted in Figure 3.27. In this respect, 38 was metalated by using
BuLi and the thus formed corresponding lithiated species gave with 2 equiv of POCl3 38-
P2O2Cl4. It was expected that the stepwise addition of 38-(Li)2 to the latter compound
should result in the formation of phosphate 77. Instead, only 12% of the bis[3]ferrocenophane
76 could be isolated (Figure 3.27). To investigate, if the intermediate bisphosphate 38-
P2O2Cl4 or a mixture of the 1,3-dioxa[3]ferrocenophane 38-POCl and POCl3 was formed,
5-Li was added instead of 38-(Li)2. After appropriate workup, 47 (42%), 70a (20%) and
bisphosphate 75 (11%) could be isolated, revealing that the respective reaction mixture
contained POCl3, 38-P2O2Cl4, and 38-POCl. The ratio of 47/70a/75 also indicated that
38-POCl was predominantly formed (Experimental Section). Treatment of 75 with LDA at
–30℃ resulted in complete decomposition of this compound by producing an insoluble residue
during column chromatographic workup. In contrast, bis[3]ferrocenophane 76 gave the double
rearranged bisphosphonate 78, which was isolated in a yield of 62% (Figure 3.27). Compared
to previous results of anionic phospho-(Section 3.1) and thia-Fries [194] rearrangements, the
meso (Rp,Sp) isomer should be exclusively formed.
The results of the reactivity of N-bonded, aliphatic Fc–O–P compounds and our previous in-
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Figure 3.27 Reaction of 38 with POCl3, and/or FcOLi for the synthesis of [3]ferroceno-
phanes 70a and 76, and phosphate 75. Yields are based on 38.
Reaction conditions: i) LDA (4 equiv), THF, –30℃, 2 h Me2SO4 (8 equiv). a) Yield based on
5. b) Yield based on 76.
vestigations within this field of chemistry (Section 3.1.1) revealed that electron-withdrawing
phosphorus groups increase the possibility of a lithiation and the occurrence of an apFr. Thus,
we replaced the aliphatic by N -bonded nitrogen heterocycles. The lone pair of the nitrogen
is rather involved in the aromatic system, which decreases the transfer of electron density to
phosphorus and the ferrocenyls. Thus, their stability toward acidic media is increased. [226]
Phosphonates 79–81 were accessible by the reaction of 5-Li with the respective dichlorophos-
phonates, whereby the size of the aromatic systems increased from 1H-pyrrole (79) to 1H-
indole (80) and 9H-carbazole (81, Figure 3.28). A wide range of pyrrole- and indole-based
phosphonates are known, whereas carbazole derivatives are sparsely investigated. [227] This
is clarified by reported procedures for the synthesis of the respective dichlorophosphates, of
which only the indolyl derivative has been reported yet. [228] Treatment of lithiated carbazole
with excess POCl3 in tetrahydrofuran at –80℃ gave the desired dichlorophosphate (Experi-
mental Section). In contrast, the decreased steric demand and thus the increased reactivity
of lithiated pyrrole toward POCl3 required a dropwise addition of pyrrole into a tetrahydro-
furan solution containing >10 equiv of POCl3 at –80℃ (Experimental Section). In contrast
to the aliphatic derivatives 12–15, the reaction of 79–81 with LDA followed by the addition
of Me2SO4 gave several 1,3-O→C (82–84, 87) anionic phospho-Fries and 1,2-N→C (85–87)
rearranged products (Figure 3.28). The latter ones are the first examples of rearrangements
of phosphonato moieties. Shifts at thiaphosphonates, [229] chiral phosphine oxides and sul-
fides [230] at pyrroles have been reported, whereas indoles have not been investigated up to
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date. It should be noted that within the synthesis of the indole systems 83 and 86, 18% of
FcOMe could also be isolated, probably due to a nucleophilic attack at the phosphorus atom,
combined with the good stabilization of a negative charge at the heterocycle. The reaction of
79 even resulted in the formation of 32% of FcOMe and 45% of recovered starting material
at –70℃, which supports the assumption of a nucleophilic attack.
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Figure 3.28 Synthesis of ferrocenyl phosphonates 79-81 and their treatment with LDA
causing 1,3-O→C and 1,2-N→C rearrangements for the synthesis of 82–87.
Reaction conditions: i) –30℃, BuLi, Cl2P(O)(NAr). Yields are based on 5. ii) LDA (6 equiv),
THF, –40℃, 2 h, Me2SO4 (8 equiv). Yields are based on 79–81. a) –70℃. b) –60℃. c) 0℃.
Contrary to the phenyl and naphthyl phosphates 11, 47–50, the first rearrangements occurred
at the ferrocenyl substituent, resulting in the formation of phosphinates 82–84 (Figure 3.28).
Increasing the temperature to 0℃ accelerated the rearrangements at the heterocycles, and
phosphonates 85 and 86, and phosphinate 87 could be isolated after appropriate workup.
The chemical properties toward lithiation reactions could also be derived from electrochemical
measurements (Table 3.8). The first rearrangement at the ferrocenyl moiety proceeded almost
racemic for 82 with a dr of 1 : 0.89, whereas 84 occurred in a ratio of 1 : 0.28 (56% de),
whereby the configuration of the predominantly formed diastereomers could be assigned as
Rp,SP /Sp,RP based on single-crystal X-ray diffraction analysis (Figure 3.35). Phosphinate 87
was formed in a ratio of 1 : 0.098 (82% de). It remains unclear, whether the diastereoselective
proceeding in case of 87 is caused by steric effects of the heterocycle or by a stabilization
of the lithium ions by the aromatic pi-system. Most of the heterocyclic phosphonates and
phosphinates showed no sign of decomposition in solution, except for 82, which rapidly
decomposed due to either a nucleophilic attack at the phosphorus atom or oxidation reactions
occurring at the pyrrole substituent. A mixture of CDCl3 and DMSO was required for NMR
investigations of compound 85, due to its bad solubility. The structure of 85 could be verified
by single-crystal X-ray diffraction analysis (Figure 3.34).
3.1.4 Characterization
NMR Spectroscopy
General features of ferrocenyl phosphates and phosphonates have already been discussed in
Section 3.1.1 and 3.1.2 and are not further discussed. The OCH3 resonances of the apFr
species,which range between 3.5–4.0 ppm, is somewhat highfield-shifted to 2.63 ppm for the
(R)-BINOL phosphonate 71b. The OH and NH hydrogen resonances were observed be-
tween 9 and 12 ppm, occurring as singlets or as doublets with a 4JH,P coupling of ≤ 1Hz
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(Experimental Section). Besides the presence of the mentioned doublet (J > 200Hz) of the
C–P bond for ferrocenyls, the signals for phenyl related CPh–P units occurred between 100–
122 ppm. The trend of the 1JC,P coupling constants follows the order (229–206Hz) phospho-
nates> phosphinates (163–184Hz)> phosphine oxides (111–107Hz) for the ferrocenyl related
carbons. Non-ferrocenyl related C–P couplings decrease from N -heterocyclic phosphonates
(236–227Hz) > non-heterocyclic phosphonates (181–190Hz) > N -heterocyclic phosphinates
(172Hz) > non-heterocyclic phosphinates (132–147Hz) > phosphine oxides (107–111Hz). As
mentioned in Section 3.1.2, the shift of the ipso-carbon atoms shifts from 116–119 ppm (CFc–
O–P) to 126–130 ppm (CFc–O–CH3). In contrast, the signals in 1,3-dioxa[3]ferrocenophanes
70a, 71a, 72, 73, 74 and 78 are observed at higher fields between 109–111 ppm for the
C–O–P, and 129–131 ppm for the C–O–CH3 fragments (Experimental Section). The N -aryl
phosphonates 79–81, showed similar 31P{1H} shifts (∼ –11 ppm) compared to the O-alkyl
derivatives (–15 to –17 ppm). In contrast, the N -alkyl substituent, occurred downfield shifted
at 2.5 ppm. Phosphorus atoms that are included in 1,3-dioxa[3]ferrocenophane moieties, in
general, showed downfield shifted 31P{1H} resonances compared to non-bridged derivatives.
Thus, the signals for exclusively ferrocenyl containing 70a and 76 occurred at –5.6 ppm, at
–2.5 ppm for the (R)-BINOL derivative 70b and at –4 to 1 ppm for the fenchyl derivatives 72
and 73. The 31P{1H} shift accordingly changes within the series of phosphonates from C-
bonded N -heterocyclic (4.0–4.5 ppm) ≤ O-/N -bonded non-bridged (14–19 ppm) < O-bonded
[3]ferrocenophanes (30–35 ppm). Phosphinates range between 25 and 45 ppm and phosphine
oxides were observed at 38–51 ppm. A trend within either the presence of an OCH3 or OH
group could be observed by comparing the a (OH containing) with the respective b deriva-
tives (OMe instead of OH), which reveals ∆σ values of 4 ppm for 59, more than 9 ppm for 61,
64, 69, and 11 ppm for 65. This is probably due to the formation of intramolecular hydrogen
bridge bonds as present in the solid state (e.g. Figures 3.30 and 3.31), in CDCl3 involving
the P=O bond, which lowers the electron density at the phosphorus atom.
Solid State Structures
The molecular structures of 48, 49, 52, 53, 56, 59a, 65b, 67, 69b, 70a, 71b, 73, 76,
80, 81 and 84–86 in the solid-state have been determined by single-crystal X-ray diffraction
analysis (Figures 3.29, 3.30, 3.31, 3.32, 3.33, 3.34 and 3.35).
The compounds crystallized in the centrosymmetric triclinic space group P 1¯ (52, 67, 69b,
76, 81 and 84), the monoclinic space groups P21/n (47 and 86), P21/c (49, 53, 59a,
65b and 80), C2/c (85), and the orthorhombic space group Pnma (56). Ferrocenes 70a,
71b and 73 crystallized in the non-centrosymmetric monoclinic space group P21 (73, abs.
struct. parameter = 0.002(8)), and the orthorhombic space groups Fdd2 (70a, abs. struct.
parameter = –0.01(2)) and P212121 (71b, abs. struct. parameter = 0.012(16)). In the
asymmetric unit these compounds are present with one (48, 49, 52, 53, 59a, 65b, 67, 69b,
70a, 71b, 80, 81 and 84–86) two (73) or a half (56 and 76) crystallographically independent
molecule(s) (Experimental Section). In phosphonate 56 a mirror plane is present in the phenyl
plane including the P1, O2 and O3 atoms (Figure 3.33). The formula unit of phosphate 76
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can be calculated by the inversion through the Fe2 atom (Figure 3.33).
Figure 3.29 ORTEP (50% probability level) of the molecular structures of rac-52 (left)
and 53 (right) with the atom-numbering Scheme. All hydrogen atoms and
disordered parts of 53 (10%) have been omitted for clarity.
Intramolecular T -shaped pi interaction between the centroids (Ct) of the C16–C20 and C21–
C25 labeled cyclopentadienyls is shown: Ct· · ·Ct, 4.585(3)Å; intersection, 72.6(3) °.
Figure 3.30 ORTEP (50% probability level) of the molecular structures of 48 (left), 59a
(middle) and 65b (right) with the atom-numbering Scheme. All C-bonded
hydrogen atoms and the disordered C5H5 unit in 65b (occupancy ratio of 0.73 :
0.27) have been omitted for clarity.
Intramolecular hydrogen bridgebond: O3· · ·O4, 2.597(2)Å; O3–H3A· · ·O4, 157 °.
Figure 3.31 ORTEP (probability levels: 30%, 49; 50%, 67 and 69b) of the molecular
structures of 49 (left), 67 (middle) and 69b (right) with the atom-numbering
Scheme. All C-bonded hydrogen atoms and the disordered parts in 67 (occu-
pancy ratio of 0.722 : 0.278) have been omitted for clarity.
Intramolecular hydrogen bridgebond: O3· · ·O4, 2.624(10)Å ; O3–H3O· · ·O4, 153 °.
The Cp· · ·Cp' torsion angles in the freely rotatable ferrocenes 47, 49, 52, 53, 59a, 65b, 67,
69b, 71b, 76, 80, 81 and 84–86 range from 0.785(5) to 14.6(14), revealing rather eclipsed
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Figure 3.32 ORTEP (50% probability level) of the molecular structures of (R,Rp)-71b
(left) and (1R-α,Rp,Sp,sP )-73 (right) with the atom-numbering Scheme. All
hydrogen atoms and one molecule of CHCl3 in the asymmetric unit of 71b
have been omitted for clarity.
Figure 3.33 ORTEP (50% probability level) of the molecular structures of 56 (left), 76
(middle) and 70 (right) with the atom-numbering Scheme. All C-bonded hy-
drogen atoms have been omitted for clarity. Symmetry operation for generating
equivalent atoms ('): x,−y + 1/2, z; (A): −x,−y,−z + 1.
conformations, whereas the disordered part in 65b (27.8(7) °) and one ferrocenyl in 70a
(36.1(5) °) and 76 (36.3(2) °) exhibit staggered conformations.
In rotatable-congested [3]-ferrocenophanes 70a, 73 and 76 an eclipsed torsion angle of up to
1.1(4) °is observed, as expected. The hydroxy functionalities in 56, 59a, 65b and 67 have
been refined idealized with the O–H torsion derived from residual electron density (AFIX
147; 56, 59a, 67) or with an idealized staggered geometry (AFIX 83; 65b). Aromatic N -
bonded hydrogen atoms haven been calculated with a constrained distance of 0.86Å (AFIX
43). The acidic protons are involved in either intra- (65b and 67) or intermolecular (56, 59a,
85 and 86) hydrogen bridge bonds. Phosphinate 67 predominantly crystallized as the Sp,SP
isomer, whereas the disordered part occurred in a Rp,RP configuration (ratio 0.722 : 0.278).
With regard to the centrosymmetric space group P 1¯ a diastereoselective crystallization of 67
took place. The other set of diastereomers (Sp,RP /Rp,SP ), present in solution in a ratio of
1 : 0.78, was not observed. A diastereoselective crystallization process also occurred in case of
phosphinate 69b. NMR investigations (vide supra) revealed a ratio of both diastereomers of
1 : 0.5, whereas single crystals of 69b appeared as a mixture of both enantiomers Rp,SP and
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Figure 3.34 ORTEP (50% probability level) of the molecular structures of 80 (left) and
86 (right) with the atom-numbering Scheme. All C-bonded hydrogen atoms,
the disordered atoms (occupancy ratio of 0.88 : 0.12) in 86 and one disordered
molecule of CHCl3 in the asymmetric unit of 86 have been omitted for clarity.
Figure 3.35 ORTEP (probability levels: 50%, 81 and 84; 30%, 85) of the molecular struc-
tures of 81 (left), 84 (middle) and 85 (right) with the atom-numbering Scheme.
All C-bonded hydrogen atoms, disordered parts (occupancy ratio of 0.78 : 0.22)
in 81 and one disordered packing solvent in the asymmetric unit of 84 (0.9 ·
CH2Cl2) have been omitted for clarity.
Sp,RP , respectively, which are the most predominantly formed configurations. Phosphate 73
possesses, similar to meso-53, a pseudochiral phosphorus atom, due to the different configura-
tions of the C5H3Me moieties, resulting in the (1R-α,Rp,Sp,sP )-73 isomer. We conclude that
this is the predominantly formed configuration within the mixture of isomers, based on NMR
investigations that showed an isomeric mixture of 1 : 0.25 : 0.3. In the carbazole derivative 84
a dr of 1 : 0.28 is characteristic as evidenced by NMR experiments (vide supra), while single
crystals of the Rp,SP - and Sp,RP - configured molecules were obtained. Examples of triple
(2-oxo)phosphine oxide structures have been reported, whereas 65b is the first example con-
taining three different substituents. Interestingly, the P=O bond (1.5013(15)Å) is enlarged
compared to the other P(V) compounds reported herein (1.441(8)–1.477(2)Å). Ferrocene
71b is the third example of a binaphthyl-related phosphonate, one has been reported with
the same configuration at the BINOL (R) [231] and one as the racemic mixture. [232] The bridg-
ing of the BINOL moiety into a phosphepine structure shifts the oxygen atoms by 0.154(6)
(O1) and 0.039(6)Å (O2) out of the C10H6 plane. However, the bending of the naphthalene
entities out of their planarity is rather low (5.7(4) and 4.4(5) °). Both planes of the two
71
CHAPTER 3. THEORETICAL PART
naphthyls are rotated by 54.6(2) °.
Electrochemistry
The electrochemical measurements were carried out in anhydrous dichloromethane so-
lutions at 25℃ with a scan rate of 100mV s−1 under inert conditions, containing
[N(Bu)4][B(C6F5)4](0.1mmol L−1) as supporting electrolyte (Experimental Section). For the
measurements a three-electrode cell containing a Pt auxiliary electrode, a glassy-carbon work-
ing electrode (surface area 0.031 cm2), and an Ag/Ag+ (0.01mmol L−1 [AgNO3]) reference
electrode fixed on a Luggin capillary was used. The measurement conditions are similar for
all experiments performed herein, except otherwise noted. All potentials are referenced to
the FcH/FcH+ redox couple. [233]
The electrochemical behavior of the ferrocenyl phosphates 47–50, 70a,b, 72, 73, 75 and 76,
the phosphonates 52 and 71b, the phosphinate 53 and the nitrogen-containing ferrocenyl
phosphoramidates 12–15, 43e, 79–81 and 84 were investigated by cyclic voltammetry (CV)
and square wave voltammetry (SWV) (Figure 3.36, Table 3.8).
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Figure 3.36 Cyclic voltammograms (solid lines) and square wave voltammograms (dotted
lines) of 47, 52, 53, 70a, 75 and 76 in CH2Cl2 solutions (1.0mmol L−1).
The charge transfer behavior of the oxidized products of 47 and 53 were studied in an
exemplary manner in more detail by in situ UV/Vis/NIR spectroelectrochemistry (Figure
3.37). All measured compounds, except 75 and 76, show for each ferrocenyl moiety one well-
separated reversible one electron redox event. For compound 47 with its three OFc units
three separated redox processes with the first one at E1°' = 30mV were found (Figure 3.36),
due to the weak coordinating electrolyte [N(Bu)4][B(C6F5)4], which is known to stabilize
highly charged species and minimize ion pairing effects. [234,235]. However, this differs, when
[N(Bu)4][ClO4] as electrolyte was used as reported by Herberhold et al. There, only two
reversib e events were observed with a two electron step for the first and a one electron step
for the second oxidation. [219] When one ferrocenyl group in 47 is replaced by an electron
poorer phenyl moiety as typical in 48, then the first redox process is shifted to a higher redox
potential (E1°' = 85mV) (Table 3.8), as expected. The same trend is observed for 11 in
which two ferrocenyl moieties are replaced by two phenyl units (E1°' = 106mV) (Table 3.8).
A replacement of the phenyl group in 48 by a naphthyl moiety as characteristic for 49 or
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50, however, does not have any notable influence on the first (48 and 49, E1°' = 85mV; 50,
E1°' = 90mV) or second redox potential (48 and 49, E1°' = 250mV; 50, E1°' = 260mV).
The apFr of 47 to 52 led to a decrease of the first redox potential, due to the more electron-
donating methoxy group, which increases the electron density at the ferrocenyl (47, E1°' =
30mV; 52, E1°' = –20mV). A second rearrangement to form compound 53 leads to a similar
reduction of the first redox event from E1°' = –20mV (52) to E1°' = –60mV (53), whereas
the second and third redox processes have not been influenced. The reason therefore is the
lower electron-withdrawing effect of the phosphonate group in methoxy ferrocene 53, leading
to a higher electron density at the ferrocenyl moiety and as a result thereof, this compound
can more easily be oxidized. In situ UV/Vis/NIR spectroelectrochemical measurements were
additionally carried out for compounds 47 and 53. However, no intervalence charge transfer
(= IVCT) absorptions were found between 1000 and 3000 nm, as exemplarily shown for 53
in Figure 3.37. This shows that no direct electronic communication between the Fc and
Fc+ units occurs, indicating significant electrostatic interaction among the terminal Fc/Fc+
groups as oxidation progresses.
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Figure 3.37 UV/Vis/NIR spectra of P(O)(OFc)3 (47, left) and phosphinate 53 (right) at
increasing potentials vs Ag/AgCl in CH2Cl2 solutions (2.0mmol L−1) at 25℃
containing 0.1mmol L−1 of [N(Bu)4][B(C6F5)4]as the supporting electrolyte.
Arrows indicate increasing absorptions.
Replacing the electron-rich [3]ferrocenophane group in 70a by a chelating (R)-BINOL sub-
stituent in 70b, increased the first redox potential from E1°' = 110mV to E1°' = 142mV.
A series of ferrocenophanes inter alia 70b was electrochemically investigated by Herberhold
using [N(Bu)4][ClO4] as electrolyte. [219] There a lower redox separation of ∆E°' = 300mV
(E1°' = 550mV, E2°' = 850mV vs SCE) was observed, which is attributed to the stronger
coordinating character of the electrolyte (vide supra). Zanello et al. studied the redox be-
havior of tri- and ditellura-ferrocenophanes and described an unambiguous assignment of the
molecule orbitals in the redox process. [236] The apFr of 70b leading to 73b shows a similar
redox behavior. The electron-donating effect of the methoxy group to the ferrocenyl moiety
in 71b is superimposed by the electron-withdrawing effect of the phosphonate moiety.
The methyl groups in 2,2'-position in 73 shift the redox potential, in comparison to 72, to
lower values (E1°' = 254mV for 73, E1°' = 302mV for 72) due to their electron-donating
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Table 3.8 Cyclic voltammetry data of ferrocenyl phosphates, phosphonates and aliphatic
derivatives 11–15, 43e, 47–50, 52, 53, 70–73, 75, 76, 79–81 and 84.a
Compd. E1°'b E2°'b E3°'b ∆E°'d Compd. E1°'b E2°'b ∆E°'d
(∆Ep)c (∆Ep)c (∆Ep)c (∆Ep)c (∆Ep)c
Phosphates and Phosphonates Aliphatic N -Derivatives
47 30(64) 235(66) 435(68) 205/200 12 –29(65)
48 85(60) 250(65) – 165 13 –50(62)
11 106(60) 14 –63(62)
49 85(60) 250(66) 165 15 62(64)
50 90(68) 260(70) 170 43e –14(74) 202(106) 216
52 –20(64) 200(62) 520(76) 220/320
53 –60(66) 205(70) 510(80) 265/305
[3]Ferrocenophanes Heterocyclic N -Derivatives
70a 110(62) 535(72) – 425 79 100(58) 260(66) 160
70b 142(64) 80 95(60) 255(62) 160
71b 152(68) 81 90(62) 250(66) 160
72 302(64) 84 60(60) 290(64) 250
73 254(60)
75 90(70) 270(60) 800(135) 180(530)
76 225(70) 540(125)e 315
a All potentials are given inmV vs FcH/FcH+, with an analyte concentration of 1.0mmol L−1 at 25℃ con-
taining 0.1mmol L−1 of [N(Bu)4][B(C6F5)4]as the supporting electrolyte.
b E°' = formal potantial.
c ∆Ep = difference between the anodic and cathodic peak potential.
d ∆E°' = potential difference between the ferrocenyl-related redox processes.
e Broad two electron process.
effect. Compound 75, bearing five ferrocenyls, showed three redox processes. The four OFc
groups are represented by the first two redox events at E1°' = 90mV and E1°' = 270mV.
Both consist of two nonseparated one-electron processes of one ferrocenyl at each phosphate
fragment. The one-electron redox wave at E3°' = 800mV represents the 1,1'-substituted
ferrocenyl (Table 3.8). The difference between the anodic and cathodic potential of ∆Ep
= 135mV indicates an electrochemical irreversibility of the third redox event. The redox
potential at E3°' = 800mV leads to the conclusion that both phosphate groups, each bearing
two oxidized ferrocenyl, exerts a high electron-withdrawing effects and therefore, for a linear
increase or decrease of the redox potential. [237] Molecule 76 containing two [3]ferrocenophane
motifs, compared to two ferrocenyls at the phosphorus atom (75), showed two redox pro-
cesses: a one electron event for the non-bridged, and a redox process with a shoulder including
two one-electron processes for both [3]ferrocenophanes (Figure 3.36). Electrochemical mea-
surements of ferrocenyl phosphoramidates 79–81 and 84 display two reversible one-electron
redox processes (Table 3.8). The nature of the N -heterocycle in 79–81 has negligible influ-
ence on the redox potential and as consequence thereof, the redox separation is with ∆E°'
= 160mV identical for all three compounds. A further redox process for the N -heterocycle
was not observed under the applied measurement conditions. The first redox process for
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84 is found at E1°' = 40mV (for comparison: 81, E1°' = 90mV), which is attributed to
the electron-donating methoxy substituent. The second redox event is with E1°' = 290mV
for 84 40mV higher than in 81, which can be explained by the more electron-withdrawing
influence of the directly to phosphorus-bonded Fc+ moiety. Besides the importance of the
electron density at the ferrocenyls for limiting a lithiation process, also the nature of the sub-
stituent is relevant. Thus, triferrocenyl phosphate 47 (30mV, Table 3.8) underwent an apFr,
whereas the borane adduct 15 (62mV) showed no attack at the phosphorus atom, although
it contained a ferrocenyl unit with a decreased electron density. Obviously, the strongly
electron-donating cyclic N -alkyl group shields the phosphorus atom and thus, prevents a
nucleophilic attack. Compared to N -aryl phosphates 79–81, this is due to the electron rich
N -alkyl substituents, enabling a better orbital overlap between the N and the P atoms. In
contrast to the compounds described above, phosphoramidates 12–15 and 43e did not un-
dergo an apFr, although lithiation reactions were observed by using the stronger base sBuLi
instead of LDA (Figure 3.6). This indicates that a higher electron density is present at the
ferrocenyls in 12–15 and 43e, which is verified by the lower redox potentials of up to 62mV
for the borane adduct 15. In contrast, the aromatic derivatives and the [3]ferrocenophanes
72 and 73 are observed at higher values of 90mV (Table 3.8). The low values for phosphonate
52 (–20mV) and phosphinate 53 (–60mV) are misleading, as the first redox event refers to
the methoxy-substituted ferrocenyl, which is not able to undergo an apFr. Within the series
of aliphatic ferrocenyl phosphates, the replacement of a P=O (14, –63mV) by a P=S (13,
–50mV) and furthermore a P→BH3 (12, –29mV) group decreases the electron density at
the ferrocenyl, while increasing the redox potential. This is contrary to the results obtained
by apFr within the series of P(E)(OFc)(OEt)2 with decreasing yields for E = O (94%) > E
= BH3 (37%) > E = S (0%), as described in Section 3.1.1. The latter one could solely be
converted by using sBuLi (50%). Replacement of an N -alkyl (14) by a FcO moiety (43e)
shifts the potential for the first redox event from –63 to –14mV.
3.1.5 Conversion of 1,2-P,O-Phosphonates to Phosphines and their
Application in C,C Cross-Coupling Reactions
Conversion of Phosphonates to Phosphines
The transformation of phosphonates rac-16 and (Rp)-31e into phosphine 91, which has been
considered as auxiliary ligand for palladium in Suzuki C,C cross-couplings, was thoroughly in-
vestigated, as outlined in Figure 3.38. The attempted direct conversion of phosphonate rac-16
into phosphine oxide rac-20 by treatment with phenylmagnesium bromide or phenyllithium
gave only unreacted starting materials. Likewise, the conversion into the dichlorophospho-
nate intermediate 89 [211,238] with subsequent introduction of the phenyl moieties [188,239] in a
one-pot reaction turned out to be unsuccessful in the case of ferrocene 16.
In contrast, reduction of this phosphonate in the presence of an excess of Li[AlH4] and
trimethylsilyl chloride followed by acidic workup under anaerobic conditions yielded phos-
phine 90a quantitatively. [239,240] Successive Pd-catalyzed Stelzer P ,C cross-coupling [15] was
chosen for the conversion of the primary phosphine into compound 91, as this transformation
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Figure 3.38 Possible Pathways for the Conversion of Phosphonate rac-6 and (Rp)-31e into
Phosphine 91.
Reaction conditions: i) Li[AlH4] (4 equiv), ClSiMe3, THF, 25℃ (6) or 50℃ (31e), 12 h. ii)
PhI (2 equiv), K3PO4 (2 equiv), [Pd(dppf)Cl2] (4 mol%), toluene, 110℃, 12 h. iii) crystal-
lization from hexane; iv) atmospheric conditions, 2 weeks in 95/5 (v/v) hexane/tBuOMe.
has, to the best of our knowledge, never been applied in ferrocene chemistry.
The phosphine 90b is accessible in a multi gram scale from O,O-diethyl ferrocenylphos-
phonate, thus, we investigated 90b instead of 16 in a test reaction to explore the reaction
conditions (Table 3.9). The best results were reached using two equivalents K3PO4 with
toluene as the solvent and [Pd(PPh3)4] giving the coupling product in 72% (Entry 4). The
usage of other bases decreases the yield dramatically.
Table 3.9 Optimization of the reaction condition for the Stelzer coupling for ferrocenyl
phosphines.a)
FeH PH2 FeH PPh2
i)
90b 90c
Entry Base (equiv) Solvent Yieldb
1 NEt3 (4) toluene 0%
2 K3PO4 (4) toluene 68%
3 CsF (4) toluene 26%
4 K3PO4 (2) toluene 72%
5 K3PO4 (4) 1,4-dioxane 65%
6 K3PO4 (2) 1,4-dioxane 48%
a Reaction conditions: i) [Pd(Ph3)4] 2mol-%, PhI
(3 equiv), 110℃.
b Isolated Yields.
With an increase of base also a significant amount of the corresponding phosphanoxide can
be detected (up to 50%, Entry 2). Nevertheless, it is known that phosphaneoxides can be
converted to the corresponding phosphane.
Application onto 1,2-disubstituted ferrocene 90a, however, gave ferrocenyl methyl ether (22)
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as the only product, which was formed due to a P,CCp bond cleavage during the catalytic
transformation (Figure 3.39). [241] The P,CCp bond cleavage proceeds through a P-aryl/aryl
exchange at a metal complex shown in Figure 3.39. Its formation can be prevented by the use
of a chelating ligand suppressing ligand scrambling as well as the absence of phenyl iodide af-
ter complete conversion of the primary and intermediately formed secondary phosphines. The
utilization of 1,1'-bis(diphenylphosphino)ferrocene (dppf) as a sterically demanding, chelat-
ing ligand for palladium and avoidance of an excess of phenyl iodide circumvented this side
reaction, giving access to the desired ferrocene 91 in 52% yield (Figure 3.38). Using the enan-
tioenriched (Rp)-31e under the same conditions gave (Rp)-91 in a similar yield of 65% and an
ee of 99% after single crystallization (Figure 3.38), evidenced by chiral HPLC (Experimental
Section). [156]
[PPh3Fc]+ I-
P Fc
Ph
H
Stelzer CouplingAryl-Aryl Exchange
[Pd]
[Pd][Pd]
+0
+II +II
Oxidative
Addition
Reductive
Elimination
Transmetalation
PhI
Ph
I
Ph
P
H2PFc,
base
HI  base
Oxidative
Addition
Reductive
Elimination H
Fc
P Fc
Ph
Ph
[Pd]
+II Ph
[Pd]
+II Ph
PPh2Fc
I
I
PhI
[Pd]
+0
[Pd]
+0 OxidativeAddition [Pd]
+II Fc
PPh3I
Figure 3.39 Mechanism of the Stelzer Coupling and the undesired Aryl-Aryl-Exchange.
Ar = single bound aromatic group.
Single crystals of rac-91 suitable for single-crystal X-ray diffraction studies were obtained
by crystallization from boiling hexane, whereas (Rp)-91 crystallized as its oxide (Rp)-20
from the HPLC solution (5% tBuOMe in hexane) after 2 weeks (Figure 3.38). The racemic
derivative 91 crystallized in the centrosymmetric space group P21/c. For enantiopure (Rp)-
20 non-centrosymmetric P212121 was present. Both were present with one molecule in the
asymmetric unit. The solid-state structures unambiguously confirmed the 1,2-substitution
pattern of the metallocene backbone, and the successful proceeding of the reduction and
Stelzer coupling procedure. As expected, the phosphorus and oxygen atoms are both located
in the plane of the cyclopentadienyl ring (91, rms deviation 0.0008Å, distance of P1 –
0.0010(3)Å and distance of O1 –0.079(3)Å; (Pp)-20, rms deviation 0.0075Å, distance of
P1 –0.095(7) and distance of O1 –0.091(6)Å). In both structures, the methyl group points
away from the phosphorus atom. In phosphine 91, the lone pair of the phosphorus atom is
directed into the vacant space between the two substituents, which in principle should allow
for a chelating complexation of a suitable transition metal, e.g. palladium. In the respective
oxide 20, the oxygen atom directs away from the vacant space to avoid steric and electronic
interactions with the ether oxygen. The P–O bond in 20 of 1.491(2)Å is significantly enlarged
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compared to those in the phosphates and phosphonates reported herein that range between
1.437(9) and 1.469(4)Å, due to the more electron rich phenyl rings.
Figure 3.40 ORTEP (50% probability level) of the molecular structures of rac-91 (left) and
(Rp)-20 (right) with the atom-numbering Scheme. All hydrogen atoms have
been omitted for clarity.
C,C Cross-Coupling Reactions
P ,O-ferrocenes show high activities in the synthesis of sterically congested biaryls via Suzuki–
Miyaura C,C couplings, as demonstrated recently. [73,74,130]
Br
R
(HO)2B
R'
+
94a−h92 93
[Pd2(dba)3]/ 91,
K3PO4 . H2O, 
toluene, 70 °C
OO
O O O Ph O
O FF
94e, 64 %
        50 %a)
94e, 70 % (1 % ee)
94b, 99 %
94b, 99 % (2 % ee)
94c, 91 %b) 94d, 93 %b)94a, 99 %
        66 %a)
94f, 92 % 94g, 99 %c) 94h, 43 %
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FeO PPh2
 rac-91
(Rp)-91
Figure 3.41 Application of phosphine rac- and (Rp)-91 in the Pd-catalyzed, (atropselec-
tive ) synthesis of tri-ortho-substituted biaryls via Suzuki-Miyaura C,C cross-
couplings.
Reaction conditions: aryl bromide (1.0mmol), boronic acid (1.5mmol), [Pd2(dba)3] 0.25mol-
%, 91 1mol-%, 24 h, K3PO4 ·H2O (3.0mmol), toluene (3mL), 70℃. Reaction times were not
optimized. Yields are based on isolated products as the average of two measurements. a)
50℃; b) K3PO4·3H2O; c) 100℃.
This prompted us to investigate the performance of phosphines rac-91 as a ligand
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in the Pd-catalyzed synthesis of racemic tri-ortho-substituted biaryls, starting from 1-
bromonaphthalenes 92 and ortho-substituted phenylboronic acids 93 (Figure 3.41). At a
catalyst concentration of 0.5mol-% and a reaction temperature of 70℃ the respective biaryls
94a–h could typically be isolated in good to excellent yields (Figure 3.41). A slightly higher
temperature was required to obtain biphenyl 94g quantitatively. For the sterically more
demanding 9-phenanthryl derivative 94h only a moderate yield of 43% was achieved. These
results are comparable with those of P ,O-substituted ferrocenes described before [73,74] and
exceed the performance of other (ferrocenebased) phosphines regarding reaction temperature
and palladium concentration. [67,108,242] These results demonstrate that P ,O-substituted fer-
rocenes, accessible through an apFr, are catalytically active for the synthesis of axial-chiral
biaryls via Suzuki–Miyaura C,C couplings in the presence of palladium. Furthermore, the
highly diastereomerically enriched phosphonate 31e could be converted to (Rp)-90, reveal-
ing that the reaction conditions for the reduction of diethylferrocenyl phosphonate 16 can
be adopted on the sterically more demanding fenchyl derivative 31e (Figure 3.38). [239,240]
When 90 was used under Pd-catalyzed Stelzer P ,C cross-coupling reaction conditions, [15]
the respective diphenylphosphino ferrocene (Pp)-91 could be obtained in 65% yield (80%
ee). Single recrystallization from hexane increased the ee to > 0.99, evidenced by chiral
HPLC. However, using enantiopure (Rp)-91 for the synthesis of 94b and 94e almost no ee
(< 2% ) could be detected (Figure 3.41).
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3.2 Oxygen-Functionalization of Hydroxyferrocenes
3.2.1 Reaction of Hydroxyferrocenes with Electrophiles
The results of the application of 2-methoxyferrocenyl phosphane in the Suzuki–Miyaura re-
action for the synthesis of hindered biaryls [73,74] showed their good catalytic activity within
this reaction.
The most important feature of molecule 91 is a better stabilization of the catalytically active
species due to a hemilabile binding of the oxygen atom to the palladium atom. [74] Due to
its potential planar chirality, the enantiopure ligand has been investigated for this catalytic
transformation. However, the stereo information of the ferrocenyl backbone could not success-
fully be transferred to a substrate, due to the sterically non-demanding methoxy substituent
(Figure 3.41). Thus, additional research on the functionalization of the oxygen moiety within
this structural motif is required. It is important to note that for the final conversion of the
phosphonates, obtained after apFr, into the 1,2-P ,O-phosphanes, a reduction and Stelzer
coupling process had to be carried out, which sets certain requirements on the tolerance of
functional groups.
Aromatic ethers are promising structural motifs, since they are known to be stable under
different reaction conditions without a C–O bond cleavage, a potentially increased steric
demand, and a stabilizing effect on aromatic substrates. [243]
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Figure 3.42 Synthetic methodologies resulting in the formation of ferrocenyl aryl ethers:
(A) Recently reported copper-mediated Ullmann-Type coupling [157], and (B)
SNAr reactions showing one of the three examples known in ferrocene chem-
istry. [164,244] ([Si] = SitBuPh2)
Possible routes were adopted from the synthesis of hydroxyl ferrocene in an Ullmann-type cou-
pling starting from ferrocenyl halides. [147,157,167,194] This approach was extended to aromatic
and aliphatic alcoholates to yield the respective ethers (A, Figure 3.42), [156,157,245] which,
however, are not known to proceed for compounds bearing a phosphorus substituent in the
ortho position. Furthermore, one example of a nucleophilic C,C aromatic substitution reac-
tion (SNAr) has been reported for an intramolecular cyclization of an enantiomerically pure
(Sp)-perfluorinated phenyl imine (B, Figure 3.42), which has been observed accidentally. [164]
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In addition, two examples of an SNAr reaction with 4-chloroquinolines were reported. [244]
Herein, the hydroxyferrocenes are obtained after apFr, which limits the hydroxy functional-
ity to act as a nucleophilic substrate.
Substitution and Addition Reactions with Aliphatics
For the conversion of the ferrocene-hydroxyl group with electrophiles to ethers, we investi-
gated the reaction of the deprotonated ferrocenol 5–Li or its ortho-phosphonato-substituted
derivative 16–Li with well-known electrophiles, such as benzyl bromide (a), propargyl deriva-
tives (b,c), the conversion to a THP (tetrahydropyran) (d), and chlorosilanes (e, f) (Figure
3.43). The results indicate a low nucleophilicity of ferrocenolates toward SN2 reactions at
carbon atoms containing bromide (a), tosylate (b, c) and phosphinates (d, e), due to a rapid
oxidation of 5 by the required quinone for d and e (Figure 3.43). [246] In contrast, the nucle-
ophilic addition reaction of 3,4-dihydro-2H-pyran (f, Figure 3.43) and ferrocenol derivatives
is known to proceed with virtually quantitative yield [120,167] and can also successfully be ap-
plied to the ortho-phosphonato ferrocenol 16–H, affording 95f in 99% yield, after an apFr.
Interestingly, 95f is not obtained as a racemic mixture but as a mixture of both diastereomers
in the ratio 0.68 : 0.32.
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Figure 3.43 Nucleophilic substitution reactions (SN2) of hydroxy ferrocenes with
electrophiles.b
Yields are based on the ferrocenyl educts. Reaction conditions: i) Et2O or THF, 18 h, 25℃;
ii) 1st CH(OH)R'Ph, BuLi, ClPPh2, THF, 2nd ,6-dimethylcyclohexa-2,5-diene-1,4-dione, 5,
18 h, 25℃; iii) HCl (∼3 M, CH2Cl2, 18 h, 25℃; a) The FcOLi compounds 5–Li and rac-16–
Li were generated either by lithiation of 5 using BuLi or by an apFr of 6; b) A nucleophilic
addition reactions occurred, instead of a substitution; Ts = SO2-C6H4-p-CH3). Yields are
based on 5 or 6.
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The usage of chlorosilanes [164] allows the synthesis of the respective ferrocenyl silyl ethers rac-
95g (56%) and rac-95h (52%). However, silyl and THP ethers are known to be unstable
under long-term basic conditions at higher temperatures or in Pd-catalyzed reactions. [247]
Phenols, as the benzene analogues of ferrocenols, can be converted into aromatic ethers,
e.g., by using iodonium [248] or diazonium compounds. [249] Attempts to adopt these reaction
conditions for ferrocenol (5) to give the appropriate ferrocenyl phenyl ether 96d by using
diphenyliodonium triflate and phenyldiazonium tetrafluoroborate failed, probably due to the
oxidation and decomposition of 5. [250]
Nucleophilic Aromatic Substitution Reactions
A further possibility for the introduction of aryl substituents at oxygen-based nucleophiles
is the usage of electron-deficient aryl halides in SNAr reactions, which is well-known for
phenyl derivatives, [251] whereas only three examples have been reported for ferrocenyl-based
compounds, i.e. reaction B (Figure 3.42), and chloroquinones. [164,244] Thus, we reacted
FcOLi (5–Li) with Sangers reagent [252], affording the respective ferrocenyl ether 96a in 81%
yield (Figure 3.44). The reaction conditions were adopted from ref 251. The reaction of
4-nitrofluorobenzene with 5 resulted in the formation of 96b in 74% yield (Experimental
Section). Less electron deficient derivatives such as c–e in Figure 3.44 did not undergo
a SNAr reaction, which is in accordance with the case for benzene-based compounds. [251]
An activation of fluorobenzene to the respective tricarbonylchromium complex, known for
alkoxy [253] and N nucleophiles, [254] did not enhance the reactivity. Nitrogen-containing aryl
halides, e.g. pyridines, pyrimidines, and pyrazines, are also not suitable for the reaction of
ferrocenol, in contrast to the phenyl-based derivatives. [255]
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Figure 3.44 Synthesis of ferrocenyl aryl ethers 96a–f.
Reaction conditions: i) BuLi, hexane, aryl fluoride, DMF, 70℃, 18 h; a) the η6-Cr(CO)3
complex was used. Yields are based on 5.
The dependence between reactivity and the presence of multiple electron-withdrawing
substituents can be optically observed as a rapid color change in the conversion with
2,4-dinitrofluorobenzene to 96a, whereas a decay of several minutes in the case of 4-
nitrofluorobenzene indicates a decreased reactivity for the single nitro-substituted derivative.
It should be noted that within the synthesis of 96a the excess of Sanger’s reagent could not
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be removed, owing to an equal chromatographic behavior. Thus, it was necessary to further
react the crude product of 96a with dicyclohexylamine and K2CO3 in acetone at 40℃ to
convert 2,4-dinitrofluorobenzene into 2,4-dinitro-N,N -dicyclohexylaniline, which could eas-
ily be separated by column chromatography. This workup step could be avoided by adding
dicyclohexylamine directly to the reaction mixture.
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Figure 3.45 Synthesis of ortho-/meta-diferrocenyl dinitroaryl ethers 99a and 100.
Reaction conditions: i) 1st, hexane, –30℃, BuLi; 2nd, DMF, 97/98, 70℃, 18 h. Yields are
based on 5.
The synthesis protocol for the ferrocenyl aryl ethers 96a,b gave access to benzenes bearing
two ferrocenyl ether groups by the treatment of 5 with the 1,3- (97) or 1,2-difluorobenzenes
(98), [256] resulting in the formation of the first meta- (99a) and ortho-disubstituted (100)
bis(ferrocenyloxy) benzenes (Figure 3.45). In the case of 97, monofunctionalized 99b and a
product bearing an NMe2 moiety (99c), which results from the nucleophilic attack of DMF
(N,N -dimethylformamide) at a fluorine-bearing carbon atom, [257] were formed. In contrast
to 97, [258] compound 98 is not known to undergo a single substitution. [259] A SciFinder search
for the conversion of 98 to a single substituted product found no reaction.
As shown in Section 3.1 ferrocenyl phosphates can undergo a 1,3-O→C apFr. The respective
rearrangement products contain a hydroxy substituent that should be suitable for SNAr
reactions with aryl fluorides. This prompted us to extend the substrate scope to ortho-
phosphonato and sulfonyl-substituted hydroxyl ferrocenes that can be obtained after the
respective anionic phospho-(Section 3.1) and thia-Fries [167,194] rearrangements of 30a and
101 (Figure 3.46). In a consecutive one-pot synthesis, ferrocenyl phosphate 30a and triflate
(101) [167,194] undergo the 1,3-O→C migration to give 1,2-X,O (X = P, S) substituted hydroxy
ferrocenes respectively (Figure 3.46). Their reaction with nitro-aryl fluorides resulted in
the formation of ortho-substituted ferrocenyl aryl ethers rac-102a,b and rac-103a, a rarely
described structural motive in ferrocene chemistry. To date, the only reported examples for
ortho-substituted ferrocenyl ethers are found in references 73, 164, 244 and [260]. In contrast
to the phosphonato ferrocenes rac-102a,b, the respective sulfonyl derivatives possess a lower
nucleophilicity of the hydroxyl oxygen, due to the highly electron withdrawing character of the
SO2CF3 moiety (vide infra). Thus, no reaction with the less electrophilic 4-nitrofluorobenzene
to ether rac-103b occurred. The ortho-substituted ferrocenyl phosphate 35a and triflate
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Figure 3.46 Synthesis of di- and trisubstitutied ferrocenyl nitroaryl ethers after anionic
phospho- and thia-Fries rearrangements.
Reaction conditions: i) 30a/35a, LDA, TMEDA, hexane, 25℃; ii) 2,4-(NO2)2-C6H3F/4-
NO2-C6H4F, DMF, 70℃, 18 h; iii) ClP(O)(OCy)2; iv) LDA, –80℃, 1 h; v) O(SO2CF3)2,
25℃. All yields are based on the respective ferrocenyl starting material.
103c can undergo a further anionic Fries rearrangement to result in the 1,3-disubstituted
ferrocenes 104–Li and 105–Li (Section 3.1). [167,194] Subsequent reaction of 104–Li with the
most electrophilic 2,4-dinitrofluorobenzene afforded the di-ortho-substituted ferrocenyl aryl
ether 104a in 49% yield. In comparison to 103–Li, 105–Li is less nucleophilic, due to one
additional electron-withdrawing substituent, which obviously prevents the reaction with the
less electrophilic mono-nitro aryl fluoride. This is comparable to SO2CF3-bearing 101, which
can only be converted using the dinitro derivative, whereas for doubly ortho-substituted 105–
Li, no reaction occurred. The reactivity can be estimated by the determination of the redox
potential by cyclic voltammetry (CV) (Table 3.11, vide infra).
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Figure 3.47 Attempted anionic carbo-Fries rearrangement of 4.
Reaction conditions: i) LDA, –80℃, THF, 2,4-dinitrobenzene, DMF, 40℃. Yields are based
on 4.
A carbo-Fries rearrangement, which has been reported for phenyl-based derivatives, for ex-
ample, alkyl amides, was also investigated by treating ferrocenyl acetate (4) with LDA at
–80℃. It should be noted that carbo-Fries rearrangements are solely described for carba-
mates. [178,223] However, instead of an ortho lithiation, a nucleophilic attack of LDA at the
carbonyl carbon atom occurred, resulting in the formation of 5–Li, and after subsequent
reaction with the dinitro arylfluoride compound 96a is formed exclusively instead of 106a
(Figure 3.47). Instead of a nucleophilic attack of LDA, this could also be explained by the
deprotonation of the acetyl group and the release of ketene. The formed double bond, thus,
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cleaved the FcO–C bond and the negative charge remains as the ferrocenolate ion. [261]
The Fries rearrangement to ortho-phosphonato ferrocenolates can additionally be performed
with the chiral pool-based di(1R)-α-fenchyl ferrocenyl phosphate 30e, affording ethers (Rp)-
107a (0.81 de) and (Rp)-107b (0.74 de) (Figure 3.48), whereas the diastereomeric excess
(de) was calculated on the basis of the integrated 31P{1H} NMR spectra.
(Rp)-107a (R = NO2), 34 % (de = 0.81)
(Rp)-107b (R = H),       9 % (de = 0.74)
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Figure 3.48 Synthesis of diastereoenriched planar-chiral 1,2-P ,O-ferrocenyl aryl ethers.
Reaction conditions: i) LiTMP, TMEDA, hexane, 25℃; ii) 2,4-(NO2)2-C6H3F/4-NO2-
C6H4F, DMF, 70℃. Yields are based on 30e.
3.2.2 Characterization of Ferrocenyloxy Nitro Arenes
NMR Characterization
In the 1H NMR spectra the resonances of the phenylic aromatic protons occur between
6.9 and 8.8 ppm. Compounds 99a–c exhibit two resonances at 6.3–6.7 and 8.7–8.8 ppm
for the protons located between the two nitro substituents. The electron-donating NMe2
group in 99c shifts the first signal to a higher field (6.26 ppm) in comparison to the OFc
(99a, 6.68 ppm) or the rather electron-withdrawing F substituent in 99b, which also splits
both signals into doublets (6.87 and 8.83 ppm) due to a JH,F coupling of 11.9 (3J) and
7.6Hz (4J). Characteristic resonance signals are also present at 2.57 ppm for the terminal
C≡CH proton in 95b and the methyl groups in 95c (1.90 ppm) and 99c (2.85 ppm). The
29Si1H NMR spectra of compounds rac-95g,h exhibit signals at 3.1 ppm for rac-95g and
17.8 ppm for rac-95h. The resonances in the 31P{1H} NMR spectra are found at 19.1
(rac-102a), 19.3 ppm (rac-102b), 20.5 ((Rp)-107a), and 21.2/22.2 ppm ((Rp)-107b). Solely
the phosphorus atom in rac-104a, bearing two phosphonato substituents, is shifted to
higher field (17.4 ppm). The electron-donating influences of the silyl (rac-95g, 24.9 ppm;
rac-95h, 24.7 ppm) and phosphato moieties (rac-102d, 21.2 ppm) also shield the phosphorus
atom. In the 13C{1H} NMR spectra, the decrease of the withdrawing character of the
nitro substituents shifts the C–P or C–S carbon atom to higher field, as expected, from
63.4 (rac-102a) to 62.9 ppm (rac-102b), 69.4 (rac-103a) to 69.2 (rac-103c) ppm, and 61.9
((Rp)-107a) to 60.6 ((Rp)-107b) ppm. The resonances of the P-CFc bond in phosphonates
rac-95g,h, rac-102a,b, 104a, and (Rp)-107a,b occur as doublets with a 1JC,P coupling
constant of 214–219Hz, similar to the ferrocenyl phosphonates reported in Section 3.1. Inter-
estingly, the influence on the C–O binding carbon of the C5H4 and C5H3 rings is in contrast
with the electron-withdrawing character of the aryl substituent, resulting in a downfield
shift from 119.5 (96a) to 119.9 (96b) ppm, 119.3 (rac-102a) to 120.1 (rac-102b) ppm, and
120.8 ((Rp)-107a) to 121.6 ppm ((Rp)-107b). In the 1,3-bisphosphonato species 104a, this
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signal is observed at 118.6 ppm. Compound 104a is formed as a mixture of two isomers
regarding the rotation of the aromatic C6H3(NO2)2 moiety, due to two sets of signals in the
1H and 13C{1H} NMR spectra formed in a ratio of approximately 0.8 : 0.2. The two sets
exhibit similar JH,H values in the 1H NMR spectrum, whereas the sum of the integrals of
both signals is required for a comparison with the integrals of the ferrocenyl and cyclohexyl
protons and, thus, an impurity of further aromatic compounds can be excluded.
Solvatochromic Behavior
The presence of electron-donating ferrocenyl [262] and electronwithdrawing NO2 substituents
combined in one molecule prompted us to investigate the solvatochromic behavior of these
species using UV/Vis spectroscopy (Table 3.10). Thus, we investigated the pi−pi∗ absorption
of compound 96a in five different solvents from hexane (nonprotic, nonpolar) to ethanol
(protic, polar) with concentrations of 3.10−5 mol L−1 (Table 3.10). The UV/Vis spectra of
96a contain one absorption between 250 and 350 nm, which can be ascribed to the pi − pi∗
absorption band of the phenyl substituent. However, a shift of 13 nm indicates that a
negligible positive solvatochromic behavior is present, probably due to the small +M/ + I
effect of the oxygen ether atom.
Table 3.10 Solvatochromic behavior of 96a.a
Entry Solvent λmax / nm
1 hexane 281
2 toluene 284
3 isopropanol 285
4 DMF 289
5 ethanol 291
6 acetone 293
a The maximum refers to the pi−pi∗ ab-
sorption.
Solid State Structures
The molecular structures of 96a,b, 98, [256] 99a-c, 100, and rac-103a in the solid state have
been determined by single-crystal X-ray diffraction analysis at 110 K (Figures 3.49, 3.50, 3.51)
and Figure SI7 in the Supporting Information of 263. Suitable single crystals of 98, 99b, and
rac-103a were obtained by evaporation of hexane solutions at ambient temperature, those
of 96a,b and 99a,c from boiling hexane, and those of 100 from boiling toluene solutions
containing the respective compounds. The compounds crystallize in triclinic (P1, 96a, rac-
103a) monoclinic (P21/n, 96b, 99b; P21, 99a; C2/c, 100) orthorhombic (P212121, 7c) and
tetragonal (P43212, 98) space groups with one (96b, 99a-c and rac-103a) two (96a), or a
half of a molecule (98) in the asymmetric unit.
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Figure 3.49 ORTEP (50% probability level) of the molecular structures of 87a (left) and
87b (right) with the atom-numbering Scheme. All hydrogen atoms have been
omitted for clarity.
Figure 3.50 ORTEP (50% probability level) of the molecular structures of 90a (left) and
91 (right) with the atom-numbering Scheme. All hydrogen atoms and one
molecule of CH2Cl2 in the asymmetric unit of 91 have been omitted for clarity.
Intramolecular T -shaped pi interaction between the centroids (Ct) of the C17–C21 and C12–
C16 labeled cyclopentadienyls is shown: Ct· · ·Ct, 4.898(6)Å; intersection, 82.8(6) °.
Figure 3.51 ORTEP (50% probability level) of the molecular structures of 90b (left), 90c
(middle) and 1,2-S,O-substituted rac-94a (right) with their atom-numbering
Schemes. All hydrogen atoms and a second crystallographically independent
molecule in the asymmetric unit of 90b have been omitted for clarity.
The ferrocenyl backbone adopts an eclipsed conformation for 96a,b, 99a-c, and 100 (0.1(2) to
5.97(18) °) and a staggered rotation for 1,2-S,O-substituted rac-103a (22.7(2) °). The phenyl
ring mainly reveals a perpendicular orientation toward the cyclopentadienyls for 99a,b, 100,
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and rac-103a (82.00(11) to 88.74(10) °) or range between 42.7(4) and 69.90(10) °for 96a
and 99a-c. In diferrocenyl-substituted compounds 99a and 8 (Figure 3.50) the different
substitution patterns (1,3 in 99a; 1,2 in 100) affects the orientation of the ferrocenyls with
respect to each other. The increased distance of the 1,3-disubstitution allows for a more
flexible rotation and, thus, a stabilization of the packing by an intramolecular T -shaped pi
interaction between a C5H5 and a C5H4 unit (Figure 3.50). In contrast, compound 100 reveals
a nearly coplanar orientation of both ferrocenyls (deviation from coplanarity 5.16(18) °) with
their backbones directed away from the phenylene core in perpendicular torsions (86.13(8),
85.65(8) °). The difference between the 1,2-/1,3-substitution pattern also affects the rotation
of the nitro groups. Thus, they are approaching a coplanar orientation in 99a (22.9(13) °),
whereas the steric demand in 1,2-positioned 100 results in an almost orthogonal orientation
(77.2(3) °). An electrostatic interaction between N2 and O4 is present, due to a separation far
below the sum of the van der Waals radii (Σ = 3.07Å) of 2.6032(1)Å. However, an interaction
of O4 to the partially positively charged N1 atom of an adjacent molecule does not seem to
be possible, due to a small N1–O4· · ·N1 angle of 94.49(14) °. Equal N1–O3/4 bond distances
of 1.222(3) and 1.227(3)Å support this conclusion. The NO2 substituents in 96a,b, 99b,c,
and rac-103a, where steric reasons are excluded, adopt plane intersection angles toward the
C6 phenyl plane between 0.04(4) °(96b) and 40.78(12) °(99b). Interestingly, the NO2· · ·C6
plane intersection of 37.0(5) °in 99c is rather small, although an NMe2 group in an ortho
position with rather coplanar C6–N3–C18 torsions (24.9(11) and 22.5(18) °) is present. This
results in a significant twisting of the C3 and C4 atoms above and C5 below the C6 ring
(rms deviation 0.0381). The rms deviation for 96a,b and 99a,b does not exceed 0.0072
and is increased to 0.0143 for 103a. The rms deviation in 99c for C1,2,6 is 0.00, which
corresponds to a shift of the N2 atom out of this plane be 0.52(7)Å and of N3 by –0.22(5)Å.
The O-CFc and O-CPhenyl bond lengths at the ether oxygen reveal a significantly enlarged
O-CFc bond distance of 1.382(10)-1.416(14)Å in comparison to 1.325(15)-1.373(4)Å for O-
CPhenyl. The longer O-CFc bond (ca. 0.05Å) might be due to the increased electron density
at the ferrocenyl groups and thus a weakening of the O-CFc bond. In comparison to the four
structures reported in the literature containing a ferrocenyl aryl ether motif, electron-rich tert-
butylsubstituted phenyl ethers also exhibit enlarged O-CFc bonds (e.g., O-CFc 1.377(3)Å vs
O-CAr 1.396(3)Å and O-CFc 1.370(2)Å vs O-CAr 1.401(2)Å), which excludes an electronic
effect of the withdrawing aryl substituent. A CSD database search resulted in four examples
of ferrocenyl aryl ethers, reported in references 73 and 164. O-alkyl, e.g. O-Me, ethers
exhibit an opposite behavior owing to an sp3-hybridized carbon atom. The angles of the
ether oxygen atoms range from 116.14(18) to 122.2(7) °, whereas values above 120 °are caused
by an intramolecular pi interaction in 99a or the distortion of the phenyl ring in 99c. The
present fluorine substituents also interact over short distances within the sum of the van der
Waals radii, in e.g., in F· · ·F (rac-103a) and F· · ·O (99b) interactions (Figure 3.51) .
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Electrochemistry
The electrochemical behavior of 6, [264] 30a, 31a, 35a, 96a,b, 99a-c, 100, 101, [194] rac-
102a,b, rac-103a, and rac-104a, were investigated by cyclic voltammetry and square wave
voltammetry (Table 3.11). In the cyclic voltammograms of 6, 30a, 31a, 35a, and 101 one
reversible redox event for the ferrocenyl unit was observed (Table 3.11). The ferrocenyl redox
processes of 6, 30a and 31a can be found between 20 and 50mV, indicating similar electron
densities at the ferrocenyl moieties in all three compounds. The second phosphonate group
in 35a and the triflate group in 101 led to decreased electron densities at the ferrocenyls, and
therefore the values for E1°' are shifted to higher potentials (335mV (101), 170mV (35a)).
The cyclic voltammograms of 96a,b show two (96b) or three (96a) redox processes in a
potential range of –1800mV to +190mV. The cathodic events between –1800 and –1485mV
could be assigned to redox processes of the nitro substituents. [265] The second nitro group
in 96a leads to a somewhat increased potential for the ferrocenyl redox events (190mV), in
comparison to 96b (105mV).
Table 3.11 Cyclic voltammetry data of ferrocenyl nitroaryl ethers.a
Compd. Ferrocenyl R1 R2 R3 E1°'(NO2)b E2°'(NO2)b E3°'(Fc)b E4°'(Fc)b
Derivative (∆Ep)c (∆Ep)c (∆Ep)c (∆Ep)c
6
FeR
2 O
R3
R1
NO2
X A (X = NO2)
B (X = H)
O2N NO2
C...
NO2
NO2
D
[P]1 H H 45 (76)
30a [P]2 H H 20 (83)
31a [P]2 Me H 40 (74)
35a [P]2 [P]2 H 170 (63)
96a A H H –1800 (86) –1485 (70) 190 (64)
96b B H H –1700 (92) 105 (70)
99a C–OFc H H –1595 (89) 155 (79) 275 (85)
99b C–F F H –1795 (89) –1465 (85) 230 (85)
99c C–NMe2 H H –1710 (96) 110 (80)
100 D H H –1560 (101)d –1330 (95) 130 (75) 340 (79)
101 [S] H H 335 (69)
102a A [P]2 H –1830 (84) –1490 (76) 345 (72)
102b B [P]2 H –1750 (211)d 275 (83)
103a A [S] H –1755 (80) –1425 (73) 725 (73)
104a A [P]2 [P]2 –1535 (125)d 520 (70)
a All potentials are given inmV vs FcH/FcH+, with an analyte concentration of 1.0mmol L−1. [P]1 =
P(O)(OEt)2. [P]2 = P(O)(OCy)2. [S] = SO2CF3.
b E°' = formal potential.
c ∆Ep = difference between the anodic and cathodic peak potential.
d The redox processes are not reversible.
For rac-102a,b, rac-103a, and 103a one reversible redox process for the ferrocenyl groups
was observed during the electrochemical measurements (Figure 3.52). The redox events for
Fc/Fc+ in rac-102a,b are found at 345mV (rac-102a) and 275mV (rac-102b), respectively.
An increasing number of phosphonate groups as well as a triflate group led to decreased
electron densities at the ferrocenyl motifs, resulting in increased redox potentials (725mV
(rac-103a), 520mV (103a)). In rac-102a and rac-103a two reversible redox events for the
nitro groups between -1830 and -1425mV are present. In contrast, during electrochemical
measurements of rac-102b and 104a in the same potential limits, irreversible redox events
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Figure 3.52 Left: Cyclic voltammograms (solid lines) and square wave voltammograms
(dashed lines) of 99a–c and 100. Right: UV/Vis/NIR spectra of 100
(2.0mmol L−1) at rising potentials (–200 to 1200mV vs Ag/AgCl). Com-
pounds were measured as CH2Cl2 solutions at 25℃ with 0.1 mol L−1
[N(Bu)4][B(C6F5)4]supporting electrolyte.
occurred, indicating a decomposition of the compounds during the electrochemical studies. A
comparison of the redox potentials of the ferrocenyl units of rac-102a,b with those of 96a,b
shows that the additional phosphonate group in rac-102a,b leads to a decreased electron
density at the ferrocenyl and, therefore, to a shift of the redox events to higher potentials.
In the cyclic voltammograms of 99a-c and 100 a reversible event for each ferrocenyl unit was
observed (99a, 155 and 275mV; 99b, 230mV; 99c, 110mV; 100, 130 and 340mV) (Figure
3.52). The potential of the first redox event in the series increases (99c < 99a < 99b),
indicating an increased electron density at the ferrocenyl moiety in 99c. The two ferrocenyl-
related events in 100 (∆E = 210mV) exhibit a larger splitting in comparison to 99a (∆E
= 120mV). Furthermore, the CVs of 99a–c and 100 show redox processes between –1795
and –1330mV for the nitro groups. With the increased electron-withdrawing character of
the substituent bonded to the C6H2 rings in 99a-c, the potentials of the ferrocenyl redox
processes are shifted toward higher potentials. The differences within the nucleophilicity can
be confirmed by comparing the potential of the first ferrocene-related redox processes of the
2,4-dinitrophenyl ethers and 102a/104a with their electronic properties solely determined
by their ortho substituents. The potentials increase as ortho (190mV, o-R = H) < 102a
(345mV, o-R = P(O)(OCy)2) < 104a (520mV, o-R = (P(O)(OCy)2)2) < 103a (725mV, o-
R = SO2CF3), confirming the sulfonyl substituent to be even more electronically withdrawing
than two phosphonato substituents. This leads to the conclusion that the respective lithium
ferrocenolato compounds follow this trend within SNAr reactions. The redox separation in
99a and 100 could be caused by either electrostatic factors or an electronic interaction be-
tween the two redox sites. Therefore, UV/Vis/NIR measurements with 100 were carried
out, for example. The UV/Vis/NIR studies of dichloromethane solutions containing 100
in different redox states are depicted in Figure 3.52. During the stepwise increase of the
potentials (step heights: 100, 50, 25mV) the compound was oxidized from the neutral 100
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to the mixed-valent [100]+ and finally to the fully oxidized species [100]2+. In the case of
an electronic interaction between the Fc/Fc+ termini an intervalence charge transfer (IVCT)
band should develop in the NIR region during the oxidation to the mixed-valent species and
disappear during the oxidation to the fully oxidized species. However, during the oxidation of
100 no such band developed and, thus, no significant electron transfer between the Fc/Fc+
termini takes place, prohibited by the two oxygen atoms that prevent a conjugation. There-
fore, the redox separations in 100 result solely from electrostatic interactions, implying that
compound 99a should exhibit a similar behavior. In contrast, for known compounds with
ferrocenyl groups directly bonded to the benzene ring, IVCT absorptions of weak strength
were found with the maximum for 1,4-diferrocenylbenzene. [266] To prove the reversibility after
complete oxidation, compound 100 was reduced at –400mV and the obtained UV/Vis/NIR
spectrum was identical with the spectrum of the starting material.
3.2.3 Multi-Ferrocenyl Aryl Ethers derived by Nucleophilic Aromatic
Substitution Reactions with Aryl Fluorides
Polyferrocenyl-containing aromatics are of interest not only because of their beauty but also
because of their electrochemical properties. Thus, hexa-ferrocenyl (A, Figure 3.53) [267] hexa-
ethynylferrocenyl (B, Figure 3.53) [268] as well as mixed ferrocenyl/ethynylferrocenyl benzene
derivatives are examples discussed so far. [269] The latter could be fused to a multi-cyclic
hexa-ferrocenyl containing benzene by reacting it with [CoCp(CO)2]. [270] The approach was
extended to polyferrocenyl-functionalized four-membered [271] and five-membered carbocy-
cles, [272] heterocycles featuring main-group elements [273] (F, G; Figure 3.53) or transition-
metal building blocks [274] and six-membered heterocyclic compounds [275] (E; Figure 3.53). A
poly-meso-ferrocenyl porphyrin also counts as this class of compound. [276] The electrochemi-
cal behavior of such compounds is summarized in a recently published review, as most of these
compounds show communication between the metallocenyl substituents in the mixed-valent
state. [277] Based on the results obtained in Section 3.2.1, further substrates for the synthesis
of poly-ferrocenyloxy-substituted compounds by SNAr reactions, which are sparsely explored.
Ru Fe
R
R
R
R
R
R
A,  R = Fc
B,  R = 
C, R = OPh
D, R = O
H, the only examples of multi
ferrocenyloxy benzenes
i)
EFc
Fc Fc
Fc
F, E = S, O, ZrCp2,
NR (R = Me, Ph)
N N
NFc
Fc
Fc
Fc
E
O2N NO2
O O
O2N NO2
O O
Fc =
Fc FcFcFc
A−D
SFc
Fc Fc
S
Fc Fc
Fc
G
Cp*
Figure 3.53 Selected examples of multi-ferrocenyl- and ferrocenylether-substituted arenes.
Reaction conditions: i) 7 equiv of [RuCp · (CH3CN)3]OTf (Cp · = η5-C5(CH3)5), CH2Cl2,
60℃, 1 h, 40%.
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In contrast, SNAr reactions involving phenol as the nucleophile and C6F6 as the electrophile
have been applied to synthesize C6(OPh)6 (C; Figure 3.53) in 1982 by the group of Mac-
Nicol. [278] The substrate scope has also been extended to substituted phenols. [279] However,
only a few examples involving ortho-substituted phenols have been synthesized to date, [280,281]
which can probably be attributed to the high reaction temperature of 220℃ and the long
reaction time of 48 h, indicating the difficulties associated with the conversion of electron-
rich aryl fluorides into the respective ethers. Hexaphenoxybenzene (C; Figure 3.53) gave,
upon its reaction with [RuCp*(CH3CN)3]OTf (Cp* = η5-C5Me5; OTf = OSO2CF3), the
corresponding hexametallocenyl-substituted type D molecule (Figure 3.53), as the only re-
ported organometallic aryl ether bearing three or more metallocenyl ether functionalities. [282]
With our previous results by using the SNAr approach (Section3.2.1), multi-ferrocenyloxy-
substituted aryl benzenes are accessible by reacting ferrocenol with aryl fluorides, which is
reported herein.
Reaction of Ferrocenol with Aryl Fluorides
The SNAr reaction of ferrocenol (5) with dinitro aryl fluorides and 4-nitrofluorobenzene pro-
ceeded, as expected, to give the respective ferrocenyl ethers, whereas fluorobenzene and 1,3-
difluorobenzene proved to be unsuitable. This low reactivity of C6H5F and C6H4F2 has also
been observed toward alkyloxy nucleophiles. [258] Due to the mechanism of the reaction, [283] a
low electron density at the benzene ring enhances the reactivity and thus aryl fluorides with n
= 3−6 (108a-d) fluoro substituents were investigated (Figures 3.54, 3.55, and 3.56). A well-
prepared review giving a broad insight to the synthesis and reaction behavior of fluorinated
aromatics can be found in references 284
Fe OH
5
Fe O
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F
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F F
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108a 108b
Fe O
110a, 73 %a)
i)
F
F
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Fe O
110b, 2 %b)
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Figure 3.54 Reaction of ferrocenol (5) with sym-trifluoro (108a) and tetrafluoro benzene
108b.
Reaction conditions: i) 1st Et2O, BuLi; 2nd 108a/b, DMF, 70℃. a) 3 equiv of 108a/b were
used. Yields are based on 5; b) 2 equiv of 5 were used. Yield based on 108b.
According to our recently reported SNAr protocol, 5 was lithiated in diethyl ether and the
formed FcOLi species was further reacted with > 2.4 equiv of fluorobenzenes 108a-d to give
109, 110a, 111a, and 112a,b (Figures 3.54, 3.55, and 3.56). The conversion of 5 within
the SNAr reaction increased with the number of fluorine atoms present, accordingly from
61% (109) to 73% (110), 92% (111) and 98% (112) based on the isolated yields of the
respective products (see the Experimental Section). The use of highly activated C6F6 (98d)
gave 1,4-substituted benzene 112b in a yield of 12% besides the formation of 112a (86%).
To increase the number of organometallic ether substituents at benzenes 108a,b, the amount
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of 5 was increased to > 2 equiv relative to 108a/108b. However, the yields of 109 and 110a
decreased to 12% (109) and 35% (110a), respectively. In addition, within this reaction a
further substitution of a fluorine atom in 110a by a FcO group was observed, resulting in
the formation of 110b in minor yield (2%) (Figure 3.53, Experimental Section), whereas
108a did not undergo a second substitution. A scifinder search revealed that multiple SNAr
reactions occur for aliphatic alconols [285], whereas solely single subsituted compounds were
observed for aromatic derivatives [286] The constitution of 110b as the 1,4-isomer could be
verified by using single-crystal X-ray diffraction analysis (Figure 3.60). It is the first example
of a double FcO-functionalized product derived from 108b by applying the SNAr reaction
protocol. It should be noted that a similar molecule, bearing two 4-phenoxy substituents,
was synthesized from 1,4-dibromo-2,5-difluoro benzene [287]
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Figure 3.55 Reaction of ferrocenol (5) with pentafluorobenzene 108c to afford arylferro-
cenyl ethers 111a–e.
Yields are based on 108c. Reaction conditions: i) 1st Et2O, BuLi; 2nd 108c, DMF, 70℃; a)
Yield based on 5; b) Obtained as a non-separable mixture (2% based on 108c) in a ratio of
101c/111d of 2 : 1.
SNAr reaction of 5 with 108c exclusively gave mono-ferrocenyl ether 111a in 94% yield
(Figure 3.55, Experimental Section). The oxygen atom is positioned para to the hydro-
gen atom, which is known to be the most reactive position in 108c, while no activating
para-fluorine is present. [288–290] Changing the ratio of 108c/5 from 3 : 1 to 1 : 2 decreased
the yield of 111a from 94 to 47% and resulted in the formation of 111b in 45% yield,
where the second nucleophilic attack occurred meta to the OFc groups. Compounds 111c
and 111d were isolated in a yield of 2% as a 2 : 1 mixture of asym-111c and sym-111d.
Compound 111c, with its 1,4,5-substituted FcO moieties, is the first example of this type,
but also molecules possessing a 1,3,5-substitution pattern, as observed in 111d, have rarely
been reported. A similar substitution pattern to that in 111d has solely been described in
reference 291,292. After appropriate workup, both isomers could be identified by 1H and
19F NMR spectroscopy (vide infra), but could not be separated, for example, by using chro-
matographic methods. As a further product, the formation of nitrile 111e was observed
within the reaction of FcOLi with 108c in DMF as solvent. NMR spectroscopic investi-
gations revealed the presence of one fluorine substituent ortho to the hydrogen atom (vide
infra). Furthermore, a weak band at 2234 cm−1 could be assigned to the C≡N unit in the IR
spectrum. [293–296] Based on the constitution of compounds 111a-c, the structure of 111e has
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been formed as reported in Figure 3.55. The introduction of nitrile functionalities has been
reported in copper-mediated reactions using DMF as the in situ cyanide source. [297] In the
presence of ammonia as the nitrogen and DMF as the carbon source, the mechanism for the
nitrile formation have been investigated for Grignard [298,299] and lithium [299] intermediates,
or in Cu- [300,301] and Pd- [300] mediated reactions. Reacting an excess of C6F6 (108d) as
the electrophile with 5 under SNAr conditions gave 112a in 86% and 112b in 12% yield
(Figure 3.56). The formation of a double substituted product is explained by the still highly
activated C6F5 moiety in 112a [288–290] and contrasts the reactions of 5 with 108b,c, where
multiple nucleophilic attacks also required an excess of the nucleophile. Compound 112b
has exclusively been formed as the 1,4-functionalized species. Examples for 1,2-disubstituted
derivatives are rarely described and can be found in references 289 and 290. In general, the
formation of para-substituted derivatives are favored and are, e.g., reported in 288–290 and
302 Changing the ratio of 5/108d from 1 : 2.4 to 3 : 1 maintains the level of conversion
of the reaction at 99%, whereby 112b was formed as the main product in a yield of 79%.
Within this reaction, triple substituted asym-112c could also be isolated in a yield of 21%
after appropriate workup. Compound 112c is thereby subsequently formed from 112b.
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Figure 3.56 Reaction of ferrocenol (5) with hexafluorobenzene 108d to afford arylferrocenyl
ethers 112a–e.
Yields are based on 5 (2.4 equiv of 108d) or 108d (0.33 equiv of 108d). Reaction conditions:
i) 1st Et2O, BuLi; 2nd 108d, DMF, 70℃; ii) 9 equiv of 5, 112b, K2CO3 (19 equiv), 1,3-
dimethyl-2-imidazolidinone, 18℃, 18 h. Yields are based on 108d, a) Reaction at 100℃.
The four chemically equal fluorine atoms in 112b resulted in the constitution of 112c as
shown in Figure 3.56. The identity and the substitution pattern of 112b have, inter alia,
been verified by using single-crystal X-ray diffraction analysis (Figure 3.60). It is the first
reported example of a solid-state structure of a tetrafluoro-1,4-diether species derived from
C6F6 (108d). For all examples derived by a CSD database search for 1,4-dioxygen-2,3,5,6-
tetrafluoro benzenes that have been reported to date, see references 303 However, compounds
bearing more than three FcO ether substituents were not obtained within this reaction pro-
tocol, probably because of the thermal instability of 5 [147,304] or the strong O· · ·Li interac-
tion. [258] Thus, 112b and 9 equiv of 5 were reacted according to a protocol for the synthesis of
C6(OPh)6 by using K2CO3 as the base instead of BuLi, and 1,3-dimethyl-2-imidazolidinone
instead of DMF (Figure 3.56). [278,280] Molecules bearing four (112d) and five (112e) FcO
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substituents could be isolated. Interestingly, FcH (1) was also formed as a side product in
3% yield with respect to 5 and 23% yield with respect to 112b, which can be explained by
the decomposition of 112b, or higher functionalized products under these relatively harsh
reaction conditions (180℃). This assumption is supported by the absence of any starting
material after the reaction. Several attempts to synthesize C6(OFc)6 failed, because of the
low thermal stability of 5 compared with C6H5OH. [147,304] Compound 112e is the second
example of a molecule bearing five ether and one fluoro substituent. [305]
Aryl Fluorides after Anionic Phospho-Fries Rearrangements
Furthermore, the SNAr etherification reaction protocol was applied to the ortho-phosphonato-
functionalized hydroxy ferrocene 31e−H by using nitro aryl fluorides, resulting in the respec-
tive nitrophenyl ethers (Section 3.2.1). Compound 31e−H was obtained by applying an apFr
on phosphate 30e. Subsequent reaction of 31e−H with 108d resulted in the formation of
ether 113 (52% de, Figure 3.57). The poor overall yield of 20% within this reaction sequence
is most likely attributed to the reduced reactivity of 108d, compared with nitro arenes and
the steric hindrance of 31e−H compared with 5. The formation of multiple substituted aryl
ethers, however, was not observed. The absolute configuration of the planar chirality of the
main isomer is assigned to (Rp) based on the results obtained within Section 3.1.
FeO
(FnO)2P i)
FeHO P(OFn)2 FeO P(OFn)2
F
F
F
F
F
ii)
Fn = (1R)-α-fenchyl
113, 20 %31e−H30e
O O O
Figure 3.57 ApFr of fenchyl phosphate 30e to phosphonate 31e–H and subsequent SNAr
reaction with C6F6 to 113.
Reaction conditions: i) LiTMP, TMEDA, hexane, 30e, 18 h; ii) DMF, 108d, 70℃, 18 h, 20%
based on 30e.
3.2.4 Characterization of Ferrocenyloxy Arylfluorides
NMR Spectroscopy
The identities of aryl ethers 109, 110a,b, 111a-e, 112a-e, and 113 were verified by 1H,
13C{1H}, 31P{1H}, and 19F NMR spectroscopy. The 19F NMR resonance signals range
between –162 ppm for the most electron-deficient (112a) and -131 ppm for the most electron-
rich (110a) aryl units (see the Experimental Section). Solely, the 19F resonance signal in
109 was observed at σ = –109 ppm, occurring as a multiplet of higher order, due to the
overlapping 3JF,H and 4JF,F coupling constants in this AA'-spin system. In the 19F NMR
spectra of 109, 110b, 111d,e, and 112b,d,e one resonance signal was observed, due to
the symmetrical structure. In non-hydrogen containing 112b,d,e, the resonances occurred
as singlets, whereas for 111e a doublet with a typical 3JF,H coupling constant of 11.4Hz
was observed. The same coupling constant was found in the 1H NMR spectrum of 111e at
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σ = 6.85 ppm. A typical distribution and coupling pattern [306] for the signals of the C6F5
substituents in 112a and 113 in the 13C{1H} and 19F NMR spectra is shown in Figure 3.58.
Owing to C,F couplings, the resonances of the C6F5 ring exhibited a complex splitting pattern
(Figure 3.58, Table 3.12). The C,F coupling constants in the 13C{1H} NMR spectra for 109,
110a,b, 111a,b and 112a-c decrease by 1J (245–253Hz) > 3J (12–15Hz) > 2J (4–12Hz) >
4J (2–4Hz) (Table 3.12). Parts of the spectra of 111b and 112a have been simulated from
the fitted 13C{1H} NMR spectra (Table 3.12) to obtain the coupling constants. The fitting
was verified by comparing the simulated spectra with the original spectra (Figure 3.58). The
introduction of the ortho-phosphonato substituent in 113 resulted in a doubling of the signal
sets in the 13C{1H} and the 19F NMR spectra (Figure 3.58). The CFc−O signal appears
as a doublet with 2JC,P = 9.3Hz. In contrast, a 5J , 6J , and 5JC,P coupling for the ortho-,
meta-, and para-carbon atoms in the C6F5 ring can be excluded. Thus, we assume steric
hindrance around the CFc−O and CC6F5−O bond, resulting in a magnetic inequality of the
carbon atoms. The effect increases for the fluorine atoms because of their increased spatial
proximity to the phosphonato moiety. Thus, the separation in the 19F NMR spectra ranges
from 13.7Hz to 48.6Hz for the ortho-substituted F atoms. A splitting based on 6J , 7J , and
8JF,P couplings can also be excluded. However, the exact C,F coupling constants could not
be determined because of an overlap of both sets of signals (Figure 3.58). The presence of
the ortho phosphonato group most significantly affects the shift of the ipso carbon atom of
the C6F5 moiety, resulting in a highfield shift from 131.9 ppm in 112a to 130.0 in 113 (see
the Experimental Section and Figure 3.58).
o- p- m-m- p- CPh–O CFc–Oo-C6F5
–154.1 ppm
3JF,F = 18.9 Hz –160.5 ppm
3JF,F = 21.9
–162.3 ppm 
Δ = 22.1 Hz
Δ = 17.2 Hz
126.6
127.3 ppm
2JC,P = 9.3
130.2 ppm
131.9 ppm
3JC,F = 13.6
2JC,F = 4.7
138.0 ppm
1JC,F = 251.7
138.5 ppm
1JC,F = 251.9142.1 ppm
1JC,F = 250.9
3JC,F = 12.0
142.1 ppm
1JC,F = 250.6 138.8 ppm
1JC,F = 251.7
138.1 ppm
1JC,F = 251.4
Δ = 48.6 Hz
Δ = 18.0 Hz
–159.4 ppm
–161.7 ppm 
Δ = 13.7 Hz
Δ = 22.0 Hz
Δ = 17.3 Hz
–152.5 ppm
Δ = 42.9 Hz
Δ = 21.9 Hz
13C{1H} NMR 19F NMR
Figure 3.58 Comparison of the 13C{1H} (left) and 19F NMR spectra (right) of 112a (top)
and 113 (bottom).
Coupling constants J are reported inHz. The assignment of o-, m- and p- refers to the C1–O
bond of the C6F5 ring. (Fn = (1R)-α-fenchyl)
Compound 111b was obtained as the 1,3-substituted species, as indicated by the doublet in
the 13C{1H} NMR spectrum for the CC6−H signal at σ = 102.1 ppm with 2JC,F = 22.5Hz
to one ortho-positioned fluorine atom. Further examples for this type of substitution pattern
are reported in references 307 and 308 In comparison, the C-H resonance for 111a at σ =
101.5 ppm occurred as a triplet with 3JC,F = 23.0Hz. The resonances of compounds 111c and
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111d were assigned within their mixture, predominantly by JH,F , JF,F , and JC,F couplings
compared to other compounds reported herein. The presence of an ortho fluorine atom in
111c compared with 111d, resulted in a doublet for the C-H carbon atom in the 13C{1H}
NMR spectrum at 101.9 ppm with 3JC,F = 24.6Hz, whereas 111d occurred as a singlet (see
the Experimental Section). The 19F spectrum for 111c showed resonances at σ = –150.6 ppm
(dd, 5JF,F = 10.7, 4JF,H = 7.6Hz), which could be assigned to the C2-bonded fluorine atom,
and at σ = 130.8 ppm (dd, 3JF,H = 11.8, 5JF,F = 10.3Hz) for the C5 bonded atom. The
doublet for 111d (4JF,H = 7.5Hz) was observed at σ = –150.5 ppm. The values of the 3JF,H
= and 4JF,H = coupling constants are also present in the 1H NMR spectra. In 111e, the
resonance signal at 100.8 pm in the 13C{1H} NMR spectrum could be assigned to the C≡N
carbon, which is consistent with a shift of 106 ppm for C6F5C≡N. [309]
Table 3.12 Summary of the C,F coupling constants of the 13C{1H} NMR signals of the
phenyl substituents of 109–112.a
Compd. CPh–O Coupling constant / Hz Compd. C–F Coupling constant /Hz
/ppmb 2JC,F 3JC,F 4JC,F /ppmb 1JC,F 2JC,F 3JC,F 4JC,F
109 161.5 13.4 (t) 109 163.4 246.8 15.4
109 142.3 7.6 13.0 3.7 110a 144.9C4 246.1 10.3 14.2
145.9C2 245.4 13.4 3.6
148.2C5 247.1 9.0 3.1
110b 141.1 9.6 12.0 110b 148.7 246.0 4.6
111a 136.4 3.6(t) 13.2(t) 111a 141.5 249.9 4.6 14.7 2.4
146.3 249.9 12.3c 12.3c 4.1
111b 135.8C3 12.9/3.7 14.1 111b 140.2C2 248.0 15.0 2.7
142.8C1 9.8d 10.8 3.6 143.3C5 248.8 4.0 2.1
146.3C4 245.9 4.1 12.8
112a 131.9 4.6(t) 16.7(t) 1.6 112a 138.0o− 251.7 5.1 14.6/13.2 3.4
138.5p− 251.9 3.8(t) 13.6(t)
142.1m− 251.0 4.2(t) 12.1 3.2
112b 132.6 multiplets non-resolvable 112b 142.0 252.5 multiplets non-resolvable
112c 132.4C1 2.2 15.2/13.2 112c 142.1C3 249.7 12.6 4.2
135.9C2 4.0 12.8 2.7 142.7C5 250.4 5.1 13.0
137.0C4 2.7(t) 11.5 146.4C6 250.1 4.1c 4.1c
a Except otherwise noted, the couplings are reported as doublets.
b The position within the phenyl ring follows the assignment in the experimental section.
c Occurred as a triplet.
Solid State Structures
The molecular structures of 110a,b, 111a, and 112a,b in the solid state have been de-
termined by single-crystal X-ray diffraction analysis (Figures 3.59 and 3.60). Suitable single
crystals were obtained by evaporation of hexane solutions containing the respective compound
at ambient temperature. The compounds crystallized in the monoclinic space groups P21/c
(110b), P21/n (111a, 112a,b) and the orthorhombic space group Pnma (110a) with one
(111a, 112a), a half (110a, 112b), or one and a half (110b) crystallographically indepen-
dent molecules in the asymmetric unit of these centrosymmetric space groups. Compounds
110a,b and 112b contain symmetry operations for generating equivalent atoms, which is
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a C2 axis in case of 110b that is present in the middle of the phenyl plane and oriented
perpendicular to it. For 112b, an inversion center is present in the midpoint of the phenyl
ring. In compound 110a, the phenyl ring acts as a mirror plane that bisects the ferrocenyl
groups through their Cβ–Cβ bonds.
Figure 3.59 ORTEP (probability levels: 30%, 110a; 50% 111a and 112a) of the molecu-
lar structures of 110a (left), 111a (middle) and 112a (right) with the atom-
numbering Scheme. All hydrogen atoms have been omitted for clarity. Sym-
metry operation for generating equivalent atoms ('): x, –y + 1/2, z.
The ferrocenyl backbones adopt ecliptic conformations for 110a,b of 0.0(0)–7.3(2) °, whereas
111a and 112a,b are rather staggered with 18.3(2)–24.99(15) °. The phenyl rings mainly
reveal a perpendicular orientation toward the cyclopentadienyls for 110a,b of 90.000(3)–
86.61(10) °and slightly deviate for 111a and 112a,b of 67.83(7)–69.92(7) °. Comparing their
CFc–CFc–O–CAr torsion angles, they are either positioned above (110a,b: ca. 90 °) or in the
cyclopentadienyl plane (111a, 112a,b: ca. 12 °). Both ferrocenyl groups in 112b and 110b
(Figure 3.60) are rotated anti toward each other. Shorter CAr–O bond lengths of 1.368(3)–
1.375(3)Å and CFc–O of 1.390Å are present in 111a and 112a,b, whereas no significant
differences are observed for 110a,b. This is in accordance with nitrosubstituted derivatives
mentioned in Section 3.2.1, also possessing enlarged CFc–O bond lengths. Supramolecular
features, for example T -shaped pi interactions, or F· · ·pi interactions are discussed in the the
Supporting Information of reference 263.
Figure 3.60 ORTEP (50% probability level) of the molecular structures of 110b (left) and
112b (right) with the atom-numbering Scheme. All hydrogen atoms and a half-
present molecule in the asymmetric unit of 110b have been omitted for clarity.
Symmetry operation for generating equivalent atoms ('): −x+ 2,−y,−z + 1.
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Electrochemistry
The electrochemical properties of 109, 110a,b, 111a-d, and 112a-e were investigated by
cyclic and square wave voltammetry (Figure 3.61, Table 3.13). In the cyclic voltammograms
of single FcO-substituted 109, 110a, 111a, and 112a, one reversible redox event for the
ferrocenyl unit was observed between 44 and 77mV, indicating similar electron densities
at the ferrocenyl groups and solely a low impact of the substitution pattern at the aryl
ether on the ferrocenyl groups. Compared with the nitro-substituted derivatives in Section
3.2.1, the first redox potential of 109, 110a,b, 111a-e, and 112a-e are cathodically shifted
by approximately 50mV, because of the lower mesomeric effect and thus, a lower electron-
withdrawing character of the fluorine substituents, as compared to Section 3.2.1
Table 3.13 Cyclic voltammetry data of 109–112.a
Compd. E1°'c E2°'c E3°'c E4°'c E5°'c ∆E°'d
(∆Ep) (∆Ep) (∆Ep) (∆Ep) (∆Ep)
109 64 (62)
110a 44 (78)
110b 11 (67) 141 (71) 130
111a 77 (62)
111b 20 (65) 145 (65) 125
111c,d –40 80 200 120/120
111ee 13 103 298 (64) 90/195
112a 68 (64)
112b 66 114 48
112c 2 95 221 93/126
112d –40 60 190 280 100/130/90
112e –38 58 (70) 193 (50) 346 (80) 535 (55) 96/135/153/189
a All potentials are given inmV vs FcH/FcH+ at 25℃ containing 0.1mmol L−1 of
[N(Bu)4][B(C6F5)4]as the supporting electrolyte.
b The number of each group, which is present in the molecule.
c E°' = formal potential inmV.
d ∆Ep = Difference between the anodic and cathodic peak potential.
e A C≡N substituent is present.
The exchange of fluorine atoms by FcO moieties accordingly shifts the values for the first
redox potential E1°' to more cathodic potentials (Table 3.13), with the exception of 111e,
112b, and 112e. The electron-withdrawing nitrile functionality increases the potential from
-40mV for 111c to 13mV for 111d. The four fluorine atoms in 112b probably superimpose
the effect of the electrondonating FcO unit, [279] maintaining the potential at 66mV, similar
to 68mV for 112a. The cyclic voltammograms of multi-ferrocenyl derivatives show two
(110b, 111b and 112b), three (111c,d and 112c), four (112d), or five (112e) reversible
Fc/Fc+ redox events, according to the number of ferrocenyl groups present in the molecule
in a potential range of –40mV to +535mV (Figure 3.61). The redox splitting ∆E°' of the
redox events of 111c-e, and 112b-d occurred in close proximity to each other, resulting in
an overlap of the potentials (E°') for each event in the CV. Thus, squarewave measurements
were carried out to determine the potential of the respective events (Figure 3.61). The values
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for the redox separations are comparable to, for example, β-ferrocenylethynyl-1H-pyrroles
(∆E°' = 95–110mV), for which no communication between the two redox centers could be
observed, although conjugation was provided. [310]
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Figure 3.61 Cyclic voltammograms (solid lines) and square wave voltammograms (dotted
lines) of 110b, 111b–e, and 112b–e in CH2Cl2 solutions (1.0mmol L−1) at
25℃ containing 0.1mmol L−1 of [N(Bu)4][B(C6F5)4]as the supporting elec-
trolyte.
An interesting feature of 12e is the increase of the redox splitting from 112e/112e+ (∆E°'
= 96mV) to 112e4+/112e5+ (∆E°' = 185mV), owing to electrostatic interactions. This
trend is also observed in 111e (90mV, 195mV) and 112c (93mV, 126mV). However, this
differs for 112d (100mV, 130mV, 90mV), probably due to an electrostatic compensation of
the positive charge at the ferrocenyl groups by the partially negatively charged ortho-fluorine
atoms. [269] The smallest redox separation is observed in 112b (∆E°' = 48mV), revealing
small electrostatic interactions through the para positioning of the OFc moieties. However,
the redox events in para-substituted 110b are separated by 130mV, which might be attributed
to the increased electron density and a better stabilization of the positive charge. This value
is similar to 111b (∆E°' = 125mV), where a meta interaction is present, meeting the value
reported in Section 3.2.1 1,5– (OFc)2 –2,4–(NO2)2 –C6H2 (E°' = 120mV). As has recently
been confirmed, the redox separations are attributed to electrostatic interactions, the oxygen
atoms prevent an electronic communication in the mixed-valent species. The impact of the
substitution pattern in the mixture of 111c and 111d does not affect the redox potential of
the ferrocenyl groups and resulted in three separated one-electron redox events (Figure 3.61).
Conclusion - Oxygen Functionalization
In addition to the methyl ethers mentioned in Section 3.2.1, hydroxyferrocenes could suc-
cessfully be converted to aryl ethers by using the nucleophilic aromatic substitution reaction
(SNAr). As electrophiles, electron deficient aryl fluorides have been shown to be the most
suitable reaction partners. Therefore electron-withdrawing fluoro and nitro-substituents had
to be present in the aryl fluoride. In contrast, studies of ferrocenol and its ortho-phosphonato-
substituted derivative have also been performed, indicating a low nucleophilicity of the oxygen
atom in nucleophilic substitution reaction with, e.g., benzyl bromide and propargyl tosylates.
However, oxophilic chlorosilanes could be converted in high yield. In contrast, the SNAr reac-
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tion protocol also tolerated ortho-phosphonato and sulfonyl substituents, resulting in 1,2-X,O
(X = S, P) ethers that can be obtained in a one-pot synthesis procedure including 1,3-O→C
anionic phospho- and thia-Fries rearrangements. Also, the first 1,3-di-ortho-phosphonato
functionalized ferrocenyl aryl ethers could be synthesized. Electrochemical studies of the
redox potentials of the obtained compounds allowed conclusions on the reactivity by vary-
ing electronic properties and the electrophilicity of different aryl fluorides, which decreased
from the dinitro (96a) to the mononitro (96b) and fianlly polyfluoro arylfluorides. The
nucleophilicity and, thus, the reactivity toward SNAr reactions of the functionalized oxyfer-
rocenes was estimated by comparing the potential of the first ferrocene-related redox pro-
cesses of dinitro benzenes, revealing the trend ortho-H (190mV) < -P(O)(OCy)2 (345mV)
< -(P(O)(OCy)2)2 (520mV) < -SO2CF3 (725mV). The usage of difluorodinitro multifluoro
(F > 4) benzenes resulted in the first examples of double- and up to penta-FcO substituted
benzenes. By changing the ratio of ferrocenol to multifluoro benzenes allowed the control
of a singles or multi substitution. Electrochemical investigations revealed a splitting of the
redox processes caused by electrostatic interactions, as confirmed by in situ UV/Vis/NIR
measurements, due to the absence of an IVCT absorption in the mono-oxidized species.
3.2.5 Conversion of Phosphonates to Phosphines
The synthesis of phosphanes, suitable for C,C cross-coupling catalysis, required a further
conversion of the phosphonates, derived after apFr, by applying a reduction and subsequent
Stelzer coupling process. Assuming that the NO2 groups are reduced by using Li[AlH4],
compound 96a has been investigated under reducing reaction conditions (Figure 3.62). The
obtained amine, which potentially gets oxidized, due to its high electron density, was subse-
quently acylated using acetic anhydride (Figure 3.62). The isolation of diamide 115 revealed
the in situ formation of diamine 114. Applying the C,P cross-coupling conditions for the
conversion of PH2-phosphanes to PPh2-phosphines on amine-containing substrates, could
additionally result in Buchwald Hartwig cross-couplings. [13,14,311] The mentioned difficulties
within this coupling reaction (Section 3.1.5) would result in further complex product mixtures
and thus, this substrates were not further investigated.
FeO
NO2
O2N
96a
FeO
NH2
H2N
114
FeO
NH
H
N
115, 7 %
O
O
Li[AlH4]
ClSiMe3
i)
Ac2O
ii)
Figure 3.62 Reduction of dinitrophenyl ferrocenyl ether 96a and subsequent acylation.
Reaction conditions: i) Li[AlH4], ClSiMe3, THF, 45℃, 12 h, H2SO4; ii) Et2O, K2CO3, Ac2O,
60℃, 1 h. Yield based on 96a.
In contrast, siloxanes 95g,h, which could be obtained in high yields (Figure 3.43), and C6F5
ether 113 should be stable under reducing conditions and should give phosphanes 116a–c.
However, after the subsequent C,P Stelzer coupling, siloxanes 117a,b were both obtained
in a poor yield of 6% (Figure 3.63). A compound derived from aryl ether 113 could not
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be isolated. The formation of phosphine 117b was inter alia verified by single-crystal X-ray
diffraction analysis (Figure 3.64). However, a second trial did not result the desired product,
revealing the difficulties within the Stelzer coupling process as mentioned in Section 3.1.5
(Figure 3.39).
FeO P(OR')2
O
 rac-95g (R = SitBuPh2, R' = Et)
 rac-95h (R = SiiPr3, R' = Et)
(Rp)-113 (R = C6F5, R' = Fn)
FeO PH2
116a (R = SitBuPh2)a)
116b (R = SiiPr3), 80 %
116c (R = C6F5)a)
Li[AlH4]
i)
R R
FeO PPh2
117a (R = SitBuPh2), 6 %
117b (R = SiiPr3),      6 %
117c (R = C6F5),        0 %
R[Pd], PhI
ii)
Figure 3.63 Reduction of and subsequent Stelzer coupling of ferrocenyl silyl ethers 95g,h
and perfluorinated 113.
Reaction conditions: i) Li[AlH4], ClSiMe3, THF, 45℃, 12 h, H2SO4; ii) Et2O, K2CO3, Ac2O,
60℃, 1 h. Fn = fenchyl. Yield based on 96a.
Siloxyl phosphine 117b crystallized in the centrosymmetric space group P 1¯ with one molecule
in the asymmetric unit (Figure 3.64). Similar to phosphine rac-91 (Figure 3.40) the lone
pair of the phosphorus atom directs into the vacant space between both donor atoms. The
increased steric demand of the silyl substituent, compared to a methyl group, rotates the
O-bonded group out of the C5H3 planarity by 53.6(4) °.
Figure 3.64 ORTEP (50% probability level) of the molecular structure of 117b with the
atom-numbering Scheme. All hydrogen atoms have been omitted for clarity.
Concluding, a different approach for the synthesis of 1,2-P ,O-ferrocenes is required, which
allows for a better oxygen functionalization. The low transfer of the chiral information of
1,2-P ,O-phosphanes on the biaryl substrate also required a change of the position of the P-
and O- donor atoms in the molecule.
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3.3 Anionic Homo Phospho-Fries Rearrangements
3.3.1 Conversion of Ferrocenylmethanol(-derivatives) to Phosphates
Retrosynthetic Considerations
Ferrocenylphosphines and 1,2-disubtituted planar-chiral ferrocenes are, for example, essential
in the field of catalysis. [130] Especially the synthesis of hindered biaryls by the Pd-catalyzed
C,C cross-coupling reaction is still a challenging task, where ferrococenyl phosphines bearing
ortho-donor atoms or groups, e. g. oxygen [73,196], aryl [107] or vinyl [75,312] have been shown to
increase the catalytic activity. The vinyl fragment thereby acts as a hemilabile group, which
enables the planar-chirality of the ferrocenyl backbone to be transferred on a substrate,
resulting in an enantiomeric excess of synthesized biaryls of up to 36%. [75] It could also be
shown that the presence of an oxygen atom attached to the ferrocenyl backbone, enhances
the catalytic activity, as it could be shown by using a 2-alkyloxy substituted phosphine [73,196]
However, a chiral 1,2-P ,O-substitution pattern is difficult to achieve, due to a lack of oxygen
electrophiles, when starting with chiral phosphines. [130,196] In contrast, the functionalization
with phosphorus electrophiles required chiral, oxygen-functionalized ortho-directing groups
to ensure an diastereoselective ortho-lithiation. Since the ether motif is a rather weak ortho-
directing group, predominantly 1,1'-functionalized products were obtained. [73,74,76]
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Figure 3.65 Comparison between 5- (A [168] and B [313]) and 6-membered (C [314] and D [313]
1,2-substituted phosphine Pd-complexes and the resulting ee of formed biaryls
within Suzuki-Miyaura C,C cross-coupling reactions. a) The Pd atom is coor-
dinated η2 to the vinyl group, which in turn is rotated by 52 °out of planarity.
To investigate, if the planar-chiral ferrocenyl backbone can transfer its chirality to a coupling
product, the presence of a further chiral group (P- or C-chiral) should be avoided. Thus, we
recently applied the anionic phospho-Fries rearrangement on ferrocenes. [196] This intramolec-
ular 1,3-O→ C migration regioselectively gave access to a broad range of 1,2-P ,O substituted
ferrocenes (Section 3.1). Using chiral pool alcohols also allowed a diastereomeric proceeding
with a de of the product with up to 96%. [168] The conversion of the formed phosphonate to
the final phosphine also proceeded enantioselectively (99% ee). Nevertheless, the usage of
this ligand did not result in a detectable ee in the formed biaryls. The lack of the transfer of
the chiral information from the planar-chiral ferrocenyl backbone in the catalytic reaction,
has been attributed to the small, hemilabile methoxy group (Section 3.1). Replacement of
the methyl by an aryl group could therefore enhance the chirality transfer within the C,C
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cross-coupling reaction, due to steric reasons and attractive dispersion interactions. [107,111,243]
Attempts to adopt this strategy on the 1,2-P ,O ferrocenes were successful by applying nucle-
ophilic aromatic substitution reactions by using electron deficient arenes, [263,315] whereby they
cause side reactions within their conversion to a phosphine. In addition 1-PPh2-2-CH2OR
ferrocenes, where an additional methylene group is present between the ferrocenyl backbone
and the oxygen donor atom, were prepared. [111,314] The usage of this type of molecules as
ligands within Suzuki-Miyaura C,C cross-coupling reactions gave the respective biaryls with
an ee of up to 37%, probably due to both, the planar and the C-central chirality. The angle
between the P- and the O- donor atoms seems to play an important role (Figure 3.65).
Whereas a 1,2-P ,O substitution pattern at ferrocene gave a 5-membered Pd-complex (type
A [196] and B [316] molecules, Figure 3.65), the introduction of a methylene linking group in-
creases the size to a 6-membered cycle (C and D [75,312,313], Figure 3.65). The P· · ·O distance
with 3.165Å in the molecular solid state structure of complex C is slightly increased, due to
a rotation of the CH2O group out of the C5H3 plane by 38.5 °toward the ferrocenyl backbone.
A mathematic transformation gave a minimum of 2.87Å for the P· · ·O distance. [317] While
increasing the steric demand of R from ethyl to (1R)-menthyl in the type C species, also
enhanced the ee from 0 to 37% (Figure 3.65). [314] The study also showed, that the increased
ee is accompanied with a loss of activity. [314] The ee of 36% for aromatic substituents could
also be explained by, e.g., attractive pi interactions.
Fe
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E[*P]
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O N NO
 anionic homo 
phospho-Fries
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Fe
E [P*]LiLi [P*] =
O
P
O
2
, ,
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Figure 3.66 Retrosynthetic pathway for the synthesis of 1,2-substituted ferrocenes by using
an anionic homo phospho-Fries rearrangement.
Besides numerous protocols for the stereoselective introduction of ortho-substituents, [130] a
procedure using cheap and easily available chiral-pool derivatives is pending. Thus, it seems
convincible to apply an anionic homo phospho-Fries rearrangement on ferrocenes. Based on
our recent results on diastereoselective anionic phospho-Fries rearrangements, the use of a
chiral pool derived phosphate seems promising (type E molecule, Figure 3.66). Furthermore,
oximes [318] (F) and imino-phosphoramidates [319–321] (G) could be used as linkers to the mi-
grating phosphorus group. Furthermore, these structural motifs could easily be functionalized
after a successful rearrangement, enabling the introduction of further substituents.
Reactions of Ferrocenylmethanols with Chlorophosphates
As shown in Figure 3.65, the simplest educts for anionic homo phospho-Fries rearrangements
(ahpFr) are ferrocenylmethanols (Figure 3.66). The usage of BuLi as base is beneficial to
ensure the complete deprotonation of alcohols 118a–c and their subsequent nucleophilic
attack. [168] We could recently show that the chiral-pool-derived chlorophosphate 29e bearing
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(1R)-α-fenchyl (= Fn) groups, showed the best results for a diastereoselective proceeding of
the lithiation and 1,3-O→C migration, as compared to other alcohols, e.g., menthol, borneol
and isopinocampheol, respectively. Thus, 29e is used as the electrophile for the reactions
reported herein.
O
Fe
OH BuLiClP(O)(OFn)2 
(29e), i) Fe
O
P OFnOFn
O
Fe
Fe FeFe
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Fe
118a (R1 = R2 = H)
118b (R1 = H, R2 = CH3)
118c (R1 = R2 = CH3)
119a−c 120a−c+
O P(OFn)2
O
121a
122a, 46 %a)
R1R
2
Fe
125b (R1 = H),     72 %b)
125c (R1 = CH3), 79 %c,d)
                              5 %c,e)
R1R1R
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R1O
P(OFn)2
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Figure 3.67 Reaction of ferrocenylmethanols 118a-c with chlorophosphate 29e.
Reaction conditions: i) THF, –50℃, BuLi, 29e, ambient temperature, 18 h. Yields are based
on 118a–c. a) 118a as the starting material. b) 118b as the starting material. c) 118c as
the starting material. d) 1 : 1 hexane/THF mixture, 60℃, 18 h. e) Hexane, 60℃, 1 h.
Figure 3.68 ORTEP (30% probability levels) of the molecular structures of 124 (left) and
127b (right) with the atom numbering schemes. All hydrogen atoms and a
second crystallographically independent molecule of the asymmetric unit of
127b have been omitted for clarity. Selected bond distances (Å), angles (°)
and torsion angles (°) for 124: C11–O1 1.440(8), O1–C12 1.410(8); C1–C11–O1
106.7(6), C11–O1–C12 115.1(5), C5–C1–C11–O1 72.0(8); for 127b: C12–C13
1.446(5), C13–C14 1.446(6), C14–C15 1.439(6), C15–C16 1.445(5), C16–C12
1.362(5), C2–C1–C11–C23 9.7(4), C5–C1–C11–C12 61.0(4).
Upon treatment of 118a–c–Li with 29e the formation of phosphates 119a–c is expected
(Figure 3.67). However, after appropriate workup they could not be isolated. In case of
118a, the main product was identified as the respective ether 122a (46% yield), besides
12% of the starting material 118a, 3% of methyl ferrocene (123) and 6% of the fenchyl
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ether 124. The formation of 123a indicates that 119a has in situ been formed, which
was consecutively attacked by 118a–Li. The nucleophilic attack is favored by the cleavage
of 121a as a leaving group. [322] Reaction with water gives 118a during the work up. It is
known that ferrocenylmethyl cations can straightforward be formed, due to their stabilization
in a benzyl-type position and by an intramolecular Fe· · ·C+ interaction. [323,324] Thus, 120+
might be a key intermediate where nucleophilic attacks have occurred, which has in situ been
formed in solution besides 121a.
The identity of 124 has inter alia been verified by applying single-crystal X-ray diffraction
analysis (Figure 3.68), revealing retention of the absolute configuration of the fenchyl group as
(1R)/endo. Thus, an attack of a fenchylate at 119a/120a+ seems to be convincing, since the
reaction of 118a–Li at an OFn functionality would have resulted in the exo-derivative. For
methyl substituted ferrocenylmethanols 118b,c, the formation of the dehydration products
125a,b was observed. Thus, the elimination reaction of 119b,c and the subsequent removal
of H+ is faster than a nucleophilic attack, probably due to the increased steric demand. The
in situ formed phosphates either underwent an intramolecular dehydrophosphorylation via
a 6-membered transition state involving the P=O bond, or an intramolecular C–O bond
cleavage (Figure 3.67).
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i)
ClP(O)(OFn)2
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+
127a  /  127b
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122b, 87 %
de = 0.52
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Ph
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Ph
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Ph
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Figure 3.69 Reaction of ferrocenylphenylmethanols 118d,e with chlorophosphates.
Reaction conditions: i) THF, BuLi, –50℃, ClP(O)(OEt)2/29e, ambient temperature, 18 h.
Yields are based on 118d,e. a) THF/hexane (1 : 1 mixture), 60℃, 18 h.
To prevent the dehydration reaction by removing β-H atoms as observed for 118b and 118c,
the alkyl chains were replaced by phenyls groups as characteristic for 118d,e (Figure 3.69).
Lithiation of 118b with BuLi and subsequent treatment of 118b–Li with 29e gave the
respective ether 122b (dr = 1 : 0.315), whereas for 118e solely the starting material could
be recovered.
Compound 122b was obtained in a high yield of 87%, which solely was exceeded by a
lewis acid catalyzed synthetic protocol using Yb(OTf)3, giving 122b in 95% yield. [325]
Since it is not clear if 118e–Li did undergo the reaction with 29e or has just been pro-
tonated during the workup procedure, we reduced the steric demand of the chlorophos-
phate from the steric demanding fenchyl to ethyl groups in ClP(O)(OEt)2 (Figure 3.69).
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The addition of ClP(O)(OEt)2 to 118e–Li immediately resulted in an exothermic reaction.
Column chromatographic separation gave 6,6-diphenylfulvene (126) in 25% yield and the
cyclopentadiene-substituted ferrocenes 127a,b (22%). Similar to the mechanism depicted in
Figure 3.67, the in situ formed ferrocenyl phosphate eliminates diethyl phosphate, leading to
the cationic species 120d+, stabilized by a benzyl- and the above mentioned interaction to
the Fe atom. [322] This cation underwent an electrophilic aromatic substitution reaction with
a hitherto nonsubstituted cyclopentadienyl, resulting in the release of a Fe· · ·Cp+ fragment,
which most probably decomposes to 126 and a Fe2+ ion. Compound 127 was obtained as
a 3 : 8 cyclopentadiene isomeric mixture of 127a/127b as indicated in Figure 3.69. After 4
weeks, the ratio had changed to 7 : 4, due to 1,5-sigmatropic rearrangements, confirming the
3-substituted derivative 127a as the thermodynamically stable product. These rearrange-
ments are typical for this kind of molecules. [326]
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Figure 3.70 Reaction of tBu substituted ferrocenylmethanols 118f,g with chlorophosphate
29e.
Reaction conditions: i) Et2O, tBuLi. ii) Et2O, tBuli, 29e.
Replacement of the CH2 by a CH(tBu) fragment (Figure 3.70) could prevent the ether forma-
tion, due to the increased steric demand, and the dehydration reaction, due to the absence
of a β-hydrogen atom in 118f. In principle, ferrocenylmethanols 118f,g are accessible by re-
duction of pivaloylferrocene 128f, or the reaction of acylferrocenes 128a,b with tBuLi. Since
treatment of 128f with NaBH4 at 60℃ solely gave the starting material, formyl- (128a, R =
H) and acetylferrocene (128b, R = CH3) were reacted with tBuLi and 29e was subsequently
added. In case of R = H, alcohol 118f was obtained probably due to a nucleophilic attack
of water to 120d within the appropriate workup, which is supported by the absence of the
Wagner-Meerwein rearrangement product 125d. In contrast, for α-ferrocenylmethanol 118g
possessing a β-hydrogen atom, the elimination reaction involving a 6-membered cycle (Fig-
ure 3.67) or the formation of 120f+ occurred, due to the stability of alkyl 4+-type systems
and the formation of 125c. [327] The alkene formation could be prevented by introducing bi-
cyclic systemssuch as 2-adamantyl and fenchyl (Figure 3.71). Compound 129 was available
by reacting mono-lithiated ferrocene [328] with 2-adamantanone, resulting in the formation of
alcohol 129 in good yields (73%).
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Figure 3.71 Synthesis of ferrocenyl alcohols 129 and 130a, and their subsequent reaction
with chlorophosphates ClP(O)(OEt)2 and 29e in the presence of a base.
Reaction conditions: i) tBuLi, THF, KOtBu, –80℃, 2-adamantanone (130)/ (1R)-fenchone
(130). Yields are based on 1. ii) BuLi, Et2O, –30℃, ClP(O)(OEt)2. Yields are based on
130.
Figure 3.72 ORTEP (50% probability levels) of the molecular structures of 129 (left) and
118g (right) with the atom numbering schemes. C-bonded hydrogen atoms
and a second crystallographically independent molecule of the asymmetric unit
of 129 have been omitted for clarity. Selected bond distances (Å), angles (°)
and torsion angles (°) for 129: C11–O1 1.451(5), C11–O1 1.440(3), O· · ·Fe
3.370(3)/3.372(2), O–H· · ·Fe 128.6/130.8, C–C1–C11– O1 48.0(4); for 118g:
O1· · ·Fe1 3.575(2), O1–H1· · ·Fe1 117.94, C2–C1–C11–C13, 85.0(4); C2–C1–
C11–O1 31.7(4).
By reacting 1–Li with the chiral-pool derived ketone (1R)-fenchone, alcohol 130 was
formed. [329–331] Compared to an earlier synthetic methodology for 130, where (1R)-fenchone
was reacted in the presence of CeCl3 with ferrocene, giving an epimeric ratio of 1 : 0. [329,330]
Herein, the ratio was improved to 1 : 0.13 (Figure 3.71). Within the synthesis of 130, the
formation of a ferrocenyl-substituted non-bicyclic side product 130c was produced (Figure
3.73). However, the formation of the latter species could not be unequivocally proven. Com-
pound 130c could be converted into the dinitrophenyl hydrazone derivative, verifying the
presence of the keto functionality, which was further evidenced by the appearance of a res-
onance signal at 210.4 ppm in the 13C{1H} NMR spectrum. For the deprotonation reaction
of 129, BuLi and sodium hydride were used as bases to investigate the effect of the counter
cation toward the nucleophilic attack at chlorophosphate 29e. Treatment of 129–Li/Na with
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29e in DMF or N -methyl-2-pyrrolidone, respectively, at 90℃, however, exclusively gave the
starting material back. The same result was obtained when 130 was consecutively treated
with BuLi followed by 29e in hexane at 80℃ for 18 h, which was proven by 31P{1H} NMR
spectroscopy. Replacing 29e by the steric less demanding ClP(O)(OEt)2, did not result in
the formation of the corresponding phosphate, rather 131, could be isolated as a single isomer
(Figure 3.71). The molecular structure of 131 was based on NMR spectroscopic and mass-
spectrometric studies (m/z = 336.1163 for C20H24FeO). The formation of 131 indicates a
cationic isomerization reaction after release of diethyl phosphate, as characteristic for 127a,b
(Figure 3.69).
130c, 3 % 130d, 30 %
N
HO NH
NO2
NO2Fe
O
HOFe i)
Figure 3.73 Structural proposal of 130c and its conversion into the dinitrophenylhydrazone.
Reaction conditions: i) CH2Cl2, 2,4-dinitrophenylhydrazine, HClaq, 25℃, 12 h. Yield based
on 130c.
The results derived by the reactions of ferrocenylmethanols 118a–g, 129 and 130 with
either the difenchyl chlorophosphate 29e or ClP(O)(OEt)2 indicate that they are rather
unsuited starting materials for anionic homo phospho-Fries rearrangements, due to their
rapid decomposition and elimination reaction of the in situ formed phosphates. Another
structural motif, which could be converted to phosphates are oximes. [332] To prove, if this
synthetic methodology is also applicable for ferrocene-based oximes, we prepared 132a–d
(Figure 3.74).
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OH
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132b (R = Me), 50 %
132c (R = tBu),   0 %
132d (R = Ph),    0 %
128a (R = H)
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133, 72 %
118f,  3 %
128a, 8 %
+
Figure 3.74 Synthesis of ferrocenyl oximes 128a,b and the reaction with chlorophosphate
29e. Yield based on 128.
Acylferrocenes 128a–d were reacted with hydroxylammonium chloride in the presence of
NEt3 (Figure 3.74). [333] Nevertheless, only formylferrocene (128a) could be converted to
oxime 132a (82% yield), while 128b–d inhibited the formation of 132c,d, which most likely
can be explained by the increased electron density of 128b–d. In case of 128b, a 1 : 1
mixture of the starting materiel with the oxime 132b was obtained after appropriate column
chromatographic workup. Compound 132c has yet not been reported in literature, most
probably, due to its rapid hydrolysis to 128d. We assume that compound 132d [334] and
partially 132b were hydrolyzed during the column chromatographic workup. Deprotonation
of 132a was achieved using tBuLi as a steric demanding, non-nucleophilic base to avoid a
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nucleophilic attack at the carbonyl carbon atom. Subsequent treatment of 132a–Li with
29e predominantly resulted in the formation of ferrocenylnitrile (133) in 72%, along with
128a (8%) and 118f (3%), while phenyl oximes can be converted into their respective
phosphates, [332] ferrocenyl based derivatives seem to undergo similar dehydration reactions
as compared to the ferrocenylmethanols 118b,c,e in the presence of 29e.
Recently electron poor pyrrolyl, indolyl and carbazolyl-containing phosphoramidates were
converted into stable ferrocenyl phosphoramidates. [335] Thus, the CR2 –O motif was replaced
by a CR=N-bonded ferrocenyl unit. This imino phosphate motif (type G molecules, Figure
3.66) has sparsely been described, especially in ferrocene chemistry, where solely a C=N–
P(O)(Ph)2 unit has been reported, however, without its synthetic procedure. [336,337] The
Fc–C=N–P structural motif is also present in 2H-azaphosphirenes, as found by a scifinder
search. [338]
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Figure 3.75 Synthesis of imino phosphates 134a–d, azine 135 and anthrylferrocene 138.
Reaction conditions: i) THF, –80℃, RLi, –30℃, 29e. Yields are based on 133. ii) THF,
KOtBu, tBuLi, –80℃, R–C≡N, –30℃, 29e. Yields are based on 29e. iii) THF, NaBH4,
H2O. Yield based on 134b. iv) Acetylacetone, K2CO3, CH2Cl2, MgSO4, 50℃ 18 h. v)
LiTMP/LDA, hexane/THF, –40℃/ 0℃. ∗The product hardly separates from the starting
material. a) 78% of ketone 128d were obtained; LiTMP, hexane, TMEDA, 25℃, 48 h without
Me2SO4.
The imino phosphato motif could, for example, be obtained by condensation reactions of
carbonyl derivatives with NH2-bearing phosphoramidates. [320] The synthesis of imino phos-
phoramidates by the condensation of an aminophosphate with a carbonyl compound in the
presence of TiCl4 was reported. [320,339,340] A protocol using oximes, tosylazide and chlorophos-
phates also allows to prepare imino phosphates. [341] In addition, reaction of organolithium
compounds with nitriles could be applied in the synthesis of imino phosphates, [342] how-
ever, the alkyl-substituted imino phosphates rapidly isomerized into the respective enamine
phosphoramidates. [340]
The latter approach was applied on ferrocenylnitrile (133), which was reacted with MeLi
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Figure 3.76 ORTEPs (30% probability level) of the molecular structures of 134b (left),
134c (middle) and 136 (right) with the atom numbering schemes. Selected hy-
drogen atoms and three additional crystallographically independent molecules
of the asymmetric unit of 136 have been omitted for clarity. Selected bond
distances (Å), angles (°) and torsion angles (°) for 134b: C11=N1 1.286(4),
N1–P1 1.645(3), C2–C1–C11–N1 175.5(3), C1–C11–N1–P1 178.3(2); for 134c:
C11=N1 1.288(11), N1–P1 1.635(8), C11– N1–P1 136.4(6), C1–C11–N1–P1
163.5(7), C2–C1–C11–N1 177.0(9); for 136: C≡N 1.456(13)–1.468(15), N–P
1.589(9) –1.619(8). C2–C1–C11–N1 52.0(14)–65.8(14). Hydrogen bridge bond
properties: C3· · ·O4 2.781(9)Å, C3· · ·H4A–O4 174 °. Intramolecular pi inter-
actions between involved centroids (Ct): Ct · · ·Ct 4.513(6), α 88.8(5) °.
Figure 3.77 ORTEPs (50% probability level) of the molecular structures of 135 (left) and
138 (right) with the atom numbering schemes. All hydrogen atoms and a
second crystallographically independent molecule of the asymmetric unit of
135 have been omitted for clarity. Selected bond distances (Å), angles (°) and
torsion angles (°) for 135: C=N 1.277(10)–1.293(10), N–N 1.389(9)/1.385(9),
C1–C11–N1, C–N–N 120.2(7)–120.5(7), C–N–N–C 126.9(8)/127.6(8); for 138:
C25–N1, 1.142(4), C18–C25 1.441(5).
and tBuLi to imine anions. In addition, commercially available nitriles were treated with
mono-lithio ferrocene 1–Li (Figure 3.75). In both cases, the in situ formed imine anion was
subsequently reacted with 29e giving imino phosphates 134a–d in up to 60% yield (R = Me,
Figure 3.75). The E-/Z-ratios for sterically non-demanding methyl (134a), phenyl (134b)
and triphenylphenyl (134c) groups are similar and ranges between 1 : 0.07 and 1 : 0.11.
Using the steric demanding tBu derivative 134d inverted the E-/Z- ratio to 0.26 : 1 (Figure
3.75). The assignment of the E-configuration at the C=N double bond for 134b,c is derived
from single-crystal X-ray diffraction analysis (Figures 3.76) and in similarity 134a. Within
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the reaction of tBuC≡N with 1–Li or 133 with tBuLi the formation of oxidative coupled azine
135 is observed possessing a Z-/Z-configuration. Azines are in general available by reacting
carbonyl compounds with hydrazine, [343] or oxidation of hydrazines with oxygen. [343] They
are also accessible under oxidative conditions by reacting nitriles with RLi and subsequent
treatment with CuCl/O2, [343] or in the presence of perbenzoates. [344] In contrast, 135 is the
first example, which has not been formed by a condensation reaction with hydrazines. [345] The
use of isopropyl nitrile as a CH acidic compound, did not produce the respective phosphate,
rather giving ferrocene. The 1-adamantyl derivative 134f was not accessible, due to its steric
demand. The reaction of 9-anthryl nitrile with 1–Li and 29e afforded, instead of the expected
phosphate 134g, compound 138 as a dark red solid. Similar to 135, the formation of 138 can
be explained by an oxidative coupling by 1–Li with 9-anthryl nitrile. However, running the
reaction of 9-anthryl nitrile with 1–Li without chlorophosphate 29e failed to give 138, which
is indicated by the absence of a color change from orange to dark red. We assume that a
nucleophilic attack of 1–Li occurred at the 10-positioin of the anthryl backbone, whereby the
negative charge is stabilized by the nitrile substituent and the two attached aromatic rings.
The removal of a hydride could be supported by chlorophosphate 29e, since chlorophosphates
can easily be reduced with metals (Na, K), potassium naphthalenide [346] or NaBH4. [347] The
9,10-substitution pattern of 138 was, for example, verified by single-crystal X-ray diffraction
analysis (Figure 3.77). The presence of a C≡N substituent was also evidenced by its 13C{1H}
NMR signal at 118 ppm and the respective stretching in the IR spectra at 2208 cm−1. [293]
It should be noted that 138 was hardly separate from the initial anthracene nitrile. The
applicability of alkylidene phosphoramidates 134a–f as starting materials for anionic homo
phospho-Fries rearrangements was proven by their treatment with lithium tetramethylpiperi-
dide (LiTMP) or LDA in either hexane or THF. As described in sections 3.1.1 and 3.1.2
ethyl phosphates are preferably lithiated in THF at low temperature, [196,263] whereas steric
demanding bicyclic, e.g. fenchyl groups require higher temperatures and a non-polar sol-
vent. [168,315] However, the applied reaction conditions described, did not indicate a lithiation
of the ferrocenyl backbone to form 139a–c, whereas molecules derived from a nucleophilic
attack of the base, e.g. 78% of 128d for 134b, were detected (Figure 3.75). The reactivity
of the C=N bond has exemplary been investigated by reacting 134b with acetylacetone in
the presence of K2CO3. In contrast to phenyl-based derivatives, where nucleophilic attacks
at the carbonyl atoms proceed [336,348–351], solely the starting material was recovered in case
of 134b. Reduction of the C=N bond of 134b by using NaBH4 gave amine 136 (20% yield)
as a 1 : 0.86 : 0.23 mixture of three isomers as evidenced by 1H, 13C{1H} and 31P{1H} NMR
measurements. Single-crystal X-ray diffraction analysis of 136 (Figure 3.76) revealed the
crystallization of a racemic mixture of two epimers with respect to their configuration at the
former carbonyl carbon atom. The redcution from 134b to 135 could also be confirmed
by IR spectroscopic measurements, where the vC=N vibration of the imino phosphoramidate
134b at 1572 and 1611 cm−1 disappeared, while a new band at 3185 cm−1 (vNH) could be
observed. The reaction of 134b with MeLi indicated a nucleophilic attack at the carbonyl
carbon, evidenced by the presence of phosphate 121a. The absence of a phosphoryl moiety in
azine 135 was verified by IR spectroscopy, since the C=N stretching frequency was shifted to
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lower energy from 1572 and 1611 in 134b to 1559 cm−1 in 135. The C≡N triple bond in 138
absorbed at 2208 cm−1. A remarkable feature of dark purple 138 is the bathochromic shift
and the high absorption coefficient of 1850Lmol−1 cm−1 of the d→d at 536 nm compared to,
for example, 135 (λmax = 431 nm,  = 883Lmol−1 cm−1) (Table 3.14).
Table 3.14 UV/Vis-measurements of 129, 134a-d, 135, 136 and 138.a)
Compd. λ / nm ( / Lmol−1 cm−1) Color of
pi-pi* band Ferrocene band the solid
129 329 (66) 447 (121) Orange
134a 275 (7909) 464 (684) Red
134b 362 (1652) 484 (1117) Red
134c 372 (1281) 502 (1106) Red
134d 281c(8211)d 460c(724)d Red
135 463 (883)b Red
136 431 (125) Yellow
138 375 (5581) 536 (1850) Dark
408 (10230) Purple
424 (9248)
a Measured in CH2Cl2 at 25℃.
b Values derived from NIR measurements.
c Occurred as a shoulder.
d Molar mass based on the Elemental Analysis.
The absorption properties, and thus the colors of the products, strongly depend on the elec-
tronic properties of the substitutents. For compound 129, bearing a electron-rich adamantyl
group, the d→d transition was observed at 447 nm with = 121LmoL−1 cm−1. While increas-
ing the electron-withdrawing character of the attached substituents, e.g., in imino phosphates
134a–f, the maximum of the d→ d absorption shifts to lower energies, along with an increase
of the absorption coefficient (Table 3.14). Replacement of a phosphoryl group in 134d by a
further –N=C group in azine 135 did not affect the energy of the d→ d transition, although
the electrochemical properties differ.
The presence of two ferrocenyl units within one molecule, separated by a pi-conjugated bridge
allows for the investigation of an electronic communication between both redox centers in the
single-oxidized mixed valent species. Thus, the electrochemical behavior of tBu-substituted,
diferrocenyl compound 135 was investigated by cyclic voltammetry (CV) and square wave
voltammetry (SWV), and compared with 134d possessing a similar substitution pattern at
the C=N carbon atom. Compound 135 showed two reversible one electron redox events, one
was observed for 134d, respectively. If the N=C group in 135 is replaced by the phosphoryl
group in 134d, the first redox event is shifted from 24 (for 135) to –135mV, ascribing the
azine motif to be more electron-withdrawing as compared to the phosphoryl group. The redox
events in 2,3-diazabutadiene 135 are separated by 201mV, which is higher than for the litera-
ture known 1,4-diaza derivative (< 100mV), [352] but lower than for 1,4-diferrocenylbutadiene
(225mV). [353] If the voltage within the CV measurement for 134d is increased to more than
1300mV, the redox event becomes irreversible, indicating the decomposition of this oxidized
species. In situ UV/Vis/NIR spectroelectrochemical measurements were additionally carried
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out for 135 to prove, if the redox separation of 201mV is due to an electronic communica-
tion between both ferrocenyls, as observed for 1,4-diferrocenyl butadiene, [353] or caused by
electrostatic interactions. However, an inter-valence charge transfer (IVCT) absorption, in
the region between 1250 and 2750 nm [269,354] has not been observed, revealing that the redox
separation is due to electrostatic interactions and no electronic communication between the
Fc and Fc+ fragments occurred in the mono-oxidized mixed-valent species. The absence of
an electronic communication between the both ferrocenyls in 135 might be supported by the
non-planar C=N–N=C moiety in the solid state structure (Figure 3.77) due a torsion angle
of 53 °.
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3.4 Functionalization of ortho-Diphenylphosphino
Ferrocenylmethanols
Attempts to apply anionic homo phospho-Fries rearrangement at ferrocenylmethanols, oximes
and imines showed that the additional methylene or CR2 fragment causes side reactions and
prevents a successful proceeding toward phosphates.
Acid Catalyzed and Base Mediated Reactions
The 1,2-P,CH2OH substitution pattern, well-suitable for further functionalization, was syn-
thesized by a literature known eight-step procedure was applied (Figure 3.78). [75,355]
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O
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Fe
OHPh2P
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ii) Fe
OHPh2P
(Sp)-143
iii)
S
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O
O
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(Sp)-144 (R = a), 0 %
(Sp)-145 (R = b), 0 %
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Figure 3.78 Synthesis of (Sp)-143 and acid catalyzed reaction with chiral-pool alcohols.
Reaction conditions: i) 1st, tBuLi, Et2O, –78℃, ClPPh2, –30℃, 99% de; 2nd, p-TsOH,
CH2Cl2/H2O, reflux, 74% based on (4S)-140. ii) NaBH4, MeOH, 2 h, 25℃, 92% based on
(Sp)-141. iii) S8, 2 h, CH2Cl2, 25℃, 95% based on (Sp)-142. iv) p-TsOH, ROH, R = a/b.
Thus, formyferrocene [356] was first converted into the chiral acetal (4S)-140, followed by di-
astereoselective lithiation in ortho position with tBuLi and consecutive reaction with ClPPh2
(Figure 3.78). After the cleavage of the acetal group in (4S)-140, the enantiopure phosphane
(Sp)-141 was obtained (Figure 3.78). [355] Aldehyde (Sp)-141 was reduced to alcohol (Sp)-143
by using NaBH4, followed by the addition of sulfur to the reaction mixture, to protect the lone
pair electron at the phosphorus atom as a sulfide. The reactions of compound (Sp)-143 with
ethanol, benzyl alcohol and menthol was recently reported, whereby the yields of the corre-
sponding ethers reduced from 56 to 27% in the same order. [314] Attempts to react (Sp)-143
with the steric more demanding (1R)-α-fenchyl (Fn, Figure 3.78) and (1S)-borneyl alcohols
(Bo) in the presence of p-TsOH afforded a mixture of non-separable ferrocenyl species instead
of (Sp)-144/145 (Figure 3.78).
Ferrocene (Sp)-143 was also reacted with p-TsOH without adding a further electrophile to
force the self-condensation to (Sp)-148 (Figure 3.79). However, instead of the oxoether
(Sp,Sp)-148, the thioether (Sp,Sp)-149 was formed in 72% yield. The replacement of the
oxygen by a sulfur atom was evidenced by a shift of the adjacent CH2 fragments in the
13C{1H} NMR spectra from 59.9 ppm (Sp)-143) to 31.3 ((Sp,Sp)-149) (Table 3.15).
The molecular structure of (Sp,Sp)-149 in the solid state was additionally confirmed by single-
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Figure 3.79 Acid induced formation of (Sp,Sp)-149.
Reaction conditions: i) p-TsOH·H2O (3 equiv), toluene, 80℃, 18 h. a) 48mmol L−1. b)
96mmol L−1. c) in 1,4-dioxane. Yields based on (Sp)-143, whereas for (Sp,Sp)-149 the
requirement of one molecule as the sulfur source has been taken into consideration.
crystal X-ray diffraction analysis (Figure 3.80). The presence of S8 within the product after
the sulfurization process of (Sp)-142 can be excluded, due to its easy separation by column
chromatography. The NMR data especially of the CH2 moiety in (Sp)-143 are in the range
for CH2–O fragments (Table 3.17), [314] Elemental analysis further evidenced the formation
of (Sp)-143 as shown in Figure 3.78. Addition of sulfur within the conversion of (Sp)-143 to
(Sp,Sp)-149 remains the yield similar at 77%, revealing that inorganic sulfur is rather not
involved within the synthesis process, since a difference between 72% (without S8) and 77%
(with S8) is a sufficient evidence might be questionable. Thus, (Sp)-146+ is considered as
the sulfur source.
Table 3.15 Optimization of the reaction conditions for the synthesis of (Sp,Sp)-149 from
(Sp)-143.
Entry (Sp)-143 / mg Solvent / mL c /mmol L−1 S8a Product Yieldb
1 300 toluene (15) 48 – (Sp,Sp)-149 72%c
2d 1000 toluene (25) 96 – (Sp,Sp)-148 17%
(Sp,Sp)-149 26%c
3 500 toluene (25) 48 1 Equiv (Sp,Sp)-149 77%c
4 1000 toluene (85) 28 1 Equiv (Sp)-150 71%
5 500 1,4-dioxane (35) 34 1 Equiv (Sp,Sp)-149 90%
6 300 1,4-dioxane (25) 29 0 Equiv (Sp,Sp)-149 80%
a With respect to 143.
b Isolated yield.
c The requirement of one molecule of 143 as the sulfur source has already been taken into consideration.
d The products were isolated as a non-separable mixture. Thus, the yields were obtained from the ratio of
the integrals in the 31P{1H} NMR spectra.
For the calculation of the herein reported yields of (Sp,Sp)-149, three molecules of (Sp)-143
were considered. Desulfurized (Sp)-146+ most likely decomposed releasing two electrons,
which are required for the formation of 149. We assume that the other reaction components
(dioxane or toluene, p-TsOH and H2O) are unsuitable as electron donors under these reaction
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conditions.
The removal of sulfur from (Sp)-143 can be excluded, since the formed (Sp)-142 can easily
be re-oxidized. According to the above mentioned stability of ferrocenyl methyl carbenium
ions, we assume the removal of the OH group in (Sp)-143 under the acidic conditions and
a migration of a P-bonded sulfur to the exo carbon atom, where the positive charge is
present (Figure 3.79). This might have occurred via an inter- or intramolecular mechanism
by passing a 5-membered transition state (Figure 3.79). In contrast to hydroxy, the formed
thiol functionality is not removed acid catalyzed and reacts with (Sp)-146+ forming thioether
(Sp,Sp)-149. It should be noted, that for the conversion of ferrocenylmethanol (118a) to the
respective thiol derivative, Lawesson’s reagent is generally required as a sulfer source. [357]
Figure 3.80 ORTEPs (50% probability level) of the molecular structures of (Sp,Sp)-149
(left) and (Sp)-155 (right) with the atom numbering schemes. All hydrogen
atoms and a second molecule in the asymmetric unit of (Sp)-155 have been
omitted for clarity. Selected bond distances (Å), angles (°) and torsion angles
(°) for (Sp,Sp)-149: P=S 1.952(5), C2–C11 1.494(17), C11–S1 1.814(13), C11–
S1–C11A 103.0(9), C2–C11–S1 106.3(9), C2–C1–P1–S2 53.2(12), C1–C2–C11–
S1 106.5(13); for (Sp)-155: P=S 1.954(5)/1.960(5), N–O 1.210(18)–1.235(19),
C2–C11–S2 102.0(10)/103.6(10), C–S–C 103.7(8)/104.1(9). Symmetry opera-
tion for generating equivalent atoms (A): –y, –x, –z+1/2.
The reaction strongly depended on the concentration of (Sp)-143 in the reaction mixture
and lowers the yield of (Sp,Sp)-149 to 26% while changing from 48mmol L−1 to 96mmol L−1
(Table 3.15). Interestingly, the higher concentration preferably resulted in the formation of
(Sp,Sp)-148, indicating that the reaction of (Sp)-143 with (Sp)-146+ is faster compared to
the removal of an OH group and the migration of the sulfur atom. However, (Sp,Sp)-148
could not be separated from its mixture with (Sp,Sp)-149, neither by crystallization nor
column chromatography. Suggesting that a further decrease of the concentration of (Sp,Sp)-
149 would improve the yield, a 28 mM solution was used for the conversion. However,
an electrophilic aromatic substitution of the solvent occurred (Figure 3.81), giving (Sp)-150
in 71% yield. The reaction of the carbocation (Sp)-146+ with toluene was suppressed by
changing the solvent to 1,4-dioxane, which increased the yield of (Sp,Sp)-149 to 90% (Figure
3.79, Table 3.15). Attempts to obtain (Sp,Sp)-148 by a similar reaction, as observed for
122a (Figure 3.67) or 122b (Figure 3.69) by using ClP(O)(OEt)2 gave, however, 50% of
the starting material back and an unidentifiable mix of compounds. The lowering of the
concentration of (Sp)-143 in the reaction mixture should not affect the sulfur migration, if
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an intramolecular mechanism is considered and thus, the yield of (Sp,Sp)-148 should not be
decreased. However, the reaction of (Sp)-146+ with the solvent (toluene), while reducing the
concentration, instead of a sulfur migration, indicates an intermolecular proceeding.
The observed reaction of carbenium ion (Sp)-146+ with the solvent toluene was further
investigated, since this electrophilic aromatic substitution reaction are sparsely described so
far. [324,358] Recently, ferrocenylmethanol (118a) was coupled with electron-rich aromatics,
e.g., 2-naphthol, pyrrole, giving 1-naphthylmethyl and 2-pyrrolylmethyl ferrocenes, by using
(NH4)2[Ce(NO3)6]. [324] The use of highly activated salicylate anions predominantly occurred
ortho to the OH group. [358] The Fc-CH2-Ar pattern is also accessible by alkylation [322,359] or
acylation of ferrocene, [360] followed by removal of the oxygen substituent.
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Figure 3.81 Electrophilic aromatic substitution of (Sp)-143 with electron-rich arenes to
150–153 and nucleophilic aromatic substitution with an aryl fluoride to 155.
Reaction conditions: i) p-TsOH, toluene (150a–c), anisole (151a,b), phenol (152), 80℃; or
CH2Cl2 and 2,4,6-trimethylphenole (153) at 50℃. a) As a 2 : 1 : 6 mixture. b) CH2Cl2 50℃;
72 h. c) K2CO3, 2,4-dinitrofluorobenzene, DMF. Yields based on (Sp)-143.
The scope of the electrophilic aromatic substitution reaction was extended by reacting planar-
chiral ferrocenylmethanol (Sp)-143 with further aromatics (Figure 3.81). Until toluene (Sp)-
150 was formed as a 2 : 1 : 6 mixture of the o-:m-:p-isomer. The three regioiseomers could
not been separated from each other under a column chromatographic purification process.
Thus, their ratio within the mixture was calculated from the integrals of the 1H NMR spec-
tra. Based on electronic and steric properties of the different isomers, the para-isomer has
predominantly been formed, which is supported by NMR investigations and a solid state
structure of (Sp)-150a. However, using anisole as the solvent afforded a 1 : 1 mixture of
the ortho- and the para-isomers. A meta-isomer was not formed. The increased amount of
ortho-substituted (Sp)-151a compared to the para-product (Sp)-151b, is due to an electro-
static attraction of the carbocation and the OMe substituents, superimposing the steric effect.
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Figure 3.82 ORTEPs of the molecular structures of (Sp)-150c (left, 50% probability level)
and (Sp)-151a (right, 30% probability level) with the atom numbering schemes.
All hydrogen atoms have been omitted for clarity. Selected bond distances
(Å), angles (°) and torsion angles (°) for (Sp)-150c: P1=S1 1.9648(16), C11–
C12 1.513(7), C2–C11–C12 112.7(4), C2–C1–P1–S1 35.2(5), C1–C2–C11–C12
77.3(6); for (Sp)-151a: P=S 1.955(2), C2–C11–C12 113.6(5), C2–C1–P1–S1
55.5(6), C1–C2–C11–C12 157.8(6).
The substitution patter in (Sp)-151a could inter alia been verified by single-crystal X-ray
diffraction analysis (Figure 3.82). Using phenol within the electrophilic aromatic substitution
reaction exclusively gave the ortho-substituted (Sp)-152. A nucleophilic attack of the oxygen
functionality at the carbocation to an arylether was not observed under the acidic condi-
tions, as it could be shown for a nucleophilic proceeding. [358] As shown in section 3.1.3, the
nucleophilicity of hydroxy-aryl species, e.g. phenolates and naphtholates is rather low. [335,361]
concluding that the electrophilic aromatic substitutuion is faster and irreversible. Attempts
to force the nucleophilic attack of the oxygen atom by blocking the electronically preferred
ortho- and para-positions in mesityl phenol, resulted in the formation of meta-substituted
(Sp)-153 (Figure 3.81). The meta-methoxy/hydroxy substitution pattern has rarely been
described and usually has to be forced by reacting the respectively lihtio-arene with formyl
ferrocene [362] cyanomethylferrocene [363] or by applying an SEAr reaction of ferrocene with
the respective aryl carbonyls. [364] It could also be shown in section 3.2.3 that ferrocenoles
can undergo reactions with aryl fluorides, resulting in stable ferrocenyl aryl ethers even at
ambient temperature by using, e.g., 2,4-dinitrofluorobenzene (Sangers reagent). [263,315] Thus,
(Sp)-143 was activated using K2CO3 and reacted with Sangers reagent (Figure 3.81). Instead
of giving the oxoether (Sp)-154, the thio derivative (Sp)-155 was obtained. The presence
of an ether sulfur was evidenced by single-crystal X-ray diffraction analysis (Figure 3.80).
Most likely, a SNAr-type reaction had occurred followed by removal of 2,4-dinitrophenolate,
subsequent migration of a sulfur atom and attack of the formed thiol/thiolate in a further
SNAr reaction. Using IR spectroscopy verified the presence of the nitro groups in (Sp)-155,
which were observed at 1520 and 1345 cm−1. As expected, [365] the P=S stretching vibration
was observed, e.g. for (Sp)-153 and (Sp)-155 at 643/645 cm−1. In phenol (Sp)-153, the OH
band occurred at 3403 cm−1. The thioether group, as found in (Sp,Sp)-149 and (Sp)-155,
has up to now solely been achieved by a nucleophilic attack of thiols or thiophenols [366] at
ferrocenylmethanols.
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Desulfurization of Phosphinesulfides
The reduction of the P(V) species (Sp,Sp)-149 and (Sp)-151a/153 to the required P(III)
phosphines was performed according to literature reported protocols by refluxing the phos-
phine sulfides with P(NMe2)3 in toluene (Figure 3.83). [314]
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Figure 3.83 Desulfurization of (Sp,Sp)-149, (Sp)-151a and (Sp)-153 using P(NMe2)3.
Reaction conditions: i) P(NMe2)3, C6H5Cl for 156 and 157 or toluene for 158, reflux, 18 h.
Yields are based on the respective ferrocenyl educt. ii) Crystallization of a CH2Cl2 solution
containing (Sp)-158 gave a few single crystals of (Sp)-159, which were suitable for single-
crystal X-Ray diffraction analysis.
Figure 3.84 ORTEP (50% probability level) of the molecular structure of (Sp)-159 with the
atom numbering scheme C-bonded hydrogen atoms and one molecule of CH2Cl2
have been omitted for clarity. Selected bond distances (Å), angles (°) and tor-
sion angles (°): P2–O1 1.627(10), P2–O2 1.482(11), P2–O3 1.486(11), P1=S1
1.948(5), C2–C11–C12 111.1(11), C2–C1–P1–S1 45.0(12), C13–C14–O1–P2
94.67(14). Hydrogen bridge bond properties (Å / °): O3· · ·N1A 2.724(18),
O2–N1A 2.708(18), O3· · ·H1A4–N1A 155, O2–H1A3–N1A 160.
However, in case of (Sp,Sp)-149 no product could be isolated under the standard conditions
applied (refluxing toluene, 18 h). Optimization of the reaction conditions showed that with
the higher boiling solvent chlorobenzene the reaction successfully proceeded at 130℃. This
allowed the isolation of (Sp,Sp)-156 after appropriate workup in a yield of 51% yield. We as-
sume that the higher reaction temperatures required for the conversion, is due to a synergistic
effect of both P=S groups, which is supported by the absence of a mono-desulfurized product.
Attempts to desulfurize OH-functionalized (Sp)-153 did not give the P(III) species (Figure
3.83). Instead, the hydroxy group bounds to P(NMe2)3 and partial hydrolysis to phosphite
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(Sp)-158 was observed after a flash column chromatographic purification process. The iden-
tity of (Sp)-158 was inter alia verified as its ammonium phosphite (Sp)-159 by single-crystal
X-ray diffraction analysis. Hydrolysis occurred during the crystallization process (Figure
3.84). The occurrence of (Sp)-158 and (Sp)-159 as the P(O)H tautomer is evidenced by a
1JH,P coupling constant of 646.2Hz for the PH fragment in the 1H and 31P NMR spectra.
C,C Cross-Coupling Reactions
Compounds (Sp,Sp)-156 and (Sp)-157 were investigated as stereopure, planar-chiral support-
ing ligands within Suzuki-Miyaura C,C cross-coupling reactions for the synthesis of hindered
biaryls, using the standard reaction conditions used in Section 3.1.5 and in reference 74.
The use of bidendate (Sp,Sp)-156 required an optimization of the Pd/L ratio and concentra-
tion (Table 3.16), which has exemplarily been performed for the synthesis of 94e by using
Pd(dba)2 (dba = dibenzylideneacetone) as the Pd source. Starting with 1mol-% of Pd and
(Sp,Sp)-156 as a ligand, biaryl 94e was formed almost quantitatively in an ee of 17%, which
is higher than for the ethyl and benzyl derivatives. [314] While decreasing the Palladium load-
ing to 0.5mol-% and 0.1mol-% respectively, reduced the ee to 12% and 7% associated with
a lowering of the yield to 57% (Entry 1–3, Table 3.16). However, a Pd/L ratio of 1 : 0.5 did
not give 94e.
Table 3.16 Optimization of the Pd/L ratio for the synthesis of 94e.a
O
Br B+
O
94e
[Pd2(dba)3], 
(Sp,Sp)-156HO
HO
92 93
Entry [Pd] / mol-% (Sp,Sp)-156 / mol-% Yield /% ee /%
1 1 1 97 17
2 0.5 0.5 97 12
3 0.1 0.1 57 7
4 1 0.5 0 –
5 1 1.5 98 20
6 1 2 0 –
a Reaction conditions: 1-bromo-2-methoxynaphthalene (1mmol), 2-tolyl-
boronic acid (1.5mmol), K3PO4 · H2O (3.0mmol), toluene (3mL), 70℃,
24 h.
Contrary, changing to a 1 : 1.5 Pd/L ratio slightly increased the ee to 20%. A further increase
of the phosphine loading prevented the formation of an active catalyst (Entry 6, Table 3.16).
The substrate scope was extended using the conditions in entry 1 (Table 3.16) for (Sp,Sp)-156
and compared with (Sp)-157 as a P ,O-substituted ferrocene (Figure 3.85).
Comparing the yield and ee of the 2-methoxy naphthyl derivatives 94e–g,i,j reveals a depen-
dency on the substitution pattern of the boronic acid. While a similar ee was observed for an
OCH3 (94f) and CH3 (94e) group, an increase of the steric demand gave a racemic mixture
for the phenyl derivative 94g. In contrast, an ortho-phenyl substituted aryl halide gave the
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Figure 3.85 C,C Cross-coupling reaction for the synthesis of ortho-substituted biaryls
94b–o by using P ,S and P ,O ferrocenes (Sp,Sp)-156 and (Sp)-157.
Reaction conditions: aryl halide (1.0mmol), boronic acid (1.5mmol), K3PO4 · H2O
(3.0mmol), toluene (3mL), 0.5mol-% [Pd2(dba)3], 1.0mol-%, (Sp,Sp)-156/ 2.0mol-% (Sp)-
157, 70℃, 24 h. Reaction times were not minimized. Yields are based on isolated material as
an average of two runs, except otherwise noted. a) 100℃. b) The product has been obtained
from the respective amine. It was converted into the amide by using PhC(O)Cl and NEt3 at
65℃ for 6 h, due to its rapid decomposition. c) Yields are obtained from the NMR data of
the crude product. d) 1,4-Dioxane, 100℃, 48 h. e) using dppf as the ligand.
product 94k with 26% ee. The Suzuki-Miyaura reactions were also carried out by using (Sp)-
157, giving similar or slightly higher yields, while a slightly decrease of the ee was observed for
94e–k (Figure 3.85). Therefore, we assume a better stabilization during the catalytic cycle
by the anisyl group. However, the flexibility of the OMe group and the distance to the planar-
chiral backbone is not beneficial. The use of the non-chiral bis(diphenylphosphino)ferrocene
(dppf) as the ligand gave 94j with a similar yield as observed for (Sp,Sp)-156 and (Sp)-157,
respectively, and as expected, as a racemic mixture. Replacement of the OCH3 by a CH3
group in biaryls 94b,l gave opposite results for yield and ee compared to 94f,j. Larger con-
densed aromatics such as 9-bromoanthracene gave 94m in a yield of 78%. Substituents,
which are able to form hydrogen-bridge bonds could interact with either the ligand or the
active Pd catalyst.
Thus, OH, NMe2 and NH2 functionalities were investigated for the synthesis of 94n–p. How-
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ever, the presence of the hydroxy group gave 94n with only 3% yield besides 1,1'-binaphthyl
and naphthalene. An interaction of the substrate molecules with the ligands is assumed, since
type 94n biaryls are known to be formed under similar reaction conditions [367] In similarity,
94o was formed in 14% yield, besides the starting halide and 1,1'-binaphthyl. Interestingly,
the presence of a NH2 group did not have a disadvantageous influence. Due to a reported
rapid oxidation of the formed biaryls [368], the reaction mixture has directly been treated with
benzoyl chloride, giving novel 94p in 75% yield and an ee of 8%. However, (Sp,Sp)-156 is
unsuitable as a ligand in the Suzuki-Miyaura reaction, if double ortho-substituted boronic
acids are used, as shown for 94q–s. GC-MS analysis revealed the presence of the starting
halide and hydro-deboronation product. Thus, the transmetallation process seems to be the
decisive step within the catalytic cycle.
3.4.1 Characterization
NMR Spectroscopy
In similarity to the previous sections, the identity of all compounds was established by 1H,
13C{1H}, and 31P{1H} NMR spectroscopy. Except for diferrocenylether 122a, all compounds
possessing a methylene group bonded to the ferrocenyl backbone also contain a further stereo
center, caused by planar chirality (142, 143 and 149–155) or by a chiral substituent (124).
Thus, the CH2 hydrogen atoms occurred diastereotopic with a 2JH,H coupling of 7 to 17Hz
(Table 3.17). The resonances of the CH2 group in the 13C{1H} NMR suggests the type of
the attached atoms. Thus, OH substituents in 142 and 143 gave a resonance signal at ∼
59 ppm. Attachment of an alkyl group in 122a and 124 resulted in a downfield shift to ∼
68 ppm. The replacement of the oxygen by a sulfur or aromatic carbon atom shifts the value
below 34 ppm. This also confirms that within the sulfurization reaction from 142 to 143 the
OH group is not removed, which supports the postulated mechanism depicted in Figure 3.79.
Compounds (Sp)-142, 156 and 157 bearing a PPh2 group also showed a 3JC,P coupling of
9–12Hz for the CH2 units, in contrast to the P(S)Ph2 derivatives. The exclusive formation of
the (1R)-α-isomer for fenchyl derivative 124, indicated by solely one set for the CH2 signals,
confirmed its formation within a nucleophilic attack at a FcCH+2 fragment.
The ratio of cyclopentadiene-substituted ferrocenyls 127a,b could be obtained by integra-
tion of the C5H5 signals in the 1H NMR spectra, whereas the assignment of the respective
set of signals to 127a and 127b is based on 13C{1H} NMR spectroscopic studies. After
synthesis, the product mixture of 127a,b showed two sets of signals in the 1H, whereas in
the 13C{1H} NMR, solely the set of the C5H5 and C5H4 carbon atoms for the 2-substituted
1H-cyclopentadiene 127b were observed (127b, C5H5, 69.2 ppm; C5H4, 67.3 and 71.2 ppm).
After isomerization of the 127a/b mixture for four weeks in solution, the amount of the
thermodynamically stable 3-substituted product 127a increased, and the 127a/127b ratio
changed from initially 3 : 8 to 7 : 4. However, the intensities of the mentioned ferrocenyl
region in the 13C{1H} NMR decreased for 127b, whereas a small increase of broad signals
occurred for 127a (127a, C5H5, 69.8; C5H4, 67.7 and 71.0 ppm), with a width of ∼20Hz for
each. This can be explained by a rapid 1,5-sigmatropic rearrangement of the 1H-hydrogen,
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Table 3.17 NMR values of the CH2 groups of Y-Fc-CH2-E compounds 122a, 124, 142,
143, 149-153, 155.
Compd. E Y CH2-group-1H (2JH,H / Hz) CH2-group-13C{1H}
122a OCH2- H 4.28(s) 67.9
124 OFn H 4.20(11.4)/4.31(11.4) 69.4
142 OH PPh2 4.41(12.4, 5.9)a/4.54 (12.5, 5.6)a 59.9 (9.6)c
143 OH P(S)Ph2 4.31(12.9, 6.1)a/4.68 (12.9, 8.4)a 58.5
149 SCH2- P(S)Ph2 3.72(13.5)/3.91(13.7) 31.3
150a o-tol P(S)Ph2 3.89(16.3)/4.03(16.3) 32.0
150c p-tol P(S)Ph2 3.87(15.1)/4.19(15.2) 33.7
151a Ar-o-OMe P(S)Ph2 3.99(15.2)/4.12(15.2) 28.5
151c Ar-p-OMe P(S)Ph2 3.83(15.1)/4.23(15.0) 33.2
152 Ar-o-OH P(S)Ph2 3.82(15.3)/4.13(15.3) 27.4
153 Ar-m-OH P(S)Ph2 3.30(17.2)/4.32(17.0) 29.1
155d SAr P(S)Ph2 4.41(12.4)/4.96(12.4) 32.0
156 SCH2- PPh2 3.60(12.1, 1.8)b/3.64(12.1) 32.1(11.7)c
157 Ar-o-OMe PPh2 3.86(15.1)/3.93(15.1, 2.0)b 28.6 (10.1)c
a 3JH,H in Hz.
b 4JH,P in Hz.
c 3JC,P in Hz.
d Overlaps with the signal of the C5H5 moiety.
which broadens the signal, as long as the shift again gives the 3-substituted derivative. The
NMR spectroscopic data of 130c (Figure 3.73) formed within the synthesis of 130a (Fig-
ure 3.71) gave 13C{1H} NMR signals at 209.8 ppm (C=O), 147.8 ppm (C=CH2), 108.7 ppm
(C=CH2), further three CH2 groups (31.0, 36.8 and 42.6 ppm), one CH fragment (46.0 ppm)
and solely one further quaternary carbon atom at 54.9 ppm. One of the signals for CH3
groups (21.2, 28.3 ppm) occurred as a singlet in the 1H NMR (1.45 ppm), whereas the other
one is broadened, due to a 4JH,H coupling with the =CH2 hydrogen atoms. However, the
coupling constant is rather low and could not be resolved.
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4.1 Working Techniques and Analytic Methods
All reactions were carried out in Schlenk tubes under an atmosphere of nitrogen using stan-
dard Schlenk techniques. If working under moisture and oxygen free conditions was required,
the Schlenk tubes were evacuated several times using oil pump vacuum, flushed with Argon
(5.0 purity). During the evacuation process, the respective vessels were heated to 200 to
300℃. The subsequent reactions were carried out with a permanent inert gas overpressure
(0.1 bar). Liquid substances, solvents and solutions were added via a septum by using plastic
single-use syringes with high-grade steel cannula. Solid compounds were, if possible, added
under an inert gas flow. Otherwise, the Schlenk vessels were evacuated and subsequently
flushed with argon, several times. If reactions carried out at low temperatures, the Schlenk
vessels were put in insolated polyurethane vessels, filled with mixtures of crushed ice and
sodium chloride (>–20℃) or with isopropanol, which was cooled to the desired tempera-
ture using liquid nitrogen (< –20℃). The temperature was controlled with an appropriate
low-temperature thermometer. Solvents were dried under nitrogen (5.0 purity) followed by
distillation: 1,4-dioxane, N -methyl-2-pyrrolidone and tetrahydrofuran over sodium. Diethyl
ether, hexane, dichloromethane and toluene were dried by the solvent purification system MB
SPS-800 (Fa. MBraun) and stored in Schlenk vessels of appropriate size, possibly over acti-
vated molecular sieve (4Å of size), and used without further purification. DMF, TMEDA and
N,N -diisopropylamine were refluxed over calcium hydride and distilled prior to use. POCl3 ,
acetonitrile and 2,4-dinitrofluorobenzene were distilled prior to use. All further solvents were
used without further purification. If reactions components were potentially unstable towards
oxygen, the solvents and reactions mixtures were degassed prior to the reaction. Therefore,
the Schlenk vessels were placed in an ultrasonic bath, evacuated and subsequently flushed
with argon. This procedure was repeated four times.
For column chromatography either silica with a particle size of 40–60µm (230–400 mesh
(ASTM); Fa. Macherey-Nagel GmbH & Co. KG) or alumina with a particle size of 90 µm
(Standard; Fa. Macherey-Nagel GmbH & Co. KG) was used. The solid material was welled
with the respective mobile phase and filled in a glass column containing a glass frit. The
solvent mixtures were determined by thin layer chromatography. Filtrations were carried out
using G 4 type glass frits covered with a 5 cm thick layer of celite (purified and calcined; Erg.
B. 6 (Fa. Riedel de Häen).
The assignment and labeling of the H and C atoms; especially of bicyclic structures, follows
the IUPAC recommendations. [218]
4.1.1 Nuclear Magnetic Resonance Spectroscopy - NMR
NMR spectra were recorded in deuterated solvents at 25℃ with a Bruker Avance III 500,
or a Varian 400 spectrometer for the collection of 19F spectra. Chemical shifts are reported
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in δ units (parts per million) downfield from tetramethylsilane with the solvent as reference
signal, external standards or with respect to the 2H solvent lock signal. [369]
1H (500.30MHz): Internal solvent reference
(CDCl3: δ = 7.26 ppm; rel. SiMe4: δ = 0.00 ppm)
(C6D6: δ = 7.16 ppm; rel. SiMe4: δ = 0.00 ppm)
((CD3)2SO: δ = 2.50 ppm; rel. SiMe4: δ = 0.00 ppm)
11B (160.42MHz): 2H Solvent lock signal
13C (125.80MHz): Internal solvent reference
(CDCl3: δ = 77.00 ppm; rel. SiMe4: δ = 0.00 ppm)
(C6D6: δ = 128.06 ppm; rel. SiMe4: δ = 0.00 ppm)
((CD3)2SO: δ = 39.52 ppm; rel. SiMe4: δ = 0.00 ppm)
19F (376.31MHz): 2H Solvent lock signal
29Si (99.33MHz): External reference
rel. SiMe4: δ = 0.00 ppm)
31P (202.53MHz): External reference
(P(OMe)3: δ = 139.0 ppm; rel. 85%-ige H3PO4: δ = 0.0 ppm)
119Sn (186.57MHz): External Standard
(SnMe4: δ = 0.0 ppm)
Iterative spectra simulations were performed with spectra processing program MestReNova.
4.1.2 Mass Spectrometry
High-resolution ESI-TOF (Electro-Spray-Ionization-Time-of-Flight) mass spectra (HRMS)
were recorded with a Bruker Daltonik micrOTOF-QII spectrometer.
4.1.3 Elemental Analysis
Elemental analyses were measured with the CHN-analysis device Thermo FlashEA 1112
instrument. All values are given in weight percent as the average of two measurements.
4.1.4 Melting Point
Melting or decomposition points were determined with a Gallenkamp MFB 595 010 M ap-
paratus.
4.1.5 Single Crystal X-Ray Diffraction Analysis
The X-ray diffraction analysis were collected with graphite-monochromated Mo-Kα (λ =
0.71073Å) or Cu-Kα (λ = 1.54184Å) radiation with an Oxford Gemini S device containing
a CCD-detector. The crystal preparation was performed in a perfluorinated polyalkylether
(DuPont, Krytox GPL 107) to protect them from oxygen and moisture. Some measurements
were carried out at at <120 K by using a low-temperature Oxford Cryojet instrument. The
molecular structures were solved by direct methods using SHELXS-97 [370] and refined by full-
matrix least-squares procedures on F 2 using SHELXL-97. [371] All non-hydrogen atoms were
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refined anisotropically, and a riding model was employed in the treatment of the hydrogen
atom positions. The absolute structure parameter [372] for compounds, crystallizing in non-
centrosymmetric space groups can be found in the attachment. The cif files were deposited
at the CSD database and are available free of charge. The assigned numbers are provided in
the appendix. The crystallographic R-values are defined as follows:
Rint =
∑
hkl
|F 2obs − F 2obs|∑
hkl
F 2obs
(4.1) R1 =
∑
hkl
||Fobs| − |Fcalc||∑
hkl
|Fobs| (4.2)
wR2 =
√√√√√√
∑
hkl
w(F 2obs − F 2calc)2∑
hkl
w(F 2obs)2
(4.3) S =
√√√√√∑hklw(F 2obs − F 2calc)2
NRef −NPar (4.4)
w = 1
σ2(F 2obs) + (a · P )2 + b · P
(4.5) P = F
2
obs + 2 · F 2calc
3 (4.6)
Parameters a and b (Equation 4.5) are optimized automatically by the SHELX package.
The analysis and calculation of intermolecular interactions, e.g., pi-interactions, and the re-
moval of solvent molecules (SQUEEZE-procedure) was performed by using the PLATON. [373]
Graphics of the molecular structures have been created by using the ORTEP program [372]
the SHELXTL package. [374]
4.1.6 High-Performance Liquid Chromatography - HPLC
The HPLC measurements were performed with Knauer System containing a HPLC pump
K-500 and an UV detector K-2000 operating at λ 245 nm. The enantiomeric excess was
determined by using a Daicel CHIRACEL OD-H or OJ-H column (4.6 × 250mm) using
different solvent mixtures. Retention times t are reported in minutes.
4.1.7 Electrochemical Investigations
Electrochemical measurements using 0.1mol L−1 [N(Bu)4][B(C6F5)4] as the supporting elec-
trolyte in anhydrous dichloromethane solutions were performed in a dried, argon-purged
cell at 25℃ with a scan rate of 100mV s−1, and a Radiometer Voltalab PGZ 100 electro-
chemical workstation interfaced with a personal computer. For the measurements a three-
electrode cell containing a Pt auxiliary electrode, a glassy-carbon working electrode (sur-
face area 0.031 cm2), and an Ag/Ag+ (0.01mmol L−1 [AgNO3]) reference electrode fixed
on a Luggin capillary was used. The working electrode was pretreated by polishing on a
Buehler microcloth first with 1 µm and then 1/4 µm diamond paste. The reference elec-
trode was constructed from a silver wire inserted into a 0.01mmol L−1 solution of [AgNO3]
and 0.1mol L−1 of an [N(Bu)4][B(C6F5)4] acetonitrile solution in a Luggin capillary with
a Vycor tip. This Luggin capillary was inserted in a second Luggin capillary containing a
0.1mol L−1 [N(Bu)4][B(C6F5)4] dichloromethane solution and a Vycor tip. Experiments un-
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der the same conditions showed that all reduction and oxidation potentials were reproducible
within ±5mV. Experimental potentials were referenced against an Ag/Ag+ reference elec-
trode, but the presented results are referenced against ferrocene as an internal standard as
required by IUPAC. [375] To achieve this, each experiment was repeated in the presence of
1mmol L−1 of decamethylferrocene (Fc*). Data were processed on a Microsoft Excel work-
sheet to set the formal reduction potentials of the FcH/FcH+ couple to 0.0V. Under our
conditions the Fc*/Fc*+ couple was at –619mV vs FcH/FcH+, ∆Ep = 60mV, while the
FcH/FcH+ couple itself was at 220mV vs Ag/Ag+, ∆Ep =61mV. [233]
4.1.8 Spectroelectrochemical Investigations
Potential-dependent spectroelectrochemical in siut UV-Vis/NIR measurements of
2.0mmol L−1 solutions of the respective compound in dry dichloromethane containing
0.1mol L−1 of [N(Bu)4][B(C6F5)4] as the supporting electrolyte were performed in an
OTTLE (OTTLE = Optically Transparent Thin-Layer Electrochemical) [376] cell with a
Varian Cary 5000 spectrophotometer at 25℃. The values obtained by deconvolution could
be reproduced within max 100 L mol−1 cm−1; νmax 50 cm−1; ∆ν1/2 50 cm−1. Within the
measurements the potentials were increased progressively by 100, 50 or 25mV. The spectra
were recorded after ∼ 10 min after the change of the potential. The reversibility of the
oxidation processes was examined by reducing the analyte at –500mV and comparison of
the obtained spectra with the initial one.
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4.2 Starting Materials
The starting materials for the described syntheses were either purchased from commercial
suppliers, present in the working group, synthesized according to literature procedures, or
obtained as side products, however, with their spectroscopic data in agreement with those
reported in literature:
Compound Reference
Ferrocenol- (5) and 1,1'-ferrocenediol (38) . . . . . . . . . . . . . . . . . [147]
Dicyclohexyl chlorophosphatea 29a . . . . . . . . . . . . . . . . . . . . . . . . [377]
Bis((1R)-/(1S)-menthyl) chlorophosphatea 29b,c . . . . . . . . . . [378]
Bis((1S)-isopinocampheyl) chlorophosphatea 29f . . . . . . . . . . [378]
Cyclohexyl dichlorophosphatea 42a . . . . . . . . . . . . . . . . . . . . . . . [377]
(1R)-Menthyl dichlorophosphatea 42b . . . . . . . . . . . . . . . . . . . . . [379]
Chloro-N ,N ,N ',N '-tetraethylphosphinediamine . . . . . . . . . . . . [380]
Di(pyrrolidin-1-yl) chlorophosphinate . . . . . . . . . . . . . . . . . . . . . . [381]
Dichloro-N ,N -diethylphosphinediamine . . . . . . . . . . . . . . . . . . . . [382]
2-Chloro-3-methyl-1,3,2-oxazaphospholidine . . . . . . . . . . . . . . . . [383]
[N(Bu)4][B(C6F5)4] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [235]
Dichloro-1-naphthylphosphatea 46d . . . . . . . . . . . . . . . . . . . . . . . [384]
Dichloro-2-naphthylphosphatea 46e . . . . . . . . . . . . . . . . . . . . . . . [385]
P-Chloro-(R)-binolphosphatea . . . . . . . . . . . . . . . . . . . . . . . . . . . . [386]
Dichloro(1H-indol-1-yl)phosphonatea . . . . . . . . . . . . . . . . . . . . . . [228]
Triferrocenyl phosphatea (47) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [219]
Triphenylbenzaldehyde . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [387]
Triphenylbenzonitrile . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [388]
(Sp)-2-(Thiodiphenylphosphino)ferrocenylmethanol (Sp)-143 [389]
Ferrocenylmethanol 118a . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [355]
Benzoylferrocene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [390]
Ferrocenyldiphenylmethanol 118e . . . . . . . . . . . . . . . . . . . . . . . . . [391]
Formylferrocene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [147]
Pivaloylferrocene 128c . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [293]
(1R, 2R, 4S)-2-Ferrocenylfenchole 130 . . . . . . . . . . . . . . . . . . . . . [329]
Ferrocenylaldehyde oxime 132a . . . . . . . . . . . . . . . . . . . . . . . . . . . [333]
Compounds purchased from commercial suppliers were used without further purification. The
spectra of all new compounds, described herein, can be found in the Supporting Information
of the underlying publications. a) The respective compounds have been reported previously.
However, they were synthesized under optimized conditions, giving higher yields, by replacing
NEt3 by BuLi.
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4.3 Synthetic Procedures
4.3.1 Synthesis of Ferrocenyl Phosphates
General Procedure for the Synthesis of Ferrocenyl Phosphates GP1
Ferrocenyl acetate (4, 1.00 g, 4.10mmol) was dissolved in ethanol (30mL), and 2 M oxygen-
free aqueous KOH (2.5mL, 5.00mmol) was added with a syringe in a single portion. The
reaction solution was heated to 70℃ and stirred for 15 min. After addition of 2M oxygen-free
aqueous HCl (2.5mL, 5.00mmol) in a single portion, all volatiles were removed under reduced
pressure. The precipitate was dissolved in diethyl ether (30mL) and filtered through a layer
of Celite (5 cm column size) . Subsequent removal of the solvent under reduced pressure
gave 5 as an orange solid in a yield of 805mg (4.00mmol, 97% based on 4). The synthesis
of ferrocenediol (38) differs from that procedure by using the double amount of KOH and
HCl solution. Afterwards, 5 was dissolved in 30mL of the respective solvent and cooled to
–30℃. A base (BuLi or NEt3) was added dropwise with a syringe followed by addition of
the respective electrophile in a single portion. The reaction mixture was allowed to warm to
ambient temperature where stirring was continued overnight. After removal of all volatiles the
residue was collected in diethyl ether or CH2Cl2 (30mL) and washed with water (100mL). The
organic layer was dried over MgSO4 and all volatiles were removed under reduced pressure.
Purification of the crude product was performed by column chromatography (column size
below) using different solvent mixtures as eluents.
Diethyl Ferrocenyl Phosphate (6)
6
Fe O
P(OEt)2
O Ferrocenol (1.00 g, 4.1mmol), NEt3 (0.63mL, 4.5mmol) and diethyl
chlorophosphate (0.65mL, 4.5mmol) were reacted in CH2Cl2 according
to the general procedure GP1. Purification was performed by column
chromatography (alumina, 3.5 · 14.5 cm column size) using CH2Cl2 as
the eluent. After removal of all volatiles, compound 6 was obtained as
an orange oil.
Yield: 1.032 g (3.05mmol, 90% based on 5). Anal. calcd for C14H19FeO4P (338.12 g/mol):
C, 49.73; H, 5.66. Found: C, 49.86; H, 5.79. IR data (NaCl, v˜/cm−1): 3098 w, 2986 m,
2932 w, 2909 w, 2871 w, 1793 w, 1711 w, 1647 w, 1460 s, 1412 w, 1394 m, 1373 m, 1278
s, 1241 m, 1166 m, 1106 m, 1065 w, 1033 s, 959 s, 887 s, 820 s, 757 m, 640 m. 1H NMR
(CDCl3, δ): 1.36 (td, 3JH,H = 7.0Hz, 2JH,P = 0.9Hz, 6H, CH3), 3.88 (pt, 3,4JH,H = 1.9Hz,
2H, C5H4), 4.13–4.21 (m, 4H, CH2), 4.25 (s, 5H, C5H5), 4.39 (pt, 3,4JH,H = 1.9Hz, 2H,
C5H4). 13C{1H} NMR (CDCl3, δ): 16.1 (d, 3JC,P = 6.9Hz, CH3), 59.6 (d, JC,P = 4.1Hz,
C5H4), 62.7 (s, C5H4), 64.3 (d, 2JC,P = 6.2Hz, 2C, CH2), 69.5 (s, C5H5), 117.7 (d, 2JC,P
= 4.8Hz, CC5H4-O). 31P{1H} NMR (CDCl3, δ): –5.4. HRMS (ESI-TOF, m/z): calcd for
C14H19FeO4P 338.0365, found 338.0367 [M]+.
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Diethyl Ferrocenyl Thiophosphate (7)
7
Fe O
P(OEt)2
S Ferrocenol (1.00 g, 4.1mmol), NEt3 (0.63mL, 4.5mmol) and diethyl
chlorophosphate (0.71mL, 4.5mmol) were reacted in CH2Cl2 according
to the general procedure GP1. Purification of the crude product was
performed by column chromatography (silica, 3.5 · 14.5 cm column size)
using toluene as the eluent, giving 7 as an orange oil.
Yield: 450mg (1.27mmol, 31% based on 5). IR data (NaCl, v˜/cm−1):
3095 m, 2982 s, 2931 w, 2904 w, 2867 w, 1629 w, 1452 s, 1390 m, 1371 m, 1352 w, 1236 s, 1162
m, 1105 m, 1025 s, 945 s, 885 s, 818 s. 1H NMR (CDCl3, δ): 1.35 (td, 3JH,H = 7.0Hz, 4JH,P
= 0.4Hz, 6H, CH3), 3.89 (pt, 3,4JH,H = 1.9Hz, 2H, m-C5H4), 4.13–4.22 (m, 4H, CH2), 4.25
(s, 5H, C5H5), 4.40 (pt, 3,4JH,H = 1.9Hz, 2H, o-C5H4). 13C{1H} NMR (CDCl3, δ): 15.9 (d,
3JC,P = 7.4Hz, CH3), 60.4 (d, 3JC,P = 3.5Hz, o-C5H4), 62.8 (s, m-C5H4), 64.9 (d, 2JC,P =
5.7Hz, CH2), 69.5 (s, C5H5), 117.5 (d, 2JC,P = 4.7Hz, CC5H4-O). 31P{1H} NMR (CDCl3,
δ): 63.8. HRMS (ESI-TOF, m/z): calcd for C14H19FePSO3 354.0136, found 354.0170 [M]+.
Diethyl Ferrocenyl Phosphite· BH3 (8)
8
Fe O
P(OEt)2
BH3 Ferrocenol (728mg, 3.60mmol), NEt3 (0.55mL, 3.96mmol) and diethyl
chlorophosphite (0.57mL, 4.5mmol) were reacted in CH2Cl2 according
to the general procedure GP1. Afterwards, 1 M solution of BH3 in
tetrahydrofuran (4.00mL, 3.95mmol) was added and the mixture was
stirred for 12 hours. Purification was realized by column chromatogra-
phy (silica, 3 · 16 cm column size: ) using a 1/1 (v/v) hexane/toluene
mixture as the eluent. Compound 8 (Rf = 0.39) was obtained as an orange oil.
Yield: 910mg (2.70mmol, 76% based on 5). 1H NMR (C6D6, δ): 1.06 (t, 3JH,H = 7.1Hz,
6H, CH3), 3.92–4.03 (m, 4H, CH2), 3.72 (pt, 3,4JH,H = 2.0Hz, 2H, m-C5H4), 4.22 (s, 5H,
C5H5), 4.46 (pt, 3,4JH,H = 2.0, 2H, o-C5H4). 13C{1H} NMR (C6D6, δ): 16.1 (d, 3JC,P =
5.5Hz, CH3), 60.8 (d, 3JC,P = 2.8Hz, o-C5H4), 63.1 (s, m-C5H4), 63.4 (d, 2JC,P = 3.1Hz,
CH2), 70.0 (s, 6C5H5), 117.7 (d, 2JC,P = 4.3Hz, CC5H4-O). 11B{1H} NMR (C6D6, δ): –42.7
(d, 1JB,P = 92Hz). 31P{1H} NMR (C6D6, δ): 128.2 (q, 1JP,B = 92Hz). HRMS (ESI-TOF,
m/z): calcd for C14H22BFeO3P–BH3 322.0416, found 322.0403 [M–BH3]+.
Ferrocenyl Diphenylphosphinate (9)
9
Fe O
PPh2
O Ferrocenol (5, 830mg, 4.1mmol), NEt3 (0.63mL, 4.5mmol) and
chlorodiphenylphosphine (0.83mL, 4.5mmol) were reacted according to the
general procedure GP1. Oxidation was realized by adding H2O2-solution
(0.40mL, ω = 35 %, 4.5mmol) followed by stirring meanwhile the reaction
mixture turned slightly darker. Purification was realized by column chro-
matography (silica, 4 · 18 cm column size) using 4/1 (v/v) CH2Cl2/ethyl
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acetate mixture as the eluent, giving 9 as a yellow solid.
Yield: 1.41 g (3.5mmol, 85% based on 5). 1H NMR (CDCl3, δ): 3.80 (s, 2H, m-C5H4),
4.18 (s, 5H, C5H5), 4.30 (s, 2H, o-C5H4), 7.46 (td, 3JH,H = 7.4Hz, 3JH,P = 3.6Hz, 4H,
m-Ph), 7.54 (t, 3JH,H = 6.9Hz, 2H, p-Ph), 7.85 (dd, 2JH,P = 12.4Hz, 3JH,H = 7.3Hz, 4H,
o-Ph). 13C{1H} NMR (CDCl3, δ): 60.3 (d, 3JC,P = 3.7Hz, o-C5H4), 62.7 (s, m-C5H4), 69.5
(s, C5H5), 117.5 (d, 2JC,P = 6.7Hz, CC5H4-O), 128.5 (d, 3JC,P = 13.1Hz, m-Ph), 130.7 (s,
Ph-P (HMBC); 132.8 (C6D6) (d, 1JC,P = 130.0Hz, Ph-P)), [392] 131.8 (d, 2JC,P = 10.2Hz,
o-Ph), 132.3 (d, 4JC,P = 2.7Hz, p-Ph). 31P{1H} NMR (CDCl3, δ): 30.1. HRMS (ESI-TOF,
m/z): calcd for C22H19FeO2P 402.0467, found 402.0465 [M]+.
Ferrocenyl Diphenylthiophosphinate (10)
10
Fe O
PPh2
S Ferrocenol (5, 828mg, 4.1mmol), NEt3 (0.63mL, 4.5mmol) and
chlorodiphenylphosphine (0.83mL, 4.5mmol) were reacted according to
the general procedure GP1. Afterwards, sulfur (160mg, 4.9mmol) was
added and stirred for additional ten min. Purification was realized by
column chromatography (alumina, 3 · 10 cm column size) using first hex-
ane to elute the excess of sulfur and then changing to CH2Cl2 which eluted
the product as a yellow solid.
Yield: 1.65 g (3.9mmol, 95% based on 5). Anal. calcd for C22H19FeOPS (418.27 g/mol): C,
63.17; H, 4.58. Found: C, 63.03; H, 4.71. Mp.: 147–149℃.1H NMR (CDCl3, δ): 3.82 (pt,
3,4JH,H = 2.0Hz, 2H, m-C5H4), 4.20 (s, 5H, C5H5), 4.24 (pt, 3,4JH,H = 1.8Hz, 2H, o-C5H4),
7.44–7.50 (m, 4H, o-Ph), 7.50–7.56 (m, 2H, p-Ph), 7.88–7.96 (m, 4H, m-Ph). 13C{1H} NMR
(CDCl3, δ): 61.1 (d, 3JC,P = 3.9Hz, o-C5H4), 62.8 (s, m-C5H4), 69.5 (s, C5H5), 117.4 (d,
2JC,P = 5.6Hz, CC5H4-O), 128.4 (d, JC,P = 13.4Hz, Ph), 131.4 (d, JC,P = 11.2Hz, Ph),
132.0 (d, 4JC,P = 2.8Hz, p-Ph), 134.2 (d, 1JC,P = 110.3Hz, Ph-P). 31P{1H} NMR (CDCl3,
δ): 81.5.
Ferrocenyl Diphenyl Phosphate (11)
11
Fe O
P(OPh)2
O Ferrocenol (5, 1.080 g, 5.3mmol), NEt3 (0.81mL, 5.8mmol) and
diphenyl chlorophosphate (1.2mL, 5.9mmol) were reacted according
to the general procedure GP1. Purification was realized using column
chromatography (alumina, 4 · 18 cm column size) using CH2Cl2 as the
eluent, giving 11 as an orange oil.
Yield: 1.45 g (3.3mmol, 62% based on 5). Anal. calcd for
C22H19FeO4P (434.04 g/mol): C, 60.86; H, 4.41. Found: C, 60.86; H, 4.29. Mp.: 67℃.
1H NMR (CDCl3, δ): 3.91 (pt, 3,4JH,H = 2.0Hz, 2H, m-C5H4), 4.22 (s, 5H, C5H5), 4.44
(pt, 3,4JH,H = 1.9Hz, 2H, o-C5H4), 7.18–7.27 (m, 6H, o, p-Ph), 7.36 (t, 3JH,H = 7.9Hz, 4H,
m-Ph). 13C{1H} NMR (CDCl3, δ): 59.8 (d, 3JC,P = 3.8Hz, o-C5H4), 62.9 (s, m-C5H4), 69.6
(s, C5H5), 117.9 (d, 2JC,P = 5.4Hz, CC5H4-O), 120.1 (d,3JC,P = 5.3Hz, 3JC,P = 2Hz, o-Ph),
132
4.3. SYNTHETIC PROCEDURES
125.5 (s, p-Ph), 129.8 (s, m-Ph), 150.5 (d, 2JC,P = 7.4Hz, Ph-O). 31P{1H} NMR (CDCl3,
δ): –16.9. HRMS (ESI-TOF, m/z): calcd for C22H19FeO4P 434.0365, found 434.0362 [M]+.
N,N,N ',N '-Tetraethyl-1-(ferrocenyloxy)phosphinediamine·BH3 (12)
12
Fe O
P(NEt2)2
BH3 Ferrocenol (5, 1.037 g, 5.13mmol), NEt3 (0.75mL, 5.41mmol) and
ClP(NEt2)2 (1.09mL, 5.17mmol) were reacted according to the gen-
eral procedure GP1. After stirring for 12 h, a 1 M solution of BH3 in
tetrahydrofuran (5.2mL, 5.2mmol) was added in a single portion and
stirring was continued for additional 2 h. Purification was realized by
column chromatography (alumina, 3.5 · 13 cm column size) using a 8:2
hexane/diethyl ether mixture (v/v) as the eluent, giving 12 as an orange oil.
Yield: 1.02 g (2.61mmol, 51% based on 5). Anal. calcd for C18H32BFeN2OP (390.09 g/mol):
C, 55.42; H, 8.27; N, 7.18. Found: C, 55.55; H, 8.08; N, 6.92. IR data (NaCl, v˜/cm−1):
3067, w, 3020 w, 2942 s, 2905 s, 2852 s, 2353 s (BH3), 1446 s, 1399 w, 1366 s, 1285 m. 1H
NMR (C6D6, δ): 0.93 (t, 3JH,H = 7.1Hz, 12H, CH3), 1.01–1.72 (br m, 3H, BH3), 2.86–3.03
(m, 8H, CH2), 3.67 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4), 4.19 (s, 5H, C5H5), 4.42 (pt, 3,4JH,H
= 2.0Hz, 2H, C5H4). 13C{1H} NMR (C6D6, δ): 14.3 (d, 3JC,P = 1.7Hz, CH3), 39.2 (d,
2JC,P = 6.3Hz, CH2), 61.4 (d, JC,P = 2.7Hz, C5H4), 63.0 (C5H4), 69.7 (C5H4), 118.1 (d,
2JC,P = 1.4Hz, CC5H4-O). 11B{1H} NMR (C6D6, δ): –39.5 (d, 1JB,P = 95Hz). 31P{1H}
NMR (C6D6, δ): 130.7–132.1 (br m). HRMS (ESI-TOF, m/z): calcd for C18H32BFeN2OP
390.1693, found 390.1702 [M]+.
N,N,N ',N '-Tetraethyl-1-(ferrocenyloxy)phosphinediamine sulfide (13)
13
Fe O
P(NEt2)2
S Ferrocenol (5, 1.102 g, 5.46mmol), NEt3 (0.77mL, 5.55mmol) and
ClP(NEt2)2 (1.26 g, 5.98mmol) were reacted according to the gen-
eral procedure described above. After stirring for 12 h, sulfur (210mg,
6.55mmol) was added in a single portion and stirring was continued
for additional 2 h. Purification was realized by column chromatogra-
phy (alumina, 2.5 · 32 cm column size) using first hexane, to remove
the excess of sulfur, followed by a 7:3 hexane/dichloromethane mixture (v/v) as the eluent,
giving 13 as an orange oil.
Yield: 1.900 g (4.65mmol, 85% based on 5). Anal. calcd for C18H29FeN2OPS (408.32 g/mol):
C, 52.95; H, 7.16; N, 6.86. Found: C, 53.17; H, 7.55; N, 6.30. 1H NMR (C6D6, δ): 0.99 (t,
3JH,H = 7.1Hz, 12H, CH3), 3.00–3.09 (m, 8H, CH2), 3.70 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4),
4.22 (s, 5H, C5H5), 4.50 (ptd, 3,4JH,H = 2.1Hz, JH,H = 0.6Hz, 2H, C5H4). 13C{1H} NMR
(C6D6, δ): 14.2 (d, 4JC,P = 3.2Hz, CH3), 40.6 (d, 3JC,P = 5.0Hz, CH2), 61.4 (d, JC,P
= 3.6Hz, C5H4), 62.9 (C5H4), 69.8 (C5H5), 117.6 (d, 2JC,P = 1.9Hz, CC5H4-O). 31P{1H}
NMR (C6D6, δ): 90.9. HRMS (ESI-TOF, m/z): calcd for C18H29FeN2OPS 408.1082, found
408.1109 [M]+.
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Ferrocenyl Di(pyrrolidin-1-yl)phosphinate (14)
14
Fe O
P
O
N
2
Ferrocenol (1, 370mg, 1.83mmol), BuLi (0.73mL, 1.83mmol) and
di(pyrrolidin-1-yl) chlorophosphinate (408mg, 1.83mmol) were re-
acted at –80℃ according to the general procedure described above.
Purification was realized by column chromatography (alumina,
4 · 8 cm column size) using a 1:1 dichloromethane/ethyl acetate mix-
ture (v/v) as the eluent, giving 14 as an orange solid.
Yield: 512mg (1.32mmol, 72% based on 1). Anal. calcd for C18H25FeN2O2P (388.22 g/mol):
C, 55.69; H, 6.49; N, 7.27. Found: C, 55.67; H, 6.54; N, 7.09. Mp.: 76–78℃. 1H NMR (C6D6,
δ): 1.40–1.43 (m, 8H, H3, H4-C4N), 3.11–3.15 (m, 8H, H2, H5-C4N), 3.71 (pt, 3,4JH,H =
1.9Hz, 2H, C5H4), 4.27 (s, 5H, C5H5), 4.60 (ptd, 3,4JH,H = 1.9Hz, JH,P = 0.6Hz, 2H,
C5H4). 13C{1H} NMR (C6D6, δ): 26.5 (d, 3JC,P = 8.9Hz, C3, C4-C4N), 46.8 (d, 2JC,P =
4.6Hz, C2, C5-C4N), 60.3 (d, JC,P = 3.8Hz, C5H4), 62.8 (C5H4), 69.9 (C5H5), 118.5 (d,
2JC,P = 4.3Hz, CC5H4-O). 31P{1H} NMR (C6D6, δ): 22.8. HRMS (ESI-TOF, m/z): calcd
for C18H25FeN2O2P+Na 411.0895, found 411.0895 [M+Na]+.
2-Ferrocenyloxy-3-methyl-1,3,2-oxaphospholidine·BH3 (15)
15
Fe O
P
N
OH3B
Ferrocenol (5, 508mg, 2.51mmol), NEt3 (0.39mL, 2.81mmol) and 2-
chloro-3-methyl-1,3,2-oxazaphospholidine (350mg, 2.51mmol) were re-
acted according to the general procedure described above. After stirring
for 12 h, a 1M solution of BH3 in tetrahydrofuran (2.8mL, 2.8mmol) was
added in a single portion and stirring was continued for additional 2 h.
Purification was realized by column chromatography (alumina, 3.5 · 13 cm
column size) using a 1:3 hexane/dichloromethane mixture (v/v) as the eluent, giving 15 as
an orange oil. Crystals, suitable for single crystal X-ray diffraction analysis, were obtained
by evaporation of a hexane solution at ambient temperature containing 15.
Yield: 270mg (0.847mmol, 34% based on 5). Anal. calcd for C13H19BFeNO2P
(318.92 g/mol): C, 48.96; H, 6.00; N, 4.39. Found: C, 49.28; H, 6.08; N, 4.35. Mp.: 153℃.
1H NMR (CDCl3, δ): 0.31–0.86 (br m, 3H, BH3), 2.79 (d, 3JH,H = 10.1Hz, 3H, CH3),
2.97 (ddd, 3JH,P = 13.1Hz, 3JH,H = 7.5Hz, 3JH,H = 4.8Hz, 1H, CH2-N), 3.08 (dtd, 3JH,P
= 11.9Hz, 3JH,H = 8.0Hz, 3JH,H = 5.9Hz, 1H, CH2-N), 3.89 (pt, 3,4JH,H = 2.0Hz, 2H,
C5H4), 4.14–4.25 (m, 8H, C5H5, C5H4, CH2-O), 4.29–4.30 (m, 1H, C5H4). 13C{1H} NMR
(CDCl3, δ): 31.2 (d, 2JC,P = 9.9Hz, CH3), 49.2 (d, 2JC,P = 2.2Hz, CH2-N), 60.6 (d, JC,P
= 1.4Hz, C5H4), 61.2 (d, JC,P = 1.8Hz, C5H4), 63.2 (d, JC,P = 19.1Hz, C5H4), 67.9 (d,
2JC,P = 10.5Hz, CH2-O), 69.6 (C5H5), 116.5 (d, 2JC,P = 11.2Hz, CC5H4-O). 11B{1H} NMR
(CDCl3, δ): –42.6 (d, 1JB,P = 92Hz). 31P{1H} NMR (CDCl3, δ): 122.0 (br m). HRMS
(ESI-TOF, m/z): calcd for C13H19BFeNO2P+Na 342.0491, found 342.0499 [M+Na]+; calcd
for C13H19BFeNO2P–BH3 305.0263305.0265 [M–BH3]+.
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Dicyclohexyl Ferrocenyl Phosphate (30a)
30a
Fe O
P O
O
2
Ferrocenol (5, 1.00 g, 4.95mmol), BuLi (2.2mL, 5.5mmol) and
dicyclohexyl chlorophosphate (29a, 1.54 g, 5.5mmol) were re-
acted as described in the general procedure. Purification was
realized by column chromatography (silica, 4 · 7 cm column size)
using a 97/3 (v/v) dichloromethane/ethyl acetate mixture, giv-
ing 30a as an orange solid.
Yield: 1.49 g (3.46mmol, 70% based on 5). 1H NMR (CDCl3, δ): 1.23–1.38 (m, 6H, CH2),
1.48–1.59 (m, 6H, CH2), 1.70–1.80 (m, 4H, CH2), 1.90–2.00 (m, 4H, CH2), 3.84–3.89 (m,
2H, C5H4), 4.25 (s, 5H, C5H5), 4.38–4.44 (m, 4H, C5H4, H1). 13C{1H} NMR (CDCl3,
δ): 23.5 (CH2), 25.1 (CH2), 33.19 (CH2), 33.23 (CH2), 33.25 (CH2), 33.29 (CH2), 59.8 (d,
3JC,P = 3.8Hz, C5H4), 62.6 (C5H4), 69.4 (C5H5), 77.8 (d, 2JC,P = 6.4Hz, C1), 117.7 (d,
2JC,P = 5.0Hz, C-O). 31P{1H} NMR (CDCl3, δ): –6.8. HRMS (ESI-TOF, m/z): calcd for
C22H31FeO4P 446.1304, found 446.1302 [M]+.
Ferrocenyl Di-(1R)-menthyl Phosphate (30b)
30b
Fe O
P O
O
2
Ferrocenol (5, 1.03 g, 5.09mmol), BuLi (2.1mL, 5.25mmol) and
di-(1R)-menthyl chlorophosphate (29b, 2.00 g, 5.09mmol) were
reacted as described in the general procedure. Purification was
realized by column chromatography (silica, 4 · 10 cm column size)
using dichloromethane as the eluent (Rf = 0.37), giving 30b as
an orange solid.
Yield: 3.00 g (4.64mmol, 91% based on 5). Anal. calcd for
C30H47FeO4P (558.51 g/mol): C, 64.51; H, 8.48; found: C, 64.67; H, 8.69. Mp.: 79–80℃.
1H NMR (CDCl3, δ): 0.77 (d, 3JH,H = 7.0Hz, 3H, CH3), 0.82 (d, 3JH,H = 7.0Hz, 3H,
CH3), 0.83–0.87 (m, 2H), 0.89 (d, 3JH,H = 7.0Hz, 3H, CH3), 0.91 (d, 3JH,H = 7.0Hz, 3H,
CH3), 0.918 (d, 3JH,H = 6.5Hz, 3H, CH3), 0.928 (d, 3JH,H = 6.5Hz, 3H, CH3), 0.95–1.05
(m, 2H), 1.11–1.18 (m, 2H), 1.29–1.39 (m, 2H), 1.40–1.50 (m, 2H), 1.62–1.70 (m, 4H),
2.11 (dsept, (s, 3JH,H = 7.0Hz, 3JH,H = 2.5Hz, 1H, CH (CH3)2), 2.17 (dsept, (s, 3JH,H =
7.0Hz, 3JH,H = 2.5Hz, 1H, CH (CH3)2), 2.21–2.30 (m, 2H), 3.86 (s, 2H, C5H4), 4.14–4.28
(m, 7H, C5H5, H1), 4.39 (s, 1H, C5H4), 4.44 (s, 1H, C5H4). 13C{1H} NMR (CDCl3, δ):
15.8 (CH3), 20.93 (CH3), 20.94 (CH3), 21.93 (CH3), 21.99 (CH3), 22.76 (CH3), 22.85 (CH3),
25.35 (CH), 25.42 (CH), 31.5 (d, 4JC,P = 2.78Hz, C5), 34.0 (CH2), 42.5 (CH2), 42.7 (CH2),
48.44 (C2) , 48.46 (C2), 48.50 (C2), 48.52 (C2), 60.0 (d, 3JC,P = 3.5Hz, C5H4), 60.1 (d,
3JC,P = 3.2Hz, C5H4), 62.62 (C5H4), 62.64 (C5H4), 69.5 (C5H5), 79.8 (d, 2JC,P = 6.9Hz,
C1), 118.625 (d, 2JC,P = 4.3Hz, C-O). 31P{1H} NMR (CDCl3, δ): –6.3. HRMS (ESI-TOF,
m/z): calcd for C31H45FeO4P 568.2400, found 568.2453 [M]+.
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Ferrocenyl Di-(1S)-menthyl phosphate (30c)
30c
Fe O
P O
O
2
Ferrocenol (5, 608mg, 3.01mmol), BuLi (1.3mL, 3.25mmol) and
di-(1S)-menthyl chlorophosphate (29c, 1.18 g, 3.01mmol) were
reacted as described in the general procedure. Purification was
realized by column chromatography (silica, 4 · 10 cm column size)
on silica using dichloromethane (Rf = 0.37), giving 30e as an
orange oil.
Yield: 1.40 g (2.51mmol, 83% based on 5). 1H NMR (CDCl3,
δ): 0.77 (d, 3JH,H = 7.0Hz, 3H, CH3), 0.82 (d, 3JH,H = 7.0Hz, 3H, CH3), 0.83–0.87 (m,
2H), 0.89 (d, 3JH,H = 7.0Hz, 3H, CH3), 0.91 (d, 3JH,H = 7.0Hz, 3H, CH3), 0.918 (d, 3JH,H
= 6.5Hz, 3H, CH3), 0.928 (d, 3JH,H = 6.5Hz, 3H, CH3), 0.95–1.05 (m, 2H), 1.11–1.18
(m, 2H), 1.23–1.39 (m, 2H), 1.40–1.50 (m, 2H), 1.62–1.70 (m, 4H), 2.11 (dsept, 3JH,H =
7.0Hz, 3JH,H = 2.5Hz, 1H, CH (CH3)2), 2.17 (dsept, 3JH,H = 7.0Hz, 3JH,H = 2.5Hz, 1H,
CH (CH3)2), 2.21–2.30 (m, 2H), 3.85 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4), 4.16–4.25 (m, 7H,
C5H5, H1), 4.37 (dd, JH,H = 3.4Hz, JH,H = 1.5Hz, 1H, C5H4), 4.44 (dd, JH,H = 3.4Hz,
JH,H = 1.5Hz, 1H, C5H4). 13C{1H} NMR (CDCl3, δ): 15.8 (CH(CH3)2), 20.93 (CH(CH3)2),
20.95 (CH(CH3)2), 21.93 (CH(CH3)), 21.99 (CH(CH3)), 22.76 (CH2) , 22.85 (CH2), 25.35
(CH(CH3)2) , 25.43 (CH(CH3)2), 31.5 (d, 4JC,P = 2.8Hz, C5), 34.0 (CH2), 42.5 (CH2), 42.7
(CH2), 48.45 (C2) , 48.47 (C2), 48.51 (C2), 48.53 (C2), 60.0 (d, 3JC,P = 3.9Hz, C5H4), 60.1
(d, 3JC,P = 3.3Hz, C5H4), 62.52 (C5H4), 62.55 (C5H4), 69.4 (C5H5), 79.78 (d, 23JC,P =
6.8Hz, C1) , 79.79 (d, 2JC,P = 6.8Hz, C1), 117.8 (d, 2JC,P = 4.3Hz, CC5H4-O). 31P{1H}
NMR (CDCl3, δ): –6.3.
Di-(1S)-borneyl Ferrocenyl Phosphate (30d)
30d
Fe O
P
O
O
2
Ferrocenol (5, 1.00 g, 4.95mmol), BuLi (2.0mL, 5.00mmol)
and di-(1S)-borneyl chlorophosphate (29d) (1.92 g,
4.95mmol) were reacted as described in the general
procedure. Purification was realized by column chromatog-
raphy (silica, 4 · 15 cm column size) using a 95/5 (v/v)
toluene/diethyl ether mixture (Rf = 0.33), giving 30d as an
orange solid.
Yield: 1.26 g (2.27mmol, 46% based on 5). Anal. calcd for C30H43FeO4P (554.48 g/mol): C,
64.98; H, 7.82; found: C, 64.88; H, 7.83. Mp.: 210–212℃. 1H NMR (CDCl3, δ): 0.86–0.90
(m, 18H, CH3), 1.22–1.30 (m, 6H), 1.66–1.69 (m, 2H), 1.70–1.77 (m, 2H), 1.91–1.97 (m,
2H), 2.25–2.34 (m, 2H), 3.86 (pt, 3,4JH,H = 1.9Hz, 2H, C5H4), 4.24 (s, 5H, C5H5), 4.39 (pt,
3JH,H = 1.9Hz, 2H, C5H4), 4.58–4.62 (m, 2H, H2). 13C{1H} NMR (CDCl3, δ): 13.28 (CH3),
13.34 (CH3), 18.8 (CH3), 19.9 (CH3), 26.4 (CH2), 26.5 (CH2), 27.9 (CH2), 28.0 (CH2), 36.8
(d, 3JC,P = 1.7Hz, C3), 37.1 (d, 3JC,P = 1.8Hz, C3), 44.8, 47.65 (C7), 47.66 (C7), 49.66 (d,
3JC,P = 1.3Hz, C1), 49.71 (d, 3JC,P = 1.3Hz, C1), 60.06 (d, 3JC,P = 0.6Hz, C5H4), 60.08
(d, 3JC,P = 1.0Hz, C5H4), 62.6 (C5H4), 69.4 (C5H5), 84.66 (d, 2JC,P = 2.2Hz, C2), 84.71 (d,
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2JC,P = 2.3Hz, C2), 117.7 (d, 2JC,P = 4.6Hz, CC5H4-O). 31P{1H} NMR (CDCl3, δ): –4.8.
HRMS (ESI-TOF, m/z): calcd for C30H43FeO4P 554.2243, found 554.2242 [M]+.
Di-(1R)-α-fenchyl Ferrocenyl Phosphate (30e)
30e
Fe O
P
O
2
O
Ferrocenol (5, 814mg, 4.03mmol), BuLi (1.65mL, 4.13mmol)
and di-(1R)-α-fenchyl chlorophosphate (29e, 1.57 g,
4.04mmol) were reacted as described in the general pro-
cedure. Purification was realized by column chromatography
(silica, 4 · 7 cm column size) using dichloromethane as the
eluent (Rf = 0.38), giving 30e as an orange oil.
Yield: 1.85 g (3.33mmol, 83% based on 5). Anal. calcd for C30H43FeO4P (554.48 g/mol):
C, 64.98; H, 7.82; found: C, 64.67; H, 7.86. Mp.: 64–68℃. 1H NMR (CDCl3, δ): 0.91 (s,
3H, CH3), 0.96 (s, 3H, CH3), 1.03–1.09 (m, 11H), 1.14–1.20 (m, 5H), 1.40–1.47 (m, 2H),
1.49–1.53 (m, 2H), 1.68–1.75 (m, 6H), 3.85 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4), 3.97–4.01
(m, 2H, C5H4), 4.24 (s, 5H, C5H5), 4.41–4.45 (m, 2H, H2). 13C{1H} NMR (CDCl3, δ):
19.36 (CH3), 19.36 (CH3), 20.8 (CH3), 21.1 (CH3), 25.67 (C5/C6), 25.74 (C5/C6), 25.95
(C5/C6), 25.98 (C5/C6), 29.9 (CH3), 39.5 (d, 3JC,P = 2.5Hz, C3), 39.7 (d, 3JC,P = 2.5Hz,
C3), 40.94 (CH2), 40.97 (CH2), 47.93 (C4), 47.95 (C4), 49.29 (C1), 49.33 (C1), 60.1–60.2
(m, C5H4), 62.6 (C5H4), 69.4 (C5H5), 91.0–91.2 (m, C2), 118.3 (HMBC, CC5H4-O). 31P{1H}
NMR (CDCl3, δ): –4.3. HRMS (ESI-TOF, m/z): calcd for C30H43FeO4P 554.2243, found
554.2265 [M]+.
Ferrocenyl Di-(1S)-isopinocampheyl Phosphate (30f)
30f
Fe O
P
O
O
2
Ferrocenol (5, 830mg, 4.11mmol), BuLi (1.65mL, 4.13mmol)
and di-(1S)-isopinocampheyl chlorophosphate (29f) (1.60 g,
4.11mmol) were reacted as described in the general procedure.
Purification was realized by column chromatography (silica,
4 · 7 cm column size) using a 8/2 (v/v) hexane/diethyl ether mix-
ture as the eluent (Rf = 0.32), giving 30f as an orange oil.
Yield: 1.90 g (3.43mmol, 83% based on 5). 1H NMR (CDCl3,
δ): 0.92 (s, 3H, H9/H10), 0.93 (s, 3H, H9/H10), 1.107 (d, 3JH,H = 9.9Hz, 1H, H7), 1.112
(d, 3JH,H = 9.9Hz, 1H, H7), 1.16 (d, 3JH,H = 7.4Hz, 3H, H8), 1.19 (d, 3JH,H = 7.4Hz, 3H,
H8), 1.22 (s, 6H, H9/H10), 1.80–1.84 (m, 2H, H1), 1.93–1.98 (m, 2H, H5), 1.99–2.04 (m,
2H, H4), 2.19–2.28 (m, 2H, H2), 2.36–2.40 (m, 2H, H7), 2.53–2.62 (m, 2H, H4), 3.86 (pt,
3,4JH,H = 1.9Hz, 2H, C5H4), 4.25 (s, 5H, C5H5), 4.42 (pt, 3,4JH,H = 1.9Hz, 2H, C5H4),
4.73–4.79 (m, 2H, H3). 13C{1H} NMR (CDCl3, δ): 20.24 (C8), 20.26 (C8), 23.89 (C9/C10),
23.91 (C9/C10), 27.40 (C9/C10), 27.41 (C9/C10), 33.76 (C7), 33.79 (C7), 36.7 (d, 3JC,P =
3.0Hz, C4), 36.8 (d, 3JC,P = 3.3Hz, C4), 38.20 (C6), 38.22 (C6), 41.46 (C5), 45.19 (C2),
45.24 (C2), 45.27 (C2), 45.32 (C2), 47.7 (C1), 59.89 (C5H4), 59.91 (C5H4), 62.6 (C5H4), 69.5
(C5H5), 79.32 (C3), 79.34 (C3), 79.38 (C3), 79.40 (C3), 117.8–117.9 (m, CC5H4-O). 31P{1H}
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NMR (CDCl3, δ): –6.0. HRMS (ESI-TOF, m/z): calcd for C30H43FeO4P 554.2243, found
554.2246 [M]+.
1,1'-Ferrocenediyl Tetracyclohexyl Bis(phosphate) (39a)
39a
Fe O
P(OCy)2
O
O P(OCy)2
O
Ferrocenediol (38, 515mg, 2.36), BuLi (1.9mL, 4.75mmol) and di-
cyclohexyl chlorophosphate (29a, 1.40 g, 5.0mmol) were reacted ac-
cording to the general procedure GP1. Purification was realized by
column chromatography (silica, 4 · 10 cm column size) using a 80/20
(v/v) dichloromethane/ethyl acetate mixture as the eluent, giving
39a as an orange oil.
Yield: 980mg (1.39mmol, 59% based on 38). 1H NMR (CDCl3, δ): 1.23–1.38 (m, 12H,
CH2), 1.47–1.57 (m, 12H, CH2), 1.70–1.77 (m, 8H, CH2), 1.89–1.98 (m, 8H, CH2), 3.96 (pt,
3,4JH,H = 1.9Hz, 4H, C5H4), 4.37–4.43 (m, 4H, H1), 4.44 (pt, 3,4JH,H = 1.9Hz, 4H, C5H4).
13C{1H} NMR (CDCl3, δ): 23.5 (CH2), 25.1 (CH2), 33.21 (CH2), 33.25 (CH2), 33.27 (CH2),
33.30 (CH2), 61.2 (d, 3JC,P = 3.7Hz, C5H4), 64.6 (C5H4), 77.9 (d, 2JC,P = 6.4Hz, C1), 118.1
(d, 2JC,P = 4.8Hz, CC5H4-O). 31P{1H} NMR (CDCl3, δ): –6.9. HRMS (ESI-TOF, m/z):
calcd for C34H52FeO8P2 +Na 729.2380, found 729.2333 [M+Na]+.
1,1'-Ferrocenediyl Tetra-(1R)-α-fenchyl Bis(phosphate) (39b)
39b
Fe O
P(OFn)2
O
O P(OFn)2
O
Ferrocenediol (38, 254mg, 1.16mmol), BuLi (0.95mL, 2.38mmol)
and dicyclohexyl chlorophosphate (29a, 1.00 g, 2.58mmol) were re-
acted according to the general procedure GP1. Purification was real-
ized by column chromatography (silica, 4 · 10 cm column size) using
a 95/5 (v/v) dichloromethane/ethyl acetate mixture as the eluent,
giving 39b as an orange oil.
Yield: 400mg (0.43mmol, 37% based on 38). 1H NMR (CDCl3, δ): 0.90–1.19 (m, 44H),
1.40–1.46 (m, 4H, CH2), 1.49–1.51 (m, 4H, CH2), 1.70–1.71 (m, 12H, CH2, CH), 3.95–4.00
(m, 8H, C5H4, H2), 4.47–4.50 (m, 4H, C5H4). 13C{1H} NMR (CDCl3, δ): 19.37 (CH3),
19.39 (CH3), 20.8 (CH3), 21.0 (CH3), 25.67 (C5/C6), 25.72 (C5/C6), 25.94 (C5/C6), 25.97
(C5/C6), 29.91 (CH3), 29.93 (CH3), 39.5–39.6 (m, C3), 40.93 (C7), 40.96 (C7), 47.92 (C4),
47.94 (C4), 49.28 (C1), 49.32 (C1), 61.3 (d, 2JC,P = 3.4Hz, C5H4), 61.4 (d, 2JC,P = 3.8Hz,
C5H4), 64.59 (C5H4), 64.65 (C5H4), 91.1–91.2 (m, C2), 118.3 (d, 2JC,P = 4.4Hz, CC5H4-O).
31P{1H} NMR (CDCl3, δ): –4.3. HRMS (ESI-TOF, m/z): calcd for C50H76FeO8P2 + H
923.4439, found 923.4426 [M+H]+.
1,1'-Ferrocenediyl Tetraethyl Bis(phosphate) (39c)
1,1'-Diacetoxyferrocene (655mg, 2.2mmol), KOH (2.5mL, 4.8mmol), HCl (2.5mL,
4.8mmol), NEt3 (0.60mL, 4.8mmol) and diethyl chlorophosphate (0.73mL, 4.8mmol) were
reacted in dichloromethane according to the general procedure GP1. Purification was real-
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ized by column chromatography (silica, 3 · 10 cm column size) using a 3/1 (v/v) CH2Cl2/ethyl
acetate mixture as the eluent, giving 39c as an orange oil.
39c
Fe O
P(OEt)2
O
O P(OEt)2
O
Yield: 635mg (1.30mmol, 60% based on diacetoxyferrocene). 1H
NMR (CDCl3, δ): 1.36 (td, 3JH,H = 7.1Hz, 4JH,P = 1.0Hz , 12H,
CH3), 3.99 (pt, 3,4JH,H = 1.9Hz, 4H, C5H4), 4.14–4.21 (m, 8H,
CH2), 4.46 (pt, 3,4JH,H = 1.9Hz, 4H, C5H4). 13C{1H} NMR (CDCl3,
δ): 16.1 (d, 3JC,P = 6.7Hz, CH3), 61.1 (d, 3JC,P = 3.8Hz, C5H4),
64.4 (d, 2JC,P = 5.6Hz, CH2), 64.6 (s, C5H4), 118.0 (d, 2JC,P =
4.6Hz, CC5H4-O). 31P{1H} NMR (CDCl3, δ): –5.4. HRMS (ESI-TOF, m/z): calcd for
C18H28FeO8P2 490.0604, found 490.0633 [M]+.
Cyclohexyl Diferrocenyl Phosphate (43a)
43a
Fe O
P
O
O
2
Ferrocenol (5, 900mg, 4.45mmol), BuLi (1.8mL, 4.5mmol) and
cyclohexyl dichlorophosphate (42a, 485mg, 2.23mmol) were re-
acted according to the general procedure GP1. Purification was
realized by column chromatography (silica, 4 · 15 cm column size)
using a 95/5 (v/v) dichloromethane/ethyl acetate mixture as the
eluent, giving 43a as an orange solid.
Yield: 771mg (1.41mmol, 63% based on 5). Anal. calcd for C26H29Fe2O4P (548.17 g/mol):
C, 56.97; H, 5.33; found: C, 57.34; H, 5.43. Mp.: 90–93℃. 1H NMR (CDCl3, δ): 1.31–1.40
(m, 2H, CH2), 1.49–1.63 (m, 4H, CH2), 1.71–1.81 (m, 2H, CH2), 1.92–2.01 (m, 2H, CH2),
3.87–3.92 (m, 4H, C5H4), 4.26 (s, 10H, C5H5), 4.37–4.43 (m, 4H, C5H4), 4.46–4.53 (m, 1H,
H1). 13C{1H} NMR (CDCl3, δ): 23.5 (CH2), 25.0 (CH2), 33.2 (d, 3JC,P = 2.9Hz, C2/C6),
59.73–59.76 (m, C5H4), 62.73–62.74 (m, C5H4), 69.6 (C5H5), 79.0 (d, 2JC,P = 6.6Hz, C1),
117.7 (d, 2JC,P = 5.3Hz, CC5H4-O). 31P{1H} NMR (CDCl3, δ): –10.9. HRMS (ESI-TOF,
m/z): calcd for C26H29Fe2O4P 548.0497, found 548.0490 [M]+.
Diferrocenyl (1R)-Menthyl Phosphate (43b)
43b
Fe O
P
O
O
2
Ferrocenol (5, 1.10 g, 5.44mmol), BuLi (2.2mL, 5.5mmol), and
(1R)-menthyl dichlorophosphate (42b,745mg, 2.73mmol) were
reacted according to the general procedure GP1. Purification
was realized by column chromatography (silica, 4 · 15 cm column
size) using a 5/95 (v/v) hexane/dichloromethane mixture as the
eluent, giving 43b as an orange solid.
Yield: 1.222 g (2.02mmol, 74% based on 5). Anal. calcd for
C30H37Fe2O4P (604.28 g/mol): C, 59.63; H, 6.17; found: C, 59.88; H, 6.31. Mp.: 90–92℃.
1H NMR (CDCl3, δ): 0.80 (d, 3JH,H = 6.9Hz, 3H, CH3), 0.88–0.94 (m, 11H), 0.98–1.06 (m,
1H), 1.19, (q, 3JH,H = 11.9Hz, 2H), 1.35–1.50 (m, 2H), 1.63–1.70 (m, 2H), 2.07–2.15 (m,
1H), 2.21–2.28 (m, 1H), 3.86–3.92 (m, 4H, C5H4), 4.20–4.35 (m, 11H, C5H5, H1), 4.37–4.44
(m, 4H). 13C{1H} NMR (CDCl3, δ): 15.7 (CH3), 20.9 (CH3), 21.9 (CH3), 22.8 (d, 3JC,P
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= 27.0Hz, CH2), 25.4 (CH), 31.6 (CH), 33.9 (CH2), 42.5 (CH2), 48.4 (d, 3JC,P = 7.3Hz,
CH), 59.8–59.9 (m, C5H4), 62.71 (C5H4), 62.74 (C5H4), 69.53 (C5H5), 69.56 (C5H5), 81.0 (d,
2JC,P = 7.4Hz, C1), 117.7 (d, 2JC,P = 5.9Hz, CC5H4-O). 31P{1H} NMR (CDCl3, δ): –10.7.
HRMS (ESI-TOF, m/z): calcd for C30H37Fe2O4P 604.1124, found 604.1167 [M]+.
(1S)-Borneyl Diferrocenyl Phosphate (43c)
43c
Fe O
P
O
2
O
The title compound was obtained as a by-product during the
synthesis of 30d by reacting ferrocenol (5, 1.00 g, 4.95mmol),
BuLi (2.0mL, 5.00mmol) and 29d (1.92mg, 4.95mmol) accord-
ing to the general procedure GP1. Purification was realized by
column chromatography (silica, 4 · 15 cm column size) using a
95/5 (v/v) toluene/diethyl ether mixture (Rf = 0.43) as the
eluent, giving 43c as an orange solid.
Yield: 260mg (0.43mmol, 17% based on 5). Anal. calcd for C30H47FeO4P (602.26 g/mol):
C, 59.83; H, 5.86; found: C, 60.44; H, 6.00. 1H NMR (CDCl3, δ): 0.86 (s, 3H, CH3), 0.87
(s, 3H, CH3), 0.88 (s, 3H, CH3), 1.22–1.31 (m, 3H, CH2), 1.67 (t, JH,H = 4.5Hz, H4),
1.70–1.78 (m, 1H, CH2), 1.89–1.95 (m, 1H, H6), 2.26–2.33 (m, 1H, H3), 3.89–3.90 (m, 4H,
C5H4), 4.261 (s, 5H, C5H5), 4.264 (s, 5H, C5H5), 4.40–4.43 (m, 4H, C5H4), 4.64–4.68 (m,
1H, H2). 13C{1H} NMR (CDCl3, δ): 13.2 (CH3), 18.8 (CH3), 19.9 (CH3), 26.4 (C5/C6), 27.9
(C5/C6), 36.7 (C3), 44.7 (C4), 47.8 (C7), 49.8 (d, 3JC,P = 6.2Hz, C1), 59.79 (C5H4), 59.83
(C5H4), 59.86 (C5H4), 59.89 (C5H4), 62.76 (C5H4), 62.79 (C5H4), 69.6 (C5H5), 85.9 (d, 2JC,P
= 6.8Hz, C2), 117.64 (CC5H4-O), 117.66 (CC5H4-O), 117.68 (CC5H4-O), 117.71 (CC5H4-O).
31P{1H} NMR (CDCl3, δ): –9.8. HRMS (ESI-TOF,m/z): calcd for C30H35Fe2O4P 602.0967,
found 602.0963 [M]+.
(1R)-α-Fenchyl Diferrocenyl Phosphate (43d)
43d
Fe O
P
O
2
O
Ferrocenol (5, 1.00 g, 4.95mmol), BuLi (2.0mL, 5.0mmol),
and 42d (680mg, 2.50mmol) were reacted according to the
general procedure GP1. Purification was realized by column
chromatography (silica, 4 · 15 cm column size) using a 95/5
(v/v) dichloromethane/ethyl acetate mixture as the eluent,
giving 43d as an orange solid.
Yield: 935mg (1.55mmol, 63% based on 5). Anal. calcd for C30H35Fe2O4P (602.26 g/mol):
C, 59.83; H, 5.86; found: C, 59.90; H, 6.00. Mp.: 129–132℃. 1H NMR (CDCl3, δ): 0.90
(s, 3H, CH3), 1.04–10.8 (m, 4H, CH3, CH2), 1.11 (s, 3H, CH3), 1.16–1.21 (m, 1H, CH2),
1.42–1.47 (m, 1H, CH2), 1.50–1.54 (m, 1H, CH2), 1.67–1.74 (m, 3H, CH2, CH), 3.87–3.90
(m, 4H, C5H4), 4.04 (dd, 3JH,P = 8.5Hz, JH,H = 1.8Hz, 1H, H2), 4.25 (s, 5H, C5H5),
4.25 (s, 5H, C5H5), 4.38–4.46 (m, 4H, C5H4). 13C{1H} NMR (CDCl3, δ): 19.2 (CH3), 20.8
(CH3), 25.7 (C5/C6), 25.9 (C5/C6), 29.9 (CH3), 39.6 (d, 3JC,P = 2.7Hz, C3), 40.9 (C7), 47.9
(C4), 49.3 (d, 3JC,P = 5.1Hz, C1), 59.91 (C5H4), 59.93 (C5H4), 59.94 (C5H4), 59.96 (C5H4),
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59.98 (C5H4), 59.98 (C5H4), 62.71 (C5H4), 62.72 (C5H4), 62.75 (C5H4), 69.54 (C5H5), 59.54
(C5H5), 92.3 (d, 2JC,P = 7.4Hz, C2), 117.77 (d, 3JC,P = 4.9Hz, CC5H4-O), 117.81 (d, 2JC,P
= 4.7Hz, CC5H4-O). 31P{1H} NMR (CDCl3, δ): –9.8. HRMS (ESI-TOF, m/z): calcd for
C30H35Fe2O4P 602.0967, found 602.1005 [M]+.
Diferrocenyl Phenyl Phosphate (48)
48
Fe O
P
O
2
OPh
Ferrocenol (5, 850mg, 4.21mmol), Buli (1.7mL, 4.25mmol) and
Cl2P(O)OPh (0.32mL, 2.07mmol) were reacted according to the
general procedure GP1. Purification was realized by column chro-
matography (silica, 2.5 · 12 cm column size) using an 4/1 hex-
ane/dichloromethane mixture (v/v) as the eluent, giving 48 as an
orange solid.
Yield: 706mg (1.30mmol, 63% based on Cl2P(O)OPh). Anal. calcd for C26H23Fe2O4P
(542.12 g/mol): C, 57.60; H, 4.28. Found: C, 57.70; H, 4.27. Mp.: 100–104℃. 1H NMR
(CDCl3, δ): 3.92 (pt, 3,4JH,H = 2.0Hz, 4H, H3/4-C5H4), 4.25 (s, 10H, C5H5), 4.44–4.46 (m,
4H, H2/5-C5H4), 7.21–7.24 (m, 1H, H4-C6H5), 7.26–7.28 (m, 2H, H3/5-C6H5), 7.37–7.40 (m
2H, H2/6-C6H5). 13C{1H} NMR (CDCl3, δ): 59.68 (C2/5-C5H4), 59.70 (C2/5-C5H4), 59.72
(C2/5-C5H4), 59.73 (C2/5-C5H4), 62.9 (C3/4-C5H4), 69.6 (C5H5), 117.8 (d, 2JC,P = 5.4Hz,
CC5H4-O), 120.0 (d, 3JC,P = 5.1Hz, C2/6-C6H5), 125.5 (d, 5JC,P = 0.8Hz, C4-C6H5), 129.8
(C3/5-C6H5), 150.4 (d, 2JC,P = 7.2Hz, CC6H5-O). 31P{1H} NMR (CDCl3, δ): –16.1. HRMS
(ESI-TOF, m/z): calcd for C26H23Fe2O4P 542.0028, found 542.0049 [M]+.
Diferrocenyl 1-Naphthyl Phosphate (49)
49
Fe O
P
O
2
O
Ferrocenol (5, 600mg, 2.97mmol), BuLi (1.2mL, 3.0mmol)
and 1-naphthyl dichlorophosphate (388mg, 1.5mmol) were
reacted according to the general procedure GP1. Purification
was realized by column chromatography (silica, 2.5 · 15 cm col-
umn size) using a 9/1 dichloromethane/hexane mixture (v/v)
as the eluent, giving 49 as an orange solid.
Yield: 195mg (0.364mmol, 25% based on 5). Anal. calcd for C30H25Fe2O4P · 1/6 C6H14
(592.18 · 1/6 86.18 g/mol): C, 61.39; H, 4.54. Found: C, 61.39; H, 4.63. Mp.: 130–134℃.
1H NMR (CDCl3, δ): 3.91 (pt, 3,4JH,H = 1.9Hz, 4H, H3,4-C5H4), 4.21 (s, 10H, C5H5),
4.44–4.46 (m, 4H, H2,5-C5H4), 7.45 (t, 3JH,H = 7.9Hz, 1H, H3-C10H7), 7.53–7.56 (m, 3H,
H2/6/7-C10H7), 7.72 (d, 3JH,H = 8.1Hz, 1H, H4-C10H7), 7.86–7.88 (m, 1H, H5-C10H7),
8.11–8.13 (m, 1H, H8-C10H7). 13C{1H} NMR (CDCl3, δ): 59.86 (d, 3JC,P = 3.9Hz, C2/5-
C5H4), 59.90 (d, 3JC,P = 3.7Hz, C2/5-C5H4), 62.9 (C3/4-C5H4), 69.6 (C5H5), 115.1 (d,
3JC,P = 2.9Hz, C2-C10H7), 117.9 (d, 2JC,P = 5.3Hz, CC5H4-O), 121.7 (C8-C10H7), 125.39
(C3-C10H7), 125.40 (C4C10H7), 126.3 (d, 3JC,P = 6.9Hz, C8a-C10H7), 126.5 (C6/7-C10H7),
126.8 (C6/7-C10H7), 127.7 (C5-C10H7), 134.8 (C4a-C10H7), 146.4 (d, 2JC,P = 7.6Hz, C1-
C10H7). 31P{1H} NMR (CDCl3, δ): –15.6. HRMS (ESI-TOF,m/z): calcd for C30H25Fe2O4P
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592.0185, found 592.0160 [M]+.
Diferrocenyl 2-Naphthyl Phosphate (50)
50
Fe O
P
O
2
O
Ferrocenol (5, 836mg, 4.138mmol), BuLi (1.7mL,
4.25mmol), NEt3 (0.6mL, 4.3mmol) and 2-naphthyl
dichlorophosphate (515mg, 1.973mmol) were reacted ac-
cording to the general procedure GP1. Purification was
realized by column chromatography (silica, 2.5 · 35 cm col-
umn size) using chloroform as the eluent, giving 50 as an
orange oil.
Yield: 380mg (0.64mmol, 65% based on the dichlorophosphate). Anal. calcd for
C30H25Fe2O8P2 · 1/3 C6H14 (741.99 · 1/3 86.18 g/mol): C, 49.87; H, 3.75. Found: C, 49.65; H,
3.59. Mp.: >230℃ (decomp.). 1H NMR (CDCl3, δ): 3.93 (pt, 3,4JH,H = 2.0Hz, 4H, H3,4-
C5H4), 4.26 (s, 10H, C5H5), 4.46–4.48 (m, 4H, H2,5-C5H4), 7.39 (dd, 3JH,H = 8.9Hz, 4JH,H
= 2.4Hz, 1H, H3), 7.45–7.53 (m, 2H, C10H7), 7.73–7.75 (m, 1H, H1), 7.82–7.87 (m, 3H,
C10H7). 13C{1H} NMR (CDCl3, δ): 59.76 (d, 3JC,P = 4.1Hz, C2/5-C5H4), 59.77 (d, 3JC,P
= 4.0Hz, C2/5-C5H4), 62.9 (s, C5H4), 69.7 (s, C5H5), 116.5 (d, 3JC,P = 5.0Hz, C1), 117.9
(d, 2JC,P = 5.4Hz, CC5H4-O), 119.8 (d, 3JC,P = 5.0Hz, C3), 125.7 (C10H7), 126.9 (C10H7),
127.6 (C10H7), 127.7 (C10H7), 130.0 (C4), 131.1 (C8a), 133.8 (C4a), 148.0 (d, 2JC,P = 7.4Hz,
C2). 31P{1H} NMR (CDCl3, δ): –16.0. HRMS (ESI-TOF, m/z): calcd for C30H25Fe2O4P
592.0185, found 592.0160 [M]+.
(R)-1,1'-Binaphthyl-2,2'-diyl Ferrocenyl Phosphate (70b)
70b
O
OFe O
P
O
Ferrocenol (5, 235mg, 1.16mmol), BuLi (0.47mL,
1.18mmol) and (R)-1,1'-binaphthyl-2,2'-diyl chlorophos-
phate (427mg, 1.16mmol) were reacted according to the
general procedure GP1. Purification was realized by column
chromatography (silica, 2.5 · 8 cm column size) using a 99/1
dichloromethane/ethyl acetate mixture (v/v) as the eluent
(Rf = 0.26), giving 70b as an orange solid.
Yield: 305mg (0.57mmol, 49% based on 5). Anal. calcd for C30H21FeO4P · 1/3 C6H14
(532.31 · 1/3 86.18 g/mol): C, 68.51; H, 4.61. Found: C, 68.56; H, 4.48. Mp.: 247℃. 1H
NMR (CDCl3, δ): 3.89–3.91 (m, 1H, H3/4-C5H4), 3.93–3.94 (m, 1H, H3/4-C5H4), 4.31 (s,
5H, C5H5), 4.34–4.40 (m, 1H, H2/5-C5H4), 4.54–4.56 (m, 1H, H2/5-C5H4), 7.30–7.41 (m,
4H, C10H8), 7.14–7.52 (m, 3H, C10H8), 7.65 (d, 3JH,H = 8.8Hz, 1H, C10H8), 7.96–7.98 (m,
2H, C10H8), 8.03 (d, 3JH,H = 8.9Hz, 1H, C10H8), 8.07 (d, 3JH,H = 8.9Hz, 1H, C10H8).
13C{1H} NMR (CDCl3, δ): 59.8 (d, JC,P = 4.6Hz, C5H4), 59.9 (d, JC,P = 3.5Hz, C5H4),
62.9 (C5H4), 63.0 (C5H4), 69.8 (C5H5), 117.9 (d, 2JC,P = 5.0Hz, CC5H4-O), 120.2 (d, JC,P
= 3.3Hz, CH), 120.6 (d, JC,P = 2.9Hz, CH), 121.2 (d, 2JC,P = 2.1Hz, qC), 121.5 (d, JC,P
=Hz, qC), 125.89 (CH), 125.92 (CH), 126.9 (CH), 127.0 (CH), 127.2 (CH), 128.45 (CH),
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128.54 (CH), 131.1 (CH), 131.6 (CH), 131.7 (d, JC,P = 0.9Hz, qC), 132.0 (d, JC,P = 1.1Hz,
qC), 132.26 (d, JC,P = 0.8Hz, qC), 132.27 (d, 2JC,P = 1.0Hz, qC), 146.1 (d, 2JC,P = 8.2Hz,
C2/2’), 147.4 (d, 2JC,P = 11.4Hz, C2/2’). 31P{1H} NMR (CDCl3, δ): –2.5. HRMS (ESI-
TOF, m/z): calcd for C30H21FeO4P+Na 555.0419, found 555.0401 [M+Na]+.
1,3-Dioxa-2-((1R)-α-fenchyl)(oxo)phospha-[3]ferrocenophane (72)
72
Fe
O
O
P
O
O
Ferrocenediol (38, 600mg, 2.75mmol), BuLi (2.20mL,
5.50mmol) and (1R)-α-fenchyl dichlorophosphate (749mg,
2.752mmol) were reacted according to the general procedure
GP1. Purification was realized by column chromatography (sil-
ica, 2.5 · 12 cm column size) using a 95/5 dichloromethane/ethyl
acetate (v/v) mixture as the eluent, giving 72 as an orange solid.
Yield: 214mg (0.51mmol, 19% based on 38). Anal. calcd for C20H25FeO4P (416.23 g/mol):
C, 57.71; H, 6.05. Found: C, 58.04; H, 6.35. Mp.: 130–133℃. 1H NMR (CDCl3, δ): 1.01 (s,
3H, CH3), 1.12 (s, 3H, CH3), 1.13–1.17 (m, 1H, H5/6), 1.20 (s, 3H, CH3), 1.22–1.24 (m, 1H,
H7), 1.46–1.52 (m, 1H, H5/6), 1.56 (ddd, 3JH,H = 10.5Hz, JH,H = 3.8Hz, JH,H = 2.2Hz,
1H, H7), 1.74–1.85 (m, 3H, H5/6, H4), 4.01 (ddd, JH,P = 3.9Hz, JH,H = 2.6Hz, JH,H =
1.3Hz, 2H, C5H4), 4.05–4.06 (m, 2H, C5H4), 4.20 (dd, 3JH,P = 8.2Hz, 1H, H2), 4.38 (dtd,
JH,P = 4.4Hz, JH,H = 2.6Hz, JH,H = 1.3Hz, 2H, C5H4), 4.63–4.64 (m, 2H, C5H4). 13C{1H}
NMR (CDCl3, δ): 19.1 (CH3), 20.8 (CH3), 25.83 (C5/6), 25.87 (C5/6), 29.8 (CH3), 39.7 (d,
3JC,P = 2.6Hz, C3), 40.9 (C7), 47.9 (C4), 49.3 (d, 3JC,P = 5.5Hz, C1), 63.30 (C5H4), 63.32
(C5H4), 63.35 (C5H4), 63.36 (C5H4), 66.0 (C5H4), 66.92 (C5H4), 66.93 (C5H4), 93.9 (d, 2JC,P
= 7.7Hz, C2), 109.4 (d, 2JC,P = 10.3Hz, CC5H4-O), 109.5 (d, 2JC,P = 10.4Hz, CC5H4-O).
31P{1H} NMR (CDCl3, δ): 0.3. HRMS (ESI-TOF, m/z): calcd for (C20H25FeO4P)2 + Na
855.1574, found 855.1581 [M2+Na]+.
Synthesis of 70a and 75
Ferrocenediol (38, 150mg, 0.688mmol) was dissolved in 30mL of diethyl ether and the so-
lution was cooled to –30℃. BuLi (0.55mL, 1.375mmol) was dropwise added and stirring
was continued for 10 min at this temperature. Afterwards, the mixture was cooled to –70℃
and POCl3 (0.125mL, 1.376mmol) was added in a single portion. Separately, ferrocenol
(5, 603mg, 2.98mmol) was dissolved in 30mL of diethyl ether, cooled to –30℃ and BuLi
(1.2mL, 3mmol) was dropwise added. Both reaction mixtures were tempered at –30℃ and
the mixture containing 5 was slowly added to the one containing 38 by using a transfer
cannula. The cooling bath was removed and stirring was continued for 18 h, followed by the
removal of all volatiles in vacuum. Purification was realized by column chromatography (sil-
ica, 2 · 15 cm column size) resulting three fractions. Fraction 1 (dichloromethane, Rf = 0.52)
contained P(O)(OFc)3 (47, 330mg, 0.415mmol, 42% based on 5), fraction 2 compound 70a
(95/5 dichloromethane/ethyl acetate (v/v) mixture, Rf = 0.57) and fraction 3 contained 75
(95/5 dichloromethane/ethyl acetate (v/v) mixture, Rf = 0.41)
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1,3-Dioxa-2-(ferrocenyloxy)(oxo)phospha-[3]ferrocenophane (70a)
70a
Fe
O
O
P
OFc
O
The spectroscopic data of this compound are in agreement with those re-
ported in reference [219]. Crystals, suitable for single crystal X-ray diffrac-
tion analysis, were obtained by crystallization from a boiling hexane
solution containing 70a.
Yield: 63mg (0.136mmol, 20% based on 38). 1H NMR (CDCl3, δ):
3.96 (pt, 3,4JH,H = 1.9Hz, 2Hz, C5H4, FcO), 4.07 (pt, 3,4JH,H = 2.0Hz, 4Hz, C5H4, ansa),
4.33 (s, 5H, C5H5), 4.41–4.42 (m, 2H, C5H4, ansa), 4.50 (pt, 3,4JH,H = 1.8Hz, 2Hz, C5H4,
FcO), 4.58–4.59 (m, 2H, C5H4, ansa). 13C{1H} NMR (CDCl3, δ): 59.4 (d, JC,P = 4.4Hz,
C5H4, FcO), 62.8 (d, JC,P = 3.1Hz, C5H4, ansa), 63.0 (s, C5H4, FcO), 63.7 (d, JC,P = 3.4Hz,
C5H4, ansa), 66.8 (s, C5H4, ansa), 69.8 (C5H5), 109.9 (d, 2JC,P = 12.5Hz, C-O, ansa), 118.0
(d, 2JC,P = 6.1Hz, C-O, FcO). 31P{1H} NMR (CDCl3, δ): –5.6. HRMS (ESI-TOF, m/z):
calcd for C20H17Fe2O4P+H 464.9636, found 464.9608 [M+H]+.
(1,1'-Ferrocenediyl)tetraferrocenyl bis(phosphate) (75)
75
Fe
O
P(O)(OFc)2
O
P(O)(OFc)2 Yield: 86mg (0.077mmol, 11% based on 38). Mp.: 167℃. 1H
NMR (CDCl3, δ): 3.93 (pt, 3,4JH,H = 2.0Hz, 8H, FcO), 4.05 (pt,
3,4JH,H = 2.0Hz, 4H, FcO2), 4.28 (s, 20H, C5H5), 4.44 (dd, JH,P
= 4.4Hz, JH,H = 2.1Hz, 8H, FcO), 4.52 (pt, 3,4JH,H = 2.0Hz,
4H, FcO2). 13C{1H} NMR (CDCl3, δ): 59.65 (C5H4, FcO), 59.66
(C5H4, FcO), 59.69, (C5H4, FcO), 59.70 (C5H4, FcO), 61.16 (C5H4,
FcO2), 61.20 (C5H4, FcO2), 62.93 (C5H4, FcO), 62.94 (C5H4, FcO), 65.1 (C5H4, FcO2), 69.7
(C5H5), 117.8 (d, 2JC,P = 5.5Hz, C-O, FcO), 118.1 (d, 2JC,P = 5.4Hz, C-O, FcO2). 31P{1H}
NMR (CDCl3, δ): –15.3. HRMS (ESI-TOF, m/z): calcd for C50H44Fe5O8P2 1113.9260,
found 1113.9205 [M]+.
1,1'-Bis(1,3-dioxa-2-(oxo)phospha-[3]ferrocenophan-2-yloxy)ferrocene (76)
76
Fe
O
O
P Fe
O
O
Fe
O
O
P
O
O
Ferrocenediol (38, 642mg, 2.94mmol) was
split in three portions of 214mg (0.982mmol)
and each of them was dissolved in 10mL of
diethyl ether. The solutions were cooled to
–30℃ and BuLi (0.79mL, 1.96mmol) was
dropwise added. The first portion was cooled
to –70℃, POCl3 (0.18mL, 1.96mmol) was added quickly via syringe and the reaction mixture
was slowly warmed to ambient temperature. After stirring for 10 min at this temperature, the
reaction mixture was cooled again to –70℃ and the second portion of lithiated 1,1'-Fc(OH)2
(38-Li2) was added via a transfer cannula. The same procedure was repeated for the third
fraction of 38-Li2. Afterwards, the mixture was allowed to warm to ambient temperature
and stirred for 18 h. All volatiles were removed in vacuum. Purification was realized using
column chromatography (silica, 2 · 12 cm column size) using a 95/5 dichloromethane/ethyl
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acetate mixture (v/v) as the eluent, giving 76 as an orange solid. The spectroscopic date
are in agreement with those reported in reference [219,220]. Crystals, suitable for single crystal
X-ray diffraction analysis, were obtained by crystallization from a boiling hexane solution
containing 76.
Yield: 94mg (0.127mmol, 12% based on 38). Anal. calcd for C30H24Fe2O8P2 · 1/3 C6H14
(741.99 · 1/3 86.18 g/mol): C, 49.87; H, 3.75. Found: C, 49.65; H, 3.59. Mp.: >230℃
(decomp.). 1H NMR (CDCl3, δ): 4.06–4.07 (m, 8H, ansa), 4.17 (pt, 3,4JH,H = 2.0Hz, 4H,
open), 4.44–4.45 (m, 4H, ansa), 4.56–4.57 (m, 4H, ansa), 4.66 (pt, 3,4JH,H = 1.9Hz, 4H,
open). 13C{1H} NMR (CDCl3, δ): 61.2 (d, JC,P = 4.5Hz, open), 62.9 (d, JC,P = 3.0Hz,
ansa), 63.7 (d, JC,P = 3.6Hz, ansa), 65.2 (open), 66.8 (ansa), 66.9 (ansa), 109.9 (d, 2JC,P =
12.8Hz, CC5H4-O, ansa), 118.3 (d, 2JC,P = 6.0Hz, CC5H4-O, open). 31P{1H} NMR (CDCl3,
δ): –5.6. HRMS (ESI-TOF, m/z): calcd for C30H24Fe3O8P2 +Na 764.8889, found 764.8862
[M+Na]+.
Diferrocenyl (1H -Pyrrol-1-yl)phosphonate (79)
79
Fe O
P N
O
2
Ferrocenol (5, 836mg, 4.14mmol), BuLi (1.7mL, 4.25mmol) and
(1H -pyrrol-1-yl) dichlorophosphonate (380mg, 2.07mmol) were re-
acted according to the general procedure GP1. Purification was
realized by column chromatography (silica, 2.5 · 12 cm column size)
using a 98/2 dichloromethane/ethyl acetate mixture (v/v) as the
eluent, giving 79 as an orange solid.
Yield: 468mg (0.91mmol, 44% based on 5). Anal. calcd for C24H22Fe2NO3P (515.10 g/mol):
C, 55.96; H, 4.30; N, 2.72. Found: C. 55.48; H, 4.48; N, 2.67. Mp.: 184℃. 1H NMR (CDCl3,
δ): 3.87–3.89 (m, 4H, C5H4), 4.21 (s, 10H, C5H5), 4.27–4.28 (m, 2H, C5H4), 4.30–4.31 (m,
2H, C5H4), 6.40 (ddd, 4JH,P = 4.7Hz, JH,H = 2.2Hz, JH,H = 2.2Hz, 2H, C3/4), 7.09 (ddd,
JH,H = 2.2Hz, JH,H = 2.2Hz, 3JH,P = 2.2Hz, 2H, C2/5). 13C{1H} NMR (CDCl3, δ): 59.4
(d, JC,P = 3.9Hz, C5H4), 59.6 (d, JC,P = 4.6Hz, C5H4), 62.96 (C5H4), 63.00 (C5H4), 69.7
(C5H5), 113.3 (d, 3JC,P = 11.5Hz, C3/4), 117.3 (d, 2JC,P = 4.5Hz, CC5H4-O), 122.8 (d,
2JC,P = 6.5Hz, C2/5). 31P{1H} NMR (CDCl3, δ): –11.5. HRMS (ESI-TOF, m/z): calcd
for C24H22Fe2NO3P 515.0031, found 515.0014 [M]+.
Diferrocenyl (1H -Indol-1-yl)phosphonate (80)
80
Fe O
P N
O
2
Ferrocenol (5, 836mg, 4.14mmol), BuLi (1.7mL, 4.25mmol)
and (1H -indol-1-yl) dichlorophosphonate (484mg, 2.07mmol)
were reacted according to the general procedure GP1. Purifica-
tion was realized by column chromatography (silica, 2.5 · 12 cm
column size) using a 98/2 dichloromethane/ethyl acetate (v/v)
mixture as the eluent, giving 80 as an orange solid. Crystals,
suitable for single crystal X-ray diffraction analysis, were obtained by crystallization from a
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boiling hexane solution containing 80.
Yield: 945mg (1.67mmol, 81% based on 5). Anal. calcd for C28H24Fe2NO3P (565.16 g/mol):
C, 59.51; H, 4.28; N, 2.48. Found: C, 59.51; H, 4.30; N, 2.60. Mp.: ∼ 25℃. 1H NMR (CDCl3,
δ): 3.82 (ddd, JH,P = 2.7Hz, JH,H = 2.7Hz, JH,H = 1.5Hz, 2H, C5H4), 3.85 (ddd, JH,P =
2.7Hz, JH,H = 2.7Hz, JH,H = 1.5Hz, 2H, C5H4), 4.13 (s, 10H, C5H5), 4.15–4.16 (m, 2H,
C5H4), 4.34–4.35 (m, 2H, C5H4), 6.72 (ddd, 4JH,P = 3.6Hz, 3JH,H = 2.7Hz, 4JH,H = 1.5Hz,
1H, H3), 7.29 (ddd, 8JH,H = 8.1Hz, 8JH,H = 7.2Hz, JH,H = 1.0Hz, 1H, H5/6), 7.39 (ddd,
3JH,H = 8.4Hz, 3JH,H = 7.2Hz, JH,H = 1.2Hz, 1H, H5/6), 7.46 (dd, 3JH,H = 3.5Hz, 3JH,P
= 2.1Hz, 1H, H2), 7.64–7.66 (m, 1H, H4), 7.87 (d, JH,H = 8.3Hz, 1H, C7). 13C{1H} NMR
(CDCl3, δ): 59.3 (d, JC,P = 3.8Hz, C5H4), 59.6 (d, JC,P = 4.5Hz, C5H4), 62.95 (C5H4),
62.98 (C5H4), 69.6 (C5H5), 108.3 (d, 3JC,P = 9.2Hz, C3), 113.9 (C7), 117. 2 (d, 2JC,P =
4.0Hz, CC5H4-O), 121.3 (C4), 122.7 (C5/6), 123.9 (C5/6), 128.5 (d, 2JC,P = 7.4Hz, C2),
131.1 (d, 3JC,P = 10.9Hz, C3a), 136.9 (d, 2JC,P = 5.0Hz, C7a). 31P{1H} NMR (CDCl3, δ):
–11.6. HRMS (ESI-TOF, m/z): calcd for C28H24Fe2NO3P + Na 588.0086, found 588.0102
[M+Na]+.
Diferrocenyl (9H -Carbazol-9-yl)phosphonate (81)
81
Fe O
P N
O
2
Ferrocenol (5, 835mg, 4.13mmol), BuLi (1.8mL, 4.5mmol) and
(9H -carbazol-9-yl) dichlorophosphate (580mg, 2.04mmol) were
reacted according to the general procedure GP1. Purification
was realized by column chromatography (silica, 3.5 · 8 cm col-
umn size) using dichloromethane as the eluent, giving 81 as an
orange solid. Crystals, suitable for single crystal X-ray diffrac-
tion analysis, were obtained by crystallization from a boiling hexane solution containing 81.
Yield: 340mg (0.553mmol, 27% based on 5). Anal. calcd for C32H26Fe2NO3P
(615.22 g/mol): C, 62.47; H, 4.26; N, 2.28. Found: C, 62.69; H, 4.40; N, 2.29. Mp.: 160℃.
1H NMR (CDCl3, δ): 3.76 (ddd, JH,H = 2.7Hz, JH,P = 2.7Hz, JH,H = 1.4Hz, 2H, C5H4),
3.81 (ddd, JH,H = 2.7Hz, JH,P = 2.7Hz, JH,H = 1.4Hz, 2H, C5H4), 4.07 (s, 10H, C5H5),
4.12–4.14 (m, 2H, C5H4), 4.35–4.36 (m, 2H, C5H4), 7.40 (ddd, 3JH,H = 7.9Hz, 3JH,H =
7.3Hz, JH,H = 0.9Hz, 2H, C12H8N), 7.53 (ddd, 3JH,H = 8.5Hz, 3JH,H = 7.2Hz, JH,H =
1.3Hz, 2H, C12H8N), 8.04–8.06 (m, 2H, C12H8N), 8.17 (d, 3JH,H = 8.4Hz, 2H, C12H8N).
13C{1H} NMR (CDCl3, δ): 59.3 (d, JC,P = 4.1Hz, C5H4), 59.5 (d, JC,P = 4.8Hz, C5H4),
62.89 (C5H4), 62.94 (C5H4), 69.5 (C5H5), 114.9 (C1, C8), 117.2 (d, 2JC,P = 3.9Hz, CC5H4-
O), 120.1, 122.8, 126.2 (d, JC,P = 9.2Hz, C4a, C4b), 127.0, 140.15 (d, JC,P = 6.6Hz, C8a,
C9a). 31P{1H} NMR (CDCl3, δ): –11.8. HRMS (ESI-TOF, m/z): calcd for C32H26Fe2NO3P
615.0345, found 615.0332 [M]+.
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4.3.2 Compounds derived from Anionic Phospho-Fries Rearrangements
General Procedure for Anionic Phospho-Fries Rearrangements - Using LDA in
THF GP2
In a Schlenk tube, tetrahydrofuran (3mL) and diisopropylamine (0.05mL, 0.36mmol) were
cooled to –30℃. Afterwards, BuLi (0.15mL, 0.38mmol) was dropwise added. The mixture
was stirred for 10 min at –30℃ and the desired reaction temperature was adjusted followed
by the addition of the corresponding ferrocenyl phosphates. The obtained reaction mixture
was stirred for the appropriate time followed by the addition of a methylation agent and
stirring at 50℃ for 1 h to complete methylation. All volatiles were removed under reduced
pressure. Purification was realized using column chromatography on silica using different
solvent mixtures as eluents (see below).
General Procedure for Anionic Phospho-Fries Rearrangements - Using LDA in
Hexane GP3
In a Schlenk tube, hexane (3mL) and diisopropylamine (0.05mL, 0.36mmol) were cooled
to –30℃. Afterwards, BuLi (0.15mL, 0.38mmol) was dropwise added followed by addition
of a diamine (tetramethylethylenediamine: 0.05mL, 0.33mmol or (−)-Sparteine (0.08mL,
0.35mmol)). The mixture was stirred for 10 min at –30℃ and the corresponding ferrocenyl
phosphates were added in a single portion. The obtained reaction mixture was allowed
to warm to ambient temperature and stirring was continued overnight. The reaction was
quenched by adding dimethyl sulfate (0.15mL, 1.58mmol) and stirred at 50℃ for 1 h to
complete methylation. All volatiles were removed under reduced pressure. Purification was
realized using column chromatography on silica using a 98/2 dichloromethane/ethyl acetate
mixtures as eluent (see below).
General Procedure for Anionic Phospho-Fries Rearrangements - Using LiTMP
GP4
In a Schlenk, tube LiTMP (56mg, 0.38mmol) was suspended in 3mL of hexane and cooled
to –30℃. The addition of the diamine, the respective ferrocenyl phosphate as well as the
reaction conditions and workup procedures were realized as described in procedure GP3.
Diethyl (2-Methoxyferrocenyl)phosphonate (rac-16)
16
Fe O(EtO)2P
O Diisopropylamine (1.25mL, 8.9mmol), BuLi (3.6mL, 9.0mmol) and
phosphate 6 (1.5 g, 4.4mmol) were reacted in 20mL between –30℃
and –15℃ according to the general procedure GP2 followed by the
addition of Me2SO4 (1.3mL, 13.7mmol). Purification was realized by
column chromatography (alumina, 2 · 8 cm column size) using ethyl
acetate as the eluent, giving rac-16 as an orange oil.
Yield: 1.46 g (4.14mmol, 94% based on 6). IR data (NaCl, v˜/cm−1): 3095 m, 2980 s, 2931
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w, 2905 w, 2865 w, 1639 m, 1482 s, 1412 s, 1388 w, 1340 m, 1254 s, 1168 m, 1106 s, 1051
s, 1029 s, 964 s, 801 s, 753 m. 1H NMR (C6D6, δ): 1.11 (t, 3JH,H = 7.1Hz, 3H, CH3),
1.17 (t, 3JH,H = 7.1Hz, 3H, CH3), 3.25 (s, 3H, OCH3), 3.71 (dd, 3JH,H = 2.7Hz, 1H,
m-OCH3), 3.76 (m, 1H, o-OCH3), 4.07 (m, 2H, CH2), 4.15 (m, 2H, CH2), 4.30 (s, 5H,
C5H5), 4.36 (m, 1H, o-P(O)). 13C{1H} NMR (C6D6, δ): 16.6 (m, CH3), 55.4 (d, 3JC,P =
11Hz, o-OCH3), 57.8 (s, OCH3), 59.2 (d, 1JC,P = 213.7Hz, C-P), 61.6 (m, CH2), 63.8 (d,
3JC,P = 13.7Hz, m-OCH3), 67.7 (d, 2JC,P = 12.8Hz, o-P(O)), 70.4 (s, C5H5), 129.0 (d,
2JC,P = 10.3Hz, C-OCH3). 13C{1H} NMR (C6D6, δ): 36.4. HRMS (ESI-TOF, m/z): calcd
for C15H21FeO4P 352.0521, found 352.0602 [M]+. HPLC (Chiralcel OD-H, flow rate 0.5mL
min−1, 9/1 hexane/2-propanol): 19.6, 20.6.
Diethyl (2-Methoxyferrocenyl)thiaphosphonate (rac-17)
17
Fe O(EtO)2P
S Instead of LDA, sBuLi (0.65mL, 0.85mmol) and diethyl ferro-
cenyl thiophosphate 7 (250mg, 0.71mmol) were reacted in 10mL of
tetrahydrofuran between –30℃ and –20℃ according to the general
procedure GP2. Iodomethane (0.1mL, 1.6mmol) was added in a sin-
gle portion as the methylation agent. Additional stirring for 18 h and
removal of all volatiles afforded a residue which was purified by col-
umn chromatography (silica, 3.5 · 6.2 cm column size). First, unreacted 7 (46%) was eluted
with a 3/1 (v/v) toluene/hexane mixture. Afterwards, the eluent was changed to pure toluene
and the product rac-17 (Rf = 0.35) was obtained as an orange oil.
Yield: 130mg (0.35mmol, 49% based on 7). 1H NMR (CDCl3, δ): 1.30 (t, 3JH,H = 7.1Hz,
3H, CH3), 1.39 (t, 3JH,H = 7.1Hz, 3H, CH3), 3.70 (s, 3H, OCH3), 4.03 (q, JH,H = 2.8Hz,
1H, C5H3), 4.09–4.37 (m, 11H, CH2, C5H5, C5H3). 13C{1H} NMR (CDCl3, δ): 16.1 (d,
3JC,P = 7.9Hz, CH3), 16.2 (d, 3JC,P = 7.9Hz, CH3), 55.3 (d, JC,P = 10.1Hz, C5H3), 58.2
(s, OCH3), 62.1 (d, 3JC,P = 6.4Hz, CH2), 62.6 (d, 3JC,P = 5.7Hz, CH2), 63.4 (d, JC,P =
14.1Hz, C5H3), 64.6 (d, 1JC,P = 174.6Hz, γ-C5H3), 67.7 (d, JC,P = 15.7Hz, C5H3), 70.2
(s, C5H5), 127.7 (d, 2JC,P = 9.0Hz, C-OCH3). 31P{1H} NMR (CDCl3, δ): 89.6. HRMS
(ESI-TOF, m/z): calcd for C15H21FeO3PS 368.0293, found 368.0310 [M]+.
Diethyl (2-Methoxyferrocenyl)phosphonite·BH3 (rac-18)
18
Fe O(EtO)2P
H3B LDA was prepared by treating diisopropylamine (0.42mL, 2.98mmol)
with BuLi (1.20mL, 3.0mmol) in tetrahydrofuran (10mL) at –60℃.
After stirring for 10 min 8 (500mg, 1.49mmol) was added as a solu-
tion in tetrahydrofuran (2mL) with a syringe in a single portion. The
solution was stirred for 4 h between –30℃ and –20℃, while the solu-
tion turned dark. The reaction was stopped by adding iodomethane
(0.30mL, 4.8mmol) in a single portion. Purification was realized by column chromatography
(silica, 2 · 16 cm column size) using a 2/1 (v/v) hexane/toluene mixture as the eluent, giving
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first unreacted 8 (31%) and second rac-18 as an orange oil after removal of all volatiles.
Yield: 190mg (0.55mmol, 37% based on 8). 1H NMR (CDCl3, δ): 1.29 (t, 3JH,H = 7.1Hz,
3H, CH3), 1.33 (t, 3JH,H = 7.1Hz, 3H, CH3), 3.69 (s, 3H, OCH3), 3.99–4.07 (m, 2H, CH2),
4.08–4.10 (m, 1H, C5H3), 4.11–4.16 (m, 2H, CH2), 4.23–4.24 (m, 1H, C5H3), 4.26–4.27 (m,
1H, C5H3), 4.32 (s, 5H, C5H5). 13C{1H} NMR (CDCl3, δ): 16.5 (d, 3JC,P = 5.8Hz, CH3),
55.3 (d, JC,P = 6.5Hz, C5H3), 58.2 (s, OCH3), 60.1 (d, 1JC,P = 90.1Hz, C-P), 62.6 (d,
2JC,P = 5.5Hz, CH2), 62.8 (d, 2JC,P = 4.9Hz, CH2), 64.2 (d, JC,P = 10.0Hz, C5H3), 70.2
(s, C5H5), 128.7 (d, 2JC,P = 6.2Hz, C-OCH3). 11B{1H} NMR (C6D6, δ): -40.8 (d, 1JB,P
= 89Hz). 31P{1H} NMR (CDCl3, δ): 135.4 (q, 1JB,P = 89Hz). HRMS (ESI-TOF, m/z):
calcd for C15H24BFeO3P+H 350.0903, found 350.0856 [M+H]+.
Ferrocenyl Bis(2-hydroxyphenyl)phosphinate (19)
19
Fe O
P
O OH
2
LDA was prepared by treating diisopropylamine (0.98mL,
7.07mmol) with BuLi (2.75mL, 6.90mmol) in tetrahydrofuran
(10mL) at –60℃. After stirring for 10 min 11 (500mg, 1.15mmol)
was added in a single portion. The solution was stirred for 5 h
between –60℃ and –40℃, while the solution turned dark. The
reaction was stopped by adding iodomethane (0.43mL, 1.6mmol)
in a single portion. The reaction mixture was allowed to warm to room temperature. Pu-
rification was realized by column chromatography (silica, 3 · 18 cm column size) using a 3/1
(v/v) CH2Cl2/ethyl acetate mixture as the eluent, giving 19 as an orange oil.
Yield: 40mg (0.10mmol, 8% based on 11). 1H NMR (CDCl3, δ): 3.85 (pt, 3,4JH,H = 1.9Hz,
2H, C5H4), 4.22 (s, 5H, C5H5), 4.29 (pt, 3,4JH,H = = 1.9Hz, 2H, C5H4), 6.92–6.98 (m, 4H,
Ph), 7.42–7.47 (m, 3H, Ph), 7.48 (dd, JH,H = 7.8Hz, JH,H = 1.6Hz, 1H, Ph), 9.86 (s, 2H,
OH). 13C{1H} NMR (CDCl3, δ): 60.0 (d, JC,P = 3.9Hz, C5H4), 63.1 (s, C5H4), 69.7 (C5H5),
111.1 (d, 1JC,P = 139.9Hz, Ph-P), 117.1 (d, 2JC,P = 6.9Hz, CC5H4-O), 118.6 (d, JC,P =
9.4Hz), 119.9 (d, JC,P = 12.8Hz), 131.6 (d, JC,P = 8.0Hz), 135.6 (d, JC,P = 1.8Hz), 162.1
(d, 2JC,P = 5.9Hz, C-OH). 31P{1H} NMR (CDCl3, δ): 42.3. HRMS (ESI-TOF, m/z): calcd
for C22H19FeO4P 434.0365, found 434.0364 [M]+.
(2-Methoxyferrocenyl)diphenylphosphine Oxide (rac-20)
20
Fe OPh2P
O LDA was prepared by treating diisopropylamine (0.33mL, 2.35mmol)
with BuLi (0.92mL, 2.30mmol) in tetrahydrofuran (10mL) at –60℃.
After stirring for 10 min 9 (500mg, 1.24mmol) was added in a single
portion. The solution was stirred for 4 h between –30℃ and –20℃,
while the reaction solution turned dark. The reaction was stopped by
adding iodomethane (0.30mL, 4.8mmol) in a single portion. Purification
was realized by column chromatography (silica, 3 · 14 cm column size) using a 2/1 (v/v)
CH2Cl2/ethyl acetate mixture as the eluent, giving rac-20 as an orange oil.
Yield: 45mg (0.10mmol, 8% based on 9). 1H NMR (CDCl3, δ): 3.58 (s, 3H, OCH3),
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4.03–4.05 (m, 1H, C5H3), 4.08 (dd, JH,P = 4.6Hz, JH,H = 2.4Hz, 1H, C5H3), 4.20 (s,
5H, C5H5), 4.28 (dd, 3.6Hz, JH,H = 1.9Hz, 1H, C5H3), 7.40 (td, JH,H = 7.4Hz, 4JH,H
= 2.7Hz, 2H, Ph), 7.42–7.53 (m, 4H, Ph), 7.63–7.68 (m, 2H, Ph), 7.84–7.90 (m, 2H, Ph).
13C{1H} NMR (CDCl3, δ): 55.5 (d, JC,P = 8.0Hz, C5H3), 58.1 (s, OCH3), 62.4 (d, 1JC,P =
116.1Hz, C5H3-P), 63.9 (d, JC,P = 10.8Hz, C5H3), 68.3 (d, JC,P = 11.0Hz, C5H3), 69.8 (s,
C5H5), 127.9–128.1 (m, Ph), 128.4–128.6 (m, C-OCH3), 131.3–131.4 (m, Ph), 131.9 (d, JC,P
= 10.0Hz, Ph), 133.6–135.0 (m, P-Ph). 31P{1H} NMR (CDCl3, δ): 28.3. HRMS (ESI-TOF,
m/z): calcd for C23H21FePO2 416.0623, found 416.0658 [M]+.
sButyldiphenylphosphine Sulfide (23)
23
S
PPh2
Ferrocenyl diphenylthiaphosphinate (10, 620mg, 1.48mmol) was dissolved in
tetrahydrofuran (10mL) and cooled to –60℃. After dropwise addition of sBuLi
(1.80mL, 2.37mmol) the reaction was stirred for 4 h at –40℃ and subsequently
stopped by adding iodomethane (0.15mL, 2.37mmol) in a single portion. Purifi-
cation was realized by column chromatography (silica, 3.5 · 11 cm column size).
Ferrocenyl methyl ether (22, 86%) was eluted using a 1/1 (v/v) hexane/toluene
mixture followed by 23 using toluene.
Yield: 280mg (1.01mmol, 68% based on 10). Anal. calcd for C16H19PS (274.36 g/mol): C,
70.04; H, 6.98. Found: C, 70.15; H, 6.93. Mp.: 93℃. 1H NMR (CDCl3, δ): 0.97 (t, 3JH,H
= 7.4Hz, 3H, CH2-CH 3), 1.15 (dq, 2JH,P = 19.4Hz, 3JH,H = 6.8Hz, 3H, Ch-CH 3), 1.43–
1.67 (m, 2H, CH2), 2.56–2.66 (m, 1H, CH), 7.41–7.51 (m, 6H, m,p-Ph), 7.89–7.97 (m, 4H,
o-Ph). 13C{1H} NMR (CDCl3, δ): 12.0 (s, CH-CH3), 12.1 (d, 3JC,P = 15.2Hz, CH2-CH3),
22.6 (s, CH2), 34.8 (d, 1JC,P = 55.7Hz, CH), 128.4–128.6 (m, m-Ph), 131.18–131.25 (m,
p-Ph), 131.3–131.4 (m, o-Ph), 131.9 (d, 1JC,P = 76.4Hz, Ph-P), 132.1 (d, 1JC,P = 76.3Hz,
Ph-P). 31P{1H} NMR (CDCl3, δ): 52.8. HRMS (ESI-TOF, m/z): calcd for C16H19PS + H
275.1018, found 275.1005 [M+H]+.
2-(Diethoxyphosphoryl)ferrocenyl Diethyl Phosphate (rac-32)
32
Fe O
P(OEt)2(EtO)2P
O O
LDA was prepared by treating diisopropylamine (0.5mL,
3.6mmol) with BuLi (1.45mL, 3.6mmol) in tetrahydrofuran
(20mL) at –60℃. After stirring for 10 min at this tempera-
ture phosphate 6 (600mg, 1.8mmol) was dropwise added. The
solution was stirred for 4 h between –30℃ and –15℃, while the
color changed from orange to red. The reaction was stopped by
adding diethyl chlorophosphate (0.75mL, 5.2mmol) in a single
portion. The reaction mixture was allowed to warm to ambient temperature. Purification
was realized by column chromatography (silica, 3 · 8 cm column size) using a 9/1 (v/v) ethyl
acetate/methanol mixture as the eluent, giving 32 as an orange oil.
Yield: 290mg (0.6mmol, 33% based on 6). 1H NMR (CDCl3, δ): 1.33 (td, 3JH,H = 7.1Hz,
4JH,P = 0.9Hz, 3H, CH3), 1.34 (t, 3JH,H = 7.0Hz, 3H, CH3), 1.38 (t, 3JH,H = 7.1Hz,
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3H, CH3), 1.43 (td, 3JH,H = 7.1Hz, 4JH,P = 1.1Hz, 3H, CH3), 4.09–4.33 (m, 10H, CH2,
C5H3), 4.39 (s, 5H, C5H5), 4.79 (ddd, JH,P = 2.3Hz, JH,H = 2.3Hz, JH,H = 1.5Hz, 2H
C5H3). 13C{1H} NMR (CDCl3, δ): 15.8–16.0 (m, CH3), 16.2–16.3 (m, CH3), 58.1 (dd, 1JC,P
= 208.7Hz, 3JC,P = 7.1Hz, C-P), 61.6 (d, 2JC,P = 5.7Hz, CH2), 61.8 (d, 2JC,P = 5.7Hz,
CH2), 62.3 (d, JC,P = 10.2Hz, C5H3), 64.4 (d, 2JC,P = 6.4Hz, CH2), 64.5 (d, 2JC,P = 6.4Hz,
CH2), 65.0 (d, JC,P = 13.7Hz, C5H3), 67.2 (d, JC,P = C5H3), 71.1 (s, C5H5), 118.3 (dd,
2JC,P = 9.1Hz, 2JC,P = 4.5Hz, C-O).31P{1H} NMR (CDCl3, δ): –6.1 (s, O–P(O)(OEt)2),
22.2 (C–P(O)(OEt)2). HRMS (ESI-TOF, m/z): calcd for C18H28FeO7P2 497.0552, found
497.0635 [M]+.
1,3-Bis(O,O'-diethylphosphonato)-2-methoxyferrocene (33)
33
Fe O(EtO)2P
O
O
P(OEt)2
LDA was prepared by treating diisopropylamine (0.11mL,
0.78mmol) with BuLi (0.31mL, 0.75mmol) in tetrahydrofuran
(10mL) at –60℃. After stirring for 10 minutes at this tempera-
ture 32 (183mg, 0.39mmol) was added in a single portion. The
solution was stirred for 4 h between –30℃ and –20℃, while
the solution turned dark. The reaction was stopped by adding
iodomethane (0.1mL, 1.6mmol) in a single portion. Purifica-
tion was realized by column chromatography (silica, 2 · 15 cm column size) using a 9/1 (v/v)
ethyl acetate/methanol mixture as the eluent, giving 33 as an orange oil.
Yield: 40mg (0.08mmol, 21% based on 32). 1H NMR (CDCl3, δ): 1.35 (t, 3JH,H = 7.0Hz,
3H, CH3), 1.38 (t, 3JH,H = 7.0Hz, 3H, CH3), 3.89 (s, 3H, OCH3), 4.13–4.26 (m, 8H, CH2),
4.43 (t, H,PJ2 =.55Hz, 2H, C5H2), 4.49 (s, 5H, C5H5). 13C{1H} NMR (CDCl3, δ): 16.4–
16.5 (m, CH3), 62.1 (t, 2JC,P = 5.5Hz, CH2), 63.1 (dd, 1JC,P = 211.9Hz, 3JC,P = 10.7Hz,
C-P), 64.0 (s, OCH3), 69.4 (t, 2JC,P = 13.6Hz, C5H2), 128.7 (t, 2JC,P = 63.2Hz, C-OCH3).
31P{1H} NMR (CDCl3, δ): 22.1. HRMS (ESI-TOF, m/z): calcd for C19H30P2O7 + Na
511.0709, found 511.0747 [M+Na]+.
Dicyclohexyl (2-Methoxyferrocenyl)phosphonate (31a)
31a
Fe OP
O
O
2
Ferrocenyl dicyclohexyl phosphate (30a, 100mg, 0.224mmol)
was reacted as described in the general procedure GP3. Com-
pound 31a was obtained as an orange oil.
Yield: 100mg (0.217mmol, 97% based on 30a). 1H NMR
(CDCl3, δ): 1.26–1.38 (m, 6H, CH2), 1.17–1.62 (m, 6H, CH2),
1.72–1.80 (m, 4H, CH2), 1.87–1.98 (m, 4H, CH2), 3.68 (s, 3H,
OCH3), 3.98–3.99 (m, 1H, C5H3), 4.16–4.17 (m, 1H, C5H3), 4.21–4.22 (m, 1H, C5H3), 4.31
(s, 5H, C5H5), 4.47–4.55 (m, 2H, H1). 13C{1H} NMR (CDCl3, δ): 23.57 (CH2), 23.59 (CH2),
25.35 (CH2), 25.36 (CH2), 33.6 (d, 2JC,P = 4.7Hz, CH2), 33.7 (d, 2JC,P = 3.2Hz, CH2), 33.8
(d, 2JC,P = 3.8Hz, CH2), 33.9 (d, 2JC,P = 3.2Hz, CH2), 55.0 (d, JC,P = 11.4Hz, C5H3),
58.0 (OCH3), 59.1 (d, 1JC,P = 216.6Hz, C-P), 63.4 (d, JC,P = 14.0Hz, C5H3), 67.1 (d, JC,P
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= 12.8Hz, C5H3), 69.9 (C5H5), 74.76 (d, 2JC,P = 6.5Hz, C1), 74.82 (d, 2JC,P = 7.2Hz, C1),
128.4 (d, 2JC,P = 10.4Hz, CC5H3-O). 31P{1H} NMR (CDCl3, δ): 21.2 (1JP,C = 216.8Hz).
HRMS (ESI-TOF, m/z): calcd for C23H33FeO4P+H 461.1539, found 461.1530 [M+H]+.
Di-(1R)-menthyl (2-Methoxyferrocenyl)phosphonate (31b)
31b
FeP
2
O
O O
Ferrocenyl di-(1R)-menthylphosphate (30b, 100mg,
0.18mmol) was reacted as described in procedure GP3.
Compound 31b was obtained as orange oil.
Yield: 101mg (0.18mmol, 99% based on 30b). Mixture
of two diastereomers. 1H NMR (CDCl3, δ): 0.41–1.06 (m,
22H), 1.12–1.50 (m, 6H), 1.57–1.71 (m, 4H), 2.02–2.48 (m,
4H), 3.62–3.68 (m, 3H, OCH3), 3.92–4.32 (m, 10H). 13C{1H}
NMR (CDCl3, δ): 15.4–15.8 (m, CH3), 21.1–21.3 (m, CH3), 22.01–22.04 (m, CH3), 22.5–22.7
(m, CH2), 24.6–25.4 (m, CH), 31.4–31.5 (m, CH), 34.1–34.2 (m, CH2), 43.2–43.5 (m, CH2),
48.7–49.1 (m, CH), 54.6–54.8 (m, C5H3), 57.4 (OCH3), 57.5 (d, 1JC,P = 216.9Hz, C-P), 57.9
(OCH3), 58.5 (d, 1JC,P = 216.4Hz, C-P), 63.4 (d, JC,P = 14.5Hz, C5H3), 66.7 (d, JC,P =
11.8Hz, C5H3), 68.1 (d, JC,P = 14.4Hz, C5H3), 69.93 (C5H5), 69.96 (C5H5), 76.4 (d, 2JC,P
= 6.3Hz, C1), 76.6 (d, 2JC,P = 6.6Hz, C1), 76.7 (d, 2JC,P = 6.8Hz, C1), 76.9 (d, 2JC,P =
7.6Hz, C1), 127.9 (d, 2JC,P = 9.0Hz, CC5H3-O), 129.0 (d, 2JC,P = 10.9Hz, C5H3). 31P{1H}
NMR (CDCl3, δ): 20.6, 21.8. HRMS (ESI-TOF, m/z): calcd for C31H49FeO4P 572.2713,
found 572.2733 [M]+.
Di-(1S)-menthyl (2-Methoxyferrocenyl)phosphonate (31c)
31c
FeP
2
O
O O
Ferrocenyl di-(1S)-menthyl phosphate (30c, 100mg,
0.18mmol) was reacted as described in procedure GP3.
Compound 31c was obtained as an orange oil and a mixture
of two diastereomers.
Yield: 101mg (0.18mmol, 99% based on 30c). 1H NMR
(CDCl3, δ): 0.41–0.57 (m, 3H, CH3), 0.78–0.94 (m, 19H,
CH2, CH3), 0.98–1.49 (m, 6H, CH2, CH), 1.55–1.68 (m, 4H,
CH2, CH), 2.00–2.49 (m, 4H, CH2, CH), 3.61–3.67 (3H, OCH3), 3.96–4.30 (m, 10H, C5H5,
C5H3, H1). 13C{1H} NMR (CDCl3, δ): 15.4–15.8 (CH3), 20.9–21.3 (CH3), 21.98 (CH3),
22.02 (CH3), 22.6–22.8 (CH2), 24.6 (CH), 25.1 (CH), 25.4 (CH), 31.4–31.5 (CH), 34.1–34.2
(CH2), 43.2–43.5 (m, C6), 48.7 (d, 3JC,P = 7.4Hz, C2), 48.8 (d, 3JC,P = 7.4Hz, C2), 48.9
(d, 3JC,P = 6.4Hz, C2), 49.1 (d, 3JC,P = 7.4Hz, C2), 54.7–54.9 (m, C5H3), 57.4 (OCH3),
57.6 (d, 1JC,P = 216.7Hz, C-P), 57.9 (OCH3), 58.6 (d, 1JC,P = 216.6Hz, C-P), 63.4 (d, JC,P
= 13.6Hz, C5H3), 66.7 (d, JC,P = 12.0Hz, C5H3), 68.0 (d, JC,P = 14.2Hz, C5H3), 69.92
(C5H5), 69.94 (C5H5), 76.4 (d, 2JC,P = 6.3Hz, C1), 76.6 (d, 2JC,P = 6.6Hz, C1), 76.7 (d,
2JC,P = 6.9Hz, C1), 76.9 (d, 2JC,P = 7.6Hz, C1), 127.9 (d, 2JC,P = 9.1Hz, CC5H3-O), 129.0
(d, 2JC,P = 10.9Hz, CC5H3-O). 31P{1H} NMR (CDCl3, δ): 20.6 (1JP,C = 216.4Hz), 21.8
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(1JP,C = 216.9Hz).
Di-(1S)-borneyl (2-Methoxyferrocenyl)phosphonate (31d)
31d
Fe OPO
O
2
Di-(1S)-borneyl ferrocenyl phosphate (30d, 100mg,
0.18mmol) was reacted as described in procedure GP3.
Compound 31d was obtained as an orange oil and a mixture
of two diastereomers.
Yield: 102mg (0.18mmol, 99% based on 30d). 1H NMR
(CDCl3, δ): 0.79–0.93 (m, 18H, CH3), 1.20–1.32 (m, 6H,
CH2), 1.60–1.67 (m, 2H, H4), 1.69–1.78 (m, 2H, CH2), 1.99–
2.13 (m, 2H, CH2), 2.17–2.36 (m, 2H, CH2), 3.65–3.66 (m, 3H, OCH3), 3.98–4.00 (m, 1H,
C5H3), 4.15–4.17 (m, 1H, C5H3), 4.20–4.24 (m, 1H, C5H3), 4.32 (s, 5H, C5H5), 4.59–4.73
(m, 2H, H2). 13C{1H} NMR (CDCl3, δ): 13.2–13.4 (CH3), 18.80–18.82 (m, CH3), 19.90–
19.93 (CH3), 26.5–26.9 (C5/C6), 28.08–28.15 (C5/C6), 37.1–37.8 (m, C3), 44.86–44.93 (C4),
47.4–47.5 (C7), 49.6–49.7 (C1), 54.7–54.9 (m, C5H3), 57.7 (OCH3), 57.9 (OCH3), 58.3 (d,
1JC,P = 218.1Hz, C-P), 58.7 (d, 1JC,P = 217.9Hz, C-P), 63.41 (d, JC,P = 14.2Hz, C5H3),
63.44 (d, JC,P = 13.9Hz, C5H3), 66.95 (d, JC,P = 12.8Hz, C5H3), 67.03 (d, JC,P = 13.2Hz,
C5H3), 69.8 (C5H5), 69.9 (C5H5), 81.24 (d, 2JC,P = 6.9Hz, C2), 81.27 (d, 2JC,P = 6.1Hz,
C2), 81.5 (d, 2JC,P = 7.1Hz, C2), 81.7 (d, 2JC,P = 6.4Hz, C2), 128.4 (d, 2JC,P = 9.9Hz,
CC5H3-O), 128.6 (d, 2JC,P = 10.3Hz, CC5H3-O). 31P{1H} NMR (CDCl3, δ): 22.9, 23.2.
HRMS (ESI-TOF, m/z): calcd for C31H45FeO4P 568.2400, found 568.2414 [M]+.
(Rp)-Di-(1R)-α-fenchyl (2-Methoxyferrocenyl)phosphonate (31e)
31e
FeO
O
P
O
2
Ferrocenyl di-(1R)-α-fenchyl phosphate (30e) (100mg,
0.18mmol) was reacted as described in procedure GP4. Com-
pound 31e was obtained as an orange solid. The spectroscopic
data correspond to the single diastereomer, which is obtained
after crystallization (0.80 de).
Yield: 90mg (0.16mmol, 88% based on 30e). Mp.: 186–
188℃. 1H NMR (CDCl3, δ): 0.87 (s, 3H, CH3), 0.88 (s, 3H, CH3), 0.92 (s, 3H, CH3),
0.96–1.06 (m, 5H), 1.10–1.18 (m, 8H), 1.39–1.52 (m, 4H), 1.64–1.87 (m, 6H), 3.68 (s, 3H,
OCH3), 3.99–4.06 (m, 3H, H2, C5H3), 4.14–4.18 (m, 1H, C5H3), 4.19–4.23 (m, 1H, C5H3),
4.35 (s, 5H, C5H5). 13C{1H} NMR (CDCl3, δ): 19.2 (CH3), 19.6 (CH3), 21.1 (CH3), 21.4
(CH3), 25.8–26.2 (m, C5/C6), 29.7 (CH3), 29.8 (CH3), 39.1 (d, 3JC,P = 2.2Hz, C7), 39.7
(d, 3JC,P = 2.2Hz, C7), 41.07 (CH2), 41.09 (CH2), 48.0 (C4), 48.1 (C4), 49.25 (d, 3JC,P =
4.8Hz, C1), 49.34 (d, 3JC,P = 4.4Hz, C1), 54.8 (d, JC,P = 11.8Hz, C5H3), 57.8 (OCH3),
58.2 (d, 1JC,P = 216.6Hz, C-P), 63.6 (d, 1JC,P = 13.6Hz, C5H3), 67.2 (d, 1JC,P = 12.1Hz,
C5H3), 69.8 (C5H5), 87.8 (d, 2JC,P = 6.4Hz, C2), 88.0 (d, 2JC,P = 6.7Hz, C2), 128.8 (d,
2JC,P = 10.3Hz, CC5H3-O). 31P{1H} NMR (CDCl3, δ): 22.4. HRMS (ESI-TOF, m/z): calcd
for C31H45FeO4P 568.2400, found 568.2433 [M]+.
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Di-(1S)-isopinocampheyl (2-Methoxyferrocenyl)phosphonate (31f)
31f
Fe O
O
PO
2
Ferrocenyl di-(1S)-isopinocampheyl phosphate (30f, 100mg,
0.18mmol) was reacted as described in procedure GP3.
Compound 31f was obtained as an orange oil in a mixture
of two diastereomers.
Yield: 85mg (0.15mmol, 80% based on 30f). 1H NMR
(CDCl3, δ): 0.90–0.93 (m, 6H), 1.05–1.21 (m, 14H), 1.77–
1.83 (m, 2H), 1.89–2.08 (m, 4H), 2.15–2.26 (m, 2H), 2.33–2.39 (m, 2H), 2.46–2.60 (m, 2H),
3.67/3.68 (s, 3H, OCH3), 3.99–4.00 (m, 1H, C5H3), 4.16–4.18 (m, 1H, C5H3), 4.22–4.27
(m, 1H, C5H3), 4.320/4.321 (s, 5H, C5H5), 4.70–4.85 (m, 2H, H1). 13C{1H} NMR (CDCl3,
δ): 19.95 (CH3), 20.02 (CH3), 23.78 (CH3), 23.81 (CH3), 23.83 (CH3), 27.43 (CH3), 27.47
(CH3), 27.49 (CH3), 27.50 (CH3), 33.6 (CH2), 33.7 (CH2), 33.8 (CH2), 37.1 (d, 3JC,P =
3.1Hz, CH2), 27.3 (d, 3JC,P = 2.87Hz, CH2), 37.4 (d, 3JC,P = 2.5Hz, CH2), 37.5 (d, 3JC,P
= 2.2Hz, CH2), 38.15 (C6), 38.17 (C6), 38.20 (C6), 41.52 (C5), 41.53 (C5), 41.56 (C5), 41.60
(C5), 45.5–45.8 (m, C2), 47.7 (C1), 47.8 (C1), 55.03 (d, JC,P = 11.3Hz, C5H3), 55.09 (d,
JC,P = 11.3Hz, C5H3), 57.96 (OCH3), 57.99 (OCH3), 58.5 (d, 1JC,P = 215.8Hz, C-P), 58.7
(d, 1JC,P = 215.7Hz, C-P), 63.4 (d, JC,P = 13.9Hz, C5H3), 63.4 (d, JC,P = 13.9Hz, C5H3),
67.2 (d, JC,P = 12.8Hz, C5H3), 67.4 (d, JC,P = 12.9Hz, C5H3), 70.0 (C5H5), 75.9 (d, 2JC,P
= 6.8Hz, C3), 76.0 (d, 2JC,P = 7.3Hz, C3), 76.2 (d, 2JC,P = 6.8Hz, C3), 76.3 (d, 2JC,P
= 7.4Hz, C3), 128.4 (d, 2JC,P = 10.1Hz, C-O), 128.6 (d, 2JC,P = 10.2Hz, C-O). 31P{1H}
NMR (CDCl3, δ): 21.24, 21.28. HRMS (ESI-TOF, m/z): calcd for C31H45FeO4P 568.24000,
found 568.2453 [M]+.
Dicyclohexyl (2-(Diphenylthiophosphinato)ferrocenyl)phosphonate (rac-34)
34
Fe O
PPh2
O
P
S
O
2
Dicyclohexyl ferrocenyl phosphate (30a, 100mg,
0.22mmol), diisopropylamine (0.07mL, 0.50mmol),
BuLi (0.2mL, 0.50mmol), TMEDA (0.07mL, 0.46mmol),
ClPPh2 (0.17mL, 0.93mmol) and sulfur (60mg, 1.9mmol)
were reacted according to the general procedure GP3.
The obtained reaction mixture was filtered through a pad
of celite using hexane to remove the excess of sulfur. Purification was realized by column
chromatography (silica, 2 · 8 cm column size) using a 9/1 (v/v) dichloromethane/ethyl
acetate mixture as the eluent, giving 34 as an orange oil.
Yield: 65mg (0.098mmol, 44% based on 30a). 1H NMR (CDCl3, δ): 1.19–1.31 (m, 6H,
CH2), 1.41–1.54 (m, 6H, CH2), 1.63–1.78 (m, 4H, CH2), 1.82–1.88 (m, 1H, CH2), 1.88–2.02
(m, 3H, CH2), 3.96 (ddd, JH,H = JH,H = JH,P = 2.8Hz, 1H, C5H3), 4.19–4.23 (m, 6H,
C5H5, C5H3), 4.45–4.54 (m, 2H, H1), 4.60–4.62 (m, 1H, C5H3), 7.39–7.43 (m, 2H, Ph),
7.45–7.49 (m, 1H, Ph), 7.50–7.56 (m, 3H, Ph), 7.96–8.00 (m, 2H, Ph), 8.12–8.17 (m, 2H,
Ph). 13C{1H} NMR (CDCl3, δ): 23.55 (CH2), 23.64 (CH2), 23.70 (CH2), 23.72 (CH2), 25.21
(CH2), 25.24 (CH2), 33.7 (d, JC,P = 4.5Hz, CH2), 33.9–34.0 (m, CH2), 59.8 (dd, 1JC,P =
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217.1Hz, 3JC,P = 5.4Hz, CC5H3-P), 62.8 (dd, JC,P = 10.3Hz, JC,P = 5.5Hz, C5H3), 64.6 (d,
JC,P = 13.9Hz, C5H3), 66.9 (d, JC,P = 12.8Hz, C5H3), 71.3 (C5H5), 75.1 (d, 2JC,P = 6.3Hz,
C1), 75.2 (d, 2JC,P = 6.5Hz, C1), 118.8 (dd, 2JC,P = 9.2Hz, 2JC,P = 6.8Hz, CC5H3-O), 128.4
(d, JC,P = 5.5Hz, Ph), 128.5 (d, JC,P = 5.5Hz, Ph), 131.5 (d, JC,P = 11.8Hz, Ph), 131.8 (d,
JC,P = 11.9Hz, Ph), 131.9 (d, JC,P = 3.0Hz, Ph), 132.1 (d, JC,P = 3.0Hz, Ph), 134.0 (d,
1JC,P = 111.1Hz, CPh-P), 134.4 (d, 1JC,P = 111.4Hz, CPh-P.) 31P{1H} NMR (CDCl3, δ):
20.4 (PO3), 80.3 (P=S). HRMS (ESI-TOF, m/z): calcd for C34H40FeO4P2S + H 663.1545,
found 663.1477 [M+H]+.
Dicyclohexyl (2-(O,O'-Dicyclohexylphosphonato)ferrocenyl) Phosphate (35a)
35a
Fe O
P
O
P
O
O
2
O
2
Dicyclohexyl ferrocenyl phosphate (30a,
100mg, 0.22mmol), diisopropylamine (0.07mL,
0.50mmol), BuLi (0.2mL, 0.50mmol), TMEDA
(0.07mL, 0.46mmol) and 29a (375mg, 1.7mmol)
were reacted according to the general procedure
GP3. Purification was realized by column chro-
matography (silica, 2 · 8 cm column size) using a 80/20 (v/v) dichloromethane/ethyl acetate
mixture (Rf = 0.43) as the eluent, giving 35a was obtained as and orange oil.
Yield: 150mg (0.188mmol, 81% based on 30a). 1H NMR (CDCl3, δ): 1.28–1.41 (m, 12H,
CH2), 1.45–1.65 (m, 12H, CH2), 1.67–1.81 (m, 8H, CH2), 1.83–1.89 (m, 1H, CH2), 1.89–
2.06 (m, 7H, CH2), 4.02–4.05 (m, 1H, C5H3), 4.22–4.25 (m, 1H, C5H3), 4.36 (s, 5H, C5H5),
4.40–4.47 (m, 1H, H1), 4.48–4.54 (m, 1H, H1), 4.78–4.82 (m, 1H, C5H3). 13C{1H} NMR
(CDCl3, δ): 23.45 (CH2), 23.49 (CH2), 23.60 (CH2), 23.62 (CH2), 23.7 (CH2), 25.11 (CH2),
25.14 (CH2), 25.30 (CH2), 25.34 (CH2), 33.2 (d, 3JC,P = 4.7Hz, CH2), 33.27 (d, 3JC,P =
4.5Hz, CH2), 33.31 (d, 3JC,P = 4.2Hz, CH2), 33.5 (d, 3JC,P = 4.4Hz, CH2), 33.8 (d, 3JC,P
= 3.7Hz, CH2), 33.9 (d, 3JC,P = 3.9Hz, CH2), 59.7 (dd, 1JC,P = 217.0Hz, 3JC,P = 8.6Hz,
C-P), 62.0 (d, JC,P = 11.3, C5H3), 64.5 (d, JC,P = 13.8, C5H3), 67.4 (d, JC,P = 13.1, C5H3),
71.2 (C5H5), 74.9 (d, 2JC,P = 5.9Hz, C1), 75.1 (d, 2JC,P = 6.6Hz, C1), 77.91 (d, 2JC,P =
6.4Hz, C), 77.94 (d, 2JC,P = 6.3Hz, C1), 118.5 (dd, 2JC,P = 8.9Hz, 2JC,P = 5.0Hz, CC5H3-
O). 31P{1H} NMR (CDCl3, δ): –7.4 (PO4), 19.8 (PO3). HRMS (ESI-TOF, m/z): calcd for
C34H52FeO7P2 +Na 713.2340, found 713.2373 [M+Na]+.
(2-(Dicyclohexylphosphonato) Ferrocenyl Di-(1R)-α-fenchyl Phosphate (35b)
35b
Fe O
P
O
P
O
O
2
O
2
Dicyclohexyl ferrocenyl phosphate (30a,
100mg, 0.22mmol), diisopropylamine (0.07mL,
0.50mmol), BuLi (0.2mL, 0.50mmol), TMEDA
(0.07mL, 0.46mmol) and 29e (370mg,
0.95mmol) were reacted according to the
general procedure GP3. Purification was real-
ized by column chromatography (silica, 2 · 12 cm
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column size) using a 80/20 (v/v) dichloromethane/ethyl acetate mixture (Rf = 0.45) as the
eluent, giving 35b as an orange oil in a mixture of two diastereomers (0.10 de).
Yield: 150mg (0.188mmol, 81% based on 30a). 1H NMR (CDCl3, δ): 0.84–1.58 (m, 40H,
C6H11, C10H17), 1.67–1.77 (m, 8H, C6H11, C10H17), 1.92–2.03 (m, 4H, C6H11), 3.98–4.13
(m, 3H, C5H3, C10H17), 4.18–4.23 (m, 1H, C5H3), 4.36 (s, 5H, C5H5), 4.44–4.57 (m, 1H,
C6H11), 4.89–4.98 (m, 1H, C5H3). 13C{1H} NMR (CDCl3, δ): 19.4–19.5 (m, CH3), 20.7–21.1
(m, CH3), 23.76–23.84 (m, CyCH2), 25.7–26.0 (m, C5/C6), 29.8–30.0 (m, CH3), 33.8–34.0
(m, CyCH2), 39.5–39.7 (m, C3), 40.9–41.0 (m, C7), 47.9–48.0 (C4), 49.2–49.4 (m, C1), 59.7
(d, 1JC,P = 218.7Hz, 3JC,P = 8.4Hz, C-P), 62.5 (d, JC,P = 10.6Hz, C5H3), 62.7 (d, JC,P =
10.8Hz, C5H3), 64.30 (d, JC,P = 13.6Hz, C5H3), 64.36 (d, JC,P = 13.7Hz, C5H3), 67.5 (d,
JC,P = 12.8Hz, C5H3), 67.6 (d, JC,P = 12.4Hz, C5H3), 71.21 (C5H5), 71.23 (C5H5), 74.9 (d,
2JC,P = 6.4Hz, CyC1), 75.05 (d, 2JC,P = 5.8Hz, CyC1), 75.18 (d, 2JC,P = 6.7Hz, CyC1),
91.3–91.5 (m, FnC1), 119.0–119.2 (m, CC5H3-O). 31P{1H} NMR (CDCl3, δ): –4.4 (PO4), -3.7
(PO4), 19.88 (C-PO3), 19.93 (C-PO3). HRMS (ESI-TOF, m/z): calcd for C42H64FeO7P2 +
H 799.3550, found 799.3496 [M+H]+.
Di-(1R)-fenchyl (2-(Di-(1R)-α-fenchylphosphonato)ferrocenyl) Phosphate (35c)
35c
Fe O
P
O
P
O
O
2
O
2
Di-(1R)-α-fenchyl ferrocenyl phosphate
(30e, 300mg, 0,54mmol), LiTMP (210mg,
1,41mmol), TMEDA (0,15mL, 1,0mmol)
and 29e (420mg, 1,08mmol) were reacted
according to the general procedure GP4.
Purification was realized by column chro-
matography (silica, 2 · 12 cm column size)
using a 96/4 (v/v) dichloromethane/ethyl acetate mixture as the eluent, giving 35c as an
orange oil in a mixture of two diastereomers (0.95 de).
Yield: 422mg (0.465mmol, 86% based on 30e). 1H NMR (CDCl3, δ): 0.73 (s, 3H, CH3),
0.88–1.27 (m, 41H, C10H17), 1.34–1.58 (m, 8H, C10H17), 1.61–1.81 (m, 11H, C10H17), 1.86–
1.90 (m, 1H, C10H17), 3.89 (dd, 3JH,P = 10.2Hz, JH,H = 1.5Hz, H2), 4.04–4.10 (m, 3H,
H2, C5H3), 4.14 (dd, 3JH,P = 8.7Hz, JH,H = 1.5Hz, H2), 4.23 (dd, 3JH,P = 9.5Hz, JH,H
= 1.4Hz, H2), 4.41 (s, 5H, C5H5), 4.97–4.98 (m, 1H, C5H3). 13C{1H} NMR (CDCl3, δ):
19.2 (CH3), 19.66 (CH3), 19.67 (CH3), 19.9 (CH3), 20.9 (CH3), 21.1 (CH3), 21.5 (CH3),
22.0 (CH3), 25.77 (C5/C6), 25.81 (C5/C6), 25.89 (C5/C6), (C5/C6), 26.00 (C5/C6), 26.03
(C5/C6), 26.13 (C5/C6), 26.14 (C5/C6), 29.7 (CH3), 29.86 (CH3), 29.89 (CH3), 30.1 (CH3),
39.3 (d, 3JC,P = 1.4Hz, C3), 39.55 (d, 3JC,P = 2.5Hz, C3), 39.64 (d, 3JC,P = 2.6Hz, C3), 39.8
(d, 3JC,P = 1.2Hz, C3), 40.8 (C7), 41.0 (C7), 41.2 (C7), 47.96 (C4), 47.98 (C4), 48.05 (C4),
48.2 (C4), 49.1 (d, 3JC,P = 5.6Hz, C1), 49.4 (d, 3JC,P = 5.1Hz, C1), 49.5 (d, 3JC,P = 5.2Hz,
C1), 59.1 (dd, 1JC,P = 217.1Hz, 3JC,P = 10.0Hz, C-P), 62.0 (d, JC,P = 10.8, C5H3), 64.7
(d, JC,P = 12.8, C5H3), 66.8 (d, JC,P = 10.3, C5H3), 71.2 (C5H5), 87.6 (d, 2JC,P = 5.5Hz,
C2PO3), 88.3 (d, 2JC,P = 7.8Hz, C2PO3), 91.1 (d, 2JC,P = 6.5Hz, C2PO4), 91.7 (d, 2JC,P =
156
4.3. SYNTHETIC PROCEDURES
6.6Hz, C2PO4), 120.69 (CC5H3-O), 120.73 (CC5H3-O), 120.78 (CC5H3-O), 120.81 (CC5H3-O).
31P{1H} NMR (CDCl3, δ): –3.5 (d, 4JP,P = 0.9Hz, PO4), 19.6 (d, 4JP,P = 1.9Hz, PO3; dd
1JP,C = 216.9Hz, 1.9Hz). HRMS (ESI-TOF, m/z): calcd for C50H76FeO7P2 +H 907.4489,
found 907.4409 [M+H]+.
1,3-Bis(O,O'-dicyclohexylphosphonato)-2-methoxyferrocene (36a)
36a
Fe O
O
PO
2
P
O
O
2
Dicyclohexyl (2-(dicyclohexylphosphonato)ferro-
cenyl) phosphate (35a, 68mg, 0.10mmol), diiso-
propylamine (0.03mL, 0.20mmol), BuLi (0.08mL,
0.20mmol), TMEDA (0.03mL, 0.20mmol) and
Me2SO4 (0.1mL, 0.8mmol) were reacted according
to the general procedure GP3. Purification was re-
alized by column chromatography (silica, 2 · 10 cm
column size) using a 95/5 (v/v) ethyl acetate/methanol mixture as the eluent, giving 36a as
an orange oil.
Yield: 28mg (0.04mmol, 41% based on 35a). 1H NMR (CDCl3, δ): 1.24–1.34 (m, 12H,
CH2), 1.42–1.56 (m, 12H, CH2), 1.64–1.80 (m, 8H, CH2), 1.81–2.02 (m, 8H, CH2), 3.91
(m, 3H, OCH3), 4.35–4.22 (m, 2H, C5H2), 4.43–4.57 (m, 9H, C5H5, H1). 13C{1H} NMR
(CDCl3, δ): 23.55 (CH2), 23.57 (CH2), 25.23 (CH2), 33.50 (CH2), 33.52 (CH2), 33.53 (CH2),
33.65 (CH2), 33.77 (CH2), 33.78 (CH2), 33.79 (CH2), 33.86 (CH2), 63.7 (CH3), 64.1 (dd,
1JC,P = 212.1Hz, 3JC,P = 10.6Hz, C-P), 69.3 (pt, 2,3JC,P = 13.6Hz, C5H2), 72.1 (C5H5),
75.14 (C1), 75.19 (C1), 75.21 (C1), 75.27 (C1), 128.1 (t, 2JC,P = 10.9Hz, CC5H2-O). 31P{1H}
NMR (CDCl3, δ): 19.8. HRMS (ESI-TOF, m/z): calcd for C35H54FeO7P2 + Na 727.2587,
found 727.2589 [M+Na]+.
1,3-Bis(O,O'-di-(1R)-α-fenchylphosphonato)-2-hydroxyferrocene (36b)
36b
Fe OH
O
PO
2
P
O
O
2
Di-(1R)-α-fenchyl (2-(O,O-di-(1R)-α-fenchyl
phosphonato)ferrocenyl) phosphate (35c,
100mg, 0.11mmol), diisopropylamine (0.05mL,
0.36mmol), BuLi (0.15mL, 0.38mmol),
TMEDA (0.06mL, 0.4mmol) and Me2SO4
(0.2mL, 2.1mmol) were reacted according to
the general procedure GP3. Purification was
realized by column chromatography (silica, 2 · 10 cm column size) using a 70/30 (v/v)
dichloromethane/ethyl acetate mixture as the eluent, giving 36b as an orange oil.
Yield: 99mg (0.109mmol, 99% based on 35c). 1H NMR (CDCl3, δ): 0.79 (s, 3H, CH3),
0.94–1.28 (m, 41H), 1.30–1.35 (m, 1H, CH2), 1.39–1.56 (m, 6H, CH2), 1.59–1.61 (m, 1H,
CH2), 1.65–1.89 (m, 11H), 1.91–1.98 (m, 1H, CH2), 3.50 (dd, 3JH,P = 9.5Hz, JH,H = 1.4Hz,
1H, H2), 3.87 (dd, 3JH,P = 9.7Hz, JH,H = 1.5Hz, 1H, H2), 4.12 (dd, J = 5.0Hz, J = 2.6Hz,
1H, C5H2), 4.21 (dd, 3JH,P = 10.2Hz, JH,H = 1.3Hz, 1H, H2), 4.30 (dd, 3JH,P = 9.0Hz,
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JH,H = 1.4Hz, 1H, H2), 4.42 (dd, J = 4.8Hz, J = 2.7Hz, 1H, C5H2), 4.48 (s, 5H, C5H5),
7.60 (s, 1H, OH). 13C{1H} NMR (CDCl3, δ): 19.2 (CH3), 19.4 (CH3), 19.7 (CH3), 19.8
(CH3), 21.5 (CH3), 21.6 (2C, CH3), 21.7 (CH3), 25.81 (CH2-CH2), 25.87 (C5/C6), 25.95
(C5/C6), 25.97 (C5/C6), 26.02 (C5/C6), 29.4 (CH3), 29.7 (CH3), 29.9 (CH3), 30.1 (CH3),
39.24 (C3), 39.26 (C3), 39.4 (d, 3JC,P = 1.9Hz, C3), 39.8 (d, 3JC,P = 1.9Hz, C3), 40.4
(C7), 40.9 (C7), 41.0 (C7), 41.1 (C7), 47.83 (C4), 47.85 (C4), 48.09 (C4), 48.12 (C4), 49.1
(d, 3JC,P = 6.9Hz, C1), 49.2 (d, 3JC,P = 4.9Hz, C1), 49.4 (d, 3JC,P = 5.7Hz, C1), 49.5 (d,
3JC,P = 4.7Hz, C1), 53.8 (dd, 1JC,P = 211.0Hz, 3JC,P = 11.1Hz, C-P), 57.5 (dd, 1JC,P =
214.8Hz, 3JC,P = 12.3Hz, C-P), 65.0 (dd, JC,P = 13.2Hz, JC,P = 12.6Hz, C5H2), 68.9 (pt,
2+3JC,P = 13.7Hz, C5H2), 72.0 (C5H5), 88.6 (d, 2JC,P = 6.5Hz, CC5H2-O), 88.8 (d, 2JC,P
= 5.4Hz, CC5H2-O), 89.0 (d, 2JC,P = 7.3Hz, CC5H2-O), 90.9 (d, 2JC,P = 8.9Hz, CC5H2-O),
130.0 (dd, 2JC,P = 13.8Hz, 2JC,P = 10.5Hz, C-OH). 31P{1H} NMR (CDCl3, δ): 21.3 (d,
3JP,P = 3.7Hz), 25.8 (d, 3JP,P = 3.7Hz).
1,1'-Bis(O,O'-di-(1R)-α-fenchylphosphonato)-2-methoxyferrocene (37)
37
FeO
O
P O
2P(O)(OFn)2
Phosphate 35c (45mg, 0.05mmol), LiTMP (24mg,
0.16mmol), TMEDA (0,03mL, 0.20mmol) and Me2SO4
(0.1mL, 1.05mmol) were reacted according to the general
procedure GP4. Purification was realized by column chro-
matography (silica, 2 · 12 cm column size) using a 85/15 (v/v)
dichloromethane/ethyl acetate mixture as the eluent, giving
37 as an orange oil.
Yield: 12mg (0.013mmol, 26% based on 35c). 1H NMR (CDCl3, δ): 0.65 (s, 3H, CH3),
0.87–1.26 (m, 37H, C10H17), 1.38–1.57 (m, 8H, C10H17), 1.59–1.87 (m, 12H, C10H17), 3.74–
3.76 (m, 4H, OCH3, H2), 4.00–4.05 (m, 2H, H2), 4.18 (dd, JH,P = 9.73Hz, JH,H = 1.5Hz,
H2), 4.27–4.30 (m, 2H, C5H3), 4.43–4.45 (m, 1H, C5H4), 4.46–4.47 (m, 1H, C5H3), 4.66–
4.68 (m, 1H, C5H4), 4.70–4.72 (m, 1H, C5H4), 4.73–4.75 (m, 1H, C5H4). 13C{1H} NMR
(CDCl3, δ): 19.15 (CH3), 19.23 (CH3), 19.6 (CH3), 19.7 (CH3), 21.1 (CH3), 21.45 (CH3),
21.48 (CH3), 21.7 (CH3), 25.77 (C5/C6), 25.84 (C5/C6), 25.95 (C5/C6), 26.0 (C5/C6), 26.1
(C5/C6), 26.2 (C5/C6), 29.65 (CH3), 29.67 (CH3), 29.69 (CH3), 29.74 (CH3), 29.80 (CH3),
39.10 (C3), 39.11 (C3), 39.15 (C3), 39.16 (C3), 39.70 (C3), 39.71 (C3), 39.72 (C3), 39.73
(C3), 40.8 (C7), 41.0 (C7), 41.1 (C7), 47.94 (C4), 47.98 (C4), 48.03 (C4), 48.08 (C4), 49.1
(d, 3JC,P = 5.4Hz, C1), 49.2 (d, 3JC,P = 5.1Hz, C1), 49.3 (d, 3JC,P = 4.7Hz, C1), 49.4 (d,
3JC,P = 5.2Hz, C1), 56.9 (d, JC,P = 11.4Hz, C5H3), 58.0 (OCH3), 58.7 (d, 1JC,P = 215.1Hz,
CC5H3-P), 66.0 (d, JC,P = 13.2Hz, C5H3), 68.0 (d, JC,P = 11.9Hz, C5H3), 68.4 (d, 1JC,P =
216.8Hz, CC5H4-P), 71.8 (d, JC,P = 13.1Hz, C5H4), 73.7 (d, JC,P = 13.4Hz, C5H4), 74.6 (d,
JC,P = 16.4Hz, C5H4), 75.0 (d, JC,P = 14.0Hz, C5H4), 88.0 (d, 2JC,P = 6.3Hz, C2), 88.1
(d, 2JC,P = 6.5Hz, C2), 88.3 (d, 2JC,P = 5.9Hz, C2), 88.5 (d, 2JC,P = 7.8Hz, C2), 129. 8
(d, 2JC,P = 10.4Hz, CC5H3-O). 31P{1H} NMR (CDCl3, δ): 21.3 (C5H3), 23.8 (C5H4).
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1'-Di-(1R)-α-fenchlphosphato (2-Methoxyferrocenyl-O,O'-di-(1R)-α-fenchyl)
phosphonate (40b)
40b
FeO
O
P O
2
OP(O)(OFn)2
1,1'-Ferrocenediyl tetra-(1R)-α-fenchyl bis(phosphate) (39b,
120mg, 0.13mmol), LiTMP (115mg, 0.78mmol), TMEDA
(0.12mL, 0.78mmol) and Me2SO4 (0.22mL, 2.3mmol) were
reacted according to the general procedure GP4. Purification
was realized by column chromatography (silica, 2 · 12 cm col-
umn size) using a 90/10 (v/v) dichloromethane/ethyl acetate
mixture as the eluent, giving 40b as an orange oil in a mixture
of both diastereomers (0.84 de).
Yield: 22mg (0.024mmol, 18% based on 39b). 1H NMR (CDCl3, δ): 0.85–1.28 (m, 44H),
1.44–1.52 (m, 8H, CH2), 1.66–1.75 (m, 12H, CH2, CH), 3.74 (s, OCH3), 3.95–4.04 (m, 4H,
H2), 4.13–4.14 (m, 2H, C5HX), 4.21–4.23 (m, 2H, C5HX), 4.28–4.29 (m, 1H, C5HX), 4.49–
4.50 (m, 1H, C5HX), 4.58–4.59 (m, 1H, C5HX). 13C{1H} NMR (CDCl3, δ): 19.18 (CH3),
19.37 (CH3), 19.41 (CH3), 19.61 (CH3), 20.8 (CH3), 21.0 (CH3), 21.1 (CH3), 21.4, 25.6–26.2
(m, C5/C6), 29.7–29.8 (m, CH3), 39.1 (d, 3JC,P = 2.2Hz, C3), 39.5 (d, 3JC,P = 2.4Hz, C3),
39.6 (d, 3JC,P = 2.4Hz, C3), 39.7 (d, 3JC,P = 2.2Hz, C3), 40.9–41.1 (m, C7), 47.9–48.1
(m, C4), 49.2–49.3 (m, C1), 57.5 (d, JC,P = 11.7Hz, C5H3), 57.9 (OCH3), 58.4 (d, 1JC,P =
218.4Hz, C-P), 60.7 (d, JC,P = 3.5Hz, C5H4), 62.0 (d, JC,P = 4.1Hz, C5H4), 64.8 (C5H4),
66.0 (d, JC,P = 13.8Hz, C5H3), 66.3 (C5H4), 67.8 (d, JC,P = 12.0Hz, C5H3) 87.8 (d, 2JC,P
= 6.1Hz, C2), 88.1 (d, 2JC,P = 8.7Hz, C2), 91.3 (d, 2JC,P = 7.0Hz, C2), 118.5 (d, 2JC,P =
4.4Hz, C–OPO4), 129.5 (d, 2JC,P = 10.1Hz, C–OPO3). 31P{1H} NMR (CDCl3, δ): –4.5
(PO4), 22.0 (PO3, ma), 22.2 (PO3, mi).
Tetracyclohexyl (2,2'-Dimethoxy-1,1'-ferrocenediyl)bis(phosphonate) (41a)
41a
Fe O
P(O)(OCy)2
P(O)(OCy)2
O
Tetracyclohexyl 1,1'-ferrocenediyl bis(phosphate) (39a, 100mg,
0.14mmol), diisopropylamine (0.08mL, 0.57mmol), BuLi (0.23mL,
0.58mmol), TMEDA (0.09mL, 0.60mmol) and Me2SO4 (0.3mL,
3.2mmol) were reacted according to the general procedure GP3.
Purification was realized by column chromatography (silica, 2 · 10 cm
column size) using a 95/5 (v/v) ethyl acetate/methanol mixture as
the eluent, giving 41a as an orange oil in a mixture of diastereomers (0.13 de).
Yield: 70mg (0.095mmol, 67% based on 39a). 1H NMR (CDCl3, δ): 1.18–1.39 (m, 12H,
CH2), 1.43–1.60 (m, 12H, CH2), 1.63–1.80 (m, 8H, CH2), 1.87–1.98 (m, 8H, CH2), 3.71
(s, 3.6H*, OCH3), 3.83 (s, 2.4H*, OCH3), 4.12–4.17 (m, 1.6H∗, C5H3), 4.21–4.22 (m, 1H,
C5H3), 4.36–4.43 (m, 4H, CyC1, C5H3), 4.45–4.57 (m, 3.4H∗, CyC1, C5H3). 13C{1H} NMR
(CDCl3, δ): 23.5–23.7 (CH2), 25.1–25.3 (CH2), 33.5–33.9 (m, CH2), 57.5 (d, JC,P = 11.1Hz,
C5H3), 58.0 (OCH3), 58.2 (OCH3), 58.4 (d, 1JC,P = 215.6Hz, C-P), 58.5 (d, 1JC,P = 215.1Hz,
C-P), 59.4 (d, JC,P =11.1Hz, C5H3), 64.8 (d, JC,P =13.8Hz, C5H3), 67.8 (d, JC,P = 14.0Hz,
C5H3), 68.9 (d, JC,P = 13.1Hz, C5H3), 74.68–74.73 (m, C1), 75.0 (d, 2JC,P = 6.2Hz, C1),
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75.22 (d, 2JC,P = 6.0Hz, C1), 75.23 (d, 2JC,P = 6.9Hz, C1), 129.0 (d, 2JC,P = 9.8Hz,
CC5H3-O), 129.5 (d, 2JC,P =10.6Hz, CC5H3-O). 31P{1H} NMR (CDCl3, δ): 20.75 (ma),
20.81 (mi).
Cyclohexyl Ferrocenyl (2-Methoxyferrocenyl)phosphonate (44a)
44a
FeO P
O
OO Fc
Cy Cyclohexyl diferrocenyl phosphate (43a, 100mg, 0.18mmol), di-
isopropylamine (0.1mL, 0.72mmol), BuLi (0.30mL, 0.75mmol),
TMEDA (0.11mL, 0.73mmol) and Me2SO4 (0.3mL, 3.2mmol) were
reacted according to the general procedure GP3. Purification was re-
alized by column chromatography (silica, 2 · 10 cm column size) using
85/15 a (v/v) dichloromethane/ethyl acetate mixture as the eluent,
giving 44a as an orange solid as a mixture of diastereomers (0.45 de).
Yield: 58mg (0.10mmol, 57% based on 43a). Mp.: 111–114℃. Anal. calcd for
C27H31Fe2O4P (562.20 g/mol): C, 57.68; H, 5.56; found: C, 57.87; H, 5.66. 1H NMR (CDCl3,
δ): 1.33–1.43 (m, 3H, CH2), 1.47–1.54 (m, 1H, CH2), 1.58–1.68 (m, 2H, CH2), 1.72–1.82 (m,
2H, CH2), 1.88–2.02 (m, 2H, CH2), 3.71/3.73 (s, 3H, OCH3), 3.81–3.85 (m, 2H, C5H3/4),
4.04–4.07 (m, 1H, C5H3/4), 4.16/4.19 (s, 5H, C5H5), 4.21–4.24 (m, 1H, C5H3/4), 4.29–
4.31 (m, 1H, C5H3/4), 4.32 (s, 5H, C5H5), 4.38–4.40 (m, 1H, C5H3/4), 4.42–4.47 (m, 1H,
C5H3/4), 4.55–4.66 (m, 1H, H1). 13C{1H} NMR (CDCl3, δ): 23.50 (CH2), 23.54 (CH2),
25.24 (CH2), 25.29 (CH2), 33.6–33.8 (m, CH2), 55.26 (d, JC,P = 11.6Hz, C5H3/4), 55.31 (d,
JC,P = 11.6Hz, C5H3/4), 57.0 (d, 1JC,P = 218.0Hz, C-P), 58.2 (OCH3), 60.0 (d, JC,P =
3.6Hz, C5H3/4), 60.1 (d, JC,P = 3.9Hz, C5H3/4), 60.26 (d, JC,P = 3.3Hz, C5H3/4), 60.33
(d, JC,P = 3.6Hz, C5H3/4), 62.4–62.5 (m, C5H3/4), 63.9 (d, JC,P = 13.7Hz, C5H3/4), 64.0
(d, JC,P = 14.6Hz, C5H3/4), 67.2 (d, JC,P = 12.8Hz, C5H3/4), 67.4 (d, JC,P = 14.1Hz,
C5H3/4), 69.27 (C5H5), 69.33 (C5H5), 70.08 (C5H5), 70.13 (C5H5), 75.7 (d, 2JC,P = 6.2Hz,
C1), 76.1 (d, 2JC,P = 7.1Hz, C1), 117.5 (d, 2JC,P = 4.8Hz, CC5H4-O), 128.6 (d, 2JC,P =
10.3Hz, CC5H3-O). 31P{1H} NMR (CDCl3, δ): 20.06 (mi), 20.09 (ma). HRMS (ESI-TOF,
m/z): calcd for C27H31Fe2O4P 562.0654, found 562.0654 [M]+.
Ferrocenyl (1R)-Menthyl (2-Methoxyferrocenyl)phosphonate (44b)
44b
FeO P
O
OO Fc
Mt Diferrocenyl (1R)-menthyl phosphate (43b, 200mg, 0.33mmol), di-
isopropylamine (0.09mL, 0.65mmol), BuLi (0.27mL, 0.68mmol),
TMEDA (0.10mL, 0.66mmol) and Me2SO4 (0.2mL, 2.1mmol) were
reacted according to the general procedure GP3. Purification was re-
alized by column chromatography (silica, 2 · 10 cm column size) using
a 95/5 (v/v) dichloromethane/ethyl acetate mixture as the eluent,
giving 44b as an orange oil as as a mixture of isomers.
Yield: 155mg (0.25mmol, 74% based on 43b). 1H NMR (CDCl3, δ): 0.74–0.96 (m, 10H,
CH3, CH2), 1.00–1.09 (m, 1H, CH2), 1.15–1.25 (m, 1H, CH2), 1.32–1.39 (m, 1H, CH), 1.44–
1.52 (m, 1H, CH), 1.62–1.71 (m, 2H, CH2, CH), 2.11–2.49 (m, 2H, CH2), 3.67–3.72 (m,
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3H, OCH3), 3.78–3.87 (m, 2H, C5H3/4), 4.01–4.07 (m, 1H, C5H3/4), 4.11–4.58 (m, 15H).
13C{1H} NMR (CDCl3, δ): 15.6–15.7 (m, CH3), 21.1–21.2 (m, CH3), 22.0–22.1 (m, CH3),
22.6–22.8 (m, CH2), 31.5–31.6 (m, CH3), 34.07–34.13 (m, CH2), 43.1–43.4 (m, CH2), 48.6–
49.0 (m, C1), 55.0–55.3 (m, C5H3), 56.17–56.21 (m, C-P), 56.8 (d, 1JC,P = 218.3Hz, C-P),
57.90–57.94 (OCH3), 58.1 (C-P), 59.8–60.5 (m, C5H4), 62.3–62.5 (m, C5H4), 63.7–64.0 (m,
C5H3), 66.7–67.8 (m, C5H3), 69.2–69.3 (m, C5H5), 70.0–70.2 (m, C5H5), 77.6–78.3 (m, C1),
117.6–117.7 (m, CC5H4-O), 128.3–128.9 (m, CC5H3-O). 31P{1H} NMR (CDCl3, δ): 19.8,
20.1, 20.4, 21.0. HRMS (ESI-TOF, m/z): calcd for C32H41Fe2O4P 632.1437, found 632.1400
[M]+.
(1S)-Borneyl Ferrocenyl (2-Methoxyferrocenyl)phosphonate (44c)
44c
FeO P
O
OO Fc
Bo (1S)-Borneyl diferrocenyl phosphate (43c, 100mg, 0.18mmol), di-
isopropylamine (0.05mL, 0.36mmol), BuLi (0.15mL, 0.38mmol),
TMEDA (0.05mL, 0.33mmol) and Me2SO4 (0.13mL, 1.37mmol)
were reacted according to the general procedure GP3. Purification
was realized by column chromatography (silica, 2 · 10 cm column size)
using a 80/20 (v/v) dichloromethane/ethyl acetate mixture as the
eluent, giving 44c as an orange oil in a mixture of isomers.
Yield: 55mg (0.089mmol, 49% based on 43c). 1H NMR (CDCl3, δ): 0.82 (s, 3H, CH3), 0.83
(s, 3H, CH3), 0.88 (s, 3H, CH3), 1.19–1.33 (m, 3H, CH2), 1.60–1.64 (m, 1H, H4), 1.66–1.74
(m, 1H, CH2), 1.91–2.10 (m, 1H, CH2), 2.12–2.35 (m, 1H, H3), 3.63–3.66 (m, 3H, OCH3),
3.71–3.78 (m, 2H, C5H3/4), 3.97–4.02 (m, 1H, C5H3/4), 4.06–4.12 (m, 5H, C5H5), 4.15–4.17
(m, 1H, C5H3/4), 4.22–4.40 (m, 8H, C5H3/4, C5H5), 4.64–4.75 (m, 1H, H2). 13C{1H} NMR
(CDCl3, δ): 31 13.2 (CH3), 13.3 (CH3), 18.9 (CH3), 20.0 (CH3), 26.5 (C5/C6), 26.6 (C5/C6),
28.10 (C5/C6), 28.12 (C5/C6), 37.2 (d, 3JC,P = 1.3Hz, C3), 37.6 (d, 3JC,P = 2.1Hz, C3),
44.91 (C4), 44.95 (C4), 47.5 (C7), 47.6 (C7), 49.7 (d, 3JC,P = 6.5Hz, C1), 49.8 (d, 3JC,P =
5.5Hz, C1), 55.20 (d, JC,P = 11.7Hz, C5H3), 55.25 (d, JC,P = 11.5Hz, C5H3), 56.6 (d, 1JC,P
= 218.4Hz, C-P), 56.8 (d, 1JC,P = 218.8Hz, C-P), 58.0 (OCH3), 58.1 (OCH3), 59.9 (d, JC,P
= 3.5Hz, C5H4), 60.0 (d, JC,P = 3.5Hz, C5H4), 60.1 (d, JC,P = 3.9Hz, C5H4), 60.2 (d, JC,P
= 3.8Hz, C5H4), 62.36 (C5H4), 62.39 (C5H4), 62.41 (C5H4), 63.99 (d, JC,P = 14.7Hz, C5H3),
64.04 (d, JC,P = 14.6Hz, C5H3), 67.3 (d, JC,P = 14.2Hz, C5H3), 67.5 (d, JC,P = 14.6Hz,
C5H3), 69.2 (C5H5), 69.3 (C5H5), 70.07 (C5H5), 70.09 (C5H5), 82.70 (d, 2JC,P = 7.5Hz, C2),
82.73 (d, 2JC,P = 7.5Hz, C2), 117.5 (m, CC5H4-O), 128.5 (d, 2JC,P = 9.8Hz, CC5H3-OCH3),
128.7 (d, 2JC,P = 10.0Hz, C-OCH3). 31P{1H} NMR (CDCl3, δ): 20.54, 20.61, 21.06, 21.11.
HRMS (ESI-TOF, m/z): calcd for C30H35Fe2O4P 602.0967, found 602.0963 [M]+.
(1R)-α-Fenchyl Ferrocenyl (2-Methoxyferrocenyl)phosphonate (44d)
(1R)-α-Fenchyl diferrocenyl phosphate (43d, 134mg, 0.22mmol), LiTMP (130mg,
0.88mmol), TMEDA (0.13mL, 0.86mmol) and Me2SO4 (0.3mL, 3.2mmol) were reacted
according to the general procedure GP3. Purification was realized by column chromatogra-
phy (silica, 2 · 10 cm column size) using a 90/10 (v/v) dichloromethane/ethyl acetate mixture
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as the eluent, giving 44d as an orange oil in a mixture of isomers.
44d
FeO P
O
OO Fc
Fn Yield: 125mg (0.20mmol, 91% based on 43d). 1H NMR (CDCl3,
δ): 0.93–1.22 (m, 11H, CH3, CH2), 1.44–1.55 (m, 2H, CH2), 1.69–
1.88 (m, 3H, CH2, CH), 3.38–3.72 (m, 3H, OCH3), 3.79–3.85 (m, 2H,
C5H4), 4.04–4.23 (m, 8H, C5H5, C5H3, H2), 4.25–4.51 (m, 8H, C5H5,
C5H3/4). 13C{1H} NMR (CDCl3, δ): 19.18 (CH3), 19.22 (CH3),
19.27 (CH3), 19.31 (CH3), 21.0 (CH3), 21.1 (CH3), 21.2 (CH3), 21.3
(CH3), 25.8–26.2 (C5/C6), 29.6–29.8 (CH3), 39.40 (d, 3JC,P = 3.0Hz, C3), 39.45–39.47 (m,
C3), 39.6 (d, 3JC,P = 2.1Hz, C3), 41.0–41.1 (C7), 47.85 (C4), 47.90 (C4), 47.99 (C4), 48.02
(C4), 49.16–49.25 (m, C1), 49.32 (d, 3JC,P = 4.7Hz, C1), 55.0–55.3 (m, C5H3), 56.45 (d,
1JC,P = 219.7Hz, C-P), 56.54 (d, 1JC,P = 219.1Hz, C-P), 57.0 (d, 1JC,P = 219.6Hz, C-P),
57.1 (d, 1JC,P = 218.3Hz, C-P), 57.8–58.0 (OCH3), 59.8 (d, JC,P = 3.4Hz, C5H4), 59.8 (d,
JC,P = 3.4Hz, C5H4), 60.1–60.2 (m, C5H4), 60.3–60.4 (m, C5H4), 60.6 (d, JC,P = 3.1Hz,
C5H4), 62.3–62.4 (m, C5H4), 63.8–64.1 (m, C5H3), 66.8 (d, JC,P = 12.3Hz, C5H3), 67.1 (d,
JC,P = 13.2Hz, C5H3), 67.2 (d, JC,P = 13.6Hz, C5H3), 67.7 (d, JC,P = 14.2Hz, C5H3),
69.17–62.22 (C5H5), 69.97–70.00 (C5H5), 88.5 (d, 2JC,P = 7.3Hz, C2), 88.95 (d, 2JC,P =
7.4Hz, C2), 89.02 (d, 2JC,P = 7.3Hz, C2), 89.5 (d, 2JC,P = 7.9Hz, C2), 117.7 (d, 2JC,P =
4.4Hz, CC5H4-O), 117.81 (d, 2JC,P = 4.6Hz, CC5H4-O), 117.84 (d, 2JC,P = 4.4Hz, CC5H4-
O), 128.41 (d, 2JC,P = 9.9Hz, CC5H3-O), 128.44 (d, 2JC,P = 10.4Hz, CC5H3-O), 128.6 (d,
2JC,P = 10.4Hz, CC5H3-O), 129.0 (d, 2JC,P = 11.2Hz, CC5H3-O). 31P{1H} NMR (CDCl3,
δ): 20.4, 20.7, 20.8, 21.5. HRMS (ESI-TOF, m/z): calcd for C31H37Fe2O4P 616.1124, found
616.1063 [M]+.
rac-/meso-Cyclohexyl Bis(2-methoxyferrocenyl)phosphinate (rac-/meso-45a)
The title compounds were obtained as side products during the synthesis of 44a by react-
ing cyclohexyl diferrocenyl phosphate (43a, 100mg, 0.18mmol), diisopropylamine (0.1mL,
0.72mmol), BuLi (0.30mL, 0.75mmol), TMEDA (0.11mL, 0.73mmol) and Me2SO4 (0.3mL,
3.2mmol) according to the general procedure GP3. Purification was realized by column chro-
matography (silica, 2 · 10 cm column size) using a 97/3 (v/v) ethyl acetate/methanol mixture
(rac-45a, Rf = 0.42; meso-45a, Rf = 0.38), both were obtained as orange oils.
meso-45a
FeO
O
O
Cy
Fe OP
meso-45a: Yield: 27mg (0.072mmol, 39% based on 43a). 1H
NMR (CDCl3, δ): 1.32–1.46 (m, 3H, CH2), 1.49–1.62 (m, 2H,
CH2), 1.69–1.89 (m, 4H, CH2), 2.05–212 (m, 1H, CH2), 3.67
(s, 3H, OCH3), 3.69 (s, 3H, OCH3), 3.96–3.97 (m, 2H, C5H3),
4.01–4.09 (m, 2H, C5H3), 4.14–4.17 (m, 2H, C5H3), 4.33 (s, 5H,
C5H5), 4.34 (s, 5H, C5H5), 4.72–4.78 (m, 1H, H1). 13C{1H}
NMR (CDCl3, δ): 23.57 (CH2), 23.61 (CH2), 25.6 (CH2), 33.8 (d, 3JC,P = 4.1Hz, CH2), 34.4
(d, 3JC,P = 3.2Hz, CH2), 55.0 (d, JC,P = 9.4Hz, C5H3), 58.0 (OCH3), 58.2 (OCH3), 63.1
(d, JC,P = 11.6Hz, C5H3), 63.3 (d, 2JC,P = 12.4Hz, C5H3), 63.6 (d, 1JC,P = 161.2Hz, C-P),
63.8 (d, 1JC,P = 155.3Hz, C-P), 67.0 (d, JC,P = 15.1Hz, C5H3), 67.1 (d, JC,P = 10.7Hz,
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C5H3), 69.8 (C5H5), 69.8 (C5H5), 73.7 (d, 2JC,P = 5.4Hz, C1), 128.3 (d, 2JC,P = 7.8Hz,
CC5H3-O), 128.6 (d, 2JC,P = 10.6Hz, CC5H3-O.) 31P{1H} NMR (CDCl3, δ): 34.2.
rac-45a
FeO
O
P
OCy
2
rac-45a: Yield: 40mg (0.105mmol, 58% based on 43a). 1H NMR
(CDCl3, δ): 1.29–1.33 (m, 3H, CH2), 1.44–1.47 (m, 1H, CH2),
1.53–1.60 (m, 1H, CH2), 1.71–1.78 (m, 2H, CH2), 1.81–1.89 (m,
2H, CH2), 3.72 (s, 6H, OCH3), 4.00–4.02 (m, 2H, C5H3), 4.18–
4.19 (m, 2H, C5H3), 4.22–4.26 (m, 12H, C5H5, C5H3), 4.46–4.53
(m, 1H, H1). 13C{1H} NMR (CDCl3, δ): 23.4 (CH2), 25.5 (CH2),
33.8 (d, 3JC,P = 3.6Hz, C2/C6), 54.8 (d, JC,P = 9.0Hz, C5H3), 58.2 (OCH3), 63.1 (d, 1JC,P
= 158.6Hz, C-P), 63.6 (d, JC,P = 12.7Hz, C5H3), 67.0 (d, JC,P = 14.6Hz, C5H3), 69.9
(C5H5), 73.8 (d, 2JC,P = 6.9Hz, C1), 128.9 (d, 2JC,P = 7.8Hz, CC5H3-O). 31P{1H} NMR
(CDCl3, δ): 35.6. HRMS (ESI-TOF, m/z): calcd for C28H33Fe2O4P + Na 599.0708, found
599.0716 [M+Na]+.
(1S)-Borneyl Bis(2-methoxyferrocenyl)phosphinate (45c)
45c
FeO
O
O
Bo
Fe OP
The title compounds was obtained as side product during the
synthesis of 44c by reacting (1S)-borneyl diferrocenyl phos-
phate (43c, 100mg, 0.18mmol), diisopropylamine (0.05mL,
0.36mmol), BuLi (0.15mL, 0.38mmol), TMEDA (0.05mL,
0.33mmol) and Me2SO4 (0.13mL, 1.37mmol) according to the
general procedure GP3. Purification was realized by column
chromatography (silica, 2 · 10 cm column size) using a 95/5 (v/v) ethyl acetate/methanol
mixture as the eluent, giving 45c as an orange oil in a mixture of diastereomers.
Yield: 42mg (0.067mmol, 37% based on 43c). 1H NMR (CDCl3, δ): 0.74 (CH3), 0.80 (CH3),
0.84 (CH3), 1.17–1.30 (m, 3H, CH2), 1.59–1.60 (m, 1H, H4), 1.68–1.76 (m, 1H, CH2), 2.07–
2.14 (m, 1H, CH2), 2.16–2.24 (m, 1H, CH2), 3.71 (s, 3H, OCH3), 3.72 (s, 3H, OCH3),
3.98–4.00 (m, 1H, C5H3), 4.00–4.02 (m, 1H, C5H3), 4.13–4.14 (m, 1H, C5H3), 4.18–4.19 (m,
3H, C5H3), 4.27 (s, 5H, C5H5), 4.31 (s, 5H, C5H5), 4.66–4.71 (m, 1H, H2). 13C{1H} NMR
(CDCl3, δ): 13.04 (CH3), 18.7 (CH3), 19.9 (CH3), 26.4 (C5/C6), 28.2 (C5/C6), 37.5 (C3),
45.1 (C4), 47.3 (C7), 49.8 (d, 3JC,P = 6.2Hz, C1), 54.6 (d, JC,P = 8.9Hz, C5H3), 54.7 (d,
JC,P = 8.9Hz, C5H3), 58.0 (OCH3), 58.1 (OCH3), 62.2 (d, 1JC,P = 158.8Hz, C-P), 62.7 (d,
1JC,P = 158.4Hz, C-P), 63.5 (C5H3), 63.6 (C5H3), 67.0 (d, JC,P = 14.1Hz, C5H3), 67.1 (d,
JC,P = 14.5Hz, C5H3), 69.8 (C5H5), 69.9 (C5H5), 80.4 (d, 2JC,P = 6.4Hz, C2), 128.8 (d,
2JC,P = 7.6Hz, CC5H3-O), 129.3 (d, 2JC,P = 7.3Hz, CC5H3-O). 31P{1H} NMR (CDCl3, δ):
36.8. HRMS (ESI-TOF, m/z): calcd for C30H35Fe2O4P 602.0967, found 602.0963 [M]+.
(1R)-α-Fenchyl Bis(2-methoxyferrocenyl)phosphinate (45d)
(1R)-α-Fenchyl ferrocenyl (2-methoxyferrocenyl) phosphonate (44d, 168mg, 0.27mmol),
diisopropylamine (0.08mL, 0.55mmol), BuLi (0.22mL, 0.55mmol), TMEDA (0.09mL,
0.55mmol) and Me2SO4 (0.3mL, 3.16mmol) were reacted according to the general procedure
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GP3. Purification was realized by column chromatography (silica, 2 · 10 cm column size) us-
ing a 98/2 (v/v) ethyl acetate/methanol mixture as the eluent, giving 45d as an orange oil
in a mixture of isomers.
45d
FeO
O
O
Fn
Fe OP
Yield: 171mg (0.265mmol, 97% based on 44d). 1H NMR
(CDCl3, δ): 0.69–1.12 (m, 11H, CH3, CH2), 1.39–1.46 (m, 2H,
CH2), 1.61–1.67 (m, 1H, H4), 1.71–1.78 (m, 1H, CH2), 1.85–
1.97 (m, 1H, CH2), 3.55–4.07 (m, 9H, OCH3, H2, C5H3), 4.13–
4.43 (m, 14H, C5H5, C5H3). 13C{1H} NMR (CDCl3, δ): 19.1
(CH3), 19.32 (CH3), 19.35 (CH3), 21.2 (CH3), 21.5 (CH3), 21.6
(CH3), 25.8–26.9 (C5/C6), 29.3 (CH3), 29.36 (CH3), 29.40 (CH3)29.7 (CH3), 39.3 (d, 3JC,P
= 1.7Hz, C3), 39.4 (d, 3JC,P = 2.1Hz, C3), 39.6 (d, 3JC,P = 3.3Hz, C3), 41.1 (C7), 41.2
(C7), 41.3 (C7), 48.0 (C4), 48.1 (C4), 48.2 (C4), 49.25 (d, 3JC,P = 3.7Hz, C3), 49.34 (d,
3JC,P = 4.8Hz, C3), 54.3 (d, JC,P = 9.9Hz, C5H3), 54.6 (d, JC,P = 9.3Hz, C5H3), 54.7 (d,
JC,P = 9.0Hz, C5H3), 54.8 (d, JC,P = 8.9Hz, C5H3), 57.40 (OCH3), 57.44 (OCH3), 57.78
(OCH3), 57.85 (OCH3), 58.0 (OCH3), 58.2 (OCH3), 61.7 (d, 1JC,P = 165.7Hz, C-P), 62.1 (d,
1JC,P = 159.1Hz, C-P), 62.4 (d, 1JC,P = 158.6Hz, C-P), 62.6 (d, 1JC,P = 160.7Hz, C-P),
63.0 (d, JC,P = 12.0Hz, C5H3), 63.1 (d, JC,P = 11.6Hz, C5H3), 63.5 (d, JC,P = 12.7Hz,
C5H3), 63.7 (d, JC,P = 12.9Hz, C5H3), 67.1 (d, JC,P = 15.0Hz, C5H3), 67.3 (d, JC,P =
15.0Hz, C5H3), 68.8 (d, JC,P = 9.7Hz, C5H3), 68.8 (d, JC,P = 10.2Hz, C5H3), 69.6 (C5H5),
69.7 (C5H5), 69.8 (C5H5), 87.5 (d, 2JC,P = 7.2Hz, C2), 87.8 (d, 2JC,P = 7.2Hz, C2), 88.0 (d,
2JC,P = 7.0Hz, C2), 129.0 (d, 2JC,P = 7.5Hz, CC5H3-O), 129.1 (d, 2JC,P = 7.1Hz, CC5H3-
O). 31P{1H} NMR (CDCl3, δ): 35.68, 35.74, 36.7, 38.0. HRMS (ESI-TOF, m/z): calcd for
C32H39Fe2O4P 630.1280, found 630.1222 [M]+.
Diferrocenyl (2-Methoxyferrocenyl)phosphonate (52)
O
Fe O
P
52
FeO
2
Triferrocenyl phosphate (47, 270mg, 0.415mmol), diisopropy-
lamine (0.23mL, 1.66mmol), BuLi (0.66mL, 1.66mmol) and
Me2SO4 (0.16mL, 1.69mmol) were reacted at –30℃ according
to the general procedure GP2. Purification was realized by col-
umn chromatography (silica, 2.5 · 10 cm column size) using a 9/1
dichloromethane/ethyl acetate mixture (v/v) as the eluent, giving
52 as an orange solid.
Yield: 106mg (0.16mmol, 86% based on 47). Anal. calcd for C31H29Fe3O4P · 1/6 C6H14
(664.07 · 1/6 86.18 g/mol): C, 56.65; H, 4.65. Found: C, 56.65; H, 4.71. Mp.: 166–168℃.
1H NMR (CDCl3, δ): 3.74 (s, 3H, OCH3), 3.85–3.90 (m, 4H, C5H4), 4.09–4.11 (m, 1H,
C5H3/C5H4), 4.21 (s, 5H, C5H5), 4.24 (s, 5H, C5H5), 4.26–4.29 (m, 2H, C5H4, C5H3), 4.31
(s, 5H, C5H5), 4.41–4.43 (m, 1H, C5H4), 4.47–4.49 (m, 2H, C5H4), 4.49–4.51 (m, 1H, C5H4).
13C{1H} NMR (CDCl3, δ): 55.3 (d, 1JC,P = 219.8Hz, C-P), 55.5 (d, JC,P = 11.9Hz, C5H3),
58.2 (OCH3), 59.9 (d, JC,P = 3.7Hz, C5H4), 60.1 (d, JC,P = 3.8Hz, C5H4), 60.25 (d, JC,P
= 4.1Hz, C5H4), 60.29 (d, JC,P = 3.6Hz, C5H4), 62.57–62.62 (m, C5H4), 64.4 (d, JC,P =
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14.8Hz, C5H3), 67.3 (d, JC,P = 14.0Hz, C5H3), 69.48 (C5H5), 69.53 (C5H5), 70.23 (C5H5),
117.4 (d, 2JC,P = 5.5Hz, CC5H4-O), 117.5 (d, 2JC,P = 6.0Hz, CC5H4-O), 128.9 (d, 2JC,P
= 10.8Hz, CC5H3-O). 31P{1H} NMR (CDCl3, δ): 18.8. HRMS (ESI-TOF, m/z): calcd for
C31H29Fe3O4P 663.9848, found 663.9809 [M]+.
Ferrocenyl Bis(2-methoxyferrocenyl)phosphinate (53)
Fe O
53
FeO
P OFc
O Diferrocenyl (2-methoxyferrocenyl)phosphonate (52, 135mg,
0.203mmol), diisopropylamine (0.13mL, 0.87mmol), BuLi
(0.35mL, 0.87mmol) and Me2SO4 (0.1mL, 1.05mmol) were
reacted 0℃ according to the general procedure GP2. Purification
was realized by column chromatography (silica, 2.5 · 10 cm column
size) using a 1/4 dichloromethane/ethyl acetate mixture (v/v) as
the eluent, giving 53 as an orange solid. The title compound was obtained as a mixture
of two diastereomers in a ratio of 1 : 0.128. Solely the data of the main diastereomer are
reported, due to the low intensity of the minor one. Note for experiments with additional
amounts of Phenol (6 equiv), diisopropylamine (6 equiv) and BuLi (12 equiv) were used. In
this case, the product was obtained as a single diastereomer.
Yield: 121mg (0.178mmol, 86% based on 52). Anal. calcd for C32H31Fe3O4P
(678.09 g/mol): C, 56.68; H, 4.61. Found: C, 56.54; H, 4.62. Mp.: 193–197℃. 1H NMR
(CDCl3, δ): 3.69 (s, 6H, OCH3), 3.78 (pt, 3,4JH,H = 1.9Hz, 2H, C5H4), 4.06–4.07 (m,
2H, C5H3), 4.19–4.20 (m, 2H, C5H3), 4.22 (s, 5H, C5H5), 4.27 (s, 10H, C5H5), 4.30 (pt,
3,4JH,H = 1.8Hz, 2H, C5H4), 4.39–4.40 (m, 2H, C5H3). 13C{1H} NMR (CDCl3, δ): 54.8
(d, JC,P = 9.9Hz, C5H3), 60.5 (d, JC,P = 3.4Hz, C2/5C5H4), 62.1 (d, 1JC,P = 162.5Hz,
C-P), 62.4 (C3/4C5H4), 63.6 (d, JC,P = 12.2Hz, C5H3), 68.0 (d, JC,P = 11.5Hz, C5H3), 69.3
(C5H5), 69.9 (C5H5), 117.1 (d, 2JC,P = 5.8Hz, CC5H4-O), 128.5 (d, 2JC,P = 10.7Hz, CC5H3-
O). 31P{1H} NMR (CDCl3, δ): 37.3. HRMS (ESI-TOF, m/z): calcd for C32H31Fe3O4P
678.0004, found 677.9992 [M]+.
Diphenyl (2-Hydroxyphenyl)phosphonate (56)
56
OH
P
O
O
2
Triphenyl phosphate (55, 100mg, 0.307mmol), diisopropylamine
(0.25mL, 1.84mmol), BuLi (0.74mL, 1.84mmol) and HCl (0.5mL,
5mmol) were reacted at –80℃ according to the general procedure
GP2. Purification was realized by column chromatography (silica,
2.5 · 10 cm column size) using dichloromethane as the eluent, giving
56 as an colorless solid.
Yield: 75mg (0.230mmol, 75% based on 55). Anal. calcd for C18H15O4P (326.28 g/mol):
C, 66.26; H, 4.63. Found: C, 66.27; H, 4.57. Mp.: 127–129℃. 1H NMR (CDCl3, δ): 6.94–
6.98 (m, 2H, C5/6C6H4), 7.16–7.20 (m, 6H, C4/2/6C6H5), 7.30–7.33 (m, 4H, C3/5C6H5),
7.45–7.48 (m, 1H, C4C6H4), 7.62 (ddd, JH,P = 14.8Hz, JH,H = 7.9Hz, JH,H = 1.5Hz, 2H,
C3C6H4), 9.86 (s, 1H, OH). 13C{1H} NMR (CDCl3, δ): 107.4 (d, 1JC,P = 185.7Hz, C1C6H4-
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P), 118.0 (d, 3JC,P = 12.7Hz, C6H4), 119.8 (d, 2JC,P = 14.3Hz, C6H4), 120.5 (d, 3JC,P
= 4.6Hz, C2/6C6H5), 125.5 (d, 5JC,P = 1.1Hz, C4C6H5), 129.8 (C3/5C6H5), 131.8 (d, JC,P
= 6.0Hz, C6H4), 136.0 (d, 4JC,P = 2.3Hz, C4C6H4), 149.8 (d, 2JC,P = 6.9Hz, C1C6H5-O),
162.2 (d, 2JC,P = 7.7Hz, C2C6H4-O). 31P{1H} NMR (CDCl3, δ): 14.9. HRMS (ESI-TOF,
m/z): calcd for C18H15O4P+H 327.0781, found 327.0767 [M+H]+.
Phenyl Bis(2-hydroxyphenyl)phosphinate (57)
57
OH
P
O
2
O
Triphenyl phosphate (55, 100mg, 0.307mmol), diisopropylamine
(0.25mL, 1.84mmol), BuLi (0.74mL, 1.84mmol) and HCl (0.5mL,
5mmol) were reacted at –70℃ according to the general procedure
GP2. Purification was realized by column chromatography (silica,
2.5 · 10 cm column size) using dichloromethane as the eluent, giving
57 as an colorless oil.
Yield: 45mg (0.238mmol, 45% based on 55). 1H NMR (CDCl3, δ): 6.93–6.97 (m, 4H,
C6H4), 7.12–7.15 (m, 1H, C4C6H5), 7.17–7.20 (m, 2H, C6H5), 7.26–7.29 (m, 2H, C3/5C6H5),
7.41–7.45 (m, 2H, C4C6H4), 7.59 (ddd, JH,P = 13.5Hz, JH,H = 8.1Hz, JH,H = 1.7Hz, 2H,
C6H4), 9.85 (s, 2H, OH). 13C{1H} NMR (CDCl3, δ): 110.9 (d, 1JC,P = 140.3Hz, C1C6H4-P),
118.5 (d, JC,P = 9.7Hz, C6H4), 119.9 (d, JC,P = 12.9Hz, C6H4), 120.6 (d, 3JC,P = 5.0Hz,
C2/6C6H5), 125.5 (d, 5JC,P = 0.9Hz, C4C6H5), 129.9 (d, 4JC,P = 0.5Hz, C3/5C6H5), 131.6
(d, JC,P = 7.8Hz, C6H4), 135.6 (d, 4JC,P = 2.1Hz, C4C6H4), 150.0 (d, 2JC,P = 8.8Hz,
C1C6H5-O), 162.2 (d, 2JC,P = 5.6Hz, C2C6H4-O). 31P{1H} NMR (CDCl3, δ): 42.3. HRMS
(ESI-TOF, m/z): calcd for C18H15O4P+H 327.0781, found 327.0767 [M+H]+.
Tris(2-hydroxyphenyl)phosphine Oxide (58)
58
OH
P
3
O Applying the same reaction conditions as for the synthesis of 56 and 57 at
0℃ gave the title compound. The spectroscopic data correspond with those
reported in reference 185.
Yield: 90mg (276mmol, 90% based on 55). 1H NMR (CDCl3, δ): 6.89–6.91
(m, 3H), 6.99–7.05 (m, 6H), 7.44–7.47 (m, 3H), 9.20 (s, 3H, OH). 13C{1H}
NMR (CDCl3, δ): 111.9 (d, 1JC,P = 107.3Hz, C1-P), 118.7 (d, JC,P = 7.3Hz),
119.8 (d, JC,P = 12.9Hz), 132.0 (d, JC,P = 10.5Hz), 135.4 (d, 5JC,P = 1.6Hz,
C4), 162.2 (d, 2JC,P = 2.6Hz, C2-O). 31P{1H} NMR (CDCl3, δ): 51.1.
Diferrocenyl (2-Hydroxyphenyl)phosphonate (59a)
Diferrocenyl phenyl phosphate (48, 100mg, 0.184mmol), diisopropylamine (0.12mL,
0.85mmol), BuLi (0.30mL, 0.75mmol) and Me2SO4 (0.12mL, 1.27mmol) were reacted at
–60℃ according to the general procedure GP2. Purification was realized by column chro-
matography (silica, 2.5 · 10 cm column size) using dichloromethane containing 0 - 50 % ethyl
acetate (v/v) as the eluents giving 59a,b and 60.
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59a
OH
P
O
Fe O
2
Orange Solid. Yield: 27% based on 48. Anal. calcd for
C26H23Fe2O4P (542.12 g/mol): C, 57.60; H, 4.28. Found: C, 57.29;
H, 4.38. Mp.: 155–159℃. 1H NMR (CDCl3, δ): 3.86–3.89 (m, 4H,
H3/4C5H4), 4.19 (s, 10H, C5H5), 4.30–4.31 (m, 2H, H2/5C5H4),
4.35–4.36 (m, 2H, H2/5C5H4), 6.94–7.01 (m, 2H, C6H4), 7.44 (ddd,
3JH,P = 14.9Hz, JH,H = 7.8Hz, JH,H = 1.7Hz, 1H, C6H4), 7.47–
7.51 (m, 1H, C6H4), 9.98 (d, 4JH,P = 0.7Hz, OH). 13C{1H} NMR (CDCl3, δ): 59.6 (d, 3JC,P
= 3.8Hz, C2,5C5H4), 59.8 (d, 3JC,P = 4.4Hz, C2,5C5H4), 62.9 (C3,4C5H4), 63.0 (C3,4C5H4),
69.6 (C5H5), 107.7 (d, 1JC,P = 184.0Hz, C1C5H4-P), 117.1 (d, 2JC,P = 4.5Hz, CC5H4-O),
118.0 (d, JC,P = 12.7Hz, C6H4), 119.7 (d, JC,P = 14.2Hz, C6H4), 131.9 (d, JC,P = 6.0Hz,
C6H4), 136.0 (d, 4JC,P = 2.5Hz, C4C6H4), 162.2 (d, 2JC,P = 7.8Hz, C2C6H4-OH). 31P{1H}
NMR (CDCl3, δ): 15.8. HRMS (ESI-TOF, m/z): calcd for C26H23Fe2O4P 542.0028, found
542.0035 [M]+.
Diferrocenyl (2-Methoxyphenyl)phosphonate (59b)
59b
O
P
O
Fe O
2
The orange oil was obtained under the same reactions conditions
as 59a. Yield: 13% based on 48. Anal. calcd for C27H25Fe2O4P
(556.15 g/mol): C, 57.60; H, 4.28. Found: C, 57.29; H, 4.38. 1H
NMR (CDCl3, δ): 3.84 (pt, 3,4JH,H = 2.0Hz, 4H, H3,4C5H4), 3.92
(s, 3H, OCH3), 4.20 (s, 10H, C5H5), 4.37–4.39 (m, 4H, H2,5), 6.96
(dd, JH,H = 7.8Hz, JH,P = 7.8Hz, 1H, C6H4), 7.05 (tdd, JH,H =
7.5Hz, JH,P = 3.8Hz, JH,H = 0.7Hz, 1H, C6H4), 7.55 (ddd, JH,H
= 8.3Hz, JH,H = 7.4Hz, JH,H = 1.8Hz, JH,P = 0.9Hz, 1H, C4C6H4), 7.91 (ddd, JH,P =
15.5Hz, JH,H = 7.6Hz, JH,H = 1.7Hz, 1H, C6H4). 13C{1H} NMR (CDCl3, δ): 55.8 (OCH3),
59.9 (d, 3JC,P = 3.9Hz, C2,5C5H4), 60.0 (d, 3JC,P = 4.0Hz, C2,5C5H4), 62.61 (C3,4C5H4),
62.65 (C3,4C5H4), 69.5 (C5H5), 111.3 (d, JC,P = 9.8Hz, C6H4), 115.1 (d, 1JC,P = 190.3Hz,
C1C6H4-P), 117.3 (d, 2JC,P = 5.0Hz, CC5H4-O), 120.5 (d, JC,P = 15.3Hz, C6H4), 135.1 (d,
4JC,P = 2.1Hz, C4C6H4), 135.6 (d, JC,P = 7.7Hz, C6H4), 161.5 (d, 2JC,P = 2.7Hz, C2C6H4-
OH). 31P{1H} NMR (CDCl3, δ): 11.5. HRMS (ESI-TOF, m/z): calcd for C27H25Fe2O4P
556.0185, found 556.0175 [M]+.
Ferrocenyl Phenyl (2-Methoxyferrocenyl)phosphonate (60)
60
OPh
O
Fe
P
O
FcO
The orange oil was obtained under the same reactions conditions as 59a.
Yield: 29% based on 48. Anal. calcd for C27H25Fe2O4P (556.15 g/mol):
C, 58.31; H, 4.53. Found: C, 58.14; H, 4.74. 1H NMR (CDCl3, δ): 3.728
(s, 2.25H, OCH3), 3.734 (s, 0.75H, OCH3), 3.83–3.85 (m, 1.5H, C5H4/3),
3.86–3.87 (m, 0.5H, C5H4/3), 4.08–4.12 (m, 1H, C5H4/3), 4.15 (s, 3.75,
OCH3), 4.19–4.21 (m, 1.5H, OCH3, C5H4/3), 4.24–4.28 (m, 6H, C5H5,
C5H4/3), 4.30–4.31 (m, 0.25H, C5H4/3), 4.32–4.34 (m, 0.75H, C5H4/3),
4.37–4.38 (m, 0.75H, C5H4/3), 4.45–4.45 (m, 0.75H, C5H4/3), 4.50–4.51 (m, 0.25H, C5H4/3),
7.13–7.20 (m, 1H, C4C6H5), 7.27–7.38 (m, 4H, C6H5). 13C{1H} NMR (CDCl3, δ): 55.4 (d,
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1JC,P = 221.4Hz, CC5H3-P), 55.55 (d, JC,P = 12.1Hz, C5H3), 55.59 (d, JC,P = 12.1Hz,
C5H3), 58.2 (s, OCH3), 59.9 (d, JC,P = 4.0Hz, C5H4), 60.18–60.23 (m, C5H4), 60.4 (d, JC,P
= 3.4Hz, C5H4), 62.55–62.63 (m, C5H4), 64.40 (d, JC,P = 14.8Hz, C5H3), 64.44 (d, JC,P
= 14.9Hz, C5H3), 67.19 (d, JC,P = 14.5Hz, C5H3), 67.21 (d, JC,P = 14.5Hz, C5H3), 69.40
(C5H5), 69.45 (C5H5), 69.47 (C5H5), 70.17 (C5H5), 117.5 (d, 2JC,P = 5.4Hz, CC5H4-O),
120.7 (d, 3JC,P = 4.7Hz, C2/6C6H5), 120.9 (d, 3JC,P = 4.8Hz, C2/6C6H5), 124.71 (d, 5JC,P
= 0.7Hz, C4C6H5), 124.74 (d, 5JC,P = 0.7Hz, C4C6H5), 128.7 (d, 2JC,P = 10.6Hz, CC5H3-O),
129.4 (C3/5C6H5), 129.5 (C3/5C6H5), 150.9 (d, 2JC,P = 7.6Hz, C1C6H5-O). 31P{1H} NMR
(CDCl3, δ): 18.3 (100%), 18.5 (27.9%). HRMS (ESI-TOF, m/z): calcd for C27H25Fe2O4P
556.0185, found 556.0181 [M]+.
Ferrocenyl (2-Hydroxyphenyl)(2-methoxyferrocenyl)phosphinate (61a)
OHO
Fe
P
O
FcO
61a
Diferrocenyl phenyl phosphate (48, 100mg, 0.184mmol), diisopropy-
lamine (0.18mL, 1.29mmol), BuLi (0.52mL, 1.30mmol) and Me2SO4
(0.24mL, 2.54mmol) were reacted at 0℃ according to the general
procedure GP2. Purification was realized by column chromatography
(silica, 2.5 · 10 cm column size) using dichloromethane containing 0 -
50 % ethyl acetate (v/v) as the eluents giving 61a,b.
The orange oil was formed with a de of 0.04 (racemic mixture). Yield:
77% based on 48. 1H NMR (CDCl3, δ): 3.67 (s, 1.5H, OCH3), 3.78–3.80 (m, 1.5H,
C5H4/3), 3.82–3.83 (m, 2H, OCH3, C5H4/3), 4.10–4.12 (m, 0.5H, C5H4/3), 4.15–4.16 (m,
0.5H, C5H4/3), 4.17–4.23 (m, 9H, C5H5, C5H4/3), 4.26 (ptd, JH,P = 2.8, 3,4JH,H = 1.5Hz,
0.5H, C5H4/3), 4.31–4.32 (m, 1H, C5H4/3), 4.41–4.42 (m, 3H, C5H5, C5H4/3), 4.47–4.48
(m, 0.5H, C5H4/3), 6.83 (tdd, JH,H = 7.5Hz, JH,P = 2.9Hz, JH,H = 1.0Hz, 0.5Hz, C6H4),
6.87–6.92 (m, 2H, C6H4),6.96 (ddd, JH,H = 8.3Hz, JH,P = 5.8Hz, JH,H = 0.6Hz, 0.5H,
C6H4), 7.35–7.42 (m, 1H, C6H4), 7.44 (ddd, JH,P = 14.7Hz, JH,H = 7.8Hz, JH,H = 1.7Hz,
0.5H, C6H4), 7.52 (ddd, JH,P = 14.9Hz, JH,H = 7.8Hz, JH,H = 1.7Hz, 0.5H, C6H4), 10.95
(d, JH,P = 0.7Hz, 0.5H, OH), 10.99 (d, JH,P = 0.7Hz, 0.5H, OH). 13C{1H} NMR (CDCl3,
δ): 55.7 (d, JC,P = 10.2Hz, C5H3), 55.9 (d, JC,P = 10.3Hz, C5H3), 58.26 (s, OCH3), 58.33
(s, OCH3), 59.92 (d, JC,P = 4.2Hz, C5H4), 59.94 (d, 1JC,P = 166.4Hz, CC5H3-P), 59.96 (d,
JC,P = 4.2Hz, C5H4), 60.01 (d, JC,P = 4.1Hz, C5H4), 60.3 (d, JC,P = 3.9Hz, C5H4), 62.7
(d, JC,P = 3.3Hz, C5H4), 62.8 (d, JC,P = 6.8Hz, C5H4), 64.4 (d, JC,P = 12.2Hz, C5H3),
64.7 (d, JC,P = 13.9Hz, C5H3), 67.0 (d, JC,P = 15.9Hz, C5H3), 67.4 (d, JC,P = 10.8Hz,
C5H3), 69.48 (C5H5), 69.51 (C5H5), 69.97 (C5H5), 70.18 (C5H5), 112.3 (d, 1JC,P = 134.0Hz,
C1C6H4-P), 112.8 (d, 1JC,P = 139.1Hz, C1C6H4-P), 117.18 (d, 2JC,P = 6.6Hz, CC5H4-O),
117.23 (d, 2JC,P = 6.2Hz, CC5H4-O), 117.62 (C6H4), 117.69 (C6H4), 117.70 (C6H4), 118.9 (d,
JC,P = 13.5Hz, C6H4), 119.1 (d, JC,P = 13.5Hz, C6H4), 128.2 (d, 2JC,P = 11.4Hz, CC5H3-
O), 128.7 (d, 2JC,P = 8.5Hz, CC5H3-O), 131.3 (d, JC,P = 10.0Hz, C6H4), 132.1 (d, JC,P =
9.5Hz, C6H4), 134.6 (d, 4JC,P = 2.3Hz, C4C6H4), 134.7 (d, 4JC,P = 2.2Hz, C4C6H4), 162.15
(d, 2JC,P = 5.8Hz, C2C6H4-OH), 162.19 (d, 2JC,P = 5.4Hz, C2C6H4-OH). 31P{1H} NMR
(CDCl3, δ): 43.4 (100%), 43.5 (92.3%). HRMS (ESI-TOF, m/z): calcd for C27H25Fe2O4P
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556.0185, found 556.0120 [M]+.
Ferrocenyl (2-Methoxyferrocenyl)(2-methoxyphenyl)phosphinate (61b)
OO
Fe
P
O
FcO
61b
The orange oil was formed within the synthesis of 61a in 13% yield as
a mixture of two diastereomers with a ratio of 0.55 (a = major) : 0.45
(b = mi) resulting a de of 0.11. Anal. calcd for C28H27Fe2O4P · 1/6
C6H14 (570.18 · 86.18 g/mol): C, 59.59; H, 5.05. Found: C, 59.78; H,
5.24. 1H NMR (CDCl3, δ): 3.60 (s, 1.65H, OCH3), 3.72 (s, 1.65H,
OCH3), 3.74 (s, 1.35H, OCH3), 3.76–3.78 (m, 2H, C5H3), 3.82 (s,
1.35H, OCH3), 4.01 (dpt, JH,P = 2.7Hz, 3,4JH,H = 2.7Hz, 0.45H,
C5H3), 4.05 (dpt, JH,P = 2.6Hz, 3,4JH,H = 2.6Hz, 0.55H, C5H3), 4.11 (dpt, JH,P = 2.7Hz,
3,4JH,H = 1.5Hz, 0.45H, C5H4/3), 4.17–4.21 (m, 6.0H, C5H4/3, C5H5), 4.23–4.24 (m, 2.7H,
C5H4/3, C5H5), 4.26–4.27 (m, 0.55H, C5H4/3), 4.37–4.39 (m, 1.1H, C5H4/3), 4.43–4.45 (m,
3.2H, C5H4/3, C5H5), 6.80 (dd, JH,H = 8.2Hz, JH,P = 6.1Hz, 0.55Hz, C6H4), 6.89 (dd,
JH,H = 8.1Hz, JH,P = 6.2Hz, 0.45Hz, C6H4), 7.01 (dddd, JH,H = 7.5Hz, JH,H = 7.5Hz,
JH,P = 2.8Hz, JH,H = 1.0Hz, 0.55H, C6H4), 7.06 (dddd, JH,H = 7.3Hz, JH,H = 7.3Hz,
JH,P = 2.6Hz, JH,H = 0.9Hz, 0.45H, C6H4), 7.44 (dddd, JH,H = 8.4Hz, JH,H = 7.4Hz,
JH,H = 1.8Hz, JH,P = 0.8Hz, 0.55H, C6H4), 7.48 (dddd, JH,H = 8.3Hz, JH,H = 7.3Hz,
JH,H = 1.8Hz, JH,P = 0.9Hz, 0.45H, C6H4), 7.97 (ddd, JH,P = 14.1Hz, JH,H = 7.6Hz, JH,H
= 1.8Hz, 0.45H, C6H4), 8.02 (ddd, JH,P = 14.1Hz, JH,H = 7.6Hz, JH,H = 1.8Hz, 0.55H,
C6H4). 13C{1H} NMR (CDCl3, δ): 55.0 (d, a, JC,P = 10.7Hz, C5H3), 55.24 (s, a, OCH3),
55.28 (d, b, JC,P = 9.8Hz, C5H3), 55.4 (s, b, OCH3), 58.26 (s, b, OCH3), 58.29 (s, a, OCH3),
60. 0 (d, a, JC,P = 3.9Hz, C5H4), 60.4 (d, b, JC,P = 3.8Hz, C5H4), 60.5 (d, a, JC,P = 3.6Hz,
C5H4), 60.6 (d, b, JC,P = 3.9Hz, C5H4), 61.4 (d, a, 1JC,P = 164.5Hz, CC5H3-P), 62.30 (s,
C5H4), 62.31 (s, C5H4), 62.38 (s, C5H4), 63.4 (d, a, JC,P = 12.2Hz, C5H3), 63.8 (d, b, JC,P
= 13.4Hz, C5H3), 67.3 (d, b, JC,P = 16.4Hz, C5H3), 67.7 (d, a, JC,P = 10.3Hz, C5H3), 69.33
(s, a, C5H5), 69.35 (s, b, C5H5), 69.98 (s, b, C5H5), 70.00 (s, b, C5H5), 110.9 (d, a, JC,P
= 7.6Hz, C6H4), 111.1 (d, b, JC,P = 7.5Hz, C6H4), 117.4 (d, a, 2JC,P = 4.4Hz, CC5H4-O),
117.9 (d, b, 2JC,P = 6.1Hz, CC5H4-O), 120.1 (d, a, 1JC,P = 135.1Hz, C1C6H4-P), 120.3 (d, b,
1JC,P = 138.3Hz, CC6H4-P), 120.5 (d, JC,P = 12.7Hz, C6H4), 129.7 (d, a, 2JC,P = 12.8Hz,
CC5H3-O), 134.00 (C4C6H4), 134.02 (C4C6H4), 134.05 (C4C6H4), 135.1 (d, b, JC,P = 7.8Hz,
C6H4), 135.6 (d, a, JC,P = 7.5Hz, C6H4), 160.7 (d, a, 2JC,P = 4.0Hz, CC6H4-O), 160.9 (d, b,
2JC,P = 3.5Hz, CC6H4-O). 31P{1H} NMR (CDCl3, δ): 29.9 (100%), 33.7 (80.5%). HRMS
(ESI-TOF, m/z): calcd for C28H27Fe2O4P 570.0341, found 556.0350 [M]+.
Ferrocenyl Phenyl (2-Hydroxyphenyl)phosphonate (62)
Ferrocenyl diphenyl phosphate (11, 200mg, 0.461mmol), diisopropylamine (0.51mL,
3.685mmol), BuLi (1.47mL, 3.675mmol) and Me2SO4 (0.35mL, 3.69mmol) were at –70℃
reacted according to the general procedure GP2. Purification was realized by column chro-
matography (silica, 2.5 · 10 cm column size) using dichloromethane containing 0 - 40 % ethyl
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acetate (v/v) as the eluent, giving 62 as an orange oil.
62
P
OPhO
Fe O
HO
Yield: 116mg (0.267mmol, 58% based on 11). Anal. calcd for
C22H19FeO4P (434.20 g/mol): C, 60.86; H, 4.41. Found: C, 60.61;
H, 4.75. 1H NMR (CDCl3, δ): 3.86–3.89 (m, 2H, H3/4C5H4), 4.18
(s, 5H, C5H5), 4.33–4.35 (m, 1H, H2/5C5H4), 4.37–4.39 (m, 1H,
H2/5C5H4), 6.94–6.99 (m, 2H, C6H4), 7.16–7.19 (m, 3H, C6H5), 7.30–
7.34 (m, 2H, C6H5), 7.46–7.49 (m, 1H, C6H4), 7.53 (dddd, JH,P =
15.1Hz, JH,H = 7.7Hz, JH,H = 1.9Hz, JH,H = 0.6Hz, 1H, C6H4), 9.92 (d, 4JH,P = 0.5Hz,
1H, OH). 13C{1H} NMR (CDCl3, δ): 59.6 (d, 3JC,P = 3.8Hz, C2/5C5H4), 59.9 (d, 3JC,P =
4.2Hz, C2/5C5H4), 62.92 (s, C3/4C5H4), 62.99 (s, C3/4C5H4), 69.6 (C5H5), 107.5 (d, 1JC,P
= 184.6Hz, CC6H4-P), 117.1 (d, 2JC,P = 4.5Hz, CC5H4-O), 118.0 (d, JC,P = 12.7Hz, C6H4),
119.7 (d, JC,P = 14.3Hz, C6H4), 120.4 (d, JC,P = 4.6Hz, C6H5), 125.5 (d, JC,P = 1.0Hz,
C6H5), 129.8 (C6H5), 131.8 (d, JC,P = 6.1Hz, C6H4), 136.0 (d, JC,P = 2.4Hz, C6H4), 149.8
(d, JC,P = 6.9Hz, CC6H5-O), 162.2 (d, JC,P = 7.8Hz, CC6H4-OH). 31P{1H} NMR (CDCl3,
δ): 15.4. HRMS (ESI-TOF, m/z): calcd for C22H19FeO4P 434.0365, found 434.0632 [M]+.
Ferrocenyl (2-Hydroxyphenyl)(2-methoxyphenyl)phosphinate (63)
63 (R = H, CH3)
OR
P
2
O
Fe O
Compound 63 was obtained by running the reaction for the syn-
thesis of 62 at 0℃. Compound 63 was obtained as an orange oil
in a mixture with 64a. Both compounds could not be separated
applying several chromatographic methods. Yield: 11% based on
11. 1H NMR (CDCl3, δ): 3.76 (s, 3H, OCH3), 3.80–3.82 (m, 1H,
C5H4), 3.83–3.85 (m, 1H, C5H4), 4.19 (s, 5H, C5H5), 4.24–4.25 (m,
1.0H, C5H4), 4.40–4.41 (m, 1H, C5H4), 6.77–6.82 (m, 1H, C6H4), 6.90–6.96 (m, 2H, C6H4),
7.07–7.11 (m, 1H, C6H4), 7.20–7.24 (m, 1H, C6H4), 7.36–7.40 (m, 1H, C6H4), 7.52–7.56 (m,
1H, C6H4), 7.92 (ddd, JH,P = 13.3Hz, JH,H = 7.6Hz, JH,H = 1.7Hz, 1H, C6H4), 7.63 (ddd,
JH,P = 14.8Hz, JH,H = 7.9Hz, JH,H = 1.7Hz, 0.8Hz, C6H4), 10.74 (d, 4JH,P = 0.4Hz, 1H,
OH). 13C{1H} NMR (CDCl3, δ): 55.8 (s, OCH3), 60.0 (d, 3JC,P = 4.1Hz, C5H4), 60.2 (d,
3JC,P = 4.1Hz, C5H4), 62.80 (s, C5H4), 62.83 (s, C5H4), 69.6 (s, C5H5), 111.8 (d, JC,P =
8.3Hz, CC6H4OMe), 112.1 (d, 1JC,P = 135.6Hz, C1C6H4OH -P), 117.2 (d, 2JC,P = 6,4Hz,
CC5H4-O), 118.9 (d, JC,P = 13.5Hz, C6H4), 119.0 (d, 1JC,P = 146.9Hz, C1C6H4OMe-P),
120.6 (d, JC,P = 12.6Hz, C6H4), 131.5 (d, JC,P = 9.7Hz, C6H4), 133.2 (d, JC,P = 5.6Hz,
C6H4), 134.6 (d, 4JC,P = 2.4Hz, C4C6H4), 134.9 (d, 4JC,P = 1.8Hz, C4C6H4), 161.8 (d, 2JC,P
= 5.0Hz, C2C6H4-OMe), 162.9 (d, 2JC,P = 5.7Hz, C2C6H4-OH). 31P{1H} NMR (CDCl3, δ):
35.8. HRMS (ESI-TOF, m/z): calcd for C23H21FeO4P 448.0522, found 448.0518 [M]+.
Phenyl (2-Hydroxyphenyl)(2-methoxyferrocenyl)phosphinate (64a)1)
1) Only the data of the first diastereomer are reported, which was obtained in a diastere-
omeric ratio of 0.798: 0.202 with 64a-2). Compound 64a was obtained by running the
reaction for the synthesis of 62 at 0℃. Orange solid.
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OH
Fe
P
O
PhO
64a
O Yield: 20% based on 11. Anal. calcd for C23H21FeO4P (448.23 g/mol):
C, 61.63; H, 4.72. Found: C, 61.43; H, 4.63.∗ Mp.: 208–210℃. 1H NMR
(CDCl3, δ): 3.69 (s, 2.4H, OCH3), 3.83 (s, 0.6H, OCH3), 3.98–4.00 (m,
0.2H, C5H3), 4.13–4.15 (m, 0.8H, C5H3), 4.17 (s, 4.0H, C5H5), 4.26–
4.28 (m, 1.0H, C5H3), 4.32–4.34 (m, 0.2H, C5H3), 4.38 (s, 1.0H, C5H5),
4.51–4.52 (m, 0.8H, C5H3), 6.77–6.68 (m, 0.2H, C6H5/4), 6.83–6.90 (m,
1.0H, C6H5/4), 6.93 (ddd, JH,H = 8.4Hz, JH,P = 5.9Hz, JH,H = 0.6Hz,
0.8H, C6H4), 7.06–7.10 (m, 1.0H, C6H5), 7.14–7.16 (m, 1.6H, C6H5/4), 7.20–7.25 (m, 2.4H,
C6H5/4), 7.30–7.33 (m, 0.2H, C6H4), 7.36–7.39 (m, 0.8H, C6H4), 7.49 (ddd, JH,P = 14.8Hz,
JH,H = 7.8Hz, JH,H = 1.9Hz, 0.2H, C6H4), 7.63 (ddd, JH,P = 14.8Hz, JH,H = 7.9Hz, JH,H
= 1.7Hz, 0.8Hz, C6H4), 10.90 (d, 4JH,P = 0.7Hz, 0.2H, OH), 10.95 (d, 4JH,P = 0.7Hz,
0.8H, OH). 13C{1H} NMR (CDCl3, δ): 55.9 (d, JC,P = 10.4Hz, C5H3), 58.3 (s, OCH3), 61.3
(d, 1JC,P = 183.9Hz, CC5H3-P), 64.4 (d, JC,P = 12.2Hz, C5H3), 67.5 (d, JC,P = 10.9Hz,
C5H3), 69.97 (s, ma, C5H5), 70.17 (s, mi, C5H5), 112.6 (d, 1JC,P = 140.6Hz, C1C6H4-P),
117.7 (d, JC,P = 9.8Hz, C6H4), 118.9 (d, JC,P = 13.7Hz, C6H4), 120.8 (d, 3JC,P = 4.9Hz,
C2,6C6H5), 124.8 (d, 5JC,P = 1.1Hz, C4C6H5), 128.0 (d, 2JC,P = 11.2Hz, CC5H3-O)∗∗, 129.56
(s, C3,5C6H5), 132.1 (d, JC,P = 9.5Hz, C6H4), 134.6 (d, JC,P = 2.2Hz, C4C6H4), 150.7 (d,
2JC,P = 8.7Hz, C1C6H5-O), 162.2 (d, 2JC,P = 6.1Hz, C2C6H4-O). 31P{1H} NMR (CDCl3,
δ): 43.5 (100%), 44.1 (25.3%). HRMS (ESI-TOF, m/z): calcd for C23H21FeO4P 448.0522,
found 448.0518 [M]+. ∗The data are related to a single measurement, due to the low amount
of substance. ∗∗This signal was taken from the 13C{1H} NMR spectra of the mixture of all
three isomers.
Phenyl (2-Hydroxyphenyl)(2-methoxyferrocenyl)phosphinate (64a)2)
2) Only the data of the second diastereomer are reported. The diastereomeric ratio of 0.124:
0.876 is inverse compared to 64a-1). Compound 64a-2) was obtained as a mixture with
63. Both compounds could not be separated by applying several chromatographic methods.
Orange Oil. 1H NMR (CDCl3, δ): 3.83 (s, 3H, OCH3), 4.13–4.15 (m, 1H, C5H3), 4.27–4.28
(m, 1H, C5H3), 4.32–4.34 (m, 1H, C5H3), 4.38 (s, 1H, C5H5), 6.77–6.82 (m, 1H, C6H4),
6.83–6.86 (m, 1H, C6H4), 7.20–7.24 (m, 3H, C6H5), 7.27–7.28 (m, 2H, C6H5), 7.30–7.33 (m,
1H, C6H4), 7.49 (ddd, JH,P = 14.5Hz, JH,H = 7.8Hz, JH,H = 1.6Hz, 1H, C6H4), 10.91 (d,
4JH,P = 0.7Hz, 1H, OH), 10.95 (d, 4JH,P = 0.7Hz, 0.1H, OH). 13C{1H} NMR (CDCl3, δ):
55.7 (d, JC,P = 10.2Hz, C5H3), 58.3 (s, OCH3), 59.9 (d, 1JC,P = 166.7Hz, CC5H3-P), 64.8
(d, JC,P = 14.0Hz, C5H3), 67.0 (d, JC,P = 16.0Hz, C5H3), 70.2 (s, C5H5), 112.0 (d, 1JC,P
= 134.8Hz, C1C6H4-P), 117.6 (d, JC,P = 9.5Hz, C6H4), 119.1 (d, JC,P = 13.5Hz, C6H4),
120.9 (d, 3JC,P = 5.1Hz, C2,6C6H5), 124.8 (d, 5JC,P = 0.8Hz, C4C6H5), 128.7 (d, 2JC,P =
8.6Hz, CC5H3-O), 131.3 (d, JC,P = 9.7Hz, C6H4), 134.6 (m, C6H4), 151.0 (d, 2JC,P = 8.3Hz,
C1C6H5-O), 162.2 (d, 2JC,P = 5.4Hz, C2C6H4-O). 31P{1H} NMR (CDCl3, δ): 43.4 (100%),
44.04 (14%). HRMS (ESI-TOF, m/z): calcd for C23H21FeO4P 448.0522, found 448.0518
[M]+.
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Phenyl (2-Methoxyferrocenyl)(2-methoxyphenyl)phosphinate (64b)
O
Fe
P
O
PhO
64b
O Compound 64b was obtained by running the reaction for the synthesis
of 62 at 0℃, and obtained as an orange oil with a ratio of both diastere-
omers of 1: 0.55. 1H NMR (CDCl3, δ): 3.60–3.76 (m, 6.5H, OCH3,
C5H3), 4.03–4.46 (m, 7.5H, C5H5, C5H3), 6.74–6.77 (m, 0.2H, C6H4),
6.83–6.87 (m, 0.95H, C6H4), 6.96–7.08 (m, 2H), 7.21–7.25 (m, 2.4H),
7.29–7.30 (m, 1H), 7.38–7.42 (m, 0.25H), 7.44–7.49 (m, 1H), 7.93–8.03
(m, 1.2H, C6H4). 13C{1H} NMR (CDCl3, δ): 55.1 (d, JC,P = 10.9Hz,
C5H3), 55.2 (d, JC,P = 9.6Hz, C5H3), 55.20 (s, C6H4-OCH3), 55.3 (s, C6H4OCH3), 55.6 (s,
C6H4-OCH3), 58.26 (C5H3-OCH3), 58.32 (C5H3-OCH3), 60.8 (d, 1JC,P = 163.7Hz, CC5H3-
P), 63.5 (d, JC,P = 12.5Hz, C5H3), 63.9 (d, JC,P = 13.7Hz, C5H3), 67.3 (d, JC,P = 16.2Hz,
C5H3), 67.7 (d, JC,P = 10.6Hz, C5H3), 69.4 (C5H5), 69.96 (C5H5), 70.00 (C5H5), 110.8 (d,
JC,P = 7.7Hz, C6H4), 111.0 (d, JC,P = 7.7Hz, C6H4), 111.3 (d, JC,P = 8.1Hz, C6H4), 120.2
(d, 1JC,P = 138.8Hz, C1C6H4-P), 120.3–120.5 (m), 120.8 (d, JC,P = 5.0Hz), 121.0 (d, JC,P =
5.0Hz, C6H4), 123.89–123.97 (m), 129.06, 129.12 (d, JC,P = 7.9Hz, CC5H3-O), 129.2, 129.7
(d, JC,P = 13.0Hz, CC5H3-O), 133.8 (d, JC,P = 1.9Hz), 134.1 (d, JC,P = 1.9Hz), 134.1 (d,
JC,P = 1.9Hz), 134.7 (d, JC,P = 6.7Hz, C6H4), 135.0 (d, JC,P = 7.9Hz, C6H4), 135.6 (d, JC,P
= 7.6Hz, C6H4), 151.6 (d, 2JC,P = 8.0Hz, C2C6H5-O), 152.1 (d, 2JC,P = 8.4Hz, C2C6H5-O),
160.8 (d, 2JC,P = 3.3Hz, C2C6H4-O), 161.1 (d, 2JC,P = 4.3Hz, C2C6H4-O). 31P{1H} NMR
(CDCl3, δ): 30.3 (55.1%), 33.7 (100%). HRMS (ESI-TOF, m/z): calcd for C24H23FeO4P
462.0678, found 462.0644 [M]+.
Bis(2-hydroxyphenyl)(2-methoxyferrocenyl)phosphine Oxide (65a)
65a (R = H, H)
OR
P
O
2
O
Fe
Compound 65a was obtained by running the reaction for the syn-
thesis of 62 at 0℃. Orange Oil. Anal. calcd for C23H20FeO4P
(447.22 g/mol): C, 57.60; H, 4.28. Found: C, 57.29; H, 4.38. 1H
NMR (CDCl3, δ): 3.62 (s, 3H, OCH3), 3.95 (dt, JH,P = 2.8Hz,
JH,H = 2.0Hz, C5H3), 4.15–4.17 (m, 1H, C5H3), 4.35–4.37 (m, 6H,
C5H5, C5H3), 6.83 (tdd, JH,H = 7.5Hz, JH,P = 2.7Hz, JH,H =
0.9Hz, 1H, C6H4), 6.84 (tdd, JH,H = 7.5Hz, JH,P = 2.7Hz, JH,H
= 0.9Hz, 1H, C6H4), 6.94 (ddd, JH,H = 8.4Hz, JH,P = 5.1Hz, JH,H = 1.0Hz, 1H, C6H4),
6.98 (ddd, JH,H = 8.4Hz, JH,P = 4.9Hz, JH,H = 1.1Hz, 1H, C6H4), 7.11 (ddd, JH,P =
13.6Hz, JH,H = 7.8Hz, JH,H = 1.6Hz, 1H, C6H4), 7.15 (ddd, JH,P = 14.4Hz, JH,H =
7.8Hz, JH,H = 1.6Hz, 1H, C6H4), 7.36–7.41 (m, 2H, C6H4), 10.42 (s, 1H, OH), 10.96 (s,
1H, OH). 13C{1H} NMR (CDCl3, δ): 56.5 (d, JC,P = 8.3Hz, C5H3), 58.4 (s, OCH3), 61.8 (d,
1JC,P = 120.0Hz, CC5H3-P), 64.7 (d, JC,P = 12.0Hz, C5H3), 67.8 (d, JC,P = 13.0Hz, C5H3),
70.0 (s, C5H5), 112.4 (d, 1JC,P = 107.7Hz, C1C6H4-P) , 113.4 (d, 1JC,P = 109.4Hz, C1C6H4-
P), 118.2 (d, JC,P = 7.8Hz, C6H4), 118.5 (d, JC,P = 7.6Hz, C6H4), 119.0 (s, C6H4), 119.1 (s,
C6H4), 128.8 (d, 2JC,P = 8.1Hz, CC5H3-O), 131.1 (d, JC,P = 10.3Hz, C6H4), 131.8 (d, JC,P
= 10.7Hz, C6H4), 134.4 (d, JC,P = 12.1Hz, C6H4), 162.2 (d, 2JC,P = 3.3Hz, C2C6H4-O),
162.9 (d, 2JC,P = 3.1Hz, C2C6H4-O). 31P{1H} NMR (CDCl3, δ): 49.3. HRMS (ESI-TOF,
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m/z): calcd for C23H21FeO4P 448.0522, found 448.0518 [M]+.
(2-Hydroxyphenyl)(2-methoxyferrocenyl)(2-methoxyphenyl)phosphine Oxide
(65b)
65b (R = H, CH3)
OR
P
O
2
O
Fe
Compound 65b was obtained by running the reaction for the syn-
thesis of 62 at 0℃. Orange Oil. Anal. calcd for C24H23FeO4P · 1/6
C6H14 (462.26 · 86.18 g/mol): C, 63.00; H, 5.36. Found: C, 62.81;
H, 5.45. 1H NMR (CDCl3, δ): 3.63 (s, 3H, C6H4-OCH3), 3.66 (s,
3H, C5H3-OCH3), 3.85 (dpt, JH,P = 2.83Hz, 3,4JH,H = 1.7Hz, 1H,
C5H3), 4.07 (ddd J = 2.6Hz, 1H, C5H3) , 4.33 (dpt, JH,P = 2.7Hz,
3,4JH,H = 1.6Hz, 1H, C5H3), 4.37 (s, 5H, C5H5), 6.73 (tdd, JH,H
= 7.6Hz, JH,P = 2.7Hz, JH,H = 1.1Hz, 1H, C6H4-OH), 6.87 (dd, JH,H = 8.2Hz, JH,P =
5.4Hz, 1H, C6H4-OCH3), 6.95–7.04 (m, 3H, C6H4), 7.36 (dddd, JH,H = 8.6Hz, JH,H =
7.2Hz, JH,H = 1.5Hz, JH,P = 1.5Hz, 1H, C6H4-OH) , 7.45 (dddd, JH,H = 8.3Hz, JH,H =
7.2Hz, JH,H = 1.9Hz, JH,P = 1.1Hz, 1H, C6H4-OCH3) , 7.56 (ddd, JH,P = 14.6Hz, JH,H =
7.6Hz, JH,H = 1.7, 1H, C6H4-OCH3), 12.17 (s, 1H, OH). 13C{1H} NMR (CDCl3, δ): 55.6 (d,
JC,P = 7.8Hz, C5H3), 55.9 (s, C6H4-OCH3), 58.5 (s, C5H3-OCH3), 63.2 (d, 1JC,P = 120.4Hz,
CC5H3-P), 64.0 (d, JC,P = 11.7Hz, C5H3), 67.3 (d, JC,P = 13.1Hz, C5H3), 70.0 (C5H5), 112.1
(d, JC,P = 6.7Hz, C6H4-OCH3), 113.2 (d, 1JC,P = 110.4Hz, C1C6H4OH -P), 117.9 (d, JC,P
= 7.9Hz, C6H4), 118.1 (d, JC,P = 13.1Hz, C6H4-OH), 120.4 (d, JC,P = 12.6Hz, C6H4),
122.0 (d, 1JC,P = 109.2Hz, C1C6H4OCH -P), 129.8 (d, 2JC,P = 6.6Hz, CC5H3-O), 130.5 (d,
JC,P = 10.9Hz, C6H4OH), 133.3 (d, JC,P = 2.2Hz, C6H4), 133.9 (d, JC,P = 8.9Hz, C6H4),
134.1 (d, JC,P = 2.0Hz, C6H4), 161.5 (d, 2JC,P = 2.9Hz, C2C6H4-OCH3), 163.9 (d, 2JC,P
= 3.3Hz, C2C6H4-OH). 31P{1H} NMR (CDCl3, δ): 38.2. HRMS (ESI-TOF, m/z): calcd for
C24H23FeO4P+Na 485.0576, found 485.0559 [M+Na]+.
Diferrocenyl (1-Hydroxynaphth-2-yl)phosphonate (66)
P
O OH
66
Fe O
2
Phosphate 49 (70mg, 0.131mmol), diisopropylamine
(0.11mL, 0.783mmol), BuLi (0.31mL, 0.78mmol) and
dimethyl sulfate (0.1mL, 1.05mmol) were reacted at 0℃ for
2 h, according to the general procedure GP2. Purification was
realized by column chromatography (silica, 2.5 · 12 cm col-
umn size) using a 95/5 dichloromethane/ethyl acetate mix-
ture (v/v) as the eluent, resulting in the elution of two fractions. At first, the phosphonate
66 was eluted followed by the phosphinate 66.
Orange solid. Yield: 13mg (0.024mmol, 19% based on 49). Anal. calcd for C30H25Fe2O4P
(592.18 g/mol): C, 60.85; H, 4.26. Found: C, 61.27; H, 4.56. Mp.: 163–168℃. 1H NMR
(CDCl3, δ): 3.83–3.84 (m, 2H, C5H4), 3.85–3.86 (m, 2H, C5H4), 4.19 (s, 10H, C5H5), 4.30–
4.31 (m, 2H, C5H4), 4.38–4.39 (m, 2H, C5H4), 7.32–7.40 (m, 2H, H3/4), 7.54 (ddd, JH,H
= 8.2Hz, JH,H = 6.8Hz, JH,H = 1.2Hz, 1H, C6H4), 7.62 (ddd, JH,H = 8.2Hz, JH,H =
6.9Hz, JH,H = 1.3Hz, 1H, C6H4), 7.77 (d, JH,H = 8.1Hz, 1H, C6H4), 8.40 (d, JH,H =
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8.3Hz, 1H, C6H4), 10.99 (s, 1H, OH). 13C{1H} NMR (CDCl3, δ): 59.6 (d, JC,P = 3.8Hz,
C5H4), 59.9 (d, JC,P = 4.2Hz, C5H4), 62.9 (C5H4), 63.0 (C5H4), 69.6 (C5H5), 99.5 (d, 1JC,P
= 185.2Hz, C1), 117.1 (d, 2JC,P = 4.2Hz, CC5H4-O), 119.5 (d, JC,P =14.1Hz, C4), 123.7
(C6H4), 124.8 (d, 3JC,P = 14.4Hz, C8a), 125.4 (d, JC,P = 6.4Hz, C3), 126.2 (C6H4), 127.6
(C6H4), 129.5 (C6H4), 137.2 (d, 4JC,P = 2.1Hz, C4a), 161.5 (d, 2JC,P = 8.1Hz, C1). 31P{1H}
NMR (CDCl3, δ): 17.7. HRMS (ESI-TOF, m/z): calcd for C30H25Fe2O4P 592.0185, found
592.0202 [M]+.
Ferrocenyl (1-Hydroxynaphth-2-yl)(2-methoxyferrocenyl)phosphinate (67)
P
O
Fe O
67
OHFcO
Orange solid. The compound was obtained in a ratio of both di-
astereomers of 1 : 0.78. Crystals, suitable for single crystal X-ray
diffraction analysis, were obtained by slow evaporation of a hex-
ane solution containing 24 at ambient temperature. Yield: 24mg
(0.040mmol, 30% based on 49). Anal. calcd for C31H27Fe2O4P
(606.21 g/mol): C, 61.42; H, 4.49. Found: C, 61.58; H, 4.73. Mp.:
194–196℃. 1H NMR (CDCl3, δ): 3.66 (s, 3H, OCH3, ma), 3.74–
3.76 (m, 1.7H, ma, mi), 3.76–3.79 (m, 1.7H, ma, mi), 3.86 (s, 2.1H, OCH3, mi), 4.10 (dd,
JH,H = 2.8H, JH,H = 2.8H, 0.7H, C5H3, mi), 4.16 (dd, JH,H = 2.6H, JH,H = 2.6H, 1H,
C5H3, ma), 4.17–4.18 (m, 5.7H, C5H5 ma, C5H3/4 mi), 4.19–4.21 (m, 9.5H, C5H5 ma, C5H5
mi, C5H3/4 ma), 4.23 (ddd, JH,H = 2.7Hz, JH,P = 2.2Hz, JH,H = 1.5Hz, 0.7H, C5H3 mi),
4.26 (ddd, JH,H = 2.8Hz, JH,P = 2.8Hz, JH,H = 1.5Hz, 1H, C5H3 ma), 4.32 (ddd, JH,H =
2.6Hz, JH,P = 2.6Hz, JH,H = 1.5Hz, 0.7H, C5H3 mi), 4.36 (dddd, J = 2.7Hz, J = 1.4Hz,
J = 1.4Hz, J = 0.7Hz, 1H, ma), 4.42 (s, 3.5H, C5H5, mi), 4.45 (dddd, J = 2.7Hz, J =
1.4Hz, J = 1.4Hz, J = 0.6Hz, 0.7H, mi), 4.51 (ddd, JH,H = 2.8Hz, JH,H = 1.7Hz, JH,P =
1.7Hz, 1H, ma), 7.26 (dd, JH,H = 8.5Hz, JH,P = 3.0Hz, 0.7H, H3/4 mi), 7.30 (dd, JH,H =
8.6Hz, JH,P = 2.9Hz, 1H, H3/4 ma), 7.39 (dd, JH,P = 12.8Hz, JH,H = 8.6Hz, 0.7H, H3/4
mi), 7.44 (dd, JH,P = 13.1Hz, JH,H = 8.6Hz, 1H, H3/4 ma), 7.48–7.52 (m, 1.7H, ma, mi),
7.54–7.58 (m, 1.7H, ma, mi), 7.71 (d, JH,H = 8.9Hz, 0.7H, mi), 7.73 (d, JH,H = 8.6Hz, 1H,
ma), 7.38 (d, JH,H = 8.4Hz, 0.7H, mi), 8.42 (d, JH,H = 8.4Hz, 1H, ma), 11.96 (s, 0.7H, OH,
mi), 11.99 (s, 1H, OH, ma). 13C{1H} NMR (CDCl3, δ): 55.7* (d, JC,P = 10.1Hz, C5H3),
55.8∗ (d, JC,P = 10.2Hz, C5H3), 58.3 (OCH3), 58.3 (OCH3), 59.9 (d, JC,P = 4.3Hz, C5H4),
60.0 (d, JC,P = 4.1Hz, C5H4), 60.1 (d, JC,P = 4.0Hz, C5H4), 60.4 (d, JC,P = 3.8Hz, C5H4),
60.6 (CC5H3-P, the second signal overlaps), 60.9 (CC5H3-P, the second signal overlaps), 62.68
(C5H4), 62.76 (C5H4), 62.77 (C5H4), 62.9 (C5H4), 64.4 (d, JC,P = 12.2Hz, C5H3), 64.6 (d,
JC,P = 13.9Hz, C5H3), 67.0∗ (d, JC,P = 15.9Hz, C5H3), 67.3 (d, JC,P = 10.8Hz, C5H3),
69.48 (C5H5), 69.49 (C5H5), 70.0 (C5H5), 70.2 (C5H5), 103.7 (C2, HMBC), 117.1 (d, 2JC,P =
6.8Hz, CC5H4-O), 128.3 (d, 2JC,P = 11.5Hz, CC5H3-O), 118.5∗ (d, JC,P = 13.5Hz, C10H6),
118.7∗ (d, JC,P = 13.5Hz, C10H6), 123.5∗ (C10H6), 123.68∗ (C10H6), 123.69∗ (C10H6), 125.5∗
(C10H6), 125.6∗ (C10H6), 125.62∗ (C10H6), 125.67∗ (C10H6), 126.2∗ (C10H6), 126.3∗ (C10H6),
127.3∗ (C10H6), 127.4∗ (C10H6), 128.1 (CC5H3-O, HMBC), 128.5 (CC5H3-O, HMBC), 136.5
(C4a/C8a, HMBC), 160.8 (C1, HMBC). (∗Obtained from DEPT90 measurements). 31P{1H}
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NMR (CDCl3, δ): 44.6 (ma), 44.7 (mi). HRMS (ESI-TOF, m/z): calcd for C31H27Fe2O4P+
H 607.0373, found 607.0376 [M+H]+.
Diferrocenyl (3-Hydroxynaphth-2-yl)phosphonate (68)
P
O
68
Fe O
OH
2
Phosphate 50 (82mg, 0.17mmol), diisopropylamine (0.14mL,
1.01mmol), BuLi (0.41mL, 1.03mmol) and Me2SO4 (0.3mL,
3.15mmol) were reacted at –80℃ (24) or 0℃ (25) for 2 h ac-
cording to the general procedure GP2. Purification was realized
by column chromatography (silica, 2.5 · 12 cm column size) using
a 95/5 dichloromethane/ethyl acetate mixture (v/v) for 68 and
69a or a 2/3 dichloromethane/ethyl acetate mixture (v/v) for 69b as the eluents.
Orange oil. Yield: 32mg (0.066mmol, 39% based on 50). Anal. calcd for C30H25Fe2O4P · 1/4
CHCl3 (592.18 · 119.38 g/mol): C, 58.41; H, 4.09. Found: C, 58.58; H, 4.43. 1H NMR (CDCl3,
δ): 3.85–3.88 (m, 4H, C5H4), 4.19 (s, 10H, C5H5), 4.31–4.32 (m, 2H, C5H4), 4.38–4.39 (m,
2H, C5H4), 7.33–7.36 (m, 2H, H4, H5/6/7/8), 7.51 (ddd, JH,H = 8.2Hz, JH,H = 6.8Hz,
JH,H = 1.0Hz, C6H4), 7.71 (d, JH,H = 8.3Hz, C6H4), 7.80 (d, JH,H = 8.2Hz, C6H4), 8.08
(d, 3JH,P = 17.0Hz, H1), 9.70 (d, 4JH,P = 0.9Hz, OH). 13C{1H} NMR (CDCl3, δ): 59.7
(d, JC,P = 3.9Hz, C5H4), 59.87 (d, JC,P = 4.1Hz, C5H4), 63.0 (C5H4), 63.1 (C5H4), 69.6
(C5H5), 112.1 (d, 3JC,P = 11.9Hz, C4), 117.2 (d, 2JC,P = 4.6Hz, CC5H4-O), 122.4 (d, 1JC,P
= 181.3Hz, C2), 124.3 (C6H4), 126.7 (C6H4), 128.7 (C6H4), 129.2 (C6H4), 134.8 (d, 2JC,P
= 5.5Hz, C1), 138.0 (C4a/C8a), 139.6 (C4a/C8a), 156.6 (d, 2JC,P = 7.8Hz, C3). 31P{1H}
NMR (CDCl3, δ): 14.6. HRMS (ESI-TOF, m/z): calcd for C30H25Fe2O4P 592.0185, found
592.0156 [M]+.
Ferrocenyl (3-Hydroxynaphth-2-yl)(2-methoxyferrocenyl)phosphinate (69a)
P
O
Fe O
69a
OHFcO
Compound 69a was obtained as an orange oil with a ratio of two
diastereomers of 1:0.51. Yield: 45mg (0.074mmol, 44% based on
50). Anal. calcd for C31H27Fe2O4P (606.21 g/mol): C, 61.42; H,
4.49. Found: C, 61.21; H, 4.94. Mp.: > 250℃ (decomp.). 1H NMR
(CDCl3, δ): 3.667 (s, 1.5H, OCH3, mi), 3.68 (d, JH,H = 3.2Hz,
1H, C5H3, ma), 3.75–3.77 (m, 1.5H, C5H3/4, mi, ma), 3.78–3.81
(m, 1.5H, C5H3/4, mi, ma), 3.88 (s, 3H, OCH3, ma), 4.10–4.12 (m,
1H, C5H3/4, ma), 4.17–4.20 (m, 11H, C5H5 ma, C5H5 mi, C5H3/4 mi), 4.21–4.23 (m, 1H,
C5H3/4, ma), 4.26–4.28 (m, 0.5H, C5H3/4, mi), 4.34–4.35 (m, 1.5H, C5H3/4, ma, mi), 4.43 (s,
5H, C5H5, ma), 4.44–4.46 (m, 1H, C5H3/4, ma), 4.54–4.55 (m, 0.5H, C5H3/4, mi), 7.26–7–32
(m, 3H, H4, H5/6/7/8, ma, mi), 7.42–7.48 (m, 1.5H, H5/6/7/8, ma, mi), 7.66 (d, JH,H =
8.2Hz, 1H, H5/6/7/8, ma), 7.69 (d, JH,H = 8.2Hz, 0.5H, H5/6/7/8, mi), 7.71 (d, JH,H =
8.2Hz, 1H, H5/6/7/8, ma), 7.75 (d, JH,H = 8.3Hz, 0.5H, H5/6/7/8, mi), 8.07 (d, 3JH,P =
16.5Hz, 1H, H1, ma), 8.16 (d, 3JH,P = 16.8Hz, 0.5H, H1, mi), 10.75 (d, 4JH,P = 0.9Hz,
1H, OH, ma), 10.83 (d, 4JH,P = 0.9Hz, 0.5H, OH, mi). 13C{1H} NMR (CDCl3, δ): 55.89
(d, JC,P = 10.5Hz, C5H3, mi), 55.92 (d, JC,P = 10.2Hz, C5H3, ma), 58.3 (OCH3, mi), 58.4
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(OCH3, ma), 59.97 (d, 1JC,P = 167.3Hz, CC5H3-P, ma), 59.98 (d, JC,P = 4.4Hz, C5H4, mi),
60.03 (d, JC,P = 4.3Hz, C5H4, ma), 60.05 (d, JC,P = 3.9Hz, C5H4, mi), 60.3 (d, JC,P =
4.0Hz, C5H4, ma), 62.77 (C5H4, mi), 62.80 (C5H4, mi), 62.86 (C5H4, ma), 62.91 (C5H4, ma),
64.5 (d, JC,P = 12.1Hz, C5H3, mi), 64.8 (d, JC,P = 13.9Hz, C5H3, ma), 67.1 (d, JC,P =
16.0Hz, C5H3, ma), 67.4 (d, JC,P = 10.9Hz, C5H3, ma), 69.62 (C5H5, ma), 69.54 (C5H5,
mi), 70.0 (C5H5, mi), 70.2 (C5H5, ma), 111.42 (d, 3JC,P = 8.6Hz, C4, mi), 111.48 (d, 3JC,P
= 9.2Hz, C4, ma), 115.6 (d, 1JC,P = 132.0Hz, C2, ma), 117.32 (CC5H4-O), 117.33 (CC5H4-
O), 117.37 (CC5H4-O), 123.61 (C5/6/7/8, ma), 123.65 (C5/6/7/8, mi), 126.49 (C5/6/7/8,
ma), 126.55 (C5/6/7/8, mi), 127.2 (d, 2JC,P = 14.6Hz, CC5H3-O, ma), 128.4 (C5/6/7/8,
ma), 128.6 (C5/6/7/8, mi), 128.65 (C5/6/7/8, mi), 128.71 (C5/6/7/8, ma), 133.8 (d, 2JC,P
= 9.9Hz, C1, ma), 134.8 (d, 2JC,P = 9.3Hz, C1, mi), 137.4 (C4a/C8a), 137.46 (C4a/C8a),
137.48 (C4a/C8a), 157.4 (d, 2JC,P = 6.1Hz, C3, ma). 31P{1H} NMR (CDCl3, δ): 42.6 (ma),
42.7 (mi). HRMS (ESI-TOF, m/z): calcd for C31H27Fe2O4P 606.0341, found 606.0316 [M]+.
Ferrocenyl (2-Methoxyferrocenyl)(3-methoxy-2-naphthyl)phosphinate (69b)
P
O
Fe O
69b
OFcO
Compound 96b was obtained as an orange solid with a d.r. of 1
: 0.97. Crystals, suitable for single crystal X-ray diffraction anal-
ysis, were obtained by slow evaporation of a hexane solution con-
taining 96b at ambient temperature. Yield: 20mg (0.032mmol,
19% based on 50). Anal. calcd for C32H29Fe2O4P · 5/6 C6H14
(620.24 · 5/6 86.18 g/mol): C, 64.22; H, 5.92. Found: C, 64.00;
H, 6.14. Mp.: 179℃. 1H NMR (CDCl3, δ): 3.57 (s, mi, 3H,
OCH3(Fc)), 3.72–3.76 (m, 4H, C5H4), 3.77 (s, ma, 3H, OCH3(Fc)), 3.82 (s, ma, 3H,
OCH3(C10H6)), 3.91 (s, mi, 3H, OCH3(C10H6)), 4.02 (dd, mi, JH,P = 5.4Hz, JH,H = 2.7Hz,
1H, C5H3), 4.07 (dd, ma, JH,P = 5.2Hz, JH,H = 2.6Hz, 1H, C5H3), 4.02 (td, mi, J = 2.7Hz,
J = 1.5Hz, 1H, C5H3), 4.17–4.19 (m, 1H, C5H3), 4.20 (s, 5H, C5H5), 4.21 (s, 5H, C5H5),
4.22–4.26 (m, 7H, C5H5, C5H4, C5H3), 4.34–4.36 (m, 1H, C5H4), 4.44–4.45 (m, 2H, C5H3,
C5H4), 4.47–4.48 (m, 6H, C5H5, C5H4), 7.02 (d, 4JH,P = 5.7Hz, 1H, H4), 7.12 (d, 4JH,P
= 5.8Hz, 1H, H4), 7.33–7.40 (m, 2H, C10H7), 7.47 (ddd, 3JH,H = 8.2Hz, JH,H = 6.9Hz, J
= 1.3Hz, 1H, C10H7), 7.52 (ddd, 3JH,H = 8.2Hz, JH,H = 6.9Hz, J = 1.3Hz, 1H, C10H7),
7.67 (d, 3JH,H = 8.2Hz, 1H, C10H7), 7.73 (d, 3JH,H = 8.2Hz, 1H, C10H7), 7.87 (d, JH,H
= 8.2Hz, 1H, C10H7), 7.90 (d, JH,H = 8.2Hz, 1H, C10H7), 8.60 (d, 2JH,H = 15.7Hz, 1H,
H1), 8.63 (d, 2JH,P = 15.5Hz, 1H, H1). 13C{1H} NMR (CDCl3, δ): 55.0 (d, JC,P = 10.8,
C5H3), 55.2 (s, OCH3(C10H6)), 55.32 (d, JC,P = 10.8, C5H3), 55.34 (s, OCH3(C10H6)), 58.2
(s, OCH3(Fc)), 58.3 (s, OCH3(Fc)), 60.0 (d, 3JC,P = 3.6Hz, C2/5C5H4) , 60.2 (d, 1JC,P
= 45.1Hz, C-P), 60.4 (d, 3JC,P = 3.7Hz, C2/5C5H4), 60.71 (d, 1JC,P = 164.4Hz, C-P),
60.74 (d, 3JC,P = 3.9Hz, C2/5C5H4), 60.8 (d, 3JC,P = 4.3Hz, C2/5C5H4), 61.1 (d, 1JC,P
= 166.2Hz, C-P), 62.36 (s, C3/4C5H4), 62.40 (s, C3/4C5H4), 62.43 (s, C3/4C5H4), 62.5 (s,
C3/4C5H4), 63.5 (d, JC,P = 12.6Hz, C5H3), 63.9 (d, JC,P = 13.7Hz, C5H3) , 67.3 (d, JC,P
= 16.5Hz, C5H3), 67.8 (d, JC,P = 10.4Hz, C5H3), 69.35 (s, C5H5), 69.38 (s, C5H5), 70.0 (s,
C5H5), 70.1 (s, C5H5), 105.6 (d, 3JC,P = 7.3Hz, C4), 105.8 (d, 3JC,P = 7.4Hz, C4), 117.3 (d,
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2JC,P = 5.7Hz, CC5H4-O), 117.8 (d, 2JC,P = 6.1Hz, CC5H4-O), 121.4 (d, 1JC,P = 133.2Hz,
C2), 122.0 (d, 1JC,P = 136.2Hz, C2), 124.1 (C10H7), 124.2 (C10H7), 126.3 (C10H7), 126.4
(C10H7), 128.3 (C10H7), 128.5 (C10H7), 129.08 (C10H7), 129.14 (C10H7), 128.0 (d, 3JC,P =
8.2Hz, C4a), 128.1 (d, 3JC,P = 8.1Hz, C4a), 129.3 (d, 2JC,P = 7.6Hz, CC5H3-O), 129.9
(d, 2JC,P = 13.1Hz, CC5H3-O), 136.76 (C8a), 136.77 (C8a), 137.7 (d, 2JC,P = 7.3Hz, C1),
138.2 (d, 2JC,P = 7.2Hz, C1), 157.3 (d, 2JC,P = 4.3Hz, C3-O), 157.5 (d, 2JC,P = 4.0Hz,
C3-O). 31P{1H} NMR (CDCl3, δ): 29.4 (ma), 33.5 (mi). HRMS (ESI-TOF, m/z): calcd for
C32H29Fe2O4P 620.0502, found 620.0508 [M]+.
1,3-Dioxa-2-((1R)-α-fenchyl)(oxo)phospha-[3](2,2'-dimethyl)-ferrocenophane
((1R)-73)
Fe
73
O
O
P
O
O
LiTMP (212mg, 1.44mmol) was dissolved in 10mL of tetrahy-
drofuran and cooled to –50℃. Compound 72 (150mg, 0.36mmol)
was added in a single portion and stirring was continued for 4 h in
a temperature range of -30 to –10℃. Dimethyl sulfate (0.3mL,
3.2mmol) was added in a single portion and the reaction mix-
ture was allowed to warm to ambient temperature. After 18 h,
all volatiles were removed in vacuum. Purification was realized using column chromatogra-
phy (silica, 2 · 25 cm column size) and dichloromethane as the eluent. Compound 73 was
obtained as an orange solid as a mixture of three diastereomers in a ratio of 1 : 0.25 : 0.3.
Single crystals, suitable for single crystal X-ray diffraction analysis, were obtained by slow
evaporation of a hexane solution containing 73 at ambient temperature.
Yield: 84mg (0.189mmol, 53% based on (1R)-72). Anal. calcd for C22H29FeO4P
(444.28 g/mol): C, 59.48; H, 6.58. Found: C, 59.46; H, 6.86. Mp.: 84℃. 1H NMR (CDCl3,
δ): An assignment of the signals to hydrogen atoms is hardly possible, due to an overlap
of all three diastereomers and their different ratio. For spectra see ESI. 13C{1H} NMR
(CDCl3, δ): 9.1 (d, 4JC,P = 5.9Hz, CH3(C5H3)), 11.5 (d, 4JC,P = 3.8Hz, CH3(C5H3)), 19.24
(CH3), 19.26 (CH3), 21.15 (CH3), 21.17 (CH3), 21.3 (CH3), 25.96 (C5/6), 26.01 (C5/6), 26.32
(C5/6), 26.34 (C5/6), 26.6 (C5/6), 29.59 (CH3), 29.66 (CH3), 29.71 (CH3), 39.78 (d, 3JC,P
= 2.6Hz, C3), 39.80 (d, 3JC,P = 2.4Hz, C3), 39.85 (d, 3JC,P = 2.1Hz, C3), 40.92 (C7),
40.97 (C7), 47.67 (C4), 47.74 (C4), 49.11 (d, 3JC,P = 5.9Hz, C1), 49.15 (d, 3JC,P = 5.6Hz,
C1), 49.18 (d, 3JC,P = 5.6Hz, C1), 60.14 (d, JC,P = 8.7Hz), 61.2 (d, JC,P = 1.8Hz), 61.3
(d, JC,P = 2.4Hz), 64.08, 64.10, 64.14, 65.9, 66.55, 66.60, 67.4 (d, JC,P = 5.4Hz), 68.1, 68.5
(d, JC,P = 4.2Hz), 68.6 (d, JC,P = 4.1Hz), 78.8 (d, 3JC,P = 5.4Hz, CC5H3-CH3), 78.95 (d,
3JC,P = 5.9Hz, CC5H3-CH3), 79.01 (d, 3JC,P = 5.6Hz, CC5H3-CH3), 94.5 (d, 2JC,P = 8.0Hz,
C2), 94.6 (d, 2JC,P = 7.9Hz, C2), 94.9 (d, 2JC,P = 8.1Hz, C2), 109.40 (d, 2JC,P = 14.8Hz,
CC5H3-O), 109.49 (d, 2JC,P = 13.9Hz, CC5H3-O), 109.58 (d, 2JC,P = 14.9Hz, CC5H3-O),
109.64 (d, 2JC,P = 14.1Hz, CC5H3-O), 110.8 (d, 2JC,P = 13.0Hz, CC5H3-O), 111.0 (d, 2JC,P
= 13.1Hz, CC5H3-O). 31P{1H} NMR (CDCl3, δ): 0.77 (30%), 0.87 (25%), 0.96 (100%).
HRMS (ESI-TOF, m/z): calcd for C22H29FeO4P 444.1148, found 444.1118 [M]+.
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(1R)-α-Fenchyl (1'-Methoxyferrocenyl) Methyl Phosphate (74)
Fe
O
O
P
O O
74
O
LiTMP (212mg, 1.44mmol) was dissolved in 10mL of tetrahy-
drofuran and cooled to –50℃. Compound (1R)-72 (150mg,
0.36mmol) was added in a single portion and the reaction mix-
ture was allowed to warm to ambient temperature. After stirring
for 18 h, dimethyl sulfate (0.3mL, 3.2mmol) was added in a sin-
gle portion and stirring was continued for additionally 6 h. All
volatiles were removed in vacuum. Purification was realized by
column chromatography (silica, 2 · 18 cm column size) using a 95/5 dichloromethane/ethyl
acetate mixture (v/v) for the elution of 1,1'-Fc(OMe)2 (18mg, 0.073mmol, 20% based on
(1R)-72). Compound 74 was eluted using a 9/1 dichloromethane/ethyl acetate mixture (v/v)
as the eluent (Rf = 0.37). The title compound was obtained as an orange oil as a mixture
of two diastereomers in a 1 : 1 ratio.
Yield: 17mg (0.037mmol, 10% based on (1R)-72). 1H NMR (CDCl3, δ): 0.89 (s, 3H, CH3),
0.92 (s, 3H, CH3), 1.05–1.07 (m, 8H, CH3, H5/6), 1.10 (s, 3H, CH3), 1.13 (s, 3H, CH3),
1.15–1.16 (m, 1H, H7), 1.18–1.19 (m, 1H, H7), 1.41–1.46 (m, 2H, H5/6), 1.49–1.52 (m,
2H, H7), 1.69–1.71 (m, 6H, H5/6, H4), 3.366 (s, 3H, C-O-CH3), 3.370 (s, 3H, C-O-CH3),
3.808 (d, 3JH,P = 11.3Hz, 3H, P-O-CH3), 3.815 (d, 3JH,P = 11.3Hz, 3H, P-O-CH3), 3.91–
3.93 (m, 8H, C5H4), 3.99 (dd, 3JH,P = 8.4Hz, JH,H = 1.9Hz, 1H, H2), 4.00 (dd, 3JH,P =
8.4Hz, JH,H = 1.8Hz, 1H, H2), 4.14–4.15 (m, 4H, C5H4), 4.41 (dd, JH,P = 3.5Hz, JH,P =
1.8Hz, 1H, C5H4), 4.42–4.43 (m, 2H, C5H4), 4.46 (dd, JH,P = 3.3Hz, JH,P = 1.6Hz, 1H,
C5H4). 13C{1H} NMR (CDCl3, δ): 19.2 (CH3), 20.74 (CH3), 20.75 (CH3), 25.62 (C5/6),
25.65 (C5/6), 25.89 (C5/6), 25.90 (C5/6), 29.8 (CH3), 39.53 (C3), 39.55 (C3), 40.92 (C7),
47.9 (C4), 49.21 (C1), 49.22 (C1), 49.25 (C1), 49.26 (C1), 54.58 (P-O-CH3), 54.60 (P-O-
CH3), 54.63 (P-O-CH3), 54.65 (P-O-CH3), 56.31 (C5H4), 57.5 (C-O-CH3), 60.29 (C5H4),
60.32 (C5H4), 60.35 (C5H4), 60.36 (C5H4), 60.37 (C5H4), 63.10 (C5H4), 63.12 (C5H4), 63.15
(C5H4), 63.15 (C5H4), 63.40 (C5H4), 63.41 (C5H4), 91.57 (C2), 91.60 (C2), 91.63 (C2), 91.66
(C2), 117.84 (CC5H4-O-P), 117.85 (CC5H4-O-P), 117.88 (CC5H4-O-P), 117.89 (CC5H4-O-P),
128.1 (CC5H4-O-C). 31P{1H} NMR (CDCl3, δ): –3.95, -3.91. HRMS (ESI-TOF, m/z): calcd
for C22H29FeO5P 462.1259, found 462.1246 [M]+.
meso-2,2'-Dimethoxy-1,1'-bis(1,3-dioxa-2-(oxo)phospha-[3]-ferrocenophan-2-yl)-
ferrocene (78)
78
Fe
P
P
Fe
Fe
O
O O
O
O
O
O
O
Phosphate 76 (36mg, 0.067mmol), diisopropy-
lamine (0.04mL, 0.27mmol), BuLi (0.11mL,
0.275mmol) and dimethyl sulfate (0.05mL,
0.527mmol) were reacted at –30℃ for 2 h ac-
cording to the general procedure GP2. Pu-
rification was realized by column chromatogra-
phy (silica, 2 · 12 cm column size) using a 1/1
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dichloromethane/ethyl acetate (v/v) mixture as the eluent. The title compound was ob-
tained as an orange oil.
Yield: 32mg (0.042mmol, 62% based on 76). Anal. calcd for C32H28Fe3O8P2 (770.04 g/mol):
C, 49.91; H, 3.67. Found: C, 53.46; H, 6.34. (∗best match, too less compound) 1H NMR
(CDCl3, δ): 3.82 (s, 6H, OCH3), 4.01–4.02 (m, 4H, C5H4), 4.08–4.10 (m, 4H, C5H4), 4.34–
4.35 (m, 4H, C5H4), 4.52 (dd, JH,P = 6.0Hz, JH,H = 2.9Hz, 2H, C5H3), 4.66–4.68 (m, 4H,
C5H3), 4.71–4.72 (m, 2H, C5H4), 4.73–4.74 (m, 2H, C5H4). 13C{1H} NMR (CDCl3, δ): 52.9
(d, 1JC,P = 227.4Hz, C-P), 58.4 (d, JC,P = 12.1Hz, C5H3), 58.6 (s, OCH3), 63.78 (C5H4),
63.82 (C5H4), 63.86 (C5H4), 63.88 (C5H4), 65.66 (C5H4), 65.69 (C5H4), 67.02 (C5H4), 67.04
(C5H4), 69.3 (d, JC,P = 15.0Hz, C5H3), 69.4 (d, JC,P = 14.0Hz, C5H3), 109.06 (d, 2JC,P =
11.8Hz, CC5H4-O), 109.12 (d, 2JC,P = 12.1Hz, CC5H4-O), 130.5 (d, 2JC,P = 10.5Hz, CC5H3-
O). 31P{1H} NMR (CDCl3, δ): 30.1. HRMS (ESI-TOF, m/z): calcd for C32H28Fe3O8P2 +
Na 792.9202, found 792.9191 [M+Na]+.
1,3-Dioxa-2-(2-methoxyferrocenyl)(oxo)phospha-[3]ferrocenophane (71a)
71a
Fe
PFe
O
O
O
O
Phosphate 70a (30mg, 0.065mmol), diisopropylamine (0.04mL,
0.27mmol), BuLi (0.11mL, 0.27mmol) and dimethyl sulfate
(0.1mL, 1.05mmol) were reacted between –30 and –10℃ for 2 h
according to the general procedure GP2. Purification was realized
by column chromatography (silica, 2.5 · 12 cm column size) using a
95/5 dichloromethane/ethyl acetate mixture (v/v) as the eluent,
giving 71a as an orange solid.
Yield: 31mg (0.0.065mmol, 99% based on 71a). Anal. calcd for C21H19Fe2O8P2
(478.04 g/mol): C, 52.76; H, 4.01. Found: C, 52.02; H, 4.52. (∗best match). Mp.: >230℃
(decomp.). 1H NMR (CDCl3, δ): 3.76 (s, 3H, OCH3), 4.00–4.01 (m, 2H, C5H4), 4.07–4.09
(m, 2H, C5H4), 4.17 (dd, JH,P = 5.9Hz, JH,H = 2.8Hz, 1H, C5H3), 4.32–4.35 (m, 3H, C5H4,
C5H3), 4.40 (s, 5H, C5H5), 4.41–4.43 (m, 1H, C5H3), 4.73–4.75 (m, 2H, C5H4). 13C{1H}
NMR (CDCl3, δ): 52.9 (d, 1JC,P = 228.6Hz, C-P), 56.0 (d, JC,P = 12.3Hz, C5H3), 58.5 (s,
CH3), 63.74 (d, JC,P = 5.7Hz, C5H4), 63.78 (d, JC,P = 5.6Hz, C5H4), 63.9 (d, JC,P = 6.2Hz,
C5H4), 64.9 (d, JC,P = 15.3Hz, C5H3), 65.49 (C5H4), 65.52 (C5H4), 66.93 (C5H4), 67.2 (d,
JC,P = 14.1Hz, C5H3), 70.5 (s, C5H5), 109.1 (d, 2JC,P = 11.8Hz, CC5H4-O), 109.3 (d, 2JC,P
= 11.8Hz, CC5H4-O), 129.4 (d, 2JC,P = 10.8Hz, CC5H3-O). 31P{1H} NMR (CDCl3, δ): 31.3.
HRMS (ESI-TOF, m/z): calcd for C50H44Fe5O8P2 +H 770.9382, found 770.9391 [M+H]+.
(R,Rp)-1,1'-Binaphthyl-2,2'-diyl (2-Methoxyferrocenyl)phosphonate (71b)
Phosphate 70b (100mg, 0.188mmol), diisopropylamine (0.16mL, 1.15mmol), BuLi (0.45mL,
1.125mmol) and dimethyl sulfate (0.3mL, 3.16mmol) were reacted in tetrahydrofuran at –
70℃ for 2 h according to the general procedure described above. Purification was realized
by column chromatography (silica, 2 · 8 cm column size) using a 9/1 dichloromethane/ethyl
acetate mixture (v/v) as the eluent. Compound 71b was obtained as an orange solid with
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a d.r. of both diastereomers of 1 : 0.045 (0.91 de). Crystals, suitable for single crystal X-
ray diffraction analysis, were obtained by crystallization from a boiling chloroform solution
containing 71b.
71b
O
O
Fe
P
O
Yield: 59mg (0.108mmol, 57% based on 70b). Anal. calcd for
C31H23FeO4P · 1/4 CH2Cl2 (546.33 · 1/4 84.93 g/mol): C, 66.13;
H, 4.17. Found: C, 66.50; H, 4.37. Mp.: > 290℃ (decomp.).
1H NMR (CDCl3, δ): 2.63 (s, 3H, OCH3), 4.10 (ddd, JH,P =
3.2Hz, JH,H = 2.6Hz, JH,H = 1.5Hz, 1H, C5H3), 4.15 (ddd,
JH,P = 2.9Hz, JH,H = 2.8Hz, JH,H = 2.8Hz, 1H, C5H3), 4.37
(s, 5H, C5H5), 4.54 (ddd, JH,H = 2.8Hz, JH,P = 2.2Hz, JH,H
= 1.5Hz, 1H, C5H3), 7.15 (dd, 3JH,H = 8.8Hz, 3JH,P = 0.9Hz,
1H, H3), 7.27–7.31 (m, 2H, C6H4), 7.37–7.39 (m, 1H, C6H4), 7.43–7.49 (m, 3H, C6H4), 7.73
(dd, 3JH,H = 8.8Hz, 3JH,P = 8.8Hz, 1H, H3’), 7.81 (d, 3JH,H = 8.8Hz, 1H, H4), 7.87–7.89
(m, 1H, C6H4), 7.96–7.97 (m, 1H, C6H4), 8.06 (d, 3JH,H = 8.8Hz, 1H, H4’). 13C{1H} NMR
(CDCl3, δ): 51.1 (d, 1JC,P = 214.3Hz, CC5H3-P), 55.9 (d, JC,P = 12.2Hz, C5H3), 57.0 (s,
OCH3), 65.0 (d, JC,P = 15.3Hz, C5H3), 67.7 (d, JC,P = 15.9Hz, C5H3), 70.5 (s, C5H5), 121.2
(d, 2JC,P = 3.1Hz, C3), 121.6 (d, 2JC,P = 2.3Hz, C3’), 121.8 (d, 3JC,P = 2.4Hz, C1/C1’),
122.3 (d, 3JC,P = 2.6Hz, C1/C1’), 125.2, 125.4, 126.2, 126.5, 127.1, 127.2, 128.1, 128.4, 128.6
(d, 2JC,P = 9.8Hz, CC5H3-O), 130.0 (d, 4JC,P = 1.4Hz, C4/C4’), 130.8 (d, 4JC,P = 0.9Hz,
C4/C4’), 131.5 (d, 4JC,P = 1.2Hz, C4a/C4a’), 131.7 (d, 4JC,P = 1.2Hz, C4a/C4a’), 132.60
(C8a/C8a’), 132.61 (C8a/C8a’), 146.7 (d, 2JC,P = 9.9Hz, C2/C2’), 147.5 (d, 2JC,P = 10.0Hz,
C2/C2’). 31P{1H} NMR (CDCl3, δ): 33.7 (4.5%), 34.6 (95.5%). HRMS (ESI-TOF, m/z):
calcd for C31H23FeO4P 547.0757, found 547.0764 [M]+.
N,N,N ',N '-Tetraethyl-1-(2-methylferrocenyloxy)phosphinediamine·BH3 (24)
24
Fe O
P(NEt2)2
BH3
Me
Compound 12 (519mg, 1.33mmol), sBuLi (1.23mL, 1.60mmol)
and MeI (0.16mL, 2.60mmol) were reacted according to the gen-
eral procedure GP2 between –20 and –10℃ for 3.5 h as described
above. Purification was realized by column chromatography (alu-
mina, 3.5 · 13 cm column size) using a 4/1 hexane/diethyl ether
mixture (v/v) as the eluent. Compound 24 was obtained as a
mixture in 436mg consisting of the starting material 12 (91mg, 0.24mmol, 18%) and 24.
Both compounds could not be separated from each other by column chromatography occur-
ring in a ratio of 1 : 0.28.
Yield: 343mg (0.85mmol, 64% based on 12). 1H NMR (C6D6, δ): 0.90 (t, 3JH,H = 7.1Hz,
6H, CH3), 1.01 (t, 3JH,H = 7.1Hz, 6H, CH3), 2.02 (s, 3H, CC5H3-CH3), 2.87–3.00 (m,
8H, CH2), 3.62 (pt, 3,4JH,H = 2.6Hz, 1H, C5H4), 3.69–3.70 (m, 1H, C5H4), 4.12 (s, 5H,
C5H5), 4.53 (dd, JH,H = 2.5Hz, JH,H = 1.5Hz, 1H, C5H4). 13C{1H} NMR (C6D6, δ): 12.4
(CC5H3-CH3), 14.2 (d, 4JC,P = 1.7Hz, CH3), 14.5 (d, 4JC,P = 1.7Hz, CH3), 39.3 (d, 3JC,P
= 6.4Hz, CH2), 39.5 (d, 3JC,P = 6.4Hz, CH2), 60.7 (C5H3), 60.95 (d, JC,P = 3.0Hz, C5H3),
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64.5 (C5H3), 70.3 (C5H5), 74.6 (d, 3JC,P = 2.6Hz, CC5H3-CH3), 117.4 (d, 2JC,P = 1.8Hz,
CC5H3-O). 31P{1H} NMR (C6D6, δ): 130.8–131.7 (br m). 11B{1H} NMR (C6D6, δ): -39.6
(d, 1JB,P = 91.3Hz). HRMS (ESI-TOF, m/z): calcd for C19H34BFeN2OP + Na 427.1747,
found 427.1724 [M+Na]+.
N,N,N ',N '-Tetraethyl-1-(2-methylferrocenyloxy)phosphinediamine Sulfide (25)
25
Fe O
P(NEt2)2
S
Me
Compound 13 (250mg, 0.61mmol), sBuLi (0.75mL, 0.98mmol)
and MeI (0.10mL, 1.59mmol) were reacted according to the
general procedure GP2 between –20 and –10℃ for 3.5 h as de-
scribed above. Purification was realized by column chromatog-
raphy (alumina, 2.5 · 17 cm column size) using an 85/15 hex-
ane/dichloromethane mixture (v/v) as the eluent. Compound 25
was obtained in a mixture of 135mg along with the starting material 13. Both compounds
could not be separated from each other by column chromatography occurring in a ratio of
1 : 0.07.
Yield: 128mg (0.302mmol, 50% based on 13). 1H NMR (C6D6, δ): 0.97 (t, 3JH,H = 7.1Hz,
6H, CH3), 1.06 (t, 3JH,H = 7.1Hz, 6H, CH3), 2.04 (s, 3H, CC5H3-CH3), 2.99–3.11 (m, 8H,
CH2), 3.64 (pt, 3,4JH,H = 2.6Hz, 1H, C5H3), 3.71–3.72 (m, 1H, C5H3), 4.14 (s, 5H, C5H5),
4.61–4.62 (m, 1H, C5H3). 13C{1H} NMR (C6D6, δ): 12.5 (CC5H3-CH3), 14.1 (d, 4JC,P =
3.3Hz, CH3), 14.4 (d, 4JC,P = 3.0Hz, CH3), 40.6 (d, 3JC,P = 5.0Hz, CH2), 40.9 (d, 3JC,P =
5.1Hz, CH2), 60.9 (C5H3), 61.0 (d, JC,P = 3.0Hz, C5H3), 64.5 (C5H3), 70.3 (C5H5), 74.9 (d,
3JC,P = 4.0Hz, CC5H3-CH3), 116.8 (d, 2JC,P = 1.3Hz, CC5H3-O). 31P{1H} NMR (C6D6, δ):
90.9. HRMS (ESI-TOF, m/z): calcd for C19H31FeN2OPS 422.1239, found 422.1262 [M]+.
(2-Methylferrocenyl) Di(pyrrolidin-1-yl)phosphinate (26)
26
Fe O
P
O
N
2
Me
Compound 14 (206mg, 0.53mmol) was dissolved in hexane
(A)/ diethyl ether (B), cooled to –30℃ and sBuLi (0.54mL,
0.69mmol) was dropwise added. The mixture was stirred for
18 h at ambient temperature (A) or 4 h between -40 and –30℃
(B). Afterwards, MeI (0.10mL, 1.59mmol) was added in a single
portion and the reaction mixture was allowed to warm to ambi-
ent temperature, where stirring was continued for 18 h. Purification was realized by column
chromatography (alumina, 2.5 · 17 cm column size) using a 9/1 dichloromethane/ethyl acetate
mixture (v/v) as the eluent. The title compounds 26 and 27 were obtained as mixtures (A,
39 : 44 : 45 = 0.24 : 1 :< 0.05; B, 39 : 44 : 45 = 0.06 : 1 : 0.65) and could not be separated
from each other by column chromatography.
Yield: A, 137mg (0.34mmol, 64% based on 14); B, 102mg (0.25mmol, 48% based on 14).
1H NMR (C6D6, δ): 1.37–1.40 (m, 4H, H3,H4-C4N), 1.48–1.51 (m, 4H, H3,H4-C4N), 2.06
(s, 3H, CH3), 3.05–3.13 (m, 4H, H2,H5-C4N), 3.16–3.20 (m, 4H, H2,H5-C4N), 3.66–3.67
(m, 1H, C5H3), 3.71–3.74 (m, 1H, C5H3), 4.19 (s, 5H, C5H5), 4.75–4.77 (m, 1H, C5H3).
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13C{1H} NMR (C6D6, δ): 12.1 (CH3), 26.5 (d, 3JC,P = 8.7Hz, C3,C4-C4N), 26.6 (d, 3JC,P
= 9.0Hz, C3,C4-C4N), 46.8 (d, 2JC,P = 4.6Hz, C2,C5-C4N), 60.2 (d, JC,P = 1.9Hz, C5H3),
60.7 (C5H3), 64.3 (C5H3), 70.5 (C5H5), 74.0 (d, 3JC,P = 5.3Hz, CC5H3-CH3), 117.2 (d, 2JC,P
= 4.0Hz, CC5H3-O). 31P{1H} NMR (C6D6, δ): 22.9. HRMS (ESI-TOF, m/z): calcd for
C19H27FeN2O2P 402.1154, found 402.1158 [M]+.
1',2-Dimethylferrocenyl Di(pyrrolidin-1-yl)phosphinate (27)
27
Fe O
P
O
N
2
Me
Me
Yield: A, 7mg (0.017mmol, 3% based on 39); B, 69mg
(0.165mmol, 31% based on 14). 1H NMR (C6D6, δ): 1.37–
1.40 (m, 4H, H3,H4-C4N), 1.48–1.51 (m, 4H, H3,H4-C4N),
2.03 (s, 3H, CH3), 2.06 (s, 3H, CH3), 3.05–3.15 (m, 4H,
H2,H5-C4N), 3.17–3.21 (m, 4H, H2,H5-C4N), 3.64 (pt, 3,4JH,H
= 2.6Hz, 1H, C5H3), 3.66–3.70 (m, 1H, C5H3/4), 4.00–4.02
(m, 1H, C5H3), 4.08–4.11 (m, 3H, C5H4), 4.71 (dd, J = 2.2Hz, JH,H = 1.8Hz, 1H, C5H3).
13C{1H} NMR (C6D6, δ): 11.8 (CH3), 13.9 (CH3), 26.5 (d, 3JC,P = 8.7Hz, C3,C4-C4N),
26.6 (d, 3JC,P = 9.0Hz, C3,C4-C4N), 46.8 (d, 2JC,P = 5.1Hz, C2,C5-C4N), 60.9 (d, JC,P =
1.8Hz, C5H3), 61.4 (C5H3), 64.8 (C5H3), 69.4 (C5H4), 69.6 (C5H4), 71.2 (C5H4), 71.9 (C5H4),
73.9 (d, 3JC,P = 5.0Hz, CC5H3-CH3), 85.0 (CC5H4-CH3), 116.8 (d, 2JC,P = 3.8Hz, CC5H3-
O). 31P{1H} NMR (C6D6, δ): 23.0. HRMS (ESI-TOF, m/z): calcd for C20H29FeN2O2P
416.1311, found 416.1336 [M]+.
Ferrocenyl (2-Methoxyferrocenyl)1H -pyrrol-1-ylphosphinate (82)
P
O
N
Fe O
FcO
82
Phosphonate 79 (100mg, 0.194mmol), diisopropylamine (0.16mL,
1.165mmol), BuLi (0.46mL, 1.15mmol) and dimethyl sulfate (0.11mL,
1.16mmol) were reacted according to the general procedure GP2 at –
70℃ for 4 h. Purification was realized by column chromatography (silica,
2.5 · 15 cm column size) using dichloromethane for the elution of FcOMe
(13mg, 0.060mmol, 31% based on 79), a 98/2 dichloromethane/ethyl
acetate mixture (v/v) for 79 (42mg, 0.082mmol, 42%) and a 95/5
dichloromethane/ethyl acetate mixture (v/v) for the elution of 82 as
the eluents. The title compound was obtained as a mixture of two diastereomers in a ratio
of 1:0.89 as an orange solid, which rapidly decomposes in solution.
Yield: 25mg (0.047mmol, 24% based on 79). Anal. calcd for C25H24Fe2NO3P
(529.13 g/mol): C, 56.75; H, 4.57; N, 2.65. Found: C, 57.34; H, 5.40; N, 2.10 (∗best match).
Mp.: 182–188℃.1H NMR (CDCl3, δ): 3.70 (s, 3H, OCH3), 3.70 (s, 3H, OCH3), 3.80–3.83
(m, 3H, C5H4), 3.85 (ddd, JH,H = 2.6Hz, JH,P = 2.6Hz, JH,H = 1.5Hz, 1H, C5H4), 4.08
(dd, JH,P = 5.7Hz, JH,H = 2.8Hz, 1H, C5H3), 4.11–4.15 (m, 4H, C5H4, C5H3), 4.19 (s, 5H,
C5H5), 4.20 (s, 5H, C5H5), 4.21–4.22 (m, 1H, C5H4), 4.23 (s, 5H, C5H5), 4.27 (ddd, JH,P =
3.2Hz, JH,H = 2.8Hz, JH,H = 1.5Hz, 1H, C5H3), 4.28–4.30 (m, 1H, C5H3), 4.33–4.34 (m,
1H, C5H4), 4.38 (s, 5H, C5H5), 4.43 (ddd, JH,H = 2.8Hz, JH,P = 2.0Hz, JH,H = 1.4, 1H,
C5H3), 6.30–6.32 (m, 2H, H3,4), 6.34–6.36 (m, 2H, H3,4), 7.15–7.16 (m, 2H, H2,5), 7.26–7.28
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(m, 2H, H2,5). 13C{1H} NMR (CDCl3, δ): 55.7 (d, JC,P = 11.6Hz, C5H3), 55.9 (d, JC,P
= 11.7Hz, C5H3), 57.1 (d, 1JC,P = 207.7Hz, C-P), 57.9 (d, 1JC,P = 206.3Hz, C-P), 58.24
(OCH3), 58.25 (OCH3), 59.74 (d, JC,P = 3.8Hz, C5H4), 59.77 (d, JC,P = 3.7Hz, C5H4),
59.82 (d, JC,P = 4.1Hz, C5H4), 60.1 (d, JC,P = 3.7Hz, C5H4), 62.76 (C5H4), 62.83 (C5H4),
62.85 (C5H4), 64.3 (d, JC,P = 14.2Hz, C5H3), 64.6 (d, JC,P = 15.1Hz, C5H3), 66.8 (d, JC,P
= 15.8Hz, C5H3), 67.8 (d, JC,P = 13.2Hz, C5H3), 69.58 (C5H5), 69.60 (C5H5), 70.0 (C5H5),
70.3 (C5H5), 112.05 (d, 3JC,P = 9.7Hz, C3,4), 112.13 (d, 3JC,P = 10.0Hz, C3,4), 116.73 (d,
2JC,P = 7.3Hz, CC5H4-O), 116.76 (d, 2JC,P = 7.1Hz, CC5H4-O), 122.3 (d, 2JC,P = 6.2Hz,
C2,5), 122.5 (d, 2JC,P = 6.3Hz, C2,5), 128.1 (d, 2JC,P = 11.1Hz, CC5H3-O), 128.7 (d, 2JC,P
= 9.9Hz, CC5H3-O). 31P{1H} NMR (CDCl3, δ): 17.8 (ma), 18.3 (mi). HRMS (ESI-TOF,
m/z): calcd for C25H24Fe2NO3P+H 530.0266, found 530.0269 [M+H]+.
Diferrocenyl (1H -pyrrol-2-yl)phosphonate (85)
P
O
H
N
85
Fe O
2
Phosphonate 79 (100mg, 0.194mmol), diisopropylamine (0.16mL,
1.165mmol), BuLi (0.46mL, 1.15mmol) and dimethyl sulfate
(0.11mL, 1.16mmol) were reacted according to the general proce-
dure GP2 at –40℃ for 4 h as described above. Purification was
realized by column chromatography (silica, 2.5 · 15 cm column size)
using a 98/2 dichloromethane/ethyl acetate mixture (v/v) as the elu-
ent. Compound 85 was obtained as a yellow, weakly soluble solid. Thus, the sample was
suspended in DMSO-d6 and 10 % CDCl3 was added to optimize the solubility.
Yield: 27mg (0.052mmol, 27% based on 79). Anal. calcd for C24H22Fe2NO3P
(515.10 g/mol): C, 55.96; H, 4.30; N, 2.72. Found: C. 55.71; H, 4.25; N, 2.82. Mp.: >
250℃. 1H NMR (CDCl3, δ): 3.87 (br, m, 4H, C5H4), 4.20 (br, m, 10H, C5H5), 4.34 (br, m,
4H, C5H4), 6.35 (br, m, 1H, C4H4N), 6.84 (br, m, 1H, C4H3N), 7.06 (br, m, 1H, C4H3N),
9.08 (br, s, 1H, NH). 13C{1H} NMR (CDCl3, δ): 59.9 (d, JC,P = 3.7Hz, C5H4), 60.1 (d,
JC,P = 4.0Hz, C5H4), 62.8 (C5H4), 62.9 (C5H4), 69.6 (C5H5). 31P{1H} NMR (CDCl3, δ):
4.3. 1H NMR (DMSO-d6, δ): 3.87 (br, m, 4H, C5H4), 4.14 (br, m, 10H, C5H5), 4.31 (br, m,
4H, C5H4), 6.24 (br, m, 1H, C4H3N), 6.80 (br, m, 1H, C4H3N), 7.13 (br, m, 1H, C4H3N),
11.93 (br, s, 1H, NH). 13C{1H} NMR (DMSO-d6, δ): 59.3∗ (d, JC,P = 3.9Hz, C5H4), 59.4∗
(d, JC,P = 4.5Hz, C5H4), 62.3 (C5H4), 62.4 (C5H4), 69.1 (C5H5), 109.2∗ (d, JC,P = 16.1Hz,
C4H3N), 114.7 (d, 1JC,P = 235.8Hz, C1C4H3N -P), 116.6 (d, 2JC,P = 4.8Hz, CC5H4-O), 120.2∗
(d, JC,P = 20.2Hz, C4H3N), 125.3∗ (d, JC,P = 13.5Hz, C4H3N). 31P{1H} NMR (DMSO-
d6, δ): 4.5. (∗Obtained from DEPT90 measurements). HRMS (ESI-TOF, m/z): calcd for
C24H22Fe2NO3P+Na 537.9929, found 537.9913 [M+Na]+.
Ferrocenyl (1H -indol-1-yl)(2-methoxyferrocenyl)phosphinate (83)
Compound 80 (100mg, 0.177mmol), diisopropylamine (0.15mL, 1.06mmol), BuLi (0.43mL,
1.08mmol) and dimethyl sulfate (0.10mL, 1.06mmol) were reacted at –40℃ for 3 h accord-
ing to the general procedure GP2 described above. Purification was realized by column
chromatography (silica, 2.5 · 22 cm column size) using a 95/5 dichloromethane/ethyl acetate
183
CHAPTER 4. EXPERIMENTAL PART
mixture (v/v) as the eluent. Compound 83 was obtained along with compound 86 in a ratio
of 1/0.78 (53/50) as a mixture of two diastereomers. Crystals, suitable for single crystal
X-ray diffraction analysis, were obtained by evaporation of a CHCl3 solution containing the
mixture of 86 or 83 at ambient temperature.
P N
Fe O
FcO
83
O Yield: 25mg (0.043mmol, 24% based on 80). 1H NMR (CDCl3,
δ): 3.56 (s, 3H, OCH3), 3.77–3.79 (m, 2H, C5H4), 3.80–3.81 (m,
5H, OCH3, C5H4), 3.95–3.96 (m, 1H, C5H3), 4.00–4.02 (m, 1H,
C5H3), 4.12–4.14 (m, 6H, C5H5, C5H3), 4.17–4.19 (m, 7H, C5H5,
C5H4), 4.22–4.24 (m, 1H, C5H3), 4.28–4.29 (m, 1H, C5H3), 4.30–
4.32 (m, 6H, C5H5, C5H4), 4.35 (s, 5H, C5H5), 4.40–4.42 (m, 1H,
C5H4), 4.48–4.49 (m, 1H, C5H3), 6.64 (ddd, 3JH,H = 3.5Hz, 4JH,P
= 2.6Hz, JH,H = 0.8Hz, 1H, H3), 6.66 (ddd, 3JH,H = 3.4Hz, 4JH,P = 2.6Hz, JH,H = 0.8Hz,
1H, H3), 7.16–7.17 (m, 1H, H4), 7.18–7.20 (m, 1H, H4), 7.20–7.23 (m, 2H, H5/6), 7.25–7.28
(m, 2H, H5/6), 7.53 (dd, 3JH,H = 3.5Hz, 4JH,P = 2.8Hz, 1H, H2), 7.55 (dd, 3JH,H = 3.5Hz,
4JH,P = 2.8Hz, 1H, H2), 7.92 (dd, 3JH,H = 8.1Hz, JH,H = 1.2Hz, 1H, H7), 8.02 (dd, 3JH,H
= 8.1Hz, JH,H = 8.1Hz, JH,H = 1.1Hz, 1H, H7). 13C{1H} NMR (CDCl3, δ): 55.8 (d, JC,P
= 11.4Hz, C5H3), 56.0 (d, JC,P = 11.8Hz, C5H3), 57.5 (d, 1JC,P = 207.5Hz, C-P), 57.7 (d,
1JC,P = 206.4Hz, C-P), 58.28 (OCH3), 58.31 (OCH3), 59.8–60.2 (m, C5H4), 62.79 (C5H4),
62.81 (C5H4), 62.83 (C5H4), 64.4 (d, JC,P = 13.6Hz, C5H3), 64.5 (d, JC,P = 14.9Hz, C5H3),
66.7 (d, JC,P = 16.0Hz, C5H3), 67.3 (d, JC,P = 12.3Hz, C5H3), 69.5 (C5H5), 69.54 (C5H5),
70.1 (C5H5), 70.3 (C5H5), 107.0 (d, 3JC,P = 7.4Hz, C3), 107.4 (d, 3JC,P = 7.5Hz, C3), 114.3
(C7), 114.5 (C7), 116.7 (d, 2JC,P = 7.0Hz, CC5H4-O), 116.9 (d, 2JC,P = 7.5Hz, CC5H4-O),
120.9, 121.8, 121.9, 122.2, 123.0, 123.2, 128.1 (d, 2JC,P = 6.6Hz, C2), 128.6 (d, 2JC,P =
6.4Hz, C2), 128.8 (d, 2JC,P = 9.7Hz, CC5H3-O), 128.9 (d, 2JC,P = 11.9Hz, CC5H3-O), 130.9
(d, 3JC,P = 8.3Hz, C3a), 131.1 (d, 3JC,P = 8.6Hz, C3a), 137.3 (d, 2JC,P = 5.0Hz, C7a),
137.7 (d, 2JC,P = 4.6Hz, C7a). 31P{1H} NMR (CDCl3, δ): 16.8, 18.2. HRMS (ESI-TOF,
m/z): calcd for C29H26Fe2NO3P+H 580.0423, found 580.0430 [M+H]+.
Ferrocenyl 9H -Carbazol-9-yl(2-methoxyferrocenyl)phosphinate (84)
P N
Fe O
FcO
84
O Compound 81 (100mg, 0.163mmol), diisopropylamine (0.14mL,
0.98mmol), BuLi (0.39mL, 0.98mmol) and dimethyl sulfate
(0.09mL, 0.98mmol) were reacted at –60℃ for 3 h according to
the general procedure GP2 described above. Purification was re-
alized by column chromatography (silica, 2.5 · 16 cm column size)
using a 95/5 dichloromethane/ethyl acetate mixture (v/v) as the
eluent. The title compound was obtained as an orange solid and
as a mixture of both diastereomers in a ratio of 1 : 0.28 (0.56 de). Crystals, suitable for
single crystal X-ray diffraction analysis, were obtained by evaporation of a dichloromethane
solution at ambient temperature containing 84.
Yield: 58mg (0.092mmol, 56% based on 81). Anal. calcd for C33H28Fe2NO3P
184
4.3. SYNTHETIC PROCEDURES
(629.24 g/mol): C, 62.99; H, 4.49; N, 2.23. Found: C. 62.98; H, 4.56; N, 2.25. Mp.: 206℃.
1H NMR (CDCl3, δ): 3.35 (s, 3H, OCH3, ma), 3.59 (ddd, JH,H = 2.7Hz, JH,P = 2.7Hz,
JH,H = 1.5Hz, 0.3H, C5H3, mi), 3.73 (ddd, JH,H = 2.6Hz, JH,P = 2.6Hz, JH,H = 1.4Hz,
0.3H, C5H4, mi), 3.76 (ddd, JH,H = 2.7Hz, JH,P = 2.7Hz, JH,H = 1.5Hz, 1H, C5H4, ma),
3.77–3–78 (m, 0.3H, C5H4, mi), 3.79 (ddd, JH,H = 2.6Hz, JH,P = 2.6Hz, JH,H = 1.5Hz,
1H, C5H4, ma), 3.83 (s, 0.9H, OCH3, mi), 3.89 (dpt, JH,P = 2.8Hz, 3,4JH,H = 2.8Hz, 0.3H,
C5H3, mi), 4.10–4.11 (m, 6H, C5H5, C5H3, ma), 4.13 (s, 1.5H, C5H5, mi), 4.15 (ddd, JH,P
= 3.5Hz, JH,H = 2.7Hz, JH,H = 1.5Hz, 1H, C5H3, ma), 4.19–4.20 (m, 0.3H, C5H4, mi),
4.21–4.22 (m, 1H, C5H4, ma), 4.27 (s, 1.5H, C5H5, mi), 4.28 (ddd, JH,H = 2.8Hz, JH,P =
2.8Hz, JH,H = 1.4Hz, 0.3H, C5H3, mi), 4.41–4.42 (m, 1H, C5H4, ma), 4.44 (s, 5H, C5H5,
ma), 4.51–4.53 (m, 0.3H, C5H4, mi), 4.54 (ddd, JH,H = 2.8Hz, JH,P = 2.8Hz, JH,H = 1.4Hz,
1H, C5H3, ma), 7.29 (ddd, JH,H = 7.9Hz, JH,H = 7.3Hz, JH,H = 1.0Hz, 2H, C12H8, ma),
7.34 (ddd, JH,H = 7.9Hz, JH,H = 7.3Hz, JH,H = 1.0Hz, 0.6H, C12H8, mi), 7.40 (ddd, JH,H
= 8.5Hz, JH,H = 7.2Hz, JH,H = 1.3Hz, 2H, C12H8, ma), 7.45 (ddd, JH,H = 8.5Hz, JH,H
= 7.2Hz, JH,H = 1.4Hz, 0.6H, C12H8, mi), 7.96–7.98 (m, 2H, C12H8, ma), 8.02–8.04 (m,
0.6H, C12H8, mi), 8.16–8.17 (m, 2H, C12H8, ma), 8.28–8.30 (m, 0.6H, C12H8, mi). 13C{1H}
NMR (CDCl3, δ): 55.8 (d, JC,P = 11.2Hz, C5H3, mi), 56.0 (d, JC,P = 12.0Hz, C5H3, ma),
58.3 (s, OCH3, ma), 58.4 (s, OCH3, mi), 58.5 (d, 1JC,P = 206.1Hz, C-P, ma), 59.8 (d, JC,P
= 4.1Hz, C5H4, ma), 60.0 (d, JC,P = 4.0Hz, C5H4, ma), 60.3 (d, JC,P = 3.7Hz, C5H4,
mi), 62.7 (C5H4, mi), 62.8 (C5H4, mi), 62.82 (C5H4, ma), 62.84 (C5H4, ma), 64.1 (d, JC,P
= 15.1Hz, C5H3, mi), 64.2 (d, JC,P = 13.8Hz, C5H3, ma), 66.5 (d, JC,P = 15.6Hz, C5H3,
mi), 67.0 (d, JC,P = 11.6Hz, C5H3, ma), 69.47 (C5H5, ma), 69.52 (C5H5, mi), 70.27 (C5H5,
mi), 70.29 (C5H5, ma), 115.3 (CH, ma), 115.4 (CH, mi), 116.6 (d, 2JC,P = 7.5Hz, CC5H4-O,
ma), 119.6 (CH, ma), 119.7 (CH, mi), 121.8 (CH, ma), 122.1 (CH, mi), 126.15 (d, 2JC,P =
7.2Hz, CC5H3-O, ma), 126.22 (CH, ma), 126.4 (CH, mi), 129.4 (d, 3JC,P = 12.6Hz, 4a/4b,
ma), 140.7 (d, 2JC,P = 5.6Hz, 8a/9a, ma), 141.0 (d, 2JC,P = 5.5Hz, 8a/ 9a, ma). 31P{1H}
NMR (CDCl3, δ): 17.0 (ma), 19.3 (mi). HRMS (ESI-TOF, m/z): calcd for C33H28Fe2NO3P
629.0501, found 629.0510 [M]+.
Diferrocenyl (1H -Indol-2-yl)phosphonate (86) (A)
P
O
H
N
86
Fe O
2
Compound 80 (100mg, 0.177mmol), diisopropylamine
(0.15mL, 1.06mmol), BuLi (0.43mL, 1.08mmol) and dimethyl
sulfate (0.10mL, 1.06mmol) were reacted at –40℃ for 3 h
according to the general procedure described above. Purifica-
tion was realized by column chromatography (silica, 2.5 · 22 cm
column size) using a 95/5 dichloromethane/ethyl acetate
mixture (v/v) as the eluent. Compound 86 was obtained in a mixture with compound 85
of ratio 1 : 0.78.
Yield: 31mg (0.055mmol, 31% based on 47). 1H NMR (CDCl3, δ): 3.86–3.87 (m, 4H,
C5H4), 4.21 (s, 10H, C5H5), 4.36–4.38 (m, 2H, C5H4), 4.38–4.40 (m, 2H, C5H4), 7.16–7.18
(m, 1H, H3), 7.33 (ddt, 3JH,H = 8.1Hz, JH,H = 7.0Hz, JH,H = 1.0Hz, 1H, H5/H6), 7.46
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(dd, 3JH,H = 8.4Hz, JH,H = 1.1Hz, 1H, H7), 7.57–7.60 (m, 1H, H5/H6), 7.70 (dd, 3JH,H
= 8.1Hz, JH,H = 1.1Hz, 1H, H4), 9.01 (s, 1H, NH). 13C{1H} NMR (CDCl3, δ): 59.9–60.1
(m, C5H4), 62.9 (d, JC,P = 4.5Hz, C5H4), 69.6 (C5H5), 112.1 (d, 4JC,P = 1.9Hz, C7), 113.7
(d, 2JC,P = 17.5Hz, C3), 117.2 (d, 2JC,P = 4.9Hz, CC5H4-O), 120.8 (C5/6), 122.1 (C4),
122.0 (d, 1JC,P = 227.4Hz, CC2-P), 125.1 (C5/6), 127.5 (d, 3JC,P = 16.5Hz, C3a), 138.2 (d,
3JC,P = 13.0Hz, C7a). 31P{1H} NMR (CDCl3, δ): 4.0. HRMS (ESI-TOF, m/z): calcd for
C28H24Fe2NO3P+H 566.0266, found 565.0295 [M+H]+.
Ferrocenyl (1H -Indol-2-yl)(2-methoxyferrocenyl)phosphinate (87)
P
O
Fe O
FcO H
N
87
Compound 80 (100mg, 0.177mmol), diisopropylamine (0.15mL,
1.06mmol), BuLi (0.43mL, 1.08mmol) and dimethyl sulfate
(0.10mL, 1.06mmol) were reacted at 0℃ for 4 h according to the
general procedure GP2 described above. Purification was realized
by column chromatography (silica, 2.5 · 12 cm column size) using a
85/15 dichloromethane/ethyl acetate mixture (v/v) as the eluent.
Compound 87 was obtained as a mixture of both diastereomers in
a ratio of 1 : 0.098 (0.82 de).
Yield: 69mg (0.119mmol, 67% based on 47). Anal. calcd for C29H26Fe2NO3P
(579.19 g/mol): C, 60.14; H, 4.52; N, 2.42. Found: C. 59.61; H, 4.30; N, 2.60. Mp.: ∼
25℃. 1H NMR (CDCl3, δ): 3.73–3.75 (m, 2H, C5H4), 3.82 (s, 3H, OCH3), 3.89 (s, 0.3H,
OCH3, mi), 3.98 (s, 5H, C5H5), 4.14–4.16 (m, 6H, C5H5, C5H3), 4.18–4.20 (m, 1H, C5H4),
4.23 (s, 0.5H, C5H5, mi), 4.24–4.26 (m, 1H, C5H4), 4.32 (ddd, JH,H = 2.6Hz, JH,P = 2.6Hz,
JH,H = 1.5Hz, 1H, C5H3), 4.43 (s, 0.5H, C5H5, mi), 4.57 (ddd, JH,H = 2.6Hz, JH,P =
2.6Hz, JH,H = 1.5Hz, 1H, C5H3), 7.17 (ddd, 3JH,H = 8.0Hz, JH,H = 7.0Hz, JH,H = 0.9Hz,
1H, H5/6), 7.32 (ddt, 3JH,H = 8.1Hz, JH,H = 7.1Hz, JH,H = 0.8Hz, 1H, H5/6), 7.36 (ddd,
3JH,P = 4.3Hz, JH,H = 1.9Hz, JH,H = 0.8Hz, 1H, H3), 7.50 (dd, 3JH,H = 8.3Hz, JH,H
= 0.7Hz, 1H, H7), 7.75 (dd, 3JH,H = 8.0Hz, JH,H = 0.5Hz, 1H, H4), 9.59 (s, 1H, NH).
13C{1H} NMR (CDCl3, δ): 56.4 (d, JC,P = 9.7Hz, C5H3), 58.5 (OCH3), 59.9 (d, 1JC,P =
167.6Hz, CC5H3-P), 60.03 (C5H4), 60.06 (C5H4), 60.08 (C5H4), 60.12 (C5H4), 62.56 (C5H4),
62.57 (C5H4), 64.4 (d, JC,P = 12.1Hz, C5H3), 67.8 (d, JC,P = 11.1Hz, C5H3), 69.5 (C5H5),
70.1 (C5H5), 111.7 (d, 4JC,P = 1.5Hz, C7), 112.4 (d, 2JC,P = 16.1Hz, C3), 117.3 (d, 2JC,P =
6.6Hz, CC5H4-O), 120.5 (C5/6), 122.3 (C4), 124.6 (C5/6), 127.0 (d, 2JC,P = 10.2Hz, CC5H3-
O), 127.3 (d, 3JC,P = 10.2Hz, C3a), 128.9 (d, 1JC,P = 172.2Hz, CC2-P), 137.9 (d, 3JC,P =
11.0Hz, C7a). 31P{1H} NMR (CDCl3, δ): 25.3 (mi), 25.9 (ma). HRMS (ESI-TOF, m/z):
calcd for C29H26Fe2NO3P 579.0344, found 579.0370 [M]+.
4.3.3 Synthesis of Phosphines and Phosphanes
General Procedure for the Reduction and the Stelzer Coupling - GP5
In a Schlenk tube, an excess of Li[AlH4] (0.6 g, 16mmol) was suspended with ∼ 20mL of
THF, followed by the dropwise addition of ClSiMe3 (1.65mL, 12.9mmol) at –30℃. After the
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suspension was stirred for 5min, the respective phosphonate (∼ 2mmol) was added dropwise.
The mixture was slowly heated to 45℃ until gas evaporation was no longer detectable.
Afterwards, the oil bath was replaced by an ice bath. Acidification was realized by dropwise
addition of oxygen-free H2SO4 (3mL, ω = 30%) until the pH value declined below 7. Caution!
During the addition an immense gas emission occurs. The mixture was extracted three times
with oxygen-free diethyl ether (3 · 20mL) under an argon atmosphere. The organic layer was
dried over degassed MgSO4, and all volatiles were removed under reduced pressure. The PPh2
derivative was obtained as an orange oil and subsequently used in further reactions. For the
Stelzer coupling, the respective PPh2 derivative (1 equiv), iodobenzene (2 equiv), K3PO4 (2
equiv), and [PdCl2(dppf)] (4 mol-%) were dissolved in 6mL of toluene. The reaction mixture
was degassed carefully and stirred for 18 h at 110℃. After the mixture was cooled to ambient
temperature, water (30mL) was added in a single portion and the mixture was extracted
with diethyl ether (3 · 20mL). The organic layer was dried over MgSO4, and the solvent was
removed under reduced pressure. The residue was purified by column chromatography (see
below).
(2-Methoxyferrocenyl)diphenylphosphane (rac-90a)
rac-90a
FeO PH2
Compound rac-16 (645mg, 1.83mmol), Li[AlH4] (0.6 g, 16mmol) and
ClSiMe3 (1.65mL, 12.9mmol) were reacted according to the general pro-
cedure GP5.
Yield: 450mg (1.82mmol, 99% based on 16). 1H NMR (CDCl3, δ):
3.62 (dd, 1JH,P = 202.6Hz, 2JH,H = 12.6Hz, 1H, PH), 3.70 (s, 3H,
OCH3), 3.81 (dd, 1JH,P = 207.8Hz, 2JH,H = 12.6Hz, 1H, PH), 3.94 (ptd, 3,4JH,H = 2.6Hz,
JH,P = 0.84Hz, 1H, o-OCH3), 4.01 (ddd, JH,H = 2.6Hz, JH,P = 1.4Hz, JH,H = 1.4Hz, 1H,
o-PH2), 4.15 (dd, JH,H = 2.6Hz, JH,H = 1.4Hz, 1H,m-OCH3), 4.16 (s, 5H, C5H5). 13C{1H}
NMR (CDCl3, δ): 54.0 (d, 3JC,P = 0.86, m-OCH3), 57.9 (s, OCH3), 62.9 (d, 3JC,P = 5.0Hz,
o-OCH3), 69.5 (s, C5H5), 70.0 (d, 2JC,P = 19.9Hz, o-PH2), 129.8 (C–OCH3). (The C–PPh2
carbon was neither detected in the 13C nor in HMBC spectra. 31P{1H} NMR (CDCl3, δ):
–159.9 (dd, 1JH,P = 202.6Hz, 1JH,P = 207.8Hz.
(2-Methoxyferrocenyl)diphenylphosphine (rac-91)
91
FeO PPh2
(2-Methoxyferrocenyl)phosphine (90a; 480mg, 1.94mmol), iodobenzene
(0.43mL, 3.90mmol), K3PO4 (825mg, 3.90mmol), and [PdCl2(dppf)]
(55mg, 4 mol-%) were reacted according to the general procedure GP5.
Purification was realized by column chromatography (silica, 2 · 6 cm col-
umn size) using a 7/3 (v/v) hexane/CH2Cl2 mixture, giving 91 (Rf =
0.14) as an orange solid.
Yield: 410mg (1.01mmol, 52% based on 90a). Anal. calcd for C23H21FeOP (400.23 g/mol):
C, 69.02; H, 5.29. Found: C, 68.48; H, 5.28. Mp.: 147℃. 1H NMR (CDCl3, δ): 3.50 (ddd,
3JH,H = 2.5Hz, 4JH,H = 1.4Hz, 3JH,P = 1.3Hz, 1H, o-PPh2), 3.67 (s, 3H, OCH3), 3.98
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(dpt, 4JH,P = 0.5Hz, 3JH,H = 2.5Hz, 1H, m-OCH3), 4.11 (s, 5H, C5H5), 4.26 (ddd, 4JH,P =
1.5Hz, 4JH,H = 1.4Hz, 3JH,H = 2.5Hz, 1H, o-OCH3), 7.24–7.29 (m, 5H, o,m-Ph), 7.36–7.39
(m, 3H, o,m-Ph), 7.53–7.58 (m, 2H, p-Ph). 13C{1H} NMR (CDCl3, δ): 54.7 (d, 3JC,P =
2.6Hz, o-OCH3), 58.0 (s, OCH3), 63.1 (s, m-OCH3), 65.0 (d, 1JC,P = 7.6Hz, C–PPh2), 65.7
(d, 2JC,P = 2.0Hz, o-PPh2), 69.3 (s, C5H5), 127.8 (s, p-Ph), 128.05 (d, 3JC,P = 6.0Hz, m-
Ph), 128.10 (d, 3JC,P = 7.7Hz, m-Ph), 129.0 (s, p-Ph), 131.1 (d, 2JC,P = 18.0Hz, C–OCH3),
132.3 (d, JC,P = 18.4Hz, o-Ph), 134.9 (d, JC,P = 21.1Hz, o-Ph), 137.3 (d, 1JC,P = 8.7Hz,
C1-Ph), 139.6 (d, 1JC,P = 11.1Hz, C1-Ph). 31P{1H} NMR (CDCl3, δ): –23.97 (s). HRMS
(ESI-TOF, m/z): calcd for C23H21FeOP 400.0674, found 400.0754 [M]+.
(2-Methoxyferrocenyl)diphenylphosphine (Rp)-91
Compound (Rp)-31e (570mg, 1.00mmol), Li[AlH4] (0.6 g, 16mmol), ClSiMe3 (1.65mL,
12.9mmol), iodobenzene (0.22mL, 2.0mmol), K3PO4 (425mg, 2.0mmol), and [PdCl2(dppf)]
(30mg, 4 mol-%) were reacted according to the general procedure GP5. The purification
procedure is similar to rac-91. HPLC measurements were performed after single recrystal-
lization from hexane. Crystals suitable for single crystal X-ray analysis of phosphine oxide
(Rp)-20 were obtained by dissolving (Rp)-90 (2mg) in 4mL of a 95/5 hexane/tBuOMe mix-
ture. On exposure to atmospheric conditions for 14 days a few single crystals of (Rp)-91
could be obtained from this solution.
Yield: 260mg (0.65mmol, 65% based on 31e). The spectroscopic data are in agreement
with those for rac-91. HPLC (Chiralcel OD-H column, flow rate 0.8mL min−1, 95/5
hexane/tBuOMe): rac-91, 26.410 (48.9%), 42.110 (51.1%); (Rp)-91, 25.485 (>99.9%); ee =
0.99.
(2-(tert-Butyldiphenylsilyloxy)ferrocenyl)diphenylphosphine (rac-117a)
117a
Fe O
SitBuPh2Ph2P
Diethyl (2-(tert-butyldiphenylsilyloxy)ferrocenyl)phosphonate
(rac-95g, 1.00 g, 1.74mmol), Li[AlH4] (0.6 g, 16mmol),
ClSiMe3 (1.65mL, 12.9mmol), iodobenzene (0.39mL,
3.50mmol), K3PO4 (745mg, 3.50mmol), and [PdCl2(dppf)]
(52mg, 4 mol-%) were reacted according to the general
procedure GP5. Purification was realized by column chromatography (alumina, 2.5 · 12 cm
column size) using a 9/1 (v/v) hexane/CH2Cl2 mixture, giving rac-117a (Rf = 0.55) as an
orange oil.
Yield: 79mg (0.126mmol, 6% based on 95g). 1H NMR (CDCl3, δ): 0.92 (s, 9H, CH3), 3.33
(ddd, 3JH,H = 2.5Hz, 4JH,H = 1.4Hz, J = 0.8Hz, 1H, C5H3), 3.68 (ddd, 3JH,H = 2.7Hz,
J = 2.7Hz, J = 0.5Hz, 1H, C5H3), 3.71 (ddd, 3JH,H = 2.9Hz, J = 2.9Hz, J = 1.5Hz,
1H, C5H3), 3.95 (s, 5H, C5H5), 7.25–7.28 (m, 5H, Ph), 7.35–7.39 (m, 6H, Ph), 7.44–7.52
(m, 5H, Ph), 7.55–7.59 (m, 2H, Ph), 7.90–7.92 (m, 2H, Ph). 13C{1H} NMR (CDCl3, δ):
19.2 (qC), 26.5 (CH3), 61.3 (d, JC,P = 2.2Hz, C5H3), 62.7 (s, C5H3), 64.5 (d, JC,P = 3.1Hz,
C5H3), 66.4 (d, 1JC,P = 5.6Hz, CFc-P), 69.9 (s, C5H5), 125.4 (d, 2JC,P = 19.1Hz, CFc-O),
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127.43 (PhSi), 127.67 (PhSi), 127.99 (d, JC,P = 2.2Hz, PhP ), 128.04 (d, JC,P = 1.5Hz, PhP ),
128.08 (C4-PhP ), 128.6 (C4-PhP ), 129.8 (C4-PhSi), 130.0 (C4-PhSi), 132.1 (C1-PhSi), 133.2
(d, JC,P = 19.7Hz, PhP ), 133.55 (C1-PhSi), 134.5 (d, JC,P = 20.4Hz, PhP ), 135.9 (PhSi),
136.0 (PhSi), 137.7 (d, 1JC,P = 10.2Hz, CPh-P), 139.1 (d, 1JC,P = 12.2Hz, CPh-P). 29Si{1H}
NMR (CDCl3, δ): –3.68. 31P{1H} NMR (CDCl3, δ): –23.96 (s). HRMS (ESI-TOF, m/z):
calcd for C38H37FeOPSi 624.1696, found 624.1659 [M]+.
(2-(Triisopropylsilyloxy)ferrocenyl)diphenylphosphane (rac-116b) and
phosphine (rac-117b)
116b
Fe O
SiiPr3H2P
Diethyl (2-(triisopropylsilyloxy)ferrocenyl)phosphonate (rac-95h,
845mg, 1.71mmol), Li[AlH4] (0.6 g, 16mmol) and ClSiMe3
(1.65mL, 12.9mmol) were reacted according to the general pro-
cedure GP5. The phosphane was subsequently used in the Stelzer
coupling reaction without further purification.
Yield: 537mg (1.37mmol, 80% based on 95h).1H NMR (CDCl3, δ): 1.07 (d, 3JH,H = 7.1Hz,
9H, CH3), 1.13 (d, 3JH,H = 6.8Hz, 9H, CH3), 1.16–1.23 (m, 3H, CH (CH3)2), 3.61 (dd, 1JH,P
= 199.9Hz, 2JH,H = 12.6Hz, 1H, PH), 3.84 (ddd, 3JH,H = 2.6Hz, JH,P = 2.6Hz, JH,H =
1.1Hz, 1H, C5H3), 3.86 (dd, 1JH,P = 207.7Hz, 2JH,H = 12.6Hz, 1H, PH), 3.95 (ddd, 3JH,H
= 2.8Hz, JH,P = 2.8Hz, JH,H = 1.5Hz, 1H, C5H3), 4.10 (s, 5H, C5H5), 4.19 (dd, 3JH,H =
2.5Hz, JH,H = 1.4Hz, 1H, C5H3). 29Si{1H} NMR (CDCl3, δ): 16.83. 31P NMR (CDCl3, δ):
–159.0 (dd, 1JP,H = 207.7Hz, 1JP,H = 199.9Hz).
117b
Fe O
SiiPr3Ph2P
Compound 116b (537mg, 1.37mmol), iodobenzene (0.31mL,
2.78mmol), K3PO4 (583mg, 2.75mmol), and [PdCl2(dppf)]
(40mg, 4 mol-%) were reacted according to the general proce-
dure GP5. Purification was realized by column chromatography
(silica, 2.5 · 12 cm column size) using a 9/1 (v/v) hexane/CH2Cl2
mixture, giving rac-117b as an orange solid. Crystals suitable for single crystal X-Ray
diffraction analysis were obtained by evaporation of an CH2Cl2 solution containing 117b at
ambient temperature.
Yield: 56mg (0.103mmol, 6% based on 95h). Mp.: 84–86℃. 1H NMR (CDCl3, δ): 0.93–0.94
(m, 9H, CH3), 1.01–1.03 (m, 12H, CH3, CH (CH3)2), 3.38 (ddd, 3JH,H = 2.8Hz, 4JH,H =
1.4Hz, J = 0.8Hz, 1H, C5H3), 3.87 (ddd, 3JH,H = 2.7Hz, J = 2.7Hz, J = 0.6Hz, 1H, C5H3),
4.8 (s, 5H, C5H5), 4.24 (ddd, 3JH,H = 2.6Hz, J = 2.6Hz, J = 1.6Hz, 1H, C5H3), 7.23–7.24
(m, 3H, Ph), 7.35–7.35 (m, 5H, Ph), 7.53–7.57 (m, 2H, Ph). 13C{1H} NMR (CDCl3, δ):
12.3 (CH(CH3)2), 17.80 (CH3), 17.89 (CH3), 61.1 (d, JC,P = 2.3Hz, C5H3), 62.6 (s, C5H3),
65.0 (d, JC,P = 2.9Hz, C5H3), 66.2 (d, 1JC,P = 5.6Hz, CFc-P), 69.9 (s, C5H5), 125.8 (d,
2JC,P = 19.4Hz, CFc-O), 127.85 (C4-PhP ), 127.9 (d, JC,P = 3.6Hz, PhP ), 128.0 (d, JC,P
= 4.8Hz, PhP ), 128.6 (C4-PhP ), 133.2 (d, JC,P = 19.8Hz, PhP ), 134.7 (d, JC,P = 20.6Hz,
PhP ), 137.8 (d, 1JC,P = 10.1Hz, CPh-P), 139.2 (d, 1JC,P = 11.9Hz, CPh-P). 29Si{1H} NMR
(CDCl3, δ): 16.7. 31P{1H} NMR (CDCl3, δ): –24.4 (s). HRMS (ESI-TOF, m/z): calcd for
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C31H39FeOPSi 542.1852, found 542.1821 [M]+.
2,4-Diacetamidophenoxyferrocene (115)
115
Fe O
HN
H
N
O
O
2,4-Dinitrophenoxyferrocene 96a (200mg, 0.543mmol),
Li[AlH4] (0.6 g, 16mmol) and ClSiMe3 (1.65mL, 12.9mmol)
were reacted according to the general procedure GP5 for the
conversion of phosphonates to phosphanes. After stirring of the
reaction mixture for 12 h at 45℃, the pH value was adjusted at
∼ 7 by using H2SO4 (ω = 30%) and K2CO3. The aqueous layer
was extracted with diethyl ether under oxygen-free conditions
until the organic layer remained colorless. The combined organic layers were dried over
MgSO4. To the mixture, acetic anhydride (0.5mL, 4.9mmol) was dropwise added. After
stirring for 5 min, NEt3 (0.5mL, 3.6mmol) was dropwise added. The mixture was heated to
60℃ and stirred for 60 min. After cooling to ambient temperature, the mixture was poured
into water and extracted with diethyl ether (3 · 50mL) followed by removal of all volatiles
in vacuum. Purification was realized by column chromatography (silica, 2.5 · 14 cm column
size) using a 35/65 (v/v) dichloromethane/ethyl acetate mixture was the eluent, giving 115
as an yellow oil.
Yield: 15mg (0.038mmol, 7% based on 96a). 1H NMR (CDCl3, δ): 2.08 (s, 3H, CH3),
2.16 (s, 3H, CH3), 3.89 (pt, 3,4JH,H = 1.9Hz, 2H, C5H4), 4.15 (pt, 3,4JH,H = 1.9Hz, 2H,
C5H4), 4.18 (s, 5H, C5H5), 6.96 (d, 3JH,H = 8.9Hz, 1H, H6-Ph), 7.45 (s, 1H, NH), 7.59 (dd,
3JH,H = 8.8Hz, 4JH,H = 1.9Hz, 1H, H5-Ph), 7.63 (s, 1H, NH), 8.07 (d, 4JH,H = 1.8Hz,
1H, H3-Ph). 13C{1H} NMR (CDCl3, δ): 24.4 (CH3), 25.0 (CH3), 59.0 (C5H4), 63.0 (C5H4),
69.3 (C5H5), 111.8 (C3-Ph), 115.8 (C5-Ph), 116.7 (C6-Ph), 122.9 (CFc-O), 128.9 (qPh), 133.4
(qPh), 143.0 (qPh), 168.30 (C=O), 168.38 (C=O).
4.3.4 Synthesis of Chloro and Dichlorophosphates
Bis((1S)-borneyl) Chlorophosphate (29d)
O
29d
PCl
O
2
(1S)-Borneol (28d; 5.82 g, 37.7mmol), was dissolved in 10mL of
tetrahydrofuran; an equal volume of diethyl ether was added, and the
mixture was cooled to –30℃. The dropwise addition of BuLi (15.1mL,
37.7mmol) resulted in the formation of a colorless precipitate. The
mixture was stirred for an additional 10 min at –30℃. POCl3 (1.8mL,
18.9mmol) was slowly added and the solution was warmed to ambient
temperature and stirred overnight. All volatiles were removed under
reduced pressure. The resulting residue was suspended in diethyl ether and filtered through a
plug of Celite (minimum 5 cm thickness) with diethyl ether to remove the lithium salt. After
removal of all volatiles chlorophosphate 29d was obtained as a colorless oil and used without
further purification.
Yield: 7.25 g (16.7mmol, 99% based on 28d). 1H NMR (CDCl3, δ): 0.887 (s, 6H, CH3),
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0.892 (s, 6H, CH3), 0.924 (s, 3H, CH3), 0.925 (s, 3H, CH3), 1.28–1.37 (m, 6H), 1.70–1.80
(m, 4H, CH2, H4), 1.89–1.96 (m, 2H, CH2), 2.32–2.42 (m, 2H, CH2), 4.68–4.75 (m, 2H,
H2). 13C{1H} NMR (CDCl3, δ): 13.1 (CH3), 13.3 (CH3), 18.75 (CH3), 18.78 (CH3), 19.9
(CH3), 26.42 (CH2), 26.47 (CH2), 27.87 (CH2), 27.90 (CH2), 36.5 (d, 3JC,P = 1.3Hz, CH2),
36.8 (d, 3JC,P = 1.5Hz, CH2), 44.8, 47.68 (C1/C7), 47.72 (C1/C7), 49.78–49.88 (m, C1/C7),
86.86–86.98 (m, C2). 31P{1H} NMR (CDCl3, δ): 5.4. HRMS (ESI-TOF, m/z): calcd for
C20H34ClO3P 411.1826, found 411.1850 [M]+.
Bis((1R)-α-fenchyl) chlorophosphate (29e)
O
29e
PCl
O
2
(1R)-α-Fenchol (28e; 6.01 g, 39.0mmol), was dissolved in 10mL of
tetrahydrofuran; an equal volume of diethyl ether was added, and the
mixture was cooled to –30℃. The dropwise addition of BuLi (15.6mL,
39.0mmol) resulted in the formation of a colorless precipitate. The mix-
ture was stirred for an additional 10 min at –30℃. POCl3 (1.8mL,
19.5mmol) was slowly added and the solution was warmed to ambi-
ent temperature and stirred overnight. All volatiles were removed under
reduced pressure. The resulting residue was suspended in diethyl ether and filtered through a
plug of Celite (minimum 5 cm thickness) with diethyl ether to remove the lithium salt. After
removal of all volatiles chlorophosphate 29e was obtained as a colorless oil and used without
further purification.
Yield: 7.51 g (19.3mmol, 99% based on 28e). 1H NMR (CDCl3, δ): 0.973 (s, 3H, CH3),
0.977 (s, 3H, CH3), 1.05–1.11 (m, 8H), 1.16 (s, 3H, CH3), 1.17 (s, 3H, CH3), 1.19–1.24 (m,
2H), 1.41–1.51 (m, 2H), 1.52–1.57 (m, 2H), 1.68–1.75 (m, 6H), 4.09 (dd, 3JH,P = 11.2Hz,
JH,H = 1.8, 1H, H2), 4.14 (dd, 3JH,P = 11.5Hz, JH,H = 1.8, 1H, H2). 13C{1H} NMR
(CDCl3, δ): 19.2 (CH3), 19.4 (CH3), 20.95 (CH3), 20.98 (CH3), 25.7–25.8 (m, C5/C6), 29.6
(CH3), 29.9 (CH3), 39.5–39.6 (m, C3), 40.8 (C7), 40.9 (C7), 47.9 (C4), 48.0 (C4), 49.3 (d,
3JC,P = 6.6Hz, C1), 49.5 (d, 3JC,P = 4.9Hz, C1), 93.0–93.1 (m, C2). 31P{1H} NMR (CDCl3,
δ): 5.9. HRMS (ESI-TOF, m/z): calcd for C20H34ClO3P+Na 411.1826, found 411.1850 [M
+ Na]+.
(1R)-α-Fenchyl Dichlorophosphate (42d)
O
42d
PCl2
O (1R)-α-Fenchol (28e; 4.23 g, 27.4mmol) was dissolved in 10mL of di-
ethyl ether and cooled to –30℃. Dropwise addition of BuLi (12mL,
30mmol) resulted in the formation of a colorless precipitate. After it
was stirred for additional 10 min at –30℃, the suspension was added
dropwise to a solution containing POCl3 (8mL, 85.5mmol) in 30mL of
diethyl ether at –30℃. Stirring was continued overnight followed by filtration through a pat
of Celite (min 5 cm thickness) with diethyl ether to remove the lithium salt. After removal
of all volatiles under reduced pressure, the title compound 42d was obtained as a colorless
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oil and used without further purification.
Yield: 7.36 g (27.1mmol, > 95 %, based on 28e). 1H NMR (CDCl3, δ): 0.99 (s, 3H, CH3),
1.12–1.18 (m, 7H), 1.26–1.28 (m, 1H), 1.48–1.54 (m, 1H), 1.56–1.59 (m, 1H), 1.69–1.76
(m, 2H), 1.78–1.79 (m, 1H), 4.33 (dd, 3JH,P = 13.1Hz, JH,H = 1.8Hz, 1H, H2). 13C{1H}
NMR (CDCl3, δ): 19.2 (CH3), 21.0 (CH3), 25.65 (C5/C6), 25.73 (C5/C6), 29.6 (CH3),
39.8 (d, 3JC,P = 2.9Hz, C3), 40.9 (C7), 47.9 (C4), 49.5 (d, 3JC,P = 5.9Hz, C1), 97.0 (d,
2JC,P = 11.7Hz, C2). 31P{1H} NMR (CDCl3, δ): 8.4. HRMS (ESI-TOF, m/z): calcd for
C10H17Cl2O2P+Na 293.0235, found 293.0252 [M+Na]+.
(1H -Pyrrol-1-yl) Dichlorophosphonate
PCl2N
O In a Schlenk tube, 1H -pyrrole (1mL, 14.46mmol) and 30mL of diethyl ether
were cooled to –30℃. To the solution BuLi (5.8mL, 14.5mmol) was dropwise
added. In a second Schlenk tube, a solution of 50mL diethyl ether and POCl3
(5mL, 54.8mmol) were cooled to –80℃. The mixture containing lithiated
pyrrole was cooled to –80℃ and was very slowly added to the POCl3 solution
by using a transfer cannula. The workup procedure is similar to the general procedure,
described above. The title compound was obtained as a colorless oil and used without further
purification.
1H NMR (CDCl3, δ): 6.47 (dt, 4JH,P = 5.2Hz, JH,H = 2.2Hz, 2H, H3,4), 7.18 (dt, 3JH,P
= 3.4Hz, JH,H = 2.2Hz, 2H, H2,5). 13C{1H} NMR (CDCl3, δ): 115.1 (d, 3JC,P = 13.2Hz,
C3,4), 122.4 (d, 2JC,P = 7.0Hz, C2,5). 31P{1H} NMR (CDCl3, δ): 5.5.
(9H -Carbazol-9-yl) Dichlorophosphonate
PCl2N
O 9H -Carbazole (2.393 g, 14.31mmol), BuLi (5.8mL, 14.5mmol) and
POCl3 (4mL, 43.83mmol) were reacted according to the synthesis of 42d.
The title compound was obtained as a colorless oil and used without fur-
ther purification.
1H NMR (CDCl3, δ): 7.45 (td, 3JH,H = 8.0Hz, H,PJ0 =.8Hz, 2H), 7.53
(dd, 3JH,H = 8.5Hz, H,HJ7 =.4Hz, 3JH,P = 1.3Hz, 2H), 8.03–8.05 (m,
2H), 8.16 (d, 3JH,H = 8.4Hz, 2H). 31P{1H} NMR (CDCl3, δ): 0.5.
4.3.5 Synthesis of Ferrocenyl Aryl Ether
General Procedure for Nucleophilic Aromatic Substitutions - GP6
The deprotonated hydroxyferrocenes were either obtained by adding 1 equiv of BuLi to the
respective compound in 10 to 30mL of THF or diethyl ether at –30℃ (in case of 5), or were
present after an anionic phospho-/thia-Fries rearrangement. Subsequently, 3mL of oxygen
free N ,N -dimethylformamide and 3 equiv of the aryl fluorides, or 0.5 equiv in case of 97
and 98, were added. The solvent was reduced to about 3mL in vacuum. After heating the
mixture to 70℃ for 18 h, all volatiles were removed in vacuum. The residue was dissolved
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in diethyl ether (50mL), washed with brine (400mL) and the latter one was extracted again
with diethyl ether (3 · 50mL). Purification was realized by column chromatography (silica,
see below) using different solvent mixtures (see below).
(Prop-2-yn-1-yloxy)ferrocene (95b)
95b
Fe O
Ferrocenol (5, 87mg, 0.43mmol) was diluted in 20mL of diethyl ether
and BuLi (0.18mL, 0.45mmol) was dropwise added at –30℃. After
stirring for 10 min at this temperature, propargyl tosylate (136mg,
0.65mmol) was added in a single portion. The reaction mixture was
warmed to ambient temperature and stirring was continued overnight.
Purification was realized by column chromatography (silica, 2 · 8 cm col-
umn size) using an 1:1 hexane/dichloromethane mixture (v/v) as the eluent, giving 95b as
an orange oil.
Yield: 11mg (0.46mmol, 11% based on 5). 1H NMR (CDCl3, δ): 2.57 (t, 4JH,H = 2.4Hz,
1H, CH), 3.85 (pt, 3,4JH,H = 1.9Hz, 2H, C5H4), 4.19 (pt, 3,4JH,H = 1.9Hz, 2H, C5H4),
4.22 (s, 5H, C5H5), 4.48 (d, 4JH,H = 2.4Hz, 2H, CH2). 13C{1H} NMR (CDCl3, δ): 56.1
(C5H4), 58.4 (CH2), 62.1 (C5H4), 68.7 (C5H5), 75.4 (C≡C), 79.1 (C≡C), 125.9 (CC5H4-O).
HRMS (ESI-TOF, m/z): decomposed before measurement.
(But-2-yn-1-yloxy)ferrocene (95c)
95c
Fe O
According to the synthesis of compound 95b, ferrocenol (5, 182mg,
0.90mmol), BuLi (0.36mL, 0.90mmol) and methylpropargyl tosylate
(243mg, 1.08mmol) were reacted. Purification was realized by column
chromatography on first silica (2 · 6 cm, dichloromethane) followed by
alumina (4 · 6 cm column size) using dichloromethane as the eluent,
giving 95c as an orange oil.
Yield: 48mg (0.46mmol, 21% based on 5). 1H NMR (CDCl3, δ): 1.90 (dd, 5JH,H = 2.3Hz,
5JH,H = 2.3Hz, 3H, CH3), 3.84 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4), 4.16 (pt, 3,4JH,H =
2.0Hz, 2H, C5H4), 4.21 (s, 5H, C5H5), 4.44 (m, 2H, CH2). 13C{1H} NMR (CDCl3, δ): 3.7
(CH3), 55.9 (C5H4), 58.9 (CH2), 62.0 (C5H4), 68.6 (C5H5), 74.4 (C≡C), 83.6 (C≡C), 125.8
(CC5H4-O). HRMS (ESI-TOF, m/z): calcd for C14H14FeO 254.0389, found 254.0404 [M]+.
Diethyl (2-(Tetrahydro-2H -pyran-2-yloxy)ferrocenyl)phosphonate (95f)
95f
Fe O O
Diethyl ferrocenyl phosphate (6, 1.08 g, 3.2mmol), diisopropylamine
(0.89mL, 6.4mmol) and BuLi (2.56mL, 6.4mmol) were reacted accord-
ing to the general procedure GP2. Afterwards, oxygen free 10 N H2SO4
(1.3mL, 12.8mmol) and oxygen-free water (10mL) were added in a sin-
gle portion. The mixture was extracted using oxygen-free diethyl ether
(3 · 50mL) and the combined organic layers were filtered through oxygen-
free MgSO4, collected in a Schlenk tube and all volatiles were removed in vacuum. The
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tetrahydropyranyl substituent was introduced related to reference [120] by diluting the precip-
itate with dichloromethane and HCl in tetrahydrofuran (0.3mL, ∼ 3 M ) and 3,4-dihydro-2H -
pyran (0.87mL, 9.6mmol) were added. The reaction mixture was stirred overnight, poured
into 100mL of NaOH (ω = 5%) and extracted with diethyl ether (3 · 50mL). The com-
bined organic layers were dried over Na2CO3 and all volatiles were removed in vacuum. The
crude product was purified by column chromatography (alumina, 4 · 10 cm column size) using
dichloromethane as the eluent, giving 95f as an orange oil with a ratio of both diastereomers
of 0.32 : 0.68.
Yield: 1.350 g (3.19mmol, 99% based on 6). 1H NMR (CDCl3, δ): 1.24–1.41 (m, 6H, CH3),
1.54–1.69 (m, 3H, CH2), 1.74–1.92 (m, 3H, CH2), 3.58–3.61 (m, 0.68H, CH2), 3.69–3.71 (m,
0.32H, CH2), 3.76–3.81 (m, 0.68H, CH2), 4.05–4.39 (m, 12H, CH2, C5H5, C5H3), 4.48–4.51
(m, 0.32H, C5H3), 4.93 (s, 0.32H, CH) , 5.36 (s, 0.68H, CH). 13C{1H} NMR (CDCl3, δ):
16.4–16.6 (m, CH3), 18.4 (0.68 C, CH2), 18.6 (0.32C, CH2), 25.2 (0.68 C, CH2), 25.3 (0.32C,
CH2), 30.2 (0.68 C, CH2), 30.4 (0.32C, CH2), 58.3 (d, 1JC,P = 213.9Hz, C-P), 59.4 (d, JC,P
= 11.2Hz, 0.68 C, C5H3), 60.3 (d, JC,P = 11.5Hz, 0.32C, C5H3), 61.5–62.1 (m, CH2), 64.5
(d, JC,P = 14.1Hz, 0.32C, C5H3), 14.2 (d, JC,P = 14.2Hz, 0.68 C, C5H3), 66.8 (d, JC,P =
13.4Hz, 0.68 C, C5H3), 66.9 (d, JC,P = 13.7Hz, 0.32C, C5H3), 70.1 (s, 3.4 C, C5H5), 70.6 (s,
1.6 C, C5H5), 99.6 (s, 0.68 C, CH), 99.9 (s, 0.32C, CH), 124.9 (d, 2JC,P = 9.7Hz, CC5H3-O).
31P{1H} NMR (CDCl3, δ): 23.7 (0.68 P), 24.1 (0.32 P). HRMS (ESI-TOF, m/z): calcd for
C19H27FeO5P+Na 445.0838, found 455.0910 [M+Na]+.
(Diphenylmethoxy)ferrocene (95e)
95e
Fe O Ph
Ph 1,1-Diphenylmethanol (275mg, 1.5mmol) was dissolved in tetrahydrofu-
ran, cooled to –30℃ and BuLi (0.6mL, 1.5mmol) was dropwise added.
After 15 min of stirring at this temperature, ClPPh2 (0.27mL, 1.5mmol)
was dropwise added and stirring was continued for additional 30 min at
ambient temperature. Afterwards, all volatiles were removed under re-
duced pressure and 2,6-dimethylquinone (136mg, 1.0mmol) and FcOH
(5) (200mg, 1.0mmol) were added in a single portion. Oxygen-free dichloromethane (10mL)
was added and the reaction mixture was stirred for 18 h at ambient temperature. Purification
was performed by column chromatography (silica, 4 · 6 cm column size) using hexane as the
eluent, giving 95e as an orange solid.
Yield: 83mg (0.23mmol, 23% based on 5). The spectroscopic data are in agreement with
those reported in literature [156].
Diethyl (2-((tert-Butyldiphenylsilyl)oxy)ferrocenyl)phosphonate (rac-95g)
Diethyl ferrocenyl phosphate (6, 1.102 g, 3.26mmol), diisopropylamine (0.92mL, 6.52mmol),
BuLi (2.6mL, 6.52mmol) and TMEDA (0.95mL, 6.52mmol) were reacted according to the
general procedure GP2. Afterwards, ClSitBuPh2 (2.5mL, 9.77mmol) was added in a single
portion at –30℃. The cooling bath was removed and stirring was continued at ambient
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temperature for 18 h. Purification was per-formed by column chromatography (silica, 2 · 15 cm
column size) using a 7/3 dichloromethane/ethyl acetate mixture (v/v) (Rf = 0.31) as the
eluent, giving rac-95g as an orange oil.
SitBuPh2
95g
Fe O(EtO)2P
O Yield: 1.06 g (1.84mmol, 56% based on 6). 1H NMR
(CDCl3, δ): 1.10 (s, 9H, C(CH3)3), 1.30 (t, 3JH,H = 7.1Hz,
3H, CH2-CH3), 1.44 (t, 3JH,H = 7.0Hz, 3H, CH2-CH 3),
3.63 (ddd, JH,H = 2.8, 2.8Hz, JH,P = 1.5Hz, 1H, C5H3),
3.76 (dd, JH,H = 2.8, 2.8Hz, 1H, C5H3), 4.08–4.17 (m, 7H,
CH2, C5H5), 4.19–4.21 (m, 1H, C5H3), 4.26–4.36 (m, 2H,
CH2), 7.32–7.35 (m, 2H, 2,6-C6H5), 7.40–7.43 (m, 1H, 4-C6H5), 7.46–7.54 (m, 3H, 2,4,6-
C6H5), 7.62–7.64 (m, 2H, 3,5-C6H5), 7.91–7.93 (m, 2H, 3,5-C6H5). 13C{1H} NMR (CDCl3,
δ): 16.4 (d, 3JC,P = 6.8Hz, CH3), 16.6 (d, 3JC,P = 7.2Hz, CH3), 19.4 (C(CH3)3), 26.5
(C(CH3)3), 57.1 (d, 1JC,P = 215.8Hz, C-P), 61.4–61.5 (m, CH2), 62.1 (d, JC,P = 11.3Hz,
C5H3), 63.8 (d, JC,P = 14.4Hz, C5H3), 66.3 (d, JC,P = 14.2Hz, C5H3), 70.5 (C5H5), 123.0
(d, 2JC,P = 9.0Hz, CC5H3-O), 127.6 (2,6-C6H5), 127.8 (2,6-C6H5), 130.0 (4-C6H5), 130.2
(4-C6H5), 132.1 (1-C6H5), 133.4 (1-C6H5), 135.6 (3,5-C6H5), 135.8 (3,5-C6H5). 29Si{1H}
NMR (CDCl3, δ): -3.1. 31P{1H} NMR (CDCl3, δ): 24.9. HRMS (ESI-TOF, m/z): calcd for
C30H37O4FePSi 576.1543, found 576.1596 [M]+.
Diethyl (2-((Triisopropylsilyl)oxy)ferrocenyl)phosphonate (rac-95h)
Si(iPr)3
95h
Fe O(EtO)2P
O In accordance to compound 95g, 6 (1.122 g, 3.32mmol),
diisopropylamine (0.92mL, 6.64mmol), BuLi (2.65mL,
6.63mmol) and TMEDA (0.95mL, 6.63mmol) were re-
acted according to the general procedure GP2. Afterwards,
ClSiiPr3 (1.4mL, 6.63mmol) was added in a single portion
at –30℃. The cooling bath was re-moved and stirring was
continued at ambient temperature for 18 h. Purification was performed by column chro-
matography (silica, 2 · 15 cm column size) using a 7/3 dichloromethane/ethyl acetate mixture
(v/v) as the eluent, giving rac-95h as an orange oil.
Yield: 845 g (1.71mmol, 52% based on 6). 1H NMR (CDCl3, δ): 1.07 (d, 3JH,H = 7.1Hz,
9H, CH(CH3)2), 1.14 (d, 3JH,H = 7.1Hz, 9H, CH(CH3)2), 1.17–1.24 (m, 3H, CH(CH3)2),
1.29 (t, 3JH,H = 7.1Hz, 3H, CH2-CH3), 1.39 (t, 3JH,H = 7.1Hz, 3H, CH2-CH3), 3.95–3.96
(m, 1H, C5H3), 4.02–4.14 (m, 2H, CH2), 4.17–4.31 (m, 9H, C5H5, CH2, C5H3). 13C{1H}
NMR (CDCl3, δ): 12.5 (CH), 16.3 (CH3), 16.4 (CH3), 16.46 (CH3), 16.51 (CH3), 17.82
(CH(CH3)2), 17.85 (CH(CH3)2), 57.2 (d, 1JC,P = 215.5Hz, C-P), 61.29 (d, 2JC,P = 5.8Hz,
CH2), 61.34 (d, 2JC,P = 6.6Hz, CH2), 61.9 (d, JC,P = 11.6Hz, C5H3), 63.5 (d, JC,P = 14.5Hz,
C5H3), 66.7 (d, JC,P = 14.3Hz, C5H3), 70.53 (C5H5), 123.2 (d, 2JC,P = 9.3Hz, CC5H3-O).
29Si{1H} NMR (CDCl3, δ): 17.8. 31P{1H} NMR (CDCl3, δ): 24.7. HRMS (ESI-TOF, m/z):
calcd for C23H39FeO4PSi + H 495.1778, found 495.1717 [M+H]+.
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1-Ferrocenyloxy-2,4-dinitrobenzene (96a)
96a
Fe O
NO2
NO2
To ferrocenol (5, 218mg, 1mmol) in toluene (10mL), BuLi
(0.43mL) was added dropwise. Afterwards, the general pro-
cedure GP6 for SNAr reactions was applied using 1-fluoro-2,4-
dinitrobenzene (101mg, 0.50mmol). Dicyclohexylamine (97mg,
0.54mmol) was added in a single portion to the solution and stir-
ring at 70℃ was continued for 3 h. Afterwards, the reaction
mixture was cooled to ambient temperature, extracted with di-
ethyl ether (3 · 50mL) and the solvent was removed under reduced pressure. Purification
was performed by column chromatography (silica, 4 · 8 cm column size) using a 1/1 hex-
ane/dichloromethane mixture (v/v) as the eluent, giving 96a was obtained as an orange
solid. Suitable single crystals were obtained by recrystallization from boiling hexane.
Yield: 323mg (0.88mmol, 81% based on 5). Mp.: 125–128℃. 1H NMR (CDCl3, δ): 4.10
(pt, 3,4JH,H = 2.0Hz, 2H, C5H4), 4.36 (s, 5H, C5H5), 4.37 (pt, 3,4JH,H = 2.0Hz, 2H,
C5H4), 7.11 (d, 3JH,H = 9.3Hz, 1H, H6), 8.28 (dd, 3JH,H = 9.3Hz, 4JH,H = 2.8Hz, 1H,
H5), 8.79 (d, 4JH,H = 28Hz, 1H, H3). 13C{1H} NMR (CDCl3, δ): 61.1 (C5H4), 64.3
(C5H4), 70.1 (C5H5), 116.9 (C6-C6H3), 119.5 (CC5H4-O), 121.7 (C3-C6H3), 128.7 (C5-C6H3),
138.6 (C2-C6H3), 140.9 (C4-C6H3), 157.7 (C1-C6H3). HRMS (ESI-TOF, m/z): calcd for
C16H12FeN2O5 368.0090, found 368.0090 [M]+.
1-Ferrocenyloxy-4-nitrobenzene (96b)
96b
Fe O
NO2 To ferrocenol (5, 247mg, 1.22mmol) dissolved in toluene (10mL),
BuLi (0.50mL, 1.25mmol) was added dropwise at –30℃. After-
wards, the general procedure GP6 for the SNAr reaction was
applied using 1-fluoro-4-nitrobenzene (86mg, 0.61mmol). Di-
cyclohexylamine (110mg, 0.60mmol) was added and stirring at
70℃ was continued for 3 h. Afterwards, the reaction mixture
was cooled to ambient temperature and extracted with diethyl
ether (3 · 50mL) and all volatiles were removed under reduced pressure. Purification was
performed by column chromatography (silica, 4 · 10 cm column size) using an 1/1 hex-
ane/dichloromethane mixture (v/v) as the eluent, giving 96b as a dark orange solid. Suitable
single crystals were obtained by recrystallization from boiling hexane.
Yield: 184mg (0.57mmol, 74% based on 5). Anal. calcd for C16H13FeN1O3 (323.12 g/mol):
C, 59.47; H, 4.06; N, 4.33. Found: C, 59.96; H, 4.05; N, 4.29. Mp.: 102–104℃. 1H NMR
(CDCl3, δ): 4.05 (pt, 3,4JH,H = 2.0Hz, 2H, H2,5-C5H4), 4.28 (pt, 3,4JH,H = 2.0Hz, 2H, H3,4-
C5H4), 4.32 (s, 5H, C5H5), 6.96–7.00 (m, 2H, H2,6-C6H4), 8.13–8.16 (m, 2H, H3,5-C6H4).
13C{1H} NMR (CDCl3, δ): 61.0 (C3,4-C5H4), 63.8 (C2,5-C5H4), 69.7 (C5H5), 115.8 (C2,6-
C6H4), 119.9 (CC5H4-O), 125.6 (C3,5-C6H4), 142.3 (C4-C6H4), 164.8 (C1-C6H4). HRMS
(ESI-TOF, m/z): calcd for C16H13FeN1O3 323.0239, found 323.0257 [M]+.
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1,5-(Ferrocenyloxy)-2,4-dinitrobenzene (99a)
Fe O
99a
O2N NO2
FeO
To ferrocenol (5, 651mg, 3.22mmol) dissolved in toluene
(10mL), BuLi (1.30mL, 3.3mmol) was added dropwise.
Afterwards, the general procedure for SNAr reactions
was applied using 1,5-difluoro-2,4-dinitrobenzene 328mg,
1.61mmol). Purification was performed by column chro-
matography (silica, 4 · 10 cm column size) using a 1/1 hex-
ane/dichloromethane mixture (v/v) as the eluent, giving 99a as a reddish-orange solid. Suit-
able single crystals were obtained by crystallization from boiling hexane.
Yield: 148mg (0.26mmol, 16% based on 5). Mp.: 167–170℃. 1H NMR (CDCl3, δ): 3.96
(pt, 3,4JH,H = 2.0Hz, 4H, C5H4), 4.19 (pt, 3,4JH,H = 2.0Hz, 4H, C5H4), 4.29 (s, 10H,
C5H5), 6.68 (s, 1H, H6), 8.75 (s, 1H, H3). 13C{1H} NMR (CDCl3, δ): 60.5 (C5H4), 64.0
(C5H4), 70.0 (C5H5), 104.3 (C6-C6H2), 119.5 (CC5H4-O), 125.1 (C3-C6H2), 132.0 (C2,C4-
C6H2), 157.9 (C1,C5-C6H2). HRMS (ESI-TOF, m/z): calcd for C26H20Fe2N2O6 568.0015,
found 568.0039 [M]+.
1-Ferrocenyloxy-5-fluoro-2,4-dinitrobenzene (99b)
Fe O
99b
O2N NO2
F
The title compound 99b was obtained as a side product within the
synthesis of 99a by reacting ferrocenol (5, 651mg, 3.22mmol),
BuLi (1.30mL, 3.3mmol) and 1,5-difluoro-2,4-dinitrobenzene
(328mg, 1.61mmol). Purification was performed by column
chromatography (silica, 4 · 10 cm column size) using a 1/1 hex-
ane/dichloromethane mixture (v/v). All volatiles were removed
in vacuum and compound 99b was obtained as an orange solid.
Suitable single crystals were obtained by crystallization from hexane.
Yield: 200mg (0.52mmol, 16% based on 5). Anal. calcd for C16H11FFeN2O5 · 0.3C6H14
(386.11 · 0.3 86.18 g/mol): C, 52.12; H, 3.81; N, 6.75. Found: C, 51.71; H, 3.41; N, 6.86. Mp.:
150–152℃. 1H NMR (CDCl3, δ): . 4.13 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4), 4.37–4.38 (m, 7H,
C5H5, C5H4), 6.87 (d, 3JH,F = 11.9Hz, 1H, H6), 8.83 (d, 4JH,F = 7.6Hz, 1H, H3). 13C{1H}
NMR (CDCl3, δ): 61.1 (C5H4), 64.6 (C5H4), 70.2 (C5H5), 106.2 (d, 2JC,F = 26.5Hz, C6),
119.3 (CC5H4-O), 125.1 (C3), 130.2 (d, 2JC,F = 7.9Hz, C4), 134.4 (d, 4JC,F = 2.6Hz, C2),
158.5 (d, 1JC,F = 273.9Hz, C5), 159.1 (d, 3JC,F = 10.9Hz, C1). HRMS (ESI-TOF, m/z):
calcd for C16H11FeN2O5F 385.9996, found 386.0024 [M]+.
5-Ferrocenyloxy-N,N -dimethyl-2,4-dinitroaniline (99c)
The title compound was obtained as a side product within the synthesis of 99a by reacting fer-
rocenol (5, 651mg, 3.22mmol), BuLi (1.30mL, 3.3mmol) and 1,5-difluoro-2,4-dinitrobenzene
(328mg, 1.61mmol). Purification was performed by column chromatography (silica, 4 · 10 cm
column size) using a 1/1 hexane/dichloromethane mixture (v/v), giving 99c as an orange
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solid. Suitable single crystals were obtained by recrystallization from boiling hexane.
Fe O
99c
O2N NO2
NMe2
Yield: 132mg (0.32mmol, 10% based on 5). Mp.: 170℃. 1H
NMR (CDCl3, δ): 2.85 (s, 6H, CH3), 4.06 (pt, 3,4JH,H = 2.0Hz,
2H, C5H4), 4.35 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4), 4.36 (s,
5H, C5H5), 6.26 (s, 1H, H6), 8.69 (s, 1H, H3). 13C{1H} NMR
(CDCl3, δ): 42.3 (CH3), 61.1 (C5H4), 64.0 (C5H4), 70.0 (C5H5),
102.3 (C6-C6H2), 119.2 (CC5H4-O), 127.6 (C3-C6H2), 128.1
(C2/C4-C6H2), 130.6 (C2/C4-C6H2), 149.7 (C1-C6H2), 157.9
(C5-C6H2). HRMS (ESI-TOF, m/z): calcd for C18H17FeN3O5 411.0512, found 411.0544
[M]+.
1,2-Diferrocenyloxy-4,5-dinitrobenzene (100)
Fe Fe
O2N NO2
100
O O
To ferrocenol (5, 864mg, 4.25mmol) dissolved in toluene
(10mL), BuLi (1.70mL) was added dropwise. Afterwards, the
general procedure GP6 for SNAr reactions was applied using
1,2-difluoro-4,5-dinitrobenzene (437mg, 2.14mmol). Purifica-
tion was performed by column chromatography (silica, 4 · 10 cm
column size) using a 1/1 hexane/dichloromethane mixture (v/v)
as the eluent, giving 100 as reddish-orange crystals. Crystals,
suitable for single crystal X-ray diffraction analysis were ob-
tained by recrystallization from boiling toluene.
Yield: 700mg (1.02mmol, 48% based on 5). Mp.: 182–184℃. 1H NMR (CDCl3, δ): 4.10 (pt,
3,4JH,H = 2.0Hz, 4H, C5H4), 4.35–4.36 (m, 14H, C5H4), 7.49 (s, 2H, C6H2). 13C{1H} NMR
(CDCl3, δ): 60.4 (C5H4), 64.1 (C5H4), 69.8 (C5H5), 111.7 (C3,6-C6H2), 120.4 (CC5H4-O),
137.1 (C4,5-C6H2), 151.7 (C1,2-C6H2). HRMS (ESI-TOF, m/z): calcd for C26H20Fe2N2O6
568.0015, found 568.0000 [M]+.
Dicyclohexyl (2-(2,4-Dinitrophenoxy)ferrocenyl)phosphonate (rac-102a)
102a
Fe OP
O
O
2
NO2
NO2
Dicyclohexyl ferrocenyl phosphate (30a,
200mg, 0.45mmol), diisopropylamine (0.13mL,
0.90mmol), BuLi (0.36mL, 0.9mmol) and
TMEDA (0.14mL, 0.93mmol) were reacted
according to the general procedure B for
anionic Fries rearrangements. Afterwards, 2,4-
dinitrofluorobenzene (250mg, 1.34mmol) was
applied within the general procedure GP6 for SNAr reactions. Purification was performed
by column chromatography (silica, 2 · 15 cm column size) using a 9/1 dichloromethane/ethyl
acetate mixture (v/v) as the eluent, giving rac-102a as an orange oil.
Yield: 135mg (0.22mmol, 49% based on 30a). 1H NMR (CDCl3, δ): 1.22–1.39 (m, 10H,
CH2), 1.48–1.53 (m, 3H, CH2), 1.58–1.68 (m, 3H, CH2), 1.72–1.81 (m, 2H, CH2), 1.83–1.89
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(m, 1H, CH2), 1.91–2.00 (m, 1H, CH2), 4.27 (dd, JH,H = 2.7Hz, JH,H = 2.7Hz, 1H, C5H3),
4.31–4.38 (m, 1H, CH), 4.39–4.47 (m, 7H, CH, C5H5, C5H3), 4.52 (m, 1H, C5H3), 7.01 (d,
3JH,H = 9.3Hz, 1H, H6), 8.24 (dd, 3JH,H = 9.3Hz, 4JH,H = 2.7Hz, 1H, H5), 8.79 (d, 4JH,H
= 2.6Hz, H3). 13C{1H} NMR (CDCl3, δ): 23.6–23.7 (m, CH2), 25.1 (CH2), 33.6–33.7 (m,
CH2), 33.8–33.9 (CH2), 63.4 (d, 1JC,P = 219.2Hz, CC5H3-P), 64.5 (d, JC,P = 10.1Hz, C5H3),
66.14 (d, JC,P = 13.6Hz, C5H3), 68.8 (d, JC,P = 13.6Hz, C5H3), 71.9 (C5H5), 75.5 (d, 2JC,P
= 6.7Hz, CH), 75.7 (d, 2JC,P = 6.3Hz, CH), 117.4 (C6), 119.3 (d, 2JC,P = 9.2Hz, CC5H3-O),
121.6 (C3), 128.5 (C5), 138.3 (C2), 141.0 (C4), 157.6 (C1). 31P{1H} NMR (CDCl3, δ): 19.1
(1JC,P = 219.2Hz). HRMS (ESI-TOF, m/z): calcd for C28H33FeN2PO8+H 613.1397, found
613.1347 [M+H]+.
Dicyclohexyl (2-(4-Nitrophenoxy)ferrocenyl)phosphonate (rac-102b)
102b
Fe OP
O
O
2
NO2 Dicyclohexyl ferrocenyl phosphate (30a,
200mg, 0.45mmol), diisopropylamine (0.13mL,
0.90mmol), BuLi (0.36mL, 0.9mmol) and
TMEDA (0.14mL, 0.93mmol) were reacted
according to the general procedure B for
anionic Fries rearrangements. Afterwards,
4-nitrofluorobenzene (190mg, 1.34mmol) was
applied in the general procedure GP6 for SNAr reactions. Purification was performed by
column chromatography (silica, 2 · 15 cm column size) using a 9/1 dichloromethane/ethyl
acetate mixture (v/v) as the eluent, giving rac-102b as an orange oil.
Yield: 85mg (0.15mmol, 33% based on 30a). 1H NMR (CDCl3, δ): 1.23–1.33 (m, 6H,
CH2), 1.38–1.52 (m, 6H, CH2), 1.64–1.72 (m, 4H, CH2), 1.79–1.88 (m, 4H, CH2), 4.23 (dd,
JH,H = 2.7Hz, JH,H = 2.7Hz, 1H, C5H3), 4.35–4.44 (m, 9H, CH, C5H5, C5H3), 6.92–6.95
(m, 2H, H2,6), 8.12–8.15 (m, 2H, H3,5). 13C{1H} NMR (CDCl3, δ): 23.4–23.5 (m, CH2),
25.17 (CH2), 25.19 (CH2), 33.6–33.8 (m, CH2), 62.8 (d, 1JC,P = 218.3Hz, CC5H3-P), 64.5
(d, JC,P = 10.6Hz, C5H3), 65.7 (d, JC,P = 13.7Hz, C5H3), 68.6 (d, JC,P = 13.4Hz, C5H3),
71.5 (C5H5), 75.1 (d, 2JC,P = 6.9Hz, CH), 75.2 (d, 2JC,P = 6.1Hz, CH), 115.9 (C2,6-C6H4),
120.1 (d, 2JC,P = 9.7Hz, CC5H3-O), 125.4 (C3,5-C6H4), 142.4 (C4-C6H4), 164.6 (C1-C6H4).
31P{1H} NMR (CDCl3, δ): 19.3 (1JC,P = 218.4Hz). HRMS (ESI-TOF, m/z): calcd for
C28H34FeNO6P+Na 590.1366, found 590.1331 [M+Na]+.
2-(2,4-Dinitrophenoxy)-1-((Trifluoromethyl)sulfonyl)ferrocene (rac-103a)
Ferrocenyl triflate (101, 150mg, 0.45mmol), diisopropylamine (0.13mL, 0.94mmol) and
BuLi (0.18mL, 0.45mmol) were reacted according to the general procedure GP2 for an-
ionic Fries rearrangements at –80℃. Afterwards, the reaction mixture was warmed to 0℃
and 2,4-dinitro-1-fluorobenzene (167mg, 0.90mmol) was applied within the general proce-
dure GP6 for SNAr reactions. Purification was performed by column chromatography (silica,
2 · 15 cm column size) using a 1/1 hexane/dichloromethane mixture (v/v) as the eluent, giv-
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ing rac-103a as an orange solid. Crystals, suitable for single X-ray diffraction analysis were
grown from a hexane solution containing rac-103a at ambient temperature.
103a
Fe OS
NO2
NO2
O
O
F3C
Yield: 180mg (0.36mmol, 80% based on 10). Anal.
calcd for C17H11F3FeN2O7S · 1/6 C6H14 (500.18 · 0.17
86.18 g/mol): C, 42.02; H, 2.61; N, 5.44. Found: C, 41.78;
H, 2.43; N, 5.54. Mp.: 172–174℃. 1H NMR (CDCl3,
δ): 4.62 (pt, 3,4JH,H = 2.9Hz, 1H, C5H3), 4.72 (s, 5H,
C5H5), 4.73 (dd, JH,H = 2.9Hz, JH,H = 1.5Hz, 1H,
C5H3), 4.88 (dd, JH,H = 2.9Hz, JH,H = 1.5Hz, 1H,
C5H3), 7.00 (d, 3JH,H = 9.2Hz, 1H, H6), 8.33 (dd, 3JH,H = 9.2Hz, 4JH,H = 2.7Hz, 1H, H5),
8.84 (d, 4JH,H = 2.7Hz, 1H, H3). 13C{1H} NMR (CDCl3, δ): 67.0 (C5H3), 68.0 (C5H3),
69.8 (C5H3), 69.4 (q, 3JC,F = 2.3Hz, C2-C5H3), 73.7 (C5H5), 117.1 (C6), 119 (q, 1JC,F
= 325.6Hz, CF3), 119.6 (CC5H3-O), 122.1 (C3), 128.6 (C5), 139.3 (C2), 142.1 (C4), 156.1
(C1). HRMS (ESI-TOF, m/z): calcd for C17H11FeN2O7SF3 +Na 522.9481, found 522.9499
[M+Na]+.
Tetracyclohexyl (2-(2,4-Dinitrophenoxy)ferrocenyl-1,3-diyl)bis(phosphonate)
(rac-104a)
104a
Fe O
O
PO
2
P
O
O
2NO2
NO2
Dicyclohexyl 2-(O,O'-dicyclohexyl phos-
phato)ferrocenylphosphonate (35a, 200mg,
0.29mmol), diisopropylamine (0.1mL, 0.58mmol),
BuLi (0.24mL, 0.6mmol) and TMEDA (0.09mL,
0.68mmol) were reacted according to the general
procedure GP3 for anionic Fries rearrangements.
Afterwards, 2,4-dinitro-1-fluorobenzene (162mg,
0.87mmol) was applied within the general pro-
cedure GP6 for SNAr reactions. Purification was performed by column chromatography
(silica, 2 · 15 cm column size) using a 98/2 ethyl acetate/methanol mixture (v/v) as the
eluent, giving rac-104a as an orange oil.
Yield: 177mg (0.21mmol, 73% based on 35a). 1H NMR (CDCl3, δ): 1.16–1.39 (m, 16H,
CH2), 1.47–1.55 (m, 6H, CH2), 1.62–1.85 (m, 16H, CH2), 1.94–1.97 (m, 4H, CH2), 4.30–4.43
(m, 4H, CH), 4.58–4.59 (m, 6H, C5H5, C5H2), 4.67–4.76 (m, 1H, C5H2), 6.93 (d, 3JH,H =
6.9Hz, 0.8H, H6), 7.02 (d, 3JH,H = 8.9Hz, 0.2H, H6), 8.22 (dd, 3JH,H = 9.3Hz, 4JH,H =
2.7Hz, 0.8H, H5), 8.26 (dd, 3JH,H = 9.3Hz, 4JH,H = 2.7Hz, 0.2H, H5), 8.81 (d, 4JH,H =
2.7Hz, 0.8H, H3), 8.84 (d, 4JH,H = 2.7Hz, 0.2H, H3). 13C{1H} NMR (CDCl3, δ): 23.4–23.8
(m, CH2), 25.0–25.1 (m, CH2), 33.5–33.9 (m, CH2), 67.0 (dd, 1JC,P = 216.6Hz, 3JC,P =
9.1Hz, C-P), 70.3 (pt, 2,3JC,P = 13.8Hz, C5H2), 73.8 (s, C5H5), 76.0 (d, 2JC,P = 6.9Hz,
CC6H11-O), 76.2 (d, 2JC,P = 6.5Hz, CC6H11-O), 117.8 (C6-C6H3), 118.6 (t, 2JC,P = 9.5Hz,
CC5H2-O), 121.7 (C3-C6H3), 128.3 (C5-C6H3), 137.9 (C2-C6H3), 141.1 (C4-C6H3), 157.4
(C1-C6H3). 31P{1H} NMR (CDCl3, δ): 17.4 (1JC,P = 215.1Hz). HRMS (ESI-TOF, m/z):
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calcd for C40H54FeN2O11P2 +H 857.2626, found 857.2593 [M+H]+.
(Rp)-Bis((1R)-α-fenchyl) (2-(2,4-Dinitrophenoxy)ferrocenyl)phosphonate
((Rp)-107a)
107a
FeO
O
P
O
2
O2N
NO2
Bis((1R)-α-fenchyl) ferrocenyl phosphate (30e,
521mg, 0.94mmol), LiTMP (227mg, 1.88mmol)
and TMEDA (0.28mL, 1.88mmol) were re-
acted according to the general procedure GP3.
Afterwards, 2,4-dinitro-1-fluorobenzene (524mg,
2.82mmol) was applied within the general pro-
cedure for SNAr reactions. Purification was performed by column chromatography (silica,
2 · 20 cm column size) using a 98/2 dichloromethane/ethyl acetate mixture (v/v) as the elu-
ent, giving (Rp)-107a as an orange oil as a mixture of two diastereomers (0.81 de). Except
otherwise noted, the signals of the main diastereomer are reported.
Yield: 230mg (0.32mmol, 34% based on 30e). 1H NMR (CDCl3, δ): 067 (s, 3H, CH3),
0.76 (s, 3H, CH3), 0.90 (s, 3H, CH3), 0.99 (s, 3H, CH3), 1.08–1.21 (m, 10H), 1.52–1.87 (m,
10H), 3.96 (dd, JH,H = 1.68Hz, JH,H = 10.1Hz, 1H, C5H3), 4.15 (dd, JH,H = 1.68Hz, JH,H
= 10.1Hz, 1H, C5H3), 4.29 (m, 1H, C5H3), 4.47–4.50 (m, 2H, H2), 4.53 (s, 5H, C5H5),
7.34 (d, 3JH,H = 9.3Hz, 1H, H6), 8.31 (dd, 3JH,H = 9.3Hz, 4JH,H = 2.7Hz, 1H, H5), 8.83
(d, 3JH,H = 2.7Hz, 1H, H3). 13C{1H} NMR (CDCl3, δ): 19.6 (CH3), 19.8 (CH3), 21.0
(CH3), 21.6 (CH3), 25.8 (C5/6), 25.9 (C5/6), 26.0 (C5/6), 26.1 (C5/6), 29.5 (CH3), 30.1
(CH3), 39.2 (d, 3JC,P = 2.3Hz, C3), 39.6 (d, 3JC,P = 2.3Hz, C3), 41.1 (C7), 41.2 (C7),
47.8 (C4), 47.9 (C4), 49.3 (d, 3JC,P = 4.8Hz, C1), 49.5 (d, 3JC,P = 4.1Hz, C1), 61.9 (d,
1JC,P = 217.9Hz, C-P), 63.7 (d, JC,P = 10.2Hz, C5H3), 66.1 (d, JC,P = 13.3Hz, C5H3),
68.8 (d, JC,P = 12.7Hz, C5H3), 71.9 (C5H5), 88.6 (d, 2JC,P = 7.0Hz, C2), 89.5 (d, 2JC,P =
7.1Hz, C2), 118.3 (C6-C6H3), 120.8 (d, 2JC,P = 7.0Hz, CC5H4-O), 122.0 (C3-C6H3), 128.4
(C5-C6H3), 139.3 (C2-C6H3), 141.4 (C4-C6H3), 157.0 (C1-C6H3). 31P{1H} NMR (CDCl3,
δ): 20.5. HRMS (ESI-TOF, m/z): calcd for C36H45FeN2O8P+Na 743.2156, found 743.2149
[M+Na]+.
(Rp)-Bis((1R)-α-fenchyl) (2-(4-nitrophenoxy)ferrocenyl)phosphonate ((Rp)-107b)
107b
FeO
O
P
O
2
O2N Bis((1R)-α-fenchyl) ferrocenyl phosphate (30e,
1.00 g, 1.80mmol), LiTMP (530mg, 3.61mmol)
and TMEDA (0.54mL, 3.61mmol) were reacted
according to the general procedure GP3. After-
wards, 4-nitrofluorobenzene (763mg, 5.41mmol)
was applied within the general procedure GP6
for SNAr reactions. Purification was performed by column chromatography (silica, 2 · 14 cm
column size) using a 95/5 dichloromethane/ethyl acetate mixture (v/v) as the eluent, giving
201
CHAPTER 4. EXPERIMENTAL PART
(Rp)-107b as an orange oil as a mixture of two diastereomers (0.74 de).
Yield: 113mg (0.17mmol, 9% based on 30e). Except otherwise noted, merely the signals
of the mainly formed diastereomer are reported. 1H NMR (CDCl3, δ): 0.73 (s, 3H, CH3),
0.82–1.84 (m, 31H, C10H17), 3.63 (dd, 3JH,P = 9.8Hz, JH,H = 1.6Hz, 1H, H2), 4.16 (dd,
3JH,P = 9.8Hz, JH,H = 1.7Hz, 1H, H2), 4.25 (dd, 3,4JH,H = 2.5Hz, 1H, C5H3), 4.34–4.36
(m, 1H, C5H3), 4.46 (s, mi, C5H5), 4.47 (s, 5H, C5H5), 4.50–4.51 (m, 1H, C5H3), 7.14–7.17
(m, 2H, 2,6-C6H4), 8.16–8.20 (m, 2H, 3,5-C6H4). 13C{1H} NMR (CDCl3, δ): 19.3 (CH3),
19.8 (CH3), 21.3 (CH3), 21.6 (CH3), 25.8 (C5/C6), 26.0 (C5/C6), 26.1 (C5/C6), 29.1 (CH3),
29.9 (CH3), 39.3 (d, 3JC,P = 1.9Hz, C3), 39.4 (d, 3JC,P = 1.3Hz, C3), 40.8 (C7), 41.1 (C7),
47.9 (C4), 48.0 (C4), 49.1 (d, 3JC,P = 5.8Hz, C1), 49.4 (d, 3JC,P = 4.8Hz, C1), 60.6 (d,
1JC,P = 216.5Hz, C-P), 63.7 (d, JC,P = 10.8Hz, C5H3), 65.7 (d, JC,P = 13.2Hz, C5H3), 68.0
(d, JC,P = 11.8Hz, C5H3), 71.3 (C5H5, mi), 71.5 (C5H5, ma), 87.8 (d, 2JC,P = 6.1Hz, C2),
89.1 (d, 2JC,P = 7.5Hz, C2), 116.8 (2,6-C6H4), 121.6 (d, 2JC,P = 10.5Hz, CC5H3-O), 125.5
(3,5-C6H4), 142.6 (C4-C6H4), 163.9 (C1-C6H4). 31P{1H} NMR (CDCl3, δ): 21.2 (100%),
22.2 (6%), 22.5 (9%). HRMS (ESI-TOF, m/z): calcd for C36H46FeNO6P 675.2407, found
675.2395 [M]+.
1-Ferrocenyloxy-3,5-difluorobenzene (109)
109
Fe O
F
F
Ferrocenol (5, 150mg, 0.74mmol), BuLi (0.3mL, 0.75mmol) and
1,3,5-trifluorobenzene (108a, 0.23mL, 2.25mmol) were reacted ac-
cording to the general procedure GP6. Purification was realized by
column chromatography (silica, 4 · 20 cm column size) using a 3/1
hexane/dichloromethane mixture (v/v) as the eluent, giving 109 as
an orange oil.
Yield: 141mg (0.45mmol, 61% based on 5). 1H NMR (CDCl3, δ):
4.01 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4), 4.26 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4), 4.30 (s, 5H,
C5H5), 6.42–6.48 (m, 3H, C6H3). 13C{1H} NMR (CDCl3, δ): 60.8 (C5H4), 63.5 (C5H4), 69.5
(C5H5), 97.5 (t, 2JC,F = 25.9Hz, C4C6H3), 99.8–100.0 (m, C2/6C6H3), 120.3 (CC5H4-O),
161.5 (t, 3JC,F = 13.4Hz, C1C6-O), 163.4 (dd, 1JC,F = 246.8Hz, 3JC,F = 15.4Hz, C3,5-
F). 19F NMR (CDCl3, δ): –109.19 – –109.11 (m, 2 F). HRMS (ESI-TOF, m/z): calcd for
C16H12F2FeO 314.0200, found 314.0199 [M]+.
1-Ferrocenyloxy-2,4,5-trifluorobenzene (110a)
110a
Fe O
F
F
F
Ferrocenol (5, 220mg, 1.09mmol), BuLi (0.44mL, 1.1mmol) and
1,2,4,5-tetrafluorobenzene (108b, 0.37mL, 3.27mmol) were reacted
according to the general procedure GP6. Purification was realized
by column chromatography (silica, 4 · 20 cm column size) using a 3/1
hexane/dichloromethane mixture (v/v) as the eluent, giving 110a as
an orange solid.
Yield: 264mg (0.795mmol, 73% based on 5). Anal. calcd for
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C16H11F3FeO (332.11 g/mol): C, 57.87; H, 3.34. Found: C. 58.08; H, 3.46. Mp.: 94–96℃.
1H NMR (CDCl3, δ): 3.97 (pt, 3,4JH,H = 1.9Hz, 2H, C5H4), 4.23 (pt, 3,4JH,H = 1.9Hz, 2H,
C5H4), 4.28 (s, 5H, C5H5), 6.91 (dt, 3JH,F = 11.1Hz, 4JH,F = 7.7Hz, 1H, H6C6H2) 7.00 (td,
3JH,F = 10.0Hz, 4JH,F = 7.4Hz, 1H, H3C6H2). 13C{1H} NMR (CDCl3, δ): 59.2 (C5H4), 63.1
(C5H4), 69.4 (C5H5), 105.9 (t, 2JC,F = 23.0Hz, C3C6), 107.7 (d, 2JC,F = 22.0Hz, C6C6),
122.6 (CC5H4-O), 142.3 (ddd, 3JC,F = 13.0Hz, 2JC,F = 7.6Hz, 4JC,F = 3.7Hz, C1C6-O),
144.9 (ddd, 1JC,F = 246.1Hz, 2JC,F = 14.2Hz, 3JC,F = 10.3Hz, C4C6), 145.9 (ddd, 1JC,F
= 245.4Hz, 3JC,F = 13.4Hz, 4JC,F = 3.6Hz, C2C6), 148.2 (ddd, 1JC,F = 247.1Hz, 2JC,F =
9.0Hz, 4JC,F = 3.1Hz, C5C6). 19F NMR (CDCl3, δ): –141.71 (ddd, 3JF,F = 22.1Hz, 3JF,H
= 9.9Hz, 4JF,H = 7.9Hz, 1 F, F4), –140.4 (dddd, 3JF,F = 22.1Hz, 5JF,F = 13.4Hz, 3JF,H =
11.1Hz, 3JF,H = 7.4Hz, 1 F, F5), –134.5 (ddd, 5JF,F = 13.4Hz, 3JF,H = 10.1Hz, 4JF,H =
7.7Hz, 1 F, F2). HRMS (ESI-TOF, m/z): calcd for C16H11F3FeO 332.0106, found 332.0106
[M]+.
1,4-Bis(ferrocenyloxy)-2,5-difluorobenzene (110b)
110b
Fe O
F
F
Fe
O
Ferrocenol (5, 600mg, 2.97mmol), BuLi (1.2mL, 3.0mmol)
and 1,2,4,5-tetrafluorobenzene (108b, 0.17mL, 1.48mmol)
were reacted according to the general procedure GP6. Pu-
rification was realized by column chromatography (silica,
4 · 20 cm column size) using a 3/1 hexane/dichloromethane
mixture (v/v) as the eluent. The title compound was isolated
after the separation of 115mg (0.329mmol, 35%) of 110a.
After evaporation of all volatiles the title compound (110b) was obtained as an orange solid.
Yield: 18mg (0.035mmol, 2% based on 108b). 1H NMR (CDCl3, δ): 3.95 (pt, 3,4JH,H =
1.9Hz, 4H, C5H4), 4.23 (pt, 3,4JH,H = 4.0Hz, 2H, C5H4), 4.27 (s, 10H, C5H5), 6.72 (t,
3,4JH,F = 9.5Hz, 2H, H3,6C6H2). 13C{1H} NMR (CDCl3, δ): 59.1 (C5H4), 63.0 (C5H4), 69.4
(C5H5), 107.7 (dd, 2JC,F = 17.9Hz, 3JC,F = 7.7Hz, C3,6C6), 123.2 (CC5H4-O), 141.1 (dd,
3JC,F = 12.0Hz, 2JC,F = 9.6Hz, C1,4C6-O), 148.7 (dd, 1JC,F = 246.0Hz, 4JC,F = 4.1Hz,
C2,5C6). 19F NMR (CDCl3, δ): –135.1 (t, 3,+4JF,H = 9.5Hz). HRMS (ESI-TOF, m/z):
calcd for C26H20F2Fe2O2 514.0125, found 514.0087 [M]+.
3-Ferrocenyloxy-1,2,4,5-tetrafluorobenzene (111a)
111a
Fe O
F
F
F
F
Ferrocenol (5, 190mg, 0.94mmol), BuLi (0.38mL, 0.95mmol) and
1,2,4,5-tetrafluorobenzene (108c, 0.44mL, 3.96mmol) were reacted
according to the general procedure described above. Purification was
realized by column chromatography (silica, 4 · 20 cm column size) us-
ing a 4/1 hexane/dichloromethane mixture (v/v) as the eluent, giving
111a as an orange solid.
Yield: 308mg (0.88mmol, 94% based on 5). Anal. calcd for
C16H10F4FeO (350.10 g/mol): C, 54.89; H, 2.88. Found: C, 55.02; H, 2.99. Mp.: 56℃.
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1H NMR (CDCl3, δ): 3.88 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4), 4.24 (s, 5H, C5H5), 4.26 (pt,
3,4JH,H = 2.0Hz, 2H, C5H4), 6.92 (tt, 3JH,F = 7.0Hz, 4JH,F = 9.9Hz, 1H, C6H). 13C{1H}
NMR (CDCl3, δ): 57.7 (C5H4), 62.4 (C5H4), 69.4 (C5H5), 101.5 (t, JC,F = 23.0Hz, C6C6-H),
126.4 (CC5H4-O), 136.4 (tt, 3JC,F = 13.2Hz, 2JC,F = 3.6Hz, C3C6-O), 141.5 (dddd, 1JC,F
= 249.9Hz, 3JC,F = 14.7Hz, 2JC,F = 4.6Hz, 4JC,F = 2.4Hz, C-F) , 146.3 (dtd, 1JC,F =
248.2Hz, 2,3JC,F = 12.3Hz, 4JC,F = 4.1Hz, C-F). 19F NMR (CDCl3, δ): –154.1 – –154.0 (m,
2 F, F1,5), –139.0 – –138.9 (m, 2 F, F2,4). HRMS (ESI-TOF, m/z): calcd for C16H10F4FeO
350.0012, found 350.0010 [M]+.
Reaction of Ferrocenol (5) with C6HF5 (108c) to give 111b-e
Ferrocenol (5, 620mg, 3.07mmol), BuLi (1.23mL, 3.07mmol) and pentafluorobenzene (108c,
0.12mL, 1.02mmol) were reacted according to the general procedure GP6. Purification was
realized by column chromatography (silica, 4 · 20 cm column size). Compounds 111a-e were
separated using hexane/dichloromethane eluent mixtures (v/v) starting from 4/1 (111a;
170mg, 0.49mmol; 47% based on 108c) to 7/3 (111b), 1/1 (111c/111d) and 1/4 (111e).
After evaporation of all volatiles the compounds 111b-e were obtained as orange solids.
1,3-Bis(ferrocenyloxy)-2,4,5-trifluorobenzene (111b)
111b
Fe O
F
F
F
FeO
Yield: 245mg (0.46mmol 0.05mmol, 45% based on 108c).
Anal. calcd for C26H19F3Fe2O2 (532.12 g/mol): C, 58.69;
H, 3.60. Found: C. 59.16; H, 3.77. Mp.: 101℃. 1H NMR
(CDCl3, δ): 3.87 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4(1)), 3.98
(pt, 3,4JH,H = 2.0Hz, 2H, C5H4(2)), 4.24 (s, 5H, C5H5),
4.25 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4(2)), 4.27 (pt, 3,4JH,H
= 1.8Hz, 2H, C5H4(1)), 4.29 (s, 5H, C5H5), 6.72 (dt, 3JH,F
= 11.2Hz, 4JH,F = 7.3Hz, 1H, C6H). 13C{1H} NMR (CDCl3, δ): 57.7 (C5H4(1)), 59.6
(C5H4(2)), 62.3 (C5H4(1)), 63.2 (C5H4(2)), 69.3 (C5H5), 69.5 (C5H5), 102.1 (d, JC,F =
22.5Hz, C6C6-H), 122.1 (CC5H4-O), 126.4 (CC5H4-O), 135.8 (ddd, 3JC,F = 14.1Hz, 2JC,F
= 12.9Hz, 2JC,F = 3.7Hz, C3C6-O), 140.2 (ddd, 1JC,F = 248.0Hz, 3JC,F = 15.0Hz, 2JC,F
= 2.7Hz, C2-F), 142.8 (ddd, 3JC,F = 10.8Hz, 2JC,F = 9.8Hz, 4JC,F = 3.6Hz, CC6-O),
143.3 (ddd, 1JC,F = 248.8Hz, 2JC,F = 4.0Hz, 4JC,F = 2.1Hz, C5-F), 146.32 (ddd, 1JC,F =
245.9Hz, 3JC,F = 12.8Hz, 2JC,F = 4.1Hz, C4-F). 19F NMR (CDCl3, δ): –156.7 (dd, 3JF,F
= 22.4Hz, 4JF,H = 7.5Hz, 1 F, F4), –150.2 (dd, 5JF,F = 10.2Hz, 4JF,H = 7.6Hz, 1 F, F2),
–139.8 (ddd, 3JF,F = 22.0Hz, 3JF,H = 10.8Hz, 5JF,F = 10.8Hz, 1 F, F5). HRMS (ESI-TOF,
m/z): calcd for C26H19F3Fe2O2 532.0031, found 532.0048 [M]+.
1,3,4-Tris(ferrocenyloxy)-2,5-difluorobenzene (111c) and
1,3,5-Tris(ferrocenyloxy)-2,4-difluorobenzene (111d)
Compounds 111c and 111d were obtained as one fraction in a ratio of 2/1 (111c : 111d).
Yield 14mg (0.02mmol, 2% based on 108c). However, the separation of 111c,d from each
other was not possible by using chromatographic methods, due to their similar physical
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properties.
111c
+ Fe O F
F
Fe
O
111d
Fe O
F
F
FeO FeO
Fe
O
1H NMR (CDCl3, δ):
3.83 (pt, 3,4JH,H =
4.0Hz, 4H, C5H4), 3.84
(pt, 3,4JH,H = 4.0Hz,
4H, C5H4), 3.87 (pt,
3,4JH,H = 2.0Hz, 2H,
C5H4, d), 3.92 (pt,
3,4JH,H = 2.0Hz, 4H,
C5H4), 3.99 (pt, 3,4JH,H
= 2.0Hz, 4H, C5H4),
4.17 (pt, 3,4JH,H =
2.0Hz, 4H, C5H4), 4.19 (pt, 3,4JH,H = 2.0Hz, 4H, C5H4), 4.21 (s, 10H, C5H5), 4.22–4.23
(m, 14H, C5H4, C5H5), 4.25 (s, 5H, C5H5, d), 4.28–4.29 (m, 6H, C5H4, d, c), 4.30 (s, 10H,
C5H5), 6.69 (dd, 3JH,F = 11.2Hz, 4JH,F = 7.3Hz, 2H, C-H, c), 6.81 (t, 4JH,F = 7.6Hz, 1H,
C-H, d). 13C{1H} NMR (CDCl3, δ): 57.6 (C5H4), 57.7 (C5H4), 58.0 (C5H4), 58.7 (C5H4),
59.8 (C5H4), 62.1 (C5H4), 62.16 (C5H4), 62.24 (C5H4), 62.9 (C5H4), 63.3 (C5H4), 57.6
(C5H4), 69.28 (C5H5), 69.32 (C5H5), 69.67 (C5H5), 69.39 (C5H5), 69.6 (C5H5), 101.9 (d,
3JC,F = 24.6Hz, CC6-H, c), 105.7 (s, CC6-H, d), 122.1 (CC5H4-O), 123.4 (CC5H4-O), 126.3
(CC5H4-O), 126.6 (CC5H4-O). 133.7 (HMBC, c), 142.7 (HMBC, d, d, C-F), 143.4 (HMBC,
d, c, C-F), 151.2 (HMBC, d, c, C-F). 19F NMR (CDCl3, δ): –150.6 (dd, JF,F = 10.7Hz,
JF,H = 7.6Hz, 1 F, c), –150.5 (d, 4JF,H = 7.5Hz, 1 F, d), –130.8 (dd, 3JF,H = 11.8Hz,
JF,F = 10.3Hz, 1 F, c). HRMS (ESI-TOF, m/z): calcd for C36H28F2Fe3O3 714.0051, found
713.9989 [M]+.
2,3,4-Tris(ferrocenyloxy)-5-fluorobenzonitrile (111e)
111e
Fe O
F
FeO
Fe
O
N
Yield: 11mg (0.015mmol, 1.5% based on 108c). IR data
(NaCl, v˜/cm−1): 3094 m (v˜ CAr-H), 2955 s, 2922 s, 2854 s,
2234 w (v˜ C≡N), 1734 vw, 1480 m, 1452 s, 1373 w, 1262 m,
1233 m. 1H NMR (CDCl3, δ): 3.89 (pt, 3,4JH,H = 2.0Hz,
2H, C5H4(1)), 3.95 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4(2)), 3.97
(pt, 3,4JH,H = 2.0Hz, 2H, C5H4(3)), 4.15 (pt, 3,4JH,H =
2.0Hz, 2H, C5H4(3)), 4.19 (s, 5H, C5H5), 4.27 (s, 5H, C5H5),
4.30 (pt, 3,4JH,H = 1.6Hz, 2H, C5H4(1)), 4.33–4.35 (m,
7H, C5H4(2), C5H5), 6.85 (d, 3JH,F = 11.4Hz, 1H, C6H).
13C{1H} NMR (CDCl3, δ): 58.3 (C5H4(2)), 58.5 (C5H4(1)),
60.7 (C5H4(3)), 62.3 (C5H4(2)), 62.5 (C5H4(1)), 63.7 (C5H4(3)), 69.6 (C5H5), 69.69 (C5H5),
69.70 (C5H5), 100.8 (C≡N), 110.0 (d, 2JC,F = 23.9Hz, CC6-H), 120.4 (CC5H4(3)-O), 126.7
(CC5H4(1/2)-O), 126.8 (CC5H4(1/2)-O), 141.0, 144.5, 149.0 (d, JC,F = 8.9Hz), 151.0 (d,
1JC,F = 249.5Hz, C-F). 19F NMR (CDCl3, δ): –126.5 (d, 3JF,H = 11.4Hz, 1 F). HRMS
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(ESI-TOF, m/z): calcd for C37H28FFe3NO3 721.0101, found 721.0058 [M]+.
1-Ferrocenyloxypentafluorobenzene (112a)
112a
Fe O
F
F
F
F
F
Ferrocenol (5, 225mg, 1.11mmol), BuLi (0.44mL, 1.10mmol) and
hexafluorobenzene (108d, 0.30mL, 2.60mmol) were reacted accord-
ing to the general procedure GP6. Purification was realized by col-
umn chromatography (silica, 4 · 20 cm column size) using a 5/1 hex-
ane/dichloromethane mixture as the eluent. The title compound
112a could be isolated followed by 71mg (0.13mmol, 12% based on
5) of 112b. After evaporation of all volatiles compounds 112a and
112b were obtained as orange solids.
Yield: 353mg (0.96mmol, 86% based on 5). Anal. calcd for C16H9F5FeO (368.08 g/mol):
C, 52.21; H, 2.46. Found: C. 52.59; H, 2.50. Mp.: 92–96℃. 1H NMR (CDCl3, δ): 3.88 (pt,
3,4JH,H = 2.0Hz, 2H, C5H4), 4.23–4.24 (m, 7H, C5H5, C5H4). 13C{1H} NMR (CDCl3, δ):
57.7 (C5H4), 62.5 (C5H4), 69.4 (C5H5), 126.6 (CC5H4-O), 131.9 (ttd, 3JC,F = 16.7Hz, 2JC,F
= 4.6Hz, 4JC,F = 1.6Hz, CC6-O), 138.0 (ddddd, 1JC,F = 251.7Hz, 3JC,F = 14.6Hz, 3JC,F
= 13.2Hz, 2JC,F = 5.1Hz, 4JC,F = 3.4Hz, C2,6-C6), 138.5 (dtt, 1JC,F = 251.9Hz, 3JC,F
= 13.6Hz, 2JC,F = 3.8Hz, C4C6), 142.1 (ddq, 1JC,F = 251.0Hz, 2JC,F = 12.2Hz, 3JC,F
= 4.0Hz, C3,5C6F5). 19F NMR (CDCl3, δ): –162.4 – –162.2 (m with the main coupling
scheme to be a dd at –162.3; 3JF,F = 22.1Hz, JF,F 21.6Hz, 2 F, F3,5), –160.5 (t, 3JF,F =
21.9Hz, 1 F, F4), –154.1 (d, 3JF,F = 18.7Hz, 2 F, F2,6). HRMS (ESI-TOF, m/z): calcd for
C16H9F5FeO 367.9917, found 367.9938 [M]+.
Reaction of Ferrocenol (5) with C6F6 (108d) to give 112b,c
Ferrocenol (5, 828mg, 4.097mmol), BuLi (1.63mL, 4.08mmol) and hexafluorobenzene
(108d, 0.16mL, 1.37mmol) were reacted according to the general procedure described above
at 100℃. Purification was realized by column chromatography (silica, 4 · 20 cm column size)
using hexane/dichloromethane mixtures as the eluents starting from 5/1 (v/v) (112b) up to
dichloromethane (112c). After evaporation of all volatiles the compounds were obtained as
an orange solid (112b) or oil (112c).
1,4-Bis(ferrocenyloxy)-2,3,5,6-tetrafluorobenzene (112b)
Fe O F
F
F
O
112b
Fe
F
Yield: 594mg (1.08mmol, 79% based on 108d). Anal.
calcd for C26H18F4Fe2O2 (550.10 g/mol): C, 56.77; H, 3.30.
Found: C. 56.77; H, 3.41. Mp.: 165–169℃. 1H NMR
(CDCl3, δ): 3.89 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4), 4.24,
(s, 5H, C5H5), 4.27 (pt, 3,4JH,H = 1.9Hz, 2H, C5H4).
13C{1H} NMR (CDCl3, δ): 57.8 (C5H4), 62.5 (C5H4), 69.4
(C5H5), 126.6 (CC5H4-O), 132.4–132.7 (m, CC6-O), 140.9–
143.1 (m, C2,6C6, C4C6F4). 19F NMR (CDCl3, δ): –154.6
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(s, 1 F). HRMS (ESI-TOF, m/z): calcd for C26H18F4Fe2O2 549.9937, found 549.9903 [M]+.
1,2,4-Tris(ferrocenyloxy)-3,5,6-trifluorobenzene (112c)
Fe O F
F
F
O
112c
Fe
Fe
O
Yield: 213mg (0.29mmol, 21% based on 108d). 1H NMR
(CDCl3, δ): 3.86 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4), 3.87 (pt,
3,4JH,H = 2.0Hz, 2H, C5H4), 3.89 (pt, 3,4JH,H = 2.0Hz,
2H, C5H4), 4.21 (pt, 3,4JH,H = 1.9Hz, 2H, C5H4), 4.236
(s, 10H, C5H5), 4.240 (s, 5H, C5H5), 4.28 (pt, 3,4JH,H
= 1.9Hz, 2H, C5H4). 13C{1H} NMR (CDCl3, δ): 57.69
(C5H4), 57.71 (C5H4), 58.00 (C5H4), 62.2 (C5H4), 62.3
(C5H4), 62.4 (C5H4), 69.30 (C5H5), 69.32 (C5H5), 69.35
(C5H5), 126.3 (CC5H4-O), 126.4 (CC5H4-O), 126.7 (CC5H4-
O), 132.4 (ddd, 3JC,F = 15.2Hz, 3JC,F = 13.2Hz, 2JC,F
= 2.2Hz, C1C6-OFc4), 135.9 (ddd, 3JC,F = 12.8Hz, 2JC,F = 4.0Hz, 4JC,F = 2.7Hz, C2C6-
OFc2), 137.0 (dt, 3JC,F = 11.5Hz, 2JC,F = 2.7Hz, C4C6-OFc1), 142.1 (ddd, 1JC,F = 249.7Hz,
3JC,F = 12.6Hz, 4JC,F = 4.2Hz, C3), 142.7 (ddd, 1JC,F = 250.4Hz, 3JC,F = 13.0Hz, 2JC,F
= 5.1Hz, C5), 146.4 (dt, 1JC,F = 250.1Hz, 2,4JC,F = 4.1Hz, C6). 19F NMR (CDCl3, δ):
–154.5 (dd, 3JF,F = 22.4Hz, 5JF,F = 7.2Hz, 1 F, F6), –153.1 (d, 3JF,F = 22.4Hz, 1 F, F5),
–145.8 (d, 5JF,F = 7.2Hz, 1 F, F3). HRMS (ESI-TOF, m/z): calcd for C36H27F3Fe3O3
731.9957, found 731.9949 [M]+.
1,2,4,5-Tetrakis(ferrocenyloxy)-3,6-difluorobenzene (112d)
Fe O F
F
O
O
112d
Fe
Fe
Fe
O
Ferrocenol (5, 820mg, 4.06mmol), K2CO3 (1.20 g,
8.68mmol) and 1,4-bis(ferrocenyloxy)-tetrafluorobenzene
(112b, 250mg, 0.45mmol) were reacted in 1,3-dimethyl-
2-imidazolidinone at 180℃ according to the general pro-
cedure described above. Purification was realized by col-
umn chromatography (silica, 4 · 20 cm column size) using
hexane/dichloromethane mixtures as the eluents starting
from 5/1 (v/v). As the first fraction, ferrocene (22mg,
0.118mmol, 3% based on 5) was eluted followed by 112d
using dichloromethane and 112e (dichloromethane/ethyl
acetate; ratio 4/1 (v/v)). After evaporation of all volatiles
the compounds were obtained as orange solids.
1,2,4,5-Tetrakis(ferrocenyloxy)-3,6-difluorobenzene (112d). Yield: 21mg (0.023mmol, 5%
based on 112b). 1H NMR (CDCl3, δ): 3.86 (pt, 3,4JH,H = 1.8Hz, 8H, C5H4), 4.22–4.23
(m, 28H, C5H4). 13C{1H} NMR (CDCl3, δ): 57.9 (C5H4), 62.2 (C5H4), 69.4 (C5H5), 126.6
(CC5H4-O), 129.8 (CC6-O), the C-F multiplet could not be observed. 19F NMR (CDCl3, δ):
–145.8. HRMS (ESI-TOF, m/z): calcd for C46H36F2Fe4O4 913.9978, found 914.0010 [M]+.
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Pentakis(ferrocenyloxy)fluorobenzene (112e)
Fe O
F
O
O
Fe
Fe
Fe
O
112e
FeO
Pentakis(ferrocenyloxy)fluorobenzene (112e). Yield:
27mg (0.025mmol, 6% based on 112b). 1H NMR
(CDCl3, δ): 3.84 (pt, 3,4JH,H = 2.0Hz, 4H, C5H4), 3.85
(pt, 3,4JH,H = 2.0Hz, 6H, C5H4), 4.17 (pt, 3,4JH,H =
1.9Hz, 4H, C5H4), 4.22–4.23 (m, 26H, C5H4), 4.27 (s,
5H, C5H5). 13C{1H} NMR (CDCl3, δ): 57.5 (C5H4),
57.7 (C5H4), 57.9 (C5H4), 57.9 (C5H4), 60.00 (C5H4),
62.03 (C5H4), 62.17 (C5H4), 62.24 (C5H4), 69.32
(C5H5), 69.34 (C5H5), 69.35 (C5H5), 126.4 (CC5H4-O),
126.52 (CC5H4-O), 126.55 (CC5H4-O), 126.6 (CC5H4-O),
126.7 (CC5H4-O), 136.8 (CC6-O), 136.9 (CC6-O), 141.62
(CC6-O), 141.64 (CC6-O), the C-F doublet could not be
observed. 19F NMR (CDCl3, δ): –143.8. HRMS (ESI-
TOF, m/z): calcd for C56H45FFe5O5 1096.0001, found 1095.9975 [M]+.
Bis((1R)-α-fenchyl) (2-(Pentafluorophenoxy)ferrocenyl)phosphonate (113)
FeO P(OFn)2
O
F
F
F
F
F
113
In a Schlenk tube, LiTMP (118mg, 0.8mmol) was
suspended in 10mL of hexane and TMEDA (0.12mL,
0.8mmol) was added. After stirring for 10 min, bis((1R)-
α-fenchyl) ferrocenyl phosphate (30e, 220mg, 0.39mmol)
was added in a single portion and the mixture was stirred
overnight at ambient temperature. Afterwards, 2mL of
DMF and hexafluorobenzene (108d) (0.15mL, 1.2mmol)
were added. The reaction mixture was heated to 70℃ and
stirred for 18 h at this temperature. All volatiles were removed in vacuum and the residue
was dissolved in diethyl ether (50mL) and washed with brine (400mL). The aqueous phase
was extracted again with diethyl ether (3·50mL). All volatiles of the combined organic ex-
tracts were removed in vacuum. Purification was realized by column chromatography (silica,
2.5 · 15 cm column size) using dichloromethane as the eluent. The title compound 113 was
obtained as an dark orange oil with a de of 52 %, based on fitted integrals of the 31P{1H}
NMR spectra.
Yield: 56mg (0.078mmol, 20% based on 30e). The intensities result of the approximated
sum of both diastereomers in the 1H NMR spectrum. In the 13C{1H} NMR spectrum solely
the signals of the major diastereomer are reported, expect otherwise noted. 1H NMR (CDCl3,
δ): 0.85–1.21 (m, 24.5H, C10H17), 1.42–1.49 (m, 1.5H, C10H17), 1.51–1.53 (m, 2H, C10H17),
1.68–1.96 (m, 4H, C10H17), 3.78–3.99 (m, 1.5H, C5H3, C10H17), 4.02 (dd, JH,H = 2.6Hz,
0.85H, C5H3), 4.05–4.11 (m, 1.6H, C5H3, C10H17), 4.29–4.33 (m, 1.05H, C5H3, C10H17),
4.41 (m, 5H, C5H5). 13C{1H} NMR (CDCl3, δ): 19.2 (CH3), 19.6 (CH3), 25.8 (C5/C6), 25.9
(C5/C6), 26.0 (C5/C6), 26.1 (C5/C6), 29.7 (CH3), 29.8 (CH3), 39.1 (d, 3JC,P = 2.3Hz, C3),
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39.6 (d, 3JC,P = 2.1Hz, C3), 41.0 (C7), 41.1 (C7), 47.9 (C4), 48.1 (C4), 49.2 (d, 3JC,P =
4.5Hz, C1), 49.3 (d, 3JC,P = 3.9Hz, C1), 57.2 (d, 1JC,P = 217.6Hz, C-P), 57.6 (d, JC,P =
9.9Hz, C5H3), 63.7 (d, JC,P = 13.4Hz, C5H3), 68.0 (d, JC,P = 12.2Hz, C5H3), 71.0 (C5H5),
88.1 (d, 2JC,P = 6.7Hz, C2), 88.9 (d, 2JC,P = 6.9Hz, C2), 127.3 (d, 2JC,P = 9.3Hz, C5H3-
O), 130.0–130.3 (C1C6F5-O), 137.0–139.3 (C2,6-C6F5), 137.7–140.0 (C4-C6F5), 141.0–143.2
(C3,5-C6F5). 19F NMR (CDCl3, δ): –161.8 – –161.6 (m, -161.6, F3/5), –159.4 (dt, J =
42.9Hz, 3JF,F = 21.9Hz, F4), –152.6 – –152.4 (m with the main coupling scheme to be a
dd at -152.5; J = 48.6Hz, 3JF,F = 18.0Hz, F2/6). 31P{1H} NMR (CDCl3, δ): 20.9 (ma),
21.6 (mi). HRMS (ESI-TOF, m/z): calcd for C36H42F5FeO4P+H 721.2164, found 721.2125
[M+H]+.
4.3.6 Reactions at Ferrocenylmethanols
(1R)-α-Fenchyloxymethylferrocene (124)
O
Fe
124
In a Schlenk tube, ferrocenylmethanol 118a (2.017g, 9.335mmol) was
dissolved in THF (20mL) and cooled to –50℃ followed by the dropwise
addition of BuLi (4mL, 10mmol). Stirring was continued for 10 min
and ClP(O)(OFn)2 (29e, 3.65 g, 9.39mmol) was added with a pasteur
pipette. The mixture was allowed to warm to ambient temperature and
stirred for 18 h. All volatiles were removed in vacuum. Purification was
realized by column chromatography (silica, 4.5 · 22 cm column size) using
hexane for the elution of methylferrocene [212] (123, 50mg, 0.25mmol,
3% based on 118a) and 124, followed by a 1:1 hexane/dichloromethane (v/v) mixture giving
bis(ferrocenylmethyl)ether [393] (122a, 886mg, 2.14mmol, 46% based on 118a) and 118a
(242mg, 1.12mmol, 12% based on 118a). After evaporation of all volatiles in vacuum 124
was obtained as an orange solid. Crystals suitable for single-crystal X-ray diffraction analysis
were obtained from boiling hexane solutions containing 124.
Yield: 188mg (0.534mmol, 6% based on 118a). Anal. calcd for C21H28FeO · 1/8 CH2Cl2
(352.29 · 1/8 94.93 g/mol): C, 69.92; H, 7.85. Found: C, 69.59; H, 7.93. Mp.: 157℃. 1H
NMR (CDCl3, δ): 0.92 (s, 3H, C(CH3)2), 0.96 (tdd, 3JH,H = 11.9Hz, JH,H = 2.8Hz, JH,H
= 1.6Hz, 1H, H5/6), 1.01 (s, 3H, C(CH3)2), 1.05–1.08 (m, 4H, C1(CH3), H7), 1.38 (tdd,
3JH,H = 12.4Hz, JH,H = 5.8Hz, JH,H = 4.1Hz, 1H, H5/6), 1.44 (ddd, 3JH,H = 10.0Hz, JH,H
= 4.0Hz, JH,H = 2.2Hz, 1H, H7), 1.62–1.63 (m, 1H, H4), 1.69 (ddt, 3JH,H = 12.0Hz, JH,H
= 9.1Hz, JH,H = 2.8Hz, 1H, C5/6), 2.98 (d, JH,H = 1.8Hz, 1H, H2), 4.12 (pt, 3,4JH,H =
1.9Hz, 1H, C5H4), 4.14 (s, 5H, C5H5), 4.20 (d, 2JH,H = 11.4Hz, 1H, CH2), 4.22 (pt, 3,4JH,H
= 1.8Hz, 1H, C5H4), 4.31 (d, 2JH,H = 11.4Hz, 1H, CH2). 13C{1H} NMR (CDCl3, δ): 20.0
(C(CH3)2), 20.8 (C(CH3)2), 26.0 (C5/6), 26.2 (C5/6), 31.6 (C1(CH3)), 39.4 (C3), 41.4 (C7),
48.8 (C4), 49.2 (C1), 67.8 (C5H4), 67.9 (C5H4), 68.4 (C5H5), 68.6 (C5H4), 68.7 (C5H4), 69.8
(CH2), 85.4 (CC5H4C), 92.1 (C2). HRMS (ESI-TOF, m/z): calcd for C21H28FeO 352.1484,
found 352.1479 [M]+.
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Cyclopenta-1,4-dien-1-yldiphenylferrocenylmethane (127a) and
Cyclopenta-1,4-dien-2-yldiphenylferrocenylmethane (127b)
Fe
PhPh
Fe
PhPh
127a
127b
In a Schlenk tube, ferrocenyldiphenylmethanol (118e, 1.00 g, 2.716mmol)
was dissolved in Et2O (50mL) and cooled to –50℃ followed by drop-
wise addition of BuLi (1.1mL, 2.75mmol). After stirring for 10 min and
warming to 0℃, diethyl chlorophosphate (0.40mL, 2.77mmol) was added
in a single portion, resulting in an exothermic reaction. The mixture was
allowed to warm to ambient temperature and stirring was continued for
18 h. All volatiles were removed in vacuum. Purification was realized
by column chromatography (silica, 2 · 14 cm column size) using a 9:1 hex-
ane/dichloromethane (v/v) mixture as the eluent. As the first fraction,
6,6'-diphenylfulvene (126, 155mg, 0.637mmol, 25% based on 118e) was
eluted followed by 127. They were obtained as an orange oil (126) and
solid (127) after removal of all volatiles in vacuum. Compound 127 was
obtained as a time dependent (vide supra) mixture of the tautomeric forms 127a and 127b.
Yield: 251mg (0.603mmol, 22% based on 118e). Anal. calcd for C28H24Fe (416.34 g/mol):
C, 80.78; H, 5.81. Found: C, 80.32; H, 5.86. Mp.: 143℃. HRMS (ESI-TOF, m/z): calcd for
C28H24Fe 416.1227 416.1187, found [ M]+. 127a: 1H NMR (CDCl3, δ): 3.05–3.06 (m, 2H,
CH2), 3.98 (m, 7H, C5H5, C5H4), 1.20 (m, 2H, C5H4), 5.72–5.74 (m, 1H, CH), 6.43–6.51
(m, 1H, CH), 6.85–6.86 (m, 1H, CH), 7.14–7.19 (m, 4H, C6H5), 7.20–7.25 (m, 6H, C6H5).
13C{1H} NMR (CDCl3, δ): 40.1 (CH2), 55.1 (qC), 67.6–67.7 (C5H4), 69.7–69.9 (C5H5), 70.9–
71.1 (C5H4), 97.4–97.5 (qC5H4, HMBC), 126.1 (C4C6H5), 127.1 (C6H5), 129.7 (C6H5), 130.1
(CH), 131.7 (CH), 136.4 (CH), 147.6 (C1C6H5), 152.9 (qCC5H5−qC).
127b: 1H NMR (CDCl3, δ): 3.33 (m, 2H, CH2), 3.82 (pt, 3,4JH,H = 1.7Hz, 2H, C5H4), 4.07
(s, 5H, C5H5), 4.19–4.21 (m, 2H, C5H4), 6.21 (dd, JH,H = 2.1Hz, JH,H = 1.2Hz, 1H, CH),
6.43–6.51 (m, 2H, CH), 7.04–7.06 (s, 4H, C6H5), 7.20–7.25 (m, 6H, C6H5). 13C{1H} NMR
(CDCl3, δ): 43.9 (CH2), 56.4 (qC), 67.3 (C5H4), 69.2 (C5H5), 71.2 (C5H4), 97.3 (qC5H4),
126.2 (C4C6H5), 127.1 (C6H5), 129.6 (C6H5), 130.9 (CH), 131.3 (CH), 132.3 (CH), 147.7
(C1C6H5), 155.0 (qCC5H5−qC).
6,6-Diphenylfulvene (126)
PhPh
126
The title compound was obtained within the synthesis of 127a,b by reacting fer-
rocenyldiphenylmethanol (118e, 1.00 g, 2.716mmol), BuLi (1.1mL, 2.75mmol)
and diethyl chlorophosphate (0.40mL, 2.77mmol). The spectroscopic data are
in agreement with those reported in literature. [394]
Yellow Solid. Yield: 155mg (0.637mmol, 25% based on 118e). 1H NMR
(CDCl3, δ): 6.32–6.34 (m, 2H, CH), 6.62–6.64 (m, 2H, CH), 7.33–7.36 (m, 4H,
C6H5), 7.37–7.42 (m, 6H, C6H5). 13C{1H} NMR (CDCl3, δ): 124.4 (CH), 127.7 (C6H5),
128.7 (C4C6H5), 132.1 (C6H5), 132.3 (CH), 141.3, 143.9, 152.0.
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2-Ferrocenyl-2-adamantanol (129)
129
OHFe
In a Schlenk tube, ferrocene (1, 2.00 g, 10.75mmol) and KOtBu
(163mg, 1.45mmol) were dissolved in 50mL of THF and cooled to
–80℃. Afterwards, tBuLi (5.7mL, 10.83mmol) was dropwise added,
the mixture was stirred for 30 min at this temperature followed by the
addition of 2-adamantanone (1.776 g, 11.82mmol). The mixture was
allowed to warm to ambient temperature and stirred for additional
18 h. All volatiles were removed in vacuum. Purification was realized
by column chromatography (silica, 4 · 14 cm column size) using hexane for the removal of
ferrocene followed by dichloromethane for the elution of 129. After removal of all volatiles
in vacuum, compound 129 was obtained as an orange solid.
Yield: 2.635 g (7.84mmol, 73% based on 1). Anal. calcd for C20H24FeO · 1/6 C6H14
(366.25 · 1/6 86.18 g/mol): C, 71.94; H, 7.57. Found: C, 71.98; H, 7.33. Mp.: 114℃. 1H
NMR (CDCl3, δ): 1.58–1.60 (m, 1H, H5/H7), 1.60–1.62 (m, 1H, H5/H7), 1.63–1.72 (m,
7H), 1.81–1.83 (m, 1H, H5/7), 1.91–1.93 (m, 2H, H1/3), 2.47–2.50 (m, 1H, CH2), 2.50–2.53
(m, 1H, CH2), 2.82 (s, 1H, OH), 4.20 (pt, 3,4JH,H = 1.7Hz, 2H, C5H4), 4.24 (s, 5H, C5H5),
4.38 (pt, 3,4JH,H = 1.6Hz, 2H, C5H4). 13C{1H} NMR (CDCl3, δ): 27.2 (C5/7), 27.2 (C5/7),
33.7 (C4/6/9/10), 35.3 (C4/6/9/10), 38.0 (C8), 38.8 (C1/3), 67.2 (C5H4), 67.7 (C5H4), 68.2
(C5H5), 72.0 (C2), 102.3 (qC5H4). UV/Vis (in nm ( in Lmol−1 cm−1), CH2Cl2): 329 (66),
447 (121). HRMS (ESI-TOF, m/z): calcd for C20H24FeO 336.11711, found 336.1170 [M]+.
Bis((1R)-α-fenchyl) Phosphate (121a)
121a
OPHO
O
2
The compound has ,e.g., been obtained by the following reaction.
Alcohol 129 (200mg, 0.546mmol) was dissolved in 20mL of DMF.
The solution was cooled to –30℃ followed by the dropwise addition of
BuLi (0.22mL, 0.546mmol). After stirring for 10 min, the reaction
mixture was allowed to warm to ambient temperature followed by
the dropwise addition of chlorophosphate 29e (215mg, 0.55mmol).
The reaction mixture was heated to 90℃ for 4 h. All volatiles were removed in vacuum.
Purification was realized by column chromatography (silica, 4 · 23 cm column size) using a
8:2 dichloromethane/ethyl acetate mixture (v/v) as the eluent. The compound was obtained
as a colorless oil.
Yield: 116mg (295mmol, 54% based on 129). 1H NMR (CDCl3, δ): 0.92–1.21 (m, 22H),
1.38–1.44 (m, 2H), 1.48–1.52 (m, 2H), 1.65–1.73 (m, 6H), 4.04–4.06 (m, 1H, H2), 4.14–4.16
(m, 1H, H2). 13C{1H} NMR (CDCl3, δ): 19.2 (CH3), 19.4 (CH3), 20.86 (CH3), 20.94 (CH3),
25.63 (CH2), 25.66 (CH2), 25.83 (CH2), 25.87 (CH2), 29.6 (CH2), 29.8 (CH2), 39.5, 40.8
(CH2), 40.9 (CH2), 47.9 (CH), 48.0 (CH), 49.26, 49.29, 49.31, 91.1 (t, J = 3.2Hz, C2), 91.5
(t, J = 3.3Hz, C2). 31P{1H} NMR (CDCl3, δ): –11.7. HRMS (ESI-TOF, m/z): calcd for
C20H34O4P+Na 393.2165, found 393.2186 [M+Na]+.
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(1R,2R,4S)-2-Ferrocenylfenchole (130a)
OH
Fe
130a
In a Schlenk tube ferrocene (1, 2.00 g, 10.75mmol) and KOtBu (163mg,
1.45mmol) were dissolved in 50mL of THF and cooled to –80℃. After-
wards, tBuLi (5.7mL, 10.83mmol) was dropwise added and the mix-
ture was stirred for 30 min at this temperature followed by the addi-
tion of (1R)-fenchone (18mL, 11.23mmol). The mixture was allowed
to warm to ambient temperature and stirred for additional 18 h. All
volatiles were removed in vacuum. Purification was realized by column chromatography
(silica, 4 · 10 cm column size) using hexane to elute the excess of 1, followed by a 30:1:0.1
hexane/diethyl ether/triethylamine (v/v/v) mixture as the eluent for 130a and 130c. After
removal of all volatiles in vacuum, compound 130a was obtained as an orange solid in a
diastereomeric ratio of (2R):(2S) of 1:0.13. The spectroscopic data are in agreement with
those reported in literature. [329]
Yield: 3.043 g (9.00mmol, 84% based on 1). Anal. calcd for C20H26FeO (338.28 g/mol): C,
71.01; H, 7.75. Found: C, 70.80; H, 8.10. Mp.: 92℃. 1H NMR (CDCl3, δ): 0.46 (s, 3H,
CH3), 0.95 (s, 3H, CH3), 1.05–1.08 (m, 1H, CH2), 1.09–1.12 (m, 1H, CH2), 1.32–1.40 (m,
1H, CH2), 1.42 (s, 3H, CH3), 1.62–1.63 (m, 1H, CH), 1.79–1.84 (m, 1H, CH2), 2.29–2.35 (m,
1H, CH2), 4.05–4.06 (m, 1H, C5H4), 4.10–4.12 (m, 1H, C5H4), 4.13–4.15 (m, 1H, C5H4),
4.17 (s, 5H, C5H5), 4.21 (s, 0.65H, C5H5 minor isomer), 4.26–4.28 (m, 1H, C5H4). 13C{1H}
NMR (CDCl3, δ): 19.4 (CH3), 22.1 (CH3), 25.3 (CH2), 29.8 (CH3), 31.9 (CH2), 41.0 (CH2),
44.7 (qC), 49.8 (CH), 52.5 (qC), 66.1 (C5H4), 66.6 (C5H4), 67.8 (C5H4), 68.6 (C5H5), 70.0
(C5H4), 80.5 (C2), 96.6 (qC5H4). HRMS (ESI-TOF, m/z): calcd for C20H26FeO 338.1328,
found 338.1311 [M]+.
1-(3-Ferrocenyl-3-hydroxy-4,4-dimethylcyclohexyl)ethanone (130c)
130c
O
HOFe
The title compound was obtained within the synthesis of 130a,
by reacting ferrocene (1, 2.00 g, 10.75mmol), KOtBu (163mg,
1.45mmol) and tBuLi (5.7mL, 10.83mmol). For Purification de-
tails see compound 130a.
Orange Oil. Yield: 95mg (0.268mmol, 2.5% based on 1). 1H
NMR (CDCl3, δ): 1.20 (s, 3H, CH3), 1.23 (s, 3H, CH3), 1.44 (s,
3H, CH3), 1.515 (ddt, 2JH,H = 12.3Hz, JH,H = 9.4Hz, JH,H = 8.6Hz, 1H, CH2), 1.59–1.63
(m, 1H, CH2), 1.618 (s, 1H, OH), 1.66 (dd, 2JH,H = 12.8Hz, 3JH,H = 7.8Hz, 1H, CH–CH2),
1.79 (dtdd, 2JH,H = 12.2Hz, 3JH,H = 7.5Hz, JH,H = 3.9Hz, JH,H = 0.9Hz, 1H, CH2), 2.15
(tt, 3JH,H = 10.2Hz, 3JH,H = 7.8Hz, CH), 2.25 (dd, 2JH,H = 12.8Hz, 3JH,H = 10.4Hz,
CH–CH2), 2.48 (ddd, 3JH,H = 12.5Hz, 3JH,H = 8.6Hz, JH,H = 4.1Hz, CH2), 4.19 (s, 5H,
C5H5), 4.47 (pt, 3,4JH,H = 8.6Hz, 2H, H3,4-C5H4), 4.80–4.81 (m, 1H, H2,5-C5H4), 4.82–4.83
(m, 1H, H2,5-C5H4). 13C{1H} NMR (CDCl3, δ): 26.5 (CH2), 27.3 (CH3), 28.2 (CH3), 28.6
(CH3), 37.4 (CH2), 38.3 (CH–CH2), 49.5 (CH), 55.4 (qC), 69.8 (C5H5), 70.8 (C5H4), 71.0
(C5H4), 71.27 (C5H4), 71.32 (C5H4), 71.6 (qC), 76.7 (qC5H4), 210.4 (C=O). IR data (KBr,
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v˜/cm−1): 3617 m (OH), 3490 m (br), 3101 m (CHAr), 2971 s, 2929 m, 2870 w, 1660 s (C=O),
1458 w, 1436 m, 1377 m, 1241 m. HRMS (ESI-TOF, m/z): calcd for C20H26FeO2 354.1282,
found 354.1272 [M]+.
5-(1-(2-(2,4-Dinitrophenyl)hydrazono)ethyl)-1-ferrocenyl-2,2-dimethylcyclo-
hexanol (130d)
130d
N
HO NH
NO2
NO2Fe
Compound 130c (95mg, 0.281mmol) and
2,4-dinitrophenylhydrazine (60mg, 0.303mmol)
were dissolved in 5mL of dichloromethane and
one drop of aqueous HCl (w = 36%) was added
with a Pasteur pipette. The mixture was stirred
for 12 h. Purification was realized by column
chromatography (silica, 2.5 · 12 cm) using a 96:4
dichloromethane/ethyl acetate mixture (v/v) as the eluent. After removal of all volatiles com-
pound 130d was obtained as a yellow solid.
Yield: 45mg (0.084mmol, 30% based on 1). 1H NMR (CDCl3, δ): 1.22 (s, 3H, CH3), 1.24
(s, 3H, CH3), 1.26 (s, 1H, OH), 1.44 (s, 3H, CH3), 1.59–1.64 (m, 1H, CH2), 1.77–1.90 (m,
3H, CH2), 2.08 (dd, 3JH,H = 12.6Hz, 3JH,H = 11.0Hz, 1H, CH2), 2.20–2.29 (m, 2H, CH2,
CH), 4.29 (s, 5H, C5H5), 4.58 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4), 4.75–4.76 (m, 1H, C5H4),
4.77–4.78 (m, 1H, C5H4), 8.07 (d, 3JH,H = 9.7Hz, 1H, H6), 8.34 (ddd, 3JH,H = 9.6Hz,
4JH,H = 2.6Hz, 5JH,H = 0.5Hz, 1H, H5), 9.17 (d, 4JH,H = 2.6Hz, 1H, H3), 11.76 (s,
1H, NH). 13C{1H} NMR (CDCl3, δ): 25.7 (CH2), 28.1 (CH3), 28.2 (CH3), 28.4 (CH3), 38.6
(CH2), 40.3 (CH–CH2), 49.1 (CH), 52.2 (qC), 69.4 (C5H4), 69.4 (C5H4), 70.0 (C5H5), 70.68
(C5H4), 70.70 (C5H4), 72.0 (qC), 72.5 (qC), 117.1 (C6), 123, 6 (C3), 129.5 (qC), 130.0 (C5),
137.8 (qC), 145.1 (qC), 162.3 (C=N).
2-Ferrocenyl-2-methyl-4-(prop-1-en-2-yl)cyclohexanone (131)
O
Fe
131
In a Schlenk tube, compound 130 (300mg, 0.887mmol) was dissolved in
20mL of diethyl ether and cooled to –80℃. Buli (0.35mL, 0.875mmol)
was dropwise added and the mixture was slowly warmed to –30℃ fol-
lowed by the dropwise addition of ClP(O)(OEt)2 (0.13mL 0.90mmol).
After stirring for 18 h at ambient temperature all volatiles were removed
in vacuum. Purification was realized by column chromatography (silica,
2.5 · 12 cm column size) using dichloromethane as the eluent, giving 131
as an orange solid.
Yield: 24mg (0.071mmol, 8% based on 130). 1H NMR (CDCl3, δ): 1.45 (s, 3H, CH3),
1.47–1.52 (m, 1H, CH2), 1.54–1.60 (m, 1H, CH2), 1.75* (s, 3H, CH3), 1.82 (ddd, JH,H =
12.9Hz, JH,H = 6.8Hz, JH,H = 1.0Hz, 1H, CH2), 1.87–1.93 (m, 1H, CH2), 2.23 (dd, JH,H
= 12.8Hz, JH,H = 11.5Hz, 1H, CH2), 2.626 (ddd, 2JH,H = 11.8Hz, 3JH,H = 8.3Hz, JH,H
= 2.9Hz, 1H, CH2), 2.64–2.68 (m, 1H, CH), 4.18 (s, 5H, C5H5), 4.47 (pt, 3,4JH,H = 2.0Hz,
213
CHAPTER 4. EXPERIMENTAL PART
4.70–4.72 (m, 1H, =CH2), 4.75–4.76 (m, 1H, =CH2), 4.78–4.79 (m, 1H, C5H4), 4.80–4.81
(m, 1H, C5H4). 13C{1H} NMR (CDCl3, δ): 21.2 (CH3), 28.3 (CH3), 31.0 (CH2), 36.8 (CH2),
42.6 (CH2), 46.0 (CH), 54.9 (qC), 69.8 (C5H5), 70.76 (C5H4), 70.83 (C5H4), 71.2 (C5H4), 71.3
(C5H4), 76.8 (qC), 108.7 (CH2), 147.8 (qC), 209.8 (C=O). HRMS (ESI-TOF, m/z): calcd for
C20H24FeO 336.1171, found 336.1163 [M]+.
Ferrocenylnitrile (133)
133
Fe N
In a Schlenk tube, oxime 128a (393mg, 1.71mmol) was dissolved in 50mL
of diethyl ether, cooled to –80℃ followed by the addition of tBuLi (0.9mL,
1.71mmol). After stirring for 30 min and warming to –30℃, 29e (667mg,
1.715mmol) was dropwise added with a Pasteur pipette. The mixture was al-
lowed to warm to ambient temperature and stirred for 18 h. All volatiles were
removed in vacuum. Purification was realized by column chromatography (sil-
ica, 2 · 12 cm column size) using a 1:3 hexane/dichloromethane (v/v) mixture
as the eluent for removing 133. By changing to a 95:5 dichloromethane/ethyl acetate (v/v)
mixture 118f (12mg, 0.05mmol, 3%) and 12a (28mg, 0.14mmol, 8% based on 132a). The
spectroscopic data are in agreement with those reported in literature. [293]
Yield: 260mg (1.23mmol, 72% based on 132a). 1H NMR (CDCl3, δ): 4.34 (s, 5H, C5H5),
4.39 (pt, 3,4JH,H = 1.7Hz, C5H4), 4.39 (pt, 3,4JH,H = 1.7Hz, C5H4), 4.66 (pt, 3,4JH,H =
1.9Hz, C5H4).
(E)-Bis((1R)-α-fenchyl) (1-Ferrocenylethylidene)phosphoramidate (134a)
Fe
N P
O
O
134a
2
In a Schlenk tube, ferrocenylnitrile (133, 230mg,
1.09mmol) was dissolved in 20mL of THF and cooled
to –80℃. A 1.6 M solution of MeLi in Et2O (0.68mL,
1.09mmol) was dropwise added. The mixture was allowed
to warm to –30℃, stirred for 30 min and 29e (423mg,
1.09mmol) was added with a Pasteur pipette. After warm-
ing to ambient condition, stirring was continued for 18 h.
All volatiles were removed in vacuum. Purification was realized by column chromatography
(silica, 2 · 12 cm column size) using dichloromethane as the eluent for the removal of unre-
acted 133 (40mg, 17% based on 133) followed by a 9:1 dichloromethane/ethyl acetate (v/v)
mixture for 134a. After removal of all volatiles, compound 134a was obtained as a red oil
in a 1 : 0.07 ratio of the (E)- to the (Z)-diastereomer.
Yield: 378mg (0.65mmol, 60% based on 133). Anal. calcd for C32H46FeNO3P · 0.5 H2O
(579.53 · 0.5 18.01 g/mol): C, 65.30; H, 8.05; N, 2.38. Found: C, 65.35; H, 7.91; N, 2.10. 1H
NMR (CDCl3, δ): 0.97 (s, 3H, CH3), 1.02 (s, 3H, CH3), 1.03 (m, 2H, H5/6, HSQC), 1.09 (s,
3H, CH3), 1.10 (s, 3H, CH3), 1.16 (m, 2H, H7, HSQC), 1.17 (s, 3H, CH3), 1.20 (s, 3H, CH3),
1-40–1.47 (m, 2H, H5/6), 1.51–1.53 (m, 2H, H7), 1.70–1.75 (m, 4H, H5/6/7), 1.76–1.82 (m,
2H, H5/6), 2.62 (d, 4JH,P = 2.3Hz, 3H, CH3-C=N), 4.01 (dd, 3JH,P = 9.3Hz, JH,H =
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1.8Hz, 1H, H2), 4.04 (dd, 3JH,P = 9.6Hz, JH,H = 1.7Hz, 1H, H2), 4.18 (s, 5H, C5H5, ma),
4.20 (s, 5H, C5H5, mi), 4.49–4.50 (m, 2H, C5H4), 4.78 (dpt, JH,H = 2.5Hz, JH,H = 1.4Hz,
1H, C5H4), 4.81 (dpt, JH,H = 2.6Hz, JH,H = 1.4Hz, 1H, C5H4). 13C{1H} NMR (CDCl3, δ):
19.1 (CH3), 19.8 (CH3), 21.1 (CH3), 21.2 (CH3), 24.0 (d, 3JC,P = 10.8Hz, CH3-C=N), 25.9
(C5/6), 25.99 (C5/6), 26.02 (C5/6), 26.1 (C5/6), 29.9 (CH3), 30.1 (CH3), 39.46 (d, 3JC,P =
2.1Hz, C3), 39.48 (d, 3JC,P = 1.9Hz, C3), 41.0 (C7), 48.00 (C4), 48.06 (C4), 49.3 (d, 3JC,P
= 4.7Hz, C1), 49.4 (d, 3JC,P = 4.9Hz, C1), 69.7 (d, JC,P = 1.0Hz, C5H4), 69.8 (d, JC,P =
1.2Hz, C5H4), 69.9 (C5H5), 72.16 (C5H4), 72.18 (C5H4), 82.9 (d, 3JC,P = 34.4Hz, +C5H4),
89.18 (d, 2JC,P = 7.3Hz, C2), 89.22 (d, 2JC,P = 7.7Hz, C2), 186.2 (d, 2JC,P = 1.7Hz, C=N).
31P{1H} NMR (CDCl3, δ): 4.05 (mi), 4.18 (ma). IR data (KBr, v˜/cm−1): 3094 m, 2955 s,
2926 m, 2867 m, 1673 s, 1611 s (ν C=N), 1452 s, 1377 m, 1244 m, 1062 w, 1036 s, 1007 s,
929 m, 919 m, 819 m. UV/Vis (in nm ( in Lmol−1 cm−1), CH2Cl2): 275 (7909), 464 (684).
HRMS (ESI-TOF, m/z): calcd for C32H46FeNO3P+H 580.2638, found 580.2590 [M+H]+.
(E)-Bis((1R)-α-fenchyl) (Ferrocenyl(phenyl)methylene)phosphoramidate (134b)
Fe
N
Ph
P
O
O
134b
2
In a Schlenk tube, ferrocene (1, 1,30 g; 7,00mmol) and
KOtBu (96mg, 0.79mmol) were dissolved in 50mL of THF
and cooled to –80℃ followed by the dropwise addition of
tBuLi (3.35mL, 6.35mmol). The orange suspension was
stirred for 30 min and benzonitrile (0.66mL, 6.40mmol)
was dropwise added. The mixture was allowed to warm to
ambient temperature and stirred until the solution turned dark-red. Afterwards, chlorophos-
phate 29e (1.95 g, 5.01mmol) was added with a Pasteur pipette and stirring was continued for
18 h. All volatiles were removed in vacuum. Purification was realized by column chromatogra-
phy (silica, 4 · 12 cm column size) using a 1:1 hexane/dichloromethane mixture (v/v) to elute
the excess of 1 (421mg, 2.27mmol), followed by a 9:1 dichloromethane/ethyl acetate (v/v)
mixture as the eluent for benzoylferrocene 128d [390] (17%) and a 4:1 dichloromethane/ethyl
acetate (v/v) mixture for 134b. After removal of all volatiles in vacuum, compound 134b
was obtained as a red solid in a 1 : 0.11 ratio of the (E)- to the (Z )-diastereomer.
Yield: 1.864 g (2.906mmol, 58% based on 29e). Anal. calcd for C37H48FeNO3P · 0.5 H2O
(641.61 · 0.5 18.01 g/mol): C, 68.31; H, 7.59; N, 2.15. Found: C, 68.07; H, 7.58; N, 2.12. Mp.:
156℃. 1H NMR (CDCl3, δ): 0.77–0.80 (m, 4H, CH3, C10H17), 0.85 (s, 3H, CH3), 0.88–0.99
(m, 1H, C10H17), 1.06–1.13 (m, 14H, CH3, C10H17), 1.16–1.21 (m, 1H, C10H17), 1.29–1.39
(m, 2H, C10H17), 1.46–1.57 (m, 5H, C10H17), 1.63–1.66 (m, 2H, C10H17), 4.00 (dd, 3JH,P
= 9.2Hz, JH,H = 1.7Hz, 1H, H2), 4.10 (dd, 3JH,P = 9.5Hz, JH,H = 1.7Hz, 1H, H2), 4.22
(s, 4.5H, C5H5, ma), 4.23 (s, 0.5H, C5H5, mi), 4.49–4.51 (m, 2H, C5H4), 4.59–4.61 (m, 1H,
C5H4), 4.66–4.68 (m, 1H, C5H4), 7.37–7.40 (m, 3H, C6H5), 7.61–7.63 (m, 1.78H, C6H5,
ma), 7.66–7.68 (m, 0.22H, C6H5, mi). 13C{1H} NMR (CDCl3, δ): 19.5 (CH3), 19.6 (CH3),
20.8 (CH3), 21.1 (CH3), 25.6 (C5/6), 25.8 (C5/6), 25.9 (C5/6), 26.0 (C5/6), 29.9 (CH3),
30.1 (CH3), 39.2 (d, 3JC,P = 2.0Hz, C3), 39.6 (d, 3JC,P = 2.4Hz, C3), 40.99 (C7), 41.03
(C7), 47.95 (C4), 47.98 (C4), 49.1 (d, 3JC,P = 4.6Hz, C1), 49.2 (d, 3JC,P = 4.9Hz, C1),
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70.1 (C5H5), 71.4 (C5H4), 71.6 (C5H4), 72.3 (C5H4), 72.4 (C5H4), 82.6 (d, 3JC,P = 2.0Hz,
C3), 82.6 (d, 3JC,P = 31.5Hz, qC5H4), 89.1 (d, 2JC,P = 8.3Hz, C2), 89.2 (d, 2JC,P = 8.1Hz,
C1), 127.7 (C6H5), 127.6 (C6H5), 129.1 (C), 139.9 (d, 3JC,P = 11.6Hz, C1C6H5), 183.8 (d,
2JC,P = 2.5Hz, C=N). 31P{1H} NMR (CDCl3, δ): 2.1 (1, ma), 2.3 (0.11, mi). IR data (KBr,
v˜/cm−1): 3093 w, 3047 w, 3029 w, 2945 s, 2920 s, 2868 s, 1608 s (ν N=C), 1596 w, 1577
m, 1447 m, 1438 w, 1376 m, 1358 w, 1336 w, 1293 m, 1274 w, 1243 s, 1055 s, 1008 s, 918
s. UV/Vis (in nm ( in Lmol−1 cm−1), CH2Cl2): 362 (1652), 484 (1117). HRMS (ESI-TOF,
m/z): calcd for C37H48FeNO3P+H 642.2795, found 642.2782 [M+H]+.
(E)-Bis((1R)-α-fenchyl) (1-Ferrocenyl(2,4,6-triphenyl)methylene)phosphor
amidate (134c)
134c
2
Fe
N
P
O
Ph
Ph
Ph
O
According to the synthesis of 129, ferrocene (1, 1.30 g,
6.99mmol), KOtBu (96mg, 0.79mmol) and tBuLi (3.4mL,
6.46mmol) were reacted for the synthesis of 1–Li. After stir-
ring for 30 min at –80℃ 2,4,6-triphenylbenzonitrile (1.41 g,
4.25mmol) was added in a single portion and the mixture
was allowed to warm to ambient temperature. Stirring was
continued until the color changed to deep red followed by
the addition of 29e (1.66mg, 4.27mmol) by using a Pas-
teur pipette. After stirring for 18 h at ambient temperature, all volatiles were removed in
vacuum. Purification was realized by column chromatography (silica, 4 · 16 cm column size)
using a 1:1 hexane/dichloromethane mixture (v/v) to elute the excess of 1 followed by a
9:1 dichloromethane/ethyl acetate (v/v) mixture as the eluent, giving 134c as a red solid
and a mixture of two isomers in a ratio of 1:0.08. Crystals suitable for single crystal X-ray
diffraction analysis were obtained by crystallization from ethanol.
Yield: 715mg (0.822mmol, 19% based on the nitrile). Anal. calcd for C55H60FeNO3P
(869.89 g/mol): C, 75.94; H, 6.95; N, 1.61. Found: C, 75.62; H, 7.22; N, 1.53. Mp.: 140–
145℃. 1H NMR (CDCl3, δ): 0.66 (s, 3H, CH3), 0.77–0.91 (m, 2H, C10H17), 1.00–1.18 (m,
15H, C10H17), 1.24 (s, 3H, CH3), 1.33–1.41 (m, 3H, C10H17), 1.48–1.54 (m, 4H, C10H17),
1.64–1.68 (m, 2H, C10H17), 3.58 (s, 5H, C5H5), 4.06–4.07 (m, 1H, C5H4), 4.08–4.10 (m, 1H,
C5H4), 4.10–4.12 (m, 1H, C5H4), 4.15–4.16 (m, 1H, C5H4), 4.25–4.28 (m, 2H, H2), 7.24–
7.28 (m, 1H), 7.31–7.38 (m, 6H), 7.43–7.46 (m, 2H), 7.48–7.49 (m, 1H), 7.53–7.54 (m, 1H),
7.63–7.65 (m, 4H), 7.71–7.73 (m, 2H). 13C{1H} NMR (CDCl3, δ): 19.8 (CH3), 19.9 (CH3),
21.3 (CH3), 21.9 (CH3), 25.8 (CH2), 25.96 (CH2), 26.00 (CH2), 29.9 (CH3), 30.0 (CH3), 39.4
(d, 3JC,P = 1.4Hz, C3), 40.0 (d, 3JC,P = 0.7Hz, C3), 41.1 (C7), 41.4 (C7), 47.8 (C4), 48.0
(C4), 49.3 (d, 3JC,P = 5.4Hz, C1), 49.4 (d, 3JC,P = 5.1Hz, C1), 69.4 (C5H5), 70.1 (C5H4),
70.3 (C5H4), 70.9 (C5H4), 71.6 (C5H4), 84.9 (d, 3JC,P = 29.5Hz, iC5H4), 89.8 (d, 2JC,P =
7.6Hz, C2), 90.2 (d, 2JC,P = 8.3Hz, C2), 127.1 (CH), 127.3 (CH), 127.4 (CH), 127.6 (CH),
127.8 (CH), 128.0 (CH), 128.6 (CH), 128.6 (CH), 128.8 (CH), 130.4 (CH), 130.4 (CH), 138.2
(qC), 138.3 (qC), 139.7 (qC), 139.8 (qC), 140.2 (qC), 140.78 (qC), 140.83 (qC), 140.9 (qC),
181.3 (d, 2JC,P = 2.7Hz, C=N). 31P{1H} NMR (CDCl3, δ): 0.9 (mi), 1.7 (ma). UV/Vis (in
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nm ( in Lmol−1 cm−1), CH2Cl2): 372 (1281), 502 (1106). HRMS (ESI-TOF, m/z): calcd
for C55H60FeNO3P+H 870.3734, found 870.3749 [M+H]+.
tert-Butylferrocenylimino Bis((1R)-α-fenchyl) Phosphate (134d)
Fe
N
tBu
134d
P
O
O
2
Path A: Reaction of 133 with tBuLi and 29e: In a Schlenk tube, 133
(500mg, 2.37mmol) was dissolved in 30mL of THF, cooled to –80℃
and tBuLi (1.25mL, 2.38mmol) was dropwise added. The mixture
was allowed to warm to ambient temperature and stirred until the
color changed to dark red. Afterwards, 29e (921mg, 2.37mmol) was
added with a Pasteur pipette and stirring was continued for 18 h. All
volatiles were removed in vacuum. Purification was realized by column
chromatography using the same conditions like in Path b, whereas the
removal of ferrocene was not required. First 135 (311mg, 0.58mmol,
49% based on 133) was eluted, followed by 134d as a 1:2 mixture with 121a similar to path
B (835mg, 25 % of 134d based on 133).
Path B: Reaction of 1–Li with tert-butylnitrile: According to the synthesis of 129, fer-
rocene (1, 1.30 g, 6.99mmol), KOtBu (96mg, 0.79mmol), tBuLi (3.4mL, 6.46mmol), tert-
butylnitrile (0.70 g, 8.42mmol) and 29e (2.44 g, 6.29mmol) were reacted. All volatiles were
removed in vacuum. Purification was realized by column chromatography (silica, 2 · 15 cm
column size) using hexane to elute the excess of 1 followed by a 1:4 hexane/dichloromethane
(v/v) mixture as the eluent for 135. The solvent was changed to dichloromethane and fi-
nally a 9:1 dichloromethane/ethyl acetate mixture was used for 128c (430mg, 1.59mmol,
25% based on tBuLi) and 134d. After removal of all volatiles in vacuum compound 134d
was obtained as a red oil with a ratio of the E-/Z- isomers of 0.259:1 (59 % de). The two
sets of signals in the 1H, 13C{1H} and 31P{1H} NMR were assigned as major (ma) and mi-
nor (mi). The title compound occurred in a 1:2 mixture of the phosphate 134d with the
bis-(1R)-α-fenchyl phosphate 121a-H. The signals of 121a-H have been avoided for clarity.
Yield: 538mg (1.62mmol, 25% based on tBuLi). Anal. calcd for C35H52FeNO3P · 2
C20H35O4P ·CH2Cl2 (621.61 · 2 370.46 · 1 84.93 g/mol): C, 63.06; H, 8.63; N, 0.97. Found: C,
62.88; H, 8.26; N, 1.02. 1H NMR (CDCl3, δ): 0.89 (s, 3H, CH3), 0.92 (s, 3H, CH3), 1.04
(s, 3H, CH3), 1.06 (s, 3H, CH3), 1.11 (s, 3H, CH3), 1.14 (s, 3H, CH3), 3.99 (dd, 3JH,P
= 8.9Hz, JH,H = 1.7Hz, 1H, H2), 4.03 (dd, 3JH,P = 9.0Hz, JH,H = 1.7Hz, 1H mi, H2),
4.09 (dd, 3JH,P = 9.1Hz, JH,H = 1.6Hz, 1H, H2), 4.22 (s, 5H, C5H5), 4.46–4.48 (m, 2H,
C5H4), 5.23 (dpt, JH,H = 2.8Hz, JH,H = 1.4Hz, 1H, C5H4), 5.25 (dpt, JH,H = 2.5Hz,
JH,H = 1.5Hz, 1H, C5H4). 13C{1H} NMR (CDCl3, δ): 19.6 (CH3), 19.89 (CH3, mi), 19.92
(CH3, mi), 25.92 (CH2), 25.94 (CH2), 26.0 (CH2), 26.1 (CH2), 29.8 (CH3), 30.0 (CH3), 30.9
(C (CH3)3), 31.5 (C (CH3)3, mi), 39.55 (C3), 39.57 (C3), 41.0 (C7), 41.1 (C7), 44.65 (d,
3JC,P = 21.0Hz, C (CH3)3, mi), 44.69 (d, 3JC,P = 21.1Hz, C (CH3)3), 47.9 (C4), 48.1 (C4),
49.33 (C1), 49.35 (C1), 49.39 (C1), 70.20 (C5H5, mi), 70.22 (C5H5), 70.85 (C5H4, mi), 70.87
(C5H4), 70.94 (C5H4), 72.4 (C5H4), 72.6 (C5H4, mi), 72.9 (C5H4), 78.2 (d, 3JC,P = 10.0Hz,
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iC5H4), 78.6 (d, 3JC,P = 10.4Hz, iC5H4), 89.4 (d, 2JC,P = 8.2Hz, C2, mi), 89.4 (d, 2JC,P =
8.1Hz, C2), 89.7 (d, 2JC,P = 8.6Hz, C2), 191.5 (d, 2JC,P = 4.4Hz, C=N), 191.8 (d, 2JC,P =
4.7Hz, C=N, mi). 31P{1H} NMR (CDCl3, δ): –1.8 (ma), –1.3 (mi). IR data (NaCl/CHCl3,
v˜/cm−1): 2961 s, 2874 s, 1715 m, 1585 m, 1468 m, 1286 m, 1027 s, 1017 s, 962 s. UV/Vis
(in nm ( in Lmol−1 cm−1), CH2Cl2): 281 (8211), 460 (724). HRMS (ESI-TOF, m/z): calcd
for C35H52FeNO3P+H 622.3107, found 622.3078 [M+H]+.
(1Z,2Z)-1,2-Bis(2,2-dimethyl-1-ferrocenylpropylidene)hydrazine (135)
135
Fe
N
N
Fe
The compound was obtained within the synthesis of 134d (see
above) and obtained as a red solid in mixture with the other di-
astereomer in a ratio of 1 : 0.09.
Yield: 380mg (0.71mmol; 22% based on tBuLi). Anal. calcd for
C30H36Fe2N2 (536.32 g/mol): C, 67.19; H, 6.77; N, 5.22. Found:
C, 66.99; H, 6.69; N, 5.08. Mp.: 148℃. 1H NMR (CDCl3, δ):
1.54 (s, 9H, CH3), 4.14 (s, 5H, C5H5), 4.30 (pt, 3,4JH,H = 2.0Hz,
2H, C5H4), 4.79 (pt, 3,4JH,H = 2.0Hz, 2H, C5H4). 13C{1H} NMR (CDCl3, δ): 30.4 (CH3),
39.7 (C(CH3)3), 69.0 (C5H4), 69.4 (C5H5), 71.6 (C5H4), 75.9 (qC5H4), 156.6 (C=N). IR data
(NaCl/CHCl3, v˜/cm−1): 3098 w, 3007 m, 2990 s, 2952 m, 2932 w, 2903 w, 2867 w, 1770 w,
1692 w, 1650 w, 1559 s, 1474 s, 1455 m, 1390 s, 1367 s, 1104 s, 1069 s, 1004 m, 984 w, 884
m. UV/Vis (in nm ( in Lmol−1 cm−1), CH2Cl2): 463 (883). HRMS (ESI-TOF, m/z): calcd
for C30H36Fe2N2 536.1573, found 536.1585 [M]+.
Bis((1R)-α-fenchyl) (Ferrocenyl(phenyl)methyl)phosphoramidate (136)
Fe
HN
Ph
P
O
O
136
2
*
In a Schlenk tube, 134b (125mg, 0.196mmol) was dis-
solved in 2mL of THF. NaBH4 (7.5mg, 0.2mmol) was
carefully added and the mixture was stirred for at 50℃
for 18 h, whereby the color changed from red to yellow.
The mixture was poured into an ice-water mixture and ex-
tracted three times with Et2O (50mL). The organic layers
were combined, dried over MgSO4 followed by removal of all
volatiles in vacuum. Purification was realized by column chromatography (alumina, 2 · 10 cm
column size) using dichloromethane as the eluent (Rf = 0.60). After removal of all volatiles
compound 136 was obtained as a yellow solid and as a ratio of three isomers of 1 : 0.86 : 0.23.
Yield: 90mg (0.14mmol, 72% based on 134b). Anal. calcd for C37H50FeNO3P
(643.62 g/mol): C, 69.05; H, 7.83; N, 2.18. Found: C, 68.73; H, 8.00; N, 2.04. Mp.: 134–
136℃. 1H NMR (CDCl3, δ): 0.84–1.70 (m, 32H), 3.12 (dd, 2JH,P = 9.2Hz, 3JH,H = 9.2Hz,
NH), 3.18 (dd, 2JH,P = 9.7Hz, 3JH,H = 8.1Hz, NH), 3.27 (dd, 2JH,P = 9.4Hz, 3JH,H =
9.4Hz, NH), 3.63 (dd, 3JH,P = 9.2Hz, JH,H = 1.7Hz, H2), 3.66 (dd, 3JH,P = 9.6Hz, JH,H
= 1.7Hz, H2), 3.87 (dd, 3JH,P = 9.5Hz, JH,H = 1.6Hz, H2), 3.89–3.96 (m, 2H, H2, C5H4),
4.10–4.12 (m, 3H, C5H4), 4.15/4.16 (s, 5H, C5H5), 5.21 (dd, 3JH,H = 8.8Hz, 3JH,P = 8.3Hz,
218
4.3. SYNTHETIC PROCEDURES
CH), 5.25 (dd, 3JH,H = 9.8Hz, 3JH,P = 8.2Hz, CH), 7.22–7.27 (m, 1H, C6H5), 7.30–7.40 (m,
4H, C6H5). 13C{1H} NMR (CDCl3, δ): 19.5 (CH3), 19.60 (CH3), 19.63 (CH3), 20.7 (CH3),
20.91 (CH3), 20.92 (CH3), 21.1 (CH3), 21.2 (CH3), 21.3 (CH3), 25.6 (CH2), 25.7 (CH2), 25.8
(CH2), 25.9 (CH2), 25.97 (CH2), 25.99 (CH2), 26.01 (CH2), 29.6 (CH3), 29.7 (CH3), 29.8
(CH3), 29.8 (CH3), 39.15 (d, 3JC,P = 2.0Hz, C3), 39.24 (d, 3JC,P = 1.8Hz, C3), 39.4 (d,
3JC,P = 1.3Hz, C3), 39.6 (d, 3JC,P = 1.4Hz, C3), 40.8 (C7), 40.89 (C7), 40.97 (C7), 41.00
(C7), 47.95 (C4), 47.97 (C4), 48.12 (C4), 48.15 (C4), 49.0 (d, 3JC,P = 4.1Hz, C1), 49.1 (d,
3JC,P = 3.2Hz, C1), 49.12 (C1), 49.13 (C1), 49.2 (C1), 54.9 (d, 2JC,P = 0.7Hz, CH=N),
55.0 (CH=N), 55.1 (d, 2JC,P = 0.8Hz, CH=N), 66.6 (C5H4), 66.7 (C5H4), 66.8 (C5H4), 67.5
(C5H4), 67.6 (C5H4), 67.68 (C5H4), 67.74 (C5H4), 67.86 (C5H4), 67.93 (C5H4), 68.1 (C5H4),
68-6 (C5H5), 68.7 (C5H5), 88.3 (d, 2JC,P = 6.2Hz, C2), 88.4 (d, 2JC,P = 6.5Hz, C2), 88.95
(d, 2JC,P = 6.4Hz, C2), 88.98 (d, 2JC,P = 7.2Hz, C2), 89.3 (d, 2JC,P = 7.0Hz, C2), 93.5 (d,
3JC,P = 10.6Hz, iC5H4), 93.6 (d, 3JC,P = 10.9Hz, iC5H4), 93.8 (d, 3JC,P = 10.6Hz, iC5H4),
126.98 (C6H5), 127.02 (C6H5), 127.2 (C6H5), 127.3 (C6H5), 127.4 (C6H5), 127.91 (C6H5),
127.95 (C6H5), 128.03 (C6H5), 143.31 (iC6H5), 143.33 (iC6H5), 143.35 (iC6H5). 31P{1H}
NMR (CDCl3, δ): 6.9 (0.86), 7.3 (1.0), 7.4 (0.23). IR data (KBr, v˜/cm−1): 3185 s (ν NH),
3101 w, 3062 w, 3026 w, 2951 s, 2926 m, 2870 m, 1734 w, 1708 vw, 1637 vw, 1601 w, 1455
s, 1374 m, 1361 w, 1328 w, 1309 w, 1234 s, 1225 s, 1108 m, 1053 s, 1030 s, 1004 s, 926 m,
816 m. UV/Vis (in nm ( in Lmol−1 cm−1), CH2Cl2): 431 (125). HRMS (ESI-TOF, m/z):
calcd for C37H50FeNO3P 643.2873, found 643.2882 [M]+.
10-Ferrocenyl-9-carbonitrile (138)
138
Fe
N
According to the synthesis of 129, ferrocene (1, 1.30 g,
6.99mmol), KOtBu (96mg, 0.79mmol) and tBuLi (3.4mL,
6.46mmol), anthracene-9-carbonitrile (1.29 g, 6.35mmol) and
29e (2.435 g, 6.26mmol) were reacted. Purification was realized
by column chromatography (silica, 2.5 · 22 cm column size) using
hexane to remove the excess of ferrocene, followed by a 1:1 hex-
ane/toluene mixture (v/v) giving the starting nitrile (82mg) as
the first, and 138 as the second fraction. It should be noted, that
both anthracenes behave similar on the column. The success of the separation on the column
could be observed by using UV-radiation showing the starting nitrile as a fluorescent band.
After removal of all volatiles compound 138 was obtained as a black solid.
Yield: 207mg (0.53mmol, 8% based on the nitrile). Anal. calcd for C25H17FeN
(387.25 g/mol): C, 77.54; H, 4.42; N, 3.62. Found: C, 77.16; H, 4.59; N, 3.84. Mp.: 218℃.
1H NMR (CDCl3, δ): 4.22 (s, 5H, C5H5), 4.66 (pt, 3,4JH,H = 1.8Hz, 2H, C5H4), 4.81 (pt,
3,4JH,H = 1.8Hz, 2H, C5H4), 7.56 (ddd, 3JH,H = 8.9Hz, 3JH,H = 6.5Hz, 4JH,H = 1.2Hz,
2H, H2/3), 7.67 (ddd, 3JH,H = 8.6Hz, 3JH,H = 6.5Hz, 4JH,H = 1.0Hz, 2H, H2/3), 8.45 (dd,
3JH,H = 8.7Hz, 4JH,H = 1.1Hz, 2H, H4/5), 9.24 (dd, 3JH,H = 8.8Hz, 4JH,H = 1.3Hz, 2H,
H1/8). 13C{1H} NMR (CDCl3, δ): 68.7 (C5H4), 70.2 (C5H5), 73.9 (C5H4), 82.9 (iC5H4),
105.1 (C9), 118.0 (C≡N), 124.9 (CH), 125.6 (CH), 128.3 (CH), 128.6 (CH), 130.1 (qC), 133.1
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(qC), 140.7 (qC). UV/Vis (in nm ( in Lmol−1 cm−1), CH2Cl2): 375 (5581), 408 (10230), 424
(9248), 536 (1850). HRMS (ESI-TOF, m/z): calcd for C25H17FeN 387.0705, found 387.0689
[M]+. IR data (KBr, v˜/cm−1): 3094 w, 3081 w, 3046 w, 3020 w, 2955 w, 2919 w, 2851 w,
2208 s, 1621 w, 1556 s, 1442 s, 1273 m, 1104 m, 1036 m, 838 m, 767 vs, 653 m.
Bis((Sp)-(2-Thiodiphenylphosphino)ferrocenylmethyl)sulfane ((Sp,Sp)-149)
Fe
SPh2P
S
(Sp,Sp)-149
2
In a Schlenk tube, compound (Sp)-143 (1.0 g, 2.4mmol) was dis-
solved in 50mL of dioxane followed by the addition of p-TsOH (1.37 g,
7.2mmol), sulfur (100mg, 3.12mmol) and MgSO4 (∼1 g). The mix-
ture was heated to 90℃ and stirred for 24 h at this temperature fol-
lowed by removal of all volatiles in vacuum. Purification was realized
by column chromatography (silica, 2.5 · 12 cm column size) using a 1:9
hexane/dichloromethane (v/v) mixture as the eluent. After evapora-
tion in vacuum, (Sp,Sp)-149 was obtained as an orange solid.
Yield: 0.619mg (0.72mmol, 90% based on (Sp)-143). Anal. calcd for C46H40Fe2P2S3
(862.63 g/mol): C, 64.04; H, 4.67. Found: C, 64.16; H, 4.94. Mp.: 115℃. 1H NMR (CDCl3,
δ): 3.72 (d, 2JH,H = 13.5Hz, 2H, CH2), 3.72–3.73 (m, 2H, C5H3), 3.91(d, 2JH,H = 13.7Hz,
2H, CH2) 4.22–4.23 (m, 2H, C5H3), 4.30 (s, 10H, C5H5), 4.46–4.47 (m, 2H, C5H3), 7.33–
7.36 (m, 4H, C6H5), 7.41–7.47 (m, 6H, C6H5), 7.48–7.52 (m, 2H, C6H5),7.58–7.62 (m, 4H,
C6H5), 7.76–7.80 (m, 4H, C6H5). 13C{1H} NMR (CDCl3, δ): 31.2 (CH2), 68.8 (d, JP,C =
10.4Hz, C5H3), 70.8 (C5H5), 73.3 (d, JP,C = 9.3Hz, C5H3) 73.6 (d, 1JC,P = 95.1Hz, CC5H3–
P), 74.2 (d, JC,P = 12.7Hz, C5H3), 89.8 (d, 2JC,P = 11.9Hz, CC5H3–C), 127.9 (d, 2JC,P =
12.4Hz, o-C6H5), 128.1 (d, 2JC,P = 12.5Hz, o-C6H5), 131.0 (d, 4JC,P = 2.9Hz, p-C6H5),
131.1 (d, 4JC,P = 2.8Hz, p-C6H5), 131.7 (d, 3JC,P = 11.1Hz, m-C6H5), 131.8 (d, 3JC,P =
11.1Hz, m-C6H5), 133.5 (d, 1JC,P = 86.0Hz, CC6H5–P), 134.6 (d, 1JC,P = 87Hz, CC6H5–P).
31P{1H} NMR (CDCl3, δ): 41.7. HRMS (ESI-TOF, m/z): calcd for C46H40Fe2P2S3 + Na
885.0360, found 885.0330 [M+Na]+.
(Sp)-2-(2-/3-/4-Methylphenylmethyl)-1-(thiodiphenylphosphino)ferrocene
((Sp)-150a/b/c)
In a Schlenk tube, compound (Sp)-143 (1.0 g, 2.4mmol) was dissolved in 70mL of toluene
followed by the addition of p-TsOH (1.37 g, 7.2mmol), sulfur (100mg, 3.12mmol) and MgSO4
(∼1 g). The mixture was heated to 90℃ and stirred for 24 h at this temperature followed
by removal of all volatiles in vacuum. Purification was realized by column chromatography
(silica, 2.5 · 12 cm column size) using a 7:3 hexane/dichloromethane (v/v) mixture as the
eluent. After evaporation in vacuum, (Sp)-150 was obtained as an orange solid and as a
2 : 1 : 6 mixture of of the ortho- ((Sp)-150a)/ meta- ((Sp)-150b)/ para-Isomer ((Sp)-150c).
The mixture could not further be purified. The yields of each isomer are based on the ratios
of the integrals in the NMR spectra.
Yield: 862mg (1.7mmol, 71% based on (Sp)-143). Anal. calcd for C30H27FePS
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(506.42 g/mol): C, 71.15; H, 5.37. Found: C, 70.25; H, 6.13 (best match). Mp.: 135℃.
HRMS (ESI-TOF, m/z): calcd for C30H27FePS 506.0915, found 506.0901 [M]+.
FePh2P
S
(Sp)-150a
(Sp)-150a: Yield: 192mg (0.38mmol, 16% based on (Sp)-143).
1H NMR (CDCl3, δ): 2.11 (s, 3H, CH3), 3.74–3.76 (m, 1H, C5H3),
3.89 (d, 2JH,H = 16.3Hz, 1H, CH2), 4.03 (d, 2JH,H = 16.3Hz, 1H,
CH2), 4.11–4.13 (m, 1H, C5H3), 4.18–4.19 (m, 1H, C5H3), 4.35 (s,
5H, C5H5), 6.94–6.98 (m, 1H, C6H4), 7.00–7.02 (m, 2H, C6H4),
7.03–7.05 (m, 1H, C6H4), 7.28–7.40 (m, 5H, C6H5), 7.59–7.64 (m,
3H, C6H5), 7.82–7.86 (m, 2H, C6H5). 13C{1H} NMR (CDCl3, δ): 19.4 (CH3), 32.0 (CH2),
68.1 (d, 2JC,P = 10.4Hz, C5H3), 70.8 (C5H5), 73.7 (d, JC,P = 9.8Hz, C5H3), 74.2 (d, JC,P =
9.8Hz, C5H3), 74.4 (d, 1JC,P = 57.6Hz, CC5H3–P), 92.1 (d, JC,P = 12.4Hz, CC5H3–C), 125.4
(C4-C6H5), 126.0 (C5-C6H5), 128.0 (d, 4JC,P = 3.9Hz, p-C6H5), 128.2 (d, 2JC,P = 12.4Hz,
o-C6H5), 129.5 (C3-C6H5), 129.8 (C6-C6H4), 131.1 (d, 4JC,P = 3.0Hz, p-C6H5), 131.8 (d,
2JC,P = 12.7Hz, o-C6H5), 131.9 (d, 3JC,P = 10.6Hz, m-C6H5), 133.4 (d, 1JC,P = 22.4Hz,
CC6H5–P), 134.1 (d, 1JC,P = 22.5Hz, CC6H4–P), 136.3 (C6H4), 138.5 (C2-C6H4). 31P{1H}
NMR (CDCl3, δ): 41.8.
FePh2P
S
(Sp)-150c
(Sp)-150c: Yield: 575mg (1.14mmol, 47% based on (Sp)-143).
1H NMR (CDCl3, δ): 2.20 (s, 3H, CH3), 3.65–3.66 (m, 1H,
C5H3), 3.88 (d, 2JH,H = 15.1Hz, 1H, CH2), 4.19 (d, 2JH,H
= 15.5Hz, 1H, CH2), 4.21–4.22 (m, 1H, C5H3), 4.33 (s, 5H,
C5H5), 4.39–4.40 (m, 1H, C5H3), 6.80 (d, 3JH,H = 7.8Hz, 2H,
H2-C6H4), 6.91 (d, 3JH,H = 7.9Hz, 2H, H3-C6H4), 7.17–7.21
(m, 2H, C6H5), 7.32–7.36 (m, 1H, C6H5), 7.42–7.46 (m, 4H, C6H5), 7.48–7.51 (m, 1H,
C6H5), 7.77–7.81 (m, 2H, C6H5). 13C{1H} NMR (CDCl3, δ): 20.9 (CH3), 33.7 (CH2), 68.5
(d, JC,P = 10.4Hz, C5H3), 70.7 (C5H5), 73.7 (d, 1JC,P = 95.3Hz, CC5H3–P), 73.6 (d, JC,P =
9.8Hz, C5H3), 74.3 (d, JC,P = 13.0Hz, C5H3), 93.3 (d, 2JC,P = 12.6Hz, CC5H3–C), 127.8 (d,
3JC,P = 3.3Hz, m-C6H5), 127.9 (d, 3JC,P = 3.0Hz, m-C6H5), 128.4 (C2-C6H4), 128.8 (C3-
C6H4), 130.5 (d, 4JC,P = 3.0Hz, p-C6H5), 131.0 (d, 4JC,P = 2.9Hz, p-C6H5), 131.9 (d, 2JC,P
= 10.6Hz, o-C6H5), 132.0 (d, 2JC,P = 10.7Hz, o-C6H5), 133.6 (d, 1JC,P = 52.2Hz, CC6H5–
P), 134.3 (d, 1JC,P = 53.0Hz, CC6H5–P), 134.9 (C4-C6H4), 137.4 (C1-C6H4). 31P{1H} NMR
(CDCl3, δ): 42.0.
(Sp)-2-(2-Methoxyphenylmethyl)-1-(thiodiphenylphosphino)ferrocene
((Sp)-151a)
FePh2P
S
(Sp)-151a
O
In a Schlenk tube, compound (Sp)-143 (200mg, 0.48mmol) was
dissolved in 20mL of anisole followed by the addition of p-TsOH
(270mg, 1.4mmol) and MgSO4 (∼1 g). The mixture was heated
to 90℃ and stirred for 24 h at this temperature followed by re-
moval of all volatiles in vacuum. Purification was realized by col-
umn chromatography (silica, 2.5 · 18 cm column size) using a 3:9
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hexane/dichloromethane (v/v) mixture for eluting (Sp)-151a followed by dichloromethane
for (Sp)-151c. Both compounds were obtained as orange solids after removal of all volatiles.
Yield: 114mg (0.17mmol, 36% based on (Sp)-143). Anal. calcd for C30H27FeOPS · 1/6
CH2Cl2 (522.42 · 1/6 84.93 g/mol): C, 67.53; H, 5.13. Found: C, 67.46; H, 5.44. Mp.: 107℃.
1H NMR (CDCl3, δ): 3.67–3.68 (m, 1H, C5H3), 3.76 (s, 3H, OCH3), 3.99 (d, 2JH,H =
15.2Hz, 1H, CH2), 4.12 (d, 2JH,H = 15.2Hz, 1H, CH2), 4.17–4.19 (m, 1H, C5H3), 4.32 (s,
5H, C5H5), 4.40–4.41 (m, 1H, C5H3), 6.56 (td, 3JH,H = 7.4Hz, 4JH,H = 1.0Hz, 1H, H4-
C6H4), 6.74 (dd, 3JH,H = 8.2Hz, 4JH,H = 1.1Hz, 1H, H6-C6H4), 6.96 (dd, 3JH,H = 7.4Hz,
4JH,H = 1.6Hz, 1H, H3-C6H4), 7.04 (td, 3JH,H = 8.0Hz, 4JH,H = 1.7Hz, 1H, H5-C6H4),
7.26–7.29 (m, 2H, C6H5), 7.36–7.40 (m, 1H, C6H5), 7.43–7.52 (m, 3H, C6H5), 7.55–7.59 (m,
2H, C6H5), 7.80–7.85 (m, 2H, C6H5). 13C{1H} NMR (CDCl3, δ): 28.5 (CH2), 55.1 (OCH3),
58.3 (d, 3JC,P = 10.6Hz, C5H3), 70.7 (C5H5), 73.7 (d, 1JC,P = 95.6Hz, CC5H3–P), 73.9 (d,
JC,P = 13.1Hz, C5H3), 74.1 (d, JC,P = 9.8Hz, C5H3), 92.7 (d, 2JC,P = 12.3Hz, CC5H3–C),
110.0 (C6-C6H4), 119.9 (C4-C6H4), 127.0 (C5-C6H4), 126.8 (d, 2JC,P = 8.0Hz, o-C6H5),
127.9 (d, 2JC,P = 8.0Hz, o-C6H5), 129.0 (C2-C6H4), 130.8 (C3-C6H4), 130.8 (d, 4JC,P =
2.9Hz, p-C6H5), 131.0 (d, 4JC,P = 2.9Hz, p-C6H5), 132.0 (d, 3JC,P = 6.4Hz, m-C6H5),
132.1 (d, 3JC,P = 6.6Hz, m-C6H5), 133.8 (d, 1JC,P = 75.5Hz, CC6H5–P), 134.5 (d, 1JC,P =
76.1Hz, CC6H5–P), 157.2 (C1-C6H4). 31P{1H} NMR (CDCl3, δ): 42.2. HRMS (ESI-TOF,
m/z): calcd for C30H27FeOPS 522.0865, found 522.0845 [M]+.
(Sp)-2-(4-Methoxyphenylmethyl)-1-(thiodiphenylphosphino)ferrocene
((Sp)-151b)
FePh2P
S
(Sp)-151b
O The compound was obtained within the synthesis of (Sp)-
151a by reacting (Sp)-143 (200mg, 0.48mmol) and p-TsOH
(270mg, 1.4mmol) in 20mL of anisole. For purification de-
tail see (Sp)-151a. Compound (Sp)-151b was obtained as
an orange solid.
Yield: 117mg (0.18mmol, 37% based on (Sp)-143). Anal.
calcd for C30H27FeOPS (522.42 g/mol): C, 68.97; H, 5.21. Found: C, 68.62; H, 5.21. Mp.:
196℃. 1H NMR (CDCl3, δ): 3.64–3.65 (m, 1H, C5H3), 3.69 (s, OCH3), 3.83 (d, 2JH,H =
15.1Hz, 1H, CH2), 4.23 (d, 2JH,H = 14.9Hz, 1H, CH2), 4.21–4.23 (m, 1H, C5H3), 4.33 (s,
5H, C5H5), 4.40–4.41 (m, 1H, C5H3), 6.52 (d, 3JH,H = 8.7Hz, 2H, H2-C6H4), 6.95 (d, 3JH,H
= 8.6Hz, 2H, H3-C6H4), 7.17–7.21 (m, 2H, C6H5), 7.31–7.35 (m, 1H, C6H5), 7.40–7.46 (m,
4H, C6H5), 7.47–7.51 (m, 1H, C6H5), 7.76–7.82 (m, 2H, C6H5). 13C{1H} NMR (CDCl3, δ):
33.2 (CH2), 55.1 (OCH3), 68.5 (d, 3JC,P = 10.5Hz, C5H3), 70.7 (C5H5), 73.6 (d, 1JC,P =
95.4Hz, CC5H3–P), 73.6 (d, 3JC,P = 9.7Hz, C5H3), 74.4 (d, 2JC,P = 12.8Hz, C5H3), 93.5
(d, 2JC,P = 12.5Hz, CC5H3–C), 113.2 (C2-C6H4), 127.8 (d, 3JC,P = 4.5Hz, m-C6H5), 127.9
(d, 3JC,P = 4.3Hz, m-C6H5), 129.9 (C3-C6H4), 130.7 (d, 4JC,P = 2.9Hz, p-C6H5), 131.1
(d, 4JC,P = 2.9Hz, p-C6H5), 131.9 (d, 2JC,P = 10.7Hz, o-C6H5), 132.0 (d, 2JC,P = 10.8Hz,
o-C6H5), 132.8 (C4-C6H4), 133.6 (d, 1JC,P = 60.9Hz, CC6H5–P), 134.3 (d, 1JC,P = 61.8Hz,
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CC6H5–P), 157.5 (C1-C6H4). 31P{1H} NMR (CDCl3, δ): 42.0. For HRMS see (Sp)-151a.
(Sp)-(Diphenylphosphino)-2-(2-hydroxyphenylmethyl)ferrocene ((Sp)-152)
(Sp)-152
FePh2P
S
OH
In a Schlenk tube, compound (Sp)-143 (200mg, 0.463mmol)
and phenol (436mg, 4.63mmol) was dissolved in 10mL of
dichloromethane followed by the addition of p-TsOH (264mg,
1.53mmol). The mixture was heated to 50℃ and stirred for 72 h
at this temperature followed by removal of all volatiles in vac-
uum. Purification was realized by column chromatography (silica,
2.5 · 18 cm column size) using dichloromethane as the eluent, giving (Sp)-152 as an orange
solid.
Yield: 175mg (0.344mmol, 74% based on (Sp)-143). Anal. calcd for C29H25FeOPS · 1/3
C6H14 (508.39 · 1/6 86.18 g/mol): C, 69.32; H, 5.57. Found: C, 69.30; H, 5.37. Mp.: 223℃.
1H NMR (CDCl3, δ): 3.65 (dd, J = 2.4Hz, J = 2.4Hz, J = 1.5Hz, 1H, C5H3), 3.82 (d,
2JH,H = 15.3Hz, 1H, CH2), 4.13 (d, 2JH,H = 15.3Hz, 1H, CH2), 4.26 (s, 5H, C5H5), 4.28–
4.30 (m, 1H, C5H3), 4.55 (ddd, J = 2.3Hz, J = 2.3Hz, J = 1.6Hz, 1H, C5H3), 6.59 (dd,
3JH,H = 8.1Hz, 4JH,H = 1.1Hz, 1H, H3-C6H4), 6.71 (td, 3JH,H = 7.4Hz, 4JH,H = 1.2Hz,
1H, H5-C6H4), 6.89 (s, 1H, OH), 6.92 (td, 3JH,H = 7.9Hz, 4JH,H = 1.7Hz, 1H, H4-C6H4),
7.02 (dd, 3JH,H = 7.6Hz, 4JH,H = 1.6Hz, 1H, H6-C6H4), 7.18–7.21 (m, 2H, Ph), 7.30–
7.34 (m, 1H, Ph), 7.36–7.41 (m, 2H, Ph), 7.45–7.49 (m, 2H, Ph), 7.51–7.55 (m, 1H, Ph),
7.76–7.80 (m, 2H, Ph). 13C{1H} NMR (CDCl3, δ): 27.4 (CH2), 69.0 (d, JC,P = 10.5Hz,
C5H3), 70.8 (C5H5), 73.0 (d, 1JC,P = 95.8Hz, CC5H3–P), 73.6 (d, JC,P = 9.9Hz, C5H3),
74.0 (d, JC,P = 12.9Hz, C5H3), 92.7 (d, 2JC,P = 12.7Hz, CC5H3–CH2), 117.2 (C3-C6H4),
120.1 (C5-C6H4), 126.6 (C1-C6H4), 127.5 (C4-C6H4), 128.0 (d, 3JC,P = 12.7Hz, C3/5-Ph),
128.1 (d, 3JC,P = 12.5Hz, C3/5-Ph), 130.1 (C6-C6H4), 131.2 (d, 4JC,P = 3.0Hz, C4-Ph),
131.5 (d, 4JC,P = 2.9Hz, C4-Ph), 131.7 (d, 2JC,P = 10.8Hz, C2/6-Ph), 132.1 (d, 2JC,P =
10.9Hz, C2/6-Ph), 132.4 (d, 1JC,P = 86.8Hz, C1-Ph), 133.5 (d, 1JC,P = 86.9Hz, C1-Ph),
153.2 (C2–OH). 31P{1H} NMR (CDCl3, δ): 42.6. IR data (KBr, v˜/cm−1): 3403 m (ν OH),
3069 w, 3049 w, 2955 m, 2919 s, 2848 m, 1710 w, 1580 m, 1484 s, 1432 s, 1260 w, 1208 m,
1166 m, 1101 s (ν C–O), 1043 w, 760 m, 715 s, 692 s, 643 m. HRMS (ESI-TOF, m/z): calcd
for C29H25FeOPS +H 509.0786, found 509.0743 [M+H]+.
(Sp)-2-(3-Hydroxy-2,4,6-trimethylphenylmethyl)-1-thiodiphenylphosphino)-
ferrocene (Sp)-153)
(Sp)-153
FePh2P
S
OH
In a Schlenk tube, compound (Sp)-143 (150mg, 0.347mmol)
and trimethylphenol (473mg, 3.47mmol) was dissolved in
10mL of dichloromethane followed by the addition of p-
TsOH (178mg, 1.04mmol). The mixture was heated to 50℃
and stirred for 72 h at this temperature followed by removal
of all volatiles in vacuum. Purification was realized by col-
umn chromatography (silica, 2.5 · 18 cm column size) using dichloromethane as the eluent.
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After removal of all volatiles, compound (Sp)-153 was obtained as an orange solid.
Yield: 173mg (0.314mmol, 90% based on (Sp)-143). Anal. calcd for C32H31FeOPS ·C6H14
(550.47 · 86.18 g/mol): C, 69.93; H, 6.95. Found: C, 69.71; H, 6.92. 1H NMR (CDCl3, δ):
1.98 (s, 3H, Mes-CH3-C2), 2.02 (s, 3H, Mes-CH3-C6), 2.19 (s, 3H, Mes-CH3-C4), 3.30 (d,
2JH,H = 17.2Hz, 1H, CH2), 3.81 (ddd, J = 2.5Hz, J = 2.0Hz, J = 1.5Hz, 1H, C5H3), 3.91
(dd, J = 3.6Hz, J = 1.9Hz, 1H, C5H3), 4.11 (ddd, J = 2.5Hz, J = 2.5Hz, J = 1.6Hz, 1H,
C5H3), 4.30 (s, 5H, C5H5), 4.32 (d, 2JH,H = 17.0Hz, 1H, CH2), 4.41 (s, 1H, OH), 6.75 (s,
1H, Mes-H), 7.40–7.44 (m, 2H, Ph), 7.46–7.53 (m, 4H, Ph), 7.80–7.84 (m, 2H, Ph), 7.89–
7.94 (m, 2H, Ph). 13C{1H} NMR (CDCl3, δ): 12.5 (Mes-CH3-C2), 15.8 (Mes-CH3-C4), 19.8
(Mes-CH3-C6), 29.1 (CH2), 67.6 (d, JC,P = 10.3Hz, C5H3), 70.9 (C5H5), 73.3 (d, JC,P =
10.0Hz, C5H3), 73.4 (d, JC,P = 12.8Hz, C5H3), 74.0 (d, 1JC,P = 96.0Hz, CC5H3–P), 93.0 (d,
2JC,P = 12.5Hz, CC5H3–CH2), 120.3 (Mes-C4), 122.1 (Mes-C2), 128.1 (d, 3JC,P = 12.4Hz,
m-Ph), 128.26 (d, 3JC,P = 12.3Hz, m-Ph), 128.33 (Mes-C6), 129.6 (Mes-C5), 131.2 (d, 4JC,P
= 3.0Hz, p-Ph), 131.3 (d, 4JC,P = 2.9Hz, p-Ph), 132.0 (d, 2JC,P = 10.7Hz, o-Ph), 132.3 (d,
2JC,P = 10.5Hz, o-Ph), 133.5 (d, 1JC,P = 85.9Hz, CPh–P), 133.8 (d, 1JC,P = 85.0Hz, CPh–
P), 135.9 (Mes-C1), 150.1 (Mes-OH). 31P{1H} NMR (CDCl3, δ): 41.2. HRMS (ESI-TOF,
m/z): calcd for C32H31FeOPS 549.1194, found 549.1050 [M]+.
(Sp)-2-((2,4-Dinitrophenyl)thiomethyl)-1-( thiodiphenylphosphino)ferrocene
((Sp)-155)
Fe
(Sp)-155
Ph2P
S S
NO2
NO2 In a Schlenk tube, compound (Sp)-143 (240mg,
0.555mmol), 1-fluoro-2,4-dinitrobenzene (310mg,
1.67mmol) and K2CO3 (384mg, 2.78mmol) were dis-
solved in 20mL of DMF, whereby the color immediately
turned dark. The mixture was heated to 40℃ and
stirred for 18 h at this temperature. After cooling to
ambient temperature, the reaction mixture was dissolved with 50mL of Et2O and washed
with acidified (HCl) brine. After extraction with Et2O (3 · 50mL) all organic extracts
were combined and dried over MgSO4 followed by removal of all volatiles in vacuum.
Purification was realized by column chromatography (silica, 2.5 · 18 cm column size) using
a dichloromethane/ethyl acetate mixture (v/v) as the eluent, giving (Sp)-155 as an orange
solid.
Yield: 95mg (0.155mmol, 56% based on (Sp)-143). Anal. calcd for C29H23FeN2O4PS2 · 1/2
C6H14 (614.45 · 1/2 86.18 g/mol): C, 58.45; H, 4.60; N, 4.26. Found: C, 58.26; H, 4.27; N,
4.45. Mp.: 245℃ (explosive decomp.). 1H NMR (CDCl3, δ): 3.84–3.86 (m, 1H, C5H3),
4.39–4.43 (m, 7H, CH2, C5H5, C5H3), 4.66–4.68 (m, 1H, C5H3), 4.96 (d, 2JH,H = 12.4Hz,
CH2), 7.30–7.34 (m, 2H, C6H5), 7.42–7.45 (m, 1H, C6H5),7.47–7.51 (m, 2H, C6H5), 7.53–
7.59 (m, 4H, C6H5, C6H3), 7.81–7.85 (m, 2H, C6H5, C6H3), 8.21 (dd, JH,H = 9.0Hz, JH,H
= 2.5Hz, C6H3), 8.94 (d, JH,H = 2.5Hz, H3C6H3). 13C{1H} NMR (CDCl3, δ): 32.0 (CH2),
69.8 (d, JC,P = 10.1Hz, C5H3), 71.3 (C5H5), 74.0 (d, JC,P = 8.9Hz, C5H3), 74.8 (d, 1JC,P
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= 94.1Hz, CC5H3–P), 75.0 (d, JC,P = 11.8Hz, C5H3), 85.2 (d, 2JC,P = 11.9Hz, CC5H3–
CH2), 121.4 (C3C6H3), 126.7 (C5/6C6H3), 127.6 (C5/6C6H3), 128.18 (d, 2JC,P = 12.5Hz,
C3/5C6H5), 128.22 (d, 2JC,P = 12.5Hz, C3/5C6H5), 131.55 (d, 4JC,P = 3.2Hz, C4C6H5),
131.57 (d, 4JC,P = 3.2Hz, C4C6H5), 131.9 (d, 3JC,P = 10.6Hz, C2/6C6H5), 132.0 (d, 3JC,P =
10.9Hz, C2/6C6H5), 132.7 (d, 1JC,P = 86.5Hz, C1C6H5), 134.1 (d, 1JC,P = 87.2Hz, C1C6H5),
143.6 (C2/4C6H3), 144.1 (C2/4C6H3), 146.9 (C1C6H3). 31P{1H} NMR (CDCl3, δ): 40.8. IR
data (KBr, v˜/cm−1): 3078 w, 3065 w, 2958 w, 2922 s, 2854 m, 1737 m, 1585 m, 1520 s (νas
NO2), 1436 m, 1345 s (νs NO2), 1169 m, 1101 w, 1042 m, 835 m, 712 s, 692 m, 645 m (ν
P=S). HRMS (ESI-TOF,m/z): calcd for C29H23FeN2O4PS2 614.0181, found 614.0193 [M]+.
Bis((Sp)-(2-diphenylphosphino)ferrocenylmethyl)sulfane ((Sp,Sp)-156)
Fe
SPh2P
(Sp,Sp)-156
2
In a Schlenk tube, compound (Sp,Sp)-149 (860mg, 1.08mmol) was
dissolved in 50mL of chlorobenzene followed by the dropwise addition
of P(NMe2)3 (1.8mL, 10mmol). The mixture was heated to 130℃ and
stirred for 18 h at this temperature and then allowed to cool to ambient
temperature. Water (10mL) was carefully added. The mixture was
poured into water and extracted three times with dichloromethane
(50mL). The combined organic extracts were dried over MgSO4 followed by removal of all
volatiles in vacuum. Purification was realized by column chromatography (silica, 2.5 · 16 cm
column size) using dichloromethane as the eluent. Compound (Sp,Sp)-156 was crystallized
from boiling hexane and obtained as an orange solid after removal of all volatiles.
Yield: 405mg (0.51mmol, 51% based on (Sp,Sp)-149). Anal. calcd for C46H40Fe2P2S
(798.51 g/mol): C, 69.19; H, 5.05. Found: C, 69.62; H, 5.44. Mp.: 98℃. 1H NMR (CDCl3,
δ): 3.60 (dd, 2JH,H = 13.1Hz, 4JH,P = 1.8Hz, 2H, CH2), 3.64 (d, 2JH,H = 13.1Hz, 2H,
CH2), 3.73–3.74 (m, 2H, C5H3), 3.91 (s, 10H, C5H5), 4.21–4.22 (m, 2H, C5H3), 4.31–4.32 (m,
2H, C5H3), 7.16–7.19 (m, 4H, C6H5), 7.22–7.25 (m, 6H, C6H5), 7.36–7.38 (m, 6H, C6H5),
7.53–7.57 (m, 4H, C6H5). 13C{1H} NMR (CDCl3, δ): 32.0 (d, 3JC,P = 11.7Hz, CH2), 69.2
(C5H3), 69.7 (C5H5), 71.1 (d, JC,P = 3.9Hz, C5H3), 71.3 (d, JC,P = 3.9Hz, C5H3), 75.5
(d, 1JC,P = 7.8Hz, CC5H3–P), 90.9 (d, 2JC,P = 25.9Hz, CC5H3–C), 127.6 (p-C6H5), 127.9
(d, 3JC,P = 5.9Hz, m-C6H5), 128.0 (d, 3JC,P = 8.0Hz, m-C6H5), 129.0 (p-C6H5), 132.2 (d,
2JC,P = 17.6Hz, o-C6H5), 135.1 (d, 2JC,P = 21.4Hz, o-C6H5), 137.7 (d, 1JC,P = 8.7Hz,
CC6H5–P), 140.0 (d, 1JC,P = 9.4Hz, CC6H5–P). 31P{1H} NMR (CDCl3, δ): –23.7. HRMS
(ESI-TOF, m/z): calcd for C46H40FePS + H 799.1099, found 799.1120 [M+H]+.
(Sp)-(Diphenylphosphino)-2-(2-methoxyphenylmethyl)ferrocene ((Sp)-157)
FePh2P
O
(Sp)-157
In a Schlenk tube, compound (Sp)-151a (192mg, 0.29mmol) was
dissolved in 20mL of chlorobenzene followed by the addition of
P(NMe2)3 (0.6mL, 2.88mmol). The mixture was heated to 130℃
and stirred for 18 h at this temperature and then allowed to cool
to ambient temperature. Water (5mL) was carefully added. The
mixture was poured into water and extracted three times with
225
CHAPTER 4. EXPERIMENTAL PART
dichloromethane (40mL). The combined organic extracts were dried over MgSO4 followed
by removal of all volatiles in vacuum. Purification was realized by column chromatography
(silica, 2.5 · 16 cm column size) using dichloromethane as the eluent. Compound (Sp)-157
was recrystallized from boiling pentane and obtained as an orange solid after removal of all
volatiles.
Yield: 145mg (0.23mmol, 79% based on (Sp)-151a). Anal. calcd for C30H27FeOP · 1.5
C5H12 (490.35 · 1.5 72.15 g/mol): C, 73.29; H, 7.38. Found: C, 73.71; H, 7.16. Mp.: 104℃.
1H NMR (CDCl3, δ): 3.71 (s, 3H, OCH3), 3.72–3.73 (m, 1H, C5H3), 3.86 (d, 2JH,H =
15.1Hz, 1H, CH2), 3.93 (dd, 2JH,H = 15.1Hz, 4JH,P = 2.1Hz, 1H, CH2), 4.01 (s, 5H,
C5H5), 4.21–4.22 (m, 1H, C5H3), 4.42–4.43 (m, 1H, C5H3), 6.61 (td, 3JH,H = 7.4Hz, 4JH,H
= 1.0Hz, 1H, H4-C6H4), 6.67–6.70 (m, 1H, H6-C6H4), 6.92 (dd, 3JH,H = 7.4Hz, 4JH,H =
1.6Hz, 1H, H3-C6H4), 7.02–7.07 (m, 3H, H5-C6H4, C6H5), 7.09–7.16 (m, 3H, C6H5), 7.37–
7.40 (m, 3H, C6H5), 7.57–7.61 (m, 2H, C6H5). 13C{1H} NMR (CDCl3, δ): 28.6 (d, 3JC,P
= 10.1Hz, CH2), 54.9 (OCH3), 68.9 (C5H3), 69.7 (C5H5), 70.6 (d, JC,P = 4.1Hz, C5H3),
72.1 (d, JC,P = 4.0Hz, C5H3), 75.3 (d, 1JC,P = 6.7Hz, CC5H3–P), 93.8 (d, 2JC,P = 26.3Hz,
CC5H3–C), 109.8 (C6-C6H4), 119.9 (C4-C6H4), 126.9 (C5-C6H4), 127.4 (C3-C6H4), 127.6 (d,
3JC,P = 6.0Hz, m-C6H5), 128.0 (d, 3JC,P = 7.9Hz, m-C6H5), 128.9 (p-C6H5), 129.4 (C2-
C6H4), 130.3 (d, 4JC,P = 1.1Hz, p-C6H5), 132.3 (d, 2JC,P = 18.0Hz, o-C6H5), 135.2 (d,
2JC,P = 21.1Hz, o-C6H5), 138.0 (d, 1JC,P = 8.5Hz, CC6H5–P), 139.8 (d, 1JC,P = 9.6Hz,
CC6H5–P), 159.9 (C1-C6H4). 31P{1H} NMR (CDCl3, δ): –22.5. HRMS (ESI-TOF, m/z):
calcd for C30H27FeOP 490.1144, found 490.1195 [M]+.
3-(2-(Thiodiphenylphosphino)ferrocenylmethyl)-2,4,6-trimethylphenyl
N,N -Dimethylphosphonamidate ((Sp)-158) and ((Sp)-159)
FePh2P
(Sp)-159
O
S P O
H
O
H2
NMe Me
FePh2P
(Sp)-158
O
S P NMe2
H
O In a Schlenk tube, compound (Sp)-153 (162mg,
0.294mmol) was dissolved in 20mL of toluene
followed by the addition of P(NMe2)3 (0.27mL,
1.3mmol). The mixture was refluxed for 18 h
and then allowed to cool to ambient temperature.
All volatiles were removed in vacuum. Purifica-
tion was realized by column chromatography (sil-
ica, 2.5 · 16 cm column size) using dichloromethane
as the eluent. After removal of all volatiles com-
pound (Sp)-158 was obtained as a yellow solid as
a 1:1 mixture of two diastereomers. Dissolving in
boiling dichloromethane and slow cooling to ambi-
ent temperature gave single crystals of (Sp)-159, suitable for single crystal X-ray diffraction
analysis. The compound decomposed rapidly in solution.
Yield: 66mg (0.103mmol, 35% based on (Sp)-153). 1H NMR (CDCl3, δ): 2.04 (s, 3H,
Mes-CH3-C2/6), 2.05 (s, 3H, Mes-CH3-C2/6), 2.06 (s, 3H, Mes-CH3-C2/6), 2.07 (s, 3H,
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Mes-CH3-C2/6), 2.28 (s, 6H, Mes-CH3-C4), 2.756 (d, 3JH,P = 11.0Hz, 6H, NMe2), 2.760
(d, 3JH,P = 11.0Hz, 6H, NMe2), 3.26 (d, 2JH,H = 17.1Hz, 1H, CH2), 3.28 (d, 2JH,H =
17.2Hz, 1H, CH2), 3.81–3.83 (m, 2H, C5H3), 3.89–3.91 (m, 2H, C5H3), 4.11–4.13 (m, 2H,
C5H3), 4.29 (s, 5H, C5H5), 4.30 (s, 5H, C5H5), 4.33 (d, 2JH,H = 17.3Hz, 1H, CH2), 4.34 (d,
2JH,H = 17.2Hz, 1H, CH2), 6.82 (s, 2H, Mes-H5), 7.02 (d, 1JH,P = 646.1Hz, 1H, P-H), 7.04
(d, 1JH,P = 646.2Hz, 1H, P-H), 7.40–7.43 (m, 4H, Ph), 7.47–7.54 (m, 8H, Ph), 7.78–7.83
(m, 4H, Ph), 7.89–7.93 (m, 4H, Ph). 13C{1H} NMR (CDCl3, δ): 14.26 (CH3), 14.28 (CH3),
17.3 (CH3), 19.90 (CH3), 19.92 (CH3), 29.3 (CH2), 34.34 (d, 2JC,P = 5.6Hz, NMe2), 34.35
(d, 2JC,P = 5.4Hz, NMe2), 67.71 (C5H3), 70.9 (C5H5), 71.0 (C5H5), 73.2 (d, JC,P = 9.8Hz,
C5H3), 73.5 (d, JC,P = 12.9Hz, C5H3), 74.0 (d, 1JC,P = 95.0Hz, C–P), 92.4 (d, 2JC,P =
12.2Hz, CC5H3–CH2), 127.4 (qC), 127.8 (qC), 128.1 (d, 3JC,P = 12.5Hz, m-Ph), 128.3 (d,
3JC,P = 12.3Hz, m-Ph), 128.9 (qC), 129.8 (qC), 130.33 (CH), 130.34 (CH), 131.18 (CH),
131.20 (CH), 131.34 (CH), 131.37 (CH), 131.9 (CH), 132.0 (CH), 132.2 (CH), 132.3 (CH),
133.0 (qC), 133.4 (qC), 133.7 (qC), 134.06 (qC), 134.07 (qC), 134.1 (qC), 136.37 (qC), 136.40
(qC), 145.5 (d, 2JC,P = 9.5Hz, C–O–P). 31P{1H} NMR (CDCl3, δ): 12.25 (1JP,H = 646Hz,
PHO2N), 12.29 (1JP,H = 646Hz, PHO2N), 41.13 (P=S), 41.15 (P=S).
4.3.7 Suzuki-Miyaura C,C Cross-Coupling Reactions
General Procedure for Suzuki-Miyaura Cross-Coupling Reactions - GP7
A glass vessel of 4mL size was charged with [Pd2(dba)3] (0.25 mol-%) and compound rac-
/(Rp)-91 (1 mol-%), or [Pd2(dba)3] (0.5 mol-%) and compounds (Sp,Sp)-156 (1 mol-%) or
(Sp)-157 (2 mol-%), boronic acid (1.5mmol), powdered K3PO4 ·H2O (690mg, 3.0mmol), the
appropriate aryl halide (1.0mmol), and dry toluene (3mL). The vessel was closed and the
reaction mixture was stirred at 70℃ for 24 h, except as otherwise noted. After it was cooled
to ambient temperature, the reaction mixture was diluted with water (25mL) and extracted
with diethyl ether (3 ·25mL). The combined organic extracts were filtered through a pad of
alumina and concentrated under reduced pressure. The obtained crude material was purified
by flash chromatography on silica (4 · 12 cm column size) (hexane/diethyl ether mixtures).
The obtained yields are based on the respective aryl halide and depend on the used ligand
(L) and on the Pd/L concentration. They are shown in Figure 3.41 and 3.85.
2-Methyl-1-(o-tolyl)naphthalene (94a)
94a
According to the general procedure for Suzuki-Miyaura cross-
coupling reactions GP7, 1-bromo-2-methylnaphthalene (221mg) and o-
tolylboronic acid (204mg) were reacted. Purification was realized by
column chromatography using hexane as the eluent. The spectroscopic
data are in agreement with those reported in literature. [312]
1H NMR (CDCl3, δ): 1.94 (s, 3H, CH3), 2.18 (s, 3H, CH3), 7.14 (d,
JH,H = 7.1Hz, 1H), 7.26 (d, JH,H = 8.4Hz, 1H), 7.31–7.34 (m, 2H), 7.35–7.39 (m, 2H), 7.41
(ddd, JH,H = 8.1Hz, JH,H = 6.8Hz, JH,H = 1.3Hz, 1H), 7.44 (d, JH,H = 8.4Hz, 1H), 7.80
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(d, JH,H = 8.4Hz, 1H), 7.85 (d, JH,H = 8.6Hz, 1H). 13C{1H} NMR (CDCl3, δ): 19.5, 20.3,
124.7, 125.87, 125.7, 125.9, 127.1, 127.4, 127.8, 128.6, 129.97, 130.04, 132.0, 132.6, 133.1,
136.8, 137.5, 139.2.
1-(2-Methoxyphenyl)-2-methylnaphthalene (94b)
O
94b
According to the general procedure for Suzuki-Miyaura cross-
coupling reactions GP7, 1-bromo-2-methylnaphthalene (221mg) and 2-
methoxyphenylboronic acid (228mg) were reacted. Purification was re-
alized by column chromatography using a 98/2 hexane/diethyl ether
mixture (v/v) as the eluent. The spectroscopic data are in agreement
with those reported in literature. [312]
1H NMR (CDCl3, δ): 2.22 (s, 3H, CH3), 3.68 (s, 3H, OCH3), 7.06–7.11
(m, 2H), 7.14 (dd, JH,H = 7.4Hz, JH,H = 1.8Hz, 1H), 7.29–7.32 (m, 1H), 7.35–7.40 (m,
2H), 7.42–7.45 (m, 2H), 7.78 (d, JH,H = 8.4Hz, 1H), 7.83 (d, JH,H = 8.1Hz, 1H). 13C{1H}
NMR (CDCl3, δ): 20.5 (CH3), 55.6 (OCH3), 111.2, 120.7, 124.6, 125.6, 125.9, 127.2, 127.8,
128.3, 128.5, 128.8, 131.8, 132.0, 132.9, 133.9, 134.6, 157.4.
1-(2-Fluorophenyl)-2-methylnaphthalene (94c)
F
94c
According to the general procedure for Suzuki-Miyaura cross-
coupling reactions GP7, 1-bromo-2-methylnaphthalene (221mg),
2-fluorophenylboronic acid (210mg) and K3PO4 · 3H2O (800mg,
3.0mmol) were reacted. Purification was realized by column chro-
matography using a 99/1 hexane/diethyl ether mixture (v/v) as the
eluent. The analytical data are in agreement with those reported in
literature. [196]
1H NMR (CDCl3, δ): 2.27 (s, 3H, CH3), 7.21–7.30 (m, 3H), 7.34–7.47 (m, 5H), 7.82 (d,
JH,H = 8.5Hz, 1H), 7.85 (d, JH,H = 8.1Hz, 1H). 13C{1H} NMR (CDCl3, δ): 20.5 (s, CH3),
115.8 (d, JC,F = 22.3Hz), 124.1 (d, JC,F = 3.6Hz), 124.9, 125.5, 126.1, 126.8 (d, 2JC,F =
17.7Hz, iC-Ph), 127.90, 127.96, 128.5, 129.4 (d, JC,F = 7.9Hz), 131.6, 132.0, 132.4 (d, JC,F
= 3.8Hz), 132.7, 134.3, 160.2 (d, 1JC,F = 245.4Hz, C–F). HRMS (ESI-TOF, m/z): calcd for
C17H13F +H 237.1074, found 237.1065 [M+H]+.
1-(2-Fluorophenyl)-2-methoxynaphthalene (94d)
According to the general procedure for Suzuki-Miyaura cross-coupling reactions GP7,
1-bromo-2-methoxynaphthalene (237mg), 2-fluorophenylboronic acid (210mg) and K3PO4
·3H2O (800mg, 3.0mmol) were reacted. Purification was realized by column chromatogra-
phy using a 94/6 hexane/diethyl ether mixture (v/v) as the eluent. The analytical data are
in agreement with those reported in literature. [67]
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O F
94d
1H NMR (CDCl3, δ): 3.88 (s, 3H, OCH3), 7.22 (ddd, JH,H = 9.3Hz,
JH,H = 8.3Hz, JH,H = 1.0Hz, 1H), 7.28 (dd, JH,H = 7.4Hz, JH,H =
1.2Hz, 1H), 7.32–7.40 (m, 4H), 7.42–7.45 (m, 2H), 7.82–7.85 (m, 1H),
7.93 (d, JH,H = 9.0Hz, 1H). 13C{1H} NMR (CDCl3, δ): 56.8 (OCH3),
113.6, 115.7 (d, JC,F = 22.5Hz), 118.8, 123.6, 123.8 (d, 2JC,F = 17.3Hz
), 123.8 (d, JC,F = 3.6Hz), 124.7, 126.6, 128.0, 129.0, 129.3 (d, JC,F =
8.0Hz), 129.9, 133.1 (d, JC,F = 3.7Hz), 133.4, 154.4, 160.6 (d, 1JC,F =
246.3Hz, C–F). HRMS (ESI-TOF, m/z): calcd for C17H13FO+H 253.1023, found 253.1036
[M+H]+.
1-(o-Tolyl)-2-methoxynaphthalene (94e)
O
94e
According to the general procedure for Suzuki-Miyaura cross-
coupling reactions GP7, 1-bromo-2-methoxynaphthalene (237mg) and
o-tolylboronic acid (204mg) were reacted. Purification was realized
by column chromatography using a 98/2 hexane/diethyl ether mixture
(v/v) as the eluent. The spectroscopic data are in agreement with those
reported in literature. [67]
1H NMR (CDCl3, δ): 2.00 (s, 3H, CH3), 3.85 (s, 3H, OCH3), 7.19 –
7.20 (m, 1H), 7.26–7.39 (m, 7H), 7.83–7.85 (m, 1H), 7.90 (d, 3JH,H = 9.0Hz, 1H). 13C{1H}
NMR (CDCl3, δ): 19.9 (CH3), 56.8 (OCH3), 113.8, 123.6, 124.7, 125.2, 125.8, 126.5, 127.6,
128.0, 129.1, 129.2, 130.0, 131.0, 133.6, 136.3, 137.8, 153.9. HPLC (Chiralcel OD-H, flow rate
0.5mL/min, hexane): 40.8, 46.2 min.
1-(2-Methoxyphenyl)-2-methoxynaphthalene (94f)
O O
94f
According to the general procedure for Suzuki-Miyaura cross-
coupling reactions GP7, 1-bromo-2-methoxynaphthalene (237mg) and
2-methoxyphenylboronic acid (228mg) were reacted. Purification was
realized by column chromatography using a 95/5 hexane/diethyl ether
mixture (v/v) as the eluent. The spectroscopic data are in agreement
with those reported in literature. [312]
1H NMR (CDCl3, δ): 3.70 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 7.08–
7.13 (m, 2H), 7.24 (dd, 3JH,H = 7.4Hz, 4JH,H = 1.7Hz, 1H), 7.31–7.35 (m, 2H), 7.44 (ddd,
3JH,H = 8.3Hz, 3JH,H = 7.6Hz, 4JH,H = 1.8Hz, 1H), 7.82–7.84 (m, 1H), 7.89 (d, 3JH,H
= 9.0Hz, 1H). 13C{1H} NMR (CDCl3, δ): 55.1 (OCH3), 57.0 (OCH3), 111.3, 114.2, 120.6,
122.1, 123.4, 125.3, 125.4, 126.1, 127.8, 128.8, 129.05, 129.08, 132.4, 133.7, 154.3, 157.8.
HPLC (Chiralcel OD-H, flow rate 0.5mL/min, hexane): 39.8, 45.5 min.
1-([1,1'-Biphenyl]2-yl)-2-methoxynaphthalene (94g)
According to the general procedure for Suzuki-Miyaura cross-coupling reactions GP7, 1-
bromo-2-methoxynaphthalene (237mg) and [1,1'-biphenyl]-2-ylboronic acid (297mg) were
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reacted.
O Ph
94g
Purification was realized by column chromatography using a 98/2 hex-
ane/diethyl ether mixture (v/v) as the eluent. The spectroscopic data
are in agreement with those reported in literature. [312]
1H NMR (CDCl3, δ): 3.52 (s, 3H, OCH3), 7.00–7.07 (m, 5H), 7.12
(d, 3JH,H = 9.0Hz, 1H), 7.29–7.36 (m, 3H), 7.46–7.55 (m, 4H), 7.76–
7.78 (m, 2H). 13C{1H} NMR (CDCl3, δ): 56.2 (OCH3), 113.3, 123.4,
124.5, 125.4, 126.4, 126.5, 127.2, 127.4, 127.9, 128.0, 128.7, 129.0, 129.2,
130.0, 132.0, 134.0, 135.0, 141.9, 143.1, 153.7. HPLC (Chiralcel OD-H, flow rate 1.0mL/min,
hexane): 68.7, 94.9 min; 1.2mL/min: 50.9, 70.0 min.
9-(2-Methoxy-1-naphthyl)phenanthrene (94h)
O
94h
According to the general procedure for Suzuki-Miyaura cross-
coupling reactions GP7, 1-bromo-2-methoxynaphthalene (237mg)
and 9-phenanthrylboronic acid (333mg) were reacted. Purification
was realized by column chromatography using a 98/2 hexane/diethyl
ether mixture (v/v) as the eluent. The analytical data are in agree-
ment with those reported in literature. [196]
1H NMR (CDCl3, δ): 3.78 (s, 3H, OCH3), 7.22 (ddd, JH,H = 8.6Hz,
JH,H = 6.6Hz, JH,H = 1.3Hz, 1H), 7.29–7.31 (m, 1H), 7.34 (ddd,
JH,H = 8.1Hz, JH,H = 6.6, JH,H = 1.2, 1H), 7.39–7.40 (m, 2H), 7.48 (d, JH,H = 9.0, 1H),
7.62–7.66 (m, 2H), 7.71 (ddd, JH,H = 8.4Hz, JH,H = 6.9Hz, JH,H = 1.3Hz, 1H), 7.73 (s,
1H), 7.89–7.91 (m, 2H), 8.01 (d, JH,H = 9.0Hz, 1H), 8.81 (t, JH,H = 7.8Hz, 2H). 13C{1H}
NMR (CDCl3, δ): 56.8 (OCH3), 113.9, 122.6, 122.8, 123.2, 123.6, 125.5, 126.45, 126.52,
126.54, 126.6, 126.8, 127.8, 128.7, 129.1, 129.6, 130.3, 130.5, 131.9, 132.1, 133.2, 134.3, 154.8.
HRMS (ESI-TOF, m/z): calcd for C25H18O+Na 357.1250, found 357.1247 [M+Na]+.
1-(2-Isopropylphenyl)-2-methoxynaphthalene (94i)
O
iPr
94i
According to the general procedure for Suzuki-Miyaura cross-
coupling reactions GP7, 1-bromo-2-methoxynaphthalene (237mg) and
2-isopropylboronic acid (246mg) were reacted. Purification was realized
by column chromatography using a 98/2 hexane/diethyl ether mixture
(v/v) as the eluent. The spectroscopic data are in agreement with those
reported in literature. [312]
1H NMR (CDCl3, δ): 0.98 (d, 3JH,H = 6.9Hz, CH(CH3)2, 3H), 1.13
(d, 3JH,H = 6.9Hz, CH(CH3)2, 3H), 2.57 (sept, 3JH,H = 6.9Hz,
CH (CH3)2, 1H), 3.84 (s, 3H, OCH3), 7.12 (dd, 3JH,H = 7.5Hz, 4JH,H = 1.0Hz, 1H), 7.24–
7.35 (m, 4H), 7.37 (d, 3JH,H = 9.0Hz, 1H), 7.44 (td, 3JH,H = 7.7Hz, 4JH,H = 1.2Hz, 1H),
7.48 (dd, 3JH,H = 7.8Hz, 4JH,H = 1.1Hz, 1H), 7.82–7.83 (m, 1H), 7.90 (d, 3JH,H = 9.0Hz,
1H). 13C{1H} NMR (CDCl3, δ): 24.0 (CH(CH3)2), 24.1 (CH(CH3)2), 30.5 (CH(CH3)2), 56.5
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(OCH3), 113.5, 123.6, 124.7, 125.5, 125.5, 125.7, 126.4, 127.9, 128.1, 129.0, 129.1, 131.0,
134.3, 135.0, 148.5, 154.0. HPLC (Chiralcel OD-H, flow rate 0.5mL/min, hexane): 33.9, 37.5
min.
2-Methoxy-1,1'-binaphthalene (94j)
O
94j
According to the general procedure for Suzuki-Miyaura cross-
coupling reactions GP7, 1-bromo-2-methoxynaphthalene (237mg) and
1-naphthylboronic acid (258mg) were reacted. Purification was realized
by column chromatography using a 98/2 hexane/diethyl ether mixture
(v/v) as the eluent. The spectroscopic data are in agreement with those
reported in literature. [312]
1H NMR (CDCl3, δ): 3.76 (s, 3H, OCH3), 7.15–7.17 (m, 1H), 7.21–7.29
(m, 2H), 7.31–7.35 (m, 2H), 7.43–7.48 (m, 3H), 7.62 (dd, 3JH,H = 8.2Hz, 3JH,H = 7.0Hz,
1H), 7.87 (d, 3JH,H = 8.2Hz, 1H), 7.94–7.96 (m, 2H), 7.99 (d, 3JH,H = 9.0Hz, 1H). 13C{1H}
NMR (CDCl3, δ): 56.9 (OCH3), 114.0, 123.4, 123.7, 125.7, 125.7, 125.8, 126.0, 126.3, 126.5,
127.9, 127.9, 128.4, 128.6, 129.2, 129.6, 133.1, 133.9, 134.4, 134.7, 154.8. HPLC (Chiralcel
OD-H, flow rate 0.6mL/min, hexane): 63.3, 74.3 min.
2-Phenyl-1-(o-tolyl)naphthalene (94k)
Ph
94k
According to the general procedure for Suzuki-Miyaura cross-
coupling reactions GP7, 1-bromo-2-phenylnaphthalene (283mg) and o-
tolylboronic acid (204mg) were reacted. Purification was realized by
column chromatography using hexane as the eluent. The spectroscopic
data are in agreement with those reported in literature. [312]
1H NMR (CDCl3, δ): 1.96 (s, 3H, CH3), 7.19–7.36 (m, 9H), 7.45–7.51
(m, 2H), 7.55–7.58 (m, 1H), 7.68 (d, 3JH,H = 8.5Hz, 1H), 7.99–8.03
(m, 2H). 13C{1H} NMR (CDCl3, δ): 19.9 (CH3), 125.2, 125.7, 126.27,
126.32, 126.6, 127.3, 127.5, 127.6, 127.9, 128.2, 129.6, 129.7, 131.6, 132.5, 132.7, 136.9, 137.1,
138.2, 138.5, 141.9 ppm. HPLC (Chiralcel OD-H, flow rate 0.5mL/min, hexane): 24.4, 25.3
min; (Chiralcel OJ-H, flow rate 0.5mL/min, hexane): 43.1, 56.5 min.
2-Methyl-1,1'-binaphthalene (94l)
94l
According to the general procedure for Suzuki-Miyaura cross-
coupling reactions GP7, 1-bromo-2-methylnaphthalene (221mg) and 1-
naphthylboronic acid (258mg) were reacted. Purification was realized
by column chromatography using hexane as the eluent. The spectro-
scopic data are in agreement with those reported in literature. [395]
1H NMR (CDCl3, δ): 7.11 (2, 3H, CH3), 7.14–7.16 (m, 1H), 7.20–7.22
(m, 1H), 7.23–7.28 (m, 2H), 7.37–7.41 (m, 2H), 7.46–7.50 (m, 2H), 7.59–7.63 (m, 1H), 7.87–
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7.89 (m, 2H), 7.94–7.96 (m, 2H). 13C{1H} NMR (CDCl3, δ): 20.5 (CH3), 124.8 (CH), 125.6
(CH), 125.85 (CH), 125.88 (CH), 126.0 (CH), 126.1 (CH), 126.3 (CH), 127.5 (CH), 127.6
(CH), 127.7 (CH), 127.8 (CH), 128.3 (CH), 128.6 (CH), 132.0, 132.6, 133.5, 133.8, 134.4,
136.1, 137.5. HPLC (Chiralcel OD-H, flow rate 0.5mL/min, hexane): 43.1, 56.5 min.
9-(o-Tolyl)anthracene (94m)
94m
According to the general procedure for Suzuki-Miyaura cross-coupling
reactions GP7, 9-bromoanthracene (257mg) and o-tolylboronic acid
(204mg) were reacted. Purification was realized by column chromatog-
raphy using a 95/5 hexane/diethyl ether mixture (v/v) as the eluent.
The spectroscopic data are in agreement with those reported in litera-
ture. [312]
1H NMR (CDCl3, δ): 1.87 (s, 3H, CH3), 7.25–7.27 (m, 1H), 7.34 (ddd,
3JH,H = 8.7Hz, 3JH,H = 6.5Hz, 4JH,H = 1.2Hz, 2H), 7.37–7.40 (m,
1H), 7.44–7.48 (m, 4H), 7.50–7.52 (m, 2H), 8.50 (s, 1H). 13C{1H} NMR (CDCl3, δ): 19.9
(CH3), 125.3, 125.6, 126.0, 126.5, 126.7, 128.0, 128.6, 130.1, 130.2, 131.4, 131.6, 136.6, 138.0,
138.3.
N -([1,1'-Binaphthalen]-2-yl)benzamide (94p)
94p
NH
Ph
O
According to the general procedure for Suzuki-Miyaura cross-coupling
reactions GP7, 2-amino-1-bromonaphthalene (222mg, 1mmol) and 1-
naphthylboronic acid (258mg, 1.5mmol) were reacted with 0.5 mol-
% [Pd2(dba)3] at 70℃. The conversion of the amine into the amide
was performed similar to a literature reported protocol. [396] The crude
reaction mixture was cooled to ambient temperature and transferred
into a Schlenk tube by using dichloromethane and diluted with 5mL
of THF. Benzoyl chloride (0.15mL, 1.3mmol) was added in a single
portion followed by triethylamine (0.28mL, 1.3mmol). The reaction
mixture was stirred at 65℃ for 6 h and afterwards allowed to cool to ambient temperature.
The solution was poured into water and extracted three times with Et2O (50mL). The
combined organic layers were dried over MgSO4 followed by removal of all volatiles in vacuum.
Purification was realized by column chromatography (silica, 4 · 23 cm column size) using a
hexane/diethyl ether mixture (v/v) as the eluent. The product is eluted as the third fraction,
after 1,1'-binaphthyl as the first, and a fluorescent fraction as the second fraction. After
removal of all volatiles 94q was obtained as a colorless oil.
Yield: 279mg (0.747mmol, 75% based on 2-amino-1-bromonaphthalene). Anal. calcd for
C27H19NO · 1.5 H2O (373.45 · 1.5 18.02 g/mol): C, 80.98; H, 5.54; N, 3.50. Found: C, 80.82;
H, 5.06; N, 3.52. 1H NMR (CDCl3, δ): 7.14–7.16 (m, 2H), 7.19–7.23 (m, 3H), 7.28 (ddd,
3JH,H = 8.4Hz, 3JH,H = 6.7Hz, JH,H = 1.3Hz, 1H), 7.33–7.39 (m, 3H), 7.43 (ddd, 3JH,H
= 8.0Hz, 3JH,H = 6.7Hz, JH,H = 1.2Hz, 1H), 7.54 (ddd, 3JH,H = 8.1Hz, JH,H = 4.0Hz,
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JH,H = 0.8Hz, 1H), 7.56 (dd, 3JH,H = 6.9Hz, JH,H = 1.2Hz, 1H), 7.65 (s, br, 1H, NH),
7.70 (dd, 3JH,H = 8.2Hz, 3JH,H = 7.0Hz, 1H), 7.94 (d, 3JH,H = 8.2Hz, 1H), 8.02 (d, 3JH,H
= 8.3Hz, 1H), 8.06 (d, 3JH,H = 7.0Hz, 1H), 8.07 (d, 3JH,H = 6.3Hz, 1H), 8.84 (d, 3JH,H
= 9.0Hz, 1H). 13C{1H} NMR (CDCl3, δ): 120.1 (CH), 124.9 (CH), 125.0 (qC), 125.6 (CH),
125.9 (CH), 126.0 (CH), 126.5 (CH), 126.6 (CH), 126.7 (CH), 127.2 (CH), 128.0 (CH), 128.6
(CH), 128.6 (CH), 129.0 (CH), 129.1 (CH), 129.2 (CH), 130.9 (qC), 131.5 (CH), 132.3 (qC),
133.0 (qC), 133.2 (qC), 134.1 (qC), 134.2 (qC), 134.7 (qC), 165.0 (C=O). HRMS (ESI-TOF,
m/z): calcd for C27H19NO+H 374.1539, found 374.1541 [M+H]+. HPLC (Chiralcel OD-H,
flow rate 0.5mL min−1, nhexane:iPrOH (98:2)): 44.7, 58.1 min. IR data (KBr, v˜/cm−1):
3412 m (NH), 3052 w, 2919 m, 2851 w, 1673 s, 1617 w, 1595 m, 1497 s, 1484 s, 1426 m, 1283
s, 780 m, 708 m.
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5 Conclusion
The present PhD thesis discusses the synthesis and characterization of planar-chiral
1,2-P ,O-substituted ferrocenes and their application in (atropselective-) Suzuki-Miyaura
C,C-cross coupling reactions of hindered biaryls. This hardly accessible substitution pattern
of the ferrocenyl backbone shall be established by applying the anionic phospho-Fries
rearrangement (apFr), as a new regioselective synthetic access to such 1,2-P ,O-substituted
ferrocenes.
The PhD thesis is structured in four main parts:
3.1 Anionic Phospho-Fries Rearrangements
3.2 Oxygen-Functionalization of Hydroxyferrocenes
3.3 Anionic Homo Phospho-Fries Rearrangements
3.4 Functionalization of ortho-Diphenylphosphino Ferrocenylmethanols
Section 3.1.1 focused on the examination of the reactions conditions, the substrate scope and
the limitations of the anionic phospho-Fries rearrangement at ferrocene. It could be shown for
the first time that these type of 1,3-O→C migrations proceed at ferrocene. Electron deficient
ferrocenyl phosphates turned out to be the preferred substrates and gave the rearranged
ferrocenyl phosphonates in high yield. Based on the ortho-directing properties of phosphoryl-
substituents, the apFr enabled an efficient and regioselective access to 1,2-P ,O-ferrocenes.
Examination of the substrate scope revealed that the electron density of the P-bonded group
is decisive for the lithiation and rearrangement process (Figure 5.1). Thus, electron rich
N -alkyl derivatives impeded the deprotonation and prevented a successful rearrangement,
giving ortho-methylated compounds instead.
Fe
P(R)2O
E
LDA, Me2SO4
H
Fe
rac-16, 94 %
O(EtO)2P
O
Fe
  rac-17, 0 %
(sBuLi): 50 %
O(EtO)2P
S
Fe
rac-18, 37 %
O(EtO)2P
H3B
Fe
rac-20 (E = O), 8 % 
rac-21 (E = S),
  
0 %
OP
E
2
Fe
PO
O
Me N
2
rac-26 (sBuLi), 64 %
successful anionic 
phospho-Fries rearrangement
no rearrangement
Electron density
Figure 5.1 Substrate scope for successful anionic phospho-Fries rearrangements.
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Functionalization of ferrocenyl phosphates with chiral pool derived alcohols (3.1.2) allowed
for the investigation of a diastereoselective proceeding of the apFr by stereoselective
ortho-directed metalation. The best results were obtained for the sterically most demanding
(1R)-α-fenchyl substituent (= Fn), which gave 1,2-P ,O-ferrocenes in a diastereomeric excess
of up to 95% (Figure 5.2). The steric demand of the bicyclic system, bearing three methyl
groups close to the linking oxygen, even prevented the methylation of the hydroxy group in a
1,3-di-ortho-functionalized product, which was further stabilized by intramolecular hydrogen
bridge bonds. The shielding of one ortho-position within the metalation with LiTMP gave a
1,1'-2-P ,P ,O-ferrocene with 95% de.
30e
Fe
(FnO)2P O
O
Fe
  (Rp)-31e, 65 %
80 % de
O P(OFn)2
O
Fn =
Fe
(FnO)2P O P(OFn)2
O
(Rp)-35c, 86 %
95 % de
O
LiTMP
TMEDA
hexane
Base
TMEDA
Me2SO4 36b, 99 %
FeHO P(OFn)2
O
(Rp)-37, 26 %
95 % de
FeO P(OFn)2
O
O
(FnO)2P
P(OFn)2
O
Me2SO4
P(OFn)2
O
Cl
LDA
LiTMP
Figure 5.2 Diastereoselective anionic phospho-Fries rearrangements.
The investigation of triferrocenyl phosphate revealed that solely one ferrocenyl fragment
undergoes an apFr per reaction step (Section 3.1.3). Nevertheless, the final phosphine oxide
could not be synthesized (Section 3.1.3). This was in contrast to triphenyl phosphate,
where the respective phosphine oxide is formed within one reaction step, and intermediate
compounds had never been reported. Thus, basic investigations of triphenyl phosphate
within apFr were performed, showing a temperature dependent formation of the phosphonate
the phosphinate and finally the respective oxide. Mixed ferrocenyl phenyl phosphates also
gave temperature-dependent mixtures, confirming both reaction behaviors, with a preferred
lithiation at the phenyl-related rings. The introduction of electron-deficient N -heterocycles
also gave the 1,2-P ,O-ferrocenes, which is in contrast to the N -alkyl derivatives. Anchoring
of the phosphates in a 1,3-dioxa[3]ferrocenophane structure allows ortho-lithiations, whereas
subsequent apFr are prevented.
Ferrocene could be used as a probe for the investigation of the electronic properties of
the different types of ferrocenyl phosphorus compounds (Section 3.1.3). Electrochemical
investigations confirmed the relation between electron density and a successful nucleophilic
attack at the phosphorus atom during the rearrangement process.
The suitability of these 1,2-P ,O-ferrocenes as ligands for C,C cross-coupling catalysis was
achieved by converting the obtained phosphonates into the respective PPh2 derivatives, by
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applying the P ,C Stelzer-coupling at ferrocenyl phosphines (PH2) for the first time. The
hemilabile bonding of the oxygen atom or the 1,2-P ,O-structural motif enhanced the catalytic
activity of the Pd(0) species and gave the three-ortho-substituted biaryls in high yield and low
catalyst loading. However, the usage of an enantiopure ligand did not result in an atropselec-
tive biaryl coupling, which was ascribed to the low steric demand of the methoxy substituent.
Fe OH
Fe O
F
O
O
Fe
Fe
Fe
O
FeO
F
F
F
F
F
F
6 %
Fe O
O
(CyO)2P
P(OCy)2
73 %
O
NO2
NO2
consecutive
anionic phospho-
Fries rearrangements
SNAr
Figure 5.3 Diastereoselective anionic phospho-Fries rearrangements.
The hydroxy group was functionalized by reacting it with different electrophiles, whereas
nucleophilic substitution reactions at aliphatic compounds proceeded poorly (3.2.1). Solely
silyl ethers were obtained in moderate yield. A successful oxygen-functionalization could
be achieved by applying nucleophilic aromatic substitutions (SNAr) reactions at hydroxy
ferrocene, which was hitherto sparsely investigated for this type of substrates (Figure 5.3).
This approach gives access to a new regioselective synthetic pathway for (multi-)ferrocenyl
aryl ether, despite Ullmann-type couplings (3.2.1). The SNAr reaction tolerated ortho-
substituents, which were introduced by anionic phospho- and thia-Fries rearrangements,
whereas the electron-withdrawing character of these groups reduced the nucleophilicity of
the hydroxy group and required strongly electron-deficient aryl fluorides for a successful
conversion, which was supported by electrochemical investigations. Using multi-fluorinated
aromatics gave multi-ferrocenyl aryl ethers with up to five ferrocenyls, as a unique example
in chemistry (Figure 5.3).
Fe
N
Ph
P(OFn)2
O
Fc
N
R
oxidative coupling
CN
FcLi + N
Fe
Fe
Fe
tBu
N N
tBu Fe OH
Fe
O
PCl
oxidative 
azine formation
alcohols
alkenes
SEAr
O
2 elimination
nucleophilic substitution
Figure 5.4 Application of a sterically hindered chiral pool-derived chloro phosphate as a
phosphorylation and oxidative coupling agent.
Besides the classic anionic ortho-Fries also the C-elongated homo-Fries version was in-
237
CHAPTER 5. CONCLUSION
vestigated (3.3.1). In contrast to ferrocenyl phosphates, which could easily be obtained,
the conversion of ferrocenyl methanols into the respective phosphates was challenging.
An isolation was not successful, due to their rapid elimination of phosphate anions and
the consecutive reactions of the thus formed α-ferrocenylmethyl carbenium ions into
alkenes, alcohols, or into arylated compounds by electrophilic aromatic substitution. Using
imino-phosphoramidates as alcohol equivalents gave a variety of novel ferrocenyl derivatives.
Interestingly, the sterically demanding chloro phosphate acted as a reducing agent, which
has not been reported so far, giving oxidative coupled products, such as azines (Figure 5.4).
FePh2P
Fe
S PPh2
FePh2P
OH
S
tolueneFePh2P
S
S NO2
NO2
FePh2P
S
CH3
(Sp)
O2N
NO2
F
2 x SNAr FePh2P
S
(Sp)
H+
−H2O
(Sp)
28 mM
SEAr
48 mM
(Sp)
(Sp,Sp)
intermolecular
"S2−" migration
S S
Figure 5.5 Carbocation formation of an enantiopure planar-chiral ferrocenyl methanol and
subsequent intermolecular “S2−“ migration.
Anionic homo phospho-Fries rearrangements were circumvented and an enantiopure 1-PPh2-
2-CH2OH compound was synthesized by a literature reported procedure. Its conversion into
an aryl ether was investigated. It could be shown that the formation of ferrocenylmethyl
carbenium ions takes place, which underwent electrophilic aromatic substitution (SEAr)
instead of an ether formation (Figure 5.5). Depending on the concentration of the reaction
mixture a sulfur migration from the thiophosphinoyl group to the carbenium carbon takes
place, giving the respective thioethers within an unique reaction mechanism. Neverthe-
less, the successfully isolated enantiopure arylated phosphines and a double-planar-chiral
thio-ether derivative were investigated for atropselective biaryl couplings, which gave the
products with up to 26% ee.
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Appendix A
Anionic Phospho-Fries Rearrangement at
Ferrocene: One-Pot Approach to
P,O-Substituted Ferrocenes
Marcus Korb, Dieter Schaarschmidt and Heinrich Lang
published in Organometallics 2014, 33, 2099–2108.
Fe O
P(X)R2
anionic Phospho-Fries
rearrangement
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Me
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i = Reduction and
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up to 94 %
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Abstract
For the first time the anionic phospho-Fries rearrangement is successfully applied in ferrocene
chemistry giving access to 1,2-P,O-substituted ferrocenes. The 1,3-(O→C) migration occurs
at ferrocenyl phosphates, thiophosphates, phosphite-borane adducts and phosphinates by
treatment with a base such as lithium diisopropylamide at low temperature, whereas the
highest yields were obtained starting from diethylferrocenyl phosphate. Complete reduction
of the phosphonate to a primary phosphine and subsequent Stelzer P,C cross-coupling allowed
the synthesis of Fe(η5-C5H3-2-OMe-PPh2)(η5-C5H5) (1). The qualification of 1 as supporting
ligand in palladium-catalyzed Suzuki-Miyaura C,C couplings has been proven by the synthesis
of sterically congested tri-ortho-substituted biaryls at mild reaction conditions in good to
excellent yields.
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Appendix B
Planar Chirality from the Chiral Pool:
Diastereoselective Anionic Phospho-Fries
Rearrangements at Ferrocene
Marcus Korb and Heinrich Lang
published in Organometallics 2014, 33, 6643–6659.
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Abstract
Exclusively, the anionic phospho-Fries rearrangement has successfully been adopted on chiral
ferrocenyl phosphates resulting in diastereomeric enriched 1,2-P,O-ferrocenes (up to 95 %
de). A simple synthetic protocol for the preparation of all starting materials based on several
chiral-pool alcohols, chiral (di-)chlorophosphates and the respective ferrocenyl phosphates is
reported. Optimized reaction conditions for the anionic phospho-Fries rearrangement allow
conversions at ambient temperature, the usage of variable lithium amid bases and diamines
in hexane, ensure virtually quantitative yields and avoid side reactions. The (bi-)cyclic alkyl
substituents result in air and moisture stable compounds and furthermore, allow the conver-
sion of 1,1'-substituted derivatives to 1,1',2,2'-functionalized ferrocenes, which is reported for
the first time. Simultaneous rearrangements at diferrocenylphosphates to phosphinates and
even 2-hydroxy-1,3-bisphosphonato ferrocenes and their work-up under ambient conditions
can be performed. Single crystal diffraction analysis allowed the determination of the abso-
lute configuration of the planar chirality of two diastereomeric pure ferrocenes being the Rp
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isomers. Furthermore, strong T-shaped pi-pi interaction patterns between aromatic C5H3 and
C5H4 cycles for three compounds are observed.
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Nucleophilic Aromatic Substitution
Reactions for the Synthesis of Ferrocenyl
Aryl Ethers
Marcus Korb, Pieter J. Swarts, Dominique Miesel, Alexander Hildebrandt, Jannie C. Swarts,
and Heinrich Lang
published in Organometallics 2016, 35, 1287–1300.
Abstract
A range of ferrocenyl aryl ethers of type Fc–O–Ar [Fc = Fe(η5-C5H5)(η5-C5HnX4−n); n =
2–4; X = H, P(O)(OEt)2, SO2CF3; Ar = 2,4-(NO2)2-C6H3, 4-NO2-C6H4] have successfully
been prepared by using the nucleophilic aromatic substitution reaction (SNAr) of Fc–OLi
(1a–Li) and electron deficient aryl fluorides, enabling a new pathway to this rarely described
family of organometallic compounds. Initial studies of 1a–Li and ortho-phosphonato substi-
tuted hydroxyferrocenes (1b–Li) have also been performed, indicating a low nucleophilicity
of the oxygen atom. The SNAr reaction protocol tolerates ortho-substituents, e.g. phos-
phonato and sulfonyl groups resulting in 1,2-X,O (X = S, P) ferrocenyl ethers that can be
obtained in an one-pot synthesis procedure including 1,3-O→C anionic phospho- and thia-
Fries rearrangements. Within these studies, the first 1,3-diortho-functionalized ferrocenyl
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aryl ether could be synthesized. An electrochemical study of the redox potentials of the
obtained compounds allows conclusions on the reactivity of the varying electronic properties
and the electrophilicity of different aryl fluorides and the nucleophilicity of the functional-
ized hydroxyl ferrocenes, which is directly reflected by the potential of the first ferrocene
related redox processes. Chiral-pool-based phosphonates rearrange to the aryl ethers with
a diastereomeric excess of 74 and 81 % after the anionic Fries rearrangement. The usage of
aryl-1,2/1,3-difluorides resulted in the synthesis of the first examples of bis(FcO) substituted
benzenes. Their electrochemical investigations reveal a splitting of the two redox processes
of the ferrocenyls that decreases from 155mV (1,2-substitution) to 130mV (1,3-substitution)
based on electrostatic interactions.
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A reactivity study of phenyl and ferrocenyl
phosphates within the anionic
phospho-Fries rearrangement
Marcus Korb and Heinrich Lang
published in Inorg. Chem. Commun. 2016, 72, 30–32.
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Abstract
Temperature-dependent anionic phospho-Fries rearrangements of ferrocenyl/phenyl phos-
phates P(O)(OFc)n(OPh)3−n (Fc = Fe(η5-C5H5)(η5-C5H4); n = 0,1,2,3) were investigated.
Whereas ferrocenyls solely undergo one rearrangement per reaction step, the number of
phenyl-based 1,3-O→C shifts depends on the temperature. This results in different types
of otherwise hardly accessible mixed ferrocenyl/phenyl organophosphorus compounds. De-
tailed investigations of the triple-rearrangement of triphenyl phosphate (n = 0) reveals a
consecutive formation of its phosphonate and phosphinate prior to the known phosphane
oxide.
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Appendix E
Multi-Ferrocenyl Aryl Ethers - Applying
Nucleophilic Aromatic Substitution
Reactions to Aryl Fluorides
Marcus Korb and Heinrich Lang
published in Eur. J. Inorg. Chem. 2017, 2017, 276–287.
This article is part of “The Multifaceted Chemistry of Ferrocene“ Cluster Issue.
Abstract
The reaction of ferrocenol [FcOH; Fc = Fe(η5-C5H5)-(η5-C5H4)] with aryl fluorides ArH6−nFn
(n = 3–6) within a nucleophilic aromatic substitution reaction (SNAr) gave ferrocenyloxy-
substituted fluorobenzenes of general type C6H0−3F1−5(OFc)1−5. For 1,3,5-C6H3F3, 1,2,4,5-
C6H2F4, and C6H6−nFn (n = 5,6), one, two, and three F atoms, respectively, could be
replaced by FcO units. The reaction of 1,4-(OFc)2-C6F4 with additional amounts of FcOH
afforded the tetra- and penta-substituted arenes 3,6-F2-C6(OFc)4 and C6F(OFc)5. Electro-
chemical investigations of both compounds showed four or five Fc/Fc+ related reversible redox
processes that were attributed to electrostatic interactions. The addition of C6F6 as the elec-
trophile after the anionic phospho-Fries rearrangement of a ferrocenyl phosphate (1,3-O→C
migration) to the 1,2-substituted ortho-phosphonato ferrocenol, resulted in the formation of
the respective ortho-functionalized ether. The constitution of all compounds was verified by
using 19F NMR spectroscopy. Steric hindrance of the ortho-substituent resulted in a doubling
of the signal sets for the C6F5 moiety in the 13C{1H} and 19F NMR spectra. The identity
and substitution pattern of five compounds could also be determined by using single-crystal
X-ray diffraction analysis, revealing the 1,4-constitution of double functionalized derivatives,
intermolecular non-classical C–H· · ·F interactions and pi interactions.
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Appendix F
Reactivity of Ferrocenyl Phosphates
Bearing (Hetero-)Aromatics and
[3]Ferrocenophanes toward Anionic
Phospho-Fries Rearrangements
Marcus Korb, Steve W. Lehrich and Heinrich Lang
published in J. Org. Chem. 2017, 82, 3102–3124.
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Abstract
The temperature-dependent behavior within anionic phospho-Fries rearrangements (apFr) of
P(O)(OFc)n(EAr)3−n (Fc = Fe(η5-C5H5)(η5-C5H4); E = O; Ar = phenyl, naphthyls, (R)-
BINOL, [3]ferrocenophanyl; E = N, 1H-pyrrolyl, 1H-indolyl, 9H-carbazolyl; n = 1–3) is
reported. While Fc undergoes one, the Ph-based apFr depends on temperature. First, the
aryls are lithiated and rearranged, followed by Fc and N-heterocycles. Addition of Me2SO4
thus gave methylated Fc, contrary to non-organometallic aromatics giving mixtures of HO
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and MeO derivatives. The (R)-BINOL Fc phosphate gave Fc-rearranged phosphonate in
91ł% de. Exchanging O- with N-aliphatics prevented apFr, due to higher electron density at
P. Also 1,2-N→C migrations were observed. X-ray analysis confirms 1D H bridge bonds for
OH and NH derivatives. The differences in reactivity between N-aliphatic and N-aromatic
phosphoramidates were verified by electrochemistry. The redox potentials revealed lower
values for the electron-rich aliphatics, showing no apFr, preventing a nucleophilic attack at
P after lithiation. Redox separations for multiple Fc molecules are based on electrostatic
interactions.
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P,C-Sulfur Migration from
Thiophosphinylferrocenyl Carbenium Ions
to Phosphinylthioethers
Marcus Korb, Julia Mahrholdt and Heinrich Lang
accepted by Eur. J. Inorg. Chem. 10.1002/ejic.201700645.
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Abstract
The reaction of FcCH2OH with chlorophosphates gave ferrocenyl phosphates
FcCH2OP(O)(OR)2 (Fc = Fe(η5-C5H5)(η5-C5H4)), which are promising starting ma-
terials for anionic homo phospho-Fries rearrangements. However, the corresponding
phosphates separate into phosphate anions and ferrocenyl carbo-cations of which the
latter one undergoes consecutive reactions. Thus, electrophilic aromatic substitutions with
the substrates occurred. As an alternative, treatment of nitriles in presence of FcLi or
tBuLi and subsequent addition of chlorophosphates gave several novel chiral-pool based
ferrocenyl imino phosphoramidates of type Fc–CR=N–P(O)(OR*)2 as auspicious educts for
anionic homo phospho-Fries rearrange-ments. Unexpectedly, the sterically demanding chiral
chlorophosphate with R* acted as a reducing agent, enabling oxidative coupling of the imines
to a diferrocenyl azine. In similarity, the reaction of Fc–Li with 9-anthrylnitrile produced a
10-ferrocenyl-substituted product, contrary to a reaction at the C≡N functionality within
this rarely described oxidative cou-pling. The ferrocenyl methanol 1,2-P(S)Ph2,CH2OH
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motif was used for the synthesis of a novel planar-chiral ligand system. Under acidic
conditions, however, dehydration occurs and the remaining ferrocenylmethyl carbo-cation
was sulfurized in a unique way giving thio ethers as evidenced by single crystal X-ray
diffraction analysis. The migration of sulfur to a carbo-cation was also observed under
nucleophilic conditions, whereby the 1,2-P(S)Ph2,CH2OH ferrocene acts as unique sulfur
and electron source. In contrast, the presence of electron-rich aromatics within this synthetic
protocol resulted in several enantiopure planar-chiral o-, p- and m-substituted arylmethyl
ferrocenes under SEAr reactions conditions, depending on the carbo-cation concentration.
For catalytic studies, a novel stereopure ferrocenylmethyl thio ether and a compound derived
from the SEAr reaction with anisol have been used as supporting ligands in Pd-catalyzed
Suzuki-Miyaura C,C cross-coupling reactions for the atropselective synthesis of hindered
biaryls with up to 26% ee at low catalyst loadings (1mol-% Pd). This verifies that the
planar-chirality of the ferrocenyl backbone transfers the chiral information via a hemilabile
bonding to the biaryl substrate.
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Table 5.1 Crystal-, collection- and refinement details for 15, 20 and 23.
Compound 15 20 23
CCDC Number 1508136 1028721 978227
Empirical Formula C13H19BFeNO2P C23H21FeO2P C16H19PS
Formula Weight / g·mol−1 318.92 416.22 274.34
Temperature / K 107.35(10) 110.00(10) 110.00(10)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Orthorhombic Orthorhombic Triclinic
Space Group Pbc P212121 P 1¯
a / Å 11.8453(10) 8.3581(4) 9.1715(7)
b / Å 11.2052(10) 8.5846(4) 11.9513(8)
c / Å 21.0840(15) 27.2615(14) 13.8640(10)
α / deg – – 86.089(6)
β/ deg – – 88.870(6)
γ/ deg – – 76.849(6)
Volume / Å3 2798.5(4) 1956.04(16) 1476.34(18)
ρber / g · cm−3 1.514 1.413 1.234
F(000) 1328 864 584
Crystal Dimensions / mm 0.40 · 0.20 · 0.20 0.3 · 0.2 · 0.08 0.4 · 0.4 · 0.4
Z 8 4 4
Max. and min. Transmission 1.00000, 0.86648 1.00000, 0.97511 1.00000, 0.61599
µ / mm−1 1.187 0.868 0.308
θ-Range / deg 3.162 to 25.997 2.99 to 25.50 3.00 to 25.00
-14≤h≤13 –10≤h≤6 –10≤h≤10
Limiting indices –8≤k≤13 –10≤k≤10 –14≤k≤13
–26≤l≤22 –31≤l≤33 –16≤l≤11
Reflections Collected / Unique 7044 / 2722 5954 / 3481 9738 / 5158
Completeness to θmax / % 99.2 99.8 99.2
Restraints / Parameters 0 / 185 93 / 246 5158 /
Rint 0.0481 0.0336 0.0700
R1, wR2 [I≥ 2σ(I)] 0.0559, 0.1429 0.0385, 0.0767 0.0907, 0.2353
R1, wR2 (all Data) 0.0699, 0.1488 0.0436, 0.0788 0.1004, 0.2484
Goodness-of-fit S 1.085 1.045 1.058
∆ρ / e−Å−3 1.190, –0.753 0.450, –0.298 1.776, –0.762
Absolute Structure Parameter – 0.012(19) –
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Table 5.2 Crystal-, collection- and refinement details for 30a, 30b and 30e.
Compound 30a 30b 30e
CCDC Number 1024126 1024118 1024119
Empirical Formula C22H31FeO4P C30H47FeO4P C60H86Fe2O8P2
Formula Weight / g·mol−1 446.29 558.50 1108.92
Temperature / K 110.00(10) 110.00(10) 110.0(10)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Monoclinic Orthorhombic Triclinic
Space Group P21/c P212121 P1
a / Å 12.4882(12) 7.3970(2) 11.6913(4)
b / Å 18.1115(14) 18.0245(4) 11.8705(4)
c / Å 9.7751(9) 21.8203(6) 12.0874(4)
α / deg – – 62.396(3)
β/ deg 111.679(11) – 77.005(3)
γ/ deg – – 69.734(3)
Volume / Å3 2054.5(3) 2909.24(13) 1390.35(9)
ρber / g · cm−3 1.443 1.275 1.324
F(000) 944 1200 592
Crystal Dimensions / mm 0.4 · 0.4 · 0.25 0.35 · 0.25 · 0.20 0.2 · 0.2 · 0.1
Z 4 4 1
Max. and min. Transmission 1.00000, 0.23774 1.00000, 0.66822 1.00000, 0.84431
µ / mm−1 0.838 0.606 0.633
θ-Range / deg 3.176 to 25.999 2.91 to 26.00 3.106 to 24.997
–14≤h≤15 9≤h≤9 –12≤h≤13
Limiting indices –20≤k≤22 –22≤k≤14 –14≤k≤13
–10≤l≤12 –18≤l≤26 –14≤l≤14
Reflections Collected / Unique 9663 / 4006 18502 / 5616 10832 / 7207
Completeness to θmax / % 99.3 99.7 99.7
Restraints / Parameters 0 / 253 0 / 331 4 / 672
Rint 0.0719 0.0590 0.0156
R1, wR2 [I≥ 2σ(I)] 0.0822, 0.2037 0.0382, 0.0879 0.0425, 0.1058
R1, wR2 (all Data) 0.0982, 0.2208 0.0439, 0.0912 0.0451, 0.1081
Goodness-of-fit S 1.007 1.035 1.043
∆ρ / e−Å−3 1.817, –1.076 0.496, –0.279 0.629, –0.527
Absolute Structure Parameter – –0.018(14) 0.012(8)
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Table 5.3 Crystal-, collection- and refinement details for 31e, 35c and 43b.
Compound 31e 35c · 0.25 CHCl2 43b
CCDC Number 1024120 1024121 1024123
Empirical Formula C31H45FeO4P C50H76FeO7P2 · 0.25 CHCl2 C30H37Fe2O4P
Formula Weight / g·mol−1 568.49 928.12 604.26
Temperature / K 110.00(10) 110.00(10) 110.2(6)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Orthorhombic Monoclinic Monoclinic
Space Group P212121 C2 P21
a / Å 7.7485(2) 43.1922(8) 14.1041(13)
b / Å 10.6896(3) 8.5461(2) 5.8359(5)
c / Å 34.4462(10) 26.5582(5) 16.704(2)
α / deg – – –
β/ deg – 90.458(2) 92.648(9)
γ/ deg – – –
Volume / Å3 2853.12(14) 9803.0(3) 1373.4(2)
ρber / g · cm−3 1.323 1.258 1.461
F(000) 1216 3988 632
Crystal Dimensions / mm 0.4 · 0.15 · 0.15 0.4 · 0.4 · 0.2 0.4 · 0.1 · 0.02
Z 4 8 2
Max. and min. Transmission 1.00000, 0.91937 1.00000, 0.91200 1.00000, 0.03517
µ / mm−1 0.619 0.449 1.149
θ-Range / deg 2.88 to 26.00 2.875 to 25.500 2.892 to 24.997
–9≤h≤9 –52≤h≤51 –16≤h≤14
Limiting indices –13≤k≤13 –8≤k≤10 –6≤k≤6
–41≤l≤42 –32≤l≤32 –18≤l≤19
Reflections Collected / Unique 25582 / 5602 41406 / 16504 5764 / 4257
Completeness to θmax / % 99.4 99.0 99.5
Restraints / Parameters 0 / 341 56 / 1114 78 / 302
Rint 0.0363 0.0229 0.1381
R1, wR2 [I≥ 2σ(I)] 0.0269, 0.0580 0.0333, 0.0807 0.0908, 0.1454
R1, wR2 (all Data) 0.0308, 0.0595 0.0370, 0.0825 0.1476, 0.1790
Goodness-of-fit S 1.022 1.021 0.907
∆ρ / e−Å−3 0.217, –0.201 1.138, –0.546 1.291, –1.310
Absolute Structure Parameter 0.000(10) 0.005(4) 0.02(6)
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Table 5.4 Crystal-, collection- and refinement details for 43e, 44a and 44c.
Compound 43e 44a 44c
CCDC Number 1525260 1024125 1024122
Empirical Formula C24H28Fe2NO3P C27H31Fe2O4P C66H84Fe4O9P2
Formula Weight / g·mol−1 521.14 562.19 1306.67
Temperature / K 110.00(10) 109.95(10) 109.95(10)
Wavelength / Å 0.71073 0.71073 1.54184
Crystal System Monoclinic Monoclinic Monoclinic
Space Group C2/c P21/c C2
a / Å 51.506(2) 13.9652(7) 34.8430(15)
b / Å 7.4283(3) 8.1909(5) 8.2055(3)
c / Å 11.2434(5) 21.2807(12) 21.7894(11)
α / deg – – –
β/ deg 90.380(4) 97.814(5) 106.881(5)
γ/ deg – – –
Volume / Å3 4301.7(3) 2411.6(2) 5961.2(5)
ρber / g · cm−3 1.609 1.548 1.456
F(000) 2160 1168 2744
Crystal Dimensions / mm 0.4 · 0.4 · 0.4 0.4 · 0.1 · 0.02 0.4 · 0.1 · 0.1
Z 8 4 4
Max. and min. Transmission 1.00000, 0.73288 1.00000, 0.73791 1.00000, 0.26850
µ / mm−1 1.451 1.302 8.621
θ-Range / deg 3.164 to 26.000 2.945 to 24.998 3.846 to 63.590
–63≤h≤63 –16≤h≤16 –40≤h≤39
Limiting indices –9≤k≤9 –9≤k≤9 –6≤k≤9
–13≤l≤13 –25≤l≤25 –25≤l≤22
Reflections Collected / Unique 27226 / 4196 11049 / 4244 13199 / 7006
Completeness to θmax / % 99.3 99.6 98.9
Restraints / Parameters 0 / 282 0 / 308 220 / 753
Rint 0.0546 0.0399 0.0259
R1, wR2 [I≥ 2σ(I)] 0.0420, 0.1043 0.0404, 0.0913 0.0316, 0.0746
R1, wR2 (all Data) 0.0456, 0.1063 0.0570, 0.0985 0.0354, 0.0762
Goodness-of-fit S 1.096 1.031 0.985
∆ρ / e−Å−3 1.014, –0.548 0.804, –0.499 0.535, –0.418 e.
Absolute Structure Parameter – – –0.003(5)
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Table 5.5 Crystal-, collection- and refinement details for 44d, 48 and 49.
Compound 44d 48 49
CCDC Number 1024124 1474110 1508129
Empirical Formula C31H37Fe2O4P C26H23Fe2O4P C30H25Fe2O4P
Formula Weight / g·mol−1 616.27 542.11 592.17
Temperature / K 293(2) 110.5(3) 110.6(2)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Monoclinic Monoclinic Monoclinic
Space Group P21 P21/n P21/c
a / Å 14.7944(13) 9.7078(5) 15.6912(9)
b / Å 8.3537(7) 9.0603(4) 10.1639(4)
c / Å 22.2802(17) 24.536(3) 17.1179(9)
α / deg – – –
β/ deg 96.930(7) 92.431(7) 117.157(7)
γ/ deg – – –
Volume / Å3 2733.4(4) 2156.1(3) 2429.1(3)
ρber / g · cm−3 1.498 1.670 1.619
F(000) 1288 1112 1216
Crystal Dimensions / mm 0.10 · 0.10 · 0.10 0.4 · 0.35 · 0.3 0.4 · 0.3 · 0.3
Z 4 4 4
Max. and min. Transmission – 1.00000, 0.68673 1.00000, 0.84124
µ / mm−1 1.156 1.453 1.298
θ-Range / deg 2.900 to 24.999 3.164 to 24.993 3.121 to 24.998
–17≤h≤17 –8≤h≤11 –18≤h≤18
Limiting indices –9≤k≤9 –7≤k≤10 –11≤k≤12
–26≤l≤26 –28≤l≤29 –20≤l≤20
Reflections Collected / Unique 22814 / 9551 7984 / 3801 11444 / 4270
Completeness to θmax / % 99.5 99.8 99.6
Restraints / Parameters 16 / 591 0 / 298 0 / 334
Rint 0.1117 0.0268 0.0222
R1, wR2 [I≥ 2σ(I)] 0.0679, 0.0825 0.0346, 0.0730 0.0675, 0.1637
R1, wR2 (all Data) 0.1636, 0.1003 0.0436, 0.0765 0.0762, 0.1719
Goodness-of-fit S 0.894 1.046 1.034
∆ρ / e−Å−3 0.514, –0.505 0.625, –0.488 0.950, –0.479
Absolute Structure Parameter 0.01(4) – –
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Table 5.6 Crystal-, collection- and refinement details for 52, 53 and 56.
Compound 52 53 56
CCDC Number 1474107 1474108 1474109
Empirical Formula C31H29Fe3O4P C32H31Fe3O4P C18H15O4P
Formula Weight / g·mol−1 664.06 678.09 326.27
Temperature / K 112.4(5) 111.8(2) 120.00(10)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Triclinic Monoclinic Orthorhombic
Space Group P 1¯ P21/c Pnm
a / Å 8.0069(5) 11.204(5) 13.5139(6)
b / Å 11.3428(11) 8.613(5) 16.1835(10)
c / Å 15.2484(14) 28.024(5) 7.1844(4)
α / deg 88.134(8) – –
β/ deg 76.822(7) 101.182(5) –
γ/ deg 78.953(6) – –
Volume / Å3 1323.3(2) 2653(2) 1571.24(15)
ρber / g · cm−3 1.667 1.698 1.379
F(000) 680 1392 680
Crystal Dimensions / mm 0.2 · 0.2 · 0.1 0.2 · 0.1 · 0.02 0.4 · 0.3 · 0.05
Z 2 4 4
Max. and min. Transmission 1.00000, 0.9513 1.00000, 0.73740 1.00000, 0.45363
µ / mm−1 1.721 1.718 0.193
θ-Range / deg 3.258 to 24.998 3.180 to 25.000 3.929 to 25.994
–9≤h≤9 –12≤h≤13 –16≤h≤14
Limiting indices –13≤k≤13 –10≤k≤10 –19≤k≤19
–18≤l≤18 –33≤l≤33 –8≤l≤7
Reflections Collected / Unique 7290 / 7290 16882 / 4664 4567 / 1589
Completeness to θmax / % 99.6 99.7 99.3
Restraints / Parameters 0 / 354 823 / 455 0 / 118
Rint – 0.0749 0.0473
R1, wR2 [I≥ 2σ(I)] 0.0409, 0.0772 0.0556, 0.1249 0.0465, 0.1099
R1, wR2 (all Data) 0.0653, 0.0812 0.0729, 0.1316 0.0646, 0.1206
Goodness-of-fit S 0.845 1.094 1.054
∆ρ / e−Å−3 0.646, –0.444 0.710, –0.559 0.287, –0.450
Absolute Structure Parameter – – –
286
Appendix H Crystallographic Data
Table 5.7 Crystal-, collection- and refinement details for 59a, 65b, and 67.
Compound 59a 65b 67
CCDC Number 1474111 1474112 1508130
Empirical Formula C26H23Fe2O4P C24H23FeO4P C31H27Fe2O4P
Formula Weight / g·mol−1 542.11 462.24 606.19
Temperature / K 110.6(2) 120.00(10) 114(3)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Monoclinic Monoclinic Triclinic
Space Group P21/c P21/c P 1¯
a / Å 13.4841(7) 9.1403(4) 7.3299(4)
b / Å 7.2373(4) 7.6690(5) 12.7651(8)
c / Å 23.0311(14) 28.9649(16) 15.0173(8)
α / deg – – 111.569(5)
β/ deg 106.700(6) 91.773(4) 97.970(4)
γ/ deg – – 94.641(4)
Volume / Å3 2152.8(2) 2029.38(19) 1280.77(13)
ρber / g · cm−3 1.673 1.513 1.572
F(000) 1112 960 624
Crystal Dimensions / mm 0.3 · 0.1 · 0.02 0.2 · 0.2 · 0.02 0.1 · 0.1 · 0.02
Z 4 4 2
Max. and min. Transmission 1.00000, 0.57123 1.00000, 0.88379 1.00000, 0.89351
µ / mm−1 1.455 0.852 1.233
θ-Range / deg 3.155 to 24.999 3.645 to 28.887 2.951 to 24.998
–16≤h≤15 –12≤h≤11 –8≤h≤8
Limiting indices –8≤k≤8 –10≤k≤10 –15≤k≤15
–27≤l≤27 –38≤l≤35 –17≤l≤15
Reflections Collected / Unique 11446 / 3778 9840 / 4556 7844 / 7844
Completeness to θmax / % 99.5 99.7 99.8
Restraints / Parameters 0 / 300 114 / 320 905 / 584
Rint 0.0693 0.0280 0.0749
R1, wR2 [I≥ 2σ(I)] 0.0516, 0.1036 0.0373, 0.0825 0.1138, 0.3270
R1, wR2 (all Data) 0.0827, 0.1137 0.0484, 0.0887 0.1718, 0.3500
Goodness-of-fit S 1.015 1.022 1.139
∆ρ / e−Å−3 1.338, –0.562 0.428, –0.328 0.38(4)
Absolute Structure Parameter – – –
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Table 5.8 Crystal-, collection- and refinement details for 69b, 70a and 71b.
Compound 69b 70a 71b · CHCl3
CCDC Number 1508131 1508132 1508133
Empirical Formula C32H29Fe2O4P C20H17Fe2O4P C31H23FeO4P · CHCl3
Formula Weight / g·mol−1 620.22 464.01 665.68
Temperature / K 115(8) 120.00(10) 120.00(10)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Triclinic Orthorhombic Orthorhombic
Space Group P 1¯ Fdd2 P212121
a / Å 11.1871(6) 37.5107(16) 10.4155(3)
b / Å 11.4582(8) 29.4085(15) 11.6395(4)
c / Å 12.6451(9) 6.2109(4) 23.3299(12)
α / deg 67.616(7) – –
β/ deg 83.493(5) – –
γ/ deg 62.541(6) – –
Volume / Å3 1326.08(17) 6851.5(6) 2828.31(19)
ρber / g · cm−3 1.553 1.799 1.563
F(000) 640 3776 1360
Crystal Dimensions / mm 0.10 · 0.05 · 0.05 0.25 · 0.18 · 0.15 0.3 · 0.3 · 0.2
Z 2 16 4
Max. and min. Transmission 1.00000, 0.79435 1.00000, 0.63392 1.00000, 0.81669
µ / mm−1 1.192 1.812 0.912
θ-Range / deg 3.190 to 24.998 3.396 to 25.000 3.150 to 25.998
–13≤h≤13 –32≤h≤44 –12≤h≤12
Limiting indices –11≤k≤13 –32≤k≤34 –9≤k≤14
–14≤l≤15 –7≤l≤5 –28≤l≤10
Reflections Collected / Unique 9547 / 4629 6036 / 2393 8885 / 5412
Completeness to θmax / % 99.5 99.6 99.7
Restraints / Parameters 0 / 354 1 / 244 0 / 371
Rint 0.0400 0.0642 0.0348
R1, wR2 [I≥ 2σ(I)] 0.0461, 0.1101 0.0316, 0.0616 0.0433, 0.0920
R1, wR2 (all Data) 0.0648, 0.1169 0.0400, 0.0640 0.0528, 0.0965
Goodness-of-fit S 1.032 1.039 1.024
∆ρ / e−Å−3 1.024, –0.384 0.382, –0.326 0.481, –0.420
Absolute Structure Parameter – –0.01(2) 0.012(16)
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Table 5.9 Crystal-, collection- and refinement details for 73, 76 and 80.
Compound 73 76 80
CCDC Number 1508134 1508135 1508137
Empirical Formula C22H29FeO4P C30H24Fe3O8P2 C28H24Fe2NO3P
Formula Weight / g·mol−1 444.27 741.98 565.15
Temperature / K 120.00(10) 120.00(10) 115.00(10)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Monoclinic Triclinic Monoclinic
Space Group P21 P 1¯ P21/c
a / Å 11.8102(2) 6.2344(4) 14.7934(9)
b / Å 10.9946(2) 7.6337(6) 10.0854(5)
c / Å 16.4247(3) 13.7942(9) 16.8952(11)
α / deg – 95.156(6) –
β/ deg 108.344(2) 91.298(5) 112.527(7)
γ/ deg – 97.059(6) –
Volume / Å3 2024.34(7) 648.50(8) 2328.4(3)
ρber / g · cm−3 1.458 1.900 1.612
F(000) 936 376 1160
Crystal Dimensions / mm 0.4 · 0.3 · 0.3 0.4 · 0.1 · 0.01 0.25 · 0.25 · 0.20
Z 4 1 4
Max. and min. Transmission 1.00000, 0.91165 1.00000, 0.92994 1.00000, 0.5350
µ / mm−1 0.850 1.837 1.348
θ-Range / deg 3.454 to 25.999 2.957 to 24.996 3.602 to 24.998
–14≤h≤13 –7≤h≤7 –17≤h≤17
Limiting indices –13≤k≤13 –9≤k≤8 –11≤k≤11
–20≤l≤19 –15≤l≤16 –12≤l≤20
Reflections Collected / Unique 17922 / 7731 4195 / 2277 10167 / 4067
Completeness to θmax / % 99.5 99.9 99.3
Restraints / Parameters 1 / 505 0 / 196 0 / 316
Rint 0.0269 0.0241 0.0508
R1, wR2 [I≥ 2σ(I)] 0.0322, 0.0847 0.0339, 0.0873 0.0483, 0.0967
R1, wR2 (all Data) 0.0344, 0.0863 0.0380, 0.0896 0.0773, 0.1058
Goodness-of-fit S 1.032 1.070 1.026
∆ρ / e−Å−3 0.297, –0.299 0.827, –0.401 0.608, –0.452
Absolute Structure Parameter 0.002(8) – –
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Table 5.10 Crystal-, collection- and refinement details for 81, 84 and 85.
Compound 81 84 · 0.9 CH2Cl2 85
CCDC Number 1508138 1508139 1508140
Empirical Formula C32H26Fe2NO3 C33H28Fe2NO3P · 0.9 CH2Cl2 C24H22Fe2NO3
Formula Weight / g·mol−1 615.21 705.67 515.09
Temperature / K 114(3) 112.8(6) 115.2(10)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Triclinic Triclinic Monoclinic
Space Group P 1¯ P 1¯ C2/c
a / Å 10.113(5) 10.3336(7) 51.278(8)
b / Å 10.722(5) 12.6046(10) 7.6986(8)
c / Å 13.199(5) 13.4915(18) 10.4339(12)
α / deg 106.582(5) 117.494(10) –
β/ deg 110.145(5) 95.558(8) 93.689(11)
γ/ deg 90.019(5) 96.286(6) –
Volume / Å3 1280.0(10) 1527.6(3) 4110.5(9)
ρber / g · cm−3 1.596 1.534 1.665
F(000) 632 724 2112
Crystal Dimensions / mm 0.23 · 0.15 · 0.01 0.40 · 0.35 · 0.30 0.10 · 0.01 · 0.01
Z 2 2 8
Max. and min. Transmission 1.00000, 0.78460 1.00000, 0.58117 1.00000, 0.4394
µ / mm−1 1.233 1.196 1.517
θ-Range / deg 3.008 to 25.000 3.323 to 24.999 3.629 to 24.993
–12≤h≤12 –12≤h≤12 –38≤h≤60
Limiting indices –12≤k≤12 –14≤k≤14 –9≤k≤8
–15≤l≤15 –16≤l≤15 –12≤l≤11
Reflections Collected / Unique 6100 / 6100 10217 / 5353 7967 / 3538
Completeness to θmax / % 99.6 99.5 97.9
Restraints / Parameters 676 / 408 4 / 417 0 / 281
Rint – 0.0369 0.0836
R1, wR2 [I≥ 2σ(I)] 0.0806, 0.2336 0.0777, 0.2109 0.0875, 0.1851
R1, wR2 (all Data) 0.1001, 0.2431 0.0954, 0.2253 0.1382, 0.2062
Goodness-of-fit S 1.029 1.053 1.059
∆ρ / e−Å−3 1.306, –1.013 1.778, –0.455 0.726, –0.496
Absolute Structure Parameter – – –
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Table 5.11 Crystal-, collection- and refinement details for 86, 91 and 96a.
Compound 86 · CHCl3 91 96a
CCDC Number 1508141 978226 1446860
Empirical Formula C28H24Fe2NO3P · CHCl3 C23H21FeOP C16H12FeN2O5
Formula Weight / g·mol−1 684.52 400.22 368.13
Temperature / K 115.00(10) 107.1(2) 110(2)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Monoclinic Monoclinic Triclinic
Space Group P21/n P21/c P 1¯
a / Å 14.5249(6) 8.1036(2) 7.6575(5)
b / Å 10.2459(5) 19.4551(4) 12.3403(8)
c / Å 19.6024(8) 12.1025(3) 16.1955(11)
α / deg – – 104.659(6)
β/ deg 107.309(4) 100.958(2) 92.163(5)
γ/ deg – – 98.373(5)
Volume / Å3 2785.1(2) 1873.25(8) 1460.35(17)
ρber / g · cm−3 1.632 1.1419 1.674
F(000) 1392 832 752
Crystal Dimensions / mm 0.40 · 0.20 · 0.02 0.40 · 0.40 · 0.20 0.3 · 0.3 · 0.2
Z 4 4 4
Max. and min. Transmission 1.00000, 0.41575 0.8407, 0.7150 1.00000, 0.87739
µ / mm−1 1.420 0.899 1.064
θ-Range / deg 2.991 to 24.998 2.99 to 25.99 2.961 to 25.000
–17≤h≤17 –9≤h≤9 –9≤h≤8
Limiting indices –12≤k≤11 –23≤k≤23 –14≤k≤14
–23≤l≤21 –14≤l≤14 –19≤l≤19
Reflections Collected / Unique 17318 / 4883 8695 / 3655 9912 / 9912
Completeness to θmax / % 99.5 99.6 99.4
Restraints / Parameters 674 / 413 0 / 236 0 / 434
Rint 0.0506 0.0240 –
R1, wR2 [I≥ 2σ(I)] 0.0418, 0.0861 0.0275, 0.0633 0.0397, 0.0830
R1, wR2 (all Data) 0.0612, 0.0924 0.0346, 0.0663 0.0507, 0.0880
Goodness-of-fit S 1.034 1.015 1.015
∆ρ / e−Å−3 0.407, –0.396 0.358, –0.233 0.586, –0.420
Absolute Structure Parameter – – –
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Table 5.12 Crystal-, collection- and refinement details for 96b, 99a and 99b.
Compound 96b 99a 99b
CCDC Number 1446861 1446863 1446864
Empirical Formula C16H13FeNO3 C26H20Fe2N2O6 C16H11FFeN2O5
Formula Weight / g·mol−1 323.12 568.14 386.12
Temperature / K 110 110 110
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Monoclinic Monoclinic Monoclinic
Space Group P21/n P21 P21/n
a / Å 11.065(3) 7.6777(6) 18.0108(4)
b / Å 10.792(2) 10.0784(6) 7.4492(2)
c / Å 11.8254(16) 14.2577(13) 22.7498(6)
α / deg – – –
β/ deg 107.86(2) 105.261(9) 107.779(2)
γ/ deg – – –
Volume / Å3 1344.1(5) 1064.34(15) 2906.48(13)
ρber / g · cm−3 1.597 1.773 1.765
F(000) 664 580 1568
Crystal Dimensions / mm 0.1 · 0.1 · 0.01 0.2 · 0.1 · 0.02 0.3 · 0.3 · 0.1
Z 4 2 8
Max. and min. Transmission 1.00000, 0.89467 0.972, 0.844 1.00000, 0.88683
µ / mm−1 1.131 1.414 1.083
θ-Range / deg 2.904 to 24.999 3.413 to 24.999 2.892 to 24.994
–8≤h≤13 –8≤h≤9 –21≤h≤21
Limiting indices –12≤k≤10 –9≤k≤11 –8≤k≤8
–14≤l≤11 –15≤l≤16 –27≤l≤27
Reflections Collected / Unique 4798 / 2356 6350 / 3045 14857 / 5109
Completeness to θmax / % 99.7 99.4 99.8
Restraints / Parameters 0 / 190 1 / 283 0 / 451
Rint 0.0536 0.0672 0.0314
R1, wR2 [I≥ 2σ(I)] 0.0483, 0.0790 0.0545, 0.1061 0.0354, 0.0773
R1, wR2 (all Data) 0.0779, 0.0878 0.0736, 0.1164 0.0496, 0.0822
Goodness-of-fit S 0.980 0.999 1.026
∆ρ / e−Å−3 0.466, –0.379 0.503, –0.783 0.503, –0.430
Absolute Structure Parameter – 0.22(4) –
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Table 5.13 Crystal-, collection- and refinement details for 99c, 100 and 103a.
Compound 99c 100 · CHCl3 103a
CCDC Number 1446865 1446866 1446867
Empirical Formula C18H17FeN3O5 C26H20Fe2N2O6 · CHCl3 C17H11F3FeN2O7S
Formula Weight / g·mol−1 411.19 687.51 500.19
Temperature / K 110 110(2) 110(2)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Orthorhombic Monoclinic Triclinic
Space Group P212121 C2/c P 1¯
a / Å 7.5258(7) 19.9437(9) 7.4788(5)
b / Å 10.2827(9) 9.7162(5) 8.7046(5)
c / Å 21.647(3) 28.3252(14) 14.8166(9)
α / deg – – 99.292(5)
β/ deg – 94.255(4) 92.546(5)
γ/ deg – – 105.141(5)
Volume / Å3 1675.1(3) 5473.6(5) 915.05(10)
ρber / g · cm−3 0.797 1.669 1.815
F(000) 848 2784 504
Crystal Dimensions / mm 0.4 · 0.2 · 0.01 0.4 · 0.3 · 0.2 0.3 · 0.2 · 0.1
Z 4 8 2
Max. and min. Transmission 0.991, 0.797 1.00000, 0.69295 1.00000, 0.76925
µ / mm−1 0.938 1.399 1.015
θ-Range / deg 3.297 to 24.996 2.884 to 25.498 3.044 to 25.499
–8≤h≤8 –24≤h≤22 –9≤h≤8
Limiting indices –4≤k≤12 –11≤k≤11 –9≤k≤10
–25≤l≤17 –34≤l≤34 –17≤l≤17
Reflections Collected / Unique 5577 / 2899 16021 / 5094 6303 / 3387
Completeness to θmax / % 99.5 99.8 99.6
Restraints / Parameters 0 / 190 0 / 392 0 / 280
Rint 0-0669 0.0364 0.0270
R1, wR2 [I≥ 2σ(I)] 0.0877, 0.1995 0.0357, 0.0857 0.0357, 0.0811
R1, wR2 (all Data) 0.1113, 0.2130 0.0462, 0.0911 0.0449, 0.0863
Goodness-of-fit S 1.028 1.062 1.048
∆ρ / e−Å−3 1.611, –1.796 0.581, –0.452 0.359, –0.434
Absolute Structure Parameter 0.50(2) – –
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Table 5.14 Crystal-, collection- and refinement details for 110a, 110b and 111a.
Compound 110a 110b 111a
CCDC Number 1491684 1491685 1491686
Empirical Formula C16H11F3FeO C26H20F2Fe2O2 C16H10F4FeO
Formula Weight / g·mol−1 332.10 514.12 350.09
Temperature / K 119.95(10) 120.00(10) 119.95(10)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Orthorhombic Monoclinic Monoclinic
Space Group Pnm P21/c P21/n
a / Å 19.3422(7) 15.3859(5) 9.9938(8)
b / Å 6.6879(3) 18.1868(5) 10.7044(9)
c / Å 10.2287(4) 11.8566(4) 12.2592(10)
α / deg – – –
β/ deg – 111.216(4) 96.973(7)
γ/ deg – – –
Volume / Å3 1323.17(9) 3092.85(19) 1301.76(19)
ρber / g · cm−3 1.667 1.656 1.786
F(000) 672 1572 704
Crystal Dimensions / mm 0.4 · 0.1 · 0.1 0.4 · 0.2 · 0.02 0.3 · 0.3 · 0.3
Z 4 6 4
Max. and min. Transmission 1.00000, 0.81777 1.00000, 0.6181 1.00000, 0.65555
µ / mm−1 1.169 1.447 1.204
θ-Range / deg 3.640 to 25.980 3.649 to 28.937 3.132 to 24.992
–22≤h≤23 –19≤h≤20 –11≤h≤11
Limiting indices –8≤k≤5 –24≤k≤22 –12≤k≤12
–12≤l≤8 –15≤l≤11 –13≤l≤14
Reflections Collected / Unique 4176 / 1409 16304 / 6978 5487 / 2280
Completeness to θmax / % 99.4 99.6 99.7
Restraints / Parameters 0 / 115 0 / 433 0 / 199
Rint 0.0207 0.0358 0.0390
R1, wR2 [I≥ 2σ(I)] 0.0644, 0.1587 0.0426, 0.0909 0.0366, 0.0910
R1, wR2 (all Data) 0.0689, 0.1636 0.0662, 0.1012 0.0423, 0.0940
Goodness-of-fit S 1.095 1.018 1.041
∆ρ / e−Å−3 0.783, –0.464 0.716, –0.647 0.523, –0.694
Absolute Structure Parameter – – –
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Table 5.15 Crystal-, collection- and refinement details for 112a, 112b and 117b.
Compound 112a 112b 117b
CCDC Number 1491687 1491688 1525592
Empirical Formula C16H9F5FeO C26H18F4Fe2O2 C31H39FeOPSi
Formula Weight / g·mol−1 368.08 550.10 542.53
Temperature / K 120.00(10) 112.8(2) 108(2)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Monoclinic Monoclinic Triclinic
Space Group P21/n P21/n P 1¯
a / Å 10.3964(4) 9.8166(3) 7.720(5)
b / Å 10.4918(4) 7.4008(3) 10.972(5)
c / Å 12.3964(4) 14.7097(6) 17.652(5)
α / deg – – 91.259(5)
β/ deg 99.464(3) 102.247(4) 99.143(5)
γ/ deg – – 107.072(5)
Volume / Å3 1333.76(8) 1044.35(7) 1407.4(12)
ρber / g · cm−3 1.833 1.749 1.280
F(000) 736 556 576
Crystal Dimensions / mm 0.2 · 0.1 · 0.1 0.4 · 0.4 · 0.2 0.25 · 0.25 · 0.02
Z 4 2 2
Max. and min. Transmission 1.00000, 0.76693 1.00000, 0.96488 1.00000, 0.67875
µ / mm−1 1.191 1.448 0.657
θ-Range / deg 3.403 to 24.999 4.193 to 25.998 2.94 to 25.50
–8≤h≤12 –11≤h≤12 –9≤h≤9
Limiting indices –12≤k≤11 –9≤k≤9 –13≤k≤13
–13≤l≤14 –13≤l≤18 –21≤l≤17
Reflections Collected / Unique 4945 / 2343 4047 / 2038 8969 / 5185
Completeness to θmax / % 99.5 99.5 98.7
Restraints / Parameters 0 / 208 0 / 154 0 / 322
Rint 0.0208 0.0224 0.0403
R1, wR2 [I≥ 2σ(I)] 0.0319, 0.0761 0.0284, 0.0625 0.0646, 0.1492
R1, wR2 (all Data) 0.0396, 0.0797 0.0344, 0.06551 0.0839, 0.1580
Goodness-of-fit S 1.089 1.072 1.073
∆ρ / e−Å−3 0.467, –0.437 0.294, –0.297 1.503, –0.511
Absolute Structure Parameter – – –
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Table 5.16 Crystal-, collection- and refinement details for 118q, 124 and 127.
Compound 118g 124 127
CCDC Number 1525943 1525944 1525945
Empirical Formula C16H22FeO C21H28FeO C28H24Fe
Formula Weight / g·mol−1 286.18 352.28 416.32
Temperature / K 112.3(3) 110(2) 110.3(5)
Wavelength / Å 0.71073 1.54184 0.71073
Crystal System Monoclinic Orthorhombic Monoclinic
Space Group P21/n P212121 P21/c
a / Å 10.7102(6) 7.7079(4) 23.946(5)
b / Å 7.5293(4) 8.5410(5) 8.927(5)
c / Å 17.0903(9) 26.6507(14) 20.292(5)
α / deg – – –
β/ deg 94.419(6) – 112.479(5)
γ/ deg – – –
Volume / Å3 1374.07(13) 1754.50(17) 4008(3)
ρber / g · cm−3 1.383 1.334 1.380
F(000) 608 752 1744
Crystal Dimensions / mm 0.2 · 0.1 · 0.1 0.4 · 0.02 · 0.02 0.2 · 0.2 · 0.15
Z 4 4 8
Max. and min. Transmission 1.00000, 0.38010 1.00000, 0.23357 1.00000, 0.81054
µ / mm−1 1.083 6.887 0.764
θ-Range / deg 3.816 to 25.000 3.317 to 64.487 3.508 to 24.999
–12≤h≤12 –9≤h≤7 –28≤h≤26
Limiting indices –8≤k≤8 –9≤k≤7 –10≤k≤10
–20≤l≤16 –31≤l≤30 –24≤l≤24
Reflections Collected / Unique 5493 / 2401) 5916 / 2715 19936 / 7037
Completeness to θmax / % 99.4 98.3 99.6
Restraints / Parameters 0 / 164 0 / 208 0 / 523
Rint 0.0576 0.0607 0.0348
R1, wR2 [I≥ 2σ(I)] 0.0486, 0.1214 0.0560, 0.1301 0.0622, 0.1622
R1, wR2 (all Data) 0.0598, 0.1288 0.0703, 0.1393 0.0762, 0.1727
Goodness-of-fit S 1.014 0.984 1.039
∆ρ / e−Å−3 0.834, –0.453 e. 0.682, –0.384 e 2.907, –0.523
Absolute Structure Parameter – 0.008(9) –
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Table 5.17 Crystal-, collection- and refinement details for 129, 134b and 134c.
Compound 129 134b 134c
CCDC Number 1525946 1525947 1525948
Empirical Formula C20H24FeO C37H48FeNO3P C55H60FeNO3P · C2H5OH
Formula Weight / g·mol−1 336.24 641.58 915.92
Temperature / K 110.00(10) 112.4(2) 114(10)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Monoclinic Monoclinic Monoclinic
Space Group I2 P21 P21
a / Å 12.8033(3) 7.3930(2) 11.856(4)
b / Å 12.4511(4) 10.3937(3) 11.260(3)
c / Å 19.1644(6) 21.3467(6) 18.383(3)
α / deg – – –
β/ deg 90.460(3) 92.463(3) 90.03(2)
γ/ deg – – –
Volume / Å3 3055.00(15) 1638.78(8) 2454.3(11)
ρber / g · cm−3 1.462 1.300 1.239
F(000) 1424 684 976
Crystal Dimensions / mm 0.2 · 0.2 · 0.18 0.25 · 0.2 · 0.1 0.12 · 0.10 · 0.01
Z 8 2 2
Max. and min. Transmission 1.00000, 0.74017 1.00000, 0.91533 1.00000, 0.61388
µ / mm−1 0.987 0.546 0.387
θ-Range / deg 3.585 to 25.000 3.384 to 24.993 3.337 to 24.998
–14≤h≤15 –8≤h≤8 –14≤h≤12
Limiting indices –14≤k≤9 –12≤k≤10 –13≤k≤13
–22≤l≤21 –25≤l≤25 –21≤l≤21
Reflections Collected / Unique 6105 / 3885 8098 / 4955 15314 / 7978
Completeness to θmax / % 99.4 99.5 97.6
Restraints / Parameters 1 / 399 1 / 388 1 / 578
Rint 0.0364 0.0241 0.0976
R1, wR2 [I≥ 2σ(I)] 0.0305, 0.0651 0.0313, 0.0655 0.0775, 0.1344
R1, wR2 (all Data) 0.0356, 0.0673 0.0350, 0.0668 0.1488, 0.1609
Goodness-of-fit S 0.998 1.036 0.956
∆ρ / e−Å−3 0.357, –0.387 0.201, –0.228 0.797, –0.424
Absolute Structure Parameter 0.5 0.007(10) –0.02(3)
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Table 5.18 Crystal-, collection- and refinement details for (E/E)-135, 136 and 138.
Compound (E,E)-135 136 138
CCDC Number 1525949 1525950 1525951
Empirical Formula C30H36Fe2N2 C37H50FeNO3P C25H17FeN
Formula Weight / g·mol−1 536.31 643.60 387.24
Temperature / K 120.00(10) 120.05(10) 119.95(10)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Monoclinic Triclinic Monoclinic
Space Group P21/n P1 P21/c
a / Å 10.6455(7) 12.1094(7) 10.0009(5)
b / Å 13.8398(8) 16.2782(9) 13.9488(8)
c / Å 34.351(2) 18.0207(10) 12.2166(7)
α / deg – 104.163(5) –
β/ deg 90.976(6) 93.995(5) 95.965(5)
γ/ deg – 95.691(5) –
Volume / Å3 5060.3(5) 3411.0(3) 1694.99(16)
ρber / g · cm−3 1.408 1.253 1.517
F(000) 2256 1376 800
Crystal Dimensions / mm 0.3 · 0.3 · 0.2 0.2 · 0.2 · 0.05 0.40 · 0.10 · 0.0
Z 8 4 4
Max. and min. Transmission 1.00000, 0.66355 1.00000, 0.52199 1.00000, 0.565
µ / mm−1 1.168 0.525 0.899
θ-Range / deg 2.944 to 24.999 2.960 to 24.999 3.353 to 24.998
–12≤h≤12 –13≤h≤14 –11≤h≤10
Limiting indices –16≤k≤16 –19≤k≤19 –16≤k≤16
–40≤l≤39 –21≤l≤19 –14≤l≤14
Reflections Collected / Unique 26359 / 8786 26338 / 17228 7225 / 2979
Completeness to θmax / % 98.5 99.6 99.6
Restraints / Parameters 126 / 671 2062 / 1565 0 / 244
Rint 0.0887 0.0501 0.0450
R1, wR2 [I≥ 2σ(I)] 0.1010, 0.2092 0.0812, 0.2244 0.0478, 0.0963
R1, wR2 (all Data) 0.1253, 0.2179 0.1019, 0.2425 0.0742, 0.1048
Goodness-of-fit S 1.079 1.028 1.014
∆ρ / e−Å−3 1.385, –1.119 0.899, –0.474 0.382, –0.283
Absolute Structure Parameter – 0.02(2) –
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Table 5.19 Crystal-, collection- and refinement details for (Sp,Sp)-149, (Sp)-150c and (Sp)-
151a.
Compound (Sp,Sp)-149 (Sp)-150c (Sp)-151a
CCDC Number 1525952 1525953 1525954
Empirical Formula C46H40Fe2P2S3 C30H27FePS C30H27FeOPS
Formula Weight / g·mol−1 862.60 506.39 522.39
Temperature / K 111.7(4) 114.90(14) 112.5(3)
Wavelength / Å 0.71073 0.71073 0.71073
Crystal System Tetragonal Orthorhombic Triclinic
Space Group P41212 P212121 P1
a / Å 8.1715(3) 8.9846(4) 7.7256(5)
b / Å – 14.1882(7) 8.4715(4)
c / Å 58.812(2) 19.1820(12) 10.1419(5)
α / deg – – 77.985(4)
β/ deg – – 71.170(5)
γ/ deg – – 83.905(5)
Volume / Å3 3927.1(3) 2445.2(2) 613.93(6)
ρber / g · cm−3 1.459 1.376 1.413
F(000) 1784 1056 272
Crystal Dimensions / mm 0.2 · 0.2 · 0.1 0.35 · 0.35 · 0.25 0.30 · 0.25 · 0.15
Z 4 4 1
Max. and min. Transmission 1.00000, 0.52635 1.00000, 0.5814 1.00000, 0.81925
µ / mm−1 1.013 0.784 0.786
θ-Range / deg 3.035 to 25.493 3.495 to 24.997 3.497 to 24.999
–7≤h≤9 –10≤h≤10 –9≤h≤9
Limiting indices –9≤k≤9 –16≤k≤11 –10≤k≤10
–71≤l≤71 –22≤l≤22 –12≤l≤12
Reflections Collected / Unique 16166 / 3622 10406 / 4248 5387 / 3559
Completeness to θmax / % 99.4 99.6 99.6
Restraints / Parameters 306 / 240 0 / 299 3 / 308
Rint 0.0963 0.0502 0.0236
R1, wR2 [I≥ 2σ(I)] 0.1051, 0.2174 0.0433, 0.0761 0.0463, 0.1111
R1, wR2 (all Data) 0.1118, 0.2202 0.0639, 0.0824 0.0483, 0.1129
Goodness-of-fit S 1.234 0.987 1.059
∆ρ / e−Å−3 0.734, –0.921 0.296, –0.239 0.542, –0.306
Absolute Structure Parameter 0.05(2) –0.033(15) 0.007(12)
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Table 5.20 Crystal-, collection- and refinement details for (Sp)-155 and (Sp)-159.
Compound (Sp)-155 (Sp)-159 · CH2Cl2
CCDC Number 1525955 1525956
Empirical Formula C29H23FeN2O4PS2 C34H37FeNO3P2S · CH2Cl2
Formula Weight / g·mol−1 614.43 742.42
Temperature / K 119.9(3) 119.9(2)
Wavelength / Å 1.54184 1.54184
Crystal System Orthorhombic Orthorhombic
Space Group P212121 P212121
a / Å 8.1644(8) 7.5912(15)
b / Å 25.333(5) 8.4182(9)
c / Å 25.871(3) 55.37(2)
α / deg – –
β/ deg – –
γ/ deg – –
Volume / Å3 5350.8(12) 3538.3(17)
ρber / g · cm−3 1.525 1.394
F(000) 2528 1544
Crystal Dimensions / mm 0.1 · 0.1 · 0.01 0.2 · 0.1 · 0.02
Z 8 4
Max. and min. Transmission 1.00000, 0.39233 1.00000, 0.47774
µ / mm−1 6.878 6.496
θ-Range / deg 3.837 to 64.487 4.792 to 64.497
–9≤h≤6 –8≤h≤8
Limiting indices –29≤k≤17 –5≤k≤9
–30≤l≤27 –64≤l≤63
Reflections Collected / Unique 12308 / 8117 8453 / 5263
Completeness to θmax / % 99.9 99.8
Restraints / Parameters 0 / 703 66 / 412
Rint 0.0884 0.0934
R1, wR2 [I≥ 2σ(I)] 0.0819, 0.1949 0.0889, 0.2042
R1, wR2 (all Data) 0.1425, 0.2440 0.1213, 0.2284
Goodness-of-fit S 0.952 1.028
∆ρ / e−Å−3 0.871, –0.671 0.930, –0.590
Absolute Structure Parameter –0.009(12) 0.049(12)
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